PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dunton, GF				Dunton, Genevieve F.			Sustaining Health-Protective Behaviors Such as Physical Activity and Healthy Eating	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		[Dunton, Genevieve F.] Univ Southern Calif, Dept Prevent Med, 2001 N Soto St,Third Floor,Room 302E,MC 9239, Los Angeles, CA 90033 USA; [Dunton, Genevieve F.] Univ Southern Calif, Dept Psychol, Los Angeles, CA USA	University of Southern California; University of Southern California	Dunton, GF (corresponding author), Univ Southern Calif, Dept Prevent Med, 2001 N Soto St,Third Floor,Room 302E,MC 9239, Los Angeles, CA 90033 USA.	dunton@usc.edu			NCI NIH HHS [P30 CA014089] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Lee-Kwan SH, 2017, MMWR-MORBID MORTAL W, V66, P1241, DOI 10.15585/mmwr.mm6645a1; Nahum-Shani I, 2018, ANN BEHAV MED, V52, P446, DOI 10.1007/s12160-016-9830-8; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2010 DIET GUID; Wood W., 2016, BEHAV SCI POLICY, V2, P71, DOI DOI 10.1353/BSP.2016.0008	7	61	60	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2018	320	7					639	640		10.1001/jama.2018.6621	http://dx.doi.org/10.1001/jama.2018.6621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR1XH	29852046	Green Accepted			2022-12-28	WOS:000442348100007
J	Lu, WY; Ridgwell, A; Thomas, E; Hardisty, DS; Luo, G; Algeo, TJ; Saltzman, MR; Gill, BC; Shen, YN; Ling, HF; Edwards, CT; Whalen, MT; Zhou, XL; Gutchess, KM; Jin, L; Rickaby, REM; Jenkyns, HC; Lyons, TW; Lenton, TM; Kump, LR; Lu, ZL				Lu, Wanyi; Ridgwell, Andy; Thomas, Ellen; Hardisty, Dalton S.; Luo, Genming; Algeo, Thomas J.; Saltzman, Matthew R.; Gill, Benjamin C.; Shen, Yanan; Ling, Hong-Fei; Edwards, Cole T.; Whalen, Michael T.; Zhou, Xiaoli; Gutchess, Kristina M.; Jin, Li; Rickaby, Rosalind E. M.; Jenkyns, Hugh C.; Lyons, Timothy W.; Lenton, Timothy M.; Kump, Lee R.; Lu, Zunli			Late inception of a resiliently oxygenated upper ocean	SCIENCE			English	Article							REDOX CONDITIONS; IODINE; EVOLUTION; MODEL; RISE; DEOXYGENATION; ELEMENT; RATIOS; PLANTS	Rising oceanic and atmospheric oxygen levels through time have been crucial to enhanced habitability of surface Earth environments. Few redox proxies can track secular variations in dissolved oxygen concentrations around threshold levels for metazoan survival in the upper ocean. We present an extensive compilation of iodine-to-calcium ratios (I/Ca) in marine carbonates. Our record supports a major rise in the partial pressure of oxygen in the atmosphere at similar to 400 million years (Ma) ago and reveals a step change in the oxygenation of the upper ocean to relatively sustainable near-modern conditions at similar to 200 Ma ago. An Earth system model demonstrates that a shift in organic matter remineralization to greater depths, which may have been due to increasing size and biomineralization of eukaryotic plankton, likely drove the I/Ca signals at similar to 200 Ma ago.	[Lu, Wanyi; Zhou, Xiaoli; Gutchess, Kristina M.; Lu, Zunli] Syracuse Univ, Dept Earth Sci, Syracuse, NY 13210 USA; [Ridgwell, Andy; Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Ridgwell, Andy] Univ Bristol, Sch Geog Sci, Bristol, Avon, England; [Thomas, Ellen] Yale Univ, Dept Geol & Geophys, New Haven, CT USA; [Thomas, Ellen] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT USA; [Hardisty, Dalton S.] Michigan State Univ, Dept Earth & Environm Sci, E Lansing, MI 48824 USA; [Luo, Genming; Algeo, Thomas J.] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan, Hubei, Peoples R China; [Luo, Genming; Algeo, Thomas J.] China Univ Geosci, Sch Earth Sci, Wuhan, Hubei, Peoples R China; [Algeo, Thomas J.] China Univ Geosci, State Key Lab Geol Proc & Mineral Resources, Wuhan, Hubei, Peoples R China; [Algeo, Thomas J.] Univ Cincinnati, Dept Geol, Cincinnati, OH USA; [Saltzman, Matthew R.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Gill, Benjamin C.] Virginia Polytech & State Univ, Dept Geosci, Blacksburg, VA USA; [Shen, Yanan] Univ Sci & Technol China, Sch Earth & Space Sci, Hefei, Anhui, Peoples R China; [Ling, Hong-Fei] Nanjing Univ, Sch Earth Sci & Engn, State Key Lab Mineral Deposits Res, Nanjing, Jiangsu, Peoples R China; [Edwards, Cole T.] Appalachian State Univ, Dept Geol & Environm Sci, Boone, NC 28608 USA; [Whalen, Michael T.] Univ Alaska, Dept Geosci, Fairbanks, AK 99701 USA; [Jin, Li] SUNY Coll Cortland, Dept Geol, Cortland, NY 13045 USA; [Rickaby, Rosalind E. M.; Jenkyns, Hugh C.] Univ Oxford, Dept Earth Sci, Oxford, England; [Lenton, Timothy M.] Univ Exeter, Coll Life & Environm Sci, Earth Syst Sci Grp, Exeter, Devon, England; [Kump, Lee R.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Syracuse University; University of California System; University of California Riverside; University of Bristol; Yale University; Wesleyan University; Michigan State University; China University of Geosciences; China University of Geosciences; China University of Geosciences; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; Virginia Polytechnic Institute & State University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing University; University of North Carolina; Appalachian State University; University of Alaska System; University of Alaska Fairbanks; State University of New York (SUNY) System; SUNY Cortland; University of Oxford; University of Exeter; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lu, ZL (corresponding author), Syracuse Univ, Dept Earth Sci, Syracuse, NY 13210 USA.	zunlilu@syr.edu	Whalen, Michael T/N-6503-2014; Gill, Benjamin C/B-8047-2012; Lenton, Tim M/X-1893-2018; Saltzman, Matthew R/B-6769-2011; Ridgwell, Andy/AAD-9487-2021; Ling, Hong-Fei/K-3362-2016; Lu, Wanyi/AFS-2639-2022; Shen, Yanan/L-3724-2018; Thomas, Ellen/E-5573-2011	Whalen, Michael T/0000-0003-0556-7471; Gill, Benjamin C/0000-0001-7402-0811; Lenton, Tim M/0000-0002-6725-7498; Saltzman, Matthew R/0000-0001-8052-1399; Ridgwell, Andy/0000-0003-2333-0128; Edwards, Cole/0000-0001-8472-7212; Shen, Yanan/0000-0001-8343-6763; Thomas, Ellen/0000-0002-7141-9904; Algeo, Thomas/0000-0002-3333-7035; Hardisty, Dalton/0000-0002-9434-081X; Lu, Wanyi/0000-0002-2837-654X; Rickaby, Rosalind/0000-0002-6095-8419	NSF [EAR-1349252, OCE-1232620, OCE-1736542, OCE-1736771, OCE-1736538]; NERC [NE/J01043X/1, ERC-2013-CoG-617313, NE/N018508/1, NE/P013643/1]; National Key RAMP;D Project of China [2016YFA0601104]; NSFC [41290260, 41330102, 41721002]; "111" project; Wolfson Research Merit award from the Royal Society; EU; NERC [NE/P013651/1] Funding Source: UKRI	NSF(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Key RAMP;D Project of China; NSFC(National Natural Science Foundation of China (NSFC)); "111" project(Ministry of Education, China - 111 Project); Wolfson Research Merit award from the Royal Society; EU(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We acknowledge funding from grants NSF EAR-1349252, OCE-1232620, and OCE-1736542 (Z.L.); NERC NE/J01043X/1, ERC-2013-CoG-617313, and NSF OCE-1736771 (A.R.); NSF OCE-1736538 (E.T.); National Key R&D Project of China 2016YFA0601104 and NSFC 41290260 (G.L.); NSFC 41330102 and 41721002 and the "111" project (Y.S.); Wolfson Research Merit award from the Royal Society and EU award (R.E.M.R.); and NERC NE/N018508/1 and NE/P013643/1 (T.M.L.).	Algeo T.J., 1995, GSA TODAY, V5, P64; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Butterfield NJ, 2009, GEOBIOLOGY, V7, P1, DOI 10.1111/j.1472-4669.2009.00188.x; Chance R, 2014, ENVIRON SCI-PROC IMP, V16, P1841, DOI 10.1039/c4em00139g; Dahl TW, 2010, P NATL ACAD SCI USA, V107, P17911, DOI 10.1073/pnas.1011287107; Edwards CT, 2018, EARTH PLANET SC LETT, V481, P125, DOI 10.1016/j.epsl.2017.10.002; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Glasspool IJ, 2010, NAT GEOSCI, V3, P627, DOI 10.1038/NGEO923; Hardisty DS, 2017, EARTH PLANET SC LETT, V463, P159, DOI 10.1016/j.epsl.2017.01.032; Hardisty DS, 2014, GEOLOGY, V42, P619, DOI 10.1130/G35439.1; Heim NA, 2015, SCIENCE, V347, P867, DOI 10.1126/science.1260065; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Katz ME, 2004, ANNU REV ECOL EVOL S, V35, P523, DOI 10.1146/annurev.ecolsys.35.112202.130137; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Knoll AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016121; KUMP LR, 1988, NATURE, V335, P152, DOI 10.1038/335152a0; Lenton TM, 2018, EARTH-SCI REV, V178, P1, DOI 10.1016/j.earscirev.2017.12.004; Lenton TM, 2016, P NATL ACAD SCI USA, V113, P9704, DOI 10.1073/pnas.1604787113; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; Loope GR, 2013, CHEM GEOL, V351, P195, DOI 10.1016/j.chemgeo.2013.05.014; Lu W, 2017, GEOCHEM PERSPECT LET, V5, P53, DOI 10.7185/geochemlet.1746; Lu W., 2018, TABLE S2 I CA RECORD; Lu ZL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11146; Lu ZL, 2010, GEOLOGY, V38, P1107, DOI 10.1130/G31145.1; LUTHER GW, 1991, DEEP-SEA RES, V38, pS875, DOI 10.1016/S0198-0149(10)80014-7; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; MARTIN RE, 1995, GLOBAL PLANET CHANGE, V11, P1, DOI 10.1016/0921-8181(94)00011-2; Meyer KM, 2016, GEOBIOLOGY, V14, P207, DOI 10.1111/gbi.12176; Payne JL, 2011, PHOTOSYNTH RES, V107, P37, DOI 10.1007/s11120-010-9593-1; Podder J, 2017, GEOCHIM COSMOCHIM AC, V198, P218, DOI 10.1016/j.gca.2016.11.032; Ridgwell A, 2007, BIOGEOSCIENCES, V4, P87, DOI 10.5194/bg-4-87-2007; Rue EL, 1997, DEEP-SEA RES PT I, V44, P113, DOI 10.1016/S0967-0637(96)00088-X; Sperling EA, 2015, NATURE, V523, P451, DOI 10.1038/nature14589; Zhou XL, 2015, PALEOCEANOGRAPHY, V30, P510, DOI 10.1002/2014PA002741; Zhou XL, 2014, PALEOCEANOGRAPHY, V29, P964, DOI 10.1002/2014PA002702	37	112	112	15	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2018	361	6398					174	177		10.1126/science.aar5372	http://dx.doi.org/10.1126/science.aar5372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8DY	29853552	Green Accepted, Green Submitted			2022-12-28	WOS:000438449200044
J	Yoon, J; Chang, E; Rubenstein, LV; Park, A; Zulman, DM; Stockdale, S; Ong, MK; Atkins, D; Schectman, G; Asch, SM				Yoon, Jean; Chang, Evelyn; Rubenstein, Lisa, V; Park, Angel; Zulman, Donna M.; Stockdale, Susan; Ong, Michael K.; Atkins, David; Schectman, Gordon; Asch, Steven M.			Impact of Primary Care Intensive Management on High-Risk Veterans' Costs and Utilization A Randomized Quality Improvement Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CENTERED MEDICAL HOME; HEALTH-CARE; OF-CARE; HOSPITALIZATION; IMPLEMENTATION; BENEFICIARIES; EXPENDITURES	Background: Primary care models that offer comprehensive, accessible care to all patients may provide insufficient resources to meet the needs of patients with complex conditions who have the greatest risk for hospitalization. Objective: To assess whether augmenting usual primary care with team-based intensive management lowers utilization and costs for high-risk patients. Design: Randomized quality improvement trial. (ClinicalTrials .gov: NCT03100526) Setting: 5 U.S. Department of Veterans Affairs (VA) medical centers. Patients: Primary care patients at high risk for hospitalization who had a recent acute care episode. Intervention: Locally tailored intensive management programs providing care coordination, goals assessment, health coaching, medication reconciliation, and home visits through an interdisciplinary team, including a physician or nurse practitioner, a nurse, and psychosocial experts. Measurements: Utilization and costs (including intensive management program expenses) 12 months before and after randomization. Results: 2210 patients were randomly assigned, 1105 to intensive management and 1105 to usual care. Patients had a mean age of 63 years and an average of 7 chronic conditions; 90% were men. Of the patients assigned to intensive management, 487 (44%) received intensive outpatient care (that is, >= 3 encounters in person or by telephone) and 204 (18%) received limited intervention. From the pre- to postrandomization periods, mean inpatient costs decreased more for the intensive management than the usual care group (-$2164 [95% CI, -$7916 to $3587]). Outpatient costs increased more for the intensive management than the usual care group ($2636 [CI, $524 to $4748]), driven by greater use of primary care, home care, telephone care, and telehealth. Mean total costs were similar in the 2 groups before and after randomization. Limitations: Sites took up to several months to contact eligible patients, limiting the time between treatment and outcome assessment. Only VA costs were assessed. Conclusion: High-risk patients with access to an intensive management program received more outpatient care with no increase in total costs.	[Yoon, Jean; Park, Angel] US Dept Vet Affairs, Hlth Econ Resource Ctr, Menlo Pk, CA USA; [Yoon, Jean; Zulman, Donna M.; Asch, Steven M.] US Dept Vet Affairs, Ctr Innovat Implementat, Menlo Pk, CA USA; [Yoon, Jean] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Chang, Evelyn; Ong, Michael K.] Univ Calif Los Angeles, US Dept Vet Affairs, Ctr Study Healthcare Innovat Implementat & Policy, Los Angeles, CA USA; [Chang, Evelyn; Ong, Michael K.] VA Greater Los Angeles Healthcare Syst, 11301 Wilshire Blvd,Bldg 500,Room 3213A, Los Angeles, CA 90073 USA; [Rubenstein, Lisa, V; Stockdale, Susan] Univ Calif Los Angeles, Los Angeles, CA USA; [Rubenstein, Lisa, V] RAND Corp, Santa Monica, CA USA; [Zulman, Donna M.; Stockdale, Susan; Asch, Steven M.] US Dept Vet Affairs, Ctr Study Healthcare Innovat Implementat & Policy, Menlo Pk, CA USA; [Zulman, Donna M.; Asch, Steven M.] Stanford Univ, Sch Med, Stanford, CA USA; [Atkins, David] US Dept Vet Affairs Hlth Serv Res & Dev, Washington, DC USA; [Schectman, Gordon] US Dept Vet Affairs Primare Care, Washington, DC USA; [Yoon, Jean; Park, Angel; Zulman, Donna M.; Asch, Steven M.] VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat, 795 Willow Rd,152 MPD, Menlo Pk, CA 94025 USA; [Chang, Evelyn] 11301 Wilshire Blvd,Dept Gen Internal Med 111G, Los Angeles, CA 90073 USA; [Rubenstein, Lisa, V] 801 North Foothill Rd, Medford, OR 97504 USA; [Stockdale, Susan] VA HSR&D Ctr Study Innovat Implementat & Policy, 16111 Plummer Ave,Bldg 25,Room A103, North Hills, CA 91343 USA; [Atkins, David] Hlth Serv Res & Dev, Dept Vet Affairs 10P9H,810 Vermont Ave Northwest, Washington, DC 20420 USA; [Schectman, Gordon] Vet Hlth Adm, Primary Care Program Off 10NC3, Washington, DC 20420 USA	US Department of Veterans Affairs; US Department of Veterans Affairs; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; US Department of Veterans Affairs; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; RAND Corporation; US Department of Veterans Affairs; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Yoon, J (corresponding author), US Dept Vet Affairs, Hlth Econ Resource Ctr, Menlo Pk, CA USA.; Yoon, J (corresponding author), US Dept Vet Affairs, Ctr Innovat Implementat, Menlo Pk, CA USA.; Yoon, J (corresponding author), VA Palo Alto Hlth Care Syst, Hlth Econ Resource Ctr, 795 Willow Rd 152 MPD, Menlo Pk, CA 94025 USA.; Yoon, J (corresponding author), VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat, 795 Willow Rd,152 MPD, Menlo Pk, CA 94025 USA.	jean.yoon@va.gov	Ong, Michael/AAR-3310-2020; Ong, Michael K/F-7397-2013	Ong, Michael/0000-0001-8530-7754; 	Veterans Health Administration Primary Care Services	Veterans Health Administration Primary Care Services	By the Veterans Health Administration Primary Care Services.	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bayliss EA, 2007, CHRONIC ILLN, V3, P167, DOI 10.1177/1742395307081501; Bell JF, 2015, HEALTH SERV RES, V50, P663, DOI 10.1111/1475-6773.12258; Berwick DM, 1996, BRIT MED J, V312, P619, DOI 10.1136/bmj.312.7031.619; Bodenheimer T, 2009, 19 ROB WOOD JOHNS FD; Bodenheimer T., 2013, STRATEGIES REDUCE CO; Bodenheimer T, 2009, NEW ENGL J MED, V361, P1521, DOI 10.1056/NEJMp0907185; Brown RS, 2012, HEALTH AFFAIR, V31, P1156, DOI 10.1377/hlthaff.2012.0393; Chang ET, 2018, CONTEMP CLIN TRIALS, V69, P65, DOI 10.1016/j.cct.2018.04.008; Chapko MK, 2009, HEALTH ECON, V18, P1188, DOI 10.1002/hec.1422; Counsell SR, 2006, J AM GERIATR SOC, V54, P1136, DOI 10.1111/j.1532-5415.2006.00791.x; Demakis JG, 2000, MED CARE, V38, pS17; Fox E., 2006, ETHICS CONSULTATION; Hebert PL, 2014, HEALTH AFFAIR, V33, P980, DOI 10.1377/hlthaff.2013.0893; Hempel S, 2015, BMJ QUAL SAF, V24, P796, DOI 10.1136/bmjqs-2014-003151; Higgins S, 2014, AM J MANAG CARE, V20, pE61; Hong CS, 2013, PRIMARY CARE INTEGRA; Leff B, 2009, AM J MANAG CARE, V15, P555; Long P., 2017, EFFECTIVE CARE HIGH; Lynn J, 2007, ANN INTERN MED, V146, P666, DOI 10.7326/0003-4819-146-9-200705010-00155; McCarthy D, 2015, MODELS CARE HIGH NEE; Nelson KM, 2014, JAMA INTERN MED, V174, P1350, DOI 10.1001/jamainternmed.2014.2488; Ogrinc G, 2008, QUAL SAF HEALTH CARE, V17, P13, DOI 10.1136/qshc.2008.029058; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Sledge William H, 2006, Dis Manag, V9, P328, DOI 10.1089/dis.2006.9.328; Veterans Health Administration, DOES YOUR HLTH EXP R; Veterans Health Administration Office of Research Oversight, 2009, VHA HDB 1004 01; Veterans Health Administration Office of Research Oversight, 2011, VHA HDB 1058 05 VHA; Wagner E H, 2001, Jt Comm J Qual Improv, V27, P63; Wang L, 2013, MED CARE, V51, P368, DOI 10.1097/MLR.0b013e31827da95a; Wong ES, 2016, J GEN INTERN MED, V31, P1467, DOI 10.1007/s11606-016-3833-9; Zulman DM, 2017, JAMA INTERN MED, V177, P166, DOI 10.1001/jamainternmed.2016.8021	32	32	32	7	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2018	168	12					846	+		10.7326/M17-3039	http://dx.doi.org/10.7326/M17-3039			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GK1TE	29868706				2022-12-28	WOS:000435903500014
J	Huttenlocker, AK; Grossnickle, DM; Kirkland, JI; Schultz, JA; Luo, ZX				Huttenlocker, Adam K.; Grossnickle, David M.; Kirkland, James, I; Schultz, Julia A.; Luo, Zhe-Xi			Late-surviving stem mammal links the lowermost Cretaceous of North America and Gondwana	NATURE			English	Article							VINTANA-SERTICHI MAMMALIA; CRANIAL ENDOCAST; EVOLUTION; TEETH; EAR; DISTRIBUTIONS; MORPHOLOGY; RELEVANCE	Haramiyida was a successful Glade of mammaliaforms, spanning the Late Triassic period to at least the Late Jurassic period, but their fossils are scant outside Eurasia and Cretaceous records are controversial(1-4). Here we report, to our knowledge, the first cranium of a large haramiyidan from the basal Cretaceous of North America. This cranium possesses an amalgam of stem mammaliaform plesiomorphies and crown mammalian apomorphies. Moreover, it shows dental traits that are diagnostic of isolated teeth of supposed multituberculate affinities from the Cretaceous of Morocco, which have been assigned to the enigmatic Hahnodontidae. Exceptional preservation of this specimen also provides insights into the evolution of the ancestral mammalian brain. We demonstrate the haramiyidan affinities of Gondwanan hahnodontid teeth, removing them from multituberculates, and suggest that hahnodontid mammaliaforms had a much wider, possibly Pangaean distribution during the Jurassic-Cretaceous transition.	[Huttenlocker, Adam K.] Univ Southern Calif, Dept Integrat Anat Sci, Los Angeles, CA 90007 USA; [Grossnickle, David M.; Luo, Zhe-Xi] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Kirkland, James, I] Utah Geol Survey, Salt Lake City, UT USA; [Kirkland, James, I] Nat Hist Museum Utah, Salt Lake City, UT USA; [Schultz, Julia A.; Luo, Zhe-Xi] Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA	University of Southern California; University of Chicago; University of Chicago	Huttenlocker, AK (corresponding author), Univ Southern Calif, Dept Integrat Anat Sci, Los Angeles, CA 90007 USA.	ahuttenlocker@gmail.com; zxluo@uchicago.edu	Luo, Zhe-XI/AAU-2263-2021		Utah Geological Survey	Utah Geological Survey	We thank R. Irmis, C. Levitt-Bussian and the Natural History Museum of Utah (UMNH); Utah Geological Survey, which funded the excavation and preparation of the specimen; A. R. C. Milner who discovered Andrew's Site (UMNH 1207); Utah Friends of Paleontology and volunteers who helped with excavation; Bureau of Land Management for permission (BLM permit #UTEX-05-031) and site supervision in 2005 under J. Cavin; J. Cavin for initial preparation and S. Madsen for final preparation of the specimen; T. Martin for the Paulchoffatia jaw from the Guimarota Mammals Collection (GUI MAM) illustrated in Fig. 2c; E. Hsu, S. Merchant and University of Utah Small Animal Imaging facility, Salt Lake City, for high-resolution X-ray computed tomography scanning; J. Lungmus and A. Neander for additional scanning at the University of Chicago PaleoCT; E. Seiffert (USC) for helpful comments. The specimen is housed at UMNH, Salt Lake City.	Anantharaman S, 2006, J VERTEBR PALEONTOL, V26, P488, DOI 10.1671/0272-4634(2006)26[488:APLCHF]2.0.CO;2; Bi SD, 2014, NATURE, V514, P579, DOI 10.1038/nature13718; Brikiatis L, 2016, EARTH-SCI REV, V159, P47, DOI 10.1016/j.earscirev.2016.05.002; Butler PM, 2000, ACTA PALAEONTOL POL, V45, P317; Butler PM, 2005, ACTA PALAEONTOL POL, V50, P185; Dunhill AM, 2016, J BIOGEOGR, V43, P1691, DOI 10.1111/jbi.12766; Gingerich P.D., 1984, SIZE SCALING PRIMATE, P257; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Grossnickle DM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2110; Hahn G., 1989, Geologica et Palaeontologica, V23, P205; Hahn G, 2003, ACTA PALAEONTOL POL, V48, P349; Hahn Gerhard, 2000, P97; Han G, 2017, NATURE, V551, P451, DOI 10.1038/nature24483; Harrison LB, 2015, SYST BIOL, V64, P307, DOI 10.1093/sysbio/syu098; Heinrich W.D., 1999, FOSS REC, V2, P159, DOI [10.1002/mmng.1999.4860020112, DOI 10.1002/MMNG.1999.4860020112]; Hoffmann S, 2014, J VERTEBR PALEONTOL, V34, P110, DOI 10.1080/02724634.2014.956878; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Krause DW, 2014, J VERTEBR PALEONTOL, V34, P14, DOI 10.1080/02724634.2014.976129; Krause DW, 2014, NATURE, V515, P512, DOI 10.1038/nature13922; LANGEVIN P, 1990, Mammalian Species, P1, DOI 10.2307/3504110; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Luo ZX, 2017, NATURE, V548, P326, DOI 10.1038/nature23483; Luo ZX, 2015, P NATL ACAD SCI USA, V112, pE7101, DOI 10.1073/pnas.1519387112; Luo ZX, 2015, SCIENCE, V347, P760, DOI 10.1126/science.1260880; Macrini TE, 2007, J MORPHOL, V268, P844, DOI 10.1002/jmor.10556; Macrini TE, 2007, ANAT REC, V290, P875, DOI 10.1002/ar.20551; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; Meng J, 2018, J MORPHOL, V279, P441, DOI 10.1002/jmor.20565; Meng QJ, 2017, NATURE, V548, P291, DOI 10.1038/nature23476; Millien V, 2010, J MAMMAL, V91, P11, DOI 10.1644/08-MAMM-A-347R1.1; Rodrigues PG, 2014, PALAEONTOL Z, V88, P329, DOI 10.1007/s12542-013-0200-6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe TB, 1986, THESIS; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Ruf I, 2013, J VERTEBR PALEONTOL, V33, P382, DOI 10.1080/02724634.2013.722575; Sigogneau-Russell D., 1991, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1991, P119; Wagner PJ, 2012, BIOL LETTERS, V8, P143, DOI 10.1098/rsbl.2011.0523; Zheng XT, 2013, NATURE, V500, P199, DOI 10.1038/nature12353; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429	40	50	52	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					108	+		10.1038/s41586-018-0126-y	http://dx.doi.org/10.1038/s41586-018-0126-y			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29795343				2022-12-28	WOS:000434273300046
J	Marczak, L; Williams, J; Loeffler, M				Marczak, Laurie; Williams, Joan; Loeffler, Michaela			Global Deaths Attributable to High Systolic Blood Pressure, 1990-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Marczak, Laurie; Williams, Joan; Loeffler, Michaela] Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation	Marczak, L (corresponding author), Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.			Marczak, Laurie/0000-0001-5979-4261					0	7	14	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2163	2163		10.1001/jama.2018.5119	http://dx.doi.org/10.1001/jama.2018.5119			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29872847	Bronze			2022-12-28	WOS:000434133400005
J	Chen, MK; Rohla, R				Chen, M. Keith; Rohla, Ryne			The effect of partisanship and political advertising on close family ties	SCIENCE			English	Article							POLARIZATION; PERCEPTION	Research on growing American political polarization and antipathy primarily studies public institutions and political processes, ignoring private effects, including strained family ties. Using anonymized smartphone-location data and precinct-level voting, we show that Thanksgiving dinners attended by residents from opposing-party precincts were 30 to 50 minutes shorter than same-party dinners. This decline from a mean of 257 minutes survives extensive spatial and demographic controls. Reductions in the duration of Thanksgiving dinner in 2016 tripled for travelers from media markets with heavy political advertising-an effect not observed in 2015-implying a relationship to election-related behavior. Effects appear asymmetric: Although fewer Democratic-precinct residents traveledin 2016 than in 2015, Republican-precinct residents shortened their Thanksgiving dinners by more minutes in response to political differences. Nationwide, 34 million hours of cross-partisan Thanksgiving dinner discourse were lost in 2016 owing to partisan effects.	[Chen, M. Keith] Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA 90095 USA; [Rohla, Ryne] Washington State Univ, Sch Econ Sci, Pullman, WA 99164 USA	University of California System; University of California Los Angeles; Washington State University	Chen, MK (corresponding author), Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA 90095 USA.	keith.chen@anderson.ucla.edu						Alford JR, 2011, J POLIT, V73, P362, DOI 10.1017/S0022381611000016; Ansolabenhere S., 1996, GOING NEGATIVE POLIT; Bakshy E, 2015, SCIENCE, V348, P1130, DOI 10.1126/science.aaa1160; Frimer JA, 2017, J EXP SOC PSYCHOL, V72, P1, DOI 10.1016/j.jesp.2017.04.003; Iyengar S, 2015, AM J POLIT SCI, V59, P690, DOI 10.1111/ajps.12152; Iyengar S, 2012, PUBLIC OPIN QUART, V76, P405, DOI 10.1093/poq/nfs038; Levendusky M, 2016, POLIT COMMUN, V33, P283, DOI 10.1080/10584609.2015.1038455; McConnell C, 2018, AM J POLIT SCI, V62, P5, DOI 10.1111/ajps.12330; Motyl M, 2014, J EXP SOC PSYCHOL, V51, P1, DOI 10.1016/j.jesp.2013.10.010; Oliphant B., 2016, AM ARE TALK TRUMPS E; Perez-Truglia R, 2017, J POLIT ECON, V125, P1208, DOI 10.1086/692711; Pew Research Center, 2016, PARTISANSHIP POLITIC; Rainie L., 2017, 10 FACTS SMARTPHONES; ROBINSON RJ, 1995, J PERS SOC PSYCHOL, V68, P404, DOI 10.1037/0022-3514.68.3.404; Rodriguez C.G., 2017, TRANSLATIONAL ISSUES, V3, P254, DOI [10.1037/tps0000121, DOI 10.1037/TPS0000121]; ROSS L, 1977, J EXP SOC PSYCHOL, V13, P279, DOI 10.1016/0022-1031(77)90049-X; Sunstein CR, 2002, J POLIT PHILOS, V10, P175, DOI 10.1111/1467-9760.00148; Tavernise S, 2016, NY TIMES; Zubak-Skees C., 2016, TRACK TV ADS 2016 PR	19	71	71	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					1020	1023		10.1126/science.aaq1433	http://dx.doi.org/10.1126/science.aaq1433			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6SL	29853686	Green Submitted			2022-12-28	WOS:000433574200043
J	Scheib, CL; Li, HJ; Desai, T; Link, V; Kendall, C; Dewar, G; Griffith, PW; Morseburg, A; Johnson, JR; Potter, A; Kerr, SL; Endicott, P; Lindo, J; Haber, M; Xue, YL; Tyler-Smith, C; Sandhu, MS; Lorenz, JG; Randall, TD; Faltyskova, Z; Pagani, L; Danecek, P; O'Connell, TC; Martz, P; Boraas, AS; Byrd, BF; Leventhal, A; Cambra, R; Williamson, R; Lesage, L; Holguin, B; Soto, EYD; Rosas, J; Metspalu, M; Stock, JT; Manica, A; Scally, A; Wegmann, D; Malhi, RS; Kivisild, T				Scheib, C. L.; Li, Hongjie; Desai, Tariq; Link, Vivian; Kendall, Christopher; Dewar, Genevieve; Griffith, Peter William; Morseburg, Alexander; Johnson, John R.; Potter, Amiee; Kerr, Susan L.; Endicott, Phillip; Lindo, John; Haber, Marc; Xue, Yali; Tyler-Smith, Chris; Sandhu, Manjinder S.; Lorenz, Joseph G.; Randall, Tori D.; Faltyskova, Zuzana; Pagani, Luca; Danecek, Petr; O'Connell, Tamsin C.; Martz, Patricia; Boraas, Alan S.; Byrd, Brian F.; Leventhal, Alan; Cambra, Rosemary; Williamson, Ronald; Lesage, Louis; Holguin, Brian; Soto, Ernestine Ygnacio-De; Rosas, JohnTommy; Metspalu, Mait; Stock, Jay T.; Manica, Andrea; Scally, Aylwyn; Wegmann, Daniel; Malhi, Ripan S.; Kivisild, Toomas			Ancient human parallel lineages within North America contributed to a coastal expansion	SCIENCE			English	Article							POPULATION HISTORY; GENOME; CLOVIS; AGE; INDIVIDUALS; ANCESTRY; SEQUENCE; SITE	Little is known regarding the first people to enter the Americas and their genetic legacy. Genomic analysis of the oldest human remains from the Americas showed a direct relationship between a Clovis-related ancestral population and all modern Central and South Americans as well as a deep split separating them from North Americans in Canada. We present 91 ancient human genomes from California and Southwestern Ontario and demonstrate the existence of two distinct ancestries in North America, which possibly split south of the ice sheets. A contribution from both of these ancestral populations is found in all modern Central and South Americans. The proportions of these two ancestries in ancient and modern populations are consistent with a coastal dispersal and multiple admixture events.	[Scheib, C. L.; Griffith, Peter William; Morseburg, Alexander; Faltyskova, Zuzana; O'Connell, Tamsin C.; Stock, Jay T.; Kivisild, Toomas] Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England; [Pagani, Luca; Metspalu, Mait; Kivisild, Toomas] Univ Tartu, Inst Genom, Estonian Bioctr, EE-51010 Tartu, Estonia; [Malhi, Ripan S.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Li, Hongjie; Malhi, Ripan S.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Desai, Tariq; Scally, Aylwyn] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Link, Vivian; Wegmann, Daniel] Univ Fribourg, Dept Biol, Fribourg, Switzerland; [Kendall, Christopher; Dewar, Genevieve] Univ Toronto, Dept Anthropol, Toronto, ON M5S 2S2, Canada; [Johnson, John R.] Santa Barbara Museum Nat Hist, Santa Barbara, CA 93105 USA; [Potter, Amiee] Portland State Univ, Dept Anthropol, Portland, OR 97232 USA; [Potter, Amiee] Oregon Hlth & Sci Univ, Knight Diagnost Lab, Portland, OR 97239 USA; [Kerr, Susan L.] Modesto Jr Coll, Dept Anthropol, Modesto, CA 95350 USA; [Endicott, Phillip] Musee Homme Paris, Dept Hommes Nat Soc, F-75016 Paris, France; [Lindo, John] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Haber, Marc; Xue, Yali; Tyler-Smith, Chris; Sandhu, Manjinder S.; Danecek, Petr] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, England; [Lorenz, Joseph G.] Cent Washington Univ, Dept Anthropol & Museum Studies, Ellensburg, WA 98926 USA; [Randall, Tori D.] San Diego City Coll, Dept Anthropol, San Diego, CA 92101 USA; [Pagani, Luca] Univ Padua, Dept Biol, APE Lab, Padua, Italy; [Martz, Patricia] Calif State Univ Los Angeles, Dept Anthropol, Los Angeles, CA 90032 USA; [Boraas, Alan S.] Kenai Peninsula Coll, Soldotna, AK 99669 USA; [Byrd, Brian F.] Far Western Anthropol Res Grp Inc, Davis, CA 95618 USA; [Leventhal, Alan; Cambra, Rosemary] Muwekma Ohlone Tribe San Francisco Bay Area, POB 360791, Milpitas, CA 95036 USA; [Leventhal, Alan] San Jose State Univ, Dept Anthropol, San Jose, CA 95192 USA; [Williamson, Ronald] Archaeol Serv Inc, Toronto, ON, Canada; [Lesage, Louis] Huron Wendat Nation, Quebec City, PQ, Canada; [Holguin, Brian] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA; [Soto, Ernestine Ygnacio-De] Santa Barbara Museum Nat Hist, Calif Indian Advisory Comm, Barbareno Chumash, Chumash, CA 93105 USA; [Rosas, JohnTommy] Tongva Nation, Chumash, CA USA; [Stock, Jay T.] Univ Western Ontario, Dept Anthropol, London, ON N6A 3K7, Canada; [Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge; Estonian Biocentre; University of Tartu; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Cambridge; University of Fribourg; University of Toronto; Portland State University; Oregon Health & Science University; Museum National d'Histoire Naturelle (MNHN); Emory University; Wellcome Trust Sanger Institute; Central Washington University; University of Padua; California State University System; California State University Los Angeles; California State University System; San Jose State University; University of California System; University of California Los Angeles; Western University (University of Western Ontario); University of Cambridge	Scheib, CL; Kivisild, T (corresponding author), Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England.; Kivisild, T (corresponding author), Univ Tartu, Inst Genom, Estonian Bioctr, EE-51010 Tartu, Estonia.; Malhi, RS (corresponding author), Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA.; Malhi, RS (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.	cls83@ut.ee; malhi@illinois.edu; tk331@cam.ac.uk	Scheib, Christiana/AAE-3886-2021; Stock, Jay T/B-6453-2011; Manica, Andrea/N-9013-2019; Manica, Andrea/B-5497-2008; Haber, Marc/Y-5090-2019; Lindo, John/R-5833-2019; Kendall, Christopher/J-7673-2019; Pagani, Luca/G-8511-2017; Wegmann, Daniel/K-2199-2012	Scheib, Christiana/0000-0003-4158-8296; Stock, Jay T/0000-0003-0147-8631; Manica, Andrea/0000-0003-1895-450X; Manica, Andrea/0000-0003-1895-450X; Haber, Marc/0000-0003-1000-1448; Kendall, Christopher/0000-0003-2252-0106; Pagani, Luca/0000-0002-6639-524X; O'Connell, Tamsin/0000-0002-4744-0332; Desai, Tariq/0000-0002-6981-3937; Dewar, Genevieve/0000-0003-3202-4720; Gerber, Zuzana/0000-0003-0846-3619; Wegmann, Daniel/0000-0003-2866-6739; Endicott, Phillip/0000-0003-2452-8507; Johnson, John/0000-0002-3920-9923; Griffith, Peter/0000-0003-2230-0808; Morseburg, Alexander/0000-0003-4832-4007	European Research Council [FP7-261213, FP7-617627, 647787]; Natural Environment Research Council (NERC) [NF/2016/1/6]; Economic and Social Research Council [RG76702]; NSF [BCS-1518026, SMA-1620239]; Wellcome grant [098051]; European Union through European Regional Development Fund [2014-2020.4.01.16-0024]; NERC [NRCF010002] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NSF(National Science Foundation (NSF)); Wellcome grant; European Union through European Regional Development Fund; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by European Research Council Starting Investigator grant FP7-261213 (T.K.); Natural Environment Research Council (NERC) Radiocarbon Facility grant NF/2016/1/6 (T.K. and C.L.S.); the Economic and Social Research Council Impact Accelerator Award RG76702 (C.L.S.); NSF grants BCS-1518026 and SMA-1620239 (R.S.M.); European Research Council Consolidator Grant FP7-617627 (J.T.S.); Wellcome grant 098051 (M.H., Y.X., C.T.-S., M.S.S., and P.D.); the European Union through European Regional Development Fund project no. 2014-2020.4.01.16-0024, MOBTT53 (L.P.); and European Research Council Consolidator Grant 647787 "Local Adaptation" (A. Ma.).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Dillehay TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141923; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Johnson J. R., 2002, P 5 CAL ISL S, V5, P541; Kerr S. L., 1999, 5 CAL ISL S SANT BAR, P546; Kousathanas A, 2017, GENETICS, V205, P317, DOI 10.1534/genetics.116.189985; Lindo J, 2017, P NATL ACAD SCI USA, V114, P4093, DOI 10.1073/pnas.1620410114; Lorenz J. G., 2006, J CALIFORNIA GREAT B, V26, P33; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Martz P., 2008, P 6 CAL ISL S SANT B, P65; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Skoglund P, 2015, NATURE, V525, P104, DOI 10.1038/nature14895; Verdu P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004530; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Waters MR, 2015, P NATL ACAD SCI USA, V112, P4263, DOI 10.1073/pnas.1420650112; Waters MR, 2011, SCIENCE, V331, P1599, DOI 10.1126/science.1201855; [No title captured]	27	57	60	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					1024	1027		10.1126/science.aar6851	http://dx.doi.org/10.1126/science.aar6851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6SL	29853687	Green Submitted			2022-12-28	WOS:000433574200044
J	Abu-Shama, Y; Cuny, T				Abu-Shama, Yazan; Cuny, Thomas			Pemberton's Sign in a Patient with a Goiter	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Abu-Shama, Yazan] Univ Hosp Nancy, Nancy, France; [Cuny, Thomas] Univ Hosp Marseille, Marseille, France	CHU de Nancy; Universite de Lorraine; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Cuny, T (corresponding author), Univ Hosp Marseille, Marseille, France.	thomas.cuny@ap-hm.fr	CUNY, Thomas/ABG-4498-2020	CUNY, Thomas/0000-0002-8440-0030					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2018	378	22							e31	10.1056/NEJMicm1712263	http://dx.doi.org/10.1056/NEJMicm1712263			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH5AL	29847764				2022-12-28	WOS:000433428000012
J	Pratilas, GC; Dinas, K				Pratilas, Georgios C.; Dinas, Konstantinos			Severe Vulvovaginal Varicosities in Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pratilas, Georgios C.; Dinas, Konstantinos] Aristotle Univ Thessaloniki, Med Sch, Thessaloniki, Greece	Aristotle University of Thessaloniki	Pratilas, GC (corresponding author), Aristotle Univ Thessaloniki, Med Sch, Thessaloniki, Greece.	georgepratilas978@gmail.com		Pratilas, Georgios Chrysostomos/0000-0002-4491-5857					0	2	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2018	378	22					2123	2123		10.1056/NEJMicm1715053	http://dx.doi.org/10.1056/NEJMicm1715053			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH5AL	29847756				2022-12-28	WOS:000433428000011
J	Bindeman, IN; Zakharov, DO; Palandri, J; Greber, ND; Dauphas, N; Retallack, GJ; Hofmann, A; Lackey, JS; Bekker, A				Bindeman, I. N.; Zakharov, D. O.; Palandri, J.; Greber, N. D.; Dauphas, N.; Retallack, G. J.; Hofmann, A.; Lackey, J. S.; Bekker, A.			Rapid emergence of subaerial landmasses and onset of a modern hydrologic cycle 2.5 billion years ago	NATURE			English	Article							GREAT OXIDATION EVENT; OXYGEN-ISOTOPE FRACTIONATION; CONTINENTAL-CRUST; GREENSTONE-BELT; ZIRCON AGE; PALEOPROTEROZOIC GLACIATIONS; ATMOSPHERIC OXYGEN; TECTONIC EVOLUTION; SOUTH-AFRICA; CONSTRAINTS	The history of the growth of continental crust is uncertain, and several different models that involve a gradual, decelerating, or stepwise process have been proposed(1-4). Even more uncertain is the timing and the secular trend of the emergence of most landmasses above the sea (subaerial landmasses), with estimates ranging from about one billion to three billion years ago(5-7). The area of emerged crust influences global climate feedbacks and the supply of nutrients to the oceans(8), and therefore connects Earth's crustal evolution to surface environmental conditions(9-11). Here we use the triple-oxygen-isotope composition of shales from all continents, spanning 3.7 billion years, to provide constraints on the emergence of continents over time. Our measurements show a stepwise total decrease of 0.08 per mille in the average triple-oxygen-isotope value of shales across the Archaean-Proterozoic boundary. We suggest that our data are best explained by a shift in the nature of water-rock interactions, from near-coastal in the Archaean era to predominantly continental in the Proterozoic, accompanied by a decrease in average surface temperatures. We propose that this shift may have coincided with the onset of a modern hydrological cycle owing to the rapid emergence of continental crust with near-modern average elevation and aerial extent roughly 2.5 billion years ago.	[Bindeman, I. N.; Zakharov, D. O.; Palandri, J.; Retallack, G. J.] Univ Oregon, Dept Earth Sci, Eugene, OR 97403 USA; [Greber, N. D.] Univ Geneva, Dept Earth Sci, Geneva, Switzerland; [Dauphas, N.] Univ Chicago, Dept Geophys Sci, Origins Lab, 5734 S Ellis Ave, Chicago, IL 60637 USA; [Dauphas, N.] Univ Chicago, Enrico Fermi Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Hofmann, A.; Bekker, A.] Univ Johannesburg, Dept Geol, Auckland Pk, South Africa; [Lackey, J. S.] Pomona Coll, Dept Geol, Claremont, CA 91711 USA; [Bekker, A.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA	University of Oregon; University of Geneva; University of Chicago; University of Chicago; University of Johannesburg; Claremont Colleges; Pomona College; University of California System; University of California Riverside	Bindeman, IN (corresponding author), Univ Oregon, Dept Earth Sci, Eugene, OR 97403 USA.	bindeman@uoregon.edu	Bindeman, Ilya N/D-2497-2012	Bindeman, Ilya N/0000-0003-2778-9083; Greber, Nicolas D./0000-0002-2209-3784; Lackey, Jade Star/0000-0001-6326-1898; Hofmann, Axel/0000-0002-8801-0443; Bekker, Andrey/0000-0002-1154-0585	National Science Foundation (NSF) [EAR1447337]; University of Oregon; NSF [EAR1502591]; National Sciences and Engineering Research Council (NSERC)	National Science Foundation (NSF)(National Science Foundation (NSF)); University of Oregon; NSF(National Science Foundation (NSF)); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Science Foundation (NSF) grant EAR1447337 and by the University of Oregon. N.D. was supported by NSF grant EAR1502591. A.B. was supported by National Sciences and Engineering Research Council (NSERC) Discovery and Accelerator grants. We thank P. Hoffman, S. Mertanen and D. Evans for discussions about Precambrian palaeogeography and environmental changes; K. Johnson for technical help with vacuum lines; and O. Melnik for help with programming.	Addison WD, 2010, GEOL SOC AM SPEC PAP, V465, P245, DOI 10.1130/2010.2465(16); ARMSTRONG RA, 1991, PRECAMBRIAN RES, V53, P243, DOI 10.1016/0301-9268(91)90074-K; Bao HMZ, 2016, ANNU REV EARTH PL SC, V44, P463, DOI 10.1146/annurev-earth-060115-012340; Barley ME, 2005, EARTH PLANET SC LETT, V238, P156, DOI 10.1016/j.epsl.2005.06.062; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; BELL MA, 1982, PALEOBIOLOGY, V8, P282, DOI 10.1017/S0094837300006990; Belousova EA, 2010, LITHOS, V119, P457, DOI 10.1016/j.lithos.2010.07.024; Bindeman IN, 2016, EARTH PLANET SC LETT, V437, P101, DOI 10.1016/j.epsl.2015.12.029; Bleeker W, 2003, LITHOS, V71, P99, DOI 10.1016/j.lithos.2003.07.003; Byerly GR, 1996, PRECAMBRIAN RES, V78, P125, DOI 10.1016/0301-9268(95)00073-9; Campbell A. S., 1944, Geological Society of America Special Paper, V51, P1; Condie K.C., 2013, PLATE TECTONICS CRUS; Cullers RL, 2002, PRECAMBRIAN RES, V117, P157, DOI 10.1016/S0301-9268(02)00079-7; Dhuime B, 2015, NAT GEOSCI, V8, P552, DOI [10.1038/ngeo2466, 10.1038/NGEO2466]; Farquhar J, 2005, GEOL SOC SPEC PUBL, V248, P167, DOI 10.1144/GSL.SP.2005.248.01.09; Flament N, 2008, EARTH PLANET SC LETT, V275, P326, DOI 10.1016/j.epsl.2008.08.029; Frieling J, 2014, GEOLOGY, V42, P767, DOI 10.1130/G35724.1; Gaschnig RM, 2016, GEOCHIM COSMOCHIM AC, V186, P316, DOI 10.1016/j.gca.2016.03.020; Greber ND, 2017, SCIENCE, V357, P1271, DOI 10.1126/science.aan8086; Gumsley AP, 2017, P NATL ACAD SCI USA, V114, P1811, DOI 10.1073/pnas.1608824114; Hawkesworth CJ, 2017, ANNU REV EARTH PL SC, V45, P169, DOI 10.1146/annurev-earth-063016-020525; Hoffman PF, 2013, CHEM GEOL, V362, P143, DOI 10.1016/j.chemgeo.2013.04.018; Hofmann A, 2003, GEOCHIM COSMOCHIM AC, V67, P421, DOI 10.1016/S0016-7037(02)01086-4; Javaux EJ, 2010, NATURE, V463, P934, DOI 10.1038/nature08793; Kah LC, 1999, CAN J EARTH SCI, V36, P313, DOI 10.1139/e98-100; Keller CB, 2015, NATURE, V523, P301, DOI 10.1038/nature14584; Key RM, 2001, J AFR EARTH SCI, V33, P503, DOI 10.1016/S0899-5362(01)00098-7; Kipp MA, 2017, P NATL ACAD SCI USA, V114, P875, DOI 10.1073/pnas.1615867114; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; Korenaga J, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2015.0393; Kositcin N, 2004, PRECAMBRIAN RES, V129, P141, DOI 10.1016/j.precamres.2003.10.011; Land LS, 1996, GEOCHIM COSMOCHIM AC, V60, P3347, DOI 10.1016/0016-7037(96)00185-8; Lee CTA, 2018, INT GEOL REV, V60, P431, DOI 10.1080/00206814.2017.1340853; LIU DY, 1992, GEOLOGY, V20, P339, DOI 10.1130/0091-7613(1992)020<0339:ROMCIT>2.3.CO;2; Luz B, 2010, GEOCHIM COSMOCHIM AC, V74, P6276, DOI 10.1016/j.gca.2010.08.016; MCKEE E H, 1969, Journal of Paleontology, V43, P716; McLennan S.M., 1993, PROCESSES CONTROLLIN, V285, P21; Mertanen S., 2012, EARTHS CORE OUTER SP, P11; Miller MF, 2002, GEOCHIM COSMOCHIM AC, V66, P1881, DOI 10.1016/S0016-7037(02)00832-3; Mukhopadhyay J, 2008, J GEOL, V116, P449, DOI 10.1086/590133; Myers JS, 2001, PRECAMBRIAN RES, V105, P129, DOI 10.1016/S0301-9268(00)00108-X; NESBITT HW, 1982, NATURE, V299, P715, DOI 10.1038/299715a0; Ovey C. D., 1950, J GLACIOL, V1, P370; Pack A, 2014, EARTH PLANET SC LETT, V390, P138, DOI 10.1016/j.epsl.2014.01.017; Pecoits E, 2016, J S AM EARTH SCI, V71, P108, DOI 10.1016/j.jsames.2016.07.003; Planavsky NJ, 2014, NAT GEOSCI, V7, P283, DOI 10.1038/ngeo2122; Podkovyrov VN, 2007, STRATIGR GEO CORREL+, V15, P41, DOI 10.1134/S0869593807010042; Rasmussen B, 2005, GEOLOGY, V33, P725, DOI 10.1130/G21616.1; Rasmussen B, 2013, EARTH PLANET SC LETT, V382, P173, DOI 10.1016/j.epsl.2013.08.037; Retallack G. J., 1997, US ANTARCTIC J, V30, P10; Retallack GJ, 2010, ECON GEOL, V105, P655, DOI 10.2113/gsecongeo.105.3.655; Rouxel OJ, 2005, SCIENCE, V307, P1088, DOI 10.1126/science.1105692; Rowley DB, 2001, EARTH PLANET SC LETT, V188, P253, DOI 10.1016/S0012-821X(01)00324-7; Ryu IC, 2003, ISL ARC, V12, P398, DOI 10.1046/j.1440-1738.2003.00409.x; SAVIN SM, 1970, GEOCHIM COSMOCHIM AC, V34, P43, DOI 10.1016/0016-7037(70)90150-X; Sharp ZD, 2016, GEOCHIM COSMOCHIM AC, V186, P105, DOI 10.1016/j.gca.2016.04.047; Sheppard S, 2016, PRECAMBRIAN RES, V286, P1, DOI 10.1016/j.precamres.2016.09.026; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; Thomson D, 2015, PRECAMBRIAN RES, V263, P232, DOI 10.1016/j.precamres.2015.02.007; Valley JW, 2005, CONTRIB MINERAL PETR, V150, P561, DOI 10.1007/s00410-005-0025-8; VINOGRADOV VI, 2000, LITHOL MINER RESOUR, V35, P141; Vlaar NJ, 2000, TECTONOPHYSICS, V322, P191, DOI 10.1016/S0040-1951(00)00063-9; Young ED, 2014, GEOCHIM COSMOCHIM AC, V135, P102, DOI 10.1016/j.gca.2014.03.026; ZHENG YF, 1993, EARTH PLANET SC LETT, V120, P247, DOI 10.1016/0012-821X(93)90243-3	64	102	104	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2018	557	7706					545	+		10.1038/s41586-018-0131-1	http://dx.doi.org/10.1038/s41586-018-0131-1			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6GP	29795252				2022-12-28	WOS:000432794900044
J	Moist, L				Moist, Louise			In type 2 diabetes with CVD and kidney disease, empagliflozin reduced mortality and hospitalization	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COTRANSPORTER 2 INHIBITORS; CARDIOVASCULAR OUTCOMES		[Moist, Louise] Western Univ, London, ON, Canada	Western University (University of Western Ontario)	Moist, L (corresponding author), Western Univ, London, ON, Canada.				Boehringer Ingelheim; Eli Lilly; Company Diabetes Alliance	Boehringer Ingelheim(Boehringer Ingelheim); Eli Lilly(Eli Lilly); Company Diabetes Alliance	Boehringer Ingelheim; Eli Lilly; Company Diabetes Alliance.	Gregg LP, 2018, AM J KIDNEY DIS; Heerspink HJL, 2016, CIRCULATION, V134, P752, DOI 10.1161/CIRCULATIONAHA.116.021887; Usman MS, 2018, EUR J PREV CARDIOL, V25, P495, DOI 10.1177/2047487318755531; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					JC52	JC52		10.7326/ACPJC-2018-168-10-052	http://dx.doi.org/10.7326/ACPJC-2018-168-10-052			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3DE	29800428				2022-12-28	WOS:000434250700004
J	Hicks, J; Vasko, P; Goicoechea, JM; Aldridge, S				Hicks, Jamie; Vasko, Petra; Goicoechea, Jose M.; Aldridge, Simon			Synthesis, structure and reaction chemistry of a nucleophilic aluminyl anion (vol 557, pg 92, 2018)	NATURE			English	Correction													Vasko, Petra/ABH-4221-2020; Goicoechea, Jose M/E-5711-2011	Vasko, Petra/0000-0003-4202-6869; Goicoechea, Jose M/0000-0002-7311-1663; Aldridge, Simon/0000-0001-9998-9434				Hicks J, 2018, NATURE, V557, P92, DOI 10.1038/s41586-018-0037-y	1	1	1	4	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2018	560	7717					E24	E24		10.1038/s41586-018-0168-1	http://dx.doi.org/10.1038/s41586-018-0168-1			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP7UJ	29867161	Bronze			2022-12-28	WOS:000441115200011
J	Nowoshilow, S; Schloissnig, S; Fei, JF; Dahl, A; Pang, AWC; Pippel, M; Winkler, S; Hastie, AR; Young, G; Roscito, JG; Falcon, F; Knapp, D; Powell, S; Cruz, A; Cao, H; Habermann, B; Hiller, M; Tanaka, EM; Myers, EW				Nowoshilow, Sergej; Schloissnig, Siegfried; Fei, Ji-Feng; Dahl, Andreas; Pang, Andy W. C.; Pippel, Martin; Winkler, Sylke; Hastie, Alex R.; Young, George; Roscito, Juliana G.; Falcon, Francisco; Knapp, Dunja; Powell, Sean; Cruz, Alfredo; Cao, Han; Habermann, Bianca; Hiller, Michael; Tanaka, Elly M.; Myers, Eugene W.			The axolotl genome and the evolution of key tissue formation regulators (vol 554, pg 50, 2018)	NATURE			English	Correction													Pippel, Martin/AGA-8156-2022; Dahl, Andreas/E-3783-2017; roscito, juliana gusson/AAI-8461-2021; Fei, Ji-Feng/O-5160-2015; Powell, Sean/B-2374-2009	Pippel, Martin/0000-0002-8134-5929; Dahl, Andreas/0000-0002-2668-8371; roscito, juliana gusson/0000-0003-1494-1162; Nowoshilow, Sergej/0000-0001-8360-5010; Fei, Ji-Feng/0000-0003-2426-9402; Powell, Sean/0000-0002-0994-5911				Nowoshilow S, 2018, NATURE, V554, P50, DOI 10.1038/nature25458	1	2	3	4	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2018	559	7712					E2	E2		10.1038/s41586-018-0141-z	http://dx.doi.org/10.1038/s41586-018-0141-z			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL6DB	29795340	Bronze			2022-12-28	WOS:000437267400011
J	Shi, SL; Wong, ZL; Buchwald, SL				Shi, Shi-Liang; Wong, Zackary L.; Buchwald, Stephen L.			Copper-catalysed enantioselective stereodivergent synthesis of amino alcohols (vol 532, pg 353, 2016)	NATURE			English	Correction																		Shi SL, 2016, NATURE, V532, P353, DOI 10.1038/nature17191	1	0	0	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2018	559	7712					E3	E3		10.1038/s41586-018-0112-4	http://dx.doi.org/10.1038/s41586-018-0112-4			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL6DB	29795353	Bronze			2022-12-28	WOS:000437267400012
J	Sharfstein, JM; Stuart, EA; Antos, J				Sharfstein, Joshua M.; Stuart, Elizabeth A.; Antos, Joseph			Global Budgets in Maryland Assessing Results to Date	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RURAL HOSPITALS		[Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 615 N Wolfe St, Baltimore, MD 21209 USA; [Stuart, Elizabeth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21209 USA; [Antos, Joseph] Amer Enterprise Inst Publ Policy Res, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; American Enterprise Institute for Public Policy Research	Sharfstein, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 615 N Wolfe St, Baltimore, MD 21209 USA.	Joshua.Sharfstein@jhu.edu		Stuart, Elizabeth/0000-0002-9042-8611	RTI	RTI	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Sharfstein reported helping to establish Maryland's system of global hospital budgeting as secretaly of the state's Department of Health and Mental Hygiene as well as organizing a policy academy for states on global budgets with support from the Robert Wood Johnson Foundation and the Milbank Memorial Fund. Since 2015, he was consulted with large health systems for Sachs Policy Group, including on the topic of global hospital budgeting. Dr Stuart reported receiving personal fees for consulting with RTI on its evaluation methodology. Dr Antos reported being the vice chair for Maryland's Health Services Cost Review Commission.	Haber S, 2018, EVALUATION MARYLAND; Hancock J, KAISER HLTH NEWS; Health Services Cost Review Commission, 2018, MAR ALL PAY HOSP MOD; Murphy KM, 2018, JAMA-J AM MED ASSOC, V319, P1193, DOI 10.1001/jama.2018.2967; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Roberts ET, 2018, HEALTH AFFAIR, V37, P644, DOI 10.1377/hlthaff.2018.0112; Roberts ET, 2018, JAMA INTERN MED, V178, P260, DOI 10.1001/jamainternmed.2017.7455; State Health and Value Strategies, GLOB BUDG POL AC STA	8	18	18	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2018	319	24					2475	2476		10.1001/jama.2018.5871	http://dx.doi.org/10.1001/jama.2018.5871			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK6ZP	29800052				2022-12-28	WOS:000436342700014
J	DiNardo, CD; Stein, EM; de Botton, S; Roboz, GJ; Altman, JK; Mims, AS; Swords, R; Collins, RH; Mannis, GN; Pollyea, DA; Donnellan, W; Fathi, AT; Pigneux, A; Erba, HP; Prince, GT; Stein, AS; Uy, GL; Foran, JM; Traer, E; Stuart, RK; Arellano, ML; Slack, JL; Sekeres, MA; Willekens, C; Choe, S; Wang, H; Zhang, V; Yen, KE; Kapsalis, SM; Yang, H; Dai, D; Fan, B; Goldwasser, M; Liu, H; Agresta, S; Wu, B; Attar, EC; Tallman, MS; Stone, RM; Kantarjian, HM				DiNardo, C. D.; Stein, E. M.; de Botton, S.; Roboz, G. J.; Altman, J. K.; Mims, A. S.; Swords, R.; Collins, R. H.; Mannis, G. N.; Pollyea, D. A.; Donnellan, W.; Fathi, A. T.; Pigneux, A.; Erba, H. P.; Prince, G. T.; Stein, A. S.; Uy, G. L.; Foran, J. M.; Traer, E.; Stuart, R. K.; Arellano, M. L.; Slack, J. L.; Sekeres, M. A.; Willekens, C.; Choe, S.; Wang, H.; Zhang, V.; Yen, K. E.; Kapsalis, S. M.; Yang, H.; Dai, D.; Fan, B.; Goldwasser, M.; Liu, H.; Agresta, S.; Wu, B.; Attar, E. C.; Tallman, M. S.; Stone, R. M.; Kantarjian, H. M.			Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; IDH2 MUTATIONS; PROGNOSTIC-SIGNIFICANCE; DIFFERENTIATION; METAANALYSIS; INHIBITOR	BACKGROUND Mutations in the gene encoding isocitrate dehydrogenase 1 (IDH1) occur in 6 to 10% of patients with acute myeloid leukemia (AML). Ivosidenib (AG-120) is an oral, targeted, small-molecule inhibitor of mutant IDH1. METHODS We conducted a phase 1 dose-escalation and dose-expansion study of ivosidenib monotherapy in IDH1-mutated AML. Safety and efficacy were assessed in all treated patients. The primary efficacy population included patients with relapsed or refractory AML receiving 500 mg of ivosidenib daily with at least 6 months of follow-up. RESULTS Overall, 258 patients received ivosidenib and had safety outcomes assessed. Among patients with relapsed or refractory AML (179 patients), treatment-related adverse events of grade 3 or higher that occurred in at least 3 patients were prolongation of the QT interval (in 7.8% of the patients), the IDH differentiation syndrome (in 3.9%), anemia (in 2.2%), thrombocytopenia or a decrease in the platelet count (in 3.4%), and leukocytosis (in 1.7%). In the primary efficacy population (125 patients), the rate of complete remission or complete remission with partial hematologic recovery was 30.4% (95% confidence interval [CI], 22.5 to 39.3), the rate of complete remission was 21.6% (95% CI, 14.7 to 29.8), and the overall response rate was 41.6% (95% CI, 32.9 to 50.8). The median durations of these responses were 8.2 months (95% CI, 5.5 to 12.0), 9.3 months (95% CI, 5.6 to 18.3), and 6.5 months (95% CI, 4.6 to 9.3), respectively. Transfusion independence was attained in 29 of 84 patients (35%), and patients who had a response had fewer infections and febrile neutropenia episodes than those who did not have a response. Among 34 patients who had a complete remission or complete remission with partial hematologic recovery, 7 (21%) had no residual detectable IDH1 mutations on digital polymerase-chain-reaction assay. No preexisting cooccurring single gene mutation predicted clinical response or resistance to treatment. CONCLUSIONS In patients with advanced IDH1-mutated relapsed or refractory AML, ivosidenib at a dose of 500 mg daily was associated with a low frequency of grade 3 or higher treatment- related adverse events and with transfusion independence, durable remissions, and molecular remissions in some patients with complete remission.	[DiNardo, C. D.; Kantarjian, H. M.] Univ Texas MD Anderson Canc Ctr, Houston, TX USA; [Stein, E. M.; Tallman, M. S.] Mem Sloan Kettering Canc Ctr, Villejuif, France; [Roboz, G. J.] Weill Cornell Med Coll, Villejuif, France; [de Botton, S.; Willekens, C.] Inst Gustave Roussy, Villejuif, France; [Pigneux, A.] CHU Bordeaux, Bordeaux, France; [Altman, J. K.] Northwestern Univ, Chicago, IL USA; [Mims, A. S.] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA; [Swords, R.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Collins, R. H.] Univ Texas Southwestern Med Ctr, Dallas, TX USA; Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Swords, R.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Stein, A. S.] City Hope Med Ctr, Duarte, CA USA; [Pollyea, D. A.] Univ Colorado, Sch Med, Aurora, CO USA; [Donnellan, W.] Sarah Cannon Res Inst, Nashville, TN USA; [Fathi, A. T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Stone, R. M.] Dana Farber Canc Inst, Boston, MA USA; [Choe, S.; Wang, H.; Zhang, V.; Yen, K. E.; Kapsalis, S. M.; Yang, H.; Dai, D.; Fan, B.; Goldwasser, M.; Liu, H.; Agresta, S.; Wu, B.; Attar, E. C.] Agios Pharmaceut, Cambridge, England; [Erba, H. P.] Univ Alabama Birmingham, Birmingham, AL USA; [Prince, G. T.] Johns Hopkins Univ, Baltimore, MD USA; [Uy, G. L.] Washington Univ, Sch Med, St Louis, MO USA; [Foran, J. M.] Mayo Clin, Jacksonville, FL USA; [Traer, E.] Oregon Hlth & Sci Univ, Knight Canc, Portland, ME USA; [Stuart, R. K.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC USA; [Arellano, M. L.] Emory Univ, Winship Canc Inst, Atlanta, GA USA; [Slack, J. L.] Mayo Clin, Phoenix, AZ USA; [Sekeres, M. A.] Cleveland Clin, Cleveland, OH USA	University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; UNICANCER; Gustave Roussy; CHU Bordeaux; Northwestern University; University System of Ohio; Ohio State University; University of Miami; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Miami; City of Hope; University of Colorado System; University of Colorado Anschutz Medical Campus; Sarah Cannon Research Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Agios Pharmaceuticals; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Washington University (WUSTL); Mayo Clinic; Oregon Health & Science University; Medical University of South Carolina; Emory University; Mayo Clinic; Mayo Clinic Phoenix; Cleveland Clinic Foundation	DiNardo, CD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Unit 0428, Houston, TX 77030 USA.	cdinardo@mdanderson.org	Uy, Geoffrey/AAD-9815-2021	DE BOTTON, stephane/0000-0002-8126-4942; Sekeres, Mikkael/0000-0003-2009-6524; Uy, Geoffrey/0000-0002-7809-0996; Willekens, Christophe/0000-0001-9814-8537; Choe, Sung/0000-0001-9140-4198	Agios Pharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002369] Funding Source: NIH RePORTER	Agios Pharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by Agios Pharmaceuticals; ClinicalTrials.gov number, NCT02074839.	Birendra KC, 2016, CL LYMPH MYELOM LEUK, V16, P460, DOI 10.1016/j.clml.2016.04.006; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DiNardo CD, 2015, AM J HEMATOL, V90, P732, DOI 10.1002/ajh.24072; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Fathi AT, 2018, JAMA ONCOL; Feng JH, 2012, AM J BLOOD RES, V2, P254; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Hansen E, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.3734.3734; IDHIFA (enasidenib), 2017, SUMMIT; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Patel KP, 2011, AM J CLIN PATHOL, V135, P35, DOI 10.1309/AJCPD7NR2RMNQDVF; Popovici-Muller J, 2018, ACS MED CHEM LETT, V9, P300, DOI 10.1021/acsmedchemlett.7b00421; Roboz GJ, 2014, J CLIN ONCOL, V32, P1919, DOI 10.1200/JCO.2013.52.8562; Stein EM, 2017, BLOOD, V130, P722, DOI 10.1182/blood-2017-04-779405; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu QY, 2017, CLIN CANCER RES, V23, P4511, DOI 10.1158/1078-0432.CCR-16-2628; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yen K, 2017, CANCER DISCOV, V7, P478, DOI 10.1158/2159-8290.CD-16-1034; Zhou KG, 2012, LEUKEMIA LYMPHOMA, V53, P2423, DOI 10.3109/10428194.2012.695359	22	749	766	8	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2018	378	25					2386	2398		10.1056/NEJMoa1716984	http://dx.doi.org/10.1056/NEJMoa1716984			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ8SS	29860938	Bronze			2022-12-28	WOS:000435661600007
J	Carey, CM; Jena, AB; Barnett, ML				Carey, Colleen M.; Jena, Anupam B.; Barnett, Michael L.			Patterns of Potential Opioid Misuse and Subsequent Adverse Outcomes in Medicare, 2008 to 2012	ANNALS OF INTERNAL MEDICINE			English	Article							DRUG-MONITORING PROGRAMS; SHOPPING BEHAVIOR; CHRONIC PAIN; OVERDOSE; DEATHS; COHORT	Background: Providers are increasingly being expected to examine their patients' opioid treatment histories before writing new opioid prescriptions. However, lithe evidence exists on how patterns of potential opioid misuse are associated with subsequent adverse outcomes nationally. Objective: To estimate how a range of patterns of potential opioid misuse relate to adverse outcomes during the subsequent year. Design: Observational study comparing outcomes for Medicare enrollees with potential opioid misuse patterns versus those for beneficiaries with no such patterns, adjusting for patient characteristics. Setting: Medicare, 2008 to 2012. Patients: A 5% sample of beneficiaries who had an opioid prescription without a cancer diagnosis. Measurements: Several measures for opioid misuse were defined on the basis of drug quantity, overlapping prescriptions, use of multiple prescribers or pharmacies, and use of out-ofstate prescribers or pharmacies. The primary outcome was a diagnosis of opioid overdose in the year after a 6-month index period. Secondary outcomes included subsequent opioid-related or overall mortality. Results: Overall, 0.6% to 8.5% of beneficiaries fulfilled a misuse measure. Subsequent opioid overdose was positively associated with successively greater numbers of prescribers or pharmacies or higher opioid quantities during the index period. For example, patients who obtained opioids from 2, 3, or 4 prescribers were increasingly more likely to have an opioid overdose (adjusted absolute risk per 1000 beneficiary-years [aAR], 3.5 [95% CI, 3.3 to 3.7]; 4.8 [CI, 4.5 to 5.2]; or 6.4 [CI, 5.8 to 6.9], respectively) than those with a single prescriber (aAR, 1.9 [CI, 1.8 to 2.0]). Subsequent overdose risk increased meaningfully with any deviation in the single prescriber-single pharmacy opioid use pattern. All misuse measures examined had a positive association with subsequent opioid overdose and death. Limitation: Risk estimates provide measures of association and may not generalize to non-Medicare populations. Conclusion: To fully assess patients' opioid overdose risk, clinicians should examine a wide range of misuse patterns.	[Carey, Colleen M.] Cornell Univ, 298 Martha van Rensselaer Hall, Ithaca, NY 14850 USA; [Jena, Anupam B.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Jena, Anupam B.] NBER, Cambridge, MA 02138 USA; [Barnett, Michael L.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Barnett, Michael L.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA	Cornell University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Barnett, ML (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	colleen.carey@cornell.edu; mbarnett@hsph.harvard.edu	Barnett, Michael/AAF-4017-2019; Barnett, Michael/ABA-4159-2021	Barnett, Michael/0000-0002-4884-6609; Barnett, Michael/0000-0002-4884-6609; carey, colleen/0000-0003-0069-9707	National Institutes of Health [1DP5OD 017897-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	By NIH Early Independence Award 1DP5OD 017897-01 (Dr. Jena).	Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2017, PRESCR DRUG AB POL S; [Anonymous], 2017, 1 5 MILLION ADULTS H; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Buchmueller TC, 2018, AM ECON J-ECON POLIC, V10, P77, DOI 10.1257/pol.20160094; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Medicare & Medicaid Services, 2017, AN PROP OP OV CRIT M; Cepeda MS, 2013, J CLIN PHARMACOL, V53, P112, DOI 10.1177/0091270012436561; Cepeda MS, 2012, DRUG SAFETY, V35, P325, DOI 10.2165/11596600-000000000-00000; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Gugelmann HM, 2011, JAMA-J AM MED ASSOC, V306, P2258, DOI 10.1001/jama.2011.1712; Haffajee RL, 2015, JAMA-J AM MED ASSOC, V313, P891, DOI 10.1001/jama.2014.18514; Irvine JM, 2014, J PAIN, V15, P747, DOI 10.1016/j.jpain.2014.04.003; Islam MM, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-46; Jena AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1393; Krueger Alan, 2016, WORKING PAPER; Lipari R.N., 2016, PRESCRIPTION DRUG US; Meara E, 2016, NEW ENGL J MED, V375, P44, DOI 10.1056/NEJMsa1514387; Morden NE, 2014, MED CARE, V52, P852, DOI 10.1097/MLR.0000000000000183; National Institute on Drug Abuse, 2014, AM ADD OP HER PRESCR; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Pischke J.S., 2014, MASTERING METRICS PA; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rowe C, 2017, ACAD EMERG MED, V24, P475, DOI 10.1111/acem.13121; Rutkow L, 2015, HEALTH AFFAIR, V34, P484, DOI 10.1377/hlthaff.2014.1085; Substance Abuse and Mental Health Services Administration, 2014, OP; U. S. Government Accountability Office, 2011, GAO11699	28	32	32	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2018	168	12					837	+		10.7326/M17-3065	http://dx.doi.org/10.7326/M17-3065			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK1TE	29800019				2022-12-28	WOS:000435903500013
J	Hess, CN; Hiatt, WR				Hess, Connie N.; Hiatt, William R.			Antithrombotic Therapy for Peripheral Artery Disease in 2018	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR EVENTS; ASPIRIN; PREVENTION		Univ Colorado, Sch Med, Dept Med, Div Cardiol, Aurora, CO USA; CPC Clin Res, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Hiatt, WR (corresponding author), Univ Colorado, Sch Med, Div Cardiol, 13199 E Montview Blvd,Ste 200, Aurora, CO 80045 USA.	Will.Hiatt@ucdenver.edu			Bayer; Merck; National Institutes of Health; AstraZeneca; Janssen	Bayer(Bayer AG); Merck(Merck & Company); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Dr Hess reports receipt of research grants to CPC Clinical Research from Bayer and Merck. Dr Hiatt reports receipt of research grants to CPC Clinical Research from the National Institutes of Health, AstraZeneca, Bayer, and Janssen.	Anand SS, 2017, LANCET, V391; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Berger JS, 2009, JAMA-J AM MED ASSOC, V301, P1909, DOI 10.1001/jama.2009.623; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bonaca MP, 2016, J AM COLL CARDIOL, V67, P2719, DOI 10.1016/j.jacc.2016.03.524; Bonaca MP, 2013, CIRCULATION, V127, P1522, DOI 10.1161/CIRCULATIONAHA.112.000679; Brass EP, 2017, CIRCULATION, V136, P785, DOI 10.1161/CIRCULATIONAHA.117.028888; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Gerhard-Herman MD, 2017, CIRCULATION, V135, pE686, DOI 10.1161/CIR.0000000000000470; Hiatt WR, 2017, NEW ENGL J MED, V376, P32, DOI 10.1056/NEJMoa1611688	10	21	23	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2018	319	22					2329	2330		10.1001/jama.2018.5422	http://dx.doi.org/10.1001/jama.2018.5422			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2UP	29860284	Bronze			2022-12-28	WOS:000435129300019
J	Wise, J				Wise, Jacqui			Isle of Wight trust remains in special measures amid significant safety concerns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Care Quality Commission June 2018], 2018, ISL WIGHT NHS TRUST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2018	361								k2496	10.1136/bmj.k2496	http://dx.doi.org/10.1136/bmj.k2496			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BX	29875254				2022-12-28	WOS:000435073600008
J	Kitterick, PT; Ferguson, MA				Kitterick, Padraig T.; Ferguson, Melanie A.			Hearing Aids and Health-Related Quality of life in Adults With Hearing Loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kitterick, Padraig T.; Ferguson, Melanie A.] Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Ropewalk House, Nottingham, England; [Kitterick, Padraig T.; Ferguson, Melanie A.] Univ Nottingham, Sch Med, Div Clin Neurosci, Otol & Hearing Grp, Nottingham, England; [Kitterick, Padraig T.; Ferguson, Melanie A.] Univ Nottingham, Hosp Natl Hlth Serv Trust, Queens Med Ctr, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham	Ferguson, MA (corresponding author), NIHR Nottingham Biomed Res Ctr, 113 Ropewalk, Nottingham NG1 5DU, England.	melanie.ferguson@nottingham.ac.uk	Ferguson, Melanie/AAY-3525-2021	Kitterick, Padraig/0000-0001-8383-5318	Cochlear Europe Ltd; Phonak	Cochlear Europe Ltd; Phonak	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kitterick reported receiving grant support from Cochlear Europe Ltd; and personal fees from Phonak. No other disclosures were reported.	Davis A, 2016, GERONTOLOGIST, V56, pS256, DOI 10.1093/geront/gnw033; Ferguson MA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012023.pub2; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; WHO, 2001, WHO INT CLASS FUNCT; Wilson BS, 2017, LANCET, V390, P2503, DOI 10.1016/S0140-6736(17)31073-5	5	10	10	3	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2225	2226		10.1001/jama.2018.5567	http://dx.doi.org/10.1001/jama.2018.5567			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29872841				2022-12-28	WOS:000434133400021
J	Voelker, R				Voelker, Rebecca			New Test Identifies Candida auris	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2164	2164		10.1001/jama.2018.6922	http://dx.doi.org/10.1001/jama.2018.6922			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29872842				2022-12-28	WOS:000434133400006
J	Chen, YY				Chen, Yvonne Y.			Increasing T Cell Versatility with SUPRA CARs	CELL			English	Editorial Material							MANAGEMENT	Chimeric antigen receptor (CAR) T cells offer a promising treatment option for advanced cancers resistant to standard therapy. Here, Cho et al. report a split-CAR design that enables the engineering of multi-feature CAR-T cells, aiming to address current challenges limiting the safety and efficacy of CAR-T cells for cancer treatment.	[Chen, Yvonne Y.] Univ Calif Los Angeles, Dept Biomol & Chem Engn, Los Angeles, CA 90095 USA; [Chen, Yvonne Y.] Univ Calif Los Angeles, Parker Inst Canc Immunotherapy Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Chen, YY (corresponding author), Univ Calif Los Angeles, Dept Biomol & Chem Engn, Los Angeles, CA 90095 USA.; Chen, YY (corresponding author), Univ Calif Los Angeles, Parker Inst Canc Immunotherapy Ctr, Los Angeles, CA 90095 USA.	yvonne.chen@ucla.edu						Brudno JN, 2016, BLOOD, V127, P3321, DOI 10.1182/blood-2016-04-703751; Chang ZL, 2017, TRENDS MOL MED, V23, P430, DOI 10.1016/j.molmed.2017.03.002; Cho JH, 2018, CELL, V173, P1426, DOI 10.1016/j.cell.2018.03.038; Grada Z, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.32; Klebanoff CA, 2016, NAT MED, V22, P26, DOI 10.1038/nm.4015; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Migliorini D, 2018, CLIN CANCER RES, V24, P535, DOI 10.1158/1078-0432.CCR-17-2871; Zah E, 2016, CANCER IMMUNOL RES, V4, P498, DOI 10.1158/2326-6066.CIR-15-0231	8	16	17	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1316	1317		10.1016/j.cell.2018.05.030	http://dx.doi.org/10.1016/j.cell.2018.05.030			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856949	Bronze			2022-12-28	WOS:000433989100004
J	Gates, B				Gates, Bill			Innovation for Pandemics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gates, Bill] Bill & Melinda Gates Fdn, Seattle, WA 98102 USA	Bill & Melinda Gates Foundation	Gates, B (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98102 USA.							[Anonymous], 2018, NIKKEI ASIAN RE 0223; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022	2	61	62	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2018	378	22					2057	2060		10.1056/NEJMp1806283	http://dx.doi.org/10.1056/NEJMp1806283			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH5AL	29847763	Bronze			2022-12-28	WOS:000433428000001
J	Knoll, E				Knoll, Emily			Learning to live with hearing voices	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2018	361								k2018	10.1136/bmj.k2018	http://dx.doi.org/10.1136/bmj.k2018			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MT	29853479	Green Published, Bronze			2022-12-28	WOS:000434276300002
J	Wong, FK; Bercsenyi, K; Sreenivasan, V; Portales, A; Fernandez-Otero, M; Marin, O				Wong, Fong Kuan; Bercsenyi, Kinga; Sreenivasan, Varun; Portales, Adrian; Fernandez-Otero, Marian; Marin, Oscar			Pyramidal cell regulation of interneuron survival sculpts cortical networks	NATURE			English	Article							AUTISM SPECTRUM DISORDERS; GABA-IMMUNOREACTIVE NEURONS; TUMOR-SUPPRESSOR GENE; GABAERGIC INTERNEURONS; CEREBRAL-CORTEX; NERVOUS-SYSTEM; NEOCORTEX; INHIBITION; DEATH; PTEN	Complex neuronal circuitries such as those found in the mammalian cerebral cortex have evolved as balanced networks of excitatory and inhibitory neurons. Although the establishment of appropriate numbers of these cells is essential for brain function and behaviour, our understanding of this fundamental process is limited. Here we show that the survival of interneurons in mice depends on the activity of pyramidal cells in a critical window of postnatal development, during which excitatory synaptic input to individual interneurons predicts their survival or death. Pyramidal cells regulate interneuron survival through the negative modulation of PTEN signalling, which effectively drives interneuron cell death during this period. Our findings indicate that activity-dependent mechanisms dynamically adjust the number of inhibitory cells in nascent local cortical circuits, ultimately establishing the appropriate proportions of excitatory and inhibitory neurons in the cerebral cortex.	[Wong, Fong Kuan; Bercsenyi, Kinga; Sreenivasan, Varun; Portales, Adrian; Fernandez-Otero, Marian; Marin, Oscar] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Dev Neurobiol, London, England; [Wong, Fong Kuan; Bercsenyi, Kinga; Sreenivasan, Varun; Portales, Adrian; Fernandez-Otero, Marian; Marin, Oscar] Kings Coll London, MRC, Ctr Neurodev Disorders, London, England	University of London; King's College London; University of London; King's College London	Marin, O (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Dev Neurobiol, London, England.; Marin, O (corresponding author), Kings Coll London, MRC, Ctr Neurodev Disorders, London, England.	oscar.marin@kcl.ac.uk	Wong, Fong Kuan/T-3257-2019; Marin, Oscar/F-3856-2012	Marin, Oscar/0000-0001-6264-7027; Fernandez-Otero, Marian/0000-0002-3570-9306; Wong, Fong Kuan/0000-0003-3319-4625; Bercsenyi, Kinga/0000-0001-5730-9752	Wellcome Trust [103714MA]; EMBO; European Commission; MRC [MR/N026063/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Bae for laboratory support, I. Andrew for management of mouse colonies, V. van den Berghe for help with breeding strategies, S. A. Anderson, N. Kessaris, R. L. Mort and K. A. Nave for mouse lines, N. Flames, C. Houart and M. Maravall for critical reading of the manuscript, and members of the Marin and Rico laboratories for stimulating discussions and ideas. This work was supported by a grant from the Wellcome Trust (103714MA) to O.M. F.K.W. was supported by an EMBO postdoctoral fellowship and is currently a Marie Sklodowska-Curie Fellow from the European Commission under the H2020 Programme. K.B. is a Henry Wellcome Postdoctoral Fellow and O.M. is a Wellcome Trust Investigator.	Anastasiades PG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10584; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bartolini G, 2013, NEURON, V79, P849, DOI 10.1016/j.neuron.2013.08.014; BEAULIEU C, 1993, BRAIN RES, V609, P284, DOI 10.1016/0006-8993(93)90884-P; Blanquie O, 2017, ELIFE, V6, DOI 10.7554/eLife.27696; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; Denaxa M, 2018, CELL REP, V22, P1710, DOI 10.1016/j.celrep.2018.01.064; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; GABBOTT PLA, 1986, EXP BRAIN RES, V61, P323; Glickstein SB, 2007, DEVELOPMENT, V134, P4083, DOI 10.1242/dev.008524; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Green DM, 1966, SIGNAL DETECTION THE; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; Heck N, 2008, CEREB CORTEX, V18, P1335, DOI 10.1093/cercor/bhm165; HENDRY SHC, 1987, J NEUROSCI, V7, P1503; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Meyer HS, 2011, P NATL ACAD SCI USA, V108, P16807, DOI 10.1073/pnas.1113648108; Mort RL, 2014, CELL CYCLE, V13, P2681, DOI 10.4161/15384101.2015.945381; Nelson SB, 2015, NEURON, V87, P684, DOI 10.1016/j.neuron.2015.07.033; Price DJ, 1997, J COMP NEUROL, V377, P414; Priya R, 2018, CELL REP, V22, P1695, DOI 10.1016/j.celrep.2018.01.007; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Verney C, 2000, DEV NEUROSCI-BASEL, V22, P125, DOI 10.1159/000017434; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	58	117	118	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					668	+		10.1038/s41586-018-0139-6	http://dx.doi.org/10.1038/s41586-018-0139-6			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29849154	Green Accepted, Green Submitted			2022-12-28	WOS:000433412900042
J	Iacobucci, G				Iacobucci, Gareth			Scrap the Cap: Elective care is being affected, says workforce leader	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lintern S., 2018, HSJ; Torjesen I, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2009	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2018	361								k2372	10.1136/bmj.k2372	http://dx.doi.org/10.1136/bmj.k2372			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MP	29848641				2022-12-28	WOS:000434275800010
J	O'Dowd, A				O'Dowd, Adrian			Child obesity plan must include legal action on junk food advertising and discounts, say MPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Health and Social Care Committee, 2018, CHILDH OB TIM ACT; HM Government, 2016, CHILDH OB PLAN ACT	2	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2018	361								k2398	10.1136/bmj.k2398	http://dx.doi.org/10.1136/bmj.k2398			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MP	29848480				2022-12-28	WOS:000434275800016
J	Wise, J				Wise, Jacqui			WHO is "cautiously optimistic" about Ebola ring vaccination programme in DRC	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Gsell PS, 2017, LANCET INFECT DIS, V17, P1276, DOI 10.1016/S1473-3099(17)30541-8	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2018	361								k2388	10.1136/bmj.k2388	http://dx.doi.org/10.1136/bmj.k2388			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MP	29848617				2022-12-28	WOS:000434275800012
J	Thiruchelvam, PTR; Fisher, CS; Leff, DR; Domchek, SM				Thiruchelvam, Paul T. R.; Fisher, Carla S.; Leff, Daniel R.; Domchek, Susan M.			Pervasive genetic testing	LANCET			English	Editorial Material							BREAST-CANCER RISK; OVARIAN-CANCER; BRCA2; MUTATIONS; FAMILIES; CARRIERS; WOMEN; PANEL		[Thiruchelvam, Paul T. R.] Imperial Coll Healthcare, Acad Dept Breast Surg, London W6 8RF, England; [Fisher, Carla S.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Leff, Daniel R.] Imperial Coll London, Dept BioSurg, London, England; [Leff, Daniel R.] Imperial Coll London, Dept Surg Technol, London, England; [Leff, Daniel R.] Imperial Coll London, Hamlyn Ctr Robot Surg, London, England; [Domchek, Susan M.] Univ Penn, Basser Ctr BRCA, Philadelphia, PA 19104 USA; [Domchek, Susan M.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA	Indiana University System; Indiana University Bloomington; Imperial College London; Imperial College London; Imperial College London; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Thiruchelvam, PTR (corresponding author), Imperial Coll Healthcare, Acad Dept Breast Surg, London W6 8RF, England.	paul.thiruchelvam@imperial.ac.uk		Leff, Daniel/0000-0002-5310-1046				[Anonymous], 2018, MAINSTREAMING CANC G; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2014, NEW ENGL J MED, V371, P497, DOI [10.1056/NEJMoa1400382, 10.1056/NEJMc1410673]; Bellcross CA, 2011, AM J PREV MED, V40, P61, DOI 10.1016/j.amepre.2010.09.027; Bradbury A, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4564; Bradbury AR, 2018, JNCI-J NATL CANCER I, V110, P985, DOI 10.1093/jnci/djy015; Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341; Eccleston A, 2017, VALUE HEALTH, V20, P567, DOI 10.1016/j.jval.2017.01.004; Fischer C, 2013, J MED GENET, V50, P360, DOI 10.1136/jmedgenet-2012-101415; King MC, 2014, JAMA-J AM MED ASSOC, V312, P1091, DOI 10.1001/jama.2014.12483; Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607; Maxwell KN, 2016, J CLIN ONCOL; Metcalfe KA, 2010, J CLIN ONCOL, V28, P387, DOI 10.1200/JCO.2009.25.0712; Minion LE, 2015, GYNECOL ONCOL, V137, P86, DOI 10.1016/j.ygyno.2015.01.537; National Institute for Health and Care Excellence, CG164 NIHCE; National Institutes of Health, EV ALT CLIN GEN CANC; National Institutes of Health, BRCA FOUND OUTR BFOR; National Institutes of Health National Cancer Institute, CANC STAT FACTS; Percival Natalie, 2016, Br J Nurs, V25, P690, DOI 10.12968/bjon.2016.25.12.690; Ringwald J, 2016, J GENET COUNS, V25, P880, DOI 10.1007/s10897-016-9949-6; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Schmidt MK, 2016, J CLIN ONCOL, V34, P2750, DOI 10.1200/JCO.2016.66.5844; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; The National Comprehensive Cancer Network (NCCN), 2018, NCCN CLIN PRACT GUID; Tung N, 2016, NAT REV CLIN ONCOL, V13, P581, DOI 10.1038/nrclinonc.2016.90; Tung N, 2015, CANCER-AM CANCER SOC, V121, P25, DOI 10.1002/cncr.29010; U.S. Food and Drug Administration, 2018, FDA AUTH SPEC CONTR	27	3	3	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2018	391	10135					2089	2091		10.1016/S0140-6736(18)30997-8	http://dx.doi.org/10.1016/S0140-6736(18)30997-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH2UJ	29856334	Green Submitted			2022-12-28	WOS:000433257200010
J	Dyer, O				Dyer, Owen			Prostate screening could rise again after new US cancer data	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cronin KA, 2018, ANN REPORT NATION 1, DOI [10.1002/cncr.31551, 10.1002/cncr.31549, DOI 10.1002/CNCR.31551]; Negoita S, 2018, ANN REPORT NATION 2, DOI [10.1002/cncr.31549, DOI 10.1002/CNCR.31549]; Thompson I., 2018, PENDULUM SWINGS BACK, DOI [10.1002/cncr.31555, DOI 10.1002/CNCR.31555]	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2018	361								k2344	10.1136/bmj.k2344	http://dx.doi.org/10.1136/bmj.k2344			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH4XO	29802098				2022-12-28	WOS:000433416200012
J	Butler-Peres, K; Scalea, JR				Butler-Peres, Kamilia; Scalea, Joseph R.			Horseshoe kidney in a deceased organ donor: a rare glimpse at an uncommon finding	LANCET			English	Editorial Material									[Butler-Peres, Kamilia; Scalea, Joseph R.] Univ Maryland, Div Transplantat, Baltimore, MD 21201 USA; [Butler-Peres, Kamilia; Scalea, Joseph R.] Univ Maryland, Dept Surg, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Scalea, JR (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21212 USA.	jscalea@som.umaryland.edu							0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2018	391	10134					2028	2028		10.1016/S0140-6736(18)30759-1	http://dx.doi.org/10.1016/S0140-6736(18)30759-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GG1IJ	29864019				2022-12-28	WOS:000432440300029
J	Horton, R				Horton, Richard			Offline: Sexual and reproductive rights-health and hypocrisy	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2018	391	10134					1981	1981		10.1016/S0140-6736(18)31089-4	http://dx.doi.org/10.1016/S0140-6736(18)31089-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GG1IJ	29864012				2022-12-28	WOS:000432440300012
J	Ebert, BL; Libby, P				Ebert, Benjamin L.; Libby, Peter			Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer: A Newly Recognized Link Between Two Major Killers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ATHEROSCLEROSIS; MICE		[Ebert, Benjamin L.] Harvard Med Sch, Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA; [Libby, Peter] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Libby, Peter] Harvard Med Sch, Brigham & Womens Hosp, 77 Ave Louis Pasteur,NRB 741-G, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Libby, P (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, 77 Ave Louis Pasteur,NRB 741-G, Boston, MA 02115 USA.	plibby@bwh.har-vard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X	NCI NIH HHS [P01 CA066996] Funding Source: Medline; NHLBI NIH HHS [R01 HL082945] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jongen-Lavrencic M, 2018, NEW ENGL J MED, V378, P1189, DOI 10.1056/NEJMoa1716863; Libby P, 2016, J AM COLL CARDIOL, V67, P1091, DOI 10.1016/j.jacc.2015.12.048; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Sano S, 2018, J AM COLL CARDIOL, V71, P875, DOI 10.1016/j.jacc.2017.12.037; Steensma DP, 2018, NEW ENGL J MED, V378, P1244, DOI 10.1056/NEJMe1802610; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Wolach O, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan8292	10	22	22	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2018	169	2					116	+		10.7326/M18-0737	http://dx.doi.org/10.7326/M18-0737			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN0TI	29809241				2022-12-28	WOS:000438689200017
J	Shitara, K; Ozguroglu, M; Bang, YJ; Di Bartolomeo, M; Mandala, M; Ryu, MH; Fornaro, L; Olesinski, T; Caglevic, C; Chung, HC; Muro, K; Goekkurt, E; Mansoor, W; McDermott, RS; Shacham-Shmueli, E; Chen, XQ; Mayo, C; Kang, SP; Ohtsu, A; Fuchs, CS				Shitara, Kohei; Ozguroglu, Mustafa; Bang, Yung-Jue; Di Bartolomeo, Maria; Mandala, Mario; Ryu, Min-Hee; Fornaro, Lorenzo; Olesinski, Tomasz; Caglevic, Christian; Chung, Hyun C.; Muro, Kei; Goekkurt, Eray; Mansoor, Wasat; McDermott, Raymond S.; Shacham-Shmueli, Einat; Chen, Xinqun; Mayo, Carlos; Kang, S. Peter; Ohtsu, Atsushi; Fuchs, Charles S.		KEYNOTE-061 Investigators	Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial	LANCET			English	Article							SOLID TUMORS; DOUBLE-BLIND; NIVOLUMAB; MULTICENTER	Background Patients with advanced gastric or gastro-oesophageal junction cancer that progresses on chemotherapy have poor outcomes. We compared pembrolizumab with paclitaxel in patients with advanced gastric or gastrooesophageal junction cancer that progressed on first-line chemotherapy with a platinum and fluoropyrimidine. Methods This randomised, open-label, phase 3 study was done at 148 medical centres in 30 countries. Eligible patients were randomised (1: 1) in blocks of four per stratum with an interactive voice-response and integrated web-response system to receive either pembrolizumab 200 mg every 3 weeks for up to 2 years or standard-dose paclitaxel. Primary endpoints were overall survival and progression-free survival in patients with a programmed cell death ligand 1 (PD-L1) combined positive score (CPS) of 1 or higher. Safety was assessed in all patients, irrespective of CPS. The significance threshold for overall survival was p=0.0135 (one-sided). This trial is registered at ClinicalTrials.gov, number NCT02370498. Findings Between June 4, 2015, and July 26, 2016, 592 patients were enrolled. Of the 395 patients who had a PD-L1 CPS of 1 or higher, 196 patients were assigned to receive pembrolizumab and 199 patients were assigned to receive paclitaxel. As of Oct 26, 2017, 326 patients in the population with CPS of 1 or higher had died (151 [77%] of 196 patients in the pembrolizumab group and 175 [88%] of 199 patients in the paclitaxel group). Median overall survival was 9.1 months (95% CI 6.2-10.7) with pembrolizumab and 8.3 months (7.6-9.0) with paclitaxel (hazard ratio [HR] 0.82, 95% CI 0.66-1.03; one-sided p=0.0421). Median progression-free survival was 1.5 months (95% CI 1.4-2.0) with pembrolizumab and 4.1 months (3.1-4.2) with paclitaxel (HR 1.27, 95% CI 1.03-1.57). In the total population, grade 3-5 treatment-related adverse events occurred in 42 (14%) of the 294 patients treated with pembrolizumab and 96 (35%) of the 276 patients treated with paclitaxel. Interpretation Pembrolizumab did not significantly improve overall survival compared with paclitaxel as second-line therapy for advanced gastric or gastro-oesophageal junction cancer with PD-L1 CPS of 1 or higher. Pembrolizumab had a better safety profile than paclitaxel. Additional trials of pembrolizumab in gastric and gastro-oesophageal cancer are ongoing. Copyright (c) 2018 Elsevier Ltd. All rights reserved.	[Shitara, Kohei; Ohtsu, Atsushi] Natl Canc Ctr Hosp East, Kashiwa, Chiba 2770882, Japan; [Ozguroglu, Mustafa] Istanbul Univ, Cerrahpasa Sch Med, Istanbul, Turkey; [Bang, Yung-Jue] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Di Bartolomeo, Maria] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Mandala, Mario] Papa Giovanni XXIII Hosp, Bergamo, Italy; [Ryu, Min-Hee] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea; [Fornaro, Lorenzo] Azienda Osped Univ Pisana, Pisa, Italy; [Olesinski, Tomasz] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Caglevic, Christian] Fdn Arturo Lopez Perez Clin Alemana Santiago, Santiago, Chile; [Chung, Hyun C.] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea; [Muro, Kei] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan; [Goekkurt, Eray] HOPE, Hamburg, Germany; [Goekkurt, Eray] Univ Canc Ctr Hamburg, Hamburg, Germany; [Mansoor, Wasat] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England; [McDermott, Raymond S.] Adelaide & Meath Hosp, Dublin, Ireland; [Shacham-Shmueli, Einat] Sheba Med Ctr, Ramat Gan, Israel; [Chen, Xinqun; Mayo, Carlos; Kang, S. Peter] Merck & Co Inc, Kenilworth, NJ USA; [Fuchs, Charles S.] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA	National Cancer Center - Japan; Istanbul University; Istanbul University - Cerrahpasa; Seoul National University (SNU); Fondazione IRCCS Istituto Nazionale Tumori Milan; ASST Papa Giovanni XXIII; University of Ulsan; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Maria Sklodowska-Curie National Research Institute of Oncology; Yonsei University; Yonsei University Health System; Aichi Cancer Center; University of Hamburg; University Medical Center Hamburg-Eppendorf; Christie NHS Foundation Trust; Christie Hospital; Trinity College Dublin; Chaim Sheba Medical Center; Merck & Company; Yale University	Shitara, K (corresponding author), Natl Canc Ctr Hosp East, Kashiwa, Chiba 2770882, Japan.	kshitara@east.ncc.go.jp	caglevic, christian/GZK-3489-2022; mandala, mario/AAB-8637-2022; MUSTAFA, ÖZGÜROĞLU/A-8234-2016; Shacham-Shmueli, Einat/AAO-5068-2021; Shitara, Kohei/AAA-3877-2021; Bang, Yung Jue/J-2759-2012; Di Bartolomeo, Maria/D-1655-2017; Chau, Ian/ABC-2023-2020; Mandala', Mario/AAA-4258-2019; WOJTUKIEWICZ, MAREK/T-1114-2018	MUSTAFA, ÖZGÜROĞLU/0000-0002-8417-8628; Bang, Yung Jue/0000-0001-6000-4597; Di Bartolomeo, Maria/0000-0002-7954-6609; Chau, Ian/0000-0003-0286-8703; YEH, Kun-Huei/0000-0002-7306-174X; McDermott, Ray/0000-0002-8952-4315; Pazo-Cid, Roberto A./0000-0002-8026-7391; Hochhauser, Daniel/0000-0001-5522-9281; Olesinski, Tomasz/0000-0001-6492-4331; Kelly, Professor Catherine M./0000-0001-8355-6714; Karapetis, Christos/0000-0003-1741-996X; Fornaro, Lorenzo/0000-0002-0187-5904; Chung, Hyun/0000-0002-0920-9471; , Markus/0000-0003-2490-9131; Lynam, James/0000-0002-6742-820X; WOJTUKIEWICZ, MAREK/0000-0002-7604-8188	Merck Sharp & Dohme, a subsidiary of Merck Co.	Merck Sharp & Dohme, a subsidiary of Merck Co.	Merck Sharp & Dohme, a subsidiary of Merck & Co.	Balar AV, 2017, LANCET ONCOL, V18, P1483, DOI 10.1016/S1470-2045(17)30616-2; Bang YJ, 2010, LANCET, V376, P1302; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Chang LS, 2018, APPL IMMUNOHISTO M M, V26, pE15, DOI 10.1097/PAI.0000000000000575; Daud AI, 2016, J CLIN ONCOL, V34, P4102, DOI 10.1200/JCO.2016.67.2477; Diaz LA, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.3071; Duke Margolis Center for Health Policy, 2018, PUBL WORKSH ONC CLIN; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Fuchs CS, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2018.0013; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Hironaka S, 2013, J CLIN ONCOL, V31, P4438, DOI 10.1200/JCO.2012.48.5805; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Kang YK, 2017, LANCET, V390, P2461, DOI 10.1016/S0140-6736(17)31827-5; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; National Comprehensive Cancer Network, 2017, NCCN CLIN PRACT GUID; Panda Anshuman, 2018, J Natl Cancer Inst, V110, P316, DOI 10.1093/jnci/djx213; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Smyth EC, 2016, ANN ONCOL, V27, pv38, DOI 10.1093/annonc/mdw350; Van Laethem JL, 2016, DIGEST LIVER DIS, V48, P1283, DOI 10.1016/j.dld.2016.08.112; Wainberg ZA, 2017, ANN ONCOL, V28; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6	28	703	746	9	136	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2018	392	10142					123	133		10.1016/S0140-6736(18)31257-1	http://dx.doi.org/10.1016/S0140-6736(18)31257-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM8RQ	29880231				2022-12-28	WOS:000438501300027
J	Shah, ND; Steyerberg, EW; Kent, DM				Shah, Nilay D.; Steyerberg, Ewout W.; Kent, David M.			Big Data and Predictive Analytics Recalibrating Expectations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MODELS; PERFORMANCE		[Shah, Nilay D.] Mayo Clin, Dept Hlth Sci Res, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA; [Steyerberg, Ewout W.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [Kent, David M.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Predict Analyt & Comparat Effectiveness Ctr, 800 Washington St,POB 63, Boston, MA 02111 USA	Mayo Clinic; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Tufts Medical Center	Kent, DM (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Predict Analyt & Comparat Effectiveness Ctr, 800 Washington St,POB 63, Boston, MA 02111 USA.	dkent1@tuftsmedicalcenter.org			Patient-Centered Outcomes Research Institute [SA.Tufts.PARC.OCSO.2018.01.25, ME-1606-35555]; National Institutes of Health [U01NS086294]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS086294] Funding Source: NIH RePORTER	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by grants from the Patient-Centered Outcomes Research Institute (SA.Tufts.PARC.OCSO.2018.01.25 and ME-1606-35555) and grant U01NS086294 from the National Institutes of Health.	[Anonymous], 2017, ANN SURG ONCOL, DOI DOI 10.1186/S41512-017-0021-2; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Specht MC, 2005, ANN SURG ONCOL, V12, P654, DOI 10.1245/ASO.2005.06.037; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Van Calster B, 2015, MED DECIS MAKING, V35, P162, DOI 10.1177/0272989X14547233; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Wessler Benjamin S, 2017, Diagn Progn Res, V1, P20, DOI 10.1186/s41512-017-0021-2	8	133	135	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2018	320	1					27	28		10.1001/jama.2018.5602	http://dx.doi.org/10.1001/jama.2018.5602			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL5PC	29813156				2022-12-28	WOS:000437219400008
J	Zhang, ZY; Romano, D; Ivison, RJ; Papadopoulos, PP; Matteucci, F				Zhang, Zhi-Yu; Romano, D.; Ivison, R. J.; Papadopoulos, Padelis P.; Matteucci, F.			Stellar populations dominated by massive stars in dusty starburst galaxies across cosmic time	NATURE			English	Article							LENSED SUBMILLIMETER GALAXIES; GALACTIC CHEMICAL EVOLUTION; FORMING GALAXIES; MOLECULAR GAS; CLOVERLEAF QUASAR; HIGH-REDSHIFT; DWARF GALAXIES; H-ALPHA; ABUNDANCES; RATIOS	All measurements of cosmic star formation must assume an initial distribution of stellar masses-the stellar initial mass function-in order to extrapolate from the star-formation rate measured for typically rare, massive stars (of more than eight solar masses) to the total star-formation rate across the full stellar mass spectrum1. The shape of the stellar initial mass function in various galaxy populations underpins our understanding of the formation and evolution of galaxies across cosmic time(2). Classical determinations of the stellar initial mass function in local galaxies are traditionally made at ultraviolet, optical and near-infrared wavelengths, which cannot be probed in dust-obscured galaxies(2,3), especially distant starbursts, whose apparent star-formation rates are hundreds to thousands of times higher than in the Milky Way, selected at submillimetre (rest-frame far-infrared) wavelengths(4,5). The C-13/O-18 isotope abundance ratio in the cold molecular gaswhich can be probed via the rotational transitions of the (CO)-C-13 and (CO)-O-18 isotopologues-is a very sensitive index of the stellar initial mass function, with its determination immune to the pernicious effects of dust. Here we report observations of (CO)-C-13 and (CO)-O-18 emission for a sample of four dust-enshrouded starbursts at redshifts of approximately two to three, and find unambiguous evidence for a top-heavy stellar initial mass function in all of them. A low (CO)-C-13/(CO)-O-18 ratio for all our targets-alongside a well tested, detailed chemical evolution model benchmarked on the Milky Way6-implies that there are considerably more massive stars in starburst events than in ordinary star-forming spiral galaxies. This can bring these extraordinary starbursts closer to the ` main sequence' of star-forming galaxies(7), although such main-sequence galaxies may not be immune to changes in initial stellar mass function, depending on their star-formation densities.	[Zhang, Zhi-Yu; Ivison, R. J.] Univ Edinburgh, Inst Astron, Edinburgh, Midlothian, Scotland; [Zhang, Zhi-Yu; Ivison, R. J.] European Southern Observ, Garching, Germany; [Romano, D.] INAF, Astrophys & Space Sci Observ, Bologna, Italy; [Papadopoulos, Padelis P.] Aristotle Univ Thessaloniki, Dept Phys, Sect Astrophys Astron & Mech, Thessaloniki, Greece; [Papadopoulos, Padelis P.] Acad Athens, Res Ctr Astron, Athens, Greece; [Matteucci, F.] Univ Trieste, Sect Astron, Dept Phys, Trieste, Italy; [Matteucci, F.] INAF, Osservatorio Astron Trieste, Trieste, Italy; [Matteucci, F.] Ist Nazl Fis Nucl, Sez Trieste, Trieste, Italy	University of Edinburgh; European Southern Observatory; Istituto Nazionale Astrofisica (INAF); Aristotle University of Thessaloniki; Academy of Athens; University of Trieste; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale di Fisica Nucleare (INFN)	Ivison, RJ (corresponding author), Univ Edinburgh, Inst Astron, Edinburgh, Midlothian, Scotland.; Ivison, RJ (corresponding author), European Southern Observ, Garching, Germany.	rob.ivison@eso.org	Romano, Donatella/AAK-6854-2021; Romano, Donatella/P-3873-2015; Papadopoulos, Panagiotis/B-2822-2012	Romano, Donatella/0000-0002-0845-6171; Zhang, Zhiyu/0000-0002-7299-2876; Ivison, Rob/0000-0001-5118-1313; Papadopoulos, Panagiotis/0000-0001-9913-9771	European Research Council in the form of the Advanced Investigator Programme, COSMICISM [321302]; Trieste University, FRA2016; Munich Institute for Astro- and Particle Physics (MIAPP) of the DFG cluster of excellence "Origin and Structure of the Universe"; STFC [ST/R000972/1] Funding Source: UKRI	European Research Council in the form of the Advanced Investigator Programme, COSMICISM; Trieste University, FRA2016; Munich Institute for Astro- and Particle Physics (MIAPP) of the DFG cluster of excellence "Origin and Structure of the Universe"; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Z.-Y.Z. is grateful to X. Fu, H.-Y.B. Liu, Y. Shirley and P. Barnes for discussions. Z.-Y.Z., R.J.I. and P. P. P. acknowledge support from the European Research Council in the form of the Advanced Investigator Programme, 321302, COSMICISM. F.M. acknowledges financial funds from Trieste University, FRA2016. This research was supported by the Munich Institute for Astro- and Particle Physics (MIAPP) of the DFG cluster of excellence "Origin and Structure of the Universe". This work also benefited from the International Space Science Institute (ISSI) in Bern, thanks to the funding of the team "The Formation and Evolution of the Galactic Halo" (Principal Investigator D.R.) This paper makes use of the ALMA data. ALMA is a partnership of ESO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada), MOST and ASIAA (Taiwan), and KASI (South Korea), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ.	AALTO S, 1995, ASTRON ASTROPHYS, V300, P369; Aravena M, 2016, MON NOT R ASTRON SOC, V457, P4406, DOI 10.1093/mnras/stw275; Ballero SK, 2007, ASTRON ASTROPHYS, V467, P123, DOI 10.1051/0004-6361:20066596; Banerjee S, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201218972; Barnes PJ, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/1/6; Bastian N, 2010, ANNU REV ASTRON ASTR, V48, P339, DOI 10.1146/annurev-astro-082708-101642; Carigi L, 2005, ASTROPHYS J, V623, P213, DOI 10.1086/428491; Cescutti G, 2009, ASTRON ASTROPHYS, V505, P605, DOI 10.1051/0004-6361/200912759; Chartas G, 2004, ASTROPHYS J, V606, P78, DOI 10.1086/382743; Dabringhausen J, 2009, MON NOT R ASTRON SOC, V394, P1529, DOI 10.1111/j.1365-2966.2009.14425.x; Dabringhausen J, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/72; Danielson ALR, 2013, MON NOT R ASTRON SOC, V436, P2793, DOI 10.1093/mnras/stt1775; Davis TA, 2014, MON NOT R ASTRON SOC, V445, P2378, DOI 10.1093/mnras/stu1850; Dye S, 2014, MON NOT R ASTRON SOC, V440, P2013, DOI 10.1093/mnras/stu305; Falgarone E, 2017, NATURE, V548, P430, DOI 10.1038/nature23298; Ferkinhoff C, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/2/260; FRERKING MA, 1982, ASTROPHYS J, V262, P590, DOI 10.1086/160451; Greve TR, 2009, ASTROPHYS J, V692, P1432, DOI 10.1088/0004-637X/692/2/1432; Griffin MJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014519; Heikkila A, 1998, ASTRON ASTROPHYS, V332, P493; Henkel C, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201322962; HENKEL C, 1993, ASTRON ASTROPHYS, V274, P730; Henkel C, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/200912889; Hughes DH, 1998, NATURE, V394, P241, DOI 10.1038/28328; Hughes GL, 2008, MON NOT R ASTRON SOC, V390, P1710, DOI 10.1111/j.1365-2966.2008.13870.x; Jimenez-Donaire MJ, 2017, ASTROPHYS J LETT, V836, DOI 10.3847/2041-8213/836/2/L29; Kalari VM, 2018, ASTROPHYS J, V857, DOI 10.3847/1538-4357/aab609; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Kobayashi C, 2011, MON NOT R ASTRON SOC, V414, P3231, DOI 10.1111/j.1365-2966.2011.18621.x; Kroupa P., 2013, STELLAR SUBSTELLAR I, P115, DOI [10.1007/978-94-007-5612-0, DOI 10.1007/978-94-007-5612-0]; Lee JC, 2009, ASTROPHYS J, V706, P599, DOI 10.1088/0004-637X/706/1/599; Li J, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201220943; Ma JZ, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/1/88; Madau P, 1996, MON NOT R ASTRON SOC, V283, P1388, DOI 10.1093/mnras/283.4.1388; MAGAIN P, 1988, NATURE, V334, P325, DOI 10.1038/334325a0; Mangum JG, 2015, PUBL ASTRON SOC PAC, V127, P266, DOI 10.1086/680323; Martin S, 2009, ASTROPHYS J, V694, P610, DOI 10.1088/0004-637X/694/1/610; MATTEUCCI F, 1986, ASTRON ASTROPHYS, V154, P279; Matteucci F., 2001, CHEM EVOLUTION GALAX, V253; Matteucci F., 2012, CHEM EVOLUTION GALAX; McMullin JP, 2007, ASTR SOC P, V376, P127; Meyer BS, 2008, REV MINERAL GEOCHEM, V68, P31, DOI 10.2138/rmg.2008.68.4; Muraoka K, 2017, ASTROPHYS J, V844, DOI 10.3847/1538-4357/aa7a0b; Negrello M, 2014, MON NOT R ASTRON SOC, V440, P1999, DOI 10.1093/mnras/stu413; Negrello M, 2010, SCIENCE, V330, P800, DOI 10.1126/science.1193420; Nishimura Y, 2016, ASTROPHYS J, V829, DOI 10.3847/0004-637X/829/2/94; Noeske KG, 2007, ASTROPHYS J, V660, pL43, DOI 10.1086/517926; Nomoto K, 2006, NUCL PHYS A, V777, P424, DOI 10.1016/j.nuclphysa.2006.05.008; Omont A, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201220811; Pagel B.E.J., 1997, NUCLEOSYNTHESIS CHEM; Pagel B.E.J., 2009, NUCLEOSYNTHESIS CHEM; Papadopoulos PP, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/153; Peacock MB, 2017, ASTROPHYS J, V841, DOI 10.3847/1538-4357/aa70eb; Pflamm-Altenburg J, 2008, NATURE, V455, P641, DOI 10.1038/nature07266; Pflamm-Altenburg J, 2009, ASTROPHYS J, V706, P516, DOI 10.1088/0004-637X/706/1/516; Romano D, 2017, MON NOT R ASTRON SOC, V470, P401, DOI 10.1093/mnras/stx1197; Romano D, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201014483; Romano D, 2015, MON NOT R ASTRON SOC, V446, P4220, DOI 10.1093/mnras/stu2427; SAGE LJ, 1991, ASTRON ASTROPHYS, V249, P31; SCHALLER G, 1992, ASTRON ASTROPHYS SUP, V96, P269; Schneider FRN, 2018, SCIENCE, V359, P69, DOI 10.1126/science.aan0106; Schoier FL, 2005, ASTRON ASTROPHYS, V432, P369, DOI 10.1051/0004-6361:20041729; Simpson JM, 2017, ASTROPHYS J, V839, DOI 10.3847/1538-4357/aa65d0; Sliwa K, 2017, ASTROPHYS J LETT, V840, DOI 10.3847/2041-8213/aa6ea4; Smail I, 1997, ASTROPHYS J, V490, pL5, DOI 10.1086/311017; Solomon P, 2003, NATURE, V426, P636, DOI 10.1038/nature02149; Speagle JS, 2014, ASTROPHYS J SUPPL S, V214, DOI 10.1088/0067-0049/214/2/15; Spilker JS, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/149; TIMMES FX, 1995, ASTROPHYS J SUPPL S, V98, P617, DOI 10.1086/192172; Tinsley B. M., 1980, Fundamentals of Cosmic Physics, V5, P287; van der Tak FFS, 2007, ASTRON ASTROPHYS, V468, P627, DOI 10.1051/0004-6361:20066820; Venturini S, 2003, ASTROPHYS J, V590, P740, DOI 10.1086/375050; Vieira JD, 2013, NATURE, V495, P344, DOI 10.1038/nature12001; Wang SX, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/179; Weiss A, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/88; Weiss A, 2003, ASTRON ASTROPHYS, V409, pL41, DOI 10.1051/0004-6361:20031337; WILSON TL, 1992, ASTRON ASTROPHYS REV, V4, P1, DOI 10.1007/BF00873568; Yang C, 2017, ASTRON ASTROPHYS, V608, DOI 10.1051/0004-6361/201731391; Zinchenko I, 2000, ASTRON ASTROPHYS, V361, P1079	80	125	126	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2018	558	7709					260	+		10.1038/s41586-018-0196-x	http://dx.doi.org/10.1038/s41586-018-0196-x			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2BI	29867162	Green Submitted			2022-12-28	WOS:000435071400047
J	Kjeldsen, SE; Esler, MD				Kjeldsen, Sverre E.; Esler, Murray D.			Take a blood pressure pill or undergo renal denervation?	LANCET			English	Editorial Material							RESISTANT HYPERTENSION; MEDICATION; TRIALS; SHAM		[Kjeldsen, Sverre E.] Univ Oslo, Fac Med, Oslo, Norway; [Kjeldsen, Sverre E.] Ullevaal Univ Hosp, Sect Cardiovasc & Renal Res, N-0407 Oslo, Norway; [Kjeldsen, Sverre E.] Ullevaal Univ Hosp, Dept Cardiol, N-0407 Oslo, Norway; [Esler, Murray D.] Baker Heart & Diabet Inst, Melbourne, Vic, Australia	University of Oslo; University of Oslo; University of Oslo; Baker Heart and Diabetes Institute	Kjeldsen, SE (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.; Kjeldsen, SE (corresponding author), Ullevaal Univ Hosp, Sect Cardiovasc & Renal Res, N-0407 Oslo, Norway.; Kjeldsen, SE (corresponding author), Ullevaal Univ Hosp, Dept Cardiol, N-0407 Oslo, Norway.	sverrkj@online.no			Norwegian Council for Cardiovascular Diseases; Norwegian National Research Council; Norwegian South-East Health Authority	Norwegian Council for Cardiovascular Diseases; Norwegian National Research Council; Norwegian South-East Health Authority	SEK has received ad-hoc honoraria for lecturing from Bayer, Merck & Co, Sanofi, and Takeda, and honoraria from Takeda for study committee work within the past 3 years, all outside the area of work commented on here. SEK's ongoing research is exclusively supported by public funds (Norwegian Council for Cardiovascular Diseases, Norwegian National Research Council, and The Norwegian South-East Health Authority). MDE is a member of Medtronic's Renal Denervation Advisory Board and receives honoraria from Medtronic.	Azizi M, 2018, LANCET, V391, P2335, DOI 10.1016/S0140-6736(18)31082-1; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Brinker S, 2014, J AM COLL CARDIOL, V63, P834, DOI 10.1016/j.jacc.2013.10.067; Bulsei J, 2018, BLOOD PRESSURE, V27, P66, DOI 10.1080/08037051.2017.1394160; de Jong MR, 2018, BLOOD PRESSURE, V27, P271, DOI 10.1080/08037051.2018.1463817; Elmula FEMF, 2017, BLOOD PRESSURE, V26, P195, DOI 10.1080/08037051.2017.1311769; Elmula FEMF, 2014, HYPERTENSION, V63, P991, DOI 10.1161/HYPERTENSIONAHA.114.03246; Elmula FEMF, 2013, HYPERTENSION, V62, P526, DOI 10.1161/HYPERTENSIONAHA.113.01452; Elmula FEMF, 2015, BLOOD PRESSURE, V24, P263, DOI 10.3109/08037051.2015.1058595; Eskas PA, 2016, BLOOD PRESSURE, V25, P199, DOI 10.3109/08037051.2015.1121706; ESLER M, 1977, NEW ENGL J MED, V296, P405, DOI 10.1056/NEJM197702242960801; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Kandzari DE, 2018, LANCET, V391, P2346, DOI 10.1016/S0140-6736(18)30951-6; Kjeldsen SE, 2015, J AM COLL CARDIOL, V65, P1322, DOI 10.1016/j.jacc.2015.01.038; Persu A, 2014, HYPERTENS RES, V37, P967, DOI 10.1038/hr.2014.83; Townsend RR, 2017, LANCET, V390, P2160, DOI 10.1016/S0140-6736(17)32281-X	16	7	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2018	391	10137					2298	2300		10.1016/S0140-6736(18)31126-7	http://dx.doi.org/10.1016/S0140-6736(18)31126-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI6WF	29803587				2022-12-28	WOS:000434643200006
J	Domingo, J; Diss, G; Lehner, B				Domingo, Julia; Diss, Guillaume; Lehner, Ben			Pairwise and higher-order genetic interactions during the evolution of a tRNA	NATURE			English	Article							EMPIRICAL FITNESS LANDSCAPES; SACCHAROMYCES-CEREVISIAE; EPISTASIS; PROTEIN; GENOTYPE; SEQUENCE; YEAST; PREDICTABILITY; DOMAIN; TOOL	A central question in genetics and evolution is the extent to which the outcomes of mutations change depending on the genetic context in which they occur(1-3). Pairwise interactions between mutations have been systematically mapped within(4-8) and between(19) genes, and have been shown to contribute substantially to phenotypic variation among individuals'. However, the extent to which genetic interactions themselves are stable or dynamic across genotypes is unclear(21,22). Here we quantify more than 45,000 genetic interactions between the same 87 pairs of mutations across more than 500 closely related genotypes of a yeast tRNA. Notably, all pairs of mutations interacted in at least 9% of genetic backgrounds and all pairs switched from interacting positively to interacting negatively in different genotypes (false discovery rate < 0.1). Higher-order interactions are also abundant and dynamic across genotypes. The epistasis in this tRNA means that all individual mutations switch from detrimental to beneficial, even in closely related genotypes. As a consequence, accurate genetic prediction requires mutation effects to be measured across different genetic backgrounds and the use of higher-order epistatic terms.	[Domingo, Julia; Diss, Guillaume; Lehner, Ben] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Syst Biol Program, Barcelona, Spain; [Lehner, Ben] UPF, Barcelona, Spain; [Lehner, Ben] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Lehner, B (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Syst Biol Program, Barcelona, Spain.; Lehner, B (corresponding author), UPF, Barcelona, Spain.; Lehner, B (corresponding author), ICREA, Barcelona, Spain.	ben.lehner@crg.eu	Lehner, Ben/L-3413-2014; Diss, Guillaume/O-3859-2019	Lehner, Ben/0000-0002-8817-1124; Diss, Guillaume/0000-0001-9153-4523; Domingo, Julia/0000-0001-6359-2785	European Research Council Consolidator grant [616434]; Spanish Ministry of Economy and Competitiveness [BFU2011-26206, SEV-2012-0208]; AXA Research Fund; Bettencourt Schueller Foundation; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR); EMBL-CRG Systems Biology Program; CERCA Program/Generalitat de Catalunya	European Research Council Consolidator grant(European Research Council (ERC)); Spanish Ministry of Economy and Competitiveness(Spanish Government); AXA Research Fund(AXA Research Fund); Bettencourt Schueller Foundation; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); EMBL-CRG Systems Biology Program; CERCA Program/Generalitat de Catalunya	We thank J. Schmiedel for statistical guidance. This work was supported by a European Research Council Consolidator grant (616434), the Spanish Ministry of Economy and Competitiveness (BFU2011-26206 and SEV-2012-0208), the AXA Research Fund, the Bettencourt Schueller Foundation, Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), the EMBL-CRG Systems Biology Program, and the CERCA Program/Generalitat de Catalunya. Deep sequencing was performed in the EMBL Heidelberg GeneCore Genomics Core Facility.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Araya CL, 2012, P NATL ACAD SCI USA, V109, P16858, DOI 10.1073/pnas.1209751109; Bank C, 2016, P NATL ACAD SCI USA, V113, P14085, DOI 10.1073/pnas.1612676113; Bank C, 2015, MOL BIOL EVOL, V32, P229, DOI 10.1093/molbev/msu301; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Crawley M.J., 2007, R BOOK; de Visser JAGM, 2014, NAT REV GENET, V15, P480, DOI 10.1038/nrg3744; Diss G, 2018, ELIFE, V7, DOI 10.7554/eLife.32472; Ferretti L, 2016, J THEOR BIOL, V396, P132, DOI 10.1016/j.jtbi.2016.01.037; Forsberg SKG, 2017, NAT GENET, V49, P497, DOI 10.1038/ng.3800; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Gong LI, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004328; Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631; Guy MP, 2014, GENE DEV, V28, P1721, DOI 10.1101/gad.245936.114; Hayden EJ, 2015, P NATL ACAD SCI USA, V112, P12444, DOI 10.1073/pnas.1420902112; Hopf TA, 2017, NAT BIOTECHNOL, V35, P128, DOI 10.1038/nbt.3769; Julien P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11558; Lehner B, 2013, NAT REV GENET, V14, P168, DOI 10.1038/nrg3404; Li C, 2016, SCIENCE, V352, P837, DOI 10.1126/science.aae0568; Marcet-Houben M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002220; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matuszewski S, 2016, GENETICS, V204, P77, DOI 10.1534/genetics.116.190462; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Melamed D, 2013, RNA, V19, P1537, DOI 10.1261/rna.040709.113; Olson CA, 2014, CURR BIOL, V24, P2643, DOI 10.1016/j.cub.2014.09.072; Palmer AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8385; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Poelwijk FJ, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004771; Puchta O, 2016, SCIENCE, V352, P840, DOI 10.1126/science.aaf0965; Rubin AF, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1272-5; Sailer ZR, 2017, GENETICS, V205, P1079, DOI 10.1534/genetics.116.195214; Sarkisyan KS, 2016, NATURE, V533, P397, DOI 10.1038/nature17995; SIKORSKI RS, 1989, GENETICS, V122, P19; Starr TN, 2016, PROTEIN SCI, V25, P1204, DOI 10.1002/pro.2897; Szendro IG, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/01/P01005; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Weinreich DM, 2013, CURR OPIN GENET DEV, V23, P700, DOI 10.1016/j.gde.2013.10.007; Weinreich DM, 2005, EVOLUTION, V59, P1165; Wu NC, 2016, ELIFE, V5, DOI 10.7554/eLife.16965; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	42	47	47	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					117	+		10.1038/s41586-018-0170-7	http://dx.doi.org/10.1038/s41586-018-0170-7			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29849145	Green Accepted			2022-12-28	WOS:000434273300048
J	Richards, T				Richards, Tessa			Bring outpatients into the 21st century	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com						Bell SK, 2017, OPENNOTES POWER KNOW; Bloem BR, 2017, HEALTH AFFAIR, V36, P1987, DOI 10.1377/hlthaff.2017.0832; de Iongh A, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k430; Eliot TS, LOVE SONG JA PRUFROC; Guthrie B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a867; Hagglund M, 2017, BMJ OPINION      JUN; Heida A, 2018, J CROHNS COLITIS, V12, P432, DOI 10.1093/ecco-jcc/jjx169; Laboi P, 2014, BMJ OPINION      NOV; Whear R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074774	9	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2018	361								k2472	10.1136/bmj.k2472	http://dx.doi.org/10.1136/bmj.k2472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BX	29875121	Bronze, Green Published			2022-12-28	WOS:000435073600006
J	Torjesen, I				Torjesen, Ingrid			Visa cap is driving up salaries of overseas doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2362; Rimmer A, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2197; Walters Smith Stone, 2018, TIER 2 RCOS ALLOCATI	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2018	361								k2461	10.1136/bmj.k2461	http://dx.doi.org/10.1136/bmj.k2461			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MZ	29858380				2022-12-28	WOS:000434276900006
J	Garzia, L; Kijima, N; Morrissy, AS; De Antonellis, P; Guerreiro-Stucklin, A; Holgado, BL; Wu, XC; Wang, X; Parsons, M; Zayne, K; Manno, A; Kuzan-Fischer, C; Nor, C; Donovan, LK; Liu, J; Qin, L; Garancher, A; Liu, KW; Mansouri, S; Luu, B; Thompson, YY; Ramaswamy, V; Peacock, J; Farooq, H; Skowron, P; Shih, DJH; Li, A; Ensan, S; Robbins, CS; Cybulsky, M; Mitra, S; Ma, Y; Moore, R; Mungall, A; Cho, YJ; Weiss, WA; Chan, JA; Hawkins, CE; Massimino, M; Jabado, N; Zapotocky, M; Sumerauer, D; Bouffet, E; Dirks, P; Tabori, U; Sorensen, PHB; Brastianos, PK; Aldape, K; Jones, SJM; Marra, MA; Woodgett, JR; Wechsler-Reya, RJ; Fults, DW; Taylor, MD				Garzia, Livia; Kijima, Noriyuki; Morrissy, A. Sorana; De Antonellis, Pasqualino; Guerreiro-Stucklin, Ana; Holgado, Borja L.; Wu, Xiaochong; Wang, Xin; Parsons, Michael; Zayne, Kory; Manno, Alex; Kuzan-Fischer, Claudia; Nor, Carolina; Donovan, Laura K.; Liu, Jessica; Qin, Lei; Garancher, Alexandra; Liu, Kun-Wei; Mansouri, Sheila; Luu, Betty; Thompson, Yuan Yao; Ramaswamy, Vijay; Peacock, John; Farooq, Hamza; Skowron, Patryk; Shih, David J. H.; Li, Angela; Ensan, Sherine; Robbins, Clinton S.; Cybulsky, Myron; Mitra, Siddhartha; Ma, Yussanne; Moore, Richard; Mungall, Andy; Cho, Yoon-Jae; Weiss, William A.; Chan, Jennifer A.; Hawkins, Cynthia E.; Massimino, Maura; Jabado, Nada; Zapotocky, Michal; Sumerauer, David; Bouffet, Eric; Dirks, Peter; Tabori, Uri; Sorensen, Poul H. B.; Brastianos, Priscilla K.; Aldape, Kenneth; Jones, Steven J. M.; Marra, Marco A.; Woodgett, James R.; Wechsler-Reya, Robert J.; Fults, Daniel W.; Taylor, Michael D.			A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases (vol 172, pg 1050, 2018)	CELL			English	Correction												mdtaylor@sickkids.ca	Jabado, Nada/AAN-4026-2020; Guerreiro Stücklin, Ana/GRR-4007-2022; Woodgett, Jim/F-1087-2010; Stucklin, Ana S. Guerreiro/Y-5794-2019; Mungall, Andrew J./U-7067-2018; de Antonellis, Pasqualino/AAT-1233-2020; Garancher, Alexandra/AAB-1569-2021; Shih, David J. H./AAE-8726-2019; Cybulsky, Myron I./AAD-6539-2019; Bouffet, Eric/AAB-8999-2020	Guerreiro Stücklin, Ana/0000-0003-3136-9241; Woodgett, Jim/0000-0003-3731-5797; Stucklin, Ana S. Guerreiro/0000-0003-3136-9241; Mungall, Andrew J./0000-0002-0905-2742; de Antonellis, Pasqualino/0000-0001-8551-9431; Shih, David J. H./0000-0002-9802-4937; Kuzan-Fischer, Claudia Miranda/0000-0003-2226-0682				Garzia L, 2018, CELL, V172, P1050, DOI 10.1016/j.cell.2018.01.038	1	25	26	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1549	1550		10.1016/j.cell.2018.05.033	http://dx.doi.org/10.1016/j.cell.2018.05.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856958	Bronze, Green Accepted			2022-12-28	WOS:000433989100024
J	Kalayil, S; Bhogaraju, S; Bonn, F; Shin, D; Liu, YB; Gan, NH; Basquin, J; Grumati, P; Luo, ZQ; Dikic, I				Kalayil, Sissy; Bhogaraju, Sagar; Bonn, Florian; Shin, Donghyuk; Liu, Yaobin; Gan, Ninghai; Basquin, Jerome; Grumati, Paolo; Luo, Zhao-Qing; Dikic, Ivan			Insights into catalysis and function of phosphoribosyl-linked serine ubiquitination	NATURE			English	Article							BIOLOGICAL MACROMOLECULES; LEGIONELLA EFFECTOR; SOLUTION SCATTERING; RESOLUTION; SOFTWARE; SYSTEM	Conventional ubiquitination regulates key cellular processes by catalysing the ATP-dependent formation of an isopeptide bond between ubiquitin (Ub) and primary amines in substrate proteins'. Recently, the SidE family of bacterial effector proteins (SdeA, SdeB, SdeC and SidE) from pathogenic Legionella pneumophila were shown to use NAD(+) to mediate phosphoribosyl-linked ubiquitination of serine residues in host proteins(2,3). However, the molecular architecture of the catalytic platform that enables this complex multistep process remains unknown. Here we describe the structure of the catalytic core of SdeA, comprising mono-ADP-ribosyltransferase (mART) and phosphodiesterase (PDE) domains, and shed light on the activity of two distinct catalytic sites for serine ubiquitination. The mART catalytic site is composed of an alpha-helical lobe (AHL) that, together with the mART core, creates a chamber for NAD(+) binding and ADP-ribosylation of ubiquitin. The catalytic site in the PDE domain cleaves ADP-ribosylated ubiquitin to phosphoribosyl ubiquitin (PR-Ub) and mediates a two-step PR-Ub transfer reaction: first to a catalytic histidine 277 (forming a transient SdeA H277-PR-Ub intermediate) and subsequently to a serine residue in host proteins. Structural analysis revealed a substrate binding cleft in the PDE domain, juxtaposed with the catalytic site, that is essential for positioning serines for ubiquitination. Using degenerate substrate peptides and newly identified ubiquitination sites in RTN4B, we show that disordered polypeptides with hydrophobic residues surrounding the target serine residues are preferred substrates for SdeA ubiquitination. Infection studies with L. pneumophila expressing substrate-binding mutants of SdeA revealed that substrate ubiquitination, rather than modification of the cellular ubiquitin pool, determines the pathophysiological effect of SdeA during acute bacterial infection.	[Kalayil, Sissy; Bhogaraju, Sagar; Bonn, Florian; Shin, Donghyuk; Liu, Yaobin; Grumati, Paolo; Dikic, Ivan] Goethe Univ Frankfurt, Univ Hosp, Med Fac, Inst Biochem 2, Frankfurt, Germany; [Kalayil, Sissy; Bhogaraju, Sagar; Shin, Donghyuk; Liu, Yaobin; Dikic, Ivan] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Gan, Ninghai; Luo, Zhao-Qing] Purdue Univ, Purdue Inst Immunol Inflammat & Infect Dis, W Lafayette, IN 47907 USA; [Gan, Ninghai; Luo, Zhao-Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Basquin, Jerome] Max Planck Inst Biochem, Dept Struct Cell Biol, Martinsried, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Max Planck Society	Dikic, I (corresponding author), Goethe Univ Frankfurt, Univ Hosp, Med Fac, Inst Biochem 2, Frankfurt, Germany.; Dikic, I (corresponding author), Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany.	ivan.dikic@biochem2.de	Shin, Donghyuk/AAM-9068-2020; Grumati, Paolo/AAA-5787-2019; Gan, Ninghai/AGX-2575-2022; Dikic, Ivan/O-4650-2015	Shin, Donghyuk/0000-0002-8272-6133; Dikic, Ivan/0000-0001-8156-9511; Gan, Ninghai/0000-0001-7238-4056; Kalayil, Sissy/0000-0002-6731-2055; Grumati, Paolo/0000-0002-9942-9389; Bhogaraju, Sagar/0000-0001-9998-5927	iNEXT [PID:3515]; DFG [SFB 1177, EXC115, SPP 1580]; European Research Council (ERC) under European Union [742720]; LOEWE program Ubiquitin Networks (Ub-Net) - State of Hesse/Germany; NIH-NIAID grant [R01AI127465]; Goethe University Nachwuchsforscher grant; LOEWE Center for Gene and Cell Therapy Frankfurt (CGT) - State of Hesse/Germany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127465] Funding Source: NIH RePORTER	iNEXT; DFG(German Research Foundation (DFG)); European Research Council (ERC) under European Union(European Research Council (ERC)); LOEWE program Ubiquitin Networks (Ub-Net) - State of Hesse/Germany; NIH-NIAID grant(CGIAR); Goethe University Nachwuchsforscher grant; LOEWE Center for Gene and Cell Therapy Frankfurt (CGT) - State of Hesse/Germany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Vogel for the gift of anti-SidC serum, R. Prabu for help with total mass analysis of proteolysed SdeA, O. Yildiz for sharing synchrotron time, A. Chaikuad for initial construct design of SdeA, T. Hunter and C. Lima for advice on histidine intermediate protocols, T. Hanke for the PDE mechanism scheme and discussion, T. Colby and I. Matic for their help with identifying ubiquitination sites of RTN4B by LC-MS/MS and B. Schulman and D. Scott for crystallography advice. Swiss Light Source beamtime was part of proposal 20161958. We thank the staff of SLS for their assistance in data collection as well as E. Veshkova, S. Rodriguez Gomez, S. Jelenic and F. Miljkovic for technical assistance; K. Koch, D. Holler, V. Dotsch and S. Knapp for comments on the paper; and D. Svergun's group at beamline P12, PETRA III, EMBL-DESY for SAXS data collection. This work was supported by iNEXT (PID:3515), the DFG-funded Collaborative Research Centre on Selective Autophagy (SFB 1177), the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No 742720), the DFG-funded Cluster of Excellence "Macromolecular Complexes" (EXC115), the DFG-funded SPP 1580 program "Intracellular Compartments as Places of Pathogen-Host-Interactions" (I.D.) and the LOEWE program Ubiquitin Networks (Ub-Net) and the LOEWE Center for Gene and Cell Therapy Frankfurt (CGT), both funded by the State of Hesse/Germany. NIH-NIAID grant R01AI127465 supported Z.-Q.L. The work of S.B. is also funded by a Goethe University Nachwuchsforscher grant.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akturk A, 2018, NATURE, V557, P729, DOI 10.1038/s41586-018-0147-6; BARRIO JR, 1972, P NATL ACAD SCI USA, V69, P2039, DOI 10.1073/pnas.69.8.2039; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Bhogaraju S, 2016, CELL, V167, P1636, DOI 10.1016/j.cell.2016.11.019; Bricogne G, 2017, BUSTER VERSION 2 10; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dong YA, 2018, NATURE, V557, P674, DOI 10.1038/s41586-018-0146-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fuhs SR, 2015, CELL, V162, P198, DOI 10.1016/j.cell.2015.05.046; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kee JM, 2012, ACS CHEM BIOL, V7, P44, DOI 10.1021/cb200445w; Kotewicz KM, 2017, CELL HOST MICROBE, V21, P169, DOI 10.1016/j.chom.2016.12.007; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Nielsen M, 2017, NUCLEIC ACIDS RES, V45, pW344, DOI 10.1093/nar/gkx276; Qiu JZ, 2016, NATURE, V533, P120, DOI 10.1038/nature17657; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Wong K, 2015, J BIOL CHEM, V290, P24727, DOI 10.1074/jbc.M115.671263; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822	30	47	49	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					734	+		10.1038/s41586-018-0145-8	http://dx.doi.org/10.1038/s41586-018-0145-8			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29795347	Green Accepted			2022-12-28	WOS:000433412900056
J	Morris, CA; Patel, MJ; Fenves, AZ; Masia, R				Morris, Charles A.; Patel, Midhir J.; Fenves, Andrew Z.; Masia, Ricard			Case 17-2018: A 40-Year-Old Woman with Leg Swelling and Abdominal Distention and Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC MEMBRANOUS NEPHROPATHY; NEPHROTIC SYNDROME; VENOUS THROMBOSIS; VEIN THROMBOSIS; RENAL-VEIN; DISEASE; ADULT; GLOMERULONEPHRITIS; THROMBOEMBOLISM; THROMBOPHILIA		[Morris, Charles A.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Patel, Midhir J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Fenves, Andrew Z.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Masia, Ricard] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Morris, Charles A.; Fenves, Andrew Z.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Patel, Midhir J.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Masia, Ricard] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Morris, CA (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Morris, CA (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.							Barbour SJ, 2012, KIDNEY INT, V81, P190, DOI 10.1038/ki.2011.312; Bataille Y, 2005, ACTA CLIN BELG, V60, P94, DOI 10.1179/acb.2005.017; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Bertina RM, 2001, THROMB HAEMOSTASIS, V86, P92; CAHEN R, 1989, NEPHROL DIAL TRANSPL, V4, P172, DOI 10.1093/oxfordjournals.ndt.a091852; Cervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187; Connors JM, 2017, NEW ENGL J MED, V377, P1177, DOI 10.1056/NEJMra1700365; Cushman M, 2004, JAMA-J AM MED ASSOC, V292, P1573, DOI 10.1001/jama.292.13.1573; DABBS DJ, 1986, AM J MED, V80, P63, DOI 10.1016/0002-9343(86)90049-5; Du Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104936; FORERO FV, 1988, AM J NEPHROL, V8, P457, DOI 10.1159/000167654; GERTZ MA, 1991, MEDICINE, V70, P246, DOI 10.1097/00005792-199107000-00002; Glassock RJ, 2003, NEPHROL DIAL TRANSPL, V18, P52, DOI 10.1093/ndt/gfg1060; Haas M, 1997, AM J KIDNEY DIS, V30, P621, DOI 10.1016/S0272-6386(97)90485-6; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; Kanigicherla D, 2013, KIDNEY INT, V83, P940, DOI 10.1038/ki.2012.486; KIERKEGAARD A, 1987, ACTA MED SCAND, V222, P409; Landolfi R, 1997, THROMB HAEMOSTASIS, V78, P617; LESLIE BR, 1978, NEW ENGL J MED, V298, P1312; Lionaki S, 2012, CLIN J AM SOC NEPHRO, V7, P43, DOI 10.2215/CJN.04250511; Loscalzo J, 2013, NEW ENGL J MED, V368, P956, DOI 10.1056/NEJMcibr1209459; Radford RG, 1996, JAMA-J AM MED ASSOC, V276, P466; Rivera F, 2004, KIDNEY INT, V66, P898, DOI 10.1111/j.1523-1755.2004.00833.x; Smalberg JH, 2012, BLOOD, V120, P4921, DOI 10.1182/blood-2011-09-376517; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504	25	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2018	378	22					2124	2132		10.1056/NEJMcpc1712228	http://dx.doi.org/10.1056/NEJMcpc1712228			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH5AL	29847754				2022-12-28	WOS:000433428000013
J	Rimmer, A				Rimmer, Abi			Doctors urge prime minister to intervene in case of surgical trainee denied right to stay in UK	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Doctors' Association UK, 2018, NHS SURG FORC RET NI; Iacobucci G, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2362	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2018	361								k2430	10.1136/bmj.k2430	http://dx.doi.org/10.1136/bmj.k2430			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MT	29853550				2022-12-28	WOS:000434276300014
J	Owen, J				Owen, Jonathan			Surgical procedures: plans to standardise access in London are being rushed through, says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2018	361								k2391	10.1136/bmj.k2391	http://dx.doi.org/10.1136/bmj.k2391			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MP	29848560				2022-12-28	WOS:000434275800013
J	Hales, CM; Kit, BK; Gu, QP; Ogden, CL				Hales, Craig M.; Kit, Brian K.; Gu, Qiuping; Ogden, Cynthia L.			Trends in Prescription Medication Use Among Children and Adolescents-United States, 1999-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NATIONAL TRENDS; ANTIBIOTIC USE; SLONE SURVEY; GUIDELINE; ADULTS; COUGH	IMPORTANCE Access to appropriate prescription medications, use of inappropriate or ineffective treatments, and adverse drug events are public health concerns among US children and adolescents. OBJECTIVE To evaluate trends in use of prescription medications among US children and adolescents. DESIGN, SETTING, AND PARTICIPANTS US children and adolescents aged 0 to 19 years in the 1999-2014 National Health and Nutrition Examination Survey (NHANES)serial cross-sectional, nationally representative surveys of the civilian noninstitutionalized population. EXPOSURES Sex, age, race and Hispanic origin, household income and education, insurance status, current health status. MAIN OUTCOMES AND MEASURES Use of any prescription medications or 2 or more prescription medications taken in the past 30 days; use of medications by therapeutic class; trends in medication use across 4-year periods from 1999-2002 to 2011-2014. Data were collected though in-home interview and direct observation of the prescription container. RESULTS Data on prescription medication use were available for 38 277 children and adolescents (mean age, 10 years; 49% girls). Overall, use of any prescription medication in the past 30 days decreased from 24.6%(95% CI, 22.6% to 26.6%) in 1999-2002 to 21.9% (95% CI, 20.3% to 23.6%) in 2011-2014 (beta = -0.41 percentage points every 2 years [95% CI, -0.79 to -0.03]; P =.04), but there was no linear trend in the use of 2 or more prescription medications (8.5%[95% CI, 7.6% to 9.4%] in 2011-2014). In 2011-2014, the most commonly used medication classes were asthma medications (6.1%[95% CI, 5.4% to 6.8%]), antibiotics (4.5%[95% CI, 3.7% to 5.5%]), attention-deficit/hyperactivity disorder (ADHD) medications (3.5%[95% CI, 2.9% to 4.2%]), topical agents (eg, dermatologic agents, nasal steroids) (3.5%[95% CI, 3.0% to 4.1%]), and antihistamines (2.0% [95% CI, 1.7% to 2.5%]). There were significant linear trends in 14 of 39 therapeutic classes or subclasses, or in individual medications, with 8 showing increases, including asthma and ADHD medications and contraceptives, and 6 showing decreases, including antibiotics, antihistamines, and upper respiratory combination medications. CONCLUSIONS AND RELEVANCE In this study of US children and adolescents based on a nationally representative survey, estimates of prescription medication use showed an overall decrease in use of any medication from 1999-2014. The prevalence of asthma medication, ADHD medication, and contraceptive use increased among certain age groups, whereas use of antibiotics, antihistamines, and upper respiratory combination medications decreased.	[Hales, Craig M.; Kit, Brian K.; Gu, Qiuping; Ogden, Cynthia L.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA; [Kit, Brian K.] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hales, CM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA.	chales@cdc.gov		Hales, Craig/0000-0002-2355-1177	National Center for Health Statistics (NCHS); Centers for Disease Control and Prevention (CDC)	National Center for Health Statistics (NCHS); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The National Center for Health Statistics (NCHS) and the Centers for Disease Control and Prevention (CDC) had a role in the design and conduct of the National Health and Nutrition Examination Survey, in the collection and management of the data, and in the review and approval of the manuscript; however, the NCHS and the CDC had no role in the analysis and interpretation of the data; preparation of the manuscript; or the decision to submit the manuscript for publication.	Akinbami LJ, PEDIATRICS; [Anonymous], 2011, PEDIATRICS S5, V128, pS213; [Anonymous], 2017, SURV AN COMPL SURV S; CDC, 2017, ANT US US PROGR OPP; Centers for Disease Control and Prevention, 2016, CDC GUID PRESCR OP C; Centers for Disease Control and Prevention (CDC), BE ANT AW SMART US B; Chai G, 2012, PEDIATRICS, V130, P23, DOI 10.1542/peds.2011-2879; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Frenk SM, 2016, J ANTIMICROB CHEMOTH, V71, P251, DOI 10.1093/jac/dkv319; Johann-Liang R, 2009, PHARMACOEPIDEM DR S, V18, P24, DOI 10.1002/pds.1679; Johnson Clifford L, 2014, Vital Health Stat 2, P1; Jonas Bruce S, 2013, NCHS Data Brief, P1; Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766; Kit BK, 2012, PEDIATRICS, V129, P62, DOI 10.1542/peds.2011-1513; Korn E, 1998, SURV METHODOL, V24, P193; National Asthma Education and Prevention Program, 2007, EXPERT PANEL REPORT, P417; National Center for Health Statistics, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2017, HLTH US 2016; National Center for Health Statistics Centers for Disease Control and Prevention (CDC), NHANES RESP RAT; National Center for Health Statistics Centers for Disease Control and Prevention (CDC), NHANES 1988 2014 DAT; National Center for Health Statistics Centers for Disease Control and Prevention (CDC), NHANES DAT DOC COD F; Olfson M, 2015, JAMA PSYCHIAT, V72, P867, DOI 10.1001/jamapsychiatry.2015.0500; Olfson M, 2012, ARCH GEN PSYCHIAT, V69, P1247, DOI 10.1001/archgenpsychiatry.2012.647; Sharfstein JM, 2007, NEW ENGL J MED, V357, P2321, DOI 10.1056/NEJMp0707400; Shehab N, 2016, JAMA-J AM MED ASSOC, V316, P2115, DOI 10.1001/jama.2016.16201; The R Project for Statistical Computing (R Core Team), 2017, R LANG ENV STAT COMP; Tobias JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2396; Tran AR, 2012, PSYCHIAT SERV, V63, P1095, DOI 10.1176/appi.ps.201100547; Vaz LE, 2014, PEDIATRICS, V133, P375, DOI 10.1542/peds.2013-2903; Vernacchio L, 2008, PEDIATRICS, V122, pE323, DOI 10.1542/peds.2008-0498; Vernacchio L, 2009, PEDIATRICS, V124, P446, DOI 10.1542/peds.2008-2869; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Youngster I, 2017, J PEDIATR-US, V182, P239, DOI 10.1016/j.jpeds.2016.11.027	34	80	80	3	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					2009	2020		10.1001/jama.2018.5690	http://dx.doi.org/10.1001/jama.2018.5690			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800213	Green Published, Bronze			2022-12-28	WOS:000432238300018
J	Smith, CA; de Lacey, S; Chapman, M; Ratcliffe, J; Norman, RJ; Johnson, NP; Boothroyd, C; Fahey, P				Smith, Caroline A.; de lacey, Sheryl; Chapman, Michael; Ratcliffe, Julie; Norman, Robert J.; Johnson, Neil P.; Boothroyd, Clare; Fahey, Paul			Effect of Acupuncture vs Sham Acupuncture on Live Births Among Women Undergoing In Vitro Fertilization A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREGNANCY; SAFETY; RATES	IMPORTANCE Acupuncture is widely used by women undergoing in vitro fertilization (IVF), although the evidence for efficacy is conflicting. OBJECTIVE To determine the efficacy of acupuncture compared with a sham acupuncture control performed during IVF on live births. DESIGN, SETTING, AND PARTICIPANTS A single-blind, parallel-group randomized clinical trial including 848 women undergoing a fresh IVF cycle was conducted at 16 IVF centers in Australia and New Zealand between June 29, 2011, and October 23, 2015, with 10 months of pregnancy follow-up until August 2016. INTERVENTIONS Women received either acupuncture (n = 424) or a sham acupuncture control (n = 424). The first treatment was administered between days 6 to 8 of follicle stimulation, and 2 treatments were administered prior to and following embryo transfer. The sham control used a noninvasive needle placed away from the true acupuncture points. MAIN OUTCOMES AND MEASURES The primary outcome was live birth, defined as the delivery of 1 or more living infants at greater than 20 weeks' gestation or birth weight of at least 400 g. RESULTS Among 848 randomized women, 24 withdrew consent, 824 were included in the study (mean [SD] age, 35.4 [4.3] years); 371 [45.0%] had undergone more than 2 previous IVF cycles), 607 proceeded to an embryo transfer, and 809 (98.2%) had data available on live birth outcomes. Live births occurred among 74 of 405 women (18.3%) receiving acupuncture compared with 72 of 404 women (17.8%) receiving sham control (risk difference, 0.5%[95% CI, -4.9% to 5.8%]; relative risk, 1.02 [95% CI, 0.76 to 1.38]). CONCLUSIONS AND RELEVANCE Among women undergoing IVF, administration of acupuncture vs sham acupuncture at the time of ovarian stimulation and embryo transfer resulted in no significant difference in live birth rates. These findings do not support the use of acupuncture to improve the rate of live births among women undergoing IVF.	[Smith, Caroline A.] Western Sydney Univ, NICM Hlth Res Inst, Locked Bag 1797, Penrith, NSW 2751, Australia; [de lacey, Sheryl] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Adelaide, SA, Australia; [Chapman, Michael] Univ New South Wales, Sch Womens & Children Hlth, IVF Australia, Sydney, NSW, Australia; [Ratcliffe, Julie] Univ South Australia, Inst Choice, Business Sch, Adelaide, SA, Australia; [Norman, Robert J.; Boothroyd, Clare] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Norman, Robert J.] Fertil SA, Adelaide, SA, Australia; [Boothroyd, Clare] Repromed, Auckland, New Zealand; [Boothroyd, Clare] Greenslopes Private Hosp, Greenslopes, Qld, Australia; [Fahey, Paul] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia	Western Sydney University; Flinders University South Australia; University of New South Wales Sydney; University of South Australia; Robinson Research Institute; University of Adelaide; Western Sydney University	Smith, CA (corresponding author), Western Sydney Univ, NICM Hlth Res Inst, Locked Bag 1797, Penrith, NSW 2751, Australia.	caroline.smith@westernsydney.edu.au	Norman, Robert J/A-1155-2007; Fahey, Paul P/B-7985-2013; Ratcliffe, Julie/G-3169-2017	Norman, Robert J/0000-0002-3118-3896; Fahey, Paul P/0000-0002-6351-9876; Ratcliffe, Julie/0000-0001-7365-1988; de Lacey, Sheryl/0000-0002-5652-9451	National Health and Medical Research Council of Australia [APP 1003661]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by project grant APP 1003661 from the National Health and Medical Research Council of Australia. Acupuncture needles were donated by Helio Supply Co.	Andersen D, 2010, REPROD BIOMED ONLINE, V21, P366, DOI 10.1016/j.rbmo.2010.03.029; Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Bovey M, 2010, FERTIL STERIL, V94, P2569, DOI 10.1016/j.fertnstert.2010.03.072; Chambers GM, 2016, ASSISTED REPROD TECH; Cheong YC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006920.pub3; Coulson Catherine, 2005, J Exp Clin Assist Reprod, V2, P5, DOI 10.1186/1743-1050-2-5; Deadman P., 1998, MANUAL ACUPUNCTURE; Dieterle S, 2006, FERTIL STERIL, V85, P1347, DOI 10.1016/j.fertnstert.2005.09.062; Glujovsky D, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002118.pub4, 10.1002/14651858.CD002118.pub5]; Lund Irene, 2006, Acupunct Med, V24, P13; MacPherson H, 2010, ACUPUNCT MED, V28, P83, DOI 10.1136/aim.2009.001370; Manheimer E, 2013, HUM REPROD UPDATE, V19, P696, DOI 10.1093/humupd/dmt026; Pariente J, 2005, NEUROIMAGE, V25, P1161, DOI 10.1016/j.neuroimage.2005.01.016; Park J, 2014, ACUPUNCT MED, V32, P257, DOI 10.1136/acupmed-2013-010480; Park Jongbae, 2002, Acupunct Med, V20, P168; Paulus WE, 2003, HUM REPROD, V18, P18; Paulus WE, 2002, FERTIL STERIL, V77, P721, DOI 10.1016/S0015-0282(01)03273-3; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, 2017, Fertil Steril, V107, P882, DOI 10.1016/j.fertnstert.2017.01.025; Smith C, 2006, FERTIL STERIL, V85, P1352, DOI 10.1016/j.fertnstert.2005.12.015; Smith CA, 2014, COMPLEMENT THER MED, V22, P710, DOI 10.1016/j.ctim.2014.06.001; Smith CA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-88; Smith CA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-60; Smith JF, 2011, FERTIL STERIL, V95, P79, DOI 10.1016/j.fertnstert.2010.06.043; So EWS, 2010, REPROD BIOMED ONLINE, V20, P814, DOI 10.1016/j.rbmo.2010.02.024; So EWS, 2009, HUM REPROD, V24, P341, DOI 10.1093/humrep/den380; Stankiewicz M, 2007, AUST NZ J OBSTET GYN, V47, P145, DOI 10.1111/j.1479-828X.2007.00702.x; Westergaard LG, 2006, FERTIL STERIL, V85, P1341, DOI 10.1016/j.fertnstert.2005.08.070; Witt CM, 2009, FORSCH KOMPLEMENTMED, V16, P91, DOI 10.1159/000209315; Wu XK, 2017, JAMA-J AM MED ASSOC, V317, P2502, DOI 10.1001/jama.2017.7217; Zhang CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140825	31	40	55	3	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					1990	1998		10.1001/jama.2018.5336	http://dx.doi.org/10.1001/jama.2018.5336			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800212	Green Published, Bronze			2022-12-28	WOS:000432238300016
J	Kishore, N; Marques, D; Mahmud, A; Kiang, MV; Rodriguez, I; Fuller, A; Ebner, P; Sorensen, C; Racy, F; Lemery, J; Maas, L; Leaning, J; Irizarry, RA; Balsari, S; Buckee, CO				Kishore, Nishant; Marques, Domingo; Mahmud, Ayesha; Kiang, Mathew V.; Rodriguez, Irmary; Fuller, Arlan; Ebner, Peggy; Sorensen, Cecilia; Racy, Fabio; Lemery, Jay; Maas, Leslie; Leaning, Jennifer; Irizarry, Rafael A.; Balsari, Satchit; Buckee, Caroline O.			Mortality in Puerto Rico after Hurricane Maria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISASTER; CYCLONE	BACKGROUND Quantifying the effect of natural disasters on society is critical for recovery of public health services and infrastructure. The death toll can be difficult to assess in the aftermath of a major disaster. In September 2017, Hurricane Maria caused massive infrastructural damage to Puerto Rico, but its effect on mortality remains contentious. The official death count is 64. METHODS Using a representative, stratified sample, we surveyed 3299 randomly chosen households across Puerto Rico to produce an independent estimate of all-cause mortality after the hurricane. Respondents were asked about displacement, infrastructure loss, and causes of death. We calculated excess deaths by comparing our estimated post-hurricane mortality rate with official rates for the same period in 2016. RESULTS From the survey data, we estimated a mortality rate of 14.3 deaths (95% confidence interval [CI], 9.8 to 18.9) per 1000 persons from September 20 through December 31, 2017. This rate yielded a total of 4645 excess deaths during this period (95% CI, 793 to 8498), equivalent to a 62% increase in the mortality rate as compared with the same period in 2016. However, this number is likely to be an underestimate because of survivor bias. The mortality rate remained high through the end of December 2017, and one third of the deaths were attributed to delayed or interrupted health care. Hurricane-related migration was substantial. CONCLUSIONS This household-based survey suggests that the number of excess deaths related to Hurricane Maria in Puerto Rico is more than 70 times the official estimate.	[Kishore, Nishant; Mahmud, Ayesha; Buckee, Caroline O.] Harvard Univ, Beth Israel Deaconess Med Ctr, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02138 USA; [Kiang, Mathew V.] Harvard Univ, Beth Israel Deaconess Med Ctr, Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02138 USA; [Irizarry, Rafael A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02138 USA; [Kishore, Nishant; Mahmud, Ayesha; Buckee, Caroline O.] Harvard Univ, Beth Israel Deaconess Med Ctr, Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02138 USA; [Fuller, Arlan; Leaning, Jennifer; Balsari, Satchit] Harvard Univ, Beth Israel Deaconess Med Ctr, Harvard TH Chan Sch Publ Hlth, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Boston, MA 02138 USA; [Racy, Fabio; Balsari, Satchit] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02138 USA; [Racy, Fabio; Balsari, Satchit] Harvard Med Sch, Boston, MA USA; [Irizarry, Rafael A.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Marques, Domingo; Rodriguez, Irmary] Carlos Albizu Univ, Dept Psychol, San Juan, PR USA; [Maas, Leslie] Puerto Rico Sci Technol & Res Trust, San Juan, PR USA; [Ebner, Peggy] Univ Southern Calif Los Angeles, Keck Sch Med, Los Angeles, CA 90007 USA; [Sorensen, Cecilia; Lemery, Jay] Univ Colorado, Sch Med, Dept Emergency Med, Sect Wilderness & Environm Med, Aurora, CO USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Colorado System; University of Colorado Anschutz Medical Campus	Buckee, CO (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02138 USA.; Buckee, CO (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02138 USA.	cbuckee@hsph.harvard.edu	Kiang, Mathew/J-5390-2019; Marqués, Domingo J./AAW-6379-2021	Kiang, Mathew/0000-0001-9198-150X; Cortes, Leslie/0000-0001-6394-8534; Kishore, Nishant/0000-0003-0408-2747	Harvard T.H. Chan School of Public Health; Harvard Francois-Xavier Bagnoud Center for Health and Human Rights; Department of Epidemiology at the Harvard T.H. Chan School of Public Health; Emergency Medicine Department at Beth Israel Deaconess Medical Center; Section of Wilderness and Environmental Medicine at the Department of Emergency Medicine, University of Colorado School of Medicine	Harvard T.H. Chan School of Public Health; Harvard Francois-Xavier Bagnoud Center for Health and Human Rights; Department of Epidemiology at the Harvard T.H. Chan School of Public Health; Emergency Medicine Department at Beth Israel Deaconess Medical Center; Section of Wilderness and Environmental Medicine at the Department of Emergency Medicine, University of Colorado School of Medicine	Supported by the Harvard T.H. Chan School of Public Health, the Harvard Francois-Xavier Bagnoud Center for Health and Human Rights, the Department of Epidemiology at the Harvard T.H. Chan School of Public Health, the Emergency Medicine Department at Beth Israel Deaconess Medical Center, and the Section of Wilderness and Environmental Medicine at the Department of Emergency Medicine, University of Colorado School of Medicine.	[Anonymous], 2017, REFERENCE GUIDE CERT; [Anonymous], 2018, PUBL HLTH SURV DIS; [Anonymous], 2018, QUICK FACTS HURRICAN; [Anonymous], 2017, PUERT RIC SPAT; [Anonymous], 2018, OFFICIAL MONTHLY MOR; [Anonymous], 2018, NBC NEWS; [Anonymous], 2009, INFORM ANUAL ESTADIS; [Anonymous], 2017, TELEMUNDO PR    1209; [Anonymous], 2017, MAR MAK LANDF NEAR Y; BERN C, 1993, B WORLD HEALTH ORGAN, V71, P73; BOSS LP, 1994, JAMA-J AM MED ASSOC, V272, P371, DOI 10.1001/jama.272.5.371; Campbell AF, 2017, PUERTO RICOS GOVERNO; Checchi F, 2005, INTERPRETING USING M; Checchi F, 2008, PLOS MED, V5, P1025, DOI 10.1371/journal.pmed.0050146; Costliest U. S. tropical cyclones tables updated, 2018, COSTL US TROP CYCL T; Disaster Epi, 2015, DIS EPI HSB STAFFS F; Finger F, 2016, P NATL ACAD SCI USA, V113, P6421, DOI 10.1073/pnas.1522305113; GLASS RI, 1977, SCIENCE, V197, P638, DOI 10.1126/science.197.4304.638; Kimberlain T.B., 2015, NATL HURRICANE CTR T, P1; Kleinpeter MA, 2011, CLIN J AM SOC NEPHRO, V6, P2337, DOI 10.2215/CJN.08690811; Lempert KD, 2013, AM J KIDNEY DIS, V61, P865, DOI 10.1053/j.ajkd.2013.03.017; Lilley S., 2018, NBC NEWS; Maria Major Hurricane, 2017, MAJ HURR MAR SEPT 20; Mazzei Patricia, 2017, NY TIMES; OpenStreetMap. org, 2017, PLAN FIL; Pascual OS, 2017, 1 10 DAYS HURRICANE; Prudhon C, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-10; Redmond AD, 2011, LANCET, V377, P1054, DOI 10.1016/S0140-6736(11)60319-X; Robles Frances, 2017, NY TIMES; Rodr?guez H., 2007, HDB DISASTER RES; Santos-Lozada AR, 2017, SOCARXIV PAPERS; Seervai S., 2017, COMMONWEALTH FU 1218; SMART, STAND MON ASS REL TR; SOMMER A, 1972, LANCET, V1, P1029; Sosa Pascual O, 2017, NEARLY 1000 MORE PEO; Sutter JD, 2017, CNN; U. S. Census Bureau, 2010, POP EST PROGR ANN ES; Varela JR, 2017, FEMA RESPONDS REPORT; Weiss DJ, 2018, NATURE, V553, P333, DOI 10.1038/nature25181	39	275	276	3	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2018	379	2					162	170		10.1056/NEJMsa1803972	http://dx.doi.org/10.1056/NEJMsa1803972			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM6DL	29809109	Green Published, Bronze			2022-12-28	WOS:000438249800012
J	Betz, ME; McCourt, AD; Vernick, JS; Ranney, ML; Maust, DT; Wintemute, GJ				Betz, Marian E.; McCourt, Alexander D.; Vernick, Jon S.; Ranney, Megan L.; Maust, Donovan T.; Wintemute, Garen J.			Firearms and Dementia: Clinical Considerations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											Betz, ME (corresponding author), Univ Colorado, Sch Med, Mail Stop B215,Leprino Bldg,12401 E 17th Ave, Aurora, CO 80045 USA.	marian.betz@ucdenver.edu	Betz, Marian/H-3303-2017	Betz, Marian/0000-0003-1643-6565	National Institute on Aging; American Federation for Aging Research; John A. Hartford Foundation; Atlantic Philanthropies [K23AG043123, K08AG048321]; Heising-Simons Foundation [2016-219]; National Institute of Mental Health [K23 MH095866]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH095866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG043123, K08AG048321] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; John A. Hartford Foundation; Atlantic Philanthropies; Heising-Simons Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the Paul Beeson Career Development Award Program from the National Institute on Aging, American Federation for Aging Research, The John A. Hartford Foundation, and The Atlantic Philanthropies (grants K23AG043123 and K08AG048321); the Heising-Simons Foundation (grant 2016-219); and the National Institute of Mental Health (grant K23 MH095866). No sponsor had any direct involvement in the study design, methods, participant recruitment, data collection, analysis, or manuscript preparation.	Betz ME, 2016, TRAFFIC INJ PREV, V17, P367, DOI 10.1080/15389588.2015.1101078; CDC Injury Prevention & Control, 2020, WISQARS WEB BAS INJ; FAA, 2017, TURB STAYING SAF; Greene E, 2007, BEHAV SCI LAW, V25, P405, DOI 10.1002/bsl.766; Parker Kim, 2017, AM COMPLEX RELATIONS; Patel D, 2015, AM J ALZHEIMERS DIS, V30, P337, DOI 10.1177/1533317514545867; Spangenberg KB, 1999, J AM GERIATR SOC, V47, P1183, DOI 10.1111/j.1532-5415.1999.tb05197.x; US Department of Veterans Affairs, 2016, VHA DEM STEER COMM R	8	30	30	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2018	169	1					47	+		10.7326/M18-0140	http://dx.doi.org/10.7326/M18-0140			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GL2FB	29801058	Green Accepted			2022-12-28	WOS:000436931900008
J	Ameismeier, M; Cheng, JD; Berninghausen, O; Beckmann, R				Ameismeier, Michael; Cheng, Jingdong; Berninghausen, Otto; Beckmann, Roland			Visualizing late states of human 40S ribosomal subunit maturation	NATURE			English	Article							CYTOPLASMIC MATURATION; NUCLEAR EXPORT; FINAL STEPS; BIOGENESIS; PROTEIN; RIO1; TOOLS	The formation of eukaryotic ribosomal subunits extends from the nucleolus to the cytoplasm and entails hundreds of assembly factors. Despite differences in the pathways of ribosome formation, high-resolution structural information has been available only from fungi. Here we present cryo-electron microscopy structures of late-stage human 40S assembly intermediates, representing one state reconstituted in vitro and five native states that range from nuclear to late cytoplasmic. The earliest particles reveal the position of the biogenesis factor RRP12 and distinct immature rRNA conformations that accompany the formation of the 40S subunit head. Molecular models of the late-acting assembly factors TSR1, RIOK1, RIOK2, ENP1, LTV1, PNO1 and NOB1 provide mechanistic details that underlie their contribution to a sequential 40S subunit assembly. The NOB1 architecture displays an inactive nuclease conformation that requires rearrangement of the PNO1-bound 3' rRNA, thereby coordinating the final rRNA folding steps with site 3 cleavage.	[Ameismeier, Michael; Cheng, Jingdong; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Gene Ctr Munich, Munich, Germany; [Ameismeier, Michael; Cheng, Jingdong] Univ Munich, CiPS M, Dept Biochem, Munich, Germany	University of Munich; University of Munich	Beckmann, R (corresponding author), Univ Munich, Gene Ctr Munich, Munich, Germany.	beckmann@genzentrum.lmu.de			Deutsche Forschungsgemeinschaft [SFB646, GRK1721, FOR1805]; European Research Council (ERC) Advanced Grant (CRYOTRANSLATION); DFG fellowship through the Graduate School of Quantitative Biosciences Munich (QBM)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council (ERC) Advanced Grant (CRYOTRANSLATION)(European Research Council (ERC)); DFG fellowship through the Graduate School of Quantitative Biosciences Munich (QBM)	The authors thank S. Rieder, H. Sieber and A. Gilmozzi for technical assistance, T. Frohlich for mass-spectrometry analysis and E. Hurt, T. Becker and L. Kater for discussions and critical comments on the manuscript. This research was supported by grants from the Deutsche Forschungsgemeinschaft (SFB646, GRK1721 and FOR1805 to R.B.) and by an European Research Council (ERC) Advanced Grant (CRYOTRANSLATION) to R.B. M.A. is supported by a DFG fellowship through the Graduate School of Quantitative Biosciences Munich (QBM).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Badertscher L, 2015, CELL REP, V13, P2879, DOI 10.1016/j.celrep.2015.11.061; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira-Cerca S, 2014, NUCLEIC ACIDS RES, V42, P8635, DOI 10.1093/nar/gku542; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Heuer A, 2017, ELIFE, V6, DOI 10.7554/eLife.30189; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Larburu N, 2016, NUCLEIC ACIDS RES, V44, P8465, DOI 10.1093/nar/gkw714; McCaughan UM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11789; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Oeffinger M, 2004, GENE DEV, V18, P196, DOI 10.1101/gad.285604; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Scaiola A, 2018, EMBO J, V37, DOI 10.15252/embj.201798499; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Sun Q, 2017, ELIFE, V6, DOI 10.7554/eLife.22086; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Turowski TW, 2014, NUCLEIC ACIDS RES, V42, P12189, DOI 10.1093/nar/gku878; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Widmann B, 2012, MOL BIOL CELL, V23, P22, DOI 10.1091/mbc.E11-07-0639; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Woolls HA, 2011, J BIOL CHEM, V286, P2578, DOI 10.1074/jbc.M110.191494; Wyler E, 2011, RNA, V17, P189, DOI 10.1261/rna.2325911; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zorbas C, 2015, MOL BIOL CELL, V26, P2080, DOI 10.1091/mbc.E15-02-0073	37	71	72	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2018	558	7709					249	+		10.1038/s41586-018-0193-0	http://dx.doi.org/10.1038/s41586-018-0193-0			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2BI	29875412				2022-12-28	WOS:000435071400045
J	van der Linde, S; Suz, LM; Orme, CDL; Cox, F; Andreae, H; Asi, E; Atkinson, B; Benham, S; Carroll, C; Cools, N; De Vos, B; Dietrich, HP; Eichhorn, J; Gehrmann, J; Grebenc, T; Gweon, HS; Hansen, K; Jacob, F; Kristofel, F; Lech, P; Manninger, M; Martin, J; Meesenburg, H; Merila, P; Nicolas, M; Pavlenda, P; Rautio, P; Schaub, M; Schrock, HW; Seidling, W; Sramek, V; Thimonier, A; Thomsen, IM; Titeux, H; Vanguelova, E; Verstraeten, A; Vesterdal, L; Waldner, P; Wijk, S; Zhang, YX; Zlindra, D; Bidartondo, MI				van der Linde, Sietse; Suz, Laura M.; Orme, C. David L.; Cox, Filipa; Andreae, Henning; Asi, Endla; Atkinson, Bonnie; Benham, Sue; Carroll, Christopher; Cools, Nathalie; De Vos, Bruno; Dietrich, Hans-Peter; Eichhorn, Johannes; Gehrmann, Joachim; Grebenc, Tine; Gweon, Hyun S.; Hansen, Karin; Jacob, Frank; Kristoefel, Ferdinand; Lech, Pawel; Manninger, Miklos; Martin, Jan; Meesenburg, Henning; Merila, Paivi; Nicolas, Manuel; Pavlenda, Pavel; Rautio, Pasi; Schaub, Marcus; Schroeck, Hans-Werner; Seidling, Walter; Sramek, Vit; Thimonier, Anne; Thomsen, Iben Margrete; Titeux, Hugues; Vanguelova, Elena; Verstraeten, Arne; Vesterdal, Lars; Waldner, Peter; Wijk, Sture; Zhang, Yuxin; Zlindra, Daniel; Bidartondo, Martin I.			Environment and host as large-scale controls of ectomycorrhizal fungi	NATURE			English	Article							SPECIES-AREA RELATIONSHIP; NITROGEN CRITICAL LOADS; FORAGING STRATEGIES; COMMUNITY STRUCTURE; FOREST; DEPOSITION; DIVERSITY; PATTERNS; PLANT; BIOGEOGRAPHY	Explaining the large-scale diversity of soil organisms that drive biogeochemical processes-and their responses to environmental change-is critical. However, identifying consistent drivers of belowground diversity and abundance for some soil organisms at large spatial scales remains problematic. Here we investigate a major guild, the ectomycorrhizal fungi, across European forests at a spatial scale and resolution that is-to our knowledge-unprecedented, to explore key biotic and abiotic predictors of ectomycorrhizal diversity and to identify dominant responses and thresholds for change across complex environmental gradients. We show the effect of 38 host, environment, climate and geographical variables on ectomycorrhizal diversity, and define thresholds of community change for key variables. We quantify host specificity and reveal plasticity in functional traits involved in soil foraging across gradients. We conclude that environmental and host factors explain most of the variation in ectomycorrhizal diversity, that the environmental thresholds used as major ecosystem assessment tools need adjustment and that the importance of belowground specificity and plasticity has previously been underappreciated.	[van der Linde, Sietse; Orme, C. David L.; Atkinson, Bonnie; Carroll, Christopher; Zhang, Yuxin; Bidartondo, Martin I.] Imperial Coll London, Life Sci, Ascot, Berks, England; [van der Linde, Sietse; Suz, Laura M.; Atkinson, Bonnie; Bidartondo, Martin I.] Royal Bot Gardens, Comparat Plant & Fungal Biol, London, England; [Cox, Filipa] Univ Manchester, Earth & Environm Sci, Manchester, Lancs, England; [Andreae, Henning] Kompetenzzentrum Wald & Forstwirtschaft, Publ Enterprise Sachsenforst, Pirna, Germany; [Asi, Endla] Estonian Environm Agcy, Tallinn, Estonia; [van der Linde, Sietse; Benham, Sue; Vanguelova, Elena] Forest Res, Alice Holt Lodge, Farnham, Surrey, England; [Cools, Nathalie; De Vos, Bruno; Verstraeten, Arne] Nat & Forest Res Inst, Environm & Climate, Geraardsbergen, Belgium; [Dietrich, Hans-Peter] Bavarian State Forestry Inst, Freising Weihenstephan, Germany; [Eichhorn, Johannes; Meesenburg, Henning] Northwest German Forest Res Inst, Gottingen, Germany; [Gehrmann, Joachim] Landesamt Nat Umwelt & Verbraucherschutz Nord, Recklinghausen, Germany; [Grebenc, Tine; Zlindra, Daniel] Slovenian Forestry Inst, Ljubljana, Slovenia; [Gweon, Hyun S.] Univ Reading, Biol Sci, Reading, Berks, England; [Gweon, Hyun S.] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Hansen, Karin] IVL Swedish Environm Res Inst, Stockholm, Sweden; [Jacob, Frank] Staatsbetrieb Sachsenforst, Pirna, Germany; [Kristoefel, Ferdinand] Fed Res & Training Ctr Forests Nat Hazards & Land, Vienna, Austria; [Lech, Pawel] Forest Res Inst, Sekocin Stary, Poland; [Manninger, Miklos] NARIC Forest Res Inst, Sarvar, Hungary; [Martin, Jan] FVI, Landesforstanstalt M BT, Schwerin, Germany; [Merila, Paivi] Nat Resources Inst Finland, Oulu, Finland; [Nicolas, Manuel] Off Natl Forets Rech Dev Innovat, Fontainebleau, France; [Pavlenda, Pavel] Natl Forest Ctr, Zvolen, Slovakia; [Rautio, Pasi] Nat Resources Inst Finland, Rovaniemi, Finland; [Schaub, Marcus; Thimonier, Anne; Waldner, Peter] WSL Swiss Fed Inst Forest, Snow & Landscape Res, Birmensdorf, Switzerland; [Schroeck, Hans-Werner] Forschungsanstalt Waldokol & Forstwirtschaft, Trippstadt, Germany; [Seidling, Walter] Thunen Inst Forest Ecosyst, Eberswalde, Germany; [Sramek, Vit] Forestry & Game Management Res Inst, Jiloviste, Czech Republic; [Thomsen, Iben Margrete; Vesterdal, Lars] Univ Copenhagen, Dept Geosci & Nat Resource Management, Frederiksberg, Denmark; [Titeux, Hugues] Univ Louvain, Earth & Life Inst, Louvain La Neuve, Belgium; [Wijk, Sture] Swedish Forest Agcy, Jonkoping, Sweden	Imperial College London; Royal Botanic Gardens, Kew; University of Manchester; Research Institute for Nature & Forest; Slovenian Forestry Institute; University of Reading; UK Centre for Ecology & Hydrology (UKCEH); IVL Swedish Environmental Research Institute; Forest Research Institute; Natural Resources Institute Finland (Luke); National Forest Center - Slovakia; Natural Resources Institute Finland (Luke); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Johann Heinrich von Thunen Institute; Forestry & Game Management Research Institute; University of Copenhagen; Universite Catholique Louvain	van der Linde, S (corresponding author), Imperial Coll London, Life Sci, Ascot, Berks, England.; van der Linde, S (corresponding author), Royal Bot Gardens, Comparat Plant & Fungal Biol, London, England.; van der Linde, S (corresponding author), Forest Res, Alice Holt Lodge, Farnham, Surrey, England.	sietse.vanderlinde@forestry.gsi.gov.uk	Schaub, Marcus/E-4874-2012; Lech, Paweł/AAA-5449-2021; Sramek, Vit/J-7108-2012; Bidartondo, Martin/AAC-9454-2021; Pavlenda, Pavel/AAC-8133-2019; Rautio, Pasi/A-6595-2013; Meesenburg, Henning/H-5794-2019; Thimonier, Anne/AAE-8786-2021; Verstraeten, Arne/C-2334-2015; Waldner, Peter/A-6941-2017; Verstraeten, Arne/L-3735-2019; Thimonier, Anne/AAS-5547-2020; Grebenc, Tine/V-1571-2019; van der Linde, Sietse/AAN-9521-2021; Forests, ICP/F-7626-2019; Suz, Laura M./W-7565-2019; Vesterdal, Lars/D-5227-2011	Schaub, Marcus/0000-0002-0158-8892; Rautio, Pasi/0000-0003-0559-7531; Meesenburg, Henning/0000-0002-3035-4737; Thimonier, Anne/0000-0002-4685-1957; Verstraeten, Arne/0000-0002-8813-1261; Waldner, Peter/0000-0001-8982-6156; Verstraeten, Arne/0000-0002-8813-1261; Thimonier, Anne/0000-0002-4685-1957; Grebenc, Tine/0000-0003-4035-8587; Suz, Laura M./0000-0003-4742-572X; Sramek, Vit/0000-0002-0655-2872; Cox, Filipa/0000-0003-1405-7481; Merila, Paivi/0000-0002-1315-6130; Benham, Suzanne/0000-0001-8218-9596; De Vos, Bruno/0000-0001-9523-3453; Lech, Pawel/0000-0003-2656-3701; van der Linde, Sietse/0000-0002-1255-8963; Vesterdal, Lars/0000-0003-0309-3735; Cools, Nathalie/0000-0002-7059-2318; Zhang, Yuxin/0000-0003-0243-2520	NERC [NE/K006339/1]; EU [2152/2003, LIFE07ENV/D/000218]; SWETHRO; RS Higher Education, Science and Technology Ministry [P4-0107]	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EU(European Commission); SWETHRO; RS Higher Education, Science and Technology Ministry	We acknowledge funding from NERC grant NE/K006339/1 to M.I.B. and C.D.L.O. Analysis was partly based on the ICP Forests PCC Database (http://icp-forests.net). ICP Forests FSCC provided the first level II soil survey data. ICP Forests PCC and observers, technicians and scientists performed long-term sampling, analyses and environmental data handling largely funded by national institutions and ministries, supported by governmental bodies, services and landowners, and partially EU-funded under Regulation (EC) No. 2152/2003 (Forest Focus), project LIFE07ENV/D/000218 (FutMon), and through SWETHRO. Co-financing for D.Z. and T.G. was provided by P4-0107 (RS Higher Education, Science and Technology Ministry). We thank D. Devey and L. Csiba for laboratory assistance; S. Boersma, F. van der Linde, H. van der Linde, J. van der Linde, C. Gonzales, A. Lenz, R. Lenz, S. Wipf, L. Garfoot, B. Spake, W. Rimington, J. Kowal, T. Solovieva, D. Gane, M. Terrington, J. Alden, A. Otway, V. Kemp, M. Edgar, Y. Lin, A. Drew, E. Booth, P. Cachera, R. De-Kayne, J. Downie, A. Tweedy, E. Moratto, E. Ek, P. Helminen, R. Lievonen, P. Narhi, A. Ryynanen, M. Rupel, J. Draing and F. Heun for field and laboratory work; R. Castilho for bioinformatics; K.-H. Larsson, P.-A. Moreau, J. Nuytinck and M. Ryberg for taxonomy; and N. Barsoum, E. Lilleskov, D. Read and T. Kuyper for discussions throughout.	Agerer R, 2001, MYCORRHIZA, V11, P107, DOI 10.1007/s005720100108; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson IC, 2007, FEMS MICROBIOL REV, V31, P388, DOI 10.1111/j.1574-6976.2007.00073.x; ARNOLDS E, 1991, AGR ECOSYST ENVIRON, V35, P209, DOI 10.1016/0167-8809(91)90052-Y; Averill C, 2014, NATURE, V505, P543, DOI 10.1038/nature12901; Bahram M, 2015, NEW PHYTOL, V205, P1454, DOI 10.1111/nph.13206; Baker ME, 2010, METHODS ECOL EVOL, V1, P25, DOI 10.1111/j.2041-210X.2009.00007.x; Bennett JA, 2017, SCIENCE, V355, P181, DOI 10.1126/science.aai8212; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bobbink R., 2011, REV REVISION EMPIRIC, P135; Boddy L, 2014, FUNGAL ECOL, V10, P20, DOI 10.1016/j.funeco.2013.10.006; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Buee M., 2016, MOL MYCORRHIZAL SYMB, P323; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Chen WL, 2016, P NATL ACAD SCI USA, V113, P8741, DOI 10.1073/pnas.1601006113; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Cools N, 2011, IFOREST, V4, P205, DOI 10.3832/ifor0588-004; Cox F, 2010, ECOL LETT, V13, P1103, DOI 10.1111/j.1461-0248.2010.01494.x; Cudlin P, 2007, PLANT BIOSYST, V141, P406, DOI 10.1080/11263500701626028; de Vries W, 2003, FOREST ECOL MANAG, V174, P77, DOI 10.1016/S0378-1127(02)00029-4; de Witte LC, 2017, SCI TOTAL ENVIRON, V605, P1083, DOI 10.1016/j.scitotenv.2017.06.142; Dirnbock T, 2014, GLOBAL CHANGE BIOL, V20, P429, DOI 10.1111/gcb.12440; Dore AJ, 2015, ATMOS ENVIRON, V119, P131, DOI 10.1016/j.atmosenv.2015.08.008; Eichhorn J., 2016, MANUAL METHODS CRITE; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ferretti M, 2013, DEV ENVIRONM SCI, V12, P1; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gardes M, 1996, CAN J BOT, V74, P1572, DOI 10.1139/b96-190; Giordani P, 2014, FOREST ECOL MANAG, V311, P29, DOI 10.1016/j.foreco.2013.05.048; Glassman SI, 2015, NEW PHYTOL, V205, P1619, DOI 10.1111/nph.13240; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hazard C, 2018, NEW PHYTOL, V220, P1122, DOI 10.1111/nph.15010; Hendershot JN, 2017, ECOLOGY, V98, P1757, DOI 10.1002/ecy.1829; Hettelingh JP, 2015, ENVIRON POLLUT SER, V25, P613, DOI 10.1007/978-94-017-9508-1_25; Hortal S, 2017, ISME J, V11, P2666, DOI 10.1038/ismej.2017.116; IUSS working group WRB, 2015, WORLD SOIL RESOURCES, V106; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/NGEO844, 10.1038/ngeo844]; Johnson N. C., 2017, MYCORRHIZAL MEDIATIO, P1; Jonard M, 2015, GLOBAL CHANGE BIOL, V21, P418, DOI 10.1111/gcb.12657; Kalogirou S., 2016, LCTOOLS LOCAL CORREL; Kauserud H, 2012, P NATL ACAD SCI USA, V109, P14488, DOI 10.1073/pnas.1200789109; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kennedy PG, 2012, MOL ECOL, V21, P4151, DOI 10.1111/j.1365-294X.2012.05703.x; Kennedy PG, 2011, MYCORRHIZA, V21, P559, DOI 10.1007/s00572-011-0366-2; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lamb AM, 2018, MOL ECOL, V27, P898, DOI 10.1111/mec.14488; Lee CR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14458; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY; Leppanen SM, 2013, ENVIRON EXP BOT, V90, P62, DOI 10.1016/j.envexpbot.2012.12.006; Levin SA, 2000, ECOSYSTEMS, V3, P498, DOI 10.1007/s100210000044; Lilleskov EA, 2011, FUNGAL ECOL, V4, P174, DOI 10.1016/j.funeco.2010.09.008; Lilleskov E. A., 2005, FUNGAL COMMUNITY ITS, P769; Lilleskov EA, 2007, NEW PHYTOL, V174, P250, DOI 10.1111/j.1469-8137.2007.02023.x; MCPFE Liaison Unit Warsaw UNECE & FAO, 2007, STAT EUR FOR MCPFE R; Molina R., 2015, MYCORRHIZAL NETW, P1, DOI [10.1007/978-94-017-7395-9_1, DOI 10.1007/978-94-017-7395-9_1]; Newton AC, 1998, NEW PHYTOL, V138, P619, DOI 10.1046/j.1469-8137.1998.00143.x; Nilsson RH, 2016, MOL MYCORRHIZAL SYMB, P301, DOI DOI 10.1002/9781118951446.CH17; Nychka D, 2015, FIELDS TOOLS SPATIAL; Ostonen I, 2017, NEW PHYTOL, V215, P977, DOI 10.1111/nph.14643; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Peay KG, 2016, ANNU REV ECOL EVOL S, V47, P143, DOI 10.1146/annurev-ecolsys-121415-032100; Peay KG, 2010, NEW PHYTOL, V185, P878, DOI 10.1111/j.1469-8137.2009.03158.x; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; Peay KG, 2016, MOL MYCORRHIZAL SYMB, P341, DOI [10.1002/9781118951446.ch19, DOI 10.1002/9781118951446.CH19]; Polme S, 2013, NEW PHYTOL, V198, P1239, DOI 10.1111/nph.12170; R Development Core Team, 2009, R LANG ENV STAT COMP; Raspe S., 2016, MANUAL METHODS CRITE, P35; Rautio P., 2016, MANUAL METHODS CRITE; Reis S, 2012, SCIENCE, V338, P1153, DOI 10.1126/science.1226514; Rinaldi AC, 2008, FUNGAL DIVERS, V33, P1; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd; Suz LM, 2015, ANN FOREST SCI, V72, P877, DOI 10.1007/s13595-014-0447-4; Suz LM, 2014, MOL ECOL, V23, P5628, DOI 10.1111/mec.12947; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; Taylor AFS, 2003, NEW PHYTOL, V159, P757, DOI 10.1046/j.1469-8137.2003.00838.x; Taylor DL, 2014, ECOL MONOGR, V84, P3, DOI 10.1890/12-1693.1; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Terrer C, 2016, SCIENCE, V353, P72, DOI 10.1126/science.aaf4610; Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621; Tripler CE, 2006, ECOL LETT, V9, P451, DOI 10.1111/j.1461-0248.2006.00891.x; UNECE ICP Forests Programme Co-ordinating Centre, 2016, MAN METH CRIT HARM S; van der Heijden MGA, 2015, NEW PHYTOL, V205, P1406, DOI 10.1111/nph.13288; van Strien AJ, 2018, J APPL ECOL, V55, P290, DOI 10.1111/1365-2664.12944; Veresoglou SD, 2014, NEW PHYTOL, V202, P422, DOI 10.1111/nph.12665; Waldner P, 2014, ATMOS ENVIRON, V95, P363, DOI 10.1016/j.atmosenv.2014.06.054; WALLANDER H, 1995, PLANT SOIL, V168, P243, DOI 10.1007/BF00029334; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White TJ., 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	96	188	191	24	365	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 14	2018	558	7709					243	+		10.1038/s41586-018-0189-9	http://dx.doi.org/10.1038/s41586-018-0189-9			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2BI	29875410	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000435071400044
J	Eigenbrode, JL; Summons, RE; Steele, A; Freissinet, C; Millan, M; Navarro-Gonzalez, R; Sutter, B; McAdam, AC; Franz, HB; Glavin, DP; Archer, PD; Mahaffy, PR; Conrad, PG; Hurowitz, JA; Grotzinger, JP; Gupta, S; Ming, DW; Sumner, DY; Szopa, C; Malespin, C; Buch, A; Coll, P				Eigenbrode, Jennifer L.; Summons, Roger E.; Steele, Andrew; Freissinet, Caroline; Millan, Maeva; Navarro-Gonzalez, Rafael; Sutter, Brad; McAdam, Amy C.; Franz, Heather B.; Glavin, Daniel P.; Archer, Paul D., Jr.; Mahaffy, Paul R.; Conrad, Pamela G.; Hurowitz, Joel A.; Grotzinger, John P.; Gupta, Sanjeev; Ming, Doug W.; Sumner, Dawn Y.; Szopa, Cyril; Malespin, Charles; Buch, Arnaud; Coll, Patrice			Organic matter preserved in 3-billion-year-old mudstones at Gale crater, Mars	SCIENCE			English	Article							PYROLYSIS; PHASES	Establishing the presence and state of organic matter, including its possible biosignatures, in martian materials has been an elusive quest, despite limited reports of the existence of organic matter on Mars. We report the in situ detection of organic matter preserved in lacustrine mudstones at the base of the similar to 3.5-billion-year-old Murray formation at Pahrump Hills, Gale crater, by the Sample Analysis at Mars instrument suite onboard the Curiosity rover. Diverse pyrolysis products, including thiophenic, aromatic, and aliphatic compounds released at high temperatures (500 to 820 degrees C), were directly detected by evolved gas analysis. Thiophenes were also observed by gas chromatography-mass spectrometry. Their presence suggests that sulfurization aided organic matter preservation. At least 50 nanomoles of organic carbon persists, probably as macromolecules containing 5% carbon as organic sulfur molecules.	[Eigenbrode, Jennifer L.; Freissinet, Caroline; McAdam, Amy C.; Franz, Heather B.; Glavin, Daniel P.; Mahaffy, Paul R.; Conrad, Pamela G.; Malespin, Charles] NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; [Summons, Roger E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Steele, Andrew] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Millan, Maeva] Univ Paris 06, Lab Atmospheres Milieux Observat Spatiales, Paris, France; [Szopa, Cyril] Univ Versailles St Quentin, Lab Atmospheres Milieux Observat Spatiales, Paris, France; [Millan, Maeva; Szopa, Cyril] CNRS, Paris, France; [Navarro-Gonzalez, Rafael] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Ciudad Univ, Cuidad De Mexico 04510, Mexico; [Archer, Paul D., Jr.] Jacobs Technol, Houston, TX 77058 USA; [Sutter, Brad; Ming, Doug W.] NASA, Johnson Space Ctr, Astromat Res & Explorat Sci Div, Houston, TX 77058 USA; [Hurowitz, Joel A.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Grotzinger, John P.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Gupta, Sanjeev] Imperial Coll London, Dept Earth Sci & Engn, London SW7 2AZ, England; [Sumner, Dawn Y.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Buch, Arnaud] Cent Supelec, Lab Genie Proc & Mat, Gif Sur Yvette, France; [Coll, Patrice] Univ Paris Diderot, Univ Paris Est Creteil, Lab Interuniv Syst Atmospher, Creteil, France; [Coll, Patrice] CNRS, Creteil, France; [Freissinet, Caroline] Inst Pierre Simon Laplace, CNRS, Lab Atmospheres Milieux Observat Spatiales, Guyancourt, France	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Massachusetts Institute of Technology (MIT); Carnegie Institution for Science; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universidad Nacional Autonoma de Mexico; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; California Institute of Technology; Imperial College London; University of California System; University of California Davis; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Eigenbrode, JL (corresponding author), NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA.	jennifer.l.eigenbrode@nasa.gov	Sumner, Dawn Y/E-8744-2011; Navarro-González, Rafael/D-1748-2009; Summons, Roger Everett/AAL-3789-2020; Glavin, Daniel P/D-6194-2012; Steele, Andrew/A-3573-2013; Eigenbrode, Jennifer L/D-4651-2012; McAdam, Amy/E-1556-2012	Sumner, Dawn Y/0000-0002-7343-2061; Navarro-González, Rafael/0000-0002-6078-7621; Glavin, Daniel P/0000-0001-7779-7765; Steele, Andrew/0000-0001-9643-2841; Eigenbrode, Jennifer L/0000-0003-3089-1986; McAdam, Amy/0000-0001-9120-2991; Summons, Roger/0000-0002-7144-8537; Sutter, Brad/0000-0002-3036-170X; Gupta, Sanjeev/0000-0001-6415-1332; Buch, Arnaud/0000-0002-2097-7252	NASA's Mars Exploration Program; UK Space Agency; Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia de Mexico	NASA's Mars Exploration Program; UK Space Agency; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia de Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by NASA's Mars Exploration Program. NASA's MSL Participating Scientist program supported J.L.E., R.E.S., and D.P.G. for this effort. S.G. acknowledges funding from the UK Space Agency. R.N.-G. was funded by the Universidad Nacional Autonoma de Mexico and the Consejo Nacional de Ciencia y Tecnologia de Mexico.	Bajus M., 1989, SULFUR REP, V9, P25, DOI DOI 10.1080/01961778908047982; Baruah BP, 2007, ENERG FUEL, V21, P3346, DOI 10.1021/ef070005i; Brown R. F. C., 1980, PYROLYTIC METHODS OR; Farley KA, 2014, SCIENCE, V343, DOI 10.1126/science.1247166; Flynn GJ, 2016, ELEMENTS, V12, P177, DOI 10.2113/gselements.12.3.177; Franz HB, 2017, NAT GEOSCI, V10, P658, DOI 10.1038/NGEO3002; Freissinet C, 2015, J GEOPHYS RES-PLANET, V120, P495, DOI 10.1002/2014JE004737; Grotzinger JP, 2015, SCIENCE, V350, DOI 10.1126/science.aac7575; Grotzinger JP, 2014, SCIENCE, V343, P386, DOI 10.1126/science.1249944; Hassler DM, 2014, SCIENCE, V343, DOI 10.1126/science.1244797; Hebting Y, 2006, SCIENCE, V312, P1627, DOI 10.1126/science.1126372; Hurowitz JA, 2017, SCIENCE, V356, DOI 10.1126/science.aah6849; Keil RG, 2014, TREATISE GEOCHEMISTR, P337, DOI DOI 10.1016/B978-0-08-095975-7.01024-X; Linstrom PJ, 69 NIST; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; Martin PE, 2017, J GEOPHYS RES-PLANET, V122, P2803, DOI 10.1002/2017JE005445; Mayer LM, 2004, MAR CHEM, V92, P135, DOI 10.1016/j.marchem.2004.06.022; McAdam AC, 2014, J GEOPHYS RES-PLANET, V119, P373, DOI 10.1002/2013JE004518; McLafferty F. W., 1993, INTERPRETATION MASS; Ming DW, 2014, SCIENCE, V343, DOI 10.1126/science.1245267; Moldoveanu S. C., 2010, TECHNIQUES INSTRUMEN, V28, P724; Moldoveanu S. C., 1998, TECHNIQUES INSTRUMEN, V20, P496; Navarro-Gonzalez R, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003599; Okumura F, 2011, GEOCHIM COSMOCHIM AC, V75, P7063, DOI 10.1016/j.gca.2011.09.015; Rampe EB, 2017, EARTH PLANET SC LETT, V471, P172, DOI 10.1016/j.epsl.2017.04.021; Remusat L, 2005, GEOCHIM COSMOCHIM AC, V69, P3919, DOI 10.1016/j.gca.2005.02.032; Sinninghe-Damste JS, 1989, GEOCHIM COSMOCHIM AC, V53, P873, DOI DOI 10.1016/0016-7037(89)90032-X; Steele A, 2016, METEORIT PLANET SCI, V51, P2203, DOI 10.1111/maps.12670; Summons RE, 2011, ASTROBIOLOGY, V11, P157, DOI 10.1089/ast.2010.0506; Sutter B, 2017, J GEOPHYS RES-PLANET, V122, P2574, DOI 10.1002/2016JE005225; Vaniman DT, 2014, SCIENCE, V343, DOI 10.1126/science.1243480; Xu L, 2004, FUEL PROCESS TECHNOL, V85, P1013, DOI 10.1016/j.fuproc.2003.11.036	32	252	256	20	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1096	1100		10.1126/science.aas9185	http://dx.doi.org/10.1126/science.aas9185			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI6TJ	29880683	Green Submitted, Green Accepted			2022-12-28	WOS:000434635500040
J	Corpechot, C; Chazouilleres, O; Rousseau, A; Le Gruyer, A; Habersetzer, F; Mathurin, P; Goria, O; Potier, P; Minello, A; Silvain, C; Abergel, A; Debette-Gratien, M; Larrey, D; Roux, O; Bronowicki, JP; Boursier, J; de Ledinghen, V; Heurgue-Berlot, A; Nguyen-Khac, E; Zoulim, F; Ollivier-Hourmand, I; Zarski, JP; Nkontchou, G; Lemoinne, S; Humbert, L; Rainteau, D; Lefevre, G; de Chaisemartin, L; Chollet-Martin, S; Gaouar, F; Admane, FH; Simon, T; Poupon, R				Corpechot, C.; Chazouilleres, O.; Rousseau, A.; Le Gruyer, A.; Habersetzer, F.; Mathurin, P.; Goria, O.; Potier, P.; Minello, A.; Silvain, C.; Abergel, A.; Debette-Gratien, M.; Larrey, D.; Roux, O.; Bronowicki, J. -P.; Boursier, J.; de Ledinghen, V.; Heurgue-Berlot, A.; Nguyen-Khac, E.; Zoulim, F.; Ollivier-Hourmand, I.; Zarski, J. -P.; Nkontchou, G.; Lemoinne, S.; Humbert, L.; Rainteau, D.; Lefevre, G.; de Chaisemartin, L.; Chollet-Martin, S.; Gaouar, F.; Admane, F. -H.; Simon, T.; Poupon, R.			A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							URSODEOXYCHOLIC ACID; BIOCHEMICAL RESPONSE; FENOFIBRATE THERAPY; COMBINATION THERAPY; OBETICHOLIC ACID; RENAL-FUNCTION; CIRRHOSIS; OUTCOMES; PROGNOSIS; MULTICENTER	BACKGROUND Patients with primary biliary cholangitis who have an inadequate response to therapy with ursodeoxycholic acid are at high risk for disease progression. Fibrates, which are agonists of peroxisome proliferator-activated receptors, in combination with ursodeoxycholic acid, have shown potential benefit in patients with this condition. METHODS In this 24-month, double-blind, placebo-controlled, phase 3 trial, we randomly assigned 100 patients who had had an inadequate response to ursodeoxycholic acid according to the Paris 2 criteria to receive bezafibrate at a daily dose of 400 mg (50 patients), or placebo (50 patients), in addition to continued treatment with ursodeoxycholic acid. The primary outcome was a complete biochemical response, which was defined as normal levels of total bilirubin, alkaline phosphatase, aminotransferases, and albumin, as well as a normal prothrombin index (a derived measure of prothrombin time), at 24 months. RESULTS The primary outcome occurred in 31% of the patients assigned to bezafibrate and in 0% assigned to placebo (difference, 31 percentage points; 95% confidence interval, 10 to 50; P<0.001). Normal levels of alkaline phosphatase were observed in 67% of the patients in the bezafibrate group and in 2% in the placebo group.Results regarding changes in pruritus, fatigue, and noninvasive measures of liver fibrosis, including liver stiffness and Enhanced Liver Fibrosis score, were consistent with the results of the primary outcome. Two patients in each group had complications from end-stage liver disease. The creatinine level increased 5% from baseline in the bezafibrate group and decreased 3% in the placebo group. Myalgia occurred in 20% of the patients in the bezafibrate group and in 10% in the placebo group. CONCLUSIONS Among patients with primary biliary cholangitis who had had an inadequate response to ursodeoxycholic acid alone, treatment with bezafibrate in addition to ursodeoxycholic acid resulted in a rate of complete biochemical response that was significantly higher than the rate with placebo and ursodeoxycholic acid therapy.	[Simon, T.] Sorbonne Univ, 184 Rue Faubourg St Antoine, F-75571 Paris 12, France; [Corpechot, C.; Chazouilleres, O.; Lemoinne, S.; Gaouar, F.; Poupon, R.] Paris Sud Univ, St Antoine Univ Hosp, Reference Ctr Inflammatory Biliary Dis & Autoimmu, AP HP,Hepatol & Gastroenterol Dept, Paris, France; [Corpechot, C.; Chazouilleres, O.; Lemoinne, S.; Poupon, R.] Paris Sud Univ, INSERM, S938, UMR, Paris, France; [Humbert, L.; Rainteau, D.] Paris Sud Univ, Biochem Lab, Paris, France; [Lefevre, G.] Paris Sud Univ, Sorbonne Univ Biochem Lab, St Antoine Univ Hosp, Tenon Univ Hosp,AP HP,INSERM,Unite 1157,UMR 7203, Paris, France; [de Chaisemartin, L.; Chollet-Martin, S.] Paris Sud Univ, Bichat Univ Hosp, AP HP, Immunol Lab,INSERM,UMR S996, Paris, France; [Rousseau, A.; Admane, F. -H.; Simon, T.] Paris Sud Univ, AP HP, Dept Clin Pharmacol & Clin Res Platform East Pari, Paris, France; [Goria, O.] Rouen Univ Hosp, Hepatol & Gastroenterol Dept, Rouen, France; [Le Gruyer, A.] Pontchaillou Univ Hosp, Hepatol & Gastroenterol Dept, Rennes, France; [Habersetzer, F.] Univ Strasbourg, Univ Hosp Strasbourg, Hepatol & Gastroenterol Dept,Unite 1110, Inst Viral & Liver Dis,INSERM,Lab Excellence HepS, Strasbourg, France; [Mathurin, P.] Claude Huriez Univ Hosp, Hepatol & Gastroenterol Dept, Lille, France; [Potier, P.] Orleans Hosp, Hepatol & Gastroenterol Dept, Orleans, France; [Minello, A.] Dijon Bourgogne Univ Hosp, Hepatol & Gastroenterol Dept, Dijon, France; [Silvain, C.] Univ Hosp Poitiers, Hepatol & Gastroenterol Dept, Poitiers, France; [Abergel, A.] Estaing Univ Hosp, Hepatol & Gastroenterol Dept, Clermont Ferrand, France; [Debette-Gratien, M.] Univ Hosp Limoges, Hepatol & Gastroenterol Dept, Limoges, France; [Larrey, D.] St Eloi Univ Hosp, Hepatol & Gastroenterol Dept, Montpellier, France; [Roux, O.] Beaujon Univ Hosp, Hepatol Dept, Clichy, France; [Zarski, J. -P.] Brabois Univ Hosp, Hepatol & Gastroenterol Dept, Nancy, France; [Boursier, J.] Bretagne Loire Univ, Hemodynam Interact Fibrosis & Tumor Invasiveness, Unite Propre Rech Enseignement Super 3859, Univ Hosp Angers,Hepatol & Gastroenterol Dept,Str, Angers, France; [de Ledinghen, V.] Haut Leveque Univ Hosp, Hepatol & Gastroenterol Dept, Pessac, France; [Heurgue-Berlot, A.] Robert Debre Univ Hosp, Hepatol & Gastroenterol Dept, Reims, France; [Nguyen-Khac, E.] Univ Hosp Amiens, Hepatol & Gastroenterol Dept, Amiens, France; [Zoulim, F.] Croix Rousse Univ Hosp, Hepatol & Gastroenterol Dept, Lyon, France; [Ollivier-Hourmand, I.] Univ Hosp Caen, Hepatol & Gastroenterol Dept, Caen, France; [Zarski, J. -P.] Michallon Univ Hosp, Hepatol & Gastroenterol Dept, Grenoble, France; [Nkontchou, G.] Jean Verdier Univ Hosp, Hepatol & Gastroenterol Dept, Bondy, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Hopital Universitaire Tenon - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Saclay; CHU de Rouen; CHU Rennes; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Lille - ISITE; CHU Lille; Centre Hospitalier Regional d'Orleans; CHU Dijon Bourgogne; CHU Poitiers; Universite de Poitiers; CHU Clermont Ferrand; CHU Limoges; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Bordeaux; CHU de Reims; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Lyon; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Grenoble Alpes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP	Corpechot, C (corresponding author), St Antoine Univ Hosp, AP HP, Reference Ctr Inflammatory Biliary Dis & Autoimmu, 184 Rue Faubourg St Antoine, F-75571 Paris 12, France.; Corpechot, C (corresponding author), Sorbonne Univ, 184 Rue Faubourg St Antoine, F-75571 Paris 12, France.	christophe.corpechot@aphp.fr	Roux, Olivier/AAE-1002-2020; Zoulim, Fabien/ABD-5594-2021	Roux, Olivier/0000-0003-1563-7066; Zoulim, Fabien/0000-0002-2245-0083	Programme Hospitalier de Recherche Clinique 2010 (Ministry of Health); Arrow Generiques, Lyon, France; Intercept France; Inventiva Pharma; GlaxoSmithKline France; Aptalis; Mayoly Spindler; Genfit; Intercept; Gilead; AbbVie; Merck; Supersonic Imagine; Echosens; Bayer; MSD; AstraZeneca; Sanofi; Novartis; GlaxoSmithKline; Eli Lilly; Daiichi Sankyo	Programme Hospitalier de Recherche Clinique 2010 (Ministry of Health); Arrow Generiques, Lyon, France; Intercept France; Inventiva Pharma(Dexcel Pharma); GlaxoSmithKline France(GlaxoSmithKline); Aptalis; Mayoly Spindler; Genfit; Intercept; Gilead(Gilead Sciences); AbbVie(AbbVie); Merck(Merck & Company); Supersonic Imagine; Echosens; Bayer(Bayer AG); MSD; AstraZeneca(AstraZeneca); Sanofi; Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); Eli Lilly(Eli Lilly); Daiichi Sankyo(Daiichi Sankyo Company Limited)	Supported by a grant from Programme Hospitalier de Recherche Clinique 2010 (Ministry of Health) and a grant from Arrow Generiques, Lyon, France.; Dr. Corpechot reports receiving consulting fees from Intercept France and Inventiva Pharma and fees for teaching from GlaxoSmithKline France; Dr. Chazouilleres, receiving grant support from Aptalis, fees for teaching from Mayoly Spindler, consulting fees from Genfit, and fees for teaching and consulting fees from Intercept; Dr. Mathurin, receiving consulting fees from Intercept; Dr. Minello, receiving lecture fees and travel support from Gilead and AbbVie and travel support from Merck; Dr. Abergel, receiving grant support, lecture fees, and consulting fees from AbbVie, Gilead, and Merck; Dr. Larrey, receiving consulting fees from Intercept; Dr. de Ledinghen, receiving consulting fees from Gilead, AbbVie, Merck, Intercept, and Supersonic Imagine and lecture fees from Echosens; Dr. Ollivier-Hourmand, serving as regional board member for Intercept and Boehringer Ingelheim, receiving travel support from Mayoly Spindler, lecture fees and travel support from Gilead, grant support, lecture fees, and travel support, and serving as a board member for Bayer and AbbVie, and receiving grant support and travel support from MSD; Dr. Simon, serving as a board member for Bristol-Myers Squibb, receiving grant support, paid to his institution, and lecture fees, and serving as a board member for AstraZeneca, receiving grant support paid to his institution and consulting fees from Sanofi, serving as a board member for Sanofi, and receiving grant support, paid to his institution, consulting fees and lecture fees from Novartis, and grant support, paid to his institution, from MSD, GlaxoSmithKline, Eli Lilly, and Daiichi Sankyo; and Dr. Poupon, receiving consulting fees from Intercept. No other potential conflict of interest relevant to this article was reported.	Carbone M, 2016, HEPATOLOGY, V63, P930, DOI 10.1002/hep.28017; Carbone M, 2013, GASTROENTEROLOGY, V144, P560, DOI 10.1053/j.gastro.2012.12.005; Carey EJ, 2015, LANCET, V386, P1565, DOI 10.1016/S0140-6736(15)00154-3; Cheung AC, 2016, ALIMENT PHARM THER, V43, P283, DOI 10.1111/apt.13465; Corpechot C, 2008, HEPATOLOGY, V48, P871, DOI 10.1002/hep.22428; Corpechot C, 2012, HEPATOLOGY, V56, P198, DOI 10.1002/hep.25599; Corpechot C, 2011, J HEPATOL, V55, P1361, DOI 10.1016/j.jhep.2011.02.031; Cuperus FJC, 2014, CURR OPIN GASTROEN, V30, P279, DOI 10.1097/MOG.0000000000000056; Dohmen K, 2004, WORLD J GASTROENTERO, V10, P894; Ghonem NS, 2015, HEPATOLOGY, V62, P635, DOI 10.1002/hep.27744; Hirschfield GM, 2017, J HEPATOL, V67, P145, DOI 10.1016/j.jhep.2017.03.022; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Honda A, 2013, HEPATOLOGY, V57, P1931, DOI 10.1002/hep.26018; Iwasaki S, 2008, HEPATOL RES, V38, P557, DOI 10.1111/j.1872-034X.2007.00305.x; Jones D, 2017, LANCET GASTROENTEROL, V2, P716, DOI 10.1016/S2468-1253(17)30246-7; Kuiper EMM, 2009, GASTROENTEROLOGY, V136, P1281, DOI 10.1053/j.gastro.2009.01.003; Kumagi T, 2010, AM J GASTROENTEROL, V105, P2186, DOI 10.1038/ajg.2010.216; Lammers WJ, 2015, GASTROENTEROLOGY, V149, P1804, DOI 10.1053/j.gastro.2015.07.061; Lammers WJ, 2014, GASTROENTEROLOGY, V147, P1338, DOI 10.1053/j.gastro.2014.08.029; Levy C, 2011, ALIMENT PHARM THER, V33, P235, DOI 10.1111/j.1365-2036.2010.04512.x; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479; Mayo MJ, 2008, HEPATOLOGY, V48, P1549, DOI 10.1002/hep.22517; Mychaleckyj JC, 2012, DIABETES CARE, V35, P1008, DOI 10.2337/dc11-1811; Nagasawa T, 2006, EUR J PHARMACOL, V536, P182, DOI 10.1016/j.ejphar.2006.02.028; Nakai S, 2000, AM J GASTROENTEROL, V95, P326; Nevens F, 2016, NEW ENGL J MED, V375, P631, DOI 10.1056/NEJMoa1509840; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Poupon RE, 2004, HEPATOLOGY, V40, P489, DOI 10.1002/hep.20276; Poupon RE, 1997, GASTROENTEROLOGY, V113, P884, DOI 10.1016/S0016-5085(97)70183-5; POUPON RE, 1991, NEW ENGL J MED, V324, P1548, DOI 10.1056/NEJM199105303242204; Reich A, 2012, ACTA DERM-VENEREOL, V92, P497, DOI 10.2340/00015555-1265; Reig A, 2018, AM J GASTROENTEROL, V113, P49, DOI 10.1038/ajg.2017.287; Sica DA, 2009, CURR ATHEROSCLER REP, V11, P338, DOI 10.1007/s11883-009-0051-5; Ting RD, 2012, DIABETES CARE, V35, P218, DOI 10.2337/dc11-1109; Zhao YY, 2012, ANN INTERN MED, V156, P560, DOI [10.7326/0003-4819-156-8-201204170-00401, 10.7326/0003-4819-156-8-201204170-00003]	36	238	250	4	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2018	378	23					2171	2181		10.1056/NEJMoa1714519	http://dx.doi.org/10.1056/NEJMoa1714519			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3HS	29874528				2022-12-28	WOS:000434263000005
J	Martinod, E; Chouahnia, K; Radu, DM; Joudiou, P; Uzunhan, Y; Bensidhoum, M; Portela, AMS; Guiraudet, P; Peretti, M; Destable, MD; Solis, A; Benachi, S; Fialaire-Legendre, A; Rouard, H; Collon, T; Piquet, J; Leroy, S; Venissac, N; Santini, J; Tresallet, C; Dutau, H; Sebbane, G; Cohen, Y; Beloucif, S; d'Audiffret, AC; Petite, H; Valeyre, D; Carpentier, A; Vicaut, E				Martinod, Emmanuel; Chouahnia, Kader; Radu, Dana M.; Joudiou, Pascal; Uzunhan, Yurdagul; Bensidhoum, Morad; Portela, Ana M. Santos; Guiraudet, Patrice; Peretti, Marine; Destable, Marie-Dominique; Solis, Audrey; Benachi, Sabiha; Fialaire-Legendre, Anne; Rouard, Helene; Collon, Thierry; Piquet, Jacques; Leroy, Sylvie; Venissac, Nicolas; Santini, Joseph; Tresallet, Christophe; Dutau, Herve; Sebbane, Georges; Cohen, Yves; Beloucif, Sadel; d'Audiffret, Alexandre C.; Petite, Herve; Valeyre, Dominique; Carpentier, Alain; Vicaut, Eric			Feasibility of Bioengineered Tracheal and Bronchial Reconstruction Using Stented Aortic Matrices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							2-YEAR FOLLOW-UP; LUNG-CANCER; TRACHEOBRONCHIAL TRANSPLANTATION; CARINAL REPLACEMENT; TISSUE; WITHDRAWAL; SOCIETY; CHILD	IMPORTANCE Airway transplantation could be an option for patients with proximal lung tumor or with end-stage tracheobronchial disease. New methods for airway transplantation remain highly controversial. OBJECrIVE To establish the feasibility of airway bioengineering using a technique based on the implantation of stented aortic matrices. DESIGN, SETTING, AND PARTICIPANTS Uncontrolled single-center cohort study including 20 patients with end-stage tracheal lesions or with proximal lung tumors requiring a pneumonectomy. The study was conducted in Paris, France, from October 2009 through February 2017; final follow-up for all patients occurred on November 2, 2017. EXPOSURES Radical resection of the lesions was performed using standard surgical techniques. After resection, airway reconstruction was performed using a human cryopreserved (-80 degrees C) aortic allograft, which was not matched by the ABO and leukocyte antigen systems. To prevent airway collapse, a custom-made stent was inserted into the allograft. In patients with proximal lung tumors, the lung-sparing intervention of bronchial transplantation was used. MAIN OUTCOMES AND MEASURES The primary outcome was 90-day mortality. The secondary outcome was 90-day morbidity. RESULTS Twenty patients were included in the study (mean age, 54.9 years; age range, 24-79 years; 13 men [65%]). Thirteen patients underwent tracheal (n = 5), bronchial (n = 7), or carinal (n = 1) transplantation. Airway transplantation was not performed in 7 patients for the following reasons: medical contraindication (n = 1), unavoidable pneumonectomy (n = 1), exploratory thoracotomy only (n = 2), and a lobectomy or bilobectomy was possible (n = 3). Among the 20 patients initially included, the overall 90-day mortality rate was 5% (1 patient underwent a carinal transplantation and died). No mortality at 90 days was observed among patients who underwent tracheal or bronchial reconstruction. Among the 13 patients who underwent airway transplantation, major 90-day morbidity events occurred in 4 (30.8%) and included laryngeal edema, acute lung edema, acute respiratory distress syndrome, and atrial fibrillation. There was no adverse event directly related to the surgical technique. Stent removal was performed at a postoperative mean of 18.2 months. At a median follow-up of 3 years 11 months, 10 of the 13 patients (76.9%) were alive. Of these 10 patients, 8 (80%) breathed normally through newly formed airways after stent removal. Regeneration of epithelium and de novo generation of cartilage were observed within aortic matrices from recipient cells. CONCLUSIONS AND RELEVANCE In this uncontrolled study, airway bioengineering using stented aortic matrices demonstrated feasibility for complex tracheal and bronchial reconstruction. Further research is needed to assess efficacy and safety.	[Martinod, Emmanuel; Radu, Dana M.; Portela, Ana M. Santos; Guiraudet, Patrice; Peretti, Marine; Destable, Marie-Dominique] Univ Paris 13, Hop Univ Paris Seine St Denis, UFR Sante Med & Biol Humaine, AP HP,Hop Avicenne,Chirurg Thorac & Vasc,Sorbonne, Bobigny, France; [Martinod, Emmanuel; Radu, Dana M.; Guiraudet, Patrice; Carpentier, Alain] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Lab Rech Biochirurg,Fdn Alain Carpentier, Paris, France; [Chouahnia, Kader] Univ Paris 13, Sorbonne Paris Cite, Hop Univ Paris Seine St Denis, AP HP,Hop Avicenne,Oncol,UFR Sante Med & Biol Hum, Bobigny, France; [Joudiou, Pascal; Uzunhan, Yurdagul; Valeyre, Dominique] Univ Paris 13, Sorbonne Paris Cite, Hop Univ Paris Seine St Denis,Pneumol, AP HP,Hop Avicenne,UFR Sante Med & Biol Humaine, Bobigny, France; [Bensidhoum, Morad; Petite, Herve] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UMR 7052,B20A, F-75010 Paris, France; [Bensidhoum, Morad; Petite, Herve] Univ Paris Est, Ecole Natl Vet Alfort, Maisons Alfort, France; [Solis, Audrey; Benachi, Sabiha; Cohen, Yves; Beloucif, Sadel] Univ Paris 13, Sorbonne Paris Cite, Hop Univ Paris Seine St Denis,AP HP, Hop Avicenne,Anesthesie Reanimat,UFR Sante Med &, Bobigny, France; [Fialaire-Legendre, Anne; Rouard, Helene] AP HP, EFS Ile France, Creteil, France; [Collon, Thierry; Piquet, Jacques] Hop Le Raincy Montfermeil, Pneumol, Montfermeil, France; [Leroy, Sylvie; Venissac, Nicolas; Santini, Joseph] Univ Cote Azur, CHU Nice, Pneumol, Chirurg Thorac,Oto Rhino Laryngol, Nice, France; [Tresallet, Christophe] Univ Paris 6 Pierre & Marie Curie, Hop La Pitie Salpetriere, AP HP, Chirurg Digest & Endocrinienne, Paris, France; [Dutau, Herve] Hop Univ Nord, AP HM, Pneumol, Marseille, France; [Sebbane, Georges] Univ Paris 13, Sorbonne Paris Cite, Hop Avicenne,AP HP, Hop Univ Paris Seine St Denis,Geriatr,UFR Sante M, Bobigny, France; [d'Audiffret, Alexandre C.] West Virginia Univ, Div Vasc Surg, Morgantown, WV 26506 USA; [Vicaut, Eric] Univ Paris Diderot, Hop St Louis Lariboisiere Fernand Widal, AP HP, Unite Rech Clin, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Ecole Nationale Veterinaire d'Alfort (ENVA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; West Virginia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Martinod, E (corresponding author), Univ Paris 13, AP HP, Dept Chirurg Thorac & Vasc, 125 Rue Stalingrad, F-93009 Bobigny, France.	emmanuel.martinod@aphp.fr	Uzunhan, Yurdagul/P-5437-2017; Petite, Herve/E-3478-2016; Uzunhan, Yurdagul/AHA-1706-2022	Uzunhan, Yurdagul/0000-0002-1607-1407; Petite, Herve/0000-0003-1694-5060; Uzunhan, Yurdagul/0000-0002-1607-1407; Martinod, Emmanuel/0000-0001-8465-4498; Guiraudet, Patrice/0000-0001-7506-9713; Radu, Dana/0000-0002-9004-4271; ROUARD, Helene/0000-0003-0711-2999; Valeyre, dominique/0000-0003-4470-1776	Direction de la Recherche Clinique at Assistance Publique-Hopitaux de Paris	Direction de la Recherche Clinique at Assistance Publique-Hopitaux de Paris	Funding for the study was provided by the Direction de la Recherche Clinique at Assistance Publique-Hopitaux de Paris.	Abouarab AA, 2017, ANN THORAC CARDIOVAS, V23, P66, DOI 10.5761/atcs.ra.16-00251; Albain KS, 2009, LANCET, V374, P379, DOI 10.1016/S0140-6736(09)60737-6; Chiang T, 2016, ANN OTO RHINOL LARYN, V125, P873, DOI 10.1177/0003489416656646; Chouillard E, 2016, SURG ENDOSC, V30, P4742, DOI 10.1007/s00464-016-4815-z; Claesson-Welsh L, 2016, LANCET, V387, P942, DOI 10.1016/S0140-6736(16)00520-1; Coraux Christelle, 2008, Proc Am Thorac Soc, V5, P689, DOI 10.1513/pats.200801-010AW; Delaere P, 2016, J THORAC DIS, V8, pS186, DOI 10.3978/j.issn.2072-1439.2016.01.85; Delaere P, 2010, NEW ENGL J MED, V362, P138, DOI 10.1056/NEJMoa0810653; Delaere PR, 2014, NEW ENGL J MED, V370, P1568, DOI 10.1056/NEJMc1315273; Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5; Fabre D, 2013, ANN THORAC SURG, V96, P1146, DOI 10.1016/j.athoracsur.2013.05.073; Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4; Grillo H.C, 2004, ONCOL, P839; Hamilton NJ, 2015, AM J TRANSPLANT, V15, P2750, DOI 10.1111/ajt.13318; Jungebluth P, 2016, LANCET, V387, P944; Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7; Kanemaru SI, 2010, ACTA OTO-LARYNGOL, V130, P79, DOI 10.3109/00016489.2010.496462; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mansour Z, 2009, ANN THORAC SURG, V88, P1737, DOI 10.1016/j.athoracsur.2009.07.016; Martinod E, 2000, CR ACAD SCI III-VIE, V323, P455, DOI 10.1016/S0764-4469(00)00150-5; Martinod E, 2005, ANN THORAC SURG, V79, P942, DOI 10.1016/j.athoracsur.2004.08.035; Martinod E, 2003, ANN THORAC SURG, V75, P1572, DOI 10.1016/S0003-4975(03)00120-6; Martinod E, 1999, PRESSE MED, V28, P1638; Martinod E, 2001, J THORAC CARDIOV SUR, V122, P197, DOI 10.1067/mtc.2001.114346; Martinod E, 2017, ANN THORAC SURG, V103, P1631, DOI 10.1016/j.athoracsur.2016.11.027; Martinod E, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-25; Martinod E, 2011, ANN THORAC SURG, V91, P837, DOI 10.1016/j.athoracsur.2010.11.013; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Oman K, 2005, ANN OTO RHINOL LARYN, V114, P429; Radu DM, 2010, ANN THORAC SURG, V90, P252, DOI 10.1016/j.athoracsur.2010.03.079; Seder CW, 2016, ANN THORAC SURG, V101, P1646, DOI 10.1016/j.athoracsur.2016.02.099; Seguin A, 2006, ANN THORAC SURG, V81, P1068, DOI 10.1016/j.athoracsur.2005.07.079; Seguin A, 2013, J THORAC CARDIOV SUR, V145, P1297, DOI 10.1016/j.jtcvs.2012.09.079; Seguin A, 2009, ANN THORAC SURG, V87, P861, DOI 10.1016/j.athoracsur.2008.11.038; Steinke M, 2015, TISSUE ENG PT A, V21, P573, DOI [10.1089/ten.TEA.2014.0200, 10.1089/ten.tea.2014.0200]; Tan Q, 2017, J THORAC DIS, V9, P22, DOI 10.21037/jtd.2017.01.50; Teixeira da Silva Jaime A, 2017, Indian J Med Ethics, V2, P270, DOI 10.20529/IJME.2017.048; Weiss DJ, 2014, CYTOTHERAPY, V16, P1601, DOI 10.1016/j.jcyt.2014.10.012; Wurtz A, 2006, NEW ENGL J MED, V355, P1938, DOI 10.1056/NEJMc066336; Wurtz A, 2010, J THORAC CARDIOV SUR, V140, P387, DOI 10.1016/j.jtcvs.2010.01.043	40	47	51	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2212	2222		10.1001/jama.2018.4653	http://dx.doi.org/10.1001/jama.2018.4653			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29800033	Bronze, Green Published			2022-12-28	WOS:000434133400019
J	Rudd, KE; Seymour, CW; Aluisio, AR; Augustin, ME; Bagenda, DS; Beane, A; Byiringiro, JC; Chang, CCH; Colas, LN; Day, NPJ; De Silva, P; Dondorp, AM; Dunser, MW; Faiz, MA; Grant, DS; Haniffa, R; Hao, NV; Kennedy, JN; Levine, AC; Limmathurotsakul, D; Mohanty, S; Nosten, F; Papali, A; Patterson, AJ; Schieffelin, JS; Shaffer, JG; Thuy, DB; Thwaites, CL; Urayeneza, O; White, NJ; West, TE; Angus, DC				Rudd, Kristina E.; Seymour, Christopher W.; Aluisio, Adam R.; Augustin, Marc E.; Bagenda, Danstan S.; Beane, Abi; Byiringiro, Jean Claude; Chang, Chung-Chou H.; Colas, L. Nathalie; Day, Nicholas P. J.; De Silva, Pubudu; Dondorp, Arjen M.; Dunser, Martin W.; Faiz, M. Abul; Grant, Donald S.; Haniffa, Rashan; Nguyen Van Hao; Kennedy, Jason N.; Levine, Adam C.; Limmathurotsakul, Direk; Mohanty, Sanjib; Nosten, Francois; Papali, Alfred; Patterson, Andrew J.; Schieffelin, John S.; Shaffer, Jeffrey G.; Thuy, Duong Bich; Thwaites, C. Louise; Urayeneza, Olivier; White, Nicholas J.; West, T. Eoin; Angus, Derek C.		Sepsis Assessment Identification	Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; SEPTIC SHOCK; PROGNOSTIC ACCURACY; CRITERIA; SOFA; PREDICTION; OUTCOMES	IMPORTANCE The quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) score has not been well-evaluated in low- and middle-income countries (LMICs). OBJECTIVE To assess the association of qSOFA with excess hospital death among patients with suspected infection in LMICs and to compare qSOFA with the systemic inflammatory response syndrome (SIRS) criteria. DESIGN, SETTINGS, AND PARTICIPANTS Retrospective secondary analysis of 8 cohort studies and 1 randomized clinical trial from 2003 to 2017. This study included 6569 hospitalized adults with suspected infection in emergency departments, inpatient wards, and intensive care units of 17 hospitals in 10 LMICs across sub-Saharan Africa, Asia, and the Americas. EXPOSURES Low (0), moderate (1), or high (>= 2) qSOFA score (range, 0 [best] to 3 [worst]) or SIRS criteria (range, 0 [best] to 4 [worst]) within 24 hours of presentation to study hospital. MAIN OUTCOMES AND MEASURES Predictive validity (measured as incremental hospital mortality beyond that predicted by baseline risk factors, as a marker of sepsis or analogous severe infectious course) of the qSOFA score (primary) and SIRS criteria (secondary). RESULTS The cohorts were diverse in enrollment criteria, demographics (median ages, 29-54 years; males range, 36%-76%), HIV prevalence (range, 2%-43%), cause of infection, and hospital mortality (range, 1%-39%). Among 6218 patients with nonmissing outcome status in the combined cohort, 643 (10%) died. Compared with a low or moderate score, a high qSOFA score was associated with increased risk of death overall (19% vs 6%; difference, 13% [95% Cl, 11%-14%]; odds ratio, 3.6 [95% Cl, 3.0-4.2]) and across cohorts (P < .05 for 8 of 9 cohorts). Compared with a low qSOFA score, a moderate qSOFA score was also associated with increased risk of death overall (8% vs 3%; difference, 5% [95% Cl, 4%-6%]; odds ratio, 2.8 [95% Cl, 2.0-3.91), but not in every cohort (P < .05 in 2 of 7 cohorts). High, vs low or moderate, SIRS criteria were associated with a smaller increase in risk of death overall (13% vs 8%; difference, 5% [95% Cl, 3%-6%]; odds ratio, 1.7 [95% Cl, 1.4-2.0]) and across cohorts (P < .05 for 4 of 9 cohorts). qSOFA discrimination (area under the receiver operating characteristic curve [AUROC], 0.70 [95% Cl, 0.68-0.72]) was superior to that of both the baseline model (AUROC, 0.56 [95% Cl, 0.53-0.58; P < .001) and SIRS (AUROC, 0.59 [95% CI, 0.57-0.62]; P < .001). CONCLUSIONS AND RELEVANCE When assessed among hospitalized adults with suspected infection in 9 LMIC cohorts, the qSOFA score identified infected patients at risk of death beyond that explained by baseline factors. However, the predictive validity varied among cohorts and settings, and further research is needed to better understand potential generalizability.	[Rudd, Kristina E.; West, T. Eoin] Univ Washington, Dept Med & Int Resp & Severe Illness Ctr INTERSEC, Seattle, WA 98195 USA; [Seymour, Christopher W.; Kennedy, Jason N.; Angus, Derek C.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Aluisio, Adam R.; Levine, Adam C.] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Augustin, Marc E.; Colas, L. Nathalie] St Luke Fdn, Port Au Prince, Haiti; [Bagenda, Danstan S.; Patterson, Andrew J.] Univ Nebraska Med Ctr, Dept Anesthesiol, Omaha, NE USA; [Beane, Abi; Day, Nicholas P. J.; Dondorp, Arjen M.; Faiz, M. Abul; Limmathurotsakul, Direk; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Beane, Abi] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands; [Byiringiro, Jean Claude] Univ Rwanda, Coll Med & Hlth Sci, Univ Teaching Hosp Kigali, Div Clin Educ & Res, Kigali, Rwanda; [Chang, Chung-Chou H.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Chang, Chung-Chou H.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Day, Nicholas P. J.; Dondorp, Arjen M.; Limmathurotsakul, Direk; Nosten, Francois; Thwaites, C. Louise; White, Nicholas J.] Nuffield Dept Clin Med, Oxford Ctr Trop Med & Global Hlth, Oxford, England; [De Silva, Pubudu; Haniffa, Rashan] Natl Intens Care Surveillance, Colombo, Sri Lanka; [De Silva, Pubudu] Intens Care Natl Audit & Res Ctr, London, England; [Dunser, Martin W.] Johannes Kepler Univ Linz, Kepler Univ Hosp, Dept Anesthesiol & Intens Care Med, Linz, Austria; [Faiz, M. Abul] Dev Care Fdn, Dhaka, Bangladesh; [Grant, Donald S.] Kenema Govt Hosp, Minist Hlth & Sanitat, Kenema, Sierra Leone; [Grant, Donald S.] Univ Sierra Leone, Coll Med & Allied Hlth Sci, Freetown, Sierra Leone; [Nguyen Van Hao; Thuy, Duong Bich] Hosp Trop Dis, Adult Intens Care Unit, Ho Chi Minh City, Vietnam; [Nguyen Van Hao] Univ Med & Pharm, Dept Infect Dis, Ho Chi Minh City, Vietnam; [Mohanty, Sanjib] Spat Gen Hosp, Rourkela, Odisha, India; [Mohanty, Sanjib] Asian Inst Publ Hlth, Ctr Emerging Infect Dis, Bhubaneswar, Odisha, India; [Nosten, Francois] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Sholdo Malaria Res Unit, Mae Sot, Thailand; [Papali, Alfred] Univ Maryland, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Papali, Alfred] Univ Maryland, Sch Med, Inst Global Hlth, Baltimore, MD 21201 USA; [Papali, Alfred] Atrium Hlth, Div Pulm & Crit Care Med, Charlotte, NC USA; [Schieffelin, John S.] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA; [Shaffer, Jeffrey G.] Tulane Univ, Dept Global Biostat & Data Sci, New Orleans, LA 70118 USA; [Thuy, Duong Bich; Thwaites, C. Louise] Univ Oxford, Hosp Trop Dis, Clin Res Unit OUCRU, Ho Chi Minh City, Vietnam; [Urayeneza, Olivier] Univ Gitwe, Gitwe, Rwanda	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University; University of Nebraska System; University of Nebraska Medical Center; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Amsterdam; Academic Medical Center Amsterdam; University of Rwanda; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oxford; Intensive Care National Audit & Research Centre; Johannes Kepler University Linz; Kepler University Hospital; Kenema Government Hospital; Ministry of Health & Sanitation Sierra Leone; Hochiminh City University of Medicine & Pharmacy; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Tulane University; Tulane University; University of Oxford	Rudd, KE (corresponding author), Univ Washington, Dept Med, Div Pulm Crit Care & Sleep Med, Seattle, WA 98104 USA.	krudd@uw.edu	BYIRINGIRO, JEAN CLAUDE/T-9719-2019; Kennedy, Jason/AAG-8399-2020; Rudd, Kristina/AFM-0440-2022; Rudd, Kristina/AAH-2770-2022; White, Nick/AAC-6527-2019; Nosten, Francois/AAC-5509-2019; Angus, Derek C/E-9671-2012; Aluisio, Adam/AGU-9179-2022; Levine, Adam/F-1813-2016	BYIRINGIRO, JEAN CLAUDE/0000-0002-6445-1797; Rudd, Kristina/0000-0002-6695-8401; Rudd, Kristina/0000-0002-6695-8401; White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Beane, Abigail/0000-0001-7046-1580; Haniffa, Rashan/0000-0002-8288-449X; West, T Eoin/0000-0001-5503-7204; Levine, Adam/0000-0003-3982-3824	NIH [R01HL113382, R35GM119519, T32HL007287, K23GM104022, NIHAI2008031, U19AI115589, K12HD043451]; Wellcome Trust [090219/Z/09/Z]; University Emergency Medicine Foundation; Society of Critical Care Medicine; European Society of Intensive Care Medicine; Hellman Foundation; University of Nebraska Medical Center Department of Anesthesiology; National Science Foundation (Sri Lanka) [RG/2016/HS/02]; Li Ka Shing Foundation; Network for Improving Critical Care Systems and Training; International Respiratory and Severe Illness Center at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113382, T32HL007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI115589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM104022, R35GM119519] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); University Emergency Medicine Foundation; Society of Critical Care Medicine; European Society of Intensive Care Medicine; Hellman Foundation; University of Nebraska Medical Center Department of Anesthesiology; National Science Foundation (Sri Lanka)(National Science Foundation (NSF)); Li Ka Shing Foundation; Network for Improving Critical Care Systems and Training; International Respiratory and Severe Illness Center at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by the NIH (R01HL113382, R35GM119519, T32HL007287, K23GM104022, NIHAI2008031, U19AI115589, and K12HD043451), the Wellcome Trust (090219/Z/09/Z), the University Emergency Medicine Foundation, the Society of Critical Care Medicine, the European Society of Intensive Care Medicine, the Hellman Foundation, the University of Nebraska Medical Center Department of Anesthesiology, the National Science Foundation (RG/2016/HS/02 Sri Lanka), the Li Ka Shing Foundation, the Network for Improving Critical Care Systems and Training, and the International Respiratory and Severe Illness Center at the University of Washington.	Aluisio AR, 2018, AM J EMERG MED, V36, P2010, DOI 10.1016/j.ajem.2018.03.014; Baker T, 2015, CRIT CARE MED, V43, P2171, DOI 10.1097/CCM.0000000000001194; Beane A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019387; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Thuy DB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184847; Faiz MA, 2005, LANCET, V366, P717; Fernando SM, 2018, ANN INTERN MED, V168, P266, DOI 10.7326/M17-2820; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Huson MAM, 2017, INFECTION, V45, P893, DOI 10.1007/s15010-017-1057-5; Huson MAM, 2017, TRAVEL MED INFECT DI, V15, P76, DOI 10.1016/j.tmaid.2016.10.014; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Machado FR, 2017, J CRIT CARE, V40, P315, DOI 10.1016/j.jcrc.2017.04.037; McNarry AF, 2004, ANAESTHESIA, V59, P34, DOI 10.1111/j.1365-2044.2004.03526.x; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Papali A, 2017, J CRIT CARE, V41, P222, DOI 10.1016/j.jcrc.2017.05.024; Papali A, 2017, J CRIT CARE, V38, P35, DOI 10.1016/j.jcrc.2016.09.031; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; Serafim R, 2018, CHEST, V153, P646, DOI 10.1016/j.chest.2017.12.015; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shaffer JG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002748; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Teparrukkul P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176233; The World Bank, WORLD BANK COUNTR LE; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wilcoxon F., 1992, SPRINGER SERIES STAT, V1, P196, DOI DOI 10.2307/3001968	25	104	107	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2202	2211		10.1001/jama.2018.6229	http://dx.doi.org/10.1001/jama.2018.6229			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29800114	Green Published, Bronze			2022-12-28	WOS:000434133400018
J	Voelker, R				Voelker, Rebecca			Electrical Stimulation for Epilepsy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2164	2164		10.1001/jama.2018.7068	http://dx.doi.org/10.1001/jama.2018.7068			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29872844				2022-12-28	WOS:000434133400008
J	Nawathe, A; Doherty, J; Pandya, P				Nawathe, Aamod; Doherty, Jane; Pandya, P.			Fetal microcephaly	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OF-THE-LITERATURE; HEAD CIRCUMFERENCE; PRENATAL-DIAGNOSIS; MENTAL-RETARDATION; ULTRASOUND; GROWTH; INFECTION; CHILDREN; DELETION; UPDATE		[Nawathe, Aamod; Pandya, P.] UCL, Med Sch, Fetal Maternal Med, London WC1E 6BT, England; [Doherty, Jane] Nexus Hlth Grp, London SE1 6JP, England	University of London; University College London	Pandya, P (corresponding author), UCL, Med Sch, Fetal Maternal Med, London WC1E 6BT, England.	pranavpandya@nhs.net						Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7; Bale JF, 2014, HAND CLINIC, V123, P319, DOI 10.1016/B978-0-444-53488-0.00015-8; Benacerraf BR, 2007, J ULTRAS MED, V26, P1513, DOI 10.7863/jum.2007.26.11.1513; Bhide P, 2016, B WHO; Bonalumi Silvia, 2011, J Prenat Med, V5, P1; BROMLEY B, 1995, J ULTRAS MED, V14, P303; Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities, 2016, FACTS MICR; CHERVENAK FA, 1984, AM J OBSTET GYNECOL, V149, P512, DOI 10.1016/0002-9378(84)90027-9; DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974; Drooger JC, 2005, ULTRASOUND OBST GYN, V26, P115, DOI 10.1002/uog.1962; Gelber SE, 2017, J PERINAT MED, V45, P167, DOI 10.1515/jpm-2016-0220; Gordon-Lipkin E, 2016, 2016 CHILD NEUR SOC; Gordon-Lipkin E, 2017, J CHILD NEUROL, V32, P804, DOI 10.1177/0883073817707301; Griffiths PD, 2017, LANCET, V389, P538, DOI 10.1016/S0140-6736(16)31723-8; Harris SR, 2015, CAN FAM PHYSICIAN, V61, P680; Ivanovic DM, 2004, NEUROPSYCHOLOGIA, V42, P1118, DOI 10.1016/j.neuropsychologia.2003.11.022; KURTZ AB, 1980, J CLIN ULTRASOUND, V8, P11, DOI 10.1002/jcu.1870080104; Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801; Malinger G, 2004, ULTRASOUND OBST GYN, V23, P333, DOI 10.1002/uog.1016; Malinger G, 2002, ULTRASOUND OBST GYN, V20, P51, DOI 10.1046/j.1469-0705.2002.00743.x; Melamed N, 2011, ULTRASOUND OBST GYN, V37, P65, DOI 10.1002/uog.7760; Mikolajewska E, 2013, ADV CLIN EXP MED, V22, P571; Miller LC, 2007, ACTA PAEDIATR, V96, P1765, DOI 10.1111/j.1651-2227.2007.00537.x; Moienafshari R, 1998, CAN FAM PHYSICIAN, V44, P2381; Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721; OCONNELL EJ, 1965, PEDIATRICS, V36, P62; Paquet C, 2013, J OBSTET GYNAECOL CA, V35, P78, DOI 10.1016/S1701-2163(15)31053-7; Pedicelli Stefania, 2009, J Clin Res Pediatr Endocrinol, V1, P105, DOI 10.4008/jcrpe.v1i3.53; Perche O, 2013, EUR J MED GENET, V56, P635, DOI 10.1016/j.ejmg.2013.07.007; Pfau RB, 2013, EUR J MED GENET, V56, P609, DOI 10.1016/j.ejmg.2013.09.007; PRYOR HB, 1968, J PEDIATR-US, V73, P593, DOI 10.1016/S0022-3476(68)80275-6; Reefhuis J, 2015, BIRTH DEFECTS RES A, V103, P656, DOI 10.1002/bdra.23384; Royal College of Obstetricians and Gynaecologists (RCOG), 2011, PLAC PRAEV PLAC ACCR; Sarris I, 2012, ULTRASOUND OBST GYN, V39, P266, DOI 10.1002/uog.10082; Stoler-Poria S, 2010, ULTRASOUND OBST GYN, V36, P154, DOI 10.1002/uog.7556; Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425; Williams Robin A, 2008, Clin Biochem Rev, V29, P31; Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003	39	8	8	4	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2018	361								k2232	10.1136/bmj.k2232	http://dx.doi.org/10.1136/bmj.k2232			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BQ	29866660				2022-12-28	WOS:000435072800001
J	Marchese, FP; Huarte, M				Marchese, Francesco P.; Huarte, Maite			A "Counter-Enhancer'' in Tumor Suppression	CELL			English	Editorial Material							CANCER; MYC; PVT1	The role of the noncoding genome in cancer biology is continually expanding. Cho et al. reveal a new and unexpected mechanism for the regulation of MYC expression mediated by the promoter sequence of its neighbor gene PVT1. This DNA element acts as a promoter-enhancer competitor and a candidate tumor suppressor.'	[Marchese, Francesco P.; Huarte, Maite] Univ Navarra, Ctr Appl Med Res CIMA, Pamplona 31008, Spain; [Marchese, Francesco P.; Huarte, Maite] Inst Hlth Res Navarra IdiSNA, Pamplona 31008, Spain	University of Navarra	Huarte, M (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Pamplona 31008, Spain.; Huarte, M (corresponding author), Inst Hlth Res Navarra IdiSNA, Pamplona 31008, Spain.	maitehuarte@unav.es	Marchese, Francesco P/AAA-6473-2021; Huarte, Maite/J-6903-2014	Marchese, Francesco P/0000-0002-6028-117X; Huarte, Maite/0000-0003-3753-6493				Acemel RD, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.265; Cho SW, 2018, CELL, V173, P1398, DOI 10.1016/j.cell.2018.03.068; Cui M, 2016, BIOCHEM BIOPH RES CO, V471, P10, DOI 10.1016/j.bbrc.2015.12.101; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311	9	3	3	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1318	1319		10.1016/j.cell.2018.05.023	http://dx.doi.org/10.1016/j.cell.2018.05.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856950	Bronze			2022-12-28	WOS:000433989100005
J	Allum, N; Besley, J; Gomez, L; Brunton-Smith, I				Allum, Nick; Besley, John; Gomez, Louis; Brunton-Smith, Ian			SCIENCE EDUCATION Disparities in science literacy	SCIENCE			English	Editorial Material									[Allum, Nick] Univ Essex, Dept Sociol, Colchester, Essex, England; [Besley, John] Michigan State Univ, Dept Advertising & Publ Relat, E Lansing, MI 48824 USA; [Gomez, Louis] Univ Calif Los Angeles, Dept Educ, Los Angeles, CA USA; [Gomez, Louis] Carnegie Fdn Adv Teaching, Stanford, CA USA; [Brunton-Smith, Ian] Univ Surrey, Dept Sociol, Guildford, Surrey, England	University of Essex; Michigan State University; University of California System; University of California Los Angeles; University of Surrey	Allum, N (corresponding author), Univ Essex, Dept Sociol, Colchester, Essex, England.	nallum@essex.ac.uk		Besley, John/0000-0002-8778-4973				Cutilli CC, 2009, ORTHOP NURS, V28, P27, DOI 10.1097/01.NOR.0000345852.22122.d6; Darling-Hammond L, 2001, HDB RES MULTICULTURA, P465; Hallman W. K., 2017, HDB SCI SCI COMMUNIC, P61; Kena G., 2014, 2014083 NCES; Malhotra N., 2007, 11 GSS NORC, V11; Museus S. D., 2011, ASHE HIGHER ED REPOR, V36; National Academies of Sciences Engineering and Medicine, 2016, SCI LIT CONC CONT CO; National Center for Education Statistics, 2012, 2012465 NCES US DEP; National Science Board, 2016, SCI ENG IND 2016; Pew Research Center, 2015, LOOK WHAT PUBL KNOWS; Plutzer E., 2013, B SCI TECHNOL SOC, V33, P146, DOI [10.1177/0270467614528902, DOI 10.1177/0270467614528902]; PRANDY K, 1990, SOCIOLOGY, V24, P629, DOI 10.1177/0038038590024004005; Quintana SM, 2016, THEOR PRACT, V55, P94, DOI 10.1080/00405841.2016.1148985; Rikard RV, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3621-9; Su LYF, 2014, SCI COMMUN, V36, P352, DOI 10.1177/1075547014529093	15	9	9	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					861	862		10.1126/science.aar8480	http://dx.doi.org/10.1126/science.aar8480			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG9RW	29798873	Green Accepted, Green Submitted			2022-12-28	WOS:000433039800031
J	Kupferschmidt, K				Kupferschmidt, Kai			A call to arms against the other retrovirus	SCIENCE			English	News Item																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					844	844		10.1126/science.360.6391.844	http://dx.doi.org/10.1126/science.360.6391.844			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798864				2022-12-28	WOS:000433039800022
J	Goel, A				Goel, Anupam			Efficacy and safety of ticagrelor were similar in patients with past MI, regardless of multivessel coronary disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Goel, Anupam] Advocate Hlth Care, Clarendon Hills, IL 60514 USA		Goel, A (corresponding author), Advocate Hlth Care, Clarendon Hills, IL 60514 USA.				AstraZeneca [PEGASUS-TIMI 54]	AstraZeneca(AstraZeneca)	AstraZeneca funded PEGASUS-TIMI 54.	Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Silverman MG, 2016, JAMA-J AM MED ASSOC, V316, P1289, DOI 10.1001/jama.2016.13985	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					JC56	JC56		10.7326/ACPJC-2018-168-10-056	http://dx.doi.org/10.7326/ACPJC-2018-168-10-056			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3DE	29800432				2022-12-28	WOS:000434250700008
J	Guzman-Limon, M; Molony, D				Guzman-Limon, Monica; Molony, Donald			In older patients with UTIs, trimethoprim vs amoxicillin was linked to higher risk for AKI at 14 d	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ACUTE KIDNEY INJURY		[Guzman-Limon, Monica; Molony, Donald] Univ Texas HSC Houston, McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Guzman-Limon, M (corresponding author), Univ Texas HSC Houston, McGovern Med Sch, Houston, TX 77030 USA.							Bird ST, 2013, CAN MED ASSOC J, V185, pE475, DOI 10.1503/cmaj.121730; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Rowe TA, 2014, INFECT DIS CLIN N AM, V28, P75, DOI 10.1016/j.idc.2013.10.004	3	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					JC58	JC58		10.7326/ACPJC-2018-168-10-058	http://dx.doi.org/10.7326/ACPJC-2018-168-10-058			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3DE	29800434				2022-12-28	WOS:000434250700010
J	[Anonymous]				[Anonymous]			Hookworm Treatment Improves Physical Stamina of Female Farmers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					1973	1973		10.1001/jama.2018.5432	http://dx.doi.org/10.1001/jama.2018.5432			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800219				2022-12-28	WOS:000432238300003
J	[Anonymous]				[Anonymous]			Contact Lenses Adjust to Sunlight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					1974	1974		10.1001/jama.2018.5585	http://dx.doi.org/10.1001/jama.2018.5585			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800196				2022-12-28	WOS:000432238300007
J	Lin, SS; Dikler, S; Blincoe, WD; Ferguson, RD; Sheridan, RP; Peng, ZW; Conway, DV; Zawatzky, K; Wang, H; Cernak, T; Davies, IW; DiRocco, DA; Sheng, HM; Welch, CJ; Dreher, SD				Lin, Shishi; Dikler, Sergei; Blincoe, William D.; Ferguson, Ronald D.; Sheridan, Robert P.; Peng, Zhengwei; Conway, Donald V.; Zawatzky, Kerstin; Wang, Heather; Cernak, Tim; Davies, Ian W.; DiRocco, Daniel A.; Sheng, Huaming; Welch, Christopher J.; Dreher, Spencer D.			Mapping the dark space of chemical reactions with extended nanomole synthesis and MALDI-TOF MS	SCIENCE			English	Article							MASS-SPECTROMETRY; CHROMATOGRAPHIC-SEPARATION; DISCOVERY; INHIBITORS; EVOLUTION	Understanding the practical limitations of chemical reactions is critically important for efficiently planning the synthesis of compounds in pharmaceutical, agrochemical, and specialty chemical research and development. However, literature reports of the scope of new reactions are often cursory and biased toward successful results, severely limiting the ability to predict reaction outcomes for untested substrates. We herein illustrate strategies for carrying out large-scale surveys of chemical reactivity by using a materialsparing nanomole-scale automated synthesis platform with greatly expanded synthetic scope combined with ultrahigh-throughput matrix-assisted laser desorption/ionizationtime-of-flight mass spectrometry (MALDI-TOF MS).	[Lin, Shishi; Ferguson, Ronald D.; Dreher, Spencer D.] Merck & Co Inc, Chem Capabil Accelerating Therapeut, Kenilworth, NJ 07033 USA; [Dikler, Sergei] Bruker Daltonics Inc, Billerica, MA 01821 USA; [Blincoe, William D.; Zawatzky, Kerstin; Wang, Heather; Sheng, Huaming; Welch, Christopher J.] Merck & Co Inc, Analyt Res & Dev, Rahway, NJ 07065 USA; [Sheridan, Robert P.; Peng, Zhengwei] Merck & Co Inc, Modeling & Informat, Kenilworth, NJ 07033 USA; [Conway, Donald V.] Merck & Co Inc, Discovery Sample Management, Kenilworth, NJ 07033 USA; [Cernak, Tim] Merck & Co Inc, Discovery Chem, Boston, MA 02115 USA; [Davies, Ian W.; DiRocco, Daniel A.] Merck & Co Inc, Proc Res & Dev, Rahway, NJ 07065 USA; [Cernak, Tim] Univ Michigan, Dept Med Chem, Dept Chem, Program Chem Biol, Ann Arbor, MI 48109 USA; [Davies, Ian W.] Princeton Univ, Princeton Catalysis Initiat, Princeton, NJ 08544 USA; [Welch, Christopher J.] Indiana Consortium Analyt Sci, Indianapolis, IN 46202 USA; [Welch, Christopher J.] Welch Innovat LLC, Cranbury, NJ 08512 USA	Merck & Company; Bruker Corporation; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; University of Michigan System; University of Michigan; Princeton University	Dreher, SD (corresponding author), Merck & Co Inc, Chem Capabil Accelerating Therapeut, Kenilworth, NJ 07033 USA.; Sheng, HM; Welch, CJ (corresponding author), Merck & Co Inc, Analyt Res & Dev, Rahway, NJ 07065 USA.; Welch, CJ (corresponding author), Indiana Consortium Analyt Sci, Indianapolis, IN 46202 USA.; Welch, CJ (corresponding author), Welch Innovat LLC, Cranbury, NJ 08512 USA.	huaming.sheng@merck.com; christopher@welchinnovation.com; spencer_dreher@merck.com		Wang, Heather/0000-0002-4001-236X	MRL Postdoctoral Research Fellows program; Merck AMP; Co., Inc., Kenilworth, NJ, USA	MRL Postdoctoral Research Fellows program; Merck AMP; Co., Inc., Kenilworth, NJ, USA	S.L. and K.Z. are grateful to the MRL Postdoctoral Research Fellows program for financial support. Additional financial support was provided by Merck & Co., Inc., Kenilworth, NJ, USA.	Ahneman DT, 2018, SCIENCE, V360, P186, DOI 10.1126/science.aar5169; Beeman K, 2017, SLAS DISCOV, V22, P1203, DOI 10.1177/2472555217727701; Boggio KJ, 2011, EXPERT REV PROTEOMIC, V8, P591, DOI [10.1586/epr.11.53, 10.1586/EPR.11.53]; Cabrera-Pardo JR, 2013, NAT CHEM, V5, P423, DOI 10.1038/nchem.1612; Coley CW, 2017, ACS CENTRAL SCI, V3, P434, DOI 10.1021/acscentsci.7b00064; Collins KD, 2013, NAT CHEM, V5, P597, DOI [10.1038/NCHEM.1669, 10.1038/nchem.1669]; Corcoran EB, 2016, SCIENCE, V353, P279, DOI 10.1126/science.aag0209; Diagne AB, 2015, ACS COMB SCI, V17, P658, DOI 10.1021/acscombsci.5b00131; Diefenbach XW, 2018, ACS OMEGA, V3, P1498, DOI 10.1021/acsomega.7b01973; Duncan Mark W., 2008, Briefings in Functional Genomics & Proteomics, V7, P355, DOI 10.1093/bfgp/eln041; Gesmundo NJ, 2018, NATURE, V557, P228, DOI 10.1038/s41586-018-0056-8; Haslam C, 2016, J BIOMOL SCREEN, V21, P176, DOI 10.1177/1087057115608605; Heap RE, 2017, SLAS DISCOV, V22, P1193, DOI 10.1177/2472555217717473; Hopkinson MN, 2016, ANGEW CHEM INT EDIT, V55, P4361, DOI 10.1002/anie.201600995; Korte AR, 2014, J MASS SPECTROM, V49, P737, DOI 10.1002/jms.3400; Krska SW, 2017, ACCOUNTS CHEM RES, V50, P2976, DOI 10.1021/acs.accounts.7b00428; Kutchukian PS, 2016, CHEM SCI, V7, P2604, DOI 10.1039/c5sc04751j; Lavecchia A, 2015, DRUG DISCOV TODAY, V20, P318, DOI 10.1016/j.drudis.2014.10.012; Martin VI, 2014, J ORG CHEM, V79, P3838, DOI 10.1021/jo500190b; McNally A, 2011, SCIENCE, V334, P1114, DOI 10.1126/science.1213920; Milo A, 2015, SCIENCE, V347, P737, DOI 10.1126/science.1261043; Montavon TJ, 2012, NAT CHEM, V4, P45, DOI 10.1038/nchem.1212; Perera D, 2018, SCIENCE, V359, P429, DOI 10.1126/science.aap9112; Richardson J, 2017, J ORG CHEM, V82, P3741, DOI 10.1021/acs.joc.7b00201; Ritorto MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5763; Santanilla AB, 2015, SCIENCE, V347, P49, DOI 10.1126/science.1259203; Sheridan R, 2016, J CHROMATOGR A, V1467, P206, DOI 10.1016/j.chroma.2016.05.066; Shi R, 2017, ACS NANO, V11, P9500, DOI 10.1021/acsnano.7b05328; Si T, 2017, J AM CHEM SOC, V139, P12466, DOI 10.1021/jacs.7b04641; Soltzberg LJ, 2004, RAPID COMMUN MASS SP, V18, P1455, DOI 10.1002/rcm.1505; Sun SW, 2012, ANAL CHEM, V84, P5794, DOI 10.1021/ac3011389; Szymkuc S, 2016, ANGEW CHEM INT EDIT, V55, P5904, DOI 10.1002/anie.201506101; Todd MH, 2005, CHEM SOC REV, V34, P247, DOI 10.1039/b104620a; Troshin K, 2017, SCIENCE, V357, P175, DOI 10.1126/science.aan1568; Wang PG, 2017, J CHROMATOGR A, V1486, P35, DOI 10.1016/j.chroma.2017.01.040; Welch CJ, 2017, ACS CENTRAL SCI, V3, P823, DOI 10.1021/acscentsci.7b00250; Winter M, 2018, SLAS DISCOV, V23, P561, DOI 10.1177/2472555218759267; Wleklinski M, 2018, CHEM SCI, V9, P1647, DOI 10.1039/c7sc04606e	38	76	76	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2018	361	6402							eaar6236	10.1126/science.aar6236	http://dx.doi.org/10.1126/science.aar6236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP8YO	29794218				2022-12-28	WOS:000441202700043
J	Azizi, M; Schmieder, RE; Mahfoud, F; Weber, MA; Daemen, J; Davies, J; Basile, J; Kirtane, AJ; Wang, YL; Lobo, MD; Saxena, M; Feyz, L; Rader, F; Lurz, P; Sayer, J; Sapoval, M; Levy, T; Sanghvi, K; Abraham, J; Sharp, ASP; Fisher, NDL; Bloch, MJ; Reeve-Stoffer, H; Coleman, L; Mullin, C; Mauri, L				Azizi, Michel; Schmieder, Roland E.; Mahfoud, Felix; Weber, Michael A.; Daemen, Joost; Davies, Justin; Basile, Jan; Kirtane, Ajay J.; Wang, Yale; Lobo, Melvin D.; Saxena, Manish; Feyz, Lida; Rader, Florian; Lurz, Philipp; Sayer, Jeremy; Sapoval, Marc; Levy, Terry; Sanghvi, Kintur; Abraham, Josephine; Sharp, Andrew S. P.; Fisher, Naomi D. L.; Bloch, Michael J.; Reeve-Stoffer, Helen; Coleman, Leslie; Mullin, Christopher; Mauri, Laura		RADIANCE-HTN Investigators	Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial	LANCET			English	Article							TREATMENT-RESISTANT HYPERTENSION; SYMPATHETIC DENERVATION; UNCONTROLLED HYPERTENSION; INTRALUMINAL ULTRASOUND; ARTERIAL-WALL; THERAPY; NERVES	Background Early studies suggest that radiofrequency-based renal denervation reduces blood pressure in patients with moderate hypertension. We investigated whether an alternative technology using endovascular ultrasound renal denervation reduces ambulatory blood pressure in patients with hypertension in the absence of antihypertensive medications. Methods RADIANCE-HTN SOLO was a multicentre, international, single-blind, randomised, sham-controlled trial done at 21 centres in the USA and 18 in Europe. Patients with combined systolic-diastolic hypertension aged 18-75 years were eligible if they had ambulatory blood pressure greater than or equal to 135/85 mm Hg and less than 170/105 mm Hg after a 4-week discontinuation of up to two antihypertensive medications and had suitable renal artery anatomy. Patients were randomised (1:1) to undergo renal denervation with the Paradise system (ReCor Medical, Palo Alto, CA, USA) or a sham procedure consisting of renal angiography only. The randomisation sequence was computer generated and stratified by centres with randomised blocks of four or six and permutation of treatments within each block. Patients and outcome assessors were blinded to randomisation. The primary effectiveness endpoint was the change in daytime ambulatory systolic blood pressure at 2 months in the intention-to-treat population. Patients were to remain off antihypertensive medications throughout the 2 months of follow-up unless specified blood pressure criteria were exceeded. Major adverse events included all-cause mortality, renal failure, an embolic event with end-organ damage, renal artery or other major vascular complications requiring intervention, or admission to hospital for hypertensive crisis within 30 days and new renal artery stenosis within 6 months. This study is registered with ClinicalTrials.gov, number NCT02649426. Findings Between March 28, 2016, and Dec 28, 2017, 803 patients were screened for eligibility and 146 were randomised to undergo renal denervation (n=74) or a sham procedure (n=72). The reduction in daytime ambulatory systolic blood pressure was greater with renal denervation (-8.5 mm Hg, SD 9.3) than with the sham procedure (-2.2 mm Hg, SD 10.0; baseline-adjusted difference between groups: -6.3 mm Hg, 95% CI -9.4 to -3.1, p=0.0001). No major adverse events were reported in either group. Interpretation Compared with a sham procedure, endovascular ultrasound renal denervation reduced ambulatory blood pressure at 2 months in patients with combined systolic-diastolic hypertension in the absence of medications. Copyright (c) 2018 Elsevier Ltd. All rights reserved.	[Azizi, Michel; Sapoval, Marc] Univ Paris 05, Paris, France; [Azizi, Michel] Hop Europeen Georges Pompidou, AP HP, Hypertens Dept, Paris, France; [Azizi, Michel] Hop Europeen Georges Pompidou, AP HP, DHU PARC, Paris, France; [Sapoval, Marc] Hop Europeen Georges Pompidou, AP HP, Vasc & Oncol Intervent Radiol Dept, Paris, France; [Azizi, Michel] INSERM, CIC1418, Paris, France; [Schmieder, Roland E.] Friedrich Alexander Univ, Univ Hosp Erlangen, Nephrol & Hypertens, Erlangen, Germany; [Mahfoud, Felix] Saarland Univ Hosp, Klin Innere Med 3, Homburg, Germany; [Mahfoud, Felix] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Weber, Michael A.] Suny Downstate Med Ctr, Div Cardiovasc Med, New York, NY USA; [Daemen, Joost] Erasmus MC, Thoraxctr, Rotterdam, Netherlands; [Davies, Justin] Hammersmith Hosp, Imperial Coll Healthcare NHS Trust, London, England; [Basile, Jan] Med Univ South Carolina, Ralph H Johnson VA Med Ctr, Seinsheimer Cardiovasc Hlth Program, Charleston, SC 29425 USA; [Kirtane, Ajay J.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Kirtane, Ajay J.] Cardiovasc Res Fdn, New York, NY USA; [Wang, Yale] Abbott NW Hosp, Minneapolis Heart Inst, Minneapolis, MN 55407 USA; [Lobo, Melvin D.; Saxena, Manish] Queen Mary Univ London, Barts NIHR Biomed Res Ctr, William Harvey Res Inst, London, England; [Rader, Florian] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Lurz, Philipp] Univ Hosp, Heart Ctr Leipzig, Dept Internal Med Cardiol, Leipzig, Germany; [Sayer, Jeremy] Essex Cardiothorac Ctr, Basildon, England; [Sapoval, Marc] INSERM, U970, Paris, France; [Levy, Terry] Royal Bournemouth Hosp, Bournemouth, Dorset, England; [Sanghvi, Kintur] Deborah Heart & Lung Ctr, Browns Mills, NJ USA; [Abraham, Josephine] Univ Utah, Med Ctr, Salt Lake City, UT USA; [Sharp, Andrew S. P.] Royal Devon & Exeter NHS Fdn Trust, Exeter, MA USA; [Fisher, Naomi D. L.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Bloch, Michael J.] Univ Nevada, Sch Med, Dept Med, Reno, NV 89557 USA; [Bloch, Michael J.] Renown Inst Heart & Vasc Hlth, Vasc Care, Reno, NV USA; [Reeve-Stoffer, Helen; Coleman, Leslie] ReCor Med, Palo Alto, CA USA; [Mullin, Christopher] NAMSA, Minneapolis, MN USA; [Mauri, Laura] Harvard Med Sch, Boston, MA USA	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Erlangen Nuremberg; Universitatsklinikum des Saarlandes; Massachusetts Institute of Technology (MIT); State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Erasmus University Rotterdam; Erasmus MC; Imperial College London; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); Minneapolis Heart Institute Foundation; University of London; Queen Mary University London; Cedars Sinai Medical Center; Heart Center Leipzig GMBH; Leipzig University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; Nevada System of Higher Education (NSHE); University of Nevada Reno; Harvard University; Harvard Medical School	Mauri, L (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	lmauri@bwh.harvard.edu	Courand, Pierre-Yves/O-1054-2016; Mahfoud, Felix/D-7707-2011; Lurz, Philipp C/B-6558-2009; Böhm, Michael/C-3638-2011; mauri, laura/GPS-4868-2022; Azizi, Michel/Y-9580-2019	Courand, Pierre-Yves/0000-0003-3199-7977; Lurz, Philipp C/0000-0002-5993-4487; Shun-Shin, Matthew/0000-0002-1179-0867; Pathak, Atul/0000-0001-6151-0096; EDROOS, Sadat/0000-0002-3267-6350; Howard, James/0000-0002-9989-6331; MAthur, Anthony/0000-0001-7941-9653; gosse, philippe/0000-0002-5840-7749; Barman, Neil/0000-0001-5713-6716	ReCor Medical	ReCor Medical	ReCor Medical.	Al Raisi SI, 2017, EUROINTERVENTION, V13, P1242, DOI 10.4244/EIJ-D-17-00278; Azizi M, 2016, CIRCULATION, V134, P847, DOI 10.1161/CIRCULATIONAHA.116.022922; Azizi M, 2015, LANCET, V385, P1957, DOI 10.1016/S0140-6736(14)61942-5; Banegas JR, 2018, NEW ENGL J MED, V378, P1509, DOI 10.1056/NEJMoa1712231; Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Booth LC, 2015, HYPERTENSION, V65, P393, DOI 10.1161/HYPERTENSIONAHA.114.04176; Coppolino G, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011499.pub2; Courand PY, 2017, J AM HEART ASSOC, V6; Daemen J, 2018, JACC-CARDIOVASC INTE, V11, pS33, DOI 10.1016/j.jcin.2018.01.105; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Fengler K, 2017, J HYPERTENS, V35, P1310, DOI 10.1097/HJH.0000000000001301; International Council for Harmonisation, 2000, PRINC CLIN EV NEW AN; James KE, 1996, STAT MED, V15, P1421; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Mahfoud F, 2017, EUR HEART J, V38, P3272, DOI 10.1093/eurheartj/ehx215; Mahfoud F, 2017, EUR HEART J, V38, P93, DOI 10.1093/eurheartj/ehw325; Mauri L, 2018, AM HEART J, V195, P115, DOI 10.1016/j.ahj.2017.09.006; MCCORMACK HM, 1988, PSYCHOL MED, V18, P1007, DOI 10.1017/S0033291700009934; Pathak A, 2015, EUROINTERVENTION, V11, P477, DOI 10.4244/EIJV11I4A96; Persu A, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-015-0610-9; Sakakura K, 2015, EUROINTERVENTION, V10, P1230, DOI 10.4244/EIJY14M10_14; Sakakura K, 2014, J AM COLL CARDIOL, V64, P635, DOI 10.1016/j.jacc.2014.03.059; Schmieder RE, 2018, J HYPERTENS, V36, P680, DOI 10.1097/HJH.0000000000001584; Townsend RR, 2017, LANCET, V390, P2160, DOI 10.1016/S0140-6736(17)32281-X; Weber MA, 2015, J CLIN HYPERTENS, V17, P743, DOI 10.1111/jch.12590; White WB, 2015, J AM SOC HYPERTENS, V9, P341, DOI 10.1016/j.jash.2015.02.012	29	330	340	8	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2018	391	10137					2335	2345		10.1016/S0140-6736(18)31082-1	http://dx.doi.org/10.1016/S0140-6736(18)31082-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI6WF	29803590				2022-12-28	WOS:000434643200030
J	Rossant, J; Tam, PPL				Rossant, Janet; Tam, Patrick P. L.			Exploring early human embryo development	SCIENCE			English	Editorial Material							STEM-CELLS; SELF-ORGANIZATION; DERIVATION; TISSUES; ABSENCE		[Rossant, Janet] Univ Toronto, Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Toronto, ON M5G 0A4, Canada; [Rossant, Janet] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 0A4, Canada; [Tam, Patrick P. L.] Univ Sydney, Fac Med & Hlth, Childrens Med Res Inst, Embryol Unit, Westmead, NSW 2145, Australia; [Tam, Patrick P. L.] Univ Sydney, Fac Med & Hlth, Sch Med Sci, Westmead, NSW 2145, Australia	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Children's Medical Research Institute - Australia; University of Sydney; University of Sydney	Rossant, J (corresponding author), Univ Toronto, Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Toronto, ON M5G 0A4, Canada.; Rossant, J (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5G 0A4, Canada.	janet.rossant@sickkids.ca; ptam@cmri.org.au						Aach J, 2017, ELIFE, V6, DOI 10.7554/eLife.20674; De Paepe C, 2014, MOL HUM REPROD, V20, P599, DOI 10.1093/molehr/gau027; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; Fogarty NME, 2017, NATURE, V550, P67, DOI 10.1038/nature24033; Harrison SE, 2017, SCIENCE, V356, DOI 10.1126/science.aal1810; Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096; Okae H, 2018, CELL STEM CELL, V22, P50, DOI 10.1016/j.stem.2017.11.004; Posfai E, 2017, ELIFE, V6, DOI 10.7554/eLife.22906; Rivron NC, 2018, NATURE, V557, P106, DOI 10.1038/s41586-018-0051-0; Rossant J, 2017, CELL STEM CELL, V20, P18, DOI 10.1016/j.stem.2016.12.004; Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347; Shao Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00236-w; Stirparo GG, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158501; Turner DA, 2017, DEVELOPMENT, V144, P3894, DOI 10.1242/dev.150391; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/NMETH.3016, 10.1038/nmeth.3016]	15	27	27	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1075	1076		10.1126/science.aas9302	http://dx.doi.org/10.1126/science.aas9302			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI6TJ	29880675				2022-12-28	WOS:000434635500030
J	Powell, K				Powell, Kendall			The power of diversity BEING INCLUSIVE GIVES TEAMS A COMPETITIVE EDGE IN SCIENCE. IT ALSO HAPPENS TO BE THE RIGHT THING TO DO	NATURE			English	News Item								Chanel Phillips tried hard to keep her nerves in check last year as she prepared to present her research at an international meeting on drowning prevention. Phillips, a doctoral student at the University of Otago in Dunedin, New Zealand, was in Vancouver, Canada, discussing water-safety strategies that she had been developing with indigenous Maori communities back home. It struck her that she and a colleague were perhaps the only indigenous presenters at the meeting.										Adams J, 2013, NATURE, V497, P557, DOI 10.1038/497557a; Bastien FA, 2013, NATURE, V500, P427, DOI 10.1038/nature12419; Burchard EG, 2015, AM J RESP CRIT CARE, V191, P514, DOI 10.1164/rccm.201410-1944PP; Freeman RB, 2014, NATURE, V513, P305, DOI 10.1038/513305a; Nielsen MW, 2017, P NATL ACAD SCI USA, V114, P1740, DOI 10.1073/pnas.1700616114	5	40	41	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					19	22		10.1038/d41586-018-05316-5	http://dx.doi.org/10.1038/d41586-018-05316-5			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29875493	Bronze			2022-12-28	WOS:000434273300021
J	Fleming, N				Fleming, Nic			Computer-calculated compounds	NATURE			English	Editorial Material																		Yu PC, 2017, NATURE, V545, P224, DOI 10.1038/nature22322	1	159	160	10	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					S55	S57		10.1038/d41586-018-05267-x	http://dx.doi.org/10.1038/d41586-018-05267-x			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH4WT	29849160	Bronze			2022-12-28	WOS:000433412900012
J	Liang, L; Fratzl, A; Goldey, G; Ramesh, RN; Sugden, AU; Morgan, JL; Chen, CF; Andermann, ML				Liang, Liang; Fratzl, Alex; Goldey, Glenn; Ramesh, Rohan N.; Sugden, Arthur U.; Morgan, Josh L.; Chen, Chinfei; Andermann, Mark L.			A Fine-Scale Functional Logic to Convergence from Retina to Thalamus	CELL			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; GANGLION-CELLS; RECEPTIVE-FIELDS; RESPONSE PROPERTIES; RETINOGENICULATE SYNAPSE; MOUSE; ORIENTATION; CAT; ORGANIZATION	Numerous well-defined classes of retinal ganglion cells innervate the thalamus to guide image-forming vision, yet the rules governing their convergence and divergence remain unknown. Using two-photon calcium imaging in awake mouse thalamus, we observed a functional arrangement of retinal ganglion cell axonal boutons in which coarse-scale retinotopic ordering gives way to fine-scale organization based on shared preferences for other visual features. Specifically, at the similar to 6 mu m scale, clusters of boutons from different axons often showed similar preferences for either one or multiple features, including axis and direction of motion, spatial frequency, and changes in luminance. Conversely, individual axons could "de-multiplex" information channels by participating in multiple, functionally distinct bouton clusters. Finally, ultrastructural analyses demonstrated that retinal axonal boutons in a local cluster often target the same dendritic domain. These data suggest that functionally specific convergence and divergence of retinal axons may impart diverse, robust, and often novel feature selectivity to visual thalamus.	[Liang, Liang; Fratzl, Alex; Goldey, Glenn; Ramesh, Rohan N.; Sugden, Arthur U.; Andermann, Mark L.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Liang, Liang; Chen, Chinfei] Harvard Med Sch, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Fratzl, Alex] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Synapt Mech, CH-1015 Lausanne, Switzerland; [Ramesh, Rohan N.; Chen, Chinfei; Andermann, Mark L.] Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA; [Morgan, Josh L.] Washington Univ, Sch Med, Dept Neurosci, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Fratzl, Alex] UCL, Sainsbury Wellcome Ctr Neural Circuits & Behav, London W1T 4JG, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Harvard Medical School; Washington University (WUSTL); University of London; University College London	Andermann, ML (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.; Chen, CF (corresponding author), Harvard Med Sch, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.; Chen, CF; Andermann, ML (corresponding author), Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA.	chinfei.chen@childrens.harvard.edu; manderma@bidmc.harvard.edu		Fratzl, Alex/0000-0003-4064-0742; Liang, Liang/0000-0001-5718-0717	Simons Collaboration on the Global Brain Postdoctoral Fellowship; Bertarelli Foundation Fellowship; NIH [F31 105678, T32 DK007516, R01EY013613, U54 HD090255]; Harvard/MIT Joint Research Grants Program in Basic Neuroscience; NIH Director's New Innovator Award [DP2DK105570, R01 DK109930]; Smith Family Foundation; Pew Scholars Program in the Biomedical Sciences; IDDRC Cellular Imaging Core; BCH Viral Core (NIH) [P30 EY012196]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012196, R01EY013613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK105678, T32DK007516, DP2DK105570, R01DK109930] Funding Source: NIH RePORTER	Simons Collaboration on the Global Brain Postdoctoral Fellowship; Bertarelli Foundation Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard/MIT Joint Research Grants Program in Basic Neuroscience; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Foundation; Pew Scholars Program in the Biomedical Sciences; IDDRC Cellular Imaging Core; BCH Viral Core (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank V. Flores-Maldonado, S. Curtiss, and X. Wang for technical support and assistance. We thank M. Do, J. Sanes, R. Masland, W.-C. Lee, V. Bonin, L. Glickfeld, R.C. Reid, E. Milner, and members of the Andermann and Chen labs for helpful discussion. We thank Drs. Jayaraman, Kerr, Kim, Looger, and Svoboda and the GENIE Project, Janelia Farm Research Campus, HHMI, for GCaMP6. The raw electron microscopy dataset was generated in the lab of Dr. Lichtman. Support was provided by a Simons Collaboration on the Global Brain Postdoctoral Fellowship (to L.L.), a Bertarelli Foundation Fellowship (to A.F.), NIH (F31 105678 to R.N.R.; T32 DK007516 to A.U.S.; R01EY013613 and U54 HD090255 to C.C.), the Harvard/MIT Joint Research Grants Program in Basic Neuroscience (C.C. and M.L.A.), an NIH Director's New Innovator Award DP2DK105570, R01 DK109930, and grants from the Smith Family Foundation, the Pew Scholars Program in the Biomedical Sciences (to M.L.A.), the IDDRC Cellular Imaging Core, and the BCH Viral Core (supported by NIH P30 EY012196).	Alonso JM, 2006, PROG BRAIN RES, V154, P3, DOI 10.1016/S0079-6123(06)54001-4; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; Dhande OS, 2015, ANNU REV VIS SCI, V1, P291, DOI 10.1146/annurev-vision-082114-035502; Durand S, 2016, J NEUROSCI, V36, P12144, DOI 10.1523/JNEUROSCI.1741-16.2016; FAMIGLIETTI EV, 1972, J COMP NEUROL, V144, P285, DOI 10.1002/cne.901440304; Gokce O, 2016, ELIFE, V5, DOI 10.7554/eLife.09222; Goldey GJ, 2014, NAT PROTOC, V9, P2515, DOI 10.1038/nprot.2014.165; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; Hammer S, 2015, CELL REP, V12, P1575, DOI 10.1016/j.celrep.2015.08.003; Hillier D, 2017, NAT NEUROSCI, V20, P960, DOI 10.1038/nn.4566; Hong YK, 2014, NEURON, V84, P332, DOI 10.1016/j.neuron.2014.08.059; Hong YK, 2011, CURR OPIN NEUROBIOL, V21, P228, DOI 10.1016/j.conb.2011.02.007; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Iacaruso MF, 2017, NATURE, V547, P449, DOI 10.1038/nature23019; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; Jeanne JM, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.018; KAPLAN E, 1984, EXP BRAIN RES, V55, P111; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Keles M, 2017, ELIFE, V6, DOI 10.7554/eLife.24896; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kremkow J, 2016, NATURE, V533, P52, DOI 10.1038/nature17936; Litvina EY, 2017, NEURON, V96, P330, DOI 10.1016/j.neuron.2017.09.037; Litvina EY, 2017, VISUAL NEUROSCI, V34, DOI 10.1017/S0952523817000104; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; Martinez LM, 2014, NEURON, V81, P943, DOI 10.1016/j.neuron.2013.12.014; MASTRONARDE DN, 1985, VISION RES, V25, P1195, DOI 10.1016/0042-6989(85)90033-1; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Moore BD, 2011, NEURON, V71, P812, DOI 10.1016/j.neuron.2011.06.025; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Rathbun DL, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00008; RODIECK RW, 1967, SCIENCE, V157, P90, DOI 10.1126/science.157.3784.90; Rompani SB, 2017, NEURON, V93, P1519, DOI [10.1016/j.neuron.2017.01.028, 10.1016/j.neuron.2017.03.009]; Sabbah S, 2017, NATURE, V546, P492, DOI 10.1038/nature22818; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Scholl B, 2013, J NEUROSCI, V33, P10616, DOI 10.1523/JNEUROSCI.0404-13.2013; STANFORD LR, 1981, J NEUROSCI, V1, P578; Storace DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10212; Sun WZ, 2016, NAT NEUROSCI, V19, P308, DOI 10.1038/nn.4196; Suresh V, 2016, J NEUROSCI, V36, P10949, DOI 10.1523/JNEUROSCI.1045-16.2016; Tang JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146017; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Tien NW, 2015, J NEUROSCI, V35, P10815, DOI 10.1523/JNEUROSCI.1521-15.2015; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; Wu B, 2017, P NATL ACAD SCI USA, V114, P7505, DOI 10.1073/pnas.1706533114; Zhao XY, 2013, J NEUROSCI, V33, P12751, DOI 10.1523/JNEUROSCI.0095-13.2013	54	37	37	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1343	+		10.1016/j.cell.2018.04.041	http://dx.doi.org/10.1016/j.cell.2018.04.041			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856953	Bronze, Green Accepted			2022-12-28	WOS:000433989100009
J	Milne, E				Milne, Eugene			The transfer of public health to local authorities suggests alternatives are possible	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												eugene.milne@newcastle.gov.uk							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2018	361								k2330	10.1136/bmj.k2330	http://dx.doi.org/10.1136/bmj.k2330			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MT	29853464				2022-12-28	WOS:000434276300006
J	Betts, A; Gray, C; Zelek, M; MacLean, RC; King, KC				Betts, A.; Gray, C.; Zelek, M.; MacLean, R. C.; King, K. C.			High parasite diversity accelerates host adaptation and diversification	SCIENCE			English	Article							ANTAGONISTIC COEVOLUTION; EVOLUTION; RESISTANCE; SELECTION; DYNAMICS; BACTERIA	Host-parasite species pairs are known to coevolve, but how multiple parasites coevolve with their host is unclear. By using experimental coevolution of a host bacterium and its viral parasites, we revealed that diverse parasite communities accelerated host evolution and altered coevolutionary dynamics to enhance host resistance and decrease parasite infectivity. Increases in parasite diversity drove shifts in the mode of selection from fluctuating (Red Queen) dynamics to predominately directional (arms race) dynamics. Arms race dynamics were characterized by selective sweeps of generalist resistance mutations in the genes for the host bacterium's cell surface lipopolysaccharide (a bacteriophage receptor), which caused faster molecular evolution within host populations and greater genetic divergence among populations. These results indicate that exposure to multiple parasites influences the rate and type of host-parasite coevolution.	[Betts, A.; Zelek, M.; MacLean, R. C.; King, K. C.] Univ Oxford, Dept Zool, South Parks Rd, Oxford OX1 3PS, England; [Gray, C.] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England	University of Oxford; Imperial College London	Betts, A; King, KC (corresponding author), Univ Oxford, Dept Zool, South Parks Rd, Oxford OX1 3PS, England.	alex.betts@evobio.eu; kayla.king@zoo.ox.ac.uk		King, Kayla/0000-0003-1393-9220; MacLean, Craig/0000-0002-7941-813X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J014427/1]; Royal Society; European Research Council [281591]; Wellcome Trust [106918/Z/15/Z]; Leverhulme research project [RPG-2015-165]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); Leverhulme research project	A.B. was supported by D.Phil. funding from the Biotechnology and Biological Sciences Research Council (BBSRC) (grant number BB/J014427/1). R.C.M. was funded by the Royal Society, European Research Council grant 281591, and Wellcome Trust grant 106918/Z/15/Z. K.C.K. was supported by Leverhulme research project grant RPG-2015-165.	Agrawal A, 2002, EVOL ECOL RES, V4, P79; Alizon S, 2013, ECOL LETT, V16, P556, DOI 10.1111/ele.12076; Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Barrett LG, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00761; Bashey F, 2013, EVOLUTION, V67, P900, DOI 10.1111/j.1558-5646.2012.01825.x; BELL G, 1982, MASTERPIECE NATURE E; Betts A, 2016, TRENDS PARASITOL, V32, P863, DOI 10.1016/j.pt.2016.08.003; Betts A, 2016, EVOLUTION, V70, P969, DOI 10.1111/evo.12909; Betts A, 2014, P NATL ACAD SCI USA, V111, P11109, DOI 10.1073/pnas.1406763111; Brockhurst MA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1382; Buckling A, 2006, P ROY SOC B-BIOL SCI, V273, P45, DOI 10.1098/rspb.2005.3279; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Calendar R., 2006, BACTERIOPHAGES; Cortez MH, 2014, P NATL ACAD SCI USA, V111, P7486, DOI 10.1073/pnas.1317693111; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Doron S, 2018, SCIENCE, V359, DOI 10.1126/science.aar4120; Duncan AB, 2011, EVOLUTION, V65, P3462, DOI 10.1111/j.1558-5646.2011.01388.x; Eizaguirre C, 2012, ECOL LETT, V15, P723, DOI 10.1111/j.1461-0248.2012.01791.x; Gandon S, 2008, J EVOLUTION BIOL, V21, P1861, DOI 10.1111/j.1420-9101.2008.01598.x; Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767; Griffiths EC, 2011, J INFECTION, V63, P200, DOI 10.1016/j.jinf.2011.06.005; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; King KC, 2009, CURR BIOL, V19, P1438, DOI 10.1016/j.cub.2009.06.062; KLEIN J, 1994, PHILOS T R SOC B, V346, P351, DOI 10.1098/rstb.1994.0152; Koskella B, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0297; Koskella B, 2009, EVOLUTION, V63, P2213, DOI 10.1111/j.1558-5646.2009.00711.x; Lello J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006565; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marcogliese DJ, 2005, INT J PARASITOL, V35, P705, DOI 10.1016/j.ijpara.2005.01.015; Marston MF, 2012, P NATL ACAD SCI USA, V109, P4544, DOI 10.1073/pnas.1120310109; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Mougi A, 2010, P ROY SOC B-BIOL SCI, V277, P3163, DOI 10.1098/rspb.2010.0691; Nicaise V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00660; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Pirie MD, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0764-3; Roche B, 2017, TRENDS PARASITOL, V33, P21, DOI 10.1016/j.pt.2016.09.010; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Schulte RD, 2010, P NATL ACAD SCI USA, V107, P7359, DOI 10.1073/pnas.1003113107; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tetreau G, 2013, ARCH INSECT BIOCHEM, V82, P71, DOI 10.1002/arch.21076; Thompson J.N., 2005, INTERSPEC INTERACT; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Wilfert L, 2010, BIOL LETTERS, V6, P666, DOI 10.1098/rsbl.2010.0329; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	49	68	68	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					907	911		10.1126/science.aam9974	http://dx.doi.org/10.1126/science.aam9974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798882	Green Accepted, Green Submitted			2022-12-28	WOS:000433039800048
J	Kuehn, B				Kuehn, Bridget			Evolution of "Nightmare Bacteria"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2070	2070		10.1001/jama.2018.5474	http://dx.doi.org/10.1001/jama.2018.5474			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800187				2022-12-28	WOS:000432679400011
J	Downing, NL; Bates, DW; Longhurst, CA				Downing, N. Lance; Bates, David W.; Longhurst, Christopher A.			Physician Burnout in the Electronic Health Record Era: Are We Ignoring the Real Cause?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PRIMARY-CARE; HITECH ERA; SATISFACTION; TIME		[Downing, N. Lance] 1265 Welch Rd,Room X265, Moffett Field, CA 94035 USA; [Bates, David W.] Harvard Univ, 1620 Tremont St, Boston, MA 02120 USA; [Longhurst, Christopher A.] Univ Calif San Diego, 9560 Towne Ctr Dr 100, San Diego, CA 92121 USA	Harvard University; University of California System; University of California San Diego	Downing, NL (corresponding author), 1265 Welch Rd,Room X265, Moffett Field, CA 94035 USA.	LDowning@stanford.edu	Downing, N Lance/W-2812-2019; Bates, David/AAE-7283-2019	Downing, N Lance/0000-0002-2133-9244; Longhurst, Christopher/0000-0003-4908-6856				Arndt BG, 2017, ANN FAM MED, V15, P419, DOI 10.1370/afm.2121; Gidwani R, 2017, ANN FAM MED, V15, P427, DOI 10.1370/afm.2122; Halamka JD, 2017, NEW ENGL J MED, V377, P907, DOI 10.1056/NEJMp1709851; Mafi JN, 2018, ANN INTERN MED, V168, P302, DOI 10.7326/M17-0583; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961; Sinsky CA, 2014, ANN INTERN MED, V160, P727, DOI 10.7326/M13-2589; Tai-Seale M, 2017, HEALTH AFFAIR, V36, P655, DOI 10.1377/hlthaff.2016.0811; Washington V, 2017, NEW ENGL J MED, V377, P904, DOI 10.1056/NEJMp1703370	9	179	178	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2018	169	1					50	+		10.7326/M18-0139	http://dx.doi.org/10.7326/M18-0139			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL2FB	29801050				2022-12-28	WOS:000436931900009
J	Juul, FE; Garborg, K; Bretthauer, M; Skudal, H; Oines, MN; Wiig, H; Rose, O; Seip, B; Lamont, JT; Midtvedt, T; Valeur, J; Kalager, M; Holme, O; Helsingen, L; Loberg, M; Adami, HO				Juul, Frederik E.; Garborg, Kjetil; Bretthauer, Michael; Skudal, Hilde; Oines, Mari N.; Wiig, Havard; Rose, Oystein; Seip, Birgitte; Lamont, J. Thomas; Midtvedt, Tore; Valeur, Jorgen; Kalager, Mette; Holme, Oyvind; Helsingen, Lise; Loberg, Magnus; Adami, Hans-Olov			Fecal Microbiota Transplantation for Primary Clostridium difficile Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Juul, Frederik E.; Garborg, Kjetil; Helsingen, Lise; Adami, Hans-Olov] Oslo Univ Hosp, Oslo, Norway; [Bretthauer, Michael; Kalager, Mette; Holme, Oyvind; Loberg, Magnus] Univ Oslo, Oslo, Norway; [Skudal, Hilde] Telemark Hosp, Skien, Norway; [Oines, Mari N.] Rigshosp, Copenhagen, Denmark; [Wiig, Havard] Sorlandet Hosp, Kristiansand, Norway; [Rose, Oystein] Vestre Viken Baerum Hosp, Gjettum, Norway; [Seip, Birgitte] Vestfold Hosp, Tonsberg, Norway; [Lamont, J. Thomas] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Midtvedt, Tore] Karolinska Inst, Stockholm, Sweden; [Valeur, Jorgen] Lovisenberg Diaconal Hosp, Oslo, Norway	University of Oslo; University of Oslo; Telemark Hospital Trust; Rigshospitalet; University of Copenhagen; Harvard University; Beth Israel Deaconess Medical Center; Karolinska Institutet	Bretthauer, M (corresponding author), Univ Oslo, Oslo, Norway.	michael.bretthauer@medisin.uio.no	Helsingen, Lise/ABD-6025-2021; Helsingen, Lise/AAU-2290-2021; Juul, Frederik Emil/AAH-3294-2020; Valeur, Jørgen/AFU-6716-2022; Valeur, Jorgen/AEO-0359-2022; Valeur, Jørgen/AGF-5332-2022	Helsingen, Lise/0000-0002-2055-3978; Valeur, Jørgen/0000-0001-7193-7069; Valeur, Jørgen/0000-0001-7193-7069; Garborg, Kjetil/0000-0002-5484-5995; Juul, Frederik Emil/0000-0003-3317-6988	Southeastern Norway Regional Health Authority	Southeastern Norway Regional Health Authority	Supported by the Toppforsk program of the Research Council of Norway, a network grant from the Southeastern Norway Regional Health Authority, and a Ph.D. scholarship grant (to Dr. Juul) from the Southeastern Norway Regional Health Authority.	[Anonymous], 2013, NAT GUID ANT US HOSP; Gustafsson A, 1999, SCAND J GASTROENTERO, V34, P580, DOI 10.1080/003655299750026038; Jorup-Ronstrom C, 2012, SCAND J GASTROENTERO, V47, P548, DOI 10.3109/00365521.2012.672587; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/ciy149, 10.1093/cid/cix1085]	5	122	131	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2018	378	26					2535	+		10.1056/NEJMc1803103	http://dx.doi.org/10.1056/NEJMc1803103			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK8UC	29860912	Green Published, Bronze			2022-12-28	WOS:000436503300015
J	Nieder, A				Nieder, Andreas			Honey bees zero in on the empty set	SCIENCE			English	Editorial Material							NUMEROSITY ZERO; NUMBER; REPRESENTATION; PRECURSORS		[Nieder, Andreas] Univ Tubingen, Inst Neurobiol, Anim Physiol Unit, Morgenstelle 28, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Nieder, A (corresponding author), Univ Tubingen, Inst Neurobiol, Anim Physiol Unit, Morgenstelle 28, D-72076 Tubingen, Germany.	andreas.nieder@uni-tuebingen.de						Dacke M, 2008, ANIM COGN, V11, P683, DOI 10.1007/s10071-008-0159-y; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Gross HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004263; Howard SR, 2018, SCIENCE, V360, P1124, DOI 10.1126/science.aar4975; Loukola OJ, 2017, SCIENCE, V355, P834, DOI 10.1126/science.aag2360; Merritt DJ, 2013, BEHAV PROCESS, V93, P91, DOI 10.1016/j.beproc.2012.11.001; Merritt DJ, 2009, J EXP PSYCHOL GEN, V138, P258, DOI 10.1037/a0015231; Nieder A., 2017, PHILOS T R SOC B, V373, P1740; Nieder A, 2016, TRENDS COGN SCI, V20, P830, DOI 10.1016/j.tics.2016.08.008; Nieder A, 2016, NAT REV NEUROSCI, V17, P366, DOI 10.1038/nrn.2016.40; Okuyama S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10059; Pepperberg IM, 2005, J COMP PSYCHOL, V119, P197, DOI 10.1037/0735-7036.119.2.197; Ramirez-Cardenas A, 2016, CURR BIOL, V26, P1285, DOI 10.1016/j.cub.2016.03.052; Wray GA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0046; Zhang SW, 2005, P NATL ACAD SCI USA, V102, P5250, DOI 10.1073/pnas.0501440102	15	9	11	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1069	1070		10.1126/science.aat8958	http://dx.doi.org/10.1126/science.aat8958			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI6TJ	29880671				2022-12-28	WOS:000434635500026
J	Pendergrass, AG				Pendergrass, Angeline G.			What precipitation is extreme?	SCIENCE			English	Editorial Material							FUTURE CHANGES; CLIMATE; RAIN		[Pendergrass, Angeline G.] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Pendergrass, AG (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	apgrass@ucar.edu	Pendergrass, Angeline G/I-2946-2017	Pendergrass, Angeline G/0000-0003-2542-1461	Regional and Global and Global Model Analysis Program (RGMA) of the U.S. Department of Energy's Office of Science (BER) [DE-FC02-97ER62402]; National Science Foundation	Regional and Global and Global Model Analysis Program (RGMA) of the U.S. Department of Energy's Office of Science (BER)(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	R. Knutti, F. Lehner, G. Meehl, P. O'Gorman, and N. Rosenbloom provided useful feedback on the manuscript. The climate model simulations were contributed by many modeling groups to the CMIP5 archive, hosted by the Program for Climate Model Diagnosis and Intercomparison at esgf-node.llnl.gov/projects/cmip5.GHCN-Daily data are made available by the National Oceanic and Atmospheric Administration National Climatic Data Center. The author was supported by the Regional and Global and Global Model Analysis Program (RGMA) of the U.S. Department of Energy's Office of Science (BER) cooperative agreement DE-FC02-97ER62402. The National Center for Atmospheric Research is sponsored by the National Science Foundation. The author declares no competing interests.	Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Menne M. J., 2012, GLOBAL HIST CLIMATOL, P2021, DOI [10.7289/V5D21VHZ, DOI 10.7289/V5D21VHZ]; O'Gorman PA, 2018, Q J ROY METEOR SOC, V144, P208, DOI 10.1002/qj.3195; Pall P, 2007, CLIM DYNAM, V28, P351, DOI 10.1007/S00382-006-0180-2; Pendergrass AG, 2014, J CLIMATE, V27, P8372, DOI 10.1175/JCLI-D-14-00183.1; Pendergrass AG, 2016, J CLIMATE, V29, P6445, DOI 10.1175/JCLI-D-16-0097.1; Pfahl S, 2017, NAT CLIM CHANGE, V7, P423, DOI [10.1038/NCLIMATE3287, 10.1038/nclimate3287]; Prein AF, 2017, NAT CLIM CHANGE, V7, P48, DOI [10.1038/NCLIMATE3168, 10.1038/nclimate3168]; Risser MD, 2017, GEOPHYS RES LETT, V44, P12457, DOI 10.1002/2017GL075888; Schar C, 2016, CLIMATIC CHANGE, V137, P201, DOI 10.1007/s10584-016-1669-2; Trenberth KE, 1999, CLIMATIC CHANGE, V42, P327, DOI 10.1023/A:1005488920935; Trenberth KE, 2015, NAT CLIM CHANGE, V5, P725, DOI 10.1038/NCLIMATE2657; van Oldenborgh GJ, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa9ef2; Wang SYS, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabb85	14	113	117	9	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1072	1073		10.1126/science.aat1871	http://dx.doi.org/10.1126/science.aat1871			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI6TJ	29880673				2022-12-28	WOS:000434635500028
J	Doubova, SV; Perez-Cuevas, R				Doubova, Svetlana V.; Perez-Cuevas, Ricardo			Going further to measure improvements in health-care access and quality	LANCET			English	Editorial Material							COVERAGE; INDEX		[Doubova, Svetlana V.] Mexican Inst Social Secur, CMN Siglo XXI, Epidemiol & Hlth Serv Res Unit, Mexico City 06725, DF, Mexico; [Perez-Cuevas, Ricardo] Natl Inst Publ Hlth, Hlth Syst Res Ctr, Cuernavaca, Morelos, Mexico	Instituto Mexicano del Seguro Social; Instituto Nacional de Salud Publica	Doubova, SV (corresponding author), Mexican Inst Social Secur, CMN Siglo XXI, Epidemiol & Hlth Serv Res Unit, Mexico City 06725, DF, Mexico.	svetlana.doubova@gmail.com		Perez-Cuevas, Ricardo/0000-0002-5564-5821; Doubova, Svetlana V./0000-0002-0521-7095				Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Fullman N, 2018, LANCET, V391, P2236, DOI [10.1016/S0140-6736(18)30994-2, 10.1016/s0140-6736(18)30994-2]; Fullman N, 2018, LANCET GLOB HEALTH, V6, pE122, DOI 10.1016/S2214-109X(17)30487-4; Hogan DR, 2018, LANCET GLOB HEALTH, V6, pE152, DOI 10.1016/S2214-109X(17)30472-2; Kruk Margaret E, 2017, Bull World Health Organ, V95, P389, DOI 10.2471/BLT.17.195099; Montenegro H, 2011, J INTEGR CARE, V19, P5, DOI 10.1108/14769011111176707; Pan American Health Organization, CD535; WHO, 2015, HLTH 2015 MDGS MILL, DOI 10.1007/BF01918387	8	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2018	391	10136					2190	2192		10.1016/S0140-6736(18)30987-5	http://dx.doi.org/10.1016/S0140-6736(18)30987-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH8GC	29803588	hybrid			2022-12-28	WOS:000433904700006
J	Bradshaw, N				Bradshaw, Nathan			Finding a community in the lab	SCIENCE			English	Editorial Material									[Bradshaw, Nathan] Northwestern Univ, Evanston, IL 60208 USA	Northwestern University	Bradshaw, N (corresponding author), Northwestern Univ, Evanston, IL 60208 USA.								0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					1038	1038		10.1126/science.360.6392.1038	http://dx.doi.org/10.1126/science.360.6392.1038			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6SL	29853689				2022-12-28	WOS:000433574200046
J	Lapiedra, O; Schoener, TW; Leal, M; Losos, JB; Kolbe, JJ				Lapiedra, Oriol; Schoener, Thomas W.; Leal, Manuel; Losos, Jonathan B.; Kolbe, Jason J.			Predator-driven natural selection on risk-taking behavior in anole lizards	SCIENCE			English	Article							FITNESS CONSEQUENCES; EVOLUTION; ECOLOGY; PERSONALITY; SURVIVAL; BOLDNESS	Biologists have long debated the role of behavior in evolution, yet understanding of its role as a driver of adaptation is hampered by the scarcity of experimental studies of natural selection on behavior in nature. After showing that individual Anolis sagrei lizards vary consistently in risk-taking behaviors, we experimentally established populations on eight small islands either with or without Leiocephalus carinatus, a major ground predator. We found that selection predictably favors different risk-taking behaviors under different treatments: Exploratory behavior is favored in the absence of predators, whereas avoidance of the ground is favored in their presence. On predator islands, selection on behavior is stronger than selection on morphology, whereas the opposite holds on islands without predators. Our field experiment demonstrates that selection can shape behavioral traits, paving the way toward adaptation to varying environmental contexts.	[Lapiedra, Oriol; Losos, Jonathan B.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Lapiedra, Oriol; Losos, Jonathan B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Schoener, Thomas W.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Leal, Manuel] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Kolbe, Jason J.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA	Harvard University; Harvard University; University of California System; University of California Davis; University of Missouri System; University of Missouri Columbia; University of Rhode Island	Lapiedra, O (corresponding author), Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA.; Lapiedra, O (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	olapiedragonzalez@fas.harvard.edu		Lapiedra, Oriol/0000-0003-0383-0061; Losos, Jonathan/0000-0003-4712-8258	AGAUR [2014 BP-A 00116]; Museum of Comparative Zoology; University of Rhode Island	AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Museum of Comparative Zoology; University of Rhode Island	Supported by the AGAUR in the form of Beatriu de Pinos postdoctoral fellowship 2014 BP-A 00116 (O.L.). Fieldwork was also funded with a Putnam Expedition Grant from the Museum of Comparative Zoology and a National Geographic Explorer Grant (O.L.) and funds from the University of Rhode Island.	Ballew NG, 2017, AM NAT, V189, P396, DOI 10.1086/690909; Bednekoff PA, 2004, P ROY SOC B-BIOL SCI, V271, P1491, DOI 10.1098/rspb.2004.2739; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; BOGERT CM, 1949, EVOLUTION, V3, P195, DOI 10.2307/2405558; Dall SRX, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00003; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dingemanse NJ, 2010, PHILOS T R SOC B, V365, P3947, DOI 10.1098/rstb.2010.0221; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Drakeley M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138016; Endler J.A., 1986, Monographs in Population Biology, pviii; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; Kolbe JJ, 2012, SCIENCE, V335, P1086, DOI 10.1126/science.1209566; Lapiedra O, 2017, GLOBAL CHANGE BIOL, V23, P592, DOI 10.1111/gcb.13395; Lapiedra O, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2893; Lopez-Darias M, 2012, ECOLOGY, V93, P2512, DOI 10.1890/12-0483.1; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Mayr E., 1963, ANIMAL SPECIES EVOLU; Munoz MM, 2018, AM NAT, V191, pE15, DOI 10.1086/694779; Pruitt JN, 2012, AM NAT, V179, P217, DOI 10.1086/663680; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Santos CD, 2015, SCI REP-UK, V5, DOI 10.1038/srep15490; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Schoener TW, 2001, NATURE, V412, P183, DOI 10.1038/35084071; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Sol D, 2005, EVOLUTION, V59, P2669, DOI 10.1111/j.0014-3820.2005.tb00978.x; Steinberg DS, 2014, P NATL ACAD SCI USA, V111, P9187, DOI 10.1073/pnas.1407190111; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; WYLES JS, 1983, P NATL ACAD SCI-BIOL, V80, P4394, DOI 10.1073/pnas.80.14.4394	34	73	74	3	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					1017	+		10.1126/science.aap9289	http://dx.doi.org/10.1126/science.aap9289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6SL	29853685	Green Submitted			2022-12-28	WOS:000433574200042
J	Lee, SF; Ng, TY; Wong, FCS; Tung, SY				Lee, Shing Fung; Ng, Ting Ying; Wong, Frank Chi Sing; Tung, Stewart Yuk			A young man with a mass on the neck	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HODGKINS LYMPHOMA; LYMPHADENOPATHY; CANCER		[Lee, Shing Fung; Ng, Ting Ying; Wong, Frank Chi Sing; Tung, Stewart Yuk] Tuen Mun Hosp, Dept Clin Oncol, Tuen Mun, Hong Kong, Peoples R China	Tuen Mun Hospital	Lee, SF (corresponding author), Tuen Mun Hosp, Dept Clin Oncol, Tuen Mun, Hong Kong, Peoples R China.	leesfm@ha.org.hk	Lee, Shing Fung/N-9653-2019	Lee, Shing Fung/0000-0003-4696-9434				Allin D, 2017, ANN ROY COLL SURG, V99, P242, DOI 10.1308/rcsann.2016.0353; Bleyer A, 2006, ONCOLOGIST, V11, P590, DOI 10.1634/theoncologist.11-6-590; Eichenauer D, 2015, LYMPHOMAS ESSENTIALS, P67; Eichenauer DA, 2014, ANN ONCOL, V25, P70, DOI 10.1093/annonc/mdu181; Engert A, 2010, NEW ENGL J MED, V363, P640, DOI 10.1056/NEJMoa1000067; FIJTEN GH, 1988, J FAM PRACTICE, V27, P373; Goyal G, 2016, CL LYMPH MYELOM LEUK, V16, P12, DOI 10.1016/j.clml.2015.11.006; Mani H, 2009, CLIN LYMPHOMA MYELOM, V9, P206, DOI 10.3816/CLM.2009.n.042; Metzgeroth G, 2012, ANN HEMATOL, V91, P1477, DOI 10.1007/s00277-012-1476-4; Ries L. A. G., 1999, SEER CANC STAT REV 1	10	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2018	361								k1598	10.1136/bmj.k1598	http://dx.doi.org/10.1136/bmj.k1598			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MT	29853443				2022-12-28	WOS:000434276300001
J	Liu, ZM; Wang, J; Cheng, H; Ke, X; Sun, L; Zhang, QC; Wang, HW				Liu, Zhongmin; Wang, Jia; Cheng, Hang; Ke, Xin; Sun, Lei; Zhang, Qiangfeng Cliff; Wang, Hong-Wei			Cryo-EM Structure of Human Dicer and Its Complexes with a Pre-miRNA Substrate (vol 173, pg 1191, 2018)	CELL			English	Correction												hongweiwang@tsinghua.edu.cn						Liu ZM, 2018, CELL, V173, P1191, DOI 10.1016/j.cell.2018.03.080	1	16	17	3	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1549	1550		10.1016/j.cell.2018.05.031	http://dx.doi.org/10.1016/j.cell.2018.05.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856959	Bronze			2022-12-28	WOS:000433989100025
J	Pawluk, A; Chen, J; Ji, WZ; Mali, P				Pawluk, April; Chen, Jia; Ji, Weizhi; Mali, Prashant			The Future of Genome Editing	CELL			English	Editorial Material								The power of CRISPR is undeniable, but where is the field heading? Cell's April Pawluk caught up with Jia Chen, Weizhi Ji, and Prashant Mali to discuss the successes and challenges we can expect in the coming years. Annotated excerpts from this conversation are presented below, and the full conversation is available with the article online.	[Chen, Jia] ShanghaiTech Univ, Shanghai, Peoples R China; [Ji, Weizhi] Kunming Univ Sci & Technol, Kunming, Yunnan, Peoples R China; [Mali, Prashant] Univ Calif San Diego, San Diego, CA 92103 USA	ShanghaiTech University; Kunming University of Science & Technology; University of California System; University of California San Diego	Chen, J (corresponding author), ShanghaiTech Univ, Shanghai, Peoples R China.								0	0	0	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1311	1313		10.1016/j.cell.2018.05.026	http://dx.doi.org/10.1016/j.cell.2018.05.026			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856947	Bronze			2022-12-28	WOS:000433989100002
J	Stark, PB				Stark, Philip B.			No reproducibility without preproducibility	NATURE			English	Editorial Material									[Stark, Philip B.] Univ Calif Berkeley, Stat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Stark, PB (corresponding author), Univ Calif Berkeley, Stat, Berkeley, CA 94720 USA.	stark@stat.berkeley.edu		Stark, Philip/0000-0002-3771-9604					0	50	54	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					613	613		10.1038/d41586-018-05256-0	http://dx.doi.org/10.1038/d41586-018-05256-0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH4WT	29795524	Bronze			2022-12-28	WOS:000433412900016
J	Christie, B				Christie, Bryan			Safe staffing legislation will be introduced in Scotland	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Johnson S., 2018, GUARDIAN	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2018	361								k2352	10.1136/bmj.k2352	http://dx.doi.org/10.1136/bmj.k2352			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MF	29844067				2022-12-28	WOS:000434274800007
J	de Lima, A; Barry, M; Majid, A				de Lima, Andres; Barry, Marianne; Majid, Adnan			A Young Woman With Cough and Lithoptysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BRONCHOLITHIASIS; HISTOPLASMOSIS; BRONCHOSCOPY; MANAGEMENT	A 28-year-old healthy woman presented with a 2-week history of dyspnea, cough, wheezing, and lithoptysis (expectoration of calcific material). She had no significant past medical history. She did not smoke, drink alcohol, or use illicit drugs. The patient was living in New England but had previously lived in Nebraska, Colorado, Mississippi, and Florida. Recent travel included visits to Uganda, Afghanistan, Albania, and Croatia and frequent hiking and camping trips. She received initial therapy with inhaled albuterol and oral azithromycin, but symptoms did not improve. A chest radiograph was unremarkable. Subsequent computed tomography (CT) of the chest revealed a mediastinal and endobronchial broncholith compromising the left main-stem bronchus lumen (Figure 1). Extensive testing for Mycobacterium tuberculosis and fungal and bacterial infectious agents were within normal limits, with the exception of a borderline urine Histoplasma antigen level (< 0.5 ng/dL).	[de Lima, Andres; Majid, Adnan] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Thorac Surg & Intervent Pulmonol, Boston, MA USA; [Barry, Marianne] Tufts Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Tufts Medical Center	Majid, A (corresponding author), Beth Israel Deaconess Med Ctr, Sect Intervent Pulmonol, 185 Pilgrim Rd,Deaconess 201, Boston, MA 02215 USA.	amajid@bidmc.harvard.edu		de Lima, Andres/0000-0002-9362-5119	Olympus America; Boston Scientific	Olympus America; Boston Scientific(Boston Scientific)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Majid reported receiving grants and personal fees from Olympus America and Boston Scientific. No other authors reported disclosures.	Cerfolio RJ, 2008, J THORAC CARDIOV SUR, V136, P186, DOI 10.1016/j.jtcvs.2007.09.084; CONCES DJ, 1991, AM J ROENTGENOL, V157, P249, DOI 10.2214/ajr.157.2.1853800; Elliott AR, 1922, J AMER MED ASSOC, V79, P1311, DOI 10.1001/jama.1922.02640160031010; Hammoud ZT, 2009, ANN THORAC SURG, V88, P399, DOI 10.1016/j.athoracsur.2009.04.041; Jin YX, 2016, THORAC CARDIOV SURG, V64, P450, DOI 10.1055/s-0034-1395388; Lim SY, 2013, RESPIROLOGY, V18, P637, DOI 10.1111/resp.12060; Reddy AJ, 2007, CHEST, V132, P1661, DOI 10.1378/chest.07-0739; Samson IM, 1997, CHEST, V112, P563, DOI 10.1378/chest.112.2.563; Wheat LJ, 2007, CLIN INFECT DIS, V45, P807, DOI 10.1086/521259	9	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2129	2130		10.1001/jama.2018.5101	http://dx.doi.org/10.1001/jama.2018.5101			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800155				2022-12-28	WOS:000432679400025
J	Wille-Jorgensen, P; Syk, I; Smedh, K; Laurberg, S; Nielsen, DT; Petersen, SH; Renehan, AG; Horvath-Puho, E; Pahlman, L; Sorensen, HT				Wille-Jorgensen, Peer; Syk, Ingvar; Smedh, Kenneth; Laurberg, Soren; Nielsen, Dennis T.; Petersen, Sune H.; Renehan, Andrew G.; Horvath-Puho, Erzsebet; Pahlman, Lars; Sorensen, Henrik T.		COLOFOL Study Grp	Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer The COLOFOL Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE GUIDELINE; CURATIVE RESECTION; METAANALYSIS; POPULATION; SURVIVAL; SURVEILLANCE; CEA	IMPORTANCE Intensive follow-up of patients after curative surgery for colorectal cancer is common in clinical practice, but evidence of a survival benefit is limited. OBJECTIVE To examine overall mortality, colorectal cancer-specific mortality, and colorectal cancer-specific recurrence rates among patients with stage II or III colorectal cancer who were randomized after curative surgery to 2 alternative schedules for follow-up testing with computed tomography and carcinoembryonic antigen. DESIGN, SETTING, AND PARTICIPANTS Unblinded randomized trial including 2509 patients with stage II or III colorectal cancer treated at 24 centers in Sweden, Denmark, and Uruguay from January 2006 through December 2010 and followed up for 5 years; follow-up ended on December 31, 2015. INTERVENTIONS Patients were randomized either to follow-up testing with computed tomography of the thorax and abdomen and serum carcinoembryonic antigen at 6, 12, 18, 24, and 36 months after surgery (high-frequency group; n = 1253 patients) or at 12 and 36 months after surgery (low-frequency group; n = 1256 patients). MAIN OUTCOMES AND MEASURES The primary outcomes were 5-year overall mortality and colorectal cancer-specific mortality rates. The secondary outcome was the colorectal cancer-specific recurrence rate. Both intention-to-treat and per-protocol analyses were performed. RESULTS Among 2555 patients who were randomized, 2509 were included in the intention-to-treat analysis (mean age, 63.5 years; 1128 women [45%]) and 2365 (94.3%) completed the trial. The 5-year overall patient mortality rate in the high-frequency group was 13.0%(161/1253) compared with 14.1%(174/1256) in the low-frequency group (risk difference, 1.1% [95% CI, -1.6% to 3.8%]; P =.43). The 5-year colorectal cancer-specific mortality rate in the high-frequency group was 10.6%(128/1248) compared with 11.4%(137/1250) in the low-frequency group (risk difference, 0.8%[ 95% CI, -1.7% to 3.3%]; P =.52). The colorectal cancer-specific recurrence rate was 21.6%(265/1248) in the high-frequency group compared with 19.4%(238/1250) in the low-frequency group (risk difference, 2.2%[ 95% CI, -1.0% to 5.4%]; P =.15). CONCLUSIONS AND RELEVANCE Among patients with stage II or III colorectal cancer, follow-up testing with computed tomography and carcinoembryonic antigen more frequently compared with less frequently did not result in a significant rate reduction in 5-year overall mortality or colorectal cancer-specific mortality.	[Horvath-Puho, Erzsebet; Sorensen, Henrik T.] Aarhus Univ Hosp, Dept Clin Epidemiol, Olof Palmes Alle 43-45, DK-8200 Aarhus N, Denmark; [Wille-Jorgensen, Peer; Petersen, Sune H.] Bispebjerg Hosp, Abdominal Dis Ctr, Copenhagen, Denmark; [Wille-Jorgensen, Peer; Petersen, Sune H.] Danish Colorectal Canc Grp, Copenhagen, Denmark; [Syk, Ingvar] Skane Univ Hosp, Dept Surg, Malmo, Sweden; [Smedh, Kenneth] Vastmanlands Hosp, Dept Surg, Vasteras, Sweden; [Laurberg, Soren] Aarhus Univ Hosp, Dept Surg, Aarhus, Denmark; [Nielsen, Dennis T.] Aarhus Univ Hosp, Dept Radiol, Aarhus, Denmark; [Renehan, Andrew G.] Univ Manchester, Manchester Canc Res Ctr, Manchester, Lancs, England; [Renehan, Andrew G.] Univ Manchester, Fac Biol Med & Hlth, NIHR Manchester Biomed Res Ctr, Sch Med Sci,Div Canc Sci,Christie NHS Fdn Trust, Manchester, Lancs, England; [Pahlman, Lars] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Sorensen, Henrik T.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Aarhus University; University of Copenhagen; Bispebjerg Hospital; Lund University; Skane University Hospital; Vasteras Central Hospital; Aarhus University; Aarhus University; University of Manchester; Christie NHS Foundation Trust; University of Manchester; Uppsala University; Stanford University	Sorensen, HT (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Olof Palmes Alle 43-45, DK-8200 Aarhus N, Denmark.	hts@clin.au.dk	Sorensen, Henrik Toft/Z-6181-2019; Smedh, Kenneth/AAN-7088-2021	Sorensen, Henrik Toft/0000-0003-4299-7040; Horvath-Puho, Erzsebet/0000-0002-3594-2212	Nordic Cancer Union; A. P. Moller Foundation; Beckett Foundation; Grosserer Chr. Andersen og hustru bursary; Sigvald og Edith Rasmussens Memorial Fund; Martha Margrethe og Christian Hermansens Fund; Danish Medical Association; Danish Cancer Society; Danish Council for Independent Research/Medical Sciences; Swedish Cancer Foundation [CAN 2013/553]	Nordic Cancer Union; A. P. Moller Foundation; Beckett Foundation; Grosserer Chr. Andersen og hustru bursary; Sigvald og Edith Rasmussens Memorial Fund; Martha Margrethe og Christian Hermansens Fund; Danish Medical Association; Danish Cancer Society(Danish Cancer Society); Danish Council for Independent Research/Medical Sciences(Det Frie Forskningsrad (DFF)); Swedish Cancer Foundation	This study was funded by unrestricted grants from the Nordic Cancer Union, A. P. Moller Foundation, Beckett Foundation, Grosserer Chr. Andersen og hustru bursary, Sigvald og Edith Rasmussens Memorial Fund, Martha Margrethe og Christian Hermansens Fund, the Danish Medical Association, the Danish Cancer Society, the Danish Council for Independent Research/Medical Sciences (all awarded to Dr Wille-Jorgensen), and by unrestricted grant CAN 2013/553 from the Swedish Cancer Foundation (awarded to Dr Pahlman).	Abraha I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2445; Andersson PH, 2016, CLIN EPIDEMIOL, V8, P15, DOI 10.2147/CLEP.S92661; Armitage P, 1994, STAT METHODS MED RES, P331; Figueredo A, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-26; GreenlandS LashTL, 2008, MODERN EPIDEMIOLOGY, P352; Hougaard P, 1995, Lifetime Data Anal, V1, P255; Jeffery GM, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002200; Jeffery M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002200.pub3; Kanas Gena P, 2012, Clin Epidemiol, V4, P283, DOI 10.2147/CLEP.S34285; Koepsell TD, 2003, EPIDEMIOLOGIC METHOD, P327; Kronborg O, 1991, Ugeskr Laeger, V153, P503; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Mant D, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21320; Maringe C, 2013, ACTA ONCOL, V52, P919, DOI 10.3109/0284186X.2013.764008; Meyerhardt JA, 2013, J CLIN ONCOL, V31, P4465, DOI 10.1200/JCO.2013.50.7442; National Comprehensive Cancer Network, GUID VERS 2 2017 COL; Primrose JN, 2014, JAMA-J AM MED ASSOC, V311, P263, DOI 10.1001/jama.2013.285718; Renehan AG, 2005, BRIT J CANCER, V92, P430, DOI 10.1038/sj.bjc.6602369; Renehan AG, 2002, BMJ-BRIT MED J, V324, P813, DOI 10.1136/bmj.324.7341.813; Rosen M, 1998, DIS COLON RECTUM, V41, P1116, DOI 10.1007/BF02239433; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Sorensen HT, 2006, HEPATOLOGY, V44, P1075, DOI 10.1002/hep.21404; Steele SR, 2015, DIS COLON RECTUM, V58, P713, DOI 10.1097/DCR.0000000000000410; Swedish National Board of Health andWelfare, NAT GUID SWED; Swedish National Medical Program, 2016, COLORECTAL CANC; Tjandra JJ, 2007, DIS COLON RECTUM, V50, P1783, DOI 10.1007/s10350-007-9030-5; Verberne CJ, 2015, EJSO-EUR J SURG ONC, V41, P1188, DOI 10.1016/j.ejso.2015.06.008	27	119	120	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2095	2103		10.1001/jama.2018.5623	http://dx.doi.org/10.1001/jama.2018.5623			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800179	Green Published, Bronze			2022-12-28	WOS:000432679400021
J	Crowther, TW; Machmuller, MB; Carey, JC; Allison, SD; Blair, JM; Bridgham, SD; Burton, AJ; Dijkstra, FA; Elberling, B; Estiarte, M; Larsen, KS; Laudon, H; Lupascu, M; Marhan, S; Mohan, J; Niu, S; Penuelas, JJ; Schmidt, IK; Templer, PH; Kroel-Dulay, G; Frey, S; Bradford, MA				Crowther, T. W.; Machmuller, M. B.; Carey, J. C.; Allison, S. D.; Blair, J. M.; Bridgham, S. D.; Burton, A. J.; Dijkstra, F. A.; Elberling, B.; Estiarte, M.; Larsen, K. S.; Laudon, H.; Lupascu, M.; Marhan, S.; Mohan, J.; Niu, S.; Penuelas, J. J.; Schmidt, I. K.; Templer, P. H.; Kroel-Dulay, G.; Frey, S.; Bradford, M. A.			Crowther et al. reply (vol 560, pg 1, 2018)	NATURE			English	Correction									[Templer, P. H.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA	Boston University			Schmidt, Inger K/A-6230-2015; Estiarte, Marc/G-2001-2016; Bradford, Mark A/G-3850-2012; ramon, anna/O-1249-2019; Lupascu, Massimo/AAD-8686-2021; Dijkstra, Feike A/H-2182-2012; Allison, Steven D./E-2978-2010	Schmidt, Inger K/0000-0003-3880-2060; Estiarte, Marc/0000-0003-1176-8480; Bradford, Mark A/0000-0002-2022-8331; Lupascu, Massimo/0000-0002-0416-629X; Dijkstra, Feike A/0000-0002-6191-6018; Allison, Steven D./0000-0003-4629-7842				Crowther TW, 2018, NATURE, V560, DOI 10.1038/s41586-018-0192-1	1	1	1	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2018	560	7716								10.1038/s41586-018-0192-1	http://dx.doi.org/10.1038/s41586-018-0192-1			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP1DE	29875404	Green Submitted			2022-12-28	WOS:000440552600012
J	Toda, S; Blauch, LR; Tang, SKY; Morsut, L; Lim, WA				Toda, Satoshi; Blauch, Lucas R.; Tang, Sindy K. Y.; Morsut, Leonardo; Lim, Wendell A.			Programming self-organizing multicellular structures with synthetic cell-cell signaling	SCIENCE			English	Article							POSITIONAL INFORMATION; DEVELOPMENTAL BIOLOGY; PATTERN-FORMATION; SPECIFICATION; CADHERINS; DETERMINANTS; UNDERSTAND; BEHAVIORS; ADHESION; COMPLEX	A common theme in the self-organization of multicellular tissues is the use of cell-cell signaling networks to induce morphological changes. We used the modular synNotch juxtacrine signaling platform to engineer artificial genetic programs in which specific cell-cell contacts induced changes in cadherin cell adhesion. Despite their simplicity, these minimal intercellular programs were sufficient to yield assemblies with hallmarks of natural developmental systems: robust self-organization into multidomain structures, well-choreographed sequential assembly, cell type divergence, symmetry breaking, and the capacity for regeneration upon injury. The ability of these networks to drive complex structure formation illustrates the power of interlinking cell signaling with cell sorting: Signal-induced spatial reorganization alters the local signals received by each cell, resulting in iterative cycles of cell fate branching. These results provide insights into the evolution of multicellularity and demonstrate the potential to engineer customized self-organizing tissues or materials.	[Toda, Satoshi; Morsut, Leonardo; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Toda, Satoshi; Morsut, Leonardo; Lim, Wendell A.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Blauch, Lucas R.; Tang, Sindy K. Y.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Morsut, Leonardo] Univ Southern Calif, Eli & Edythe Broad CIRM Ctr Regenerat Med & Stem, Los Angeles, CA 90033 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of Southern California	Morsut, L; Lim, WA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Morsut, L; Lim, WA (corresponding author), Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA.; Morsut, L (corresponding author), Univ Southern Calif, Eli & Edythe Broad CIRM Ctr Regenerat Med & Stem, Los Angeles, CA 90033 USA.	leonardo.morsut@med.usc.edu; wendell.lim@ucsf.edu	Toda, Satoshi/AAN-3245-2020	Toda, Satoshi/0000-0003-4997-9558; Tang, Sindy/0000-0003-1465-2432	Japan Society for the Promotion of Science (JSPS) Overseas Research Fellowships; Human Frontiers of Science Program (HFSP); European Molecular Biology Organization (EMBO) Postdoctoral Fellowship; NIH [K99 1K99EB021030, 5P50GM081879, T32GM008412]; NSF [DBI-1548297]; DARPA Engineered Living Materials program; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K99EB021030, R00EB021030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, T32GM008412] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS) Overseas Research Fellowships; Human Frontiers of Science Program (HFSP); European Molecular Biology Organization (EMBO) Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DARPA Engineered Living Materials program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by Japan Society for the Promotion of Science (JSPS) Overseas Research Fellowships (S.T.); a Human Frontiers of Science Program (HFSP) (S.T. and L.M.); a European Molecular Biology Organization (EMBO) Postdoctoral Fellowship (L.M.); NIH grants K99 1K99EB021030 (L.M.), 5P50GM081879 (W.A.L.), and T32GM008412 (L.R.B.); NSF DBI-1548297 Center for Cellular Construction (W.A.L. and S.K.Y.T.); the DARPA Engineered Living Materials program; and the Howard Hughes Medical Institute (W.A.L.).	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Alegado RA, 2012, ELIFE, V1, DOI 10.7554/eLife.00013; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Antebi Yaron E, 2017, Curr Opin Syst Biol, V1, P16, DOI 10.1016/j.coisb.2016.12.003; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Blauch LR, 2017, P NATL ACAD SCI USA, V114, P7283, DOI 10.1073/pnas.1705059114; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cachat E, 2016, SCI REP-UK, V6, DOI 10.1038/srep20664; Chazaud C, 2016, DEVELOPMENT, V143, P1063, DOI 10.1242/dev.128314; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Davies J, 2017, DEVELOPMENT, V144, P1146, DOI 10.1242/dev.144196; Davies JA, 2008, J ANAT, V212, P707, DOI 10.1111/j.1469-7580.2008.00896.x; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Gilmour D, 2017, NATURE, V541, P311, DOI 10.1038/nature21348; Green JBA, 2015, DEVELOPMENT, V142, P1203, DOI 10.1242/dev.114991; Harrison SE, 2017, SCIENCE, V356, DOI 10.1126/science.aal1810; Hart Y, 2014, CELL, V158, P1022, DOI 10.1016/j.cell.2014.07.033; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jang SS, 2012, ACS SYNTH BIOL, V1, P365, DOI 10.1021/sb300034m; Kicheva A, 2017, DEVELOPMENT, V144, P733, DOI 10.1242/dev.144915; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Matsuda M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7195; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Newman SA, 2009, INT J DEV BIOL, V53, P693, DOI 10.1387/ijdb.072481sn; Nichols SA, 2012, P NATL ACAD SCI USA, V109, P13046, DOI 10.1073/pnas.1120685109; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Rubenstein M, 2014, SCIENCE, V345, P795, DOI 10.1126/science.1254295; Scarpa E, 2016, J CELL BIOL, V212, P143, DOI 10.1083/jcb.201508047; Teague BP, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023929; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; van den Brink SC, 2014, DEVELOPMENT, V141, P4231, DOI 10.1242/dev.113001; Vendome J, 2014, P NATL ACAD SCI USA, V111, pE4175, DOI 10.1073/pnas.1416737111; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wennekamp S, 2013, NAT REV MOL CELL BIO, V14, P452, DOI 10.1038/nrm3602; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Woznica A, 2016, P NATL ACAD SCI USA, V113, P7894, DOI 10.1073/pnas.1605015113	40	199	201	18	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2018	361	6398					156	+		10.1126/science.aat0271	http://dx.doi.org/10.1126/science.aat0271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8DY	29853554	Green Accepted			2022-12-28	WOS:000438449200040
J	Gill, J; Obley, AJ; Prasad, V				Gill, Jennifer; Obley, Adam J.; Prasad, Vinay			Direct-to-Consumer Genetic Testing The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SERVICES; CANCER; IMPACT; WOMEN		[Gill, Jennifer; Prasad, Vinay] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol Oncol, Portland, OR 97239 USA; [Obley, Adam J.] Vet Affairs Med Ctr, Sect Gen Internal Med, Portland, OR USA; [Prasad, Vinay] Oregon Hlth & Sci Univ, Ctr Hlth Care Eth, Portland, OR 97239 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University	Prasad, V (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	prasad@ohsu.edu		Gill, Jennifer/0000-0002-5591-6855; Prasad, Vinayak/0000-0002-6110-8221				Desai S, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6357; Jolie A., MY MED CHOICE; Lowery JT, 2008, GENET MED, V10, P888, DOI 10.1097/GIM.0b013e31818de6d7; Manchanda R, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju379; Mouchawar J, 2005, GENET MED, V7, P191, DOI 10.1097/01.GIM.0000156526.16967.7A; Moyer VA, 2014, ANN INTERN MED, V160, P271, DOI 10.7326/M13-2747; Park A., YOU CAN NOW ORDER HO; Roberts MC, 2017, J COMMUN GENET, V8, P141, DOI 10.1007/s12687-017-0295-7; US Food and Drug Administration, FDA AUTH SPEC CONTR; Wojcicki A., MAJOR MILESTONE CONS	10	37	38	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2018	319	23					2377	2378		10.1001/jama.2018.5330	http://dx.doi.org/10.1001/jama.2018.5330			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ7JX	29800087				2022-12-28	WOS:000435564100013
J	Hassan, N; Cunningham, S; Mourigal, M; Zhilyaeva, EI; Torunova, SA; Lyubovskaya, RN; Schlueter, JA; Drichko, N				Hassan, Nora; Cunningham, Streit; Mourigal, Martin; Zhilyaeva, Elena I.; Torunova, Svetlana A.; Lyubovskaya, Rimma N.; Schlueter, John A.; Drichko, Natalia			Evidence for a quantum dipole liquid state in an organic quasi-two-dimensional material	SCIENCE			English	Article							THERMODYNAMIC PROPERTIES; CONDUCTORS; SUPERCONDUCTIVITY; SCATTERING; METALS; SALTS; RAMAN	Mott insulators are commonly pictured with electrons localized on lattice sites, with their low-energy degrees of freedom involving spins only. Here, we observe emergent charge degrees of freedom in a molecule-based Mott insulator kappa-(BEDT-TTF)(2)Hg(SCN)(2)Br, resulting in a quantum dipole liquid state. Electrons localized on molecular dimer lattice sites form electric dipoles that do not order at low temperatures and fluctuate with frequency detected experimentally in our Raman spectroscopy experiments. The heat capacity and Raman scattering response are consistent with a scenario in which the composite spin and electric dipole degrees of freedom remain fluctuating down to the lowest measured temperatures.	[Hassan, Nora; Cunningham, Streit; Drichko, Natalia] Johns Hopkins Univ, Inst Quantum Matter, Baltimore, MD 21218 USA; [Hassan, Nora; Cunningham, Streit; Drichko, Natalia] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Mourigal, Martin] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Zhilyaeva, Elena I.; Torunova, Svetlana A.; Lyubovskaya, Rimma N.] Inst Problems Chem Phys, Chernogolovka, Russia; [Schlueter, John A.] Natl Sci Fdn, Div Mat Res, Alexandria, VA 22314 USA; [Schlueter, John A.] Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA	Johns Hopkins University; Johns Hopkins University; University System of Georgia; Georgia Institute of Technology; Russian Academy of Sciences; Institute of Problems of Chemical Physics of the Russian Academy of Sciences; National Science Foundation (NSF); NSF - Directorate for Mathematical & Physical Sciences (MPS); NSF - Division of Materials Research (DMR); United States Department of Energy (DOE); Argonne National Laboratory	Drichko, N (corresponding author), Johns Hopkins Univ, Inst Quantum Matter, Baltimore, MD 21218 USA.; Drichko, N (corresponding author), Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA.	drichko@jhu.edu	Hassan, Nora/U-5237-2019; Mourigal, Martin/F-4495-2010; Cunningham, William Streit/AAU-3605-2021; Mourigal, Martin/AAJ-4237-2020	Hassan, Nora/0000-0003-2539-8660; Mourigal, Martin/0000-0003-2772-8440; Cunningham, William Streit/0000-0003-3166-3563; Mourigal, Martin/0000-0003-2772-8440; Drichko, Natalia/0000-0002-6538-1292; Zhilyaeva, Elena/0000-0002-9540-5304	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Material Sciences and Engineering [DE-FG02-08ER46544]; FASO Russia [0089-2014-0036]; Independent Research and Development program from the NSF; National High Magnetic Field Laboratory (NHMFL) User Collaboration Grants Program (UCGP); University of Chicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne") Argonne; U.S. Department of Energy Office of Science laboratory [DE-AC02-06CH11357]	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Material Sciences and Engineering(United States Department of Energy (DOE)); FASO Russia; Independent Research and Development program from the NSF; National High Magnetic Field Laboratory (NHMFL) User Collaboration Grants Program (UCGP); University of Chicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne") Argonne(University of Chicago); U.S. Department of Energy Office of Science laboratory(United States Department of Energy (DOE))	The work at the Institute of Quantum Matter was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Material Sciences and Engineering under grant no. DE-FG02-08ER46544. The work in Chernogolovka was supported by FASO Russia, state registration number 0089-2014-0036. J.A.S acknowledges support from the Independent Research and Development program from the NSF while working at the Foundation and from the National High Magnetic Field Laboratory (NHMFL) User Collaboration Grants Program (UCGP). Work at ANL was supported by University of Chicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne") Argonne, a U.S. Department of Energy Office of Science laboratory, is operated under contract no. DE-AC02-06CH11357.	ALDOSHINA MZ, 1993, SYNTHETIC MET, V56, P1905, DOI 10.1016/0379-6779(93)90345-W; ANDERSON PW, 1987, PHYS REV LETT, V58, P2790, DOI 10.1103/PhysRevLett.58.2790; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Caprara S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.117004; Chen G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096406; Dayal S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245106; Devereaux TP, 2007, REV MOD PHYS, V79, P175, DOI 10.1103/RevModPhys.79.175; Dressel M, 2004, CHEM REV, V104, P5689, DOI 10.1021/cr030642f; Dressel M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.167002; Drichko N, 2007, PHYSICA C, V460, P125, DOI 10.1016/j.physc.2007.03.375; Drichko N, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.161112; Drichko N, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.075133; Girlando A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.174503; Hotta C, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.241104; Ivek T, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.085116; Kandpal HC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.067004; Lohle A, 2017, J PHYS-CONDENS MAT, V29, DOI 10.1088/1361-648X/29/5/055601; Lyubovskii RB, 1996, J PHYS I, V6, P1609, DOI 10.1051/jp1:1996178; MALINOVSKY VK, 1986, SOLID STATE COMMUN, V57, P757, DOI 10.1016/0038-1098(86)90854-9; Merino J, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.245121; Naka M, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.195114; Naka M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20781; Nakamura Y., 2016, J PHYS SOC JPN, V86; Nakamura Y, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.074708; Nakazawa Y, 2012, CRYSTALS, V2, P741, DOI 10.3390/cryst2030741; Powell BJ, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.087204; Rowley SE, 2014, NAT PHYS, V10, P367, DOI [10.1038/nphys2924, 10.1038/NPHYS2924]; Sedlmeier K, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.245103; Shen SP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10569; Shimizu Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.107001; Yakushi K, 2015, J PHYS SOC JPN, V84, DOI 10.7566/JPSJ.84.084711; Yakushi K, 2012, CRYSTALS, V2, P1291, DOI 10.3390/cryst2031291; Yamamoto T, 2005, J PHYS CHEM B, V109, P15226, DOI 10.1021/jp050247o; Yamashita S, 2008, NAT PHYS, V4, P459, DOI 10.1038/nphys942; Yao NY, 2018, NAT PHYS, V14, P405, DOI 10.1038/s41567-017-0030-7; Zhou Y, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.025003	37	37	37	4	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1101	1104		10.1126/science.aan6286	http://dx.doi.org/10.1126/science.aan6286			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI6TJ	29880684	Green Submitted			2022-12-28	WOS:000434635500041
J	Goedert, J; Lecuyer, C; Amiot, R; Arnaud-Godet, F; Wang, X; Cui, LL; Cuny, G; Douay, G; Fourel, F; Panczer, G; Simon, L; Steyer, JS; Zhu, M				Goedert, Jean; Lecuyer, Christophe; Amiot, Romain; Arnaud-Godet, Florent; Wang, Xu; Cui, Linlin; Cuny, Gilles; Douay, Guillaume; Fourel, Francois; Panczer, Gerard; Simon, Laurent; Steyer, J-Sebastien; Zhu, Min			Euryhaline ecology of early tetrapods revealed by stable isotopes	NATURE			English	Article							DEVONIAN TETRAPOD; EARLY EVOLUTION; BONE PHOSPHATE; EAST GREENLAND; FISH DEBRIS; OXYGEN; CARBONATE; FRACTIONATION; VERTEBRATES; DIAGENESIS	The fish-to-tetrapod transition-followed later by terrestrialization-represented a major step in vertebrate evolution that gave rise to a successful clade that today contains more than 30,000 tetrapod species. The early tetrapod Ichthyostega was discovered in 1929 in the Devonian Old Red Sandstone sediments of East Greenland (dated to approximately 365 million years ago). Since then, our understanding of the fish-to-tetrapod transition has increased considerably, owing to the discovery of additional Devonian taxa that represent early tetrapods or groups evolutionarily close to them. However, the aquatic environment of early tetrapods and the vertebrate fauna associated with them has remained elusive and highly debated. Here we use a multi-stable isotope approach (delta C-13, delta O-18 and delta S-34) to show that some Devonian vertebrates, including early tetrapods, were euryhaline and inhabited transitional aquatic environments subject to high-magnitude, rapid changes in salinity, such as estuaries or deltas. Euryhalinity may have predisposed the early tetrapod clade to be able to survive Late Devonian biotic crises and then successfully colonize terrestrial environments.	[Goedert, Jean; Lecuyer, Christophe; Amiot, Romain; Arnaud-Godet, Florent; Cuny, Gilles] Univ Lyon 1, Univ Lyon, CNRS, UMR LGL TPE 5276,Ens Lyon, Villeurbanne, France; [Goedert, Jean] Univ Bordeaux, UMR PACEA 5199, CNRS, Bordeaux, France; [Lecuyer, Christophe] Inst Univ France, Paris, France; [Wang, Xu; Cui, Linlin] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China; [Douay, Guillaume] Zoo Lyon, Lyon, France; [Fourel, Francois; Simon, Laurent] Univ Lyon, ENTPE, Univ Claude Bernard Lyon 1, UMR LEHNA 5023,CNRS, Villeurbanne, France; [Panczer, Gerard] Univ Lyon, Univ Claude Bernard Lyon 1, UMR ILM 5306, CNRS, Villeurbanne, France; [Steyer, J-Sebastien] UPMC, MNHN, Galerie Paleontol, UMR CR2P 7207,CNRS, Paris, France; [Zhu, Min] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Institut Universitaire de France; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Goedert, J; Lecuyer, C (corresponding author), Univ Lyon 1, Univ Lyon, CNRS, UMR LGL TPE 5276,Ens Lyon, Villeurbanne, France.; Goedert, J (corresponding author), Univ Bordeaux, UMR PACEA 5199, CNRS, Bordeaux, France.; Lecuyer, C (corresponding author), Inst Univ France, Paris, France.	jean.goedert@ens-lyon.fr; christophe.lecuyer@univ-lyon1.fr	Cuny, Gilles/F-8949-2017; Lecuyer, Christophe/AAO-8154-2021; Zhu, Min/E-8728-2012; min, zhu/AAL-6712-2021; Simon, Laurent/B-4641-2009; Wang, Xu/J-3860-2013; Amiot, Romain/C-8132-2012; FOUREL, Francois/G-6734-2015	Cuny, Gilles/0000-0001-7680-1697; Zhu, Min/0000-0002-4786-0898; Simon, Laurent/0000-0003-1389-9871; Steyer, J.-Sebastien/0000-0003-1835-7852; Douay, Guillaume/0000-0002-7739-4023; Panczer, Gerard/0000-0001-5708-6376	Natural Science Foundation of China [41530102]; Key Research Program of Frontier Sciences of CAS [QYZDJ-SSW-DQC002]; CNRS INSU program InterrVie; Institut Universitaire de France	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of Frontier Sciences of CAS; CNRS INSU program InterrVie; Institut Universitaire de France	We thank N. Scharff and B. Lindow (Natural History Museum of Denmark) for authorizing the sampling of Devonian material; M. Creuze des Chatelliers for access to the zoology collections of the Centre de Ressources pour les Sciences de l'Evolution (CERESE, FED 4271, Universite de Lyon, Universite Claude Bernard Lyon 1); O. de Lataillade (Ferme du Ciron), P. Francois (Pierrelatte), E. Liatout (Maison Liatout) and the fishery (Maison Pupier) for providing present-day material; and L. De Brito. M.Z. was supported by Natural Science Foundation of China (41530102) and Key Research Program of Frontier Sciences of CAS (QYZDJ-SSW-DQC002). This study was supported by the CNRS INSU program InterrVie, and the Institut Universitaire de France (C.L.).	Agassiz L., 1845, MONOGRAPHIE POISSONS; AHLBERG PE, 1995, NATURE, V373, P420, DOI 10.1038/373420a0; AHLBERG PE, 1994, PHILOS T ROY SOC B, V343, P303, DOI 10.1098/rstb.1994.0027; [Anonymous], 2004, ACTA U LATVIENSIS; Barrell J, 1916, P NATL ACAD SCI USA, V2, P499, DOI 10.1073/pnas.2.8.499; Berzin F, 2017, COMPOSITES POLYM FIB; Blieck A, 2007, GEOL SOC SPEC PUBL, V278, P219, DOI 10.1144/SP278.10; Blom H., 2005, MEDDELELSER GRONLAND, V43; Blom H, 2007, GEODIVERSITAS, V29, P119; Bouillon S, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 7: FUNCTIONING OF ECOSYSTEMS AT THE LAND-OCEAN INTERFACE, P143; BRAY AA, 1985, PHILOS T R SOC B, V309, P289, DOI 10.1098/rstb.1985.0088; Brudevold F., 1967, STRUCTURAL CHEM ORG, P247; Campbell KSW, 1977, ALCHERINGA, V1, P369, DOI 10.1080/03115517708527771; Carr R. K., 2010, GUIDE GEOLOGY PALEON; Clack JA, 2003, NATURE, V425, P65, DOI 10.1038/nature01904; Clack JA, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0002; Clack JA, 2012, PALAEONTOLOGY, V55, P73, DOI 10.1111/j.1475-4983.2011.01117.x; Clement G, 2004, NATURE, V427, P412, DOI 10.1038/427412a; COATES MI, 1990, NATURE, V347, P66, DOI 10.1038/347066a0; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; CROWSON RA, 1991, ANAL CHEM, V63, P2397, DOI 10.1021/ac00020a038; DAESCHLER EB, 1994, SCIENCE, V265, P639, DOI 10.1126/science.265.5172.639; Fourel F, 2015, GEOSTAND GEOANAL RES, V39, P47, DOI 10.1111/j.1751-908X.2014.00297.x; Fourel F, 2011, RAPID COMMUN MASS SP, V25, P2691, DOI 10.1002/rcm.5056; Fry B, 2011, LIMNOL OCEANOGR, V56, P1563, DOI 10.4319/lo.2011.56.5.1563; Godwin- Austen R., 1855, Q J GEOL SOC LOND, V11, P533; Goedert J, 2016, RAPID COMMUN MASS SP, V30, P2002, DOI 10.1002/rcm.7690; Iacumin P, 1996, EARTH PLANET SC LETT, V142, P1, DOI 10.1016/0012-821X(96)00093-3; Joachimski MM, 2009, EARTH PLANET SC LETT, V284, P599, DOI 10.1016/j.epsl.2009.05.028; Kampschulte A, 2004, CHEM GEOL, V204, P255, DOI 10.1016/j.chemgeo.2003.11.013; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Laurin M, 2010, GEOL SOC SPEC PUBL, V339, P151, DOI 10.1144/SP339.13; LEBEDEV OA, 1993, PALAEONTOLOGY, V36, P721; LECUYER C, 1993, PALAEOGEOGR PALAEOCL, V105, P235, DOI 10.1016/0031-0182(93)90085-W; Lecuyer C, 2007, J MASS SPECTROM, V42, P36, DOI 10.1002/jms.1130; Lecuyer C, 2013, CHEM GEOL, V347, P217, DOI 10.1016/j.chemgeo.2013.03.008; Licht A, 2014, NATURE, V513, P501, DOI 10.1038/nature13704; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Marshall JEA, 1999, GEOLOGY, V27, P637, DOI 10.1130/0091-7613(1999)027<0637:EGTADI>2.3.CO;2; MCCLAY KR, 1986, NATURE, V323, P147, DOI 10.1038/323147a0; Nehlich O, 2015, EARTH-SCI REV, V142, P1, DOI 10.1016/j.earscirev.2014.12.002; Nehlich O, 2013, RAPID COMMUN MASS SP, V27, P2255, DOI 10.1002/rcm.6682; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Nouri F, 2017, J LUMIN, V192, P590, DOI 10.1016/j.jlumin.2017.07.033; Nriagu J.O., 1991, STABLE ISOTOPES NATU, P177; Olsen H, 1993, GREENLAND GEOL SURV, V165, P1; Pan J., 1987, CONTINENTAL DEVONIAN; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; RINK WJ, 1995, J ARCHAEOL SCI, V22, P251, DOI 10.1006/jasc.1995.0026; Sallan LC, 2010, P NATL ACAD SCI USA, V107, P10131, DOI 10.1073/pnas.0914000107; Save- Soderbergh G., 1932, MEDD GRONLAND, V94; SCHMITZ B, 1991, GEOL SOC AM BULL, V103, P786, DOI 10.1130/0016-7606(1991)103<0786:SSNFSA>2.3.CO;2; Schultze Hans-Peter, 1996, P348; SHEMESH A, 1990, GEOCHIM COSMOCHIM AC, V54, P2433, DOI 10.1016/0016-7037(90)90230-I; Shubin NH, 2004, SCIENCE, V304, P90, DOI 10.1126/science.1094295; Spotl C, 2003, RAPID COMMUN MASS SP, V17, P1004, DOI 10.1002/rcm.1010; Stepanczak B, 2014, GEOCHRONOMETRIA, V41, P147, DOI 10.2478/s13386-013-0146-1; SWART PK, 1991, CHEM GEOL, V86, P89, DOI 10.1016/0168-9622(91)90055-2; Sweet WC, 2001, J PALEONTOL, V75, P1174, DOI 10.1666/0022-3360(2001)075<1174:CPPF>2.0.CO;2; Szostek K, 2009, ANTHROPOL REV, V72, P3, DOI 10.2478/v10044-008-0013-5; TERMINE JD, 1966, SCIENCE, V153, P1523, DOI 10.1126/science.153.3743.1523; Vennemann TW, 2001, GEOCHIM COSMOCHIM AC, V65, P1583, DOI 10.1016/S0016-7037(00)00629-3; Wagman D.D., 1982, NBS TABLES CHEM THER; WOODWARD AS, 1991, CATALOGUE FOSSIL F 2; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P1, DOI 10.1016/S0016-7037(03)00278-3; Zhu M, 2002, NATURE, V420, P760, DOI 10.1038/420760a	67	18	20	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					68	+		10.1038/s41586-018-0159-2	http://dx.doi.org/10.1038/s41586-018-0159-2			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI3LQ	29849142				2022-12-28	WOS:000434273300038
J	Sclafani, A; VanderLaan, P				Sclafani, Alyssa; VanderLaan, Paul			Lymphangioleiomyomatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sclafani, Alyssa] Massachusetts Gen Hosp, Boston, MA 02114 USA; [VanderLaan, Paul] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center	Sclafani, A (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	asclafani1@partners.org	VanderLaan, Paul Andrew/AAX-8124-2020	VanderLaan, Paul Andrew/0000-0002-7234-5652; Soskis, Alyssa/0000-0001-8229-8266					0	1	2	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2018	378	23					2224	2224		10.1056/NEJMicm1712581	http://dx.doi.org/10.1056/NEJMicm1712581			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3HS	29874537				2022-12-28	WOS:000434263000010
J	Wang, L; Gillis-Smith, S; Peng, YQ; Zhang, JE; Chen, XK; Salzman, CD; Ryba, NJP; Zuker, CS				Wang, Li; Gillis-Smith, Sarah; Peng, Yueqing; Zhang, Juen; Chen, Xiaoke; Salzman, C. Daniel; Ryba, Nicholas J. P.; Zuker, Charles S.			The coding of valence and identity in the mammalian taste system	NATURE			English	Article							BASOLATERAL AMYGDALA; NEURAL CIRCUITS; WHOLE-BRAIN; STIMULI; NEURONS; CORTEX; BEHAVIORS; MECHANISM; RESPONSES; PATHWAYS	The ability of the taste system to identify a tastant (what it tastes like) enables animals to recognize and discriminate between the different basic taste qualities(1,2). The valence of a tastant (whether it is appetitive or aversive) specifies its hedonic value and elicits the execution of selective behaviours. Here we examine how sweet and bitter are afforded valence versus identity in mice. We show that neurons in the sweet-responsive and bitter-responsive cortex project to topographically distinct areas of the amygdala, with strong segregation of neural projections conveying appetitive versus aversive taste signals. By manipulating selective taste inputs to the amygdala, we show that it is possible to impose positive or negative valence on a neutral water stimulus, and even to reverse the hedonic value of a sweet or bitter tastant. Remarkably, mice with silenced neurons in the amygdala no longer exhibit behaviour that reflects the valence associated with direct stimulation of the taste cortex, or with delivery of sweet and bitter chemicals. Nonetheless, these mice can still identify and discriminate between tastants, just as wild-type controls do. These results help to explain how the taste system generates stereotypic and predetermined attractive and aversive taste behaviours, and support the existence of distinct neural substrates for the discrimination of taste identity and the assignment of valence.	[Wang, Li; Gillis-Smith, Sarah; Peng, Yueqing; Zhang, Juen; Chen, Xiaoke; Zuker, Charles S.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Wang, Li; Gillis-Smith, Sarah; Peng, Yueqing; Zhang, Juen; Chen, Xiaoke; Zuker, Charles S.] Columbia Univ, Dept Biochem & Mol Biophys, Columbia Coll Phys & Surg, New York, NY 10027 USA; [Wang, Li; Gillis-Smith, Sarah; Peng, Yueqing; Zhang, Juen; Salzman, C. Daniel; Zuker, Charles S.] Columbia Univ, Dept Neurosci, Columbia Coll Phys & Surg, New York, NY 10027 USA; [Salzman, C. Daniel] Columbia Univ, Dept Psychiat, New York, NY USA; [Salzman, C. Daniel] Columbia Univ, New York State Psychiat Inst, New York, NY USA; [Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA; [Chen, Xiaoke] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Stanford University	Zuker, CS (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.; Zuker, CS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Columbia Coll Phys & Surg, New York, NY 10027 USA.; Zuker, CS (corresponding author), Columbia Univ, Dept Neurosci, Columbia Coll Phys & Surg, New York, NY 10027 USA.	cz2195@columbia.edu	Wang, Li/AAB-8164-2020; Core, Vector/CAF-4832-2022	Ryba, Nicholas/0000-0002-2060-8393; Wang, Li/0000-0001-8527-6345	National Institute on Drug Abuse of the National Institutes of Health [R01DA035025]; Intramural Research Program of the NIH, NIDCR; NIMH [R01 MH082017]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035025] Funding Source: NIH RePORTER	National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Intramural Research Program of the NIH, NIDCR; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Tessier-Lavigne, N. Renier and P. Ariel for help with CUBIC; members of the Zuker laboratory and R. Axel for helpful discussions. We also acknowledge the Bio-Imaging Resource Center at Rockefeller University. Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under award number R01DA035025 (C.S.Z). N.J.P.R. is supported by the Intramural Research Program of the NIH, NIDCR; and C.D.S. was supported by R01 MH082017 from NIMH. C.S.Z. is an investigator of the Howard Hughes Medical Institute and a Senior Fellow at Janelia Farm Research Campus.	Accolla R, 2007, J NEUROSCI, V27, P1396, DOI 10.1523/JNEUROSCI.5188-06.2007; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bakker R, 2015, NEUROINFORMATICS, V13, P353, DOI 10.1007/s12021-014-9258-x; Beyeler A, 2018, CELL REP, V22, P905, DOI 10.1016/j.celrep.2017.12.097; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cai HJ, 2014, NAT NEUROSCI, V17, P1240, DOI 10.1038/nn.3767; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Douglass AM, 2017, NAT NEUROSCI, V20, P1384, DOI 10.1038/nn.4623; Gore F, 2015, CELL, V162, P134, DOI 10.1016/j.cell.2015.06.027; GRILL HJ, 1978, BRAIN RES, V143, P281, DOI 10.1016/0006-8993(78)90569-3; Han WF, 2017, CELL, V168, P311, DOI 10.1016/j.cell.2016.12.027; Ilango A, 2014, J NEUROSCI, V34, P817, DOI 10.1523/JNEUROSCI.1703-13.2014; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Kim CK, 2017, CELL, V170, P1013, DOI 10.1016/j.cell.2017.07.020; Kim J, 2017, NEURON, V93, P1464, DOI 10.1016/j.neuron.2017.02.034; Kim J, 2016, NAT NEUROSCI, V19, P1636, DOI 10.1038/nn.4414; KRETTEK JE, 1978, J COMP NEUROL, V178, P255, DOI 10.1002/cne.901780205; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Peng YQ, 2015, NATURE, V527, P512, DOI 10.1038/nature15763; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Spector Alan C, 2005, Behav Cogn Neurosci Rev, V4, P143, DOI 10.1177/1534582305280031; Stachniak TJ, 2014, NEURON, V82, P797, DOI 10.1016/j.neuron.2014.04.008; Susaki EA, 2015, NAT PROTOC, V10, P1709, DOI 10.1038/nprot.2015.085; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Yoshimura H, 2004, NEUROREPORT, V15, P17, DOI 10.1097/00001756-200401190-00005; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zingg B, 2017, NEURON, V93, P33, DOI 10.1016/j.neuron.2016.11.045	36	89	92	4	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					127	+		10.1038/s41586-018-0165-4	http://dx.doi.org/10.1038/s41586-018-0165-4			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29849148	Green Accepted			2022-12-28	WOS:000434273300050
J	Dyer, C				Dyer, Clare			Obstetrician who delivered decapitated baby is cleared of wrongdoing by tribunal	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2018	361								k2506	10.1136/bmj.k2506	http://dx.doi.org/10.1136/bmj.k2506			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BX	29875103				2022-12-28	WOS:000435073600010
J	Lv, YB; Gao, X; Yin, ZX; Chen, HS; Luo, JS; Brasher, MS; Kraus, VB; Li, TT; Zeng, Y; Shi, XM				Lv, Yue-Bin; Gao, Xiang; Yin, Zhao-Xue; Chen, Hua-Shuai; Luo, Jie-Si; Brasher, Melanie Sereny; Kraus, Virginia Byers; Li, Tian-Tian; Zeng, Yi; Shi, Xiao-Ming			Revisiting the association of blood pressure with mortality in oldest old people in China: community based, longitudinal prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEAN ARTERIAL-PRESSURE; PULSE PRESSURE; HEART-FAILURE; AGED 85; FOLLOW-UP; ALL-CAUSE; POPULATION; SURVIVAL; HYPERTENSION; FRAILTY	OBJECTIVE To examine the associations of blood pressure with all cause mortality and cause specific mortality at three years among oldest old people in China. DESIGN Community based, longitudinal prospective study. SETTING 2011 and 2014 waves of the Chinese Longitudinal Healthy Longevity Survey, conducted in 22 Chinese provinces. PARTICIPANTS 4658 oldest old individuals (mean age 92.1 years). MAIN OUTCOME MEASURES All cause mortality and cause specific mortality assessed at three year follow-up. RESULTS 1997 deaths were recorded at three year follow-up. U shaped associations of mortality with systolic blood pressure, mean arterial pressure, and pulse pressure were identified; values of 143.5 mm Hg, 101 mm Hg, and 66 mm Hg conferred the minimum mortality risk, respectively. After adjustment for covariates, the U shaped association remained only for systolic blood pressure (minimum mortality risk at 129 mm Hg). Compared with a systolic blood pressure value of 129 mm Hg, risk of all cause mortality decreased for values lower than 107 mm Hg (from 1.47 (95% confidence interval 1.01 to 2.17) to 1.08 (1.01 to 1.17)), and increased for values greater than 154 mm Hg (from 1.08 (1.01 to 1.17) to 1.27 (1.02 to 1.58)). In the cause specific analysis, compared with a middle range of systolic blood pressure (107-154 mm Hg), higher values (>154 mm Hg) were associated with a higher risk of cardiovascular mortality (adjusted hazard ratio 1.51 (95% confidence interval 1.12 to 2.02)); lower values (<107 mm Hg) were associated with a higher risk of non-cardiovascular mortality (1.58 (1.26 to 1.98)). The U shaped associations remained in sensitivity and subgroup analyses. CONCLUSIONS This study indicates a U shaped association between systolic blood pressure and all cause mortality at three years among oldest old people in China. This association could be explained by the finding that higher systolic blood pressure predicted a higher risk of death from cardiovascular disease, and that lower systolic blood pressure predicted a higher risk of death from non-cardiovascular causes. These results emphasise the importance of revisiting blood pressure management or establishing specific guidelines for management among oldest old individuals.	[Lv, Yue-Bin; Li, Tian-Tian; Shi, Xiao-Ming] Chinese Ctr Dis Control & Prevent, Natl Inst Environm Hlth, Beijing, Peoples R China; [Gao, Xiang] Penn State Univ, Nutr Epidemiol Lab, Philadelphia, PA USA; [Yin, Zhao-Xue; Luo, Jie-Si] Chinese Ctr Dis Control & Prevent, Div Noncommunicable Dis Control & Community Hlth, Beijing, Peoples R China; [Chen, Hua-Shuai; Zeng, Yi] Duke Univ, Sch Med, Ctr Study Aging & Human Dev, Durham, NC USA; [Chen, Hua-Shuai; Zeng, Yi] Duke Univ, Sch Med, Geriatr Div, Durham, NC USA; [Brasher, Melanie Sereny] Univ Rhode Isl, Dept Sociol & Anthropol, Kingston, RI 02881 USA; [Brasher, Melanie Sereny] Univ Rhode Isl, Dept Human Dev Family Studies, Kingston, RI 02881 USA; [Kraus, Virginia Byers] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC USA; [Kraus, Virginia Byers] Duke Univ, Sch Med, Dept Med, Div Rheumatol, Durham, NC 27706 USA; [Zeng, Yi] Peking Univ, Ctr Study Hlth Aging & Dev Studies, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Chinese Center for Disease Control & Prevention; Duke University; Duke University; University of Rhode Island; University of Rhode Island; Duke University; Duke University; Peking University	Shi, XM (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Environm Hlth, Beijing, Peoples R China.	shixm@chinacdc.cn	Shi, Xiaoming/V-2119-2018	Shi, Xiaoming/0000-0002-7071-571X; , Xiang/0000-0003-2617-6509; Brasher, Melanie/0000-0002-3601-4047	National Natural Sciences Foundation of China [71233001, 71490732, 81573247]; US National Institute of Ageing [2P01AG031719]; United Nations Fund for Population Activities; Claude D Pepper Older Americans Independence Center (National Institute of Ageing) [5P30 AG028716]; NATIONAL INSTITUTE ON AGING [P30AG028716, P01AG031719] Funding Source: NIH RePORTER	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institute of Ageing; United Nations Fund for Population Activities; Claude D Pepper Older Americans Independence Center (National Institute of Ageing); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Chinese Longitudinal Healthy Longevity Survey, which provided the data analysed in this article, is jointly supported by National Natural Sciences Foundation of China (71233001, 71490732, and 81573247), US National Institute of Ageing (2P01AG031719), United Nations Fund for Population Activities, and a grant from the Claude D Pepper Older Americans Independence Center (5P30 AG028716 from the National Institute of Ageing to VBK). The funders had no role in the study design or implementation; the data collection, management, analysis, and interpretation; the manuscript preparation, review, or approval; or the decision to submit the manuscript for publication.	Allison PD., 2002, MISSING DATA, DOI [10.4135/9781412985079, DOI 10.4135/9781412985079]; [Anonymous], 1991, JAMA, V265, P3255; Avanzini F, 2006, J HYPERTENS, V24, P2377, DOI 10.1097/01.hjh.0000251897.40002.bf; Farre TB, 2011, MED CLIN-BARCELONA, V137, P97, DOI 10.1016/j.medcli.2010.11.029; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Bejan-Angoulvant T, 2010, J HYPERTENS, V28, P1366, DOI 10.1097/HJH.0b013e328339f9c5; Benetos A, 1997, HYPERTENSION, V30, P1410, DOI 10.1161/01.HYP.30.6.1410; Benetos A, 2012, J AM COLL CARDIOL, V60, P1503, DOI 10.1016/j.jacc.2012.04.055; Boshuizen HC, 1998, BMJ-BRIT MED J, V316, P1780, DOI 10.1136/bmj.316.7147.1780; Bulpitt CJ, 2012, J HUM HYPERTENS, V26, P157, DOI 10.1038/jhh.2011.10; Bulpitt CJ, 2003, J HYPERTENS, V21, P2409, DOI 10.1097/00004872-200312000-00030; Dupre ME, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1175; Eisen EA, 2004, OCCUP ENVIRON MED, V61, P854, DOI 10.1136/oem.2004.013136; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Franklin SS, 2015, HYPERTENSION, V65, P299, DOI 10.1161/HYPERTENSIONAHA.114.04581; Fraser GE, 1997, ARCH INTERN MED, V157, P2249, DOI 10.1001/archinte.157.19.2249; Glynn RJ, 2000, ARCH INTERN MED, V160, P2765, DOI 10.1001/archinte.160.18.2765; GLYNN RJ, 1995, LANCET, V345, P825, DOI 10.1016/S0140-6736(95)92964-9; Goggins WB, 2005, J GERONTOL A-BIOL, V60, P1046, DOI 10.1093/gerona/60.8.1046; GRAY RJ, 1992, J AM STAT ASSOC, V87, P942, DOI 10.2307/2290630; Hakala SM, 1997, EUR HEART J, V18, P1019; HEIKINHEIMO RJ, 1990, J HYPERTENS, V8, P361, DOI 10.1097/00004872-199004000-00010; Hospers GP, 2015, J INTERN MED, V277, P488, DOI 10.1111/joim.12284; Kagiyama S, 2008, HYPERTENS RES, V31, P265, DOI 10.1291/hypres.31.265; Kagiyama S, 2009, CLIN EXP HYPERTENS, V31, P639, DOI 10.3109/10641960903407009; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; LANGER RD, 1991, AM J EPIDEMIOL, V134, P29, DOI 10.1093/oxfordjournals.aje.a115990; LANGER RD, 1993, HYPERTENSION, V22, P551, DOI 10.1161/01.HYP.22.4.551; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lv YB, 2015, ATHEROSCLEROSIS, V239, P137, DOI 10.1016/j.atherosclerosis.2015.01.002; Malloy EJ, 2009, COMPUT STAT DATA AN, V53, P2605, DOI 10.1016/j.csda.2008.12.008; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; MATTILA K, 1988, BRIT MED J, V296, P887, DOI 10.1136/bmj.296.6626.887; Meira-Machado L, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/745742; Molander L, 2008, J AM GERIATR SOC, V56, P1853, DOI 10.1111/j.1532-5415.2008.01948.x; Molander L, 2010, DEMENT GERIATR COGN, V30, P269, DOI 10.1159/000320252; OSULLIVAN F, 1993, ANN STAT, V21, P124, DOI 10.1214/aos/1176349018; Pastor-Barriuso R, 2003, ANN INTERN MED, V139, P731, DOI 10.7326/0003-4819-139-9-200311040-00007; Poortvliet RKE, 2013, EUR J HEART FAIL, V15, P528, DOI 10.1093/eurjhf/hfs203; Qiu L, 2012, BRIT J NUTR, V108, P1686, DOI 10.1017/S0007114511007173; Rastas S, 2006, J AM GERIATR SOC, V54, P912, DOI 10.1111/j.1532-5415.2006.00742.x; Satish S, 2001, J AM GERIATR SOC, V49, P367, DOI 10.1046/j.1532-5415.2001.49078.x; Sesso HD, 2000, HYPERTENSION, V36, P801, DOI 10.1161/01.HYP.36.5.801; Sorensen K H, 1988, Scand J Prim Health Care, V6, P105, DOI 10.3109/02813438809009299; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Strandberg TE, 2007, LANCET, V369, P1328, DOI 10.1016/S0140-6736(12)62167-9; van Bemmel T, 2006, J HYPERTENS, V24, P287, DOI 10.1097/01.hjh.0000200513.48441.8e; van Bemmel T, 2009, J HUM HYPERTENS, V23, P27, DOI 10.1038/jhh.2008.79; Weidung B, 2015, J AM MED DIR ASSOC, V16, P208, DOI 10.1016/j.jamda.2014.09.004; Zeng Y, 2017, LANCET, V389, P1619, DOI 10.1016/S0140-6736(17)30548-2	51	76	88	2	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2018	361								k2158	10.1136/bmj.k2158	http://dx.doi.org/10.1136/bmj.k2158			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GJ2BU	29871897	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000435073300001
J	Wu, A				Wu, Audrey			In the Clinic Heart Failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIAC-RESYNCHRONIZATION THERAPY; LEFT-VENTRICULAR DYSFUNCTION; BRAIN NATRIURETIC PEPTIDE; PULMONARY-ARTERY PRESSURE; 2013 ACCF/AHA GUIDELINE; ASSOCIATION TASK-FORCE; HIGH-RISK; DEFIBRILLATOR IMPLANTATION; MYOCARDIAL-INFARCTION; EJECTION FRACTION	Heart failure affects more than 6 million people in the United States and incurs a heavy toll in morbidity, mortality, and health care costs. It frequently coexists with other important disorders, including hypertension, coronary artery disease, diabetes, and obesity. Decades of clinical trials have shown that several medications and interventions are effective for improving outcomes; however, mortality and hospitalization rates remain high. More recently, additional medications and devices have shown promise in reducing the health burden of heart failure.										Abraham WT, 2016, LANCET, V387, P453, DOI 10.1016/S0140-6736(15)00723-0; Aguilar D, 2009, J AM COLL CARDIOL, V54, P422, DOI 10.1016/j.jacc.2009.04.049; Arany Z, 2016, CIRCULATION, V133, P1397, DOI 10.1161/CIRCULATIONAHA.115.020491; Arnold JMO, 2003, CIRCULATION, V107, P1284, DOI 10.1161/01.CIR.0000054165.93055.42; Avery CL, 2012, J AM COLL CARDIOL, V60, P1640, DOI 10.1016/j.jacc.2012.07.022; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Barlera S, 2013, CIRC-HEART FAIL, V6, P31, DOI 10.1161/CIRCHEARTFAILURE.112.967828; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Birnie DH, 2016, J AM COLL CARDIOL, V68, P411, DOI 10.1016/j.jacc.2016.03.605; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Dao Q, 2001, J AM COLL CARDIOL, V37, P379, DOI 10.1016/S0735-1097(00)01156-6; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Dei Cas A, 2015, JACC-HEART FAIL, V3, P136, DOI 10.1016/j.jchf.2014.08.004; Doukky R, 2016, JACC-HEART FAIL, V4, P24, DOI 10.1016/j.jchf.2015.08.007; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Felker GM, 2017, JAMA-J AM MED ASSOC, V318, P713, DOI 10.1001/jama.2017.10565; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Gerdes AM, 2010, CIRCULATION, V122, P385, DOI 10.1161/CIRCULATIONAHA.109.917922; Givertz MM, 2017, J AM COLL CARDIOL, V70, P1875, DOI 10.1016/j.jacc.2017.08.010; Goldberg LR, 2006, CIRCULATION, V113, P2851, DOI 10.1161/CIRCULATIONAHA.105.600437; Goldenberg I, 2014, NEW ENGL J MED, V370, P1694, DOI 10.1056/NEJMoa1401426; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Hjalmarson A, 1999, LANCET, V353, P2001; Homma S, 2012, NEW ENGL J MED, V366, P1859, DOI 10.1056/NEJMoa1202299; Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kavalieratos D, 2017, J AM COLL CARDIOL, V70, P1919, DOI 10.1016/j.jacc.2017.08.036; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Kober L, 2016, NEW ENGL J MED, V375, P1221, DOI 10.1056/NEJMoa1608029; Lechat P, 1999, LANCET, V353, P9; Ledwidge M, 2013, JAMA-J AM MED ASSOC, V310, P66, DOI 10.1001/jama.2013.7588; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Lind M, 2011, LANCET, V378, P140, DOI 10.1016/S0140-6736(11)60471-6; Lindenfeld J, 2010, J CARD FAIL, V16, pe1, DOI DOI 10.1016/J.CARDFAIL.2010.04.004; Lip GYH, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003336.pub3; LOEB HS, 1993, CIRCULATION, V87, P78; Logeart D, 2004, J AM COLL CARDIOL, V43, P635, DOI 10.1016/j.jacc.2003.09.044; Maggioni AP, 2002, J AM COLL CARDIOL, V40, P1414, DOI 10.1016/S0735-1097(02)02304-5; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Masson S, 2008, J AM COLL CARDIOL, V52, P997, DOI 10.1016/j.jacc.2008.04.069; Matsue Y, 2017, J AM COLL CARDIOL, V69, P3042, DOI 10.1016/j.jacc.2017.04.042; Maurer MS, 2017, CIRCULATION, V135, P1357, DOI 10.1161/CIRCULATIONAHA.116.024438; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Morrison LK, 2002, J AM COLL CARDIOL, V39, P202, DOI 10.1016/S0735-1097(01)01744-2; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Nichols GA, 2013, J AM COLL CARDIOL, V62, P121, DOI 10.1016/j.jacc.2013.04.031; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Perry G, 1997, NEW ENGL J MED, V336, P525; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; Rawshani A, 2017, CIRCULATION, V135, P1522, DOI 10.1161/CIRCULATIONAHA.116.025961; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; Soliman EZ, 2017, CIRCULATION, V136, P440, DOI 10.1161/CIRCULATIONAHA.117.028441; SWEDBERG K, 1988, AM J CARDIOL, V62, pA60, DOI 10.1016/S0002-9149(88)80087-0; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Thrainsdottir IS, 2005, DIABETES CARE, V28, P612, DOI 10.2337/diacare.28.3.612; Walsh CR, 2002, ANN INTERN MED, V136, P181, DOI 10.7326/0003-4819-136-3-200202050-00005; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Whelton PK, 2017, HYPERTENSION, DOI 10.1016/j.jacc.2017.11.006; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S., 1992, NEW ENGL J MED, V327, P685, DOI [DOI 10.1056/NEJM199209033271003, 10.1056/NEJM199209033271003.Erratumin]; Zannad F, 2012, EUR HEART J, V33, P1049, DOI 10.1093/eurheartj/ehr437; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	78	7	10	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2018	168	11					ITC81	ITC95		10.7326/AITC201806050	http://dx.doi.org/10.7326/AITC201806050			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3EK	29868816				2022-12-28	WOS:000434254100001
J	Arnold, C				Arnold, Carrie			THE ANTI-POVERTY EXPERIMENT	NATURE			English	News Item																		CAN ELF, 2011, PUBLIC POLICY, V37, P283; Robertson L, 2013, LANCET, V381, P1283, DOI 10.1016/S0140-6736(12)62168-0	2	7	7	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					626	628		10.1038/d41586-018-05259-x	http://dx.doi.org/10.1038/d41586-018-05259-x			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29844547				2022-12-28	WOS:000433412900023
J	Williamson, J; Oakeshott, P; Dallimore, J				Williamson, Jonathan; Oakeshott, Pippa; Dallimore, Jon			Altitude sickness and acetazolamide	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE MOUNTAIN-SICKNESS; METAANALYSIS; PREVENTION		[Williamson, Jonathan] St George Hosp, London, England; [Oakeshott, Pippa] Univ London, St Georges Hosp, Populat Hlth Res Inst, London, England; [Dallimore, Jon] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England	St Georges University London; St Georges University London; University of London; Bristol Royal Infirmary	Williamson, J (corresponding author), St George Hosp, London, England.	jdwilliamson115@gmail.com		Oakeshott, Pippa/0000-0003-2568-8211				Burtscher M, 2014, INT J CLIN EXP MED, V7, P4378; Johnson C, 2015, OXFORD HDB EXPEDITIO, DOI [10.1093/med/9780199688418.001.0001, DOI 10.1093/MED/9780199688418.001.0001]; Kayser B, 2012, HIGH ALT MED BIOL, V13, P82, DOI 10.1089/ham.2011.1084; Low EV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6779; Luks AM, 2014, WILD ENVIRON MED, V25, pS4, DOI 10.1016/j.wem.2014.06.017; Milledge JS, 2008, PREEXISTING MED COND; Netzer N, 2013, J TRAVEL MED, V20, P247, DOI 10.1111/jtm.12017; Pesce C, 2005, HIGH ALT MED BIOL, V6, P158, DOI 10.1089/ham.2005.6.158	8	10	11	4	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2018	361								k2153	10.1136/bmj.k2153	http://dx.doi.org/10.1136/bmj.k2153			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MT	29853484				2022-12-28	WOS:000434276300003
J	Wood, RD				Wood, Richard D.			A catalyst for 50 years of cancer research	NATURE			English	Editorial Material							DNA-REPAIR; XERODERMA-PIGMENTOSUM; EXCISION NUCLEASE; THYMINE DIMERS; REPLICATION; MECHANISM; LIGHT	In 1968, a defect in DNA repair was found to underlie a disorder that makes people extremely sensitive to sunlight. This finding continues to influence research into the origins, diagnosis and treatment of cancer.	[Wood, Richard D.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center	Wood, RD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA.	rwood@mdanderson.org	Wood, Richard D/M-6319-2018	Wood, Richard D/0000-0002-9495-6892				ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; BOYCE RP, 1964, P NATL ACAD SCI USA, V51, P293, DOI 10.1073/pnas.51.2.293; Cleaver JE, 2011, DNA REPAIR, V10, P906, DOI 10.1016/j.dnarep.2011.04.004; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; DEWEERDK.EA, 1972, NATURE-NEW BIOL, V238, P80, DOI 10.1038/newbio238080a0; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Gavande NS, 2016, PHARMACOL THERAPEUT, V160, P65, DOI 10.1016/j.pharmthera.2016.02.003; Kaposi M., 1882, WIEN MED JB; Knijnenburg TA, 2018, CELL REP, V23, P239, DOI 10.1016/j.celrep.2018.03.076; Lederberg J., 1968, WASHINGTON POST 0608, pA13; Lehmann AR, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-70; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; Perlman D., 1967, SAN FRANCISCO CHRON, P4; PETTIJOHN DE, 1964, J MOL BIOL, V9, P395, DOI 10.1016/S0022-2836(64)80216-3; RASMUSSEN RE, 1964, NATURE, V203, P1360, DOI 10.1038/2031360a0; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; SETLOW RB, 1964, P NATL ACAD SCI USA, V51, P226, DOI 10.1073/pnas.51.2.226; Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031	19	5	5	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					648	649		10.1038/d41586-018-05255-1	http://dx.doi.org/10.1038/d41586-018-05255-1			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH4WT	29844546	Bronze			2022-12-28	WOS:000433412900039
J	Mann, A				Mann, Adam			B612 plans asteroid hunt with fleet of small satellites	SCIENCE			English	News Item																			0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					842	843		10.1126/science.360.6391.842	http://dx.doi.org/10.1126/science.360.6391.842			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798863				2022-12-28	WOS:000433039800021
J	Mimee, M; Nadeau, P; Hayward, A; Carim, S; Flanagan, S; Jerger, L; Collins, J; McDonnell, S; Swartwout, R; Citorik, RJ; Bulovic, V; Langer, R; Traverso, G; Chandrakasan, AP; Lu, TK				Mimee, Mark; Nadeau, Phillip; Hayward, Alison; Carim, Sean; Flanagan, Sarah; Jerger, Logan; Collins, Joy; McDonnell, Shane; Swartwout, Richard; Citorik, Robert J.; Bulovic, Vladimir; Langer, Robert; Traverso, Giovanni; Chandrakasan, Anantha P.; Lu, Timothy K.			An ingestible bacterial-electronic system to monitor gastrointestinal health	SCIENCE			English	Article							LAB-ON-CHIP; MAMMALIAN GUT; DIAGNOSTICS; EVOLUTION; SENSORS	Biomolecular monitoring in the gastrointestinal tract could offer rapid, precise disease detection and management but is impeded by access to the remote and complex environment. Here, we present an ingestible micro-bio-electronic device (IMBED) for in situ biomolecular detection based on environmentally resilient biosensor bacteria and miniaturized luminescence readout electronics that wirelessly communicate with an external device. As a proof of concept, we engineer heme-sensitive probiotic biosensors and demonstrate accurate diagnosis of gastrointestinal bleeding in swine. Additionally, we integrate alternative biosensors to demonstrate modularity and extensibility of the detection platform. IMBEDs enable new opportunities for gastrointestinal biomarker discovery and could transform the management and diagnosis of gastrointestinal disease.	[Mimee, Mark; Citorik, Robert J.] MIT, Microbiol Program, Cambridge, MA 02139 USA; [Mimee, Mark; Carim, Sean; Jerger, Logan; Citorik, Robert J.; Lu, Timothy K.] MIT, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Nadeau, Phillip; Flanagan, Sarah; Swartwout, Richard; Chandrakasan, Anantha P.; Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Hayward, Alison] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Hayward, Alison; McDonnell, Shane; Langer, Robert; Traverso, Giovanni] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Jerger, Logan] MassGen Hosp Children, Div Pediat Gastroentrol Hepatol & Nutr, Dept Pediat, Boston, MA 02114 USA; [Jerger, Logan] Harvard Med Sch, Boston, MA 02115 USA; [Langer, Robert; Traverso, Giovanni] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Traverso, Giovanni] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Lu, Timothy K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Nadeau, Phillip] Analog Devices Inc, Boston, MA 02110 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Analog Devices	Lu, TK (corresponding author), MIT, Synthet Biol Ctr, Cambridge, MA 02139 USA.; Chandrakasan, AP; Lu, TK (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.; Lu, TK (corresponding author), MIT, Dept Biol Engn, Cambridge, MA 02139 USA.	anantha@mtl.mit.edu; timlu@mit.edu	Traverso, Carlo Giovanni/ABC-9065-2020; Bulovic, Vladimir/U-5449-2019	Traverso, Carlo Giovanni/0000-0001-7851-4077; Citorik, Robert/0000-0002-6397-5417; Flanagan, Sarah/0000-0002-8670-6340; /0000-0002-7820-1625; Hayward, Alison/0000-0002-9581-8563; Mimee, Mark/0000-0002-0749-8054; /0000-0003-1603-3491; /0000-0002-3083-2671; Collins, Joy/0000-0002-9232-4517	Texas Instruments; Hong Kong Innovation and Technology Fund [ITS/195/14FP]; Office of Naval Research [N00014-13-1-0424]; NSF Biological Computing [1522074]; Center for Microbiome Informatics and Therapeutics [15127713]; Division of Gastroenterology, Brigham and Women's Hospital; NIH [EB-000244]; Qualcomm Innovation Fellowship; HHMI International Student Fellowship; Natural Sciences and Engineering Council of Canada Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000244, R37EB000244] Funding Source: NIH RePORTER	Texas Instruments; Hong Kong Innovation and Technology Fund; Office of Naval Research(Office of Naval Research); NSF Biological Computing; Center for Microbiome Informatics and Therapeutics; Division of Gastroenterology, Brigham and Women's Hospital; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qualcomm Innovation Fellowship; HHMI International Student Fellowship; Natural Sciences and Engineering Council of Canada Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Supported by Texas Instruments (A.P.C.); the Hong Kong Innovation and Technology Fund (ITS/195/14FP) (A.P.C. and T.K.L.); Office of Naval Research (N00014-13-1-0424) (T.K.L.); NSF Biological Computing (1522074) (T.K.L.); the Center for Microbiome Informatics and Therapeutics (15127713) (T.K.L.); Division of Gastroenterology, Brigham and Women's Hospital (G.T.); NIH (EB-000244) (R.L.); the Qualcomm Innovation Fellowship (M.M. and P.N.); the HHMI International Student Fellowship (M.M.); and the Natural Sciences and Engineering Council of Canada Fellowship (P.N.). We also thank the TSMC University Shuttle Program for chip fabrication.	Barkun A, 2003, ANN INTERN MED, V139, P843, DOI 10.7326/0003-4819-139-10-200311180-00012; Bellinger AM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag2374; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; Close D, 2012, SENSORS-BASEL, V12, P732, DOI 10.3390/s120100732; Courbet A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3601; Daeffler KNM, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167416; Eltoukhy H, 2006, IEEE J SOLID-ST CIRC, V41, P651, DOI 10.1109/JSSC.2006.869785; Hafezi H, 2015, IEEE T BIO-MED ENG, V62, P99, DOI 10.1109/TBME.2014.2341272; Hwang IY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15028; Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Kirtane AR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02294-6; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Lanas A, 2017, LANCET, V390, P613, DOI 10.1016/S0140-6736(16)32404-7; Lechardeur D, 2012, J BIOL CHEM, V287, P4752, DOI 10.1074/jbc.M111.297531; Lim B, 2017, CELL, V169, P547, DOI 10.1016/j.cell.2017.03.045; Mimee M, 2015, CELL SYST, V1, P62, DOI 10.1016/j.cels.2015.06.001; Nadeau P, 2017, ISSCC DIG TECH PAP I, P352, DOI 10.1109/ISSCC.2017.7870406; Nobles CL, 2015, J MICROBIOL METH, V118, P7, DOI 10.1016/j.mimet.2015.07.011; Norian H, 2014, LAB CHIP, V14, P4076, DOI 10.1039/c4lc00443d; Otis B., 2014, GOOGLE OFF BLOG; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Riglar DT, 2017, NAT BIOTECHNOL, V35, P653, DOI 10.1038/nbt.3879; Rockey DC, 1998, NEW ENGL J MED, V339, P153, DOI 10.1056/NEJM199807163390303; Roggo C, 2017, CURR OPIN BIOTECH, V45, P24, DOI 10.1016/j.copbio.2016.11.023; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; Singh RR, 2012, IEEE J SOLID-ST CIRC, V47, P2822, DOI 10.1109/JSSC.2012.2214182; Slomovic S, 2015, P NATL ACAD SCI USA, V112, P14429, DOI 10.1073/pnas.1508521112; van der Schaar PJ, 2013, GASTROINTEST ENDOSC, V78, P520, DOI 10.1016/j.gie.2013.03.170; Wang H, 2013, IEEE MICROW MAG, V14, P110, DOI 10.1109/MMM.2013.2259402	30	227	239	30	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					915	918		10.1126/science.aas9315	http://dx.doi.org/10.1126/science.aas9315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798884	Green Accepted, Green Published			2022-12-28	WOS:000433039800050
J	Jones, CD; Burke, RE				Jones, Christine D.; Burke, Robert E.			Inpatient Notes: Getting Past the "Black Box"-Opportunities for Hospitalists to Improve Postacute Care Transitions	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Jones, Christine D.; Burke, Robert E.] Univ Colorado, Sch Med, Aurora, CO 80045 USA; [Burke, Robert E.] Dept Vet Affairs Med Ctr, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Jones, CD (corresponding author), Univ Colorado, Sch Med, Div Hosp Med, Dept Med, 12401 East 17th Ave, Aurora, CO 80045 USA.	christine.jones@ucdenver.edu		Burke, Robert/0000-0002-9521-8699	Agency for Healthcare Research and Quality [K08HS024569]; Veterans Affairs Health Services Research and Development Career Development Award; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS024569] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Veterans Affairs Health Services Research and Development Career Development Award(US Department of Veterans Affairs); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: Dr. Jones is supported by grant K08HS024569 from the Agency for Healthcare Research and Quality. Dr. Burke is supported by a Veterans Affairs Health Services Research and Development Career Development Award.	Burke RE, 2017, J AM GERIATR SOC, V65, P2466, DOI 10.1111/jgs.14954; Jones CD, 2017, J GEN INTERN MED, V32, P1114, DOI 10.1007/s11606-017-4104-0; Jones CD, 2017, J AM MED DIR ASSOC, V18, P70, DOI 10.1016/j.jamda.2016.09.009; Moore AB, 2017, AM J MED, V130, P1199, DOI 10.1016/j.amjmed.2017.04.041; Vasilevskis EE, 2017, J AM GERIATR SOC, V65, P269, DOI 10.1111/jgs.14557	5	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					HO2	HO3		10.7326/M18-0940	http://dx.doi.org/10.7326/M18-0940			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3DE	29800449	Green Accepted			2022-12-28	WOS:000434250700001
J	[Anonymous]				[Anonymous]			New Physician Requirements to Use Permanent Birth Control Device	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					1974	1974		10.1001/jama.2018.5587	http://dx.doi.org/10.1001/jama.2018.5587			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800197				2022-12-28	WOS:000432238300006
J	Dhruva, SS; Ross, JS; Schulz, WL; Krumholz, HM				Dhruva, Sanket S.; Ross, Joseph S.; Schulz, Wade L.; Krumholz, Harlan M.			Fulfilling the Promise of Unique Device Identifiers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IDENTIFICATION		[Dhruva, Sanket S.] Yale Sch Med, Natl Clinician Scholars Program, New Haven, CT USA; [Dhruva, Sanket S.] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA; [Ross, Joseph S.] Yale Sch Publ Hlth, Yale Sch Med, Natl Clinician Scholars Program, New Haven, CT USA; [Ross, Joseph S.; Schulz, Wade L.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Schulz, Wade L.; Krumholz, Harlan M.] Yale Sch Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Yale Sch Publ Hlth, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), 1 Church St,Suite 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020; Schulz, Wade/N-8029-2013	Schulz, Wade/0000-0002-2048-4028; Ross, Joseph/0000-0002-9218-3320	Department of Veterans Affairs; Yale, from the Food and Drug Administration [U01FD005938]; Agency for Healthcare Research and Quality [R01HS022882]; National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HS025164]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS025164, R01HS022882] Funding Source: NIH RePORTER; FOOD AND DRUG ADMINISTRATION [U01FD005938] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Yale, from the Food and Drug Administration; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	Dr. Dhruva is supported by the Department of Veterans Affairs. Dr. Ross has received research support, through Yale, from the Food and Drug Administration to establish the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (U01FD005938); from the Agency for Healthcare Research and Quality (R01HS022882); and from the National Heart, Lung, and Blood Institute of the National Institutes of Health (R01HS025164).	Department of Health and Human Services, 2013, UN DEV ID SYST; Department of Health and Human Services Office of the Inspector General, 2017, SHORT DEV CLAIMS CLA; Drozda JP, 2016, HEALTHCARE-J DEL SCI, V4, P116, DOI 10.1016/j.hjdsi.2015.07.002; Medicare Payment Advisor Commision, 2017, OV MED DEV IND, P207; Moscovitch B, 2017, JAMA-J AM MED ASSOC, V318, P1936, DOI 10.1001/jama.2017.15146; US Food and Drug Administration, IS PROD MED DEV	6	9	9	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2018	169	3					183	+		10.7326/M18-0526	http://dx.doi.org/10.7326/M18-0526			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ0AJ	29868760				2022-12-28	WOS:000441277700007
J	Shiels, MS; Islam, JY; Rosenberg, PS; Hall, HI; Jacobson, E; Engels, EA				Shiels, Meredith S.; Islam, Jessica Y.; Rosenberg, Philip S.; Hall, H. Irene; Jacobson, Evin; Engels, Eric A.			Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS-DEFINING CANCERS; LUNG-CANCER; ANTIRETROVIRAL THERAPY; TRANSPLANT RECIPIENTS; RISK-FACTORS; TIME TRENDS; INDIVIDUALS; METAANALYSIS; MORTALITY	Background: Persons living with HIV (PLWH) have an elevated risk for certain types of cancer. With modern antiretroviral therapy, PLWH are aging and cancer rates are changing. Objective: To project cancer incidence rates and burden (number of new cancer diagnoses) among adult PLWH in the United States through 2030. Design: Descriptive. Setting: HIV/AIDS Cancer Match Study to project cancer rates and HIV Optimization and Prevention Economics model to project HIV prevalence. Participants: HIV-infected adults. Measurements: Projected cancer rates and burden among HIV-infected adults in the United States by age during 2006 to 2030 for AIDS-defining cancer (ADC)-that is, Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer-and certain types of non-AIDS-defining cancer (NADC). All other cancer types were combined. Results: The proportion of adult PLWH in the United States aged 65 years or older is projected to increase from 8.5% in 2010 to 21.4% in 2030. Age-specific rates are projected to decrease through 2030 across age groups for Kaposi sarcoma, non-Hodgkin lymphoma, cervical cancer, lung cancer, Hodgkin lymphoma, and other cancer types combined, and among those aged 65 years or older for colon cancer. Prostate cancer rates are projected to increase. The estimated total cancer burden in PLWH will decrease from 8150 cases in 2010 (2730 of ADC and 5420 of NADC) to 6690 cases in 2030 (720 of ADC and 5980 of NADC). In 2030, prostate cancer (n = 1590) and lung cancer (n = 1030) are projected to be the most common cancer types. Limitation: Projections assume that current trends in cancer incidence rates, HIV transmission, and survival will continue. Conclusion: The cancer burden among PLWH is projected to shift, with prostate and lung cancer expected to emerge as the most common types by 2030. Cancer will remain an important comorbid condition, and expanded access to HIV therapies and cancer prevention, screening, and treatment is needed.	[Shiels, Meredith S.; Islam, Jessica Y.; Rosenberg, Philip S.; Engels, Eric A.] NCI, Rockville, MD USA; [Islam, Jessica Y.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Hall, H. Irene; Jacobson, Evin] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA	Shiels, MS (corresponding author), NCI, NIH, 9609 Med Ctr Dr,Room 6E218,MSC 9767, Bethesda, MD 20892 USA.	shielsms@mail.nih.gov		Rosenberg, Philip/0000-0001-6349-9126; Islam, Jessica/0000-0002-3690-3848	Intramural Research Program of the National Cancer Institute; SEER Program of the National Cancer Institute: Connecticut [HHSN261201300019I]; SEER Program of the National Cancer Institute: New Jersey [HHSN261201300021I, N01-PC-2013-00021]; National Program of Cancer Registries of the Center for Disease Control and Prevention: Colorado [NU58DP006347-01]; National Program of Cancer Registries of the Center for Disease Control and Prevention: Georgia [5U58DP003875-01]; National Program of Cancer Registries of the Center for Disease Control and Prevention: Maryland [5NU58DP003919-05-00]; National Program of Cancer Registries of the Center for Disease Control and Prevention: Michigan [17NU58DP006334]; National Program of Cancer Registries of the Center for Disease Control and Prevention: New Jersey [NU58/DP003931-05-00]; National Program of Cancer Registries of the Center for Disease Control and Prevention: New York [U58/DP003879]; National Program of Cancer Registries of the Center for Disease Control and Prevention: Texas [1NU58DP006308]; state of New Jersey; state of Maryland; Maryland Cigarette Restitution Fund; state of New York; National HIV Surveillance System of the Center for Disease Control and Prevention HIV Incidence and Case Surveillance Branch: Colorado [NU62PS003960]; National HIV Surveillance System of the Center for Disease Control and Prevention HIV Incidence and Case Surveillance Branch: Connecticut [5U62PS001005-05]; National HIV Surveillance System of the Center for Disease Control and Prevention HIV Incidence and Case Surveillance Branch: Michigan [U62PS004011-02]; National HIV Surveillance System of the Center for Disease Control and Prevention HIV Incidence and Case Surveillance Branch: New Jersey [U62PS004001-2]; NATIONAL CANCER INSTITUTE [ZIACP010150] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SEER Program of the National Cancer Institute: Connecticut; SEER Program of the National Cancer Institute: New Jersey; National Program of Cancer Registries of the Center for Disease Control and Prevention: Colorado; National Program of Cancer Registries of the Center for Disease Control and Prevention: Georgia; National Program of Cancer Registries of the Center for Disease Control and Prevention: Maryland; National Program of Cancer Registries of the Center for Disease Control and Prevention: Michigan; National Program of Cancer Registries of the Center for Disease Control and Prevention: New Jersey; National Program of Cancer Registries of the Center for Disease Control and Prevention: New York; National Program of Cancer Registries of the Center for Disease Control and Prevention: Texas; state of New Jersey; state of Maryland; Maryland Cigarette Restitution Fund; state of New York; National HIV Surveillance System of the Center for Disease Control and Prevention HIV Incidence and Case Surveillance Branch: Colorado; National HIV Surveillance System of the Center for Disease Control and Prevention HIV Incidence and Case Surveillance Branch: Connecticut; National HIV Surveillance System of the Center for Disease Control and Prevention HIV Incidence and Case Surveillance Branch: Michigan; National HIV Surveillance System of the Center for Disease Control and Prevention HIV Incidence and Case Surveillance Branch: New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	In part by the Intramural Research Program of the National Cancer Institute. The following cancer registries were supported by the SEER Program of the National Cancer Institute: Connecticut (HHSN261201300019I) and New Jersey (HHSN261201300021I; N01-PC-2013-00021). The following cancer registries were supported by the National Program of Cancer Registries of the Centers for Disease Control and Prevention: Colorado (NU58DP006347-01), Georgia (5U58DP003875-01), Maryland (5NU58DP003919-05-00), Michigan (17NU58DP006334), New Jersey (NU58/DP003931-05-00), New York (U58/DP003879), and Texas (1NU58DP006308). The New Jersey State Cancer Registry was also supported by the state of New Jersey, the Maryland Cancer Registry was also supported by the state of Maryland and the Maryland Cigarette Restitution Fund, and the New York State Cancer Registry was also supported by the state of New York. The following HIV registries were supported by the National HIV Surveillance System of the Centers for Disease Control and Prevention HIV Incidence and Case Surveillance Branch: Colorado (NU62PS003960), Connecticut (5U62PS001005-05), Michigan (U62PS004011-02), and New Jersey (U62PS004001-2).	[Anonymous], C RETR OPP INF SEATT; [Anonymous], 2016, SEER STAT DAT INC SE; Centers for Disease Control and Prevention, 2009, HIV AIDS SURV REP, V19; Centers for Disease Control and Prevention, 2016, HIV AIDS SURV REP, V27; Coghill AE, 2018, JNCI-J NATL CANCER I, V110, P959, DOI 10.1093/jnci/djy010; Coghill AE, 2015, J CLIN ONCOL, V33, P2376, DOI 10.1200/JCO.2014.59.5967; Dinenno Elizabeth A, 2012, Open AIDS J, V6, P169, DOI 10.2174/1874613601206010169; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hernandez-Ramirez RU, 2017, LANCET HIV, V4, pE495, DOI 10.1016/S2352-3018(17)30125-X; Hleyhel M, 2014, AIDS, V28, P2109, DOI 10.1097/QAD.0000000000000382; Jacobson EU, 2018, J PUBLIC HEALTH MAN, V24, pE1, DOI [10.1097/phh.0000000000000717, 10.1097/PHH.0000000000000717]; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; O'Leary A, 2017, AIDS BEHAV, V21, P2895, DOI 10.1007/s10461-016-1635-z; Panel on Antiretroviral Guidelines for Adults and Adolescents; Department of Health and Human Services, 2015, GUIDELINES USE ANTIR; Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, 2016, GUID PREV TREATM OPP; Park LS, 2016, AIDS, V30, P1795, DOI 10.1097/QAD.0000000000001112; Park LS, 2016, AIDS, V30, P273, DOI 10.1097/QAD.0000000000000922; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Robbins HA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju503; Robbins HA, 2014, AIDS, V28, P881, DOI 10.1097/QAD.0000000000000163; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Shiels MS, 2017, CURR OPIN HIV AIDS, V12, P6, DOI 10.1097/COH.0000000000000327; Shiels MS, 2015, CANCER-AM CANCER SOC, V121, P2063, DOI 10.1002/cncr.29324; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shiels MS, 2010, JAIDS-J ACQ IMM DEF, V55, P510, DOI 10.1097/QAI.0b013e3181f53783; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Sigel K, 2017, LANCET HIV, V4, pE67, DOI 10.1016/S2352-3018(16)30215-6; Sigel K, 2012, AIDS, V26, P1017, DOI 10.1097/QAD.0b013e328352d1ad; Sorensen SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029098; Suneja G, 2016, CANCER-AM CANCER SOC, V122, P2399, DOI 10.1002/cncr.30052; Suneja G, 2014, J CLIN ONCOL, V32, P2344, DOI 10.1200/JCO.2013.54.8644; Wilkin T, 2010, J INFECT DIS, V202, P1246, DOI 10.1086/656320; World Health Organization, 2000, INT CLASSIFICATION D; Worm SW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-471	35	73	73	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2018	168	12					866	+		10.7326/M17-2499	http://dx.doi.org/10.7326/M17-2499			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK1TE	29801099	Green Accepted			2022-12-28	WOS:000435903500016
J	Reardon, PK; Seidlitz, J; Vandekar, S; Liu, SY; Patel, R; Park, MTM; Alexander-Bloch, A; Clasen, LS; Blumenthal, JD; Lalonde, FM; Giedd, JN; Gur, RC; Gur, RE; Lerch, JP; Chakravarty, MM; Satterthwaite, TD; Shinohara, RT; Raznahan, A				Reardon, P. K.; Seidlitz, Jakob; Vandekar, Simon; Liu, Siyuan; Patel, Raihaan; Park, Min Tae M.; Alexander-Bloch, Aaron; Clasen, Liv S.; Blumenthal, Jonathan D.; Lalonde, Francois M.; Giedd, Jay N.; Gur, Ruben C.; Gur, Raquel E.; Lerch, Jason P.; Chakravarty, M. Mallar; Satterthwaite, Theodore D.; Shinohara, Russell T.; Raznahan, Armin			Normative brain size variation and brain shape diversity in humans	SCIENCE			English	Article							CEREBRAL-CORTEX; ORGANIZATION; NETWORK; EXPANSION; EVOLUTION	Brain size variation over primate evolution and human development is associated with shifts in the proportions of different brain regions. Individual brain size can vary almost twofold among typically developing humans, but the consequences of this for brain organization remain poorly understood. Using in vivo neuroimaging data from more than 3000 individuals, we find that larger human brains show greater areal expansion in distributed frontoparietal cortical networks and related subcortical regions than in limbic, sensory, and motor systems. This areal redistribution recapitulates cortical remodeling across evolution, manifests by early childhood in humans, and is linked to multiple markers of heightened metabolic cost and neuronal connectivity. Thus, human brain shape is systematically coupled to naturally occurring variations in brain size through a scaling map that integrates spatiotemporally diverse aspects of neurobiology.	[Reardon, P. K.; Seidlitz, Jakob; Liu, Siyuan; Clasen, Liv S.; Blumenthal, Jonathan D.; Lalonde, Francois M.; Raznahan, Armin] NIMH, Dev Neurogen Unit, NIH, Bethesda, MD 20892 USA; [Reardon, P. K.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Reardon, P. K.] Vagelos Coll Phys & Surg, New York, NY USA; [Seidlitz, Jakob] Univ Cambridge, Dept Psychiat, Cambridge, England; [Vandekar, Simon; Shinohara, Russell T.] Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Patel, Raihaan; Park, Min Tae M.; Chakravarty, M. Mallar] Douglas Mental Hlth Univ Inst, Cerebral Imaging Ctr, Montreal, PQ, Canada; [Patel, Raihaan; Chakravarty, M. Mallar] McGill Univ, Dept Biol & Biomed Engn, Montreal, PQ, Canada; [Park, Min Tae M.] Western Univ, Schulich Sch Med & Dent, London, ON, Canada; [Alexander-Bloch, Aaron] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Giedd, Jay N.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Gur, Ruben C.; Gur, Raquel E.; Satterthwaite, Theodore D.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Lerch, Jason P.] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Oxford; University of Cambridge; University of Pennsylvania; McGill University; Western University (University of Western Ontario); Yale University; University of California System; University of California San Diego; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Raznahan, A (corresponding author), NIMH, Dev Neurogen Unit, NIH, Bethesda, MD 20892 USA.	raznahana@mail.nih.gov	Seidlitz, Jakob/K-9360-2019; Raznahan, Armin/F-4534-2012; Gur, Ruben/K-1999-2019; Giedd, Jay/J-9644-2015	Seidlitz, Jakob/0000-0002-8164-7476; Raznahan, Armin/0000-0002-5622-1190; Gur, Ruben/0000-0002-9657-1996; Reardon, PK/0000-0002-2461-1004; Lalonde, Francois/0000-0002-4945-0032; Vandekar, Simon/0000-0002-7457-9073; Park, Min Tae/0000-0002-4268-7432; Giedd, Jay/0000-0003-2002-8978; Liu, Siyuan/0000-0003-3661-6248	NIMH [ZIA MH002794, R01MH107235, R01NS085211, R01NS060910, R01MH112847, R01MH107703]; McDonnell Center for Systems Neuroscience at Washington University; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002794, R01MH107703, R01MH112847, U54MH091657, ZIAMH002949, R01MH107235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085211, R01NS060910] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); McDonnell Center for Systems Neuroscience at Washington University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was partially funded by the NIMH Intramural (ZIA MH002794, PI A.R.) and Extramural (R01MH107235, R01NS085211, R01NS060910, R01MH112847, and R01MH107703, PIs S.V., R.C.G., R.E.G., T.D.S., and R.T.S.) Research Programs. Data were provided in part by the Human Connectome Project, WU-Minn Consortium (PIs: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University.	Ad-Dabbagh Y, 2006, P 12 ANN M ORG HUM B; Cahalane DJ, 2012, FRONT NEUROANAT, V6, P1, DOI 10.3389/fnana.2012.00028; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elston GN, 2003, CEREB CORTEX, V13, P1124, DOI 10.1093/cercor/bhg093; Elston GN, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00078; Giedd JN, 2015, NEUROPSYCHOPHARMACOL, V40, P43, DOI 10.1038/npp.2014.236; Glasser MF, 2014, NEUROIMAGE, V93, P165, DOI 10.1016/j.neuroimage.2013.03.060; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hill J, 2010, P NATL ACAD SCI USA, V107, P13135, DOI 10.1073/pnas.1001229107; Huxley JS, 1924, NATURE, V114, P895, DOI 10.1038/114895a0; Kuzawa CW, 2014, P NATL ACAD SCI USA, V111, P13010, DOI 10.1073/pnas.1323099111; Mankiw C, 2017, J NEUROSCI, V37, P5221, DOI 10.1523/JNEUROSCI.2158-16.2017; Margulies DS, 2016, P NATL ACAD SCI USA, V113, P12574, DOI 10.1073/pnas.1608282113; Medaglia JD, 2015, J COGNITIVE NEUROSCI, V27, P1471, DOI 10.1162/jocn_a_00810; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Rubinov M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13812; Satterthwaite TD, 2014, P NATL ACAD SCI USA, V111, P8643, DOI 10.1073/pnas.1400178111; Satterthwaite TD, 2014, NEUROIMAGE, V86, P544, DOI 10.1016/j.neuroimage.2013.07.064; Sipser M, 2006, INTRO THEORY COMPUTA; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Stasinopoulos M., 2007, BIOMETRICS, V63, P1298; von Economo C, 1925, CYTOARCHITEKTONIK HI; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	23	92	92	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2018	360	6394					1222	1226		10.1126/science.aar2578	http://dx.doi.org/10.1126/science.aar2578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ4OM	29853553	Green Accepted, Green Submitted			2022-12-28	WOS:000435360400051
J	Cook, DA; Sherbino, J; Durning, SJ				Cook, David A.; Sherbino, Jonathan; Durning, Steven J.			Management Reasoning Beyond the Diagnosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cook, David A.] Mayo Clin, Off Appl Scholarship & Educ Sci, Coll Med, Rochester, MN USA; [Cook, David A.] Mayo Clin, Div Gen Internal Med, Rochester, MN USA; [Sherbino, Jonathan] McMaster Univ, McMaster Educ Res Innovat & Theory, Fac Hlth Sci, Hamilton, ON, Canada; [Durning, Steven J.] Uniformed Serv Univ Hlth Sci, Div Hlth Profess Educ, Bethesda, MD 20814 USA	Mayo Clinic; Mayo Clinic; McMaster University; Uniformed Services University of the Health Sciences - USA	Cook, DA (corresponding author), Mayo Clin, Coll Med, Div Gen Internal Med, 200 First St SW,Mayo 17-W, Rochester, MN 55905 USA.	cook.david33@mayo.edu						Balogh EP, 2015, IMPR DIAGN HLTH CAR; Durning SJ, 2013, ACAD MED, V88, P442, DOI [10.1097/ACM.0b013e3182851b5b, 10.1097/ACM.0b013e3182953763]; Gruppen LD, 2002, INT HDB RES MED ED, P205; Ilgen JS, 2016, J GEN INTERN MED, V31, P435, DOI 10.1007/s11606-016-3592-7; McBee E, 2016, ACAD MED, V91, P1022, DOI 10.1097/ACM.0000000000001024; Mercuri M, 2015, ACAD MED, V90, P191, DOI 10.1097/ACM.0000000000000542; Norman G, 2005, MED EDUC, V39, P418, DOI 10.1111/j.1365-2929.2005.02127.x	7	61	61	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2018	319	22					2267	2268		10.1001/jama.2018.4385	http://dx.doi.org/10.1001/jama.2018.4385			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2UP	29800012	Bronze			2022-12-28	WOS:000435129300008
J	Goldfarb, B				Goldfarb, Ben			BEAVERS, REBOOTED	SCIENCE			English	Editorial Material																			0	9	9	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1058	1061		10.1126/science.360.6393.1058	http://dx.doi.org/10.1126/science.360.6393.1058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI6TJ	29880669				2022-12-28	WOS:000434635500015
J	Broglio, K				Broglio, Kristine			Randomization in Clinical Trials Permuted Blocks and Stratification	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALLOCATION		[Broglio, Kristine] Berry Consultants LLC, 3345 Bee Caves Rd,Ste 201, Austin, TX 78746 USA		Broglio, K (corresponding author), Berry Consultants LLC, 3345 Bee Caves Rd,Ste 201, Austin, TX 78746 USA.	kristine@berryconsultants.com						Bilecen S, 2017, JAMA-J AM MED ASSOC, V317, P738, DOI 10.1001/jama.2016.21037; Hey SP, 2014, NEUROLOGY, V82, P77, DOI 10.1212/01.wnl.0000438226.10353.1c; Kernan WN, 1999, J CLIN EPIDEMIOL, V52, P19, DOI 10.1016/S0895-4356(98)00138-3; Kim YW, 2017, JAMA-J AM MED ASSOC, V317, P2097, DOI 10.1001/jama.2017.5703; LACHIN JM, 1988, CONTROL CLIN TRIALS, V9, P289, DOI 10.1016/0197-2456(88)90045-1; LACHIN JM, 1988, CONTROL CLIN TRIALS, V9, P365, DOI 10.1016/0197-2456(88)90049-9; MATTS JP, 1988, CONTROL CLIN TRIALS, V9, P327, DOI 10.1016/0197-2456(88)90047-5; POCOCK SJ, 1979, BIOMETRICS, V35, P183, DOI 10.2307/2529944; THERNEAU TM, 1993, CONTROL CLIN TRIALS, V14, P98, DOI 10.1016/0197-2456(93)90013-4; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	10	94	94	4	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2223	2224		10.1001/jama.2018.6360	http://dx.doi.org/10.1001/jama.2018.6360			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29872845				2022-12-28	WOS:000434133400020
J	Robinson, JC; Howell, S; Pearson, SD				Robinson, James C.; Howell, Scott; Pearson, Steven D.			Value-Based Pricing and Patient Access for Specialty Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Robinson, James C.] Univ Calif Berkeley, 247 Univ Hall, Berkeley, CA 94720 USA; [Howell, Scott] Novartis Pharmaceut, E Hanover, NJ USA; [Pearson, Steven D.] Inst Clin & Econ Review, Boston, MA USA	University of California System; University of California Berkeley; Novartis	Robinson, JC (corresponding author), Univ Calif Berkeley, 247 Univ Hall, Berkeley, CA 94720 USA.	James.Robinson@Berkeley.edu		Robinson, James/0000-0003-0056-3017	Blue Shield of California Foundation; California Health Care Foundation; Laura and John Arnold Foundation; Aetna; America's Health Insurance Plans; Anthem; Blue Shield of California; CVS Caremark; Express Scripts; Harvard Pilgrim Health Care; OmedaRx; United Healthcare; Kaiser Permanente; Prernera; AstraZeneca; Genentech; GlaxoSmithKline; Johnson Johnson; Merck; National Pharmaceutical Council; Prime Therapeutics; Sanofi; Novartis; Spark Therapeutics; Health Care Service Corp; Editas; Alnylam	Blue Shield of California Foundation; California Health Care Foundation; Laura and John Arnold Foundation; Aetna; America's Health Insurance Plans; Anthem; Blue Shield of California; CVS Caremark; Express Scripts; Harvard Pilgrim Health Care; OmedaRx; United Healthcare; Kaiser Permanente; Prernera; AstraZeneca(AstraZeneca); Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Merck(Merck & Company); National Pharmaceutical Council; Prime Therapeutics; Sanofi; Novartis(Novartis); Spark Therapeutics; Health Care Service Corp; Editas; Alnylam	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest Dr Howell reported being previously employed by Jazz Pharmaceuticals and Cardinal Health; being currently employed by Novartis Pharmaceuticals Corp; and owning a number of health care-related stocks, including pharmaceutical manufacturers, pharmacy benefit managers, and insurance companies. Dr Pearson is president of the Institute for Clinical and Economic Review, which receives funding from Blue Shield of California Foundation, California Health Care Foundation, and Laura and John Arnold Foundation; other funding from Aetna, America's Health Insurance Plans, Anthem, Blue Shield of California, CVS Caremark, Express Scripts, Harvard Pilgrim Health Care, OmedaRx, United Healthcare, Kaiser Permanente, Prernera, AstraZeneca, Genentech, GlaxoSmithKline, Johnson & Johnson, Merck, National Pharmaceutical Council, Prime Therapeutics, Sanofi, Novartis, Spark Therapeutics, Prime Therapeutics, Health Care Service Corp, Editas, and Alnylam. No other disclosures were reported.	American Medical Association, 2017, 2016 AMA PRIOR AUTH; Claxton G, EMPLOYER HLTH BENEFI; Hoadley J, 2006, MEDICARE D; Howard DH, 2015, J ECON PERSPECT, V29, P139, DOI 10.1257/jep.29.1.139; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237; Langreth R, BLOOMBERG	6	20	20	3	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2169	2170		10.1001/jama.2018.5367	http://dx.doi.org/10.1001/jama.2018.5367			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29801023				2022-12-28	WOS:000434133400011
J	Voelker, R				Voelker, Rebecca			FDA Blitz on Nicotine Product Sales to Minors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2164	2164		10.1001/jama.2018.6923	http://dx.doi.org/10.1001/jama.2018.6923			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29872843				2022-12-28	WOS:000434133400007
J	Foo, JL; Chang, MW				Foo, Jee Loon; Chang, Matthew Wook			Yeast shuffles towards a diverse future	NATURE			English	Editorial Material							CHROMOSOME	A redesigned yeast genome is being constructed to allow it to be extensively rearranged on demand. A suite of studies reveals the versatility of the genome-shuffling system, and shows how it could be used for biotechnology applications.	[Foo, Jee Loon; Chang, Matthew Wook] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117456, Singapore; [Foo, Jee Loon; Chang, Matthew Wook] Natl Univ Singapore, NUS Synthet Biol Clin & Technol Innovat SynCTI, Ctr Life Sci, Singapore 117456, Singapore	National University of Singapore; National University of Singapore	Chang, MW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117456, Singapore.; Chang, MW (corresponding author), Natl Univ Singapore, NUS Synthet Biol Clin & Technol Innovat SynCTI, Ctr Life Sci, Singapore 117456, Singapore.	bchcmw@nus.edu.sg		Foo, Jee Loon/0000-0002-9900-0224				Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Blount BA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03143-w; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Enyeart PJ, 2011, NATURE, V477, P413, DOI 10.1038/477413a; Hochrein L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02208-6; Jia B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03084-4; Liu W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04254-0; Luo ZQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-00806-y; Shen MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04157-0; Shen Y, 2016, GENOME RES, V26, P36, DOI 10.1101/gr.193433.115; van der Sloot A, 2017, MOL CELL, V66, P441, DOI 10.1016/j.molcel.2017.05.007; Wu Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03743-6	12	9	9	6	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					647	648		10.1038/d41586-018-05164-3	http://dx.doi.org/10.1038/d41586-018-05164-3			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH4WT	29805162	Bronze			2022-12-28	WOS:000433412900038
J	Menon, R				Menon, Rajgopalan			The NHS owes doctors who trained abroad an apology for racism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Racial abuse was ubiquitous but the NHS offered a total lack of support, writes Rajgopalan Menon, reflecting on a 40-odd year career as a GP.				menonsnr@btinternet.com							0	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2018	361								k2360	10.1136/bmj.k2360	http://dx.doi.org/10.1136/bmj.k2360			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MT	29853542				2022-12-28	WOS:000434276300009
J	Ni, GX; McLeod, AS; Sun, Z; Wang, L; Xiong, L; Post, KW; Sunku, SS; Jiang, BY; Hone, J; Dean, CR; Fogler, MM; Basov, DN				Ni, G. X.; McLeod, A. S.; Sun, Z.; Wang, L.; Xiong, L.; Post, K. W.; Sunku, S. S.; Jiang, B-Y; Hone, J.; Dean, C. R.; Fogler, M. M.; Basov, D. N.			Fundamental limits to graphene plasmonics	NATURE			English	Article							BORON-NITRIDE; POLARITONS; SUPERLATTICES; CONDUCTIVITY; LAYER	Plasmon polaritons are hybrid excitations of light and mobile electrons that can confine the energy of long-wavelength radiation at the nanoscale. Plasmon polaritons may enable many enigmatic quantum effects, including lasing(1), topological protection(2,3) and dipole-forbidden absorption(4). A necessary condition for realizing such phenomena is a long plasmonic lifetime, which is notoriously difficult to achieve for highly confined modes(5). Plasmon polaritons in graphene-hybrids of Dirac quasiparticles and infrared photons-provide a platform for exploring light-matter interaction at the nanoscale(6,7). However, plasmonic dissipation in graphene is substantial(8) and its fundamental limits remain undetermined. Here we use nanometre-scale infrared imaging to investigate propagating plasmon polaritons in high-mobility encapsulated graphene at cryogenic temperatures. In this regime, the propagation of plasmon polaritons is primarily restricted by the dielectric losses of the encapsulated layers, with a minor contribution from electron-phonon interactions. At liquid-nitrogen temperatures, the intrinsic plasmonic propagation length can exceed 10 micrometres, or 50 plasmonic wavelengths, thus setting a record for highly confined and tunable polariton modes. Our nanoscale imaging results reveal the physics of plasmonic dissipation and will be instrumental in mitigating such losses in heterostructure engineering applications.	[Ni, G. X.; McLeod, A. S.; Xiong, L.; Sunku, S. S.; Dean, C. R.; Basov, D. N.] Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA; [Ni, G. X.; McLeod, A. S.; Sun, Z.; Xiong, L.; Post, K. W.; Jiang, B-Y; Fogler, M. M.; Basov, D. N.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Wang, L.; Hone, J.] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Sunku, S. S.] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY USA	Columbia University; University of California System; University of California San Diego; Columbia University; Columbia University	Basov, DN (corresponding author), Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA.; Basov, DN (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	db3056@columbia.edu	Ni, Guangxin/AAE-6412-2019; Fogler, Michael M/O-4610-2017; Hone, James C/E-1879-2011; Wang, Lei/K-1160-2012; Sun, Zhiyuan/AAZ-5050-2020; Xiong, Lin/GZL-9582-2022	Fogler, Michael M/0000-0001-8239-7221; Hone, James C/0000-0002-8084-3301; Wang, Lei/0000-0002-1919-9107; Sun, Zhiyuan/0000-0002-0342-6248; 	DOE-BES [DE-SC0018426, DE-SC0018218]; AFOSR [FA9550-15-1-0478]; ONR [N00014-15-1-2671, N00014-13-1-0662]; ARO [W911nf-17-1-0543]; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4533]	DOE-BES(United States Department of Energy (DOE)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ONR(Office of Naval Research); ARO; Gordon and Betty Moore Foundation's EPiQS Initiative	We thank A. Charnukha, A. Frenzel, R. Ribeiro-Palau and A. Sternbach for discussions. Research on Dirac quasiparticle dissipation in graphene was supported by DOE-BES DE-SC0018426. Plasmonic nanoscale imaging at cryogenic temperatures was supported by DOE-BES DE-SC0018218. Work on infrared nanoscale antennas and metasurfaces was supported by AFOSR FA9550-15-1-0478. The development of scanning plasmon interferometry was supported by ONR N00014-15-1-2671. Upgrades of the ultrahigh vacuum scanning probe system were supported by ARO grant W911nf-17-1-0543. D.N.B was supported by the Gordon and Betty Moore Foundation's EPiQS Initiative through Grant GBMF4533. J.H. acknowledges support from ONR N00014-13-1-0662.	Alonso-Gonzalez P, 2014, SCIENCE, V344, P1369, DOI 10.1126/science.1253202; Amorim B, 2016, PHYS REP, V617, P1, DOI 10.1016/j.physrep.2015.12.006; Atkin JM, 2012, ADV PHYS, V61, P745, DOI 10.1080/00018732.2012.737982; Bandurin DA, 2016, SCIENCE, V351, P1055, DOI 10.1126/science.aad0201; Basko DM, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.041409; Basov DN, 2016, SCIENCE, V354, DOI 10.1126/science.aag1992; Boltasseva A, 2011, SCIENCE, V331, P290, DOI 10.1126/science.1198258; Caldwell JD, 2015, NANOPHOTONICS-BERLIN, V4, P44, DOI 10.1515/nanoph-2014-0003; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Chochol J, 2017, J EUR OPT SOC-RAPID, V13, DOI 10.1186/s41476-017-0044-x; Dai S, 2014, SCIENCE, V343, P1125, DOI 10.1126/science.1246833; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Fei Z, 2011, NANO LETT, V11, P4701, DOI 10.1021/nl202362d; Giuliani G.F., 2005, QUANTUM THEORY ELECT; Halbertal D, 2017, SCIENCE, V358, P1303, DOI 10.1126/science.aan0877; Hwang EH, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115449; Jin DF, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.019901; Jin DF, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.245301; Karzig T, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031001; Kumar RK, 2017, NAT PHYS, V13, P1182, DOI 10.1038/NPHYS4240; Kuzmenko A. B., REFFIT SOFTWARE FIT, V1, P95; Low T, 2017, NAT MATER, V16, P182, DOI [10.1038/NMAT4792, 10.1038/nmat4792]; Lu YJ, 2012, SCIENCE, V337, P450, DOI 10.1126/science.1223504; Lundeberg MB, 2017, SCIENCE, V357, P187, DOI 10.1126/science.aan2735; Mariani E, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195403; Maslov DL, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/80/2/026503; McLeod AS, 2017, NAT PHYS, V13, P80, DOI [10.1038/NPHYS3882, 10.1038/nphys3882]; Ni GX, 2016, NAT PHOTONICS, V10, P244, DOI [10.1038/nphoton.2016.45, 10.1038/NPHOTON.2016.45]; Ni GX, 2015, NAT MATER, V14, P1217, DOI 10.1038/nmat4425; Novotny L., 2012, PRINCIPLES NANOOPTIC; Park CH, 2014, NANO LETT, V14, P1113, DOI 10.1021/nl402696q; Phan T. V., 2013, PREPRINT; PIETRONERO L, 1980, PHYS REV B, V22, P904, DOI 10.1103/PhysRevB.22.904; Piscanec S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.185503; Principi A, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.165408; Rivera N, 2016, SCIENCE, V353, P263, DOI 10.1126/science.aaf6308; Sohier T, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.165428; Sohier T, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.125414; Sun LY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09402-y; Sun ZY, 2018, P NATL ACAD SCI USA, V115, P3285, DOI 10.1073/pnas.1717010115; Sun ZY, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.076805; von Oppen F, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.075420; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Waxenegger J, 2015, COMPUT PHYS COMMUN, V193, P138, DOI 10.1016/j.cpc.2015.03.023; Woessner A, 2015, NAT MATER, V14, P421, DOI [10.1038/NMAT4169, 10.1038/nmat4169]; Woods LM, 2000, PHYS REV B, V61, P10651, DOI 10.1103/PhysRevB.61.10651	47	322	329	18	463	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2018	557	7706					530	+		10.1038/s41586-018-0136-9	http://dx.doi.org/10.1038/s41586-018-0136-9			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6GP	29795255	Green Published			2022-12-28	WOS:000432794900041
J	Click, B; Pinsky, PF; Hickey, T; Doroudi, M; Schoen, RE				Click, Benjamin; Pinsky, Paul F.; Hickey, Tom; Doroudi, Maryam; Schoen, Robert E.			Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; SURVEILLANCE COLONOSCOPY; FLEXIBLE SIGMOIDOSCOPY; SCREENING TRIAL; FOLLOW-UP; RISK; MORTALITY; PROSTATE; METAANALYSIS; HISTORY	IMPORTANCE Individuals with adenomatous polyps are advised to undergo repeated colonoscopy surveillance to prevent subsequent colorectal cancer (CRC), but the relationship between adenomas at colonoscopy and long-term CRC incidence is unclear. OBJECTIVE To compare long-term CRC incidence by colonoscopy adenoma findings. DESIGN, SETTING, AND PARTICIPANTS Multicenter, prospective cohort study of participants in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer randomized clinical trial of flexible sigmoidoscopy (FSG) beginning in 1993 with follow-up for CRC incidence to 2013 across the United States. Participants included 154 900 men and women aged 55 to 74 years enrolled in PLCO of whom 15 935 underwent colonoscopy following their first positive FSG screening result. The final day of follow-up was December 31, 2013. EXPOSURES Enrolled participants had been randomized to FSG or usual care. Participants who underwent FSG and had abnormal findings were referred for follow-up. Subsequent colonoscopy findings were categorized as advanced adenoma (>= 1 cm, high-grade dysplasia, or tubulovillous or villous histology), nonadvanced adenoma (< 1 cm without advanced histology), or no adenoma. MAIN OUTCOMES AND MEASURES The primary outcome was CRC incidence within 15 years of the baseline colonoscopy. The secondary outcome was CRC mortality. RESULTS There were 15 935 participants who underwent colonoscopy (men, 59.7%; white, 90.7%; median age, 64 y [IQR, 61-68]). On initial colonoscopy, 2882 participants (18.1%) had an advanced adenoma, 5068 participants (31.8%) had a nonadvanced adenoma, and 7985 participants (50.1%) had no adenoma; median follow-up for CRC incidence was 12.9 years. CRC incidence rates per 10 000 person-years of observation were 20.0 (95% CI, 15.3-24.7; n = 70) for advanced adenoma, 9.1 (95% CI, 6.7-11.5; n=55) for nonadvanced adenoma, and 7.5 (95% CI, 5.8-9.7; n = 71) for no adenoma. Participants with advanced adenoma were significantly more likely to develop CRC compared with participants with no adenoma (rate ratio [RR], 2.7 [95% CI, 1.9-3.7]; P<.001). There was no significant difference in CRC risk between participants with nonadvanced adenoma compared with no adenoma (RR, 1.2 [95% CI, 0.8-1.7]; P=.30). Compared with participants with no adenoma, those with advanced adenoma were at significantly increased risk of CRC death (RR, 2.6 [95% CI, 1.2-5.7], P=.01), but mortality risk in participants with nonadvanced adenoma was not significantly different (RR, 1.2 [95% CI, 0.5-2.7], P=.68). CONCLUSIONS AND RELEVANCE Over a median of 13 years of follow-up, participants with an advanced adenoma at diagnostic colonoscopy prompted by a positive flexible sigmoidoscopy result were at significantly increased risk of developing colorectal cancer compared with those with no adenoma. Identification of nonadvanced adenoma may not be associated with increased colorectal cancer risk.	[Click, Benjamin; Schoen, Robert E.] Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Pinsky, Paul F.; Doroudi, Maryam] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [Hickey, Tom] Informat Management Serv Inc, Rockville, MD USA; [Schoen, Robert E.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schoen, RE (corresponding author), Div Gastroenterol Hepatol & Nutr, C Wing,200 Lothrop St, Pittsburgh, PA 15213 USA.	rschoen@pitt.edu			Division of Cancer Prevention, National Cancer Institute [N02-CN-05019-61]; National Institutes of Health [5T32DK063922-15]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK063922] Funding Source: NIH RePORTER	Division of Cancer Prevention, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by contract N02-CN-05019-61 from the Division of Cancer Prevention, National Cancer Institute. Dr Click reports support by grant 5T32DK063922-15 from the National Institutes of Health.	Atkin W, 2017, LANCET ONCOL, V18, P823, DOI 10.1016/S1470-2045(17)30187-0; Atkin W, 2017, LANCET, V389, P1299, DOI 10.1016/S0140-6736(17)30396-3; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; Ben QW, 2012, GASTROENTEROLOGY, V142, P762, DOI 10.1053/j.gastro.2011.12.050; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chung SJ, 2011, GUT, V60, P1537, DOI 10.1136/gut.2010.232876; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Cottet V, 2012, GUT, V61, P1180, DOI 10.1136/gutjnl-2011-300295; Doubeni CA, 2018, GUT, V67, P291, DOI 10.1136/gutjnl-2016-312712; Doubeni CA, 2013, ANN INTERN MED, V158, P312, DOI 10.7326/0003-4819-158-5-201303050-00003; Dube C, 2017, AM J GASTROENTEROL, V112, P1790, DOI 10.1038/ajg.2017.360; Heitman SJ, 2009, CLIN GASTROENTEROL H, V7, P1272, DOI 10.1016/j.cgh.2009.05.032; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P606, DOI 10.1001/jama.2014.8266; Huang YL, 2012, INT J COLORECTAL DIS, V27, P1651, DOI 10.1007/s00384-012-1516-5; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Jover R, 2016, ENDOSCOPY, V48, P571, DOI 10.1055/s-0042-104116; Ladabaum U, 2016, GASTROENTEROLOGY, V150, P791, DOI 10.1053/j.gastro.2016.01.033; Laiyemo AO, 2008, ANN INTERN MED, V148, P419, DOI 10.7326/0003-4819-148-6-200803180-00004; Laiyemo AO, 2009, CLIN GASTROENTEROL H, V7, P562, DOI 10.1016/j.cgh.2008.12.009; Leung K, 2010, GASTROINTEST ENDOSC, V71, P111, DOI 10.1016/j.gie.2009.05.010; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Loberg M, 2014, NEW ENGL J MED, V371, P799, DOI 10.1056/NEJMoa1315870; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Miller AB, 2000, CONTROL CLIN TRIALS, V21, p400S, DOI 10.1016/S0197-2456(00)00095-7; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Pinsky PF, 2017, CANCER-AM CANCER SOC, V123, P592, DOI 10.1002/cncr.30474; Pinsky PF, 2009, CLIN GASTROENTEROL H, V7, P86, DOI 10.1016/j.cgh.2008.07.014; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Saini SD, 2006, GASTROINTEST ENDOSC, V64, P614, DOI 10.1016/j.gie.2006.06.057; Schoen RE, 2015, GASTROENTEROLOGY, V149, P1438, DOI 10.1053/j.gastro.2015.07.055; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Schoen RE, 2010, GASTROENTEROLOGY, V138, P73, DOI 10.1053/j.gastro.2009.09.062; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Sturmer T, 2000, J NATL CANCER I, V92, P1178, DOI 10.1093/jnci/92.14.1178; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; Troisi RJ, 1999, CANCER, V85, P1670, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1670::AID-CNCR5>3.0.CO;2-M; Weissfeld JL, 2012, JNCI-J NATL CANCER I, V104, P280, DOI 10.1093/jnci/djr549	38	128	131	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					2021	2031		10.1001/jama.2018.5809	http://dx.doi.org/10.1001/jama.2018.5809			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800214	Green Published, Bronze			2022-12-28	WOS:000432238300019
J	Sood, N; Ung, D; Shankar, A; Strom, BL				Sood, Neeraj; Ung, Diane; Shankar, Anil; Strom, Brian L.			A Novel Strategy for Increasing Access to Treatment for Hepatitis C Virus Infection for Medicaid Beneficiaries	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES; SOFOSBUVIR; MORTALITY		[Sood, Neeraj] Univ Southern Calif, Verna & Peter Dauter Hall 210,635 Downey Way, Los Angeles, CA 90089 USA; [Ung, Diane; Shankar, Anil] Foley & Lardner, 555 South Flower St,Suite 3500, Los Angeles, CA 90071 USA; [Strom, Brian L.] Rutgers State Univ, Biomed & Hlth Sci, Stanley S Bergen Bldg,65 Berge St, Newark, NJ 07103 USA	University of Southern California; Rutgers State University Newark; Rutgers State University New Brunswick	Sood, N (corresponding author), Univ Southern Calif, Verna & Peter Dauter Hall 210,635 Downey Way, Los Angeles, CA 90089 USA.	nsood@healthpolicy.usc.edu						Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; Centers for Disease Control and Prevention (CDC), 2018, VIR HEP STAT SURV; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111; National Academies of Sciences Engineering and Medicine, 2017, NAT STRAT EL HEP B C; Rosenthal ES, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0071-z; Suwanthawornkul T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145953; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878	10	10	10	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2018	169	2					118	+		10.7326/M18-0186	http://dx.doi.org/10.7326/M18-0186			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN0TI	29799973				2022-12-28	WOS:000438689200018
J	Marten, R; Kadandale, S; Butler, J; Aguayo, VM; Axelrod, S; Banatvala, N; Bettcher, D; Brumana, L; Buse, K; Casswell, S; Dain, K; Glassman, A; Heymann, DL; Kickbusch, I; Marquez, PV; Nordstrom, A; Paul, J; Peterson, S; Ralston, J; Rasanathan, K; Reddy, S; Smith, RD; Soucat, A; Sperkova, K; Thompson, F; Webb, D				Marten, Robert; Kadandale, Sowmya; Butler, John; Aguayo, Victor M.; Axelrod, Svetlana; Banatvala, Nicholas; Bettcher, Douglas; Brumana, Luisa; Buse, Kent; Casswell, Sally; Dain, Katie; Glassman, Amanda; Heymann, David L.; Kickbusch, Ilona; Marquez, Patricio V.; Nordstrom, Anders; Paul, Jeremias, Jr.; Peterson, Stefan; Ralston, Johanna; Rasanathan, Kumanan; Reddy, Srinath; Smith, Richard D.; Soucat, Agnes; Sperkova, Kristina; Thompson, Francis; Webb, Douglas		Sugar Tobacco & Alcohol Taxes STAX	Sugar, tobacco, and alcohol taxes to achieve the SDGs	LANCET			English	Editorial Material									[Marten, Robert; Heymann, David L.; Smith, Richard D.; Sugar Tobacco & Alcohol Taxes STAX] London Sch Hyg & Trop Med, London WC1H 9SH, England; [Kadandale, Sowmya; Aguayo, Victor M.; Brumana, Luisa; Peterson, Stefan] UNICEF, New York, NY USA; [Butler, John] NCD Child, Elk Grove Village, IL USA; [Axelrod, Svetlana; Banatvala, Nicholas; Bettcher, Douglas; Paul, Jeremias, Jr.; Rasanathan, Kumanan; Soucat, Agnes] WHO, Geneva, Switzerland; [Buse, Kent] UNAIDS, Geneva, Switzerland; [Casswell, Sally] Massey Univ, Palmerston North, New Zealand; [Dain, Katie] NCD Alliance, Geneva, Switzerland; [Glassman, Amanda] Ctr Global Dev, Washington, DC USA; [Kickbusch, Ilona] Global Hlth Ctr, Grad Inst, Geneva, Switzerland; [Marquez, Patricio V.] World Bank, 1818 H St NW, Washington, DC 20433 USA; [Nordstrom, Anders] Swedish Minist Foreign Affairs, Stockholm, Sweden; [Ralston, Johanna] World Obes Federat, London, England; [Reddy, Srinath] Publ Hlth Fdn India, New Delhi, India; [Sperkova, Kristina] IOGT Int, Stockholm, Sweden; [Thompson, Francis] Framework Convent Alliance, Geneva, Switzerland; [Webb, Douglas] UNDP, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; UNICEF; World Health Organization; UNAIDS; Massey University; The World Bank; Public Health Foundation of India	Marten, R (corresponding author), London Sch Hyg & Trop Med, London WC1H 9SH, England.	robert.marten@lshtm.ac.uk	Buse, Kent/AAK-6688-2020	Buse, Kent/0000-0002-5485-0110; Banatvala, Nick/0000-0001-8130-154X; Reddy, K Srinath/0000-0003-3416-3548; Casswell, Sally/0000-0002-2211-7096	Multidonor Trust Fund (MDT); Bloomberg Philanthropies; Bill & Melinda Gates Foundation; Vital Strategies; New Venture Fund; Cancer Research UK; Norwegian Cancer Society; Cancer Council Victoria; Campaign for Tobacco-Free Kids; International Development Research Centre	Multidonor Trust Fund (MDT); Bloomberg Philanthropies; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Vital Strategies; New Venture Fund; Cancer Research UK(Cancer Research UK); Norwegian Cancer Society(Norwegian Cancer Society); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Campaign for Tobacco-Free Kids; International Development Research Centre	IK and KD are members of the WHO Independent High-Level Commission on NCDs. PVM coordinates the World Bank Group Global Tobacco Control Program, funded under a Multidonor Trust Fund (MDT) with grants from the Bloomberg Philanthropies and the Bill & Melinda Gates Foundation, complementing budgetary allocations from the World Bank Group. FT reports grants from Vital Strategies, the Bill & Melinda Gates Foundation, New Venture Fund, Cancer Research UK, Norwegian Cancer Society, Cancer Council Victoria, and Campaign for Tobacco-Free Kids and personal fees from International Development Research Centre. We declare no other competing interests. The views and conclusions in this Comment are those of the authors and do not necessarily represent the views and positions of the institutions with which they are affiliated.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; [Anonymous], 2017, LANCET DIABETES ENDO, V5, P235, DOI 10.1016/S2213-8587(17)30070-0; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fuchs A., 2018, LONG RUN IMPACTS INC; Fuchs Alan, 2017, REGRESSIVE PROGR EFF; Fuchs Tarlovsky A, 2017, ARE TOBACCO TAXES RE; Guerrero-Lopez CM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4098-x; Herttua K, 2008, AM J EPIDEMIOL, V168, P1110, DOI 10.1093/aje/kwn216; Marquez PV., 2017, TOBACCO TAX REFORM C, DOI [10.1596/28494, DOI 10.1596/28494]; Sassi F, 2018, LANCET, V391, P2059, DOI [10.1016/S0140-6736(18)30531-2, 10.1016/s0140-6736(18)30531-2]; Summers LH, 2018, LANCET, V391, P1974, DOI 10.1016/S0140-6736(18)30629-9; Van Walbeek Corne, 2005, Promot Educ, VSuppl 4, P25; Whitaker K, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k110; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2018, GLOB HLTH EST 2019 D; World Health Organization, 2017, WHO REP GLOB TOB EP; [No title captured]	18	25	26	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2018	391	10138					2400	2401		10.1016/S0140-6736(18)31219-4	http://dx.doi.org/10.1016/S0140-6736(18)31219-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GK7QC	29858115				2022-12-28	WOS:000436402000010
J	Powell, BJ				Powell, Ben J.			The expanding materials multiverse	SCIENCE			English	Editorial Material							ICE		[Powell, Ben J.] Univ Queensland, Sch Math & Phys, Brisbane, Qld 4072, Australia	University of Queensland	Powell, BJ (corresponding author), Univ Queensland, Sch Math & Phys, Brisbane, Qld 4072, Australia.	bjpowell@gmail.com	Powell, Benjamin J/B-1281-2009	Powell, Benjamin J/0000-0002-5161-1317				Anderson P.W., 1984, BASIC NOTIONS CONDEN, DOI 10.4324/9780429494116; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Benoit M, 1998, NATURE, V392, P258, DOI 10.1038/32609; Castelnovo C, 2012, ANNU REV CONDEN MA P, V3, P35, DOI 10.1146/annurev-conmatphys-020911-125058; Demadis KD, 2001, CHEM REV, V101, P2655, DOI 10.1021/cr990413m; dePicciotto R, 1997, NATURE, V389, P162, DOI 10.1038/38241; Hassan N, 2018, SCIENCE, V360, P1101, DOI 10.1126/science.aan6286; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Powell BJ, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/5/056501; Powell BJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047004; Shen SP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10569; Yao NY, 2018, NAT PHYS, V14, P405, DOI 10.1038/s41567-017-0030-7	12	3	3	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1073	1074		10.1126/science.aat7282	http://dx.doi.org/10.1126/science.aat7282			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI6TJ	29880674				2022-12-28	WOS:000434635500029
J	Brown, S; Janssen, M; Adumitroaie, V; Atreya, S; Bolton, S; Gulkis, S; Ingersoll, A; Levin, S; Li, C; Li, LM; Lunine, J; Misra, S; Orton, G; Steffes, P; Tabataba-Vakili, F; Kolmasova, I; Imai, M; Santolik, O; Kurth, W; Hospodarsky, G; Gurnett, D; Connerney, J				Brown, Shannon; Janssen, Michael; Adumitroaie, Virgil; Atreya, Sushil; Bolton, Scott; Gulkis, Samuel; Ingersoll, Andrew; Levin, Steven; Li, Cheng; Li, Liming; Lunine, Jonathan; Misra, Sidharth; Orton, Glenn; Steffes, Paul; Tabataba-Vakili, Fachreddin; Kolmasova, Ivana; Imai, Masafumi; Santolik, Ondrej; Kurth, William; Hospodarsky, George; Gurnett, Donald; Connerney, John			Prevalent lightning sferics at 600 megahertz near Jupiter's poles	NATURE			English	Article							MOIST CONVECTION; ATMOSPHERE; AMMONIA; IMAGES; WATER; MODEL	Lightning has been detected on Jupiter by all visiting spacecraft through night-side optical imaging and whistler (lightning-generated radio waves) signatures(1-6). Jovian lightning is thought to be generated in the mixed-phase (liquid-ice) region of convective water clouds through a charge-separation process between condensed liquid water and water-ice particles, similar to that of terrestrial (cloud-to-cloud) lightning(7-9). Unlike terrestrial lightning, which emits broadly over the radio spectrum up to gigahertz frequencies(10,11),lightning on Jupiter has been detected only at kilohertz frequencies, despite a search for signals in the megahertz range(12). Strong ionospheric attenuation or a lightning discharge much slower than that on Earth have been suggested as possible explanations for this discrepancy(13,14). Here we report observations of Jovian lightning sferics (broadband electromagnetic impulses) at 600 megahertz from the Microwave Radiometer(15) onboard the Juno spacecraft. These detections imply that Jovian lightning discharges are not distinct from terrestrial lightning, as previously thought. In the first eight orbits of Juno, we detected 377 lightning sferics from pole to pole. We found lightning to be prevalent in the polar regions, absent near the equator, and most frequent in the northern hemisphere, at latitudes higher than 40 degrees north. Because the distribution of lightning is a proxy for moist convective activity, which is thought to be an important source of outward energy transport from the interior of the planet(16,17,) increased convection towards the poles could indicate an outward internal heat flux that is preferentially weighted towards the poles(9,16,18). The distribution of moist convection is important for understanding the composition, general circulation and energy transport on Jupiter.	[Brown, Shannon; Janssen, Michael; Adumitroaie, Virgil; Gulkis, Samuel; Levin, Steven; Misra, Sidharth; Orton, Glenn] CALTECH, Jet Prop Lab, Pasadena, CA 91125 USA; [Atreya, Sushil] Univ Michigan, Climate & Space Sci & Engn, Ann Arbor, MI 48109 USA; [Bolton, Scott] Southwest Res Inst, San Antonio, TX USA; [Ingersoll, Andrew; Li, Cheng; Tabataba-Vakili, Fachreddin] CALTECH, Pasadena, CA 91125 USA; [Li, Liming] Univ Houston, Dept Phys, Houston, TX USA; [Lunine, Jonathan] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Steffes, Paul] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Kolmasova, Ivana; Santolik, Ondrej] Czech Acad Sci, Inst Atmospher Phys, Dept Space Phys, Prague, Czech Republic; [Kolmasova, Ivana; Santolik, Ondrej] Charles Univ Prague, Fac Math & Phys, Prague, Czech Republic; [Imai, Masafumi; Kurth, William; Hospodarsky, George; Gurnett, Donald] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Connerney, John] NASA, Goddard Spaceflight Ctr, Greenbelt, MD USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Michigan System; University of Michigan; Southwest Research Institute; California Institute of Technology; University of Houston System; University of Houston; Cornell University; University System of Georgia; Georgia Institute of Technology; Czech Academy of Sciences; Institute of Atmospheric Physics of the Czech Academy of Sciences; Charles University Prague; University of Iowa; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Brown, S (corresponding author), CALTECH, Jet Prop Lab, Pasadena, CA 91125 USA.	shannon.t.brown@jpl.nasa.gov	Hospodarsky, George B/A-7996-2015; Santolik, Ondrej/F-7766-2014; Kurth, William/AAA-7334-2019; Orton, Glenn/AAD-9862-2020; Bolton, Scott/M-4392-2019; Kolmasova, Ivana/AAC-3569-2020; Kolmasova, Ivana/H-6191-2014; Imai, Masafumi/S-8736-2016	Hospodarsky, George B/0000-0001-9200-9878; Santolik, Ondrej/0000-0002-4891-9273; Kurth, William/0000-0002-5471-6202; Kolmasova, Ivana/0000-0002-1704-3846; Kolmasova, Ivana/0000-0002-1704-3846; Li, Liming/0000-0002-5257-9849; Lunine, Jonathan/0000-0003-2279-4131; Levin, Steven/0000-0003-2242-5459; Li, Cheng/0000-0002-8280-3119; bolton, scott/0000-0002-9115-0789; Imai, Masafumi/0000-0002-2814-4036	NASA [699041X]; Southwest Research Institute; Praemium Academiae award;  [MSM100421701];  [LTAUSA17070]	NASA(National Aeronautics & Space Administration (NASA)); Southwest Research Institute; Praemium Academiae award; ; 	This research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration. The research at the University of Iowa was supported by NASA through contract 699041X with the Southwest Research Institute. The work of I.K. and O.S. was supported by grants MSM100421701 and LTAUSA17070 and by the Praemium Academiae award.	Atreya SK, 1999, PLANET SPACE SCI, V47, P1243, DOI 10.1016/S0032-0633(99)00047-1; Baines KH, 2007, SCIENCE, V318, P226, DOI 10.1126/science.1147912; Bolton SJ, 2017, SCIENCE, V356, P821, DOI 10.1126/science.aal2108; BORUCKI WJ, 1992, ICARUS, V96, P1, DOI 10.1016/0019-1035(92)90002-O; Connerney JEP, 1998, J GEOPHYS RES-SPACE, V103, P11929, DOI 10.1029/97JA03726; COOK AF, 1979, NATURE, V280, P794, DOI 10.1038/280794a0; Dyudina UA, 2004, ICARUS, V172, P24, DOI 10.1016/j.icarus.2004.07.014; Farrell WM, 2000, GEOPH MONOG SERIES, V119, P179; GIBBARD S, 1995, NATURE, V378, P592, DOI 10.1038/378592a0; GUILLOT T, 1995, SCIENCE, V269, P1697, DOI 10.1126/science.7569896; GURNETT DA, 1979, GEOPHYS RES LETT, V6, P511, DOI 10.1029/GL006i006p00511; Hueso R, 2001, ICARUS, V151, P257, DOI 10.1006/icar.2000.6606; Janssen MA, 2017, SPACE SCI REV, V213, P139, DOI 10.1007/s11214-017-0349-5; Kolmasova I, 2018, NAT ASTRON, V2, P544, DOI 10.1038/s41550-018-0442-z; LEVINE DM, 1978, RADIO SCI, V13, P801, DOI 10.1029/RS013i005p00801; Li C, 2017, GEOPHYS RES LETT, V44, P5317, DOI 10.1002/2017GL073159; Little B, 1999, ICARUS, V142, P306, DOI 10.1006/icar.1999.6195; Majeed T, 1999, GEOPHYS RES LETT, V26, P2335, DOI 10.1029/1999GL900530; Niemann HB, 1998, J GEOPHYS RES-PLANET, V103, P22831, DOI 10.1029/98JE01050; OH LL, 1969, IEEE T ELECTROMAGN C, VEM11, P125, DOI 10.1109/TEMC.1969.303024; PIRRAGLIA JA, 1984, ICARUS, V59, P169, DOI 10.1016/0019-1035(84)90020-4; Porco CC, 2003, SCIENCE, V299, P1541, DOI 10.1126/science.1079462; Rinnert K, 1998, J GEOPHYS RES-PLANET, V103, P22979, DOI 10.1029/98JE00830; RINNERT K, 1985, J GEOPHYS RES-ATMOS, V90, P6225, DOI 10.1029/JD090iD04p06225; STOKER CR, 1986, ICARUS, V67, P106, DOI 10.1016/0019-1035(86)90179-X; ZARKA P, 1985, ASTRON ASTROPHYS, V146, pL15	30	37	38	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					87	+		10.1038/s41586-018-0156-5	http://dx.doi.org/10.1038/s41586-018-0156-5			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29875484				2022-12-28	WOS:000434273300041
J	Rosenbaum, JT; Silverman, GJ				Rosenbaum, James T.; Silverman, Gregg J.			The Microbiome and Systemic Lupus Erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSLOCATION		[Rosenbaum, James T.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Rosenbaum, James T.] Legacy Devers Eye Inst, Portland, OR 97201 USA; [Silverman, Gregg J.] NYU, Med Ctr, New York, NY 10016 USA	Oregon Health & Science University; Devers Eye Institute; New York University	Rosenbaum, JT (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.; Rosenbaum, JT (corresponding author), Legacy Devers Eye Inst, Portland, OR 97201 USA.			Silverman, Gregg/0000-0001-9480-9457	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR070591] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Cirera I, 2001, J HEPATOL, V34, P32, DOI 10.1016/S0168-8278(00)00013-1; Vieira SM, 2018, SCIENCE, V359, P1156, DOI 10.1126/science.aar7201	3	18	19	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2018	378	23					2236	2237		10.1056/NEJMcibr1804368	http://dx.doi.org/10.1056/NEJMcibr1804368			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3HS	29874543				2022-12-28	WOS:000434263000015
J	Dyer, O				Dyer, Owen			Sixty seconds on . . . Nipah virus	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ashraf NA, 2018, THE NEWS MINUTE 0604, DOI [10.1016/j.antiviral.2013.07.01123911335, DOI 10.1016/J.ANTIVIRAL.2013.07.01123911335]; Luby SP, 2013, ANTIVIR RES, V100, P38, DOI 10.1016/j.antiviral.2013.07.011	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2018	361								k2485	10.1136/bmj.k2485	http://dx.doi.org/10.1136/bmj.k2485			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BU	29871862				2022-12-28	WOS:000435073300009
J	Iacobucci, G				Iacobucci, Gareth			RCGP urges home secretary to act swiftly to enable foreign GPs to work in NHS	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2479	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2018	361								k2489	10.1136/bmj.k2489	http://dx.doi.org/10.1136/bmj.k2489			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BU	29871988				2022-12-28	WOS:000435073300010
J	Hodapp, T; Brown, E				Hodapp, Theodore; Brown, Erika			Making physics more inclusive	NATURE			English	Editorial Material									[Hodapp, Theodore] Amer Phys Soc, Educ & Divers Dept, College Pk, MD 20740 USA; [Brown, Erika] Amer Phys Soc, College Pk, MD USA		Hodapp, T (corresponding author), Amer Phys Soc, Educ & Divers Dept, College Pk, MD 20740 USA.		Hodapp, Theodore/GXZ-6154-2022	Hodapp, Theodore/0000-0001-8877-2942	Direct For Education and Human Resources [1143070] Funding Source: National Science Foundation	Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))		Duckworth AL, 2007, J PERS SOC PSYCHOL, V92, P1087, DOI 10.1037/0022-3514.92.6.1087; Educational Testing Scores, 2017, GRE GUID US SCOR; Hodapp T, 2017, PHYS TODAY, V70, P50, DOI 10.1063/PT.3.3464; Miller C., SCI ADV; Posselt, 2016, INSIDE GRADUATE ADMI; Potvin G, 2017, PHYS REV PHYS EDUC R, V13, DOI 10.1103/PhysRevPhysEducRes.13.020142; Scherr RE, 2017, PHYS REV PHYS EDUC R, V13, DOI 10.1103/PhysRevPhysEducRes.13.020133; Sowell R., 2008, PH D COMPLETION ATTR; Steele Claude M., 2010, WHISTLING VIVALDI OT	9	13	13	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					629	632		10.1038/d41586-018-05260-4	http://dx.doi.org/10.1038/d41586-018-05260-4			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH4WT	29844548				2022-12-28	WOS:000433412900024
J	Tse, T; Fain, KM; Zarin, DA				Tse, Tony; Fain, Kevin M.; Zarin, Deborah A.			How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESULTS DATABASE; CLINICAL-TRIALS; UPDATE	ClinicalTrials. gov, a repository of information about clinical studies and their results, together with specialised search tools, provides a unique window into the clinical research enterprise, which includes all initiated, ongoing, and completed or terminated clinical studies. Researchers are increasingly using information from the database to assess research reporting practices, or to characterise the clinical research enterprise. Conducting valid analyses requires an understanding of both the capabilities and limitations of the database ( that is, intrinsic factors) as well as reporting policies and other factors external to the database that influence the types of studies in ClinicalTrials. gov in a specified time. This article discusses 10 key issues that researchers need to consider when using the database to conduct research.	[Tse, Tony; Fain, Kevin M.; Zarin, Deborah A.] NIH, Natl Lib Med, Dept Hlth & Human Serv, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Fain, KM (corresponding author), NIH, Natl Lib Med, Dept Hlth & Human Serv, Bethesda, MD 20894 USA.	kevin.fain@nih.gov	Fain, Kevin/H-6573-2019	Fain, Kevin/0000-0001-7839-7149; Tse, Tony/0000-0002-9906-6864	National Institutes of Health, National Library of Medicine; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	National Institutes of Health, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors are supported by the Intramural Research Program of the National Institutes of Health, National Library of Medicine.	Anderson ML, 2015, NEW ENGL J MED, V372, P1031, DOI 10.1056/NEJMsa1409364; [Anonymous], 2018, KOREA BIOMEDICAL REV; Becker JE, 2014, JAMA-J AM MED ASSOC, V311, P1063, DOI 10.1001/jama.2013.285634; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Clinical Trials Transformation Initiative, IMPR PUBL ACC AGGR C; ClinicalTrials.govPRS, 2017, PRS US GUID; De Angelis CD, 2005, NEW ENGL J MED, V352, P2436, DOI 10.1056/NEJMe058127; Dobbins HD, 2017, 8 INT C PEER REV SCI; Fain K, 2017, 38 ANN M SOC CLIN TR; Gopal AD, 2015, JAMA-J AM MED ASSOC, V313, P1163, DOI 10.1001/jama.2015.1697; Hartung DM, 2014, ANN INTERN MED, V160, P477, DOI 10.7326/M13-0480; Huic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025258; International Committee of Medical Journal Editors, CLIN TRIALS REG; National Institutes of Health Department of Health and Human Services, 2016, FED REGISTER; National Institutes of Health Department of Health and Human Services, 2016, FED REGISTER; NIH.U.S. National Library of Medicine, DAT EL DEF; NIH. U.S. National Library of Medicine, REV CRIT OTH SUPP MA; Pranic S, 2016, J CLIN EPIDEMIOL, V70, P26, DOI 10.1016/j.jclinepi.2015.07.007; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Schwartz LM, 2016, ANN INTERN MED, V165, P421, DOI 10.7326/M15-2658; van Valkenhoef G, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0283-8; Viergever RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084727; Williams RJ, 2010, CAN MED ASSOC J, V182, P1638, DOI 10.1503/cmaj.092252; Zarin DA, 2017, PRINCIPLES PRACTICE, P111; Zarin DA, 2017, NEW ENGL J MED, V376, P383, DOI 10.1056/NEJMsr1601330; Zarin DA, 2016, NEW ENGL J MED, V375, P1998, DOI 10.1056/NEJMsr1611785; Zarin DA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001946; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	29	83	85	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2018	361								k1452	10.1136/bmj.k1452	http://dx.doi.org/10.1136/bmj.k1452			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH4XO	29802130	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000433416200001
J	McIntyre, WF; Um, KJ; Alhazzani, W; Lengyel, AP; Hajjar, L; Gordon, AC; Lamontagne, F; Healey, JS; Whitlock, RP; Belley-Cote, EP				McIntyre, William F.; Um, Kevin J.; Alhazzani, Waleed; Lengyel, Alexandra P.; Hajjar, Ludhmila; Gordon, Anthony C.; Lamontagne, Francois; Healey, Jeff S.; Whitlock, Richard P.; Belley-Cote, Emilie P.			Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HYPERDYNAMIC SEPTIC SHOCK; NOREPINEPHRINE; TERLIPRESSIN; INFUSION; NORADRENALINE; CIRRHOSIS	IMPORTANCE Vasopressin is an alternative to catecholamine vasopressors for patients with distributive shock-a condition due to excessive vasodilation, most frequently from severe infection. Blood pressure support with a noncatecholamine vasopressor may reduce stimulation of adrenergic receptors and decrease myocardial oxygen demand. Atrial fibrillation is common with catecholamines and is associated with adverse events, including mortality and increased length of stay (LOS). OBJECTIVES To determine whether treatment with vasopressin + catecholamine vasopressors compared with catecholamine vasopressors alone was associated with reductions in the risk of adverse events. DATA SOURCES MEDLINE, EMBASE, and CENTRAL were searched from inception to February 2018. Experts were asked and meta-registries searched to identify ongoing trials. STUDY SELECTION Pairs of reviewers identified randomized clinical trials comparing vasopressin in combination with catecholamine vasopressors to catecholamines alone for patients with distributive shock. DATA EXTRACTION AND SYNTHESIS Two reviewers abstracted data independently. A random-effects model was used to combine data. MAIN OUTCOMES AND MEASURES The primary outcome was atrial fibrillation. Other outcomes included mortality, requirement for renal replacement therapy (RRT), myocardial injury, ventricular arrhythmia, stroke, and LOS in the intensive care unit and hospital. Measures of association are reported as risk ratios (RRs) for clinical outcomes and mean differences for LOS. RESULTS Twenty-three randomized clinical trials were identified (3088 patients; mean age, 61.1 years [14.2]; women, 45.3%). High-quality evidence supported a lower risk of atrial fibrillation associated with vasopressin treatment (RR, 0.77 [95% CI, 0.67 to 0.88]; risk difference [RD], -0.06 [95% CI, -0.13 to 0.01]). For mortality, the overall RR estimate was 0.89 (95% CI, 0.82 to 0.97; RD, -0.04 [95% CI, -0.07 to 0.00]); however, when limited to trials at low risk of bias, the RR estimate was 0.96 (95% CI, 0.84 to 1.11). The overall RR estimate for RRT was 0.74 (95% CI, 0.51 to 1.08; RD, -0.07 [95% CI, -0.12 to -0.01]). However, in an analysis limited to trials at low risk of bias, RR was 0.70 (95% CI, 0.53 to 0.92, P for interaction =.77). There were no significant differences in the pooled risks for other outcomes. CONCLUSIONS AND RELEVANCE In this systematic review and meta-analysis, the addition of vasopressin to catecholamine vasopressors compared with catecholamines alone was associated with a lower risk of atrial fibrillation. Findings for secondary outcomes varied.	[McIntyre, William F.; Um, Kevin J.; Alhazzani, Waleed; Lengyel, Alexandra P.; Healey, Jeff S.; Whitlock, Richard P.; Belley-Cote, Emilie P.] McMaster Univ, Hamilton, ON, Canada; [Hajjar, Ludhmila] Univ Sao Paulo, Sao Paulo, Brazil; [Gordon, Anthony C.] Charing Cross Hosp, London, England; [Gordon, Anthony C.] Imperial Coll London, London, England; [Lamontagne, Francois] Univ Sherbrooke, Sherbrooke, PQ, Canada	McMaster University; Universidade de Sao Paulo; Imperial College London; Imperial College London; University of Sherbrooke	Belley-Cote, EP (corresponding author), David Braley Cardiac Vasc & Stroke Res Inst, 237 Barton St E,Room 1C1-5B, Hamilton, ON L8L 2X2, Canada.	emilie.belley-cote@phri.ca	Whitlock, Richard/AAQ-1593-2021; Gordon, Anthony/A-3472-2012	Whitlock, Richard/0000-0002-6863-5884; Gordon, Anthony/0000-0002-0419-547X; Lamontagne, Francois/0000-0002-0360-3427; McIntyre, William F/0000-0001-6082-7542; Abrahao Hajjar, Ludhmila/0000-0001-5645-2055	Canadian Stroke Prevention Intervention Network; National Institute for Health Research; Tenax Therapeutics; Orion Pharma; Ferring Pharmaceuticals; GlaxoSmithKline; Bristol-Myers Squibb; Amomed Pharma; Medtronic; Bristol-Meyers Squibb/Pfizer; Canadian Institutes of Health Research	Canadian Stroke Prevention Intervention Network; National Institute for Health Research(National Institute for Health Research (NIHR)); Tenax Therapeutics; Orion Pharma; Ferring Pharmaceuticals(Ferring Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); Amomed Pharma(Dexcel Pharma); Medtronic(Medtronic); Bristol-Meyers Squibb/Pfizer; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr McIntyre reported receiving grant funding from the Canadian Stroke Prevention Intervention Network and being a trainee member of the Cardiac Arrhythmia Network of Canada. Dr Gordon reported receiving grant funding from the National Institute for Health Research and Tenax Therapeutics; personal fees and nonfinancial support from Orion Pharma, Tenax Therapeutics, Ferring Pharmaceuticals, GlaxoSmithKline, and Bristol-Myers Squibb; and personal fees from Amomed Pharma. Dr Healey reported receiving grant funding from Medtronic and Bristol-Meyers Squibb/Pfizer. Dr Belley-Cote reported receiving grant funding from the Canadian Institutes of Health Research. No other disclosures were reported.	Abdullah MH, 2012, EGYPT J ANAESTH, V28, P29, DOI 10.1016/j.egja.2011.10.002; Acevedo JG, 2009, J HEPATOL, V50, pS73, DOI 10.1016/S0168-8278(09)60176-8; Albanese J, 2005, CRIT CARE MED, V33, P1897, DOI 10.1097/01.CCM.0000178182.37639.D6; Barrett LK, 2007, CRIT CARE MED, V35, P2337, DOI 10.1097/01.CCM.0000281861.72907.17; Barzegar Elchin, 2016, Acta Med Iran, V54, P15; Belletti A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142605; Capoletto C, 2017, CRIT CAR C 37 INT S; Chen Zhi, 2017, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V29, P111, DOI 10.3760/cma.j.issn.2095-4352.2017.02.004; Choudhury A, 2017, LIVER INT, V37, P552, DOI 10.1111/liv.13252; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Dunser Martin W, 2009, J Intensive Care Med, V24, P293, DOI 10.1177/0885066609340519; Dunser MW, 2003, CIRCULATION, V107, P2313, DOI 10.1161/01.CIR.0000066692.71008.BB; Dunser MW, 2002, INTENS CARE MED, V28, P746, DOI 10.1007/s00134-002-1265-y; Fonseca-Ruiz NJ, 2013, ACTA COLOMBIANA CUID, V33, P114; Gamper G, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003709.pub4; Gkisioti S, 2011, OPEN ACCESS EMERG M, V3, P1, DOI 10.2147/OAEM.S10388; Gordon AC, 2016, JAMA-J AM MED ASSOC, V316, P509, DOI 10.1001/jama.2016.10485; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Hajjar LA, 2017, ANESTHESIOLOGY, V126, P85, DOI 10.1097/ALN.0000000000001434; Hammond D, 2016, CRIT CARE MED, V44; Han Xu-dong, 2012, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V24, P33; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hua F, 2013, J EMERG MED, V44, P434, DOI 10.1016/j.jemermed.2012.02.073; Klouwenberg PMCK, 2017, AM J RESP CRIT CARE, V195, P205, DOI [10.1164/rccm.201603-06180C, 10.1164/rccm.201603-0618OC]; Landry DW, 1997, CIRCULATION, V95, P1122; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Lauzier F, 2006, INTENS CARE MED, V32, P1782, DOI 10.1007/s00134-006-0378-0; Levy B, 2010, INTENS CARE MED, V36, P2019, DOI 10.1007/s00134-010-2045-8; Machado FR, 2017, LANCET INFECT DIS, V17, P1180, DOI 10.1016/S1473-3099(17)30322-5; Malay MB, 1999, J TRAUMA, V47, P699, DOI 10.1097/00005373-199910000-00014; McIntyre WF, 2018, CURR OPIN CARDIOL, V33, P58, DOI 10.1097/HCO.0000000000000475; Morelli A, 2009, CRIT CARE, V13, DOI 10.1186/cc7990; Moss TJ, 2017, CRIT CARE MED, V45, P790, DOI 10.1097/CCM.0000000000002325; Nagendran Myura, 2016, J Intensive Care Soc, V17, P136, DOI 10.1177/1751143715620203; Oliveira O, 2014, CRITICAL CARE S, V38, P556, DOI [10.1186/cc.13348, DOI 10.1186/CC13348]; Patel BM, 2002, ANESTHESIOLOGY, V96, P576, DOI 10.1097/00000542-200203000-00011; Prakash V, 2017, HEPATOLOGY, V66, p138A; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Russell JA, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1798-7; Russell JA, 2013, AM J RESP CRIT CARE, V188, P356, DOI 10.1164/rccm.201302-0355OC; Schmittinger CA, 2012, INTENS CARE MED, V38, P950, DOI 10.1007/s00134-012-2531-2; SepNet Critical Care Trials Grp, 2016, INTENS CARE MED, V42, P1980, DOI 10.1007/s00134-016-4504-3; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; SUZUKI Y, 1993, STROKE, V24, P1049, DOI 10.1161/01.STR.24.7.1049; Svoboda P, 2012, HEPATO-GASTROENTEROL, V59, P1043, DOI 10.5754/hge10550; Tan JX, 2016, INT J CLIN EXP MED, V9, P14183; Vincent JL, 2013, NEW ENGL J MED, V369, P1726, DOI 10.1056/NEJMra1208943; Walkey AJ, 2011, JAMA-J AM MED ASSOC, V306, P2248, DOI 10.1001/jama.2011.1615; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135	50	86	87	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1889	1900		10.1001/jama.2018.4528	http://dx.doi.org/10.1001/jama.2018.4528			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29801010	Green Published, Bronze			2022-12-28	WOS:000431668600018
J	Draznin, B; Nathan, DM; Korytkowski, MT; McDonnell, ME; Golden, SH; Schutta, MH; Cefalu, WT				Draznin, Boris; Nathan, David M.; Korytkowski, Mary T.; McDonnell, Marie E.; Golden, Sherita Hill; Schutta, Mark H.; Cefalu, William T.			Guidelines Versus Guidelines: What's Best for the Patient?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DIABETES-MELLITUS; FOLLOW-UP; COMPLICATIONS		[Draznin, Boris] Univ Colorado, Anschutz Med Campus, Aurora, CO USA; [Nathan, David M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Nathan, David M.; McDonnell, Marie E.] Harvard Med Sch, Boston, MA USA; [Korytkowski, Mary T.] Univ Pittsburgh, Pittsburgh, PA USA; [McDonnell, Marie E.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Golden, Sherita Hill] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Schutta, Mark H.] Univ Penn, Philadelphia, PA 19104 USA; [Cefalu, William T.] Amer Diabet Assoc, Arlington, VA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Johns Hopkins University; University of Pennsylvania; American Diabetes Association	Draznin, B (corresponding author), 12801 East 17th Ave, Aurora, CO 80045 USA.	Boris.Draznin@ucdenver.edu		McDonnell, Marie/0000-0002-2263-9783				Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS55, DOI 10.2337/dc18-S006; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Nathan DM, 2013, DIABETES, V62, P3976, DOI 10.2337/db13-1093; Qaseem A, 2018, ANN INTERN MED, V168, P569, DOI 10.7326/M17-0939; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	10	6	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2018	169	3					186	+		10.7326/M18-0939	http://dx.doi.org/10.7326/M18-0939			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ0AJ	29800101				2022-12-28	WOS:000441277700008
J	Hirschtritt, ME; Heaton, PM; Insel, TR				Hirschtritt, Matthew E.; Heaton, Penny M.; Insel, Thomas R.			Preparing Physician-Scientists for an Evolving Research Ecosystem	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hirschtritt, Matthew E.] Univ Calif San Francisco, Weill Inst Neurosci, Dept Psychiat, 401 Parnassus Ave,POB 0984, San Francisco, CA 94143 USA; [Heaton, Penny M.] Bill & Melinda Gates Med Res Inst, Seattle, WA USA; [Insel, Thomas R.] Mindstrong Hlth Inc, Palo Alto, CA USA	University of California System; University of California San Francisco	Hirschtritt, ME (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, Dept Psychiat, 401 Parnassus Ave,POB 0984, San Francisco, CA 94143 USA.	matthew.hirschtritt@ucsf.edu		Hirschtritt, Matthew/0000-0001-8654-1825				Daniels RJ, 2015, P NATL ACAD SCI USA, V112, P313, DOI 10.1073/pnas.1418761112; FASEB, NIH RES FUND TRENDS; Insel TR, 2017, NATURE, V551, P23, DOI 10.1038/551023a; Jain R, 2017, ROCK HLTH; Jain R, 2017, JAMA; Lauer M., MANY RES REVISITED L; Moses H, 2015, JAMA-J AM MED ASSOC, V313, P174, DOI 10.1001/jama.2014.15939; Physician-Scientist Workforce Working Group, 2014, NAT I HLTH PHYS SCI	8	10	10	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2018	320	1					31	32		10.1001/jama.2018.4478	http://dx.doi.org/10.1001/jama.2018.4478			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL5PC	29799967	Bronze			2022-12-28	WOS:000437219400010
J	Lu, HS; Yu, D; Hansen, AS; Ganguly, S; Liu, RD; Heckert, A; Darzacq, X; Zhou, Q				Lu, Huasong; Yu, Dan; Hansen, Anders S.; Ganguly, Sourav; Liu, Rongdiao; Heckert, Alec; Darzacq, Xavier; Zhou, Qiang			Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II	NATURE			English	Article							LOW-COMPLEXITY DOMAINS; TRANSCRIPTIONAL ELONGATION; BINDING; CTD; PROTEINS; REGIONS; TEFB; FORM; CODE	Hyperphosphorylation of the C-terminal domain (CTD) of the RPB1 subunit of human RNA polymerase (Pol) II is essential for transcriptional elongation and mRNA processing(1-3). The CTD contains 52 heptapeptide repeats of the consensus sequence YSPTSPS. The highly repetitive nature and abundant possible phosphorylation sites of the CTD exert special constraints on the kinases that catalyse its hyperphosphorylation. Positive transcription elongation factor b (P-TEFb)-which consists of CDK9 and cyclin T1-is known to hyperphosphorylate the CTD and negative elongation factors to stimulate Pol II elongation(1,4,5). The sequence determinant on P-TEFb that facilitates this action is currently unknown. Here we identify a histidine-rich domain in cyclin T1 that promotes the hyperphosphorylation of the CTD and stimulation of transcription by CDK9. The histidine-rich domain markedly enhances the binding of P-TEFb to the CTD and functional engagement with target genes in cells. In addition to cyclin T1, at least one other kinase-DYRK1A(6)-also uses a histidine-rich domain to target and hyperphosphorylate the CTD. As a low-complexity domain, the histidine-rich domain also promotes the formation of phase-separated liquid droplets in vitro, and the localization of P-TEFb to nuclear speckles that display dynamic liquid properties and are sensitive to the disruption of weak hydrophobic interactions. The CTD-which in isolation does not phase separate, despite being a low-complexity domain-is trapped within the cyclin T1 droplets, and this process is enhanced upon pre-phosphorylation by CDK7 of transcription initiation factor TFIIH1-3. By using multivalent interactions to create a phase-separated functional compartment, the histidine-rich domain in kinases targets the CTD into this environment to ensure hyperphosphorylation and efficient elongation of Pol II.	[Lu, Huasong; Liu, Rongdiao] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Peoples R China; [Lu, Huasong; Yu, Dan; Hansen, Anders S.; Ganguly, Sourav; Heckert, Alec; Darzacq, Xavier; Zhou, Qiang] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	Xiamen University; University of California System; University of California Berkeley	Zhou, Q (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	qzhou@berkeley.edu	Hansen, Anders Sejr/M-9989-2019	Hansen, Anders Sejr/0000-0001-7540-7858; Yu, Dan/0000-0003-3488-0467	National Institutes of Health [R01AI041757]; California Institute of Regenerative Medicine grant [LA1-08013]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM098218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA047729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. McKnight, M. Geyer, J. Hurley and their colleagues for providing the various expression plasmids, and U. Schulze-Gahmen for technical help. This work was supported by the National Institutes of Health grant R01AI041757 to Q.Z. and the California Institute of Regenerative Medicine grant LA1-08013 to X.D.	Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Courchaine EM, 2016, EMBO J, V35, P1603, DOI 10.15252/embj.201593517; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Di Vona C, 2015, MOL CELL, V57, P506, DOI 10.1016/j.molcel.2014.12.026; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Hansen AS, 2018, ELIFE, V7, DOI [10.7554/eLife.33125.001, 10.7554/eLife.33125]; Hansen AS, 2017, ELIFE, V6, DOI 10.7554/eLife.25776; Harlen KM, 2017, NAT REV MOL CELL BIO, V18, P263, DOI 10.1038/nrm.2017.10; Herrmann CH, 2001, J CELL SCI, V114, P1491; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Marcello A, 2003, EMBO J, V22, P2156, DOI 10.1093/emboj/cdg205; Mitrea DM, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-015-0125-7; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Mortillaro MJ, 1996, P NATL ACAD SCI USA, V93, P8253, DOI 10.1073/pnas.93.16.8253; Salichs E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000397; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Taube R, 2002, MOL CELL BIOL, V22, P321, DOI 10.1128/MCB.22.1.321-331.2002; Xiang JX, 2017, P NATL ACAD SCI USA, V114, pE1224, DOI 10.1073/pnas.1614893114; Ying Y, 2017, CELL, V170, P312, DOI 10.1016/j.cell.2017.06.022; Zaborowska J, 2016, NAT STRUCT MOL BIOL, V23, P771, DOI 10.1038/nsmb.3285; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	26	272	279	12	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2018	558	7709					318	+		10.1038/s41586-018-0174-3	http://dx.doi.org/10.1038/s41586-018-0174-3			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2BI	29849146	Green Accepted			2022-12-28	WOS:000435071400059
J	Iacobucci, G				Iacobucci, Gareth			Home secretary announces review of visa cap	BMJ-BRITISH MEDICAL JOURNAL			English	News Item									[Iacobucci, Gareth] Edgehill Univ, Ormskirk, England	Edge Hill University	Iacobucci, G (corresponding author), Edgehill Univ, Ormskirk, England.							Rimmer A, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2197	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2018	361								k2479	10.1136/bmj.k2479	http://dx.doi.org/10.1136/bmj.k2479			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BQ	29866712				2022-12-28	WOS:000435072800011
J	Cho, A				Cho, Adrian			THE GALAXY BUILDERS	SCIENCE			English	Editorial Material																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					954	957		10.1126/science.360.6392.954	http://dx.doi.org/10.1126/science.360.6392.954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6SL	29853669				2022-12-28	WOS:000433574200019
J	Dolgin, E				Dolgin, Elie			Ahead of time	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					S44	S45		10.1038/d41586-018-05178-x	http://dx.doi.org/10.1038/d41586-018-05178-x			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IH1VP	29844553	Bronze			2022-12-28	WOS:000474281100001
J	Ostapcuk, V; Mohn, F; Carl, SH; Basters, A; Hess, D; Iesmantavicius, V; Lampersberger, L; Flemr, M; Pandey, A; Thoma, NH; Betschinger, J; Buhler, M				Ostapcuk, Veronika; Mohn, Fabio; Carl, Sarah H.; Basters, Anja; Hess, Daniel; Iesmantavicius, Vytautas; Lampersberger, Lisa; Flemr, Matyas; Pandey, Aparna; Thoma, Nicolas H.; Betschinger, Joerg; Buhler, Marc			Activity-dependent neuroprotective protein recruits HP1 and CHD4 to control lineage-specifying genes	NATURE			English	Article							EMBRYONIC STEM-CELLS; HISTONE H3; DNA METHYLATION; LYSINE 9; CHROMATIN; DIFFERENTIATION; EXPRESSION; BINDING; ADNP; HETEROCHROMATIN	De novo mutations in ADNP, which encodes activity-dependent neuroprotective protein (ADNP), have recently been found to underlie Helsmo ortel-Van der Aa syndrome, a complex neurological developmental disorder that also affects several other organ functions'. ADNP is a putative transcription factor that is essential for embryonic development(2). However, its precise roles in transcriptional regulation and development are not understood. Here we show that ADNP interacts with the chromatin remodeller CHD4 and the chromatin architectural protein HP1 to form a stable complex, which we refer to as ChAHP. Besides mediating complex assembly, ADNP recognizes DNA motifs that specify binding of ChAHP to euchromatin. Genetic ablation of ChAHP components in mouse embryonic stem cells results in spontaneous differentiation concomitant with premature activation of lineage specific genes and in a failure to differentiate towards the neuronal lineage. Molecularly, ChAHP-mediated repression is fundamentally different from canonical HP1-mediated silencing: HP1 proteins, in conjunction with histone H3 lysine 9 trimethylation (H3K9me3), are thought to assemble broad heterochromatin domains that are refractory to transcription. ChAHP-mediated repression, however, acts in a locally restricted manner by establishing inaccessible chromatin around its DNA-binding sites and does not depend on H3K9me3-modified nucleosomes. Together, our results reveal that ADNP, via the recruitment of HP1 and CHD4, regulates the expression of genes that are crucial for maintaining distinct cellular states and assures accurate cell fate decisions upon external cues. Such a general role of ChAHP in governing cell fate plasticity may explain why ADNP mutations affect several organs and body functions and contribute to cancer progression(1,3,4). Notably, we found that the integrity of the ChAHP complex is disrupted by nonsense mutations identified in patients with Helsmoortel-Van der Aa syndrome, and this could be rescued by aminoglycosides that suppress translation terminations. Therefore, patients might benefit from therapeutic agents that are being developed to promote ribosomal read-through of premature stop codons(6,7).	[Ostapcuk, Veronika; Mohn, Fabio; Carl, Sarah H.; Basters, Anja; Hess, Daniel; Iesmantavicius, Vytautas; Lampersberger, Lisa; Flemr, Matyas; Pandey, Aparna; Thoma, Nicolas H.; Betschinger, Joerg; Buhler, Marc] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Ostapcuk, Veronika; Pandey, Aparna; Buhler, Marc] Univ Basel, Basel, Switzerland; [Carl, Sarah H.] Swiss Inst Bioinformat, Basel, Switzerland; [Lampersberger, Lisa] Univ Vienna, Vienna, Austria	Friedrich Miescher Institute for Biomedical Research; University of Basel; Swiss Institute of Bioinformatics; University of Vienna	Buhler, M (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.; Buhler, M (corresponding author), Univ Basel, Basel, Switzerland.	marc.buehler@fmi.ch	Buehler, Marc/S-5866-2019	Buehler, Marc/0000-0001-6661-9795; Mohn, Fabio/0000-0001-9889-5225; Betschinger, Joerg/0000-0002-2627-8479; Carl, Sarah/0000-0003-3927-2559	Swiss National Science Foundation (SNF)	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	We thank A. Peters and D. Schubeler for discussion and feedback on the manuscript, and H. Pickersgill for editing assistance. We thank Y. Shimada and N. Laschet for technical support. We would like to thank the FMI Functional Genomics facility for assistance in library construction and next generation sequencing, and J. Seebacher for discussions. This work was supported by funds from the Swiss National Science Foundation (SNF).	Abdulrahman W, 2009, ANAL BIOCHEM, V385, P383, DOI 10.1016/j.ab.2008.10.044; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cho LTY, 2012, DEVELOPMENT, V139, P2866, DOI 10.1242/dev.078519; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; de Dieuleveult M, 2016, NATURE, V530, P113, DOI 10.1038/nature16505; Domcke S, 2015, NATURE, V528, P575, DOI 10.1038/nature16462; Flemr M, 2015, CELL REP, V12, P709, DOI 10.1016/j.celrep.2015.06.051; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Gaidatzis D, 2015, BIOINFORMATICS, V31, P1130, DOI 10.1093/bioinformatics/btu781; Gozes I, 2015, J MOL NEUROSCI, V56, P751, DOI 10.1007/s12031-015-0586-6; Gozes I, 2015, J ALZHEIMERS DIS, V45, P57, DOI 10.3233/JAD-142490; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helsmoortel C, 2014, NAT GENET, V46, P380, DOI 10.1038/ng.2899; Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Knuckles P, 2017, NAT STRUCT MOL BIOL, V24, P561, DOI 10.1038/nsmb.3419; Kwon SH, 2008, MOL CELLS, V26, P217; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu N, 2015, GENE DEV, V29, P379, DOI 10.1101/gad.254425.114; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Maison C, 2012, NAT STRUCT MOL BIOL, V19, P458, DOI 10.1038/nsmb.2244; Mandel S, 2007, J BIOL CHEM, V282, P34448, DOI 10.1074/jbc.M704756200; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Mosch K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015894; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Niwa H, 2010, DEV GROWTH DIFFER, V52, P275, DOI 10.1111/j.1440-169X.2009.01166.x; Peltz SW, 2013, ANNU REV MED, V64, P407, DOI 10.1146/annurev-med-120611-144851; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Tiwari VK, 2012, NAT GENET, V44, P94, DOI 10.1038/ng.1036; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	54	72	72	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					739	+		10.1038/s41586-018-0153-8	http://dx.doi.org/10.1038/s41586-018-0153-8			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29795351				2022-12-28	WOS:000433412900057
J	LaManna, JA; Mangan, SA; Alonso, A; Bourg, NA; Brockelman, WY; Bunyavejchewin, S; Chang, LW; Chiang, JM; Chuyong, GB; Clay, K; Cordell, S; Davies, SJ; Furniss, TJ; Giardina, CP; Gunatilleke, IAUN; Gunatilleke, CVS; He, FL; Howe, RW; Hubbell, SP; Hsieh, CF; Inman-Narahari, FM; Janik, D; Johnson, DJ; Kenfack, D; Korte, L; Kral, K; Larson, AJ; Lutz, JA; McMahon, SM; McShea, WJ; Memiaghe, HR; Nathalang, A; Novotny, V; Ong, PS; Orwig, DA; Ostertag, R; Parker, GG; Phillips, RP; Sack, L; Sun, IF; Tello, JS; Thomas, DW; Turner, BL; Diaz, DMV; Vrska, T; Weiblen, GD; Wolf, A; Yap, S; Myers, JA				LaManna, Joseph A.; Mangan, Scott A.; Alonso, Alfonso; Bourg, Norman A.; Brockelman, Warren Y.; Bunyavejchewin, Sarayudh; Chang, Li-Wan; Chiang, Jyh-Min; Chuyong, George B.; Clay, Keith; Cordell, Susan; Davies, Stuart J.; Furniss, Tucker J.; Giardina, Christian P.; Gunatilleke, I. A. U. Nimal; Gunatilleke, C. V. Savitri; He, Fangliang; Howe, Robert W.; Hubbell, Stephen P.; Hsieh, Chang-Fu; Inman-Narahari, Faith M.; Janik, David; Johnson, Daniel J.; Kenfack, David; Korte, Lisa; Kral, Kamil; Larson, Andrew J.; Lutz, James A.; McMahon, Sean M.; McShea, William J.; Memiaghe, Herve R.; Nathalang, Anuttara; Novotny, Vojtech; Ong, Perry S.; Orwig, David A.; Ostertag, Rebecca; Parker, Geoffrey G.; Phillips, Richard P.; Sack, Lawren; Sun, I-Fang; Tello, J. Sebastian; Thomas, Duncan W.; Turner, Benjamin L.; Diaz, Dilys M. Vela; Vrska, Tomas; Weiblen, George D.; Wolf, Amy; Yap, Sandra; Myers, Jonathan A.			Response to Comment on "Plant diversity increases with the strength of negative density dependence at the global scale"	SCIENCE			English	Editorial Material							SEED DISPERSAL; NEOTROPICAL FOREST; TROPICAL FOREST; RECRUITMENT; LIMITATION; PATTERNS	Hulsmann and Hartig suggest that ecological mechanisms other than specialized natural enemies or intraspecific competition contribute to our estimates of conspecific negative density dependence (CNDD). To address their concern, we show that our results are not the result of amethodological artifact and present a null-model analysis that demonstrates that our original findings-(i) stronger CNDD at tropical relative to temperate latitudes and (ii) a latitudinal shift in the relationship between CNDD and species abundance-persist even after controlling for other processes that might influence spatial relationships between adults and recruits.	[LaManna, Joseph A.; Myers, Jonathan A.] Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA; [LaManna, Joseph A.; Mangan, Scott A.; Diaz, Dilys M. Vela; Myers, Jonathan A.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Alonso, Alfonso; Korte, Lisa] Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Conservat & Sustainabil, Washington, DC USA; [Bourg, Norman A.] US Geol Survey, Water Miss Area, Earth Syst Proc Div, Hydrol Ecol Interact Branch, 959 Natl Ctr, Reston, VA 22092 USA; [Brockelman, Warren Y.; Nathalang, Anuttara] Dev Agcy, Natl Sci & Technol, BIOTEC, Ecol Lab, Sci Pk, Pathum Thani, Thailand; [Brockelman, Warren Y.] Mahidol Univ Salaya, Inst Mol Biosci, Nakhon, Pathom, Thailand; [Bunyavejchewin, Sarayudh] Wildlife & Plant Conservat, Dept Natl Pk, Res Off, Bangkok, Thailand; [Chang, Li-Wan] Taiwan Forestry Res Inst, Taipei 10066, Taiwan; [Chiang, Jyh-Min] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Chuyong, George B.] Univ Buea, Dept Bot & Plant Physiol, Buea, Cameroon; [Clay, Keith; Phillips, Richard P.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Cordell, Susan; Giardina, Christian P.; Inman-Narahari, Faith M.] US Forest Serv, USDA, Inst Pacific Islands Forestry, Hilo, HI USA; [Davies, Stuart J.; Kenfack, David] Smithsonian Trop Res Inst, Forest Global Earth Observ, Ctr Trop Forest Sci, Panama City, Panama; [Davies, Stuart J.; Kenfack, David] Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Furniss, Tucker J.; Lutz, James A.] Utah State Univ, Wildland Resources Dept, Logan, UT 84322 USA; [Gunatilleke, I. A. U. Nimal; Gunatilleke, C. V. Savitri] Univ Peradeniya, Fac Sci, Dept Bot, Peradeniya, Sri Lanka; [He, Fangliang] SYSU, Univ Alberta, Sch Life Sci, Joint Lab Biodivers Conservat,State Key Lab Bioco, Guangzhou 510275, Guangdong, Peoples R China; [He, Fangliang] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Howe, Robert W.; Wolf, Amy] Univ Wisconsin, Dept Nat & Appl Sci, Green Bay, WI 54302 USA; [Hubbell, Stephen P.; Sack, Lawren] Univ Calif Los Angeles, Dept Ecol & Evolut Biol, Los Angeles, CA USA; [Hsieh, Chang-Fu] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei, Taiwan; [Janik, David; Kral, Kamil; Vrska, Tomas] Silva Tarouca Res Inst, Dept Forest Ecol, Brno, Czech Republic; [Johnson, Daniel J.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Larson, Andrew J.] Univ Montana, Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA; [McMahon, Sean M.] Smithsonian Environm Res Ctr, Forest Global Earth Observ, Ctr Trop Forest Sci, POB 28, Edgewater, MD 21037 USA; [McMahon, Sean M.; Parker, Geoffrey G.] Smithsonian Environm Res Ctr, Forest Ecol Grp, POB 28, Edgewater, MD 21037 USA; [McShea, William J.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA USA; [Memiaghe, Herve R.] Ctr Natl Rech Sci & Technol, Inst Rech Ecol Tropicale, Libreville, Gabon; [Novotny, Vojtech] New Guinea Binatang Res Ctr, POB 604, Madang, Papua N Guinea; [Novotny, Vojtech] Acad Sci Czech Republ, Biol Ctr, Prague, Czech Republic; [Novotny, Vojtech] Univ South Bohemia, Fac Sci, Branisovska 31, Ceske Budejovice 37005, Czech Republic; [Ong, Perry S.] Univ Philippines Diliman, Inst Biol, Quezon City, Philippines; [Orwig, David A.] Harvard Univ, Harvard Forest, Petersham, MA USA; [Ostertag, Rebecca] Univ Hawaii, Dept Biol, Hilo, HI 96720 USA; [Sun, I-Fang] Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, Hualien, Taiwan; [Tello, J. Sebastian] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, Pob 299, St Louis, MO 63166 USA; [Thomas, Duncan W.] Washington State Univ, Sch Biol Sci, Vancouver, WA USA; [Turner, Benjamin L.] Smithsonian Trop Res Inst, Balboa, Panama; [Weiblen, George D.] Univ Minnesota, Dept Plant & Microbial Biol, St Paul, MN 55108 USA; [Wolf, Amy] Univ Wisconsin, Dept Biol, Green Bay, WI 54302 USA; [Yap, Sandra] Far Eastern Univ Manila, Inst Arts & Sci, Manila, Philippines	Washington University (WUSTL); Washington University (WUSTL); Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; United States Department of the Interior; United States Geological Survey; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Tunghai University; Indiana University System; Indiana University Bloomington; United States Department of Agriculture (USDA); United States Forest Service; Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; Utah System of Higher Education; Utah State University; University of Peradeniya; Sun Yat Sen University; University of Alberta; University of Wisconsin System; University of California System; University of California Los Angeles; National Taiwan University; Utah System of Higher Education; Utah State University; University of Montana System; University of Montana; Smithsonian Institution; Smithsonian Environmental Research Center; Smithsonian Institution; Smithsonian Environmental Research Center; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of the Philippines System; University of the Philippines Diliman; Harvard University; University of Hawaii System; University Hawaii Hilo; National Dong Hwa University; Missouri Botanical Gardens; Washington State University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; Far Eastern University	LaManna, JA (corresponding author), Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA.; LaManna, JA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	joe.a.lamanna@gmail.com	Díaz, Dilys M Vela/N-4481-2018; Kral, Kamil/E-4415-2014; Turner, Benjamin L/E-5940-2011; Lutz, James/AAA-9574-2019; Ostertag, Rebecca/B-1756-2013; Sack, Lawren/A-5492-2008; Giardina, Christian P/C-3120-2011; Novotny, Vojtech/G-9434-2014; Phillips, Richard P/C-6429-2009; Johnson, Daniel J./L-4899-2019; Janík, David/H-1334-2018	Díaz, Dilys M Vela/0000-0002-5332-1305; Turner, Benjamin L/0000-0002-6585-0722; Sack, Lawren/0000-0002-7009-7202; Giardina, Christian P/0000-0002-3431-5073; Novotny, Vojtech/0000-0001-7918-8023; Phillips, Richard P/0000-0002-1345-4138; Johnson, Daniel J./0000-0002-8585-2143; Janík, David/0000-0002-8271-7456; Orwig, David/0000-0001-7822-3560; Alonso, Alfonso/0000-0001-6860-8432; LaManna, Joseph/0000-0002-8229-7973; Lutz, James/0000-0002-2560-0710; Chiang, Jyh-Min/0000-0002-6293-1551; Ong, Perry/0000-0002-1597-1921; McShea, William/0000-0002-8102-0200; Bourg, Norman/0000-0002-7443-1992; Chuyong, George/0000-0002-0235-211X; Kral, Kamil/0000-0002-3848-2119; Kenfack, David/0000-0001-8208-3388; Ostertag, Rebecca/0000-0002-5747-3285	NSF [DEB-1545761, DEB-1256788, DEB-1557094, DEB-1257989]; Tyson Research Center; Direct For Biological Sciences [1237491] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Tyson Research Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank an anonymous reviewer for suggesting the distance-weighted approach. We also thank everyone involved in the collection of the vast quantity of data in the CTFS-ForestGEO network; see table S20 in our original paper for site-specific acknowledgments. Supported by NSF grant DEB-1545761 (S.J.D.), NSF grants DEB-1256788 and DEB-1557094 (J.A.M.), NSF grant DEB-1257989 (S.A.M.), and the Tyson Research Center. We declare no conflicts of interest. The data and R code for analyses are available at the Smithsonian Institution's ForestGEO database portal: https://forestgeo.si.edu/explore-data and https://forestgeo.si.edu/plant-diversity-increases-strength-negativedensity-dependence-global-scale.	Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Dickie IA, 2012, SCIENCE, V338, DOI 10.1126/science.1225520; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hulsmann L, 2018, SCIENCE, V360, DOI 10.1126/science.aar2435; LaManna JA, 2018, SCIENCE, V360, DOI 10.1126/science.aar5245; LaManna JA, 2017, SCIENCE, V356, P1389, DOI 10.1126/science.aam5678; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Wiegand T, 2014, CH HALL CRC APP ENV, P1; Yenni G, 2012, ECOLOGY, V93, P456, DOI 10.1890/11-1087.1; Zhu K, 2015, ECOLOGY, V96, P2319, DOI 10.1890/14-1780.1	16	6	6	4	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391							aar3824	10.1126/science.aar3824	http://dx.doi.org/10.1126/science.aar3824			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG9RW	29798853	Green Submitted			2022-12-28	WOS:000433039800002
J	Normile, D				Normile, Dennis			China's ambitious brain science project inches forward	SCIENCE			English	News Item																			0	2	2	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					840	841		10.1126/science.360.6391.840	http://dx.doi.org/10.1126/science.360.6391.840			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798861				2022-12-28	WOS:000433039800019
J	Guglielmi, G				Guglielmi, Giorgia			GUT MICROBES JOIN THE FIGHT AGAINST CANCER	NATURE			English	News Item							IMMUNOTHERAPY; EFFICACY							Guglielmi, Giorgia/0000-0003-0649-3232				Alang N, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv004; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537	9	16	20	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2018	557	7706					482	484		10.1038/d41586-018-05208-8	http://dx.doi.org/10.1038/d41586-018-05208-8			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6GP	29795257				2022-12-28	WOS:000432794900020
J	Torjesen, I				Torjesen, Ingrid			Taxes must rise to fund 5% budget increase the NHS needs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Institute for Fiscal Studies. Health Foundation, 2018, SEC FUT FUND HLTH SO	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2018	361								k2337	10.1136/bmj.k2337	http://dx.doi.org/10.1136/bmj.k2337			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH4XN	29794079				2022-12-28	WOS:000433416100011
J	Zarocostas, J				Zarocostas, John			HIV/AIDS community divided over allegations about UNAIDS	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2018	391	10134					1984	1984		10.1016/S0140-6736(18)31074-2	http://dx.doi.org/10.1016/S0140-6736(18)31074-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GG1IJ	29864014				2022-12-28	WOS:000432440300014
J	Shillcutt, SK				Shillcutt, Sasha K.			Rounds	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Shillcutt, Sasha K.] Univ Nebraska, Med Ctr, Dept Anesthesiol, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center	Shillcutt, SK (corresponding author), Univ Nebraska, Med Ctr, Nebraska Med Ctr 984455, Omaha, NE 68198 USA.	sshillui@unmc.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1863	1863		10.1001/jama.2018.4307	http://dx.doi.org/10.1001/jama.2018.4307			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29801015				2022-12-28	WOS:000431668600012
J	Migden, MR; Rischin, D; Schmults, CD; Guminski, A; Hauschild, A; Lewis, KD; Chung, CH; Hernandez-Aya, L; Lim, AM; Chang, ALS; Rabinowits, G; Thai, AA; Dunn, LA; Hughes, BGM; Khushalani, NI; Modi, B; Schadendorf, D; Gao, B; Seebach, F; Li, S; Li, J; Mathias, M; Booth, J; Mohan, K; Stankevich, E; Babiker, HM; Brana, I; Gil-Martin, M; Homsi, J; Johnson, ML; Moreno, V; Niu, J; Owonikoko, TK; Papadopoulos, KP; Yancopoulos, GD; Lowy, I; Fury, MG				Migden, M. R.; Rischin, D.; Schmults, C. D.; Guminski, A.; Hauschild, A.; Lewis, K. D.; Chung, C. H.; Hernandez-Aya, L.; Lim, A. M.; Chang, A. L. S.; Rabinowits, G.; Thai, A. A.; Dunn, L. A.; Hughes, B. G. M.; Khushalani, N. I.; Modi, B.; Schadendorf, D.; Gao, B.; Seebach, F.; Li, S.; Li, J.; Mathias, M.; Booth, J.; Mohan, K.; Stankevich, E.; Babiker, H. M.; Brana, I.; Gil-Martin, M.; Homsi, J.; Johnson, M. L.; Moreno, V.; Niu, J.; Owonikoko, T. K.; Papadopoulos, K. P.; Yancopoulos, G. D.; Lowy, I.; Fury, M. G.			PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONMELANOMA SKIN-CANCER; MISMATCH-REPAIR DEFICIENCY; TUMOR MUTATIONAL BURDEN; SOLID TUMORS; LANDSCAPE; SENSITIVITY; MANAGEMENT; GUIDELINE; CONSENSUS	BACKGROUND No systemic therapies have been approved for the treatment of advanced cutaneous squamous-cell carcinoma. This cancer may be responsive to immune therapy, because the mutation burden of the tumor is high and the disease risk is strongly associated with immunosuppression. In the dose-escalation portion of the phase 1 study of cemiplimab, a deep and durable response was observed in a patient with metastatic cutaneous squamous-cell carcinoma. METHODS We report the results of the phase 1 study of cemiplimab for expansion cohorts of patients with locally advanced or metastatic cutaneous squamous-cell carcinoma, as well as the results of the pivotal phase 2 study for a cohort of patients with metastatic disease (metastatic-disease cohort). In both studies, the patients received an intravenous dose of cemiplimab (3 mg per kilogram of body weight) every 2 weeks and were assessed for a response every 8 weeks. In the phase 2 study, the primary end point was the response rate, as assessed by independent central review. RESULTS In the expansion cohorts of the phase 1 study, a response to cemiplimab was observed in 13 of 26 patients (50%; 95% confidence interval [CI], 30 to 70). In the metastatic-disease cohort of the phase 2 study, a response was observed in 28 of 59 patients (47%; 95% CI, 34 to 61). The median follow-up was 7.9 months in the metastatic-disease cohort of the phase 2 study. Among the 28 patients who had a response, the duration of response exceeded 6 months in 57%, and 82% continued to have a response and to receive cemiplimab at the time of data cutoff. Adverse events that occurred in at least 15% of the patients in the metastatic-disease cohort of the phase 2 study were diarrhea, fatigue, nausea, constipation, and rash; 7% of the patients discontinued treatment because of an adverse event. CONCLUSIONS Among patients with advanced cutaneous squamous-cell carcinoma, cemiplimab induced a response in approximately half the patients and was associated with adverse events that usually occur with immune checkpoint inhibitors.	[Migden, M. R.] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1400 Pressler St 1452, Houston, TX 73030 USA; [Migden, M. R.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, 1400 Pressler St 1452, Houston, TX 73030 USA; [Papadopoulos, K. P.] START, San Antonio, TX USA; [Rischin, D.; Thai, A. A.] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia; [Rischin, D.; Thai, A. A.] Univ Melbourne, Melbourne, Vic, Australia; [Guminski, A.] Royal North Shore Hosp, Dept Med Oncol, St Leonards, Vic, Australia; [Lim, A. M.] Sir Charles Gairdner Hosp, Dept Med Oncol, Perth, WA, Australia; [Hughes, B. G. M.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Hughes, B. G. M.] Univ Queensland, Brisbane, Qld, Australia; [Schmults, C. D.] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA; [Schmults, C. D.] Harvard Med Sch, Dept Dermatol, Boston, MA USA; [Rabinowits, G.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hauschild, A.] Schleswig Holstein Univ Hosp, Kiel, Germany; [Schadendorf, D.] Univ Hosp Essen, Essen, Germany; [Schadendorf, D.] German Canc Consortium, Essen, Germany; [Lewis, K. D.] Univ Colorado Denver, Sch Med, Aurora, CO USA; [Chung, C. H.] H Lee Moffitt Canc Ctr & Res Inst, Dept Head & Neck Endocrine Oncol, Tampa, FL USA; [Khushalani, N. I.] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL USA; [Hernandez-Aya, L.] Washington Univ, Sch Med, Div Med Oncol, Dept Med, St Louis, MO 63130 USA; [Chang, A. L. S.] Stanford Univ, Sch Med, Dept Dermatol, Redwood City, CA USA; [Modi, B.] City Hope Natl Med Ctr, Div Dermatol, Duarte, CA USA; [Dunn, L. A.] Mem Sloan Kettering Canc Ctr, Dept Med Head & Neck Med Oncol, 1275 York Ave, New York, NY 10021 USA; [Seebach, F.; Mathias, M.; Mohan, K.; Yancopoulos, G. D.; Lowy, I.; Fury, M. G.] Regeneron Pharmaceut, Tarrytown, NY USA; [Gao, B.; Li, S.; Li, J.; Booth, J.; Stankevich, E.] Regeneron Pharmaceut, Basking Ridge, NJ USA; [Babiker, H. M.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Homsi, J.] Banner MD Anderson Canc Ctr, Banner MD Anderson Canc, Gilbert, AZ USA; [Niu, J.] Banner MD Anderson Canc Ctr, Dept Med Oncol, Gilbert, AZ USA; [Brana, I.] Vall DHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain; [Gil-Martin, M.] Inst Catala Oncol, Barcelona, Spain; [Moreno, V.] Hosp Fdn Jimenez Diaz, START Madrid FJD, Madrid, Spain; [Johnson, M. L.] Sarah Cannon Res Inst, Nashville, TN USA; [Owonikoko, T. K.] Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Royal North Shore Hospital; University of Western Australia; Royal Brisbane & Women's Hospital; University of Queensland; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Kiel; Schleswig Holstein University Hospital; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Washington University (WUSTL); Stanford University; City of Hope; Memorial Sloan Kettering Cancer Center; Regeneron; University of Arizona; Banner Research; Banner Health; University of Texas System; UTMD Anderson Cancer Center; Banner Research; Banner Health; University of Texas System; UTMD Anderson Cancer Center; Hospital Universitari Vall d'Hebron; Catalan Institute of Oncology; Fundacion Jimenez Diaz; Sarah Cannon Research Institute; Emory University	Migden, MR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1400 Pressler St 1452, Houston, TX 73030 USA.; Migden, MR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, 1400 Pressler St 1452, Houston, TX 73030 USA.	mrmigden@mdanderson.org	Hughes, Brett/A-4546-2015; Moreno, Victor/GNN-0449-2022; guminski, alexander/AAI-2307-2019; Schadendorf, Dirk/AAE-8206-2019	Hughes, Brett/0000-0002-1811-0537; Moreno, Victor/0000-0001-6099-4236; Babiker, Hani M./0000-0002-9368-6296; Brana, Irene/0000-0002-1068-9601; Schadendorf, Dirk/0000-0003-3524-7858	Regeneron Pharmaceuticals; Sanofi	Regeneron Pharmaceuticals(Regeneron); Sanofi	Funded by Regeneron Pharmaceuticals and Sanofi	Burova E, 2017, MOL CANCER THER, V16, P861, DOI 10.1158/1535-7163.MCT-16-0665; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Cranmer LD, 2010, ONCOLOGIST, V15, P1320, DOI 10.1634/theoncologist.2009-0210; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Falchook GS, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0176-3; Goodman AM, 2017, MOL CANCER THER, V16, P2598, DOI 10.1158/1535-7163.MCT-17-0386; Hillen U, 2018, EUR J CANCER, V96, P34, DOI 10.1016/j.ejca.2018.01.075; Jarkowski A, 2016, AM J CLIN ONCOL-CANC, V39, P545, DOI 10.1097/COC.0000000000000088; Karia PS, 2013, J AM ACAD DERMATOL, V68, P957, DOI 10.1016/j.jaad.2012.11.037; Kauvar ANB, 2015, DERMATOL SURG, V41, P1214, DOI 10.1097/DSS.0000000000000478; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187; Spain L, 2016, CANCER TREAT REV, V44, P51, DOI 10.1016/j.ctrv.2016.02.001; Stratigos A, 2015, EUR J CANCER, V51, P1989, DOI 10.1016/j.ejca.2015.06.110; Weber JS, 2016, ONCOLOGIST, V21, P1230, DOI 10.1634/theoncologist.2016-0055; Zimmer L, 2016, EUR J CANCER, V60, P210, DOI 10.1016/j.ejca.2016.02.024	22	662	675	6	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2018	379	4					341	351		10.1056/NEJMoa1805131	http://dx.doi.org/10.1056/NEJMoa1805131			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GO1YK	29863979	Bronze, Green Published			2022-12-28	WOS:000439757700007
J	Garner, MH; Li, HX; Chen, Y; Su, TA; Shangguan, Z; Paley, DW; Liu, TF; Ng, F; Li, HX; Xiao, SX; Nuckolls, C; Venkataraman, L; Solomon, GC				Garner, Marc H.; Li, Haixing; Chen, Yan; Su, Timothy A.; Shangguan, Zhichun; Paley, Daniel W.; Liu, Taifeng; Ng, Fay; Li, Hexing; Xiao, Shengxiong; Nuckolls, Colin; Venkataraman, Latha; Solomon, Gemma C.			Comprehensive suppression of single-molecule conductance using destructive sigma-interference	NATURE			English	Article							CONFORMATIONAL DEPENDENCE; QUANTUM INTERFERENCE; ELECTRON-TRANSPORT; JUNCTIONS; OLIGOSILANES; THERMOPOWER; TRANSMISSION; INTERFACES; DEVICES; SILVER	The tunnelling of electrons through molecules (and through any nanoscale insulating and dielectric material(1)) shows exponential attenuation with increasing length(2), a length dependence that is reflected in the ability of the electrons to carry an electrical current. It was recently demonstrated(3-5) that coherent tunnelling through a molecular junction can also be suppressed by destructive quantum interference(6), a mechanism that is not length-dependent. For the carbon-based molecules studied previously, cancelling all transmission channels would involve the suppression of contributions to the current from both the pi-orbital and sigma-orbital systems. Previous reports of destructive interference have demonstrated a decrease in transmission only through the pi-channel. Here we report a saturated silicon-based molecule with a functionalized bicyclo [2.2.2] octasilane moiety that exhibits destructive quantum interference in its sigma-system. Although molecular silicon typically forms conducting wires, we use a combination of conductance measurements and ab initio calculations to show that destructive sigma-interference, achieved here by locking the silicon-silicon bonds into eclipsed conformations within a bicyclic molecular framework, can yield extremely insulating molecules less than a nanometre in length. Our molecules also exhibit an unusually high thermopower (0.97 millivolts per kelvin), which is a further experimental signature of the suppression of all tunnelling paths by destructive interference: calculations indicate that the central bicyclo[2.2.2]octasilane unit is rendered less conductive than the empty space it occupies. The molecular design presented here provides a proof-of-concept for a quantum-interference-based approach to single-molecule insulators.	[Garner, Marc H.; Solomon, Gemma C.] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Garner, Marc H.; Solomon, Gemma C.] Univ Copenhagen, Dept Chem, Copenhagen, Denmark; [Li, Haixing; Venkataraman, Latha] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY USA; [Chen, Yan; Liu, Taifeng; Li, Hexing; Xiao, Shengxiong; Nuckolls, Colin] Shanghai Normal Univ, Optoelect Nano Mat & Devices Inst, Key Lab Resource Chem,Educ Minist, Shanghai Key Lab Rare Earth Funct Mat,Dept Chem, Shanghai, Peoples R China; [Su, Timothy A.; Paley, Daniel W.; Ng, Fay; Nuckolls, Colin; Venkataraman, Latha] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Paley, Daniel W.] Columbia Univ, Columbia Nano Initiat, New York, NY USA; [Li, Haixing] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Su, Timothy A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Shangguan, Zhichun] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, Shanghai, Peoples R China	University of Copenhagen; University of Copenhagen; Columbia University; Shanghai Normal University; Columbia University; Columbia University; Columbia University; University of California System; University of California Berkeley; Shanghai Jiao Tong University	Solomon, GC (corresponding author), Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark.; Solomon, GC (corresponding author), Univ Copenhagen, Dept Chem, Copenhagen, Denmark.; Xiao, SX; Nuckolls, C (corresponding author), Shanghai Normal Univ, Optoelect Nano Mat & Devices Inst, Key Lab Resource Chem,Educ Minist, Shanghai Key Lab Rare Earth Funct Mat,Dept Chem, Shanghai, Peoples R China.; Nuckolls, C; Venkataraman, L (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	xiaosx@shnu.edu.cn; cn37@columbia.edu; lv2117@columbia.edu; gsolomon@chem.ku.dk	Venkataraman, Latha/G-9786-2011; Xiao, Shengxiong/C-6156-2009	Venkataraman, Latha/0000-0002-6957-6089; Xiao, Shengxiong/0000-0002-9151-9558; Shangguan, Zhichun/0000-0003-0517-0677; Li, Haixing/0000-0002-1383-4907; Garner, Marc H./0000-0002-7270-8353	Danish Council for Independent Research\ Natural Sciences; Carlsberg Foundation; National Science Foundation (NSF) [CHE-1404922]; Columbia University's Research Initiatives in Science and Engineering; National Natural Science Foundation of China [21473113, 51502173]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [2013-57]; Shanghai Education Development Foundation; Shanghai Municipal Education Commission [14SG40]; Program of Shanghai Academic/Technology Research Leader [16XD1402700]; National Natural Science Foundation of Shanghai [15ZR1431100]; Ministry of Education of China [PCSIRT_16R49]; International Joint Laboratory of Resource Chemistry (IJLRC); NSF [11-44155]; Columbia University	Danish Council for Independent Research\ Natural Sciences(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation); National Science Foundation (NSF)(National Science Foundation (NSF)); Columbia University's Research Initiatives in Science and Engineering; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai Education Development Foundation; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Program of Shanghai Academic/Technology Research Leader; National Natural Science Foundation of Shanghai; Ministry of Education of China(Ministry of Education, China); International Joint Laboratory of Resource Chemistry (IJLRC); NSF(National Science Foundation (NSF)); Columbia University	G.C.S. and M.H.G. received funding from the Danish Council for Independent Research vertical bar Natural Sciences and the Carlsberg Foundation. We thank the National Science Foundation (NSF) for the support of experimental studies under grant no. CHE-1404922 (Ha.L.) and Columbia University's Research Initiatives in Science and Engineering. Y.C., Z.S., T.L. and S.X. are sponsored by the National Natural Science Foundation of China (grant nos 21473113 and 51502173), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (no. 2013-57), the "Shuguang Program" supported by Shanghai Education Development Foundation and Shanghai Municipal Education Commission (14SG40), the Program of Shanghai Academic/Technology Research Leader (no. 16XD1402700), the National Natural Science Foundation of Shanghai (no. 15ZR1431100), the Ministry of Education of China (PCSIRT_16R49) and the International Joint Laboratory of Resource Chemistry (IJLRC). T.A.S. was supported by an NSF Graduate Research Fellowship under grant no. 11-44155. We thank B. Fowler for mass spectrometry characterization. Single-crystal X-ray diffraction was performed at the Shared Materials Characterization Laboratory (SMCL) at Columbia University. Use of the SMCL was made possible by funding from Columbia University.	Adak O, 2015, NANO LETT, V15, P4143, DOI 10.1021/acs.nanolett.5b01270; Andrews DQ, 2008, J AM CHEM SOC, V130, P17309, DOI 10.1021/ja804399q; [Anonymous], 2016, VIRTUAL NANOLAB VERS; Aradhya SV, 2012, NANO LETT, V12, P1643, DOI 10.1021/nl2045815; Arroyo CR, 2013, ANGEW CHEM INT EDIT, V52, P3152, DOI 10.1002/anie.201207667; Atomistix toolkit, 2016, ATOMISTIX TOOLKIT VE; Bahn SR, 2002, COMPUT SCI ENG, V4, P56, DOI 10.1109/5992.998641; Bande A, 2009, CHEM-EUR J, V15, P8504, DOI 10.1002/chem.200901521; Bergfield JP, 2010, ACS NANO, V4, P5314, DOI 10.1021/nn100490g; Borges A, 2016, J PHYS CHEM LETT, V7, P4825, DOI 10.1021/acs.jpclett.6b02494; Brandbyge M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165401; Fischer R, 2003, J ORGANOMET CHEM, V685, P79, DOI 10.1016/j.jorganchem.2003.02.002; George CB, 2009, J PHYS CHEM A, V113, P3876, DOI 10.1021/jp809963r; Guedon CM, 2012, NAT NANOTECHNOL, V7, P304, DOI [10.1038/nnano.2012.37, 10.1038/NNANO.2012.37]; Ha YG, 2014, ACCOUNTS CHEM RES, V47, P1019, DOI 10.1021/ar4002262; Kim T, 2013, NANO LETT, V13, P3358, DOI 10.1021/nl401654s; Kingon AI, 2000, NATURE, V406, P1032, DOI 10.1038/35023243; Larsen AH, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.195112; Li HX, 2017, ANGEW CHEM INT EDIT, V56, P14145, DOI 10.1002/anie.201708524; Li HX, 2017, J AM CHEM SOC, V139, P10212, DOI 10.1021/jacs.7b05599; Lofas H, 2013, J PHYS CHEM C, V117, P21692, DOI 10.1021/jp407485n; Markussen T, 2013, PHYS STATUS SOLIDI B, V250, P2394, DOI 10.1002/pssb.201349217; Mayor M, 2003, ANGEW CHEM INT EDIT, V42, P5834, DOI 10.1002/anie.200352179; Meisner JS, 2012, J AM CHEM SOC, V134, P20440, DOI 10.1021/ja308626m; Nitzan A, 2001, ANNU REV PHYS CHEM, V52, P681, DOI 10.1146/annurev.physchem.52.1.681; Park YS, 2007, J AM CHEM SOC, V129, P15768, DOI 10.1021/ja0773857; Paulsson M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.241403; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Reddy P, 2007, SCIENCE, V315, P1568, DOI 10.1126/science.1137149; Rincon-Garcia L, 2016, CHEM SOC REV, V45, P4285, DOI 10.1039/c6cs00141f; Robertson J, 2015, MAT SCI ENG R, V88, P1, DOI 10.1016/j.mser.2014.11.001; SAUTET P, 1988, CHEM PHYS LETT, V153, P511, DOI 10.1016/0009-2614(88)85252-7; SIMMONS JG, 1963, J APPL PHYS, V34, P1793, DOI 10.1063/1.1702682; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; Solomon GC, 2010, NAT CHEM, V2, P223, DOI [10.1038/NCHEM.546, 10.1038/nchem.546]; Su TA, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.2; Su TA, 2015, NAT CHEM, V7, P215, DOI [10.1038/nchem.2180, 10.1038/NCHEM.2180]; Tamblyn I, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.201402; Trouwborst ML, 2011, NANO LETT, V11, P614, DOI 10.1021/nl103699t; Tsuji H, 2003, J ORGANOMET CHEM, V685, P9, DOI 10.1016/S0022-328X(03)00162-1; Tsuji H, 2003, J AM CHEM SOC, V125, P7486, DOI 10.1021/ja034500e; Venkataraman L, 2006, NANO LETT, V6, P458, DOI 10.1021/nl052373+; Venkataraman L, 2006, NATURE, V442, P904, DOI 10.1038/nature05037; Widawsky JR, 2012, NANO LETT, V12, P354, DOI 10.1021/nl203634m; Xu BQ, 2003, SCIENCE, V301, P1221, DOI 10.1126/science.1087481; Yoshizawa K, 2008, J AM CHEM SOC, V130, P9406, DOI 10.1021/ja800638t	47	173	174	20	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2018	558	7710					415	+		10.1038/s41586-018-0197-9	http://dx.doi.org/10.1038/s41586-018-0197-9			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3IU	29875407				2022-12-28	WOS:000436037800044
J	Clery, D				Clery, Daniel			Middleweight black holes found at last	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1057	1057		10.1126/science.360.6393.1057	http://dx.doi.org/10.1126/science.360.6393.1057			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI6TJ	29880668				2022-12-28	WOS:000434635500014
J	Lawler, A				Lawler, Andrew			Dig seeks site of first English settlement in the New World	SCIENCE			English	News Item																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1056	1056		10.1126/science.360.6393.1056	http://dx.doi.org/10.1126/science.360.6393.1056			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI6TJ	29880667				2022-12-28	WOS:000434635500013
J	Arboine, L; Palacios, JM				Arboine, Luis; Palacios, Juan M.			Left Main Coronary Artery Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Arboine, Luis; Palacios, Juan M.] Hosp Enfermedades Cardiovasc & Torax, Monterrey, Mexico		Arboine, L (corresponding author), Hosp Enfermedades Cardiovasc & Torax, Monterrey, Mexico.	luisarboine1986@gmail.com							0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2018	378	23					E32	E32		10.1056/NEJMicm1708877	http://dx.doi.org/10.1056/NEJMicm1708877			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3HS	29874527				2022-12-28	WOS:000434263000011
J	Hurley, R				Hurley, Richard			Art dealing: raffle tickets fund pill testing at festivals	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2018, BBC NEWS JUN; Busby M., 2018, INDEPENDENT; Royal Society for Public Health, 2017, LET FEST GOERS CLUBB	3	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2018	361								k2501	10.1136/bmj.k2501	http://dx.doi.org/10.1136/bmj.k2501			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BX	29875093				2022-12-28	WOS:000435073600009
J	Oliver, D				Oliver, David			David Oliver: Constant structural reorganisation won't improve or transform healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Bohmer RMJ, 2016, HARD WORK HLTH CARE; Department of Health and Social Care, 2010, LIB NHS WHIT PAP; Goddard M, 1997, NUFFIELD OCCASIONAL, V1; Ham C., 2014, REFORMING NHS HIERAR; Institute for Government, 2012, NEV AG STOR HLTH SOC; King's Fund, 2017, IS NHS STRUCT; Kirkpatrick I, 2018, USING MANAGEMENT CON; Kuziemsky Craig, 2016, Healthc Manage Forum, V29, P4, DOI 10.1177/0840470415614842; Lewis R., 2013, SIZE VERSUS QUALITY; Malby B, 2012, EFFECTIVE ORG FORMS; Maybin J, 2010, HIGH PERFORMING NHS; NHS England, 2018, NHS IMPR M COMM BOAR; Oliver D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7243; Timmins N., 2018, WORLDS BIGGEST QUANG	14	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2018	361								k2433	10.1136/bmj.k2433	http://dx.doi.org/10.1136/bmj.k2433			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BU	29871880	Green Published, Bronze			2022-12-28	WOS:000435073300004
J	Wise, J				Wise, Jacqui			Junior doctors see "substantial improvements" to their working lives, progress report shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		British Medical Association, 2018, ENH JUN DOCT WORK LI	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2018	361								k2444	10.1136/bmj.k2444	http://dx.doi.org/10.1136/bmj.k2444			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MT	29853446				2022-12-28	WOS:000434276300016
J	Oliver, D				Oliver, David			David Oliver: "Ghost wards" and rota gaps show the need for official safe staffing levels	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2016, BMJ-BRIT MED J, V353, pi2665, DOI [10.1136/bmj.i266527177770, DOI 10.1136/BMJ.I266527177770]; Campbell D, 2018, GUARDIAN; Clarke R., 2018, HADIZA BAWA GARBA CA; NHS Providers, 2017, SUMM VAC SHORTF FILL; Royal College of Physicians, 2017, CENS; Triggle N., 2018, BBC NEWS	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2018	361								k2322	10.1136/bmj.k2322	http://dx.doi.org/10.1136/bmj.k2322			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MF	29844020	Green Published, Bronze			2022-12-28	WOS:000434274800001
J	Jin, XH; Price, MB; Finnegan, JR; Boott, CE; Richter, JM; Rao, A; Menke, M; Friend, RH; Whittell, GR; Manners, I				Jin, Xu-Hui; Price, Michael B.; Finnegan, John R.; Boott, Charlotte E.; Richter, Johannes M.; Rao, Akshay; Menke, Matthew; Friend, Richard H.; Whittell, George R.; Manners, Ian			Long-range exciton transport in conjugated polymer nanofibers prepared by seeded growth	SCIENCE			English	Article							ORGANIC SEMICONDUCTORS; ENERGY-TRANSFER; DIFFUSION LENGTH; PHOTOPHYSICAL PROPERTIES; ROOM-TEMPERATURE; MIGRATION; MICELLES; POLYFLUORENE; ARCHITECTURE; ABSORPTION	Easily processed materials with the ability to transport excitons over length scales of more than 100 nanometers are highly desirable for a range of light-harvesting and optoelectronic devices. We describe the preparation of organic semiconducting nanofibers comprising a crystalline poly(di-n-hexylfluorene) core and a solvated, segmented corona consisting of polyethylene glycol in the center and polythiophene at the ends. These nanofibers exhibit exciton transfer from the core to the lower-energy polythiophene coronas in the end blocks, which occurs in the direction of the interchain pi-pi stacking with very long diffusion lengths (>200 nanometers) and a large diffusion coefficient (0.5 square centimeters per second). This is made possible by the uniform exciton energetic landscape created by the well-ordered, crystalline nanofiber core.	[Jin, Xu-Hui; Finnegan, John R.; Boott, Charlotte E.; Whittell, George R.; Manners, Ian] Univ Bristol, Sch Chem, Bristol BS8, Avon, England; [Price, Michael B.; Richter, Johannes M.; Rao, Akshay; Menke, Matthew; Friend, Richard H.] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge CB3 0HE, England	University of Bristol; University of Cambridge	Whittell, GR; Manners, I (corresponding author), Univ Bristol, Sch Chem, Bristol BS8, Avon, England.; Friend, RH (corresponding author), Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge CB3 0HE, England.	rhf10@cam.ac.uk; g.whittell@bristol.ac.uk; ian.manners@bristol.ac.uk	Whittell, George/AAP-1578-2021	Finnegan, John/0000-0002-2848-5025; Price, Michael/0000-0003-2227-0514; jin, xuhui/0000-0002-5100-5704; Friend, Richard Henry/0000-0001-6565-6308; Rao, Akshay/0000-0003-4261-0766; Boott, Charlotte/0000-0003-0902-030X	EPSRC [EP/K017799/1, EP/K016520/1, EP/M005143/1]; KAUST; EPSRC [EP/M006360/1, EP/K03927X/1, EP/L022532/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K03927X/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); KAUST(King Abdullah University of Science & Technology); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by EPSRC grants EP/K017799/1 (I.M.), EP/K016520/1 (R.H.F.), and EP/M005143/1 (R.H.F. and M.B.P.) and by a KAUST Competitive Research Grant (S.M.M. and R.H.F.).	Arno MC, 2017, J AM CHEM SOC, V139, P16980, DOI 10.1021/jacs.7b10199; Barford W, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075207; Bernardi M, 2013, NANO LETT, V13, P3664, DOI 10.1021/nl401544y; BULOVIC V, 1995, CHEM PHYS LETT, V238, P88, DOI 10.1016/0009-2614(95)00378-9; Collini E, 2009, SCIENCE, V323, P369, DOI 10.1126/science.1164016; Dubin F, 2006, NAT PHYS, V2, P32, DOI 10.1038/nphys196; Haedler AT, 2015, NATURE, V523, P196, DOI 10.1038/nature14570; HALLS JJM, 1995, NATURE, V376, P498, DOI 10.1038/376498a0; Hestand NJ, 2017, ACCOUNTS CHEM RES, V50, P341, DOI 10.1021/acs.accounts.6b00576; Kilina S, 2008, ACS NANO, V2, P1381, DOI 10.1021/nn800204m; King SM, 2007, CHEM PHYS LETT, V440, P268, DOI 10.1016/j.cplett.2007.04.068; Kuo CC, 2007, MACROMOLECULES, V40, P6959, DOI 10.1021/ma071182l; Li XY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15909; Lin CH, 2008, MACROMOLECULES, V41, P8759, DOI 10.1021/ma8016629; Lin HZ, 2010, NANO LETT, V10, P620, DOI 10.1021/nl9036559; Lin JDA, 2014, MATER HORIZONS, V1, P280, DOI 10.1039/c3mh00089c; Lunt RR, 2010, ADV MATER, V22, P1233, DOI 10.1002/adma.200902827; Menke SM, 2015, ACS APPL MATER INTER, V7, P2912, DOI 10.1021/am508332n; Mikhnenko OV, 2015, ENERG ENVIRON SCI, V8, P1867, DOI 10.1039/c5ee00925a; Monkman A, 2008, ADV POLYM SCI, V212, P187, DOI 10.1007/12_2008_147; Ogi S, 2014, NAT CHEM, V6, P188, DOI [10.1038/NCHEM.1849, 10.1038/nchem.1849]; Peumans P, 2003, J APPL PHYS, V93, P3693, DOI 10.1063/1.1534621; Pope M., 1999, ELECT PROCESSES ORGA; Qiu HB, 2016, SCIENCE, V352, P697, DOI 10.1126/science.aad9521; Scholes GD, 2003, ANNU REV PHYS CHEM, V54, P57, DOI 10.1146/annurev.physchem.54.011002.103746; Scully SR, 2006, J APPL PHYS, V100, DOI 10.1063/1.2226687; Spano FC, 2014, ANNU REV PHYS CHEM, V65, P477, DOI 10.1146/annurev-physchem-040513-103639; Tao DL, 2017, J AM CHEM SOC, V139, P7136, DOI 10.1021/jacs.7b02208; Vezie MS, 2016, NAT MATER, V15, P746, DOI [10.1038/NMAT4645, 10.1038/nmat4645]; Vogelsang J, 2011, NAT MATER, V10, P942, DOI [10.1038/NMAT3127, 10.1038/nmat3127]; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Wiesenhofer H, 2005, ADV FUNCT MATER, V15, P155, DOI 10.1002/adfm.200400108; Zhang W, 2011, SCIENCE, V334, P340, DOI 10.1126/science.1210369	33	196	197	24	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					897	900		10.1126/science.aar8104	http://dx.doi.org/10.1126/science.aar8104			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798881	Green Submitted			2022-12-28	WOS:000433039800045
J	Vogel, G				Vogel, Gretchen			German law allows use of DNA to predict suspects' looks	SCIENCE			English	News Item																			0	6	7	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					841	842		10.1126/science.360.6391.841	http://dx.doi.org/10.1126/science.360.6391.841			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798862				2022-12-28	WOS:000433039800020
J	O'Dowd, A				O'Dowd, Adrian			Government's response to 239m pound worth of inquiries has been "opaque," says NAO	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Audit Office, 2018, INV GOV FUND INQ	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2018	361								k2332	10.1136/bmj.k2332	http://dx.doi.org/10.1136/bmj.k2332			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH4XN	29794070				2022-12-28	WOS:000433416100010
J	Wallach, JD; Egilman, AC; Dhruva, SS; McCarthy, ME; Miller, JE; Woloshin, S; Schwartz, LM; Ross, JS				Wallach, Joshua D.; Egilman, Alexander C.; Dhruva, Sanket S.; McCarthy, Margaret E.; Miller, Jennifer E.; Woloshin, Steven; Schwartz, Lisa M.; Ross, Joseph S.			Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							THERAPEUTIC AGENTS; ACCELERATED APPROVAL; FDA APPROVAL; CLINICALTRIALS.GOV; POSTAPPROVAL; ACT	OBJECTIVES To characterize postmarketing requirements for new drugs and biologics approved by the US Food and Drug Administration (FDA), and to examine rates and timeliness of registration, results reporting, and publication of required prospective cohort studies, registries, and clinical trials. DESIGN Cross sectional analysis. SETTING Postmarketing requirements for all new drugs and biologics approved by the FDA between 1 January 2009 and 31 December 2012, with follow-up up to 15 November 2017. MAIN OUTCOME MEASURES Postmarketing requirements and their characteristics known at the time of FDA approval, including FDA authority, study design, and study characteristics. Rates and timeliness of registration and results reporting on ClinicalTrials. gov and publication in peer reviewed journals of required prospective cohort studies, registries, and clinical trials. RESULTS Between 2009 and 12, the FDA approved 97 new drugs and biologics for 106 indications with at least one postmarketing requirement at the time of first approval, for a total of 437 postmarketing requirements. Postmarket study descriptions were short (median word count 44 (interquartile range 29-71)) and often lacked information to determine an up to date progress (131 (30%)). 220 (50.3%) postmarketing requirements were for new animal or other studies (including pharmacokinetic studies); 134 (30.7%) were for prospective cohort studies, registries, and clinical trials; and 83 (19.0%) were for secondary analyses or follow-up studies. Of 110 clinical trials, 38 (34.5%), 44 (40.0%), 62 (56.4%), 66 (60.0%), and 98 (89.1%) did not report enough information to establish use of randomization, comparator type, allocation, outcome, and number of patients to be enrolled, respectively. Of 134 required prospective cohort studies, registries, and clinical trials, 102 (76.1%) were registered on ClinicalTrials. gov; of 50 registered and completed studies, 36 (72.0%) had reported results on ClinicalTrials. gov. Among 65 completed studies, 47 (72.3%) had either reported results or were published a median of 47 months (interquartile range 32-67) after FDA approval. 32 (68.1%) of these 47 studies did not report results publicly by the time of their original FDA report submission deadline. CONCLUSIONS Postmarketing requirements for new drugs and biologics were often briefly described and did not contain enough information to characterize study designs. Approximately three quarters of postmarketing requirements for prospective cohort studies, registries, and clinical trials were registered on ClinicalTrials. gov, and nearly three quarters of completed studies reported results or were published, suggesting that at least a quarter of these required studies are not being publicly disseminated.	[Wallach, Joshua D.; Egilman, Alexander C.; Ross, Joseph S.] Yale New Haven Med Ctr, CORE, New Haven, CT 06510 USA; [Wallach, Joshua D.; Egilman, Alexander C.; McCarthy, Margaret E.] Yale Law Sch, CRIT, New Haven, CT 06511 USA; [Dhruva, Sanket S.; Ross, Joseph S.] Yale Sch Med, Dept Internal Med, Natl Clinician Scholars Program, New Haven, CT USA; [Dhruva, Sanket S.] Veterans Affairs Connecticut Healthcare Syst, New Haven, CT USA; [Miller, Jennifer E.] NYU, Sch Med & Bioeth Int, Dept Populat Hlth, Div Med Eth, New York, NY USA; [Woloshin, Steven; Schwartz, Lisa M.] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Ross, Joseph S.] Yale Sch Med, Dept Internal Med, Sect Gen Med, New Haven, CT USA; [Ross, Joseph S.] Yale Sch Publ Hlth, Departmen Hlth Policy & Management, New Haven, CT USA	Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; New York University; Dartmouth College; Yale University; Yale University	Wallach, JD (corresponding author), Yale New Haven Med Ctr, CORE, New Haven, CT 06510 USA.; Wallach, JD (corresponding author), Yale Law Sch, CRIT, New Haven, CT 06511 USA.	joshua.wallach@yale.edu		Ross, Joseph/0000-0002-9218-3320; Miller, Jennifer/0000-0002-3591-369X; Wallach, Joshua/0000-0002-2816-6905	Laura and John Arnold Foundation; Robert Wood Johnson Foundation Clinical Scholars Program; Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Laura and John Arnold Foundation; Robert Wood Johnson Foundation Clinical Scholars Program(Robert Wood Johnson Foundation (RWJF)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project was conducted as part of the Collaboration for Research Integrity and Transparency (CRIT) at Yale, funded by the Laura and John Arnold Foundation, which supports JDW, ACE, MEM, and JSR. SSD is supported by the Robert Wood Johnson Foundation Clinical Scholars Program and the Department of Veterans Affairs. JEM receives funding from the Laura and John Arnold Foundation. These funders played no role in the design of the study, analysis or interpretation of findings, or drafting the manuscript and did not review or approval the manuscript before submission. The authors assume full responsibility for the accuracy and completeness of the ideas presented.	Anderson ML, 2015, NEW ENGL J MED, V372, P1031, DOI 10.1056/NEJMsa1409364; [Anonymous], POSTM REQ COMM; Chen RJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i637; ClinicalTrials.gov, GLOSS COMM SIT TERMS; ClinicalTrials. gov, 801 FDAAA CLINICALTR; Cruz ML, 2017, JAMA INTERN MED, V177, P1207, DOI 10.1001/jamainternmed.2017.1313; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Fain K, 2013, JAMA-J AM MED ASSOC, V310, P202, DOI 10.1001/jama.2013.7900; Institute of Medicine, FUT DRUG SAF PROM PR; Kashoki M, 2017, NEW ENGL J MED, V377, P1201, DOI 10.1056/NEJMc1709185; Kesselheim AS, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4633; Miller JE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017917; Miller JE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009758; Naci H, 2017, JAMA-J AM MED ASSOC, V318, P626, DOI 10.1001/jama.2017.9415; Naci H, 2017, MILBANK Q, V95, P261, DOI 10.1111/1468-0009.12261; Pease AM, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1680; Phillips AT, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2068-3; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Psaty BM, 2012, JAMA-J AM MED ASSOC, V307, P2491, DOI 10.1001/jama.2012.5545; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Sharfstein JM, 2017, JAMA-J AM MED ASSOC, V317, P1621, DOI 10.1001/jama.2017.2481; Smithy JW, 2014, JAMA INTERN MED, V174, P1518, DOI 10.1001/jamainternmed.2014.3438; Stockmann C, 2014, J ALLERGY CLIN IMMUN, V134, P1443, DOI 10.1016/j.jaci.2014.09.019; US Food and Drug Administration, PRIOR REV; US Food and Drug Administration, POSTM REQ COMM FAQ; US Food and Drug Administration, DRUGS FDA FDA APPR D; US Food and Drug Administration, 2014, GUID IND EXP PROGR S; US Food and Drug Administration (FDA), POST STUD PAS; US Food And Drugs Administration (FDA), POSTM DRUG BIOL SAF; Wallach JD, 2018, RES INTEGR PEER REV, V3, DOI 10.1186/s41073-017-0045-8; Woloshin S, 2017, NEW ENGL J MED, V377, P1114, DOI 10.1056/NEJMp1705800; World Health Organization (WHO) Collaborating Center for Drug Statistics Methodology, ATC DDD IND 2017	33	42	42	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2018	361								k2031	10.1136/bmj.k2031	http://dx.doi.org/10.1136/bmj.k2031			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH4XN	29794072	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000433416100003
J	Zuger, A				Zuger, Abigail			Television's The Good Doctor Raises Good Questions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Zuger, Abigail] Mt Sinai West & Mt Sinai St Lukes Hosp, Dept Med, 1000 10th Ave,2T, New York, NY 10019 USA	Mount Sinai St. Luke's; Mount Sinai West	Zuger, A (corresponding author), Mt Sinai West & Mt Sinai St Lukes Hosp, Dept Med, 1000 10th Ave,2T, New York, NY 10019 USA.	abzug@panix.com							0	4	4	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1848	+		10.1001/jama.2018.4665	http://dx.doi.org/10.1001/jama.2018.4665			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29800993				2022-12-28	WOS:000431668600001
J	McMahon, LF; Chopra, V				McMahon, Laurence F., Jr.; Chopra, Vineet			Starving the Hungry Tapeworm: How Businessmen May Reform Health Care Cost	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[McMahon, Laurence F., Jr.; Chopra, Vineet] Michigan Med, Ann Arbor, MI USA; [McMahon, Laurence F., Jr.] North Campus Res Complex,429W,Bldg 16, Ann Arbor, MI 48109 USA; [Chopra, Vineet] North Campus Res Complex,432W,Bldg 16, Ann Arbor, MI 48109 USA		McMahon, LF (corresponding author), North Campus Res Complex,429W,Bldg 16, Ann Arbor, MI 48109 USA.	lmcmahon@umich.edu		Chopra, Vineet/0000-0001-8670-9376				Barkley JE, 2017, GAMES HEALTH J, V6, P165, DOI 10.1089/g4h.2017.0009; Bomey Nathan, 2018, US TODAY; de Mast J, 2012, INT J PROD ECON, V139, P604, DOI 10.1016/j.ijpe.2012.05.035; McMahon LF, 2012, JAMA-J AM MED ASSOC, V307, P671, DOI 10.1001/jama.2012.136; McWilliams JM, 2017, HEALTH AFFAIR, V36, P2085, DOI 10.1377/hlthaff.2017.0814; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Society of General Internal Medicine, 2017, CHOOS WISL GEN HLTH; Wicklund E., 2018, MHEALTH INTELLIGENCE; Wingfield K, 2018, NY TIMES	9	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2018	169	2					120	+		10.7326/M18-0432	http://dx.doi.org/10.7326/M18-0432			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN0TI	29809240				2022-12-28	WOS:000438689200019
J	Smyth, EC; Petty, RD				Smyth, Elizabeth C.; Petty, Russell D.			Pembrolizumab versus paclitaxel in gastro-oesophageal adenocarcinoma	LANCET			English	Editorial Material							DOUBLE-BLIND; IPILIMUMAB; NIVOLUMAB		[Smyth, Elizabeth C.] Royal Marsden Hosp, London SW3 6JJ, England; [Petty, Russell D.] Univ Dundee, Ninewells Hosp, Dundee, Scotland; [Petty, Russell D.] Univ Dundee, Sch Med, Dundee, Scotland	Royal Marsden NHS Foundation Trust; University of Dundee; University of Dundee	Smyth, EC (corresponding author), Royal Marsden Hosp, London SW3 6JJ, England.	elizabeth.smyth2@nhs.net	Smyth, Elizabeth/N-6541-2019		Bristol-Myers Squibb; AstraZeneca; Merck Serono; Merck Co; Five Prime Therapeutics; ARMO Biosciences	Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Merck Serono(Merck & Company); Merck Co(Merck & Company); Five Prime Therapeutics; ARMO Biosciences	ECS has received honoraria from Five Prime Therapeutics, Gritstone Oncology, and Celgene for advisory roles, from Servier for giving a lecture about gastro-oesophageal cancer, and from BMS for an education day on treatments in melanoma. RDP has received honoraria from Bristol-Myers Squibb and Roche for advisory roles and from Pfizer for lectures on precision cancer medicine; RDP has also received grants for clinical research from Bristol-Myers Squibb, AstraZeneca, Merck Serono, Merck & Co, Five Prime Therapeutics, and ARMO Biosciences; this research involves immunotherapies in gastric and oesophageal cancer but is not related to the clinical trial discussed in this Comment.	Anagnostou V, 2017, CLIN CANCER RES, V23, P4959, DOI 10.1158/1078-0432.CCR-16-3065; Ascierto PA, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9520; Fuchs CS, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2018.0013; Kang YK, 2017, LANCET, V390, P2461, DOI 10.1016/S0140-6736(17)31827-5; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Secrier M, 2016, NAT GENET, V48, P1131, DOI 10.1038/ng.3659; Shitara K, 2018, LANCET, V392, P123, DOI 10.1016/S0140-6736(18)31257-1; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; Yarchoan M, 2017, NEW ENGL J MED, V377, P2500, DOI 10.1056/NEJMc1713444	10	4	5	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2018	392	10142					97	98		10.1016/S0140-6736(18)31277-7	http://dx.doi.org/10.1016/S0140-6736(18)31277-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GM8RQ	29880232				2022-12-28	WOS:000438501300005
J	Francis, PA; Pagani, O; Fleming, GF; Walley, BA; Colleoni, M; Lang, I; Gomez, HL; Tondini, C; Ciruelos, E; Burstein, HJ; Bonnefoi, HR; Bellet, M; Martino, S; Geyer, CE; Goetz, MP; Stearns, V; Pinotti, G; Puglisi, F; Spazzapan, S; Climent, MA; Pavesi, L; Ruhstaller, T; Davidson, NE; Coleman, R; Debled, M; Buchholz, S; Ingle, JN; Winer, EP; Maibach, R; Rabaglio-Poretti, M; Ruepp, B; Di Leo, A; Coates, AS; Gelber, RD; Goldhirsch, A; Regan, MM				Francis, P. A.; Pagani, O.; Fleming, G. F.; Walley, B. A.; Colleoni, M.; Lang, I.; Gomez, H. L.; Tondini, C.; Ciruelos, E.; Burstein, H. J.; Bonnefoi, H. R.; Bellet, M.; Martino, S.; Geyer, C. E., Jr.; Goetz, M. P.; Stearns, V.; Pinotti, G.; Puglisi, F.; Spazzapan, S.; Climent, M. A.; Pavesi, L.; Ruhstaller, T.; Davidson, N. E.; Coleman, R.; Debled, M.; Buchholz, S.; Ingle, J. N.; Winer, E. P.; Maibach, R.; Rabaglio-Poretti, M.; Ruepp, B.; Di Leo, A.; Coates, A. S.; Gelber, R. D.; Goldhirsch, A.; Regan, M. M.		SOFT TEXT Investigators Grp; Int Breast Canc Study Grp	Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OVARIAN-FUNCTION SUPPRESSION; PATIENT-LEVEL METAANALYSIS; POPULATION-BASED COHORT; RANDOMIZED-TRIALS; YOUNG-WOMEN; REPORTED OUTCOMES; SOFT TRIALS; TAMOXIFEN; TEXT; OOPHORECTOMY	BACKGROUND In the Suppression of Ovarian Function Trial (SOFT) and the Tamoxifen and Exemestane Trial (TEXT), the 5-year rates of recurrence of breast cancer were significantly lower among premenopausal women who received the aromatase inhibitor exemestane plus ovarian suppression than among those who received tamoxifen plus ovarian suppression. The addition of ovarian suppression to tamoxifen did not result in significantly lower recurrence rates than those with tamoxifen alone. Here, we report the updated results from the two trials. METHODS Premenopausal women were randomly assigned to receive 5 years of tamoxifen, tamoxifen plus ovarian suppression, or exemestane plus ovarian suppression in SOFT and to receive tamoxifen plus ovarian suppression or exemestane plus ovarian suppression in TEXT. Randomization was stratified according to the receipt of chemotherapy. RESULTS In SOFT, the 8-year disease-free survival rate was 78.9% with tamoxifen alone, 83.2% with tamoxifen plus ovarian suppression, and 85.9% with exemestane plus ovarian suppression (P = 0.009 for tamoxifen alone vs. tamoxifen plus ovarian suppression). The 8-year rate of overall survival was 91.5% with tamoxifen alone, 93.3% with tamoxifen plus ovarian suppression, and 92.1% with exemestane plus ovarian suppression (P = 0.01 for tamoxifen alone vs. tamoxifen plus ovarian suppression); among the women who remained premenopausal after chemotherapy, the rates were 85.1%, 89.4%, and 87.2%, respectively. Among the women with cancers that were negative for HER2 who received chemotherapy, the 8-year rate of distant recurrence with exemestane plus ovarian suppression was lower than the rate with tamoxifen plus ovarian suppression (by 7.0 percentage points in SOFT and by 5.0 percentage points in TEXT). Grade 3 or higher adverse events were reported in 24.6% of the tamoxifen-alone group, 31.0% of the tamoxifen-ovarian suppression group, and 32.3% of the exemestane-ovarian suppression group. CONCLUSIONS Among premenopausal women with breast cancer, the addition of ovarian suppression to tamoxifen resulted in significantly higher 8-year rates of both disease-free and overall survival than tamoxifen alone. The use of exemestane plus ovarian suppression resulted in even higher rates of freedom from recurrence. The frequency of adverse events was higher in the two groups that received ovarian suppression than in the tamoxifen-alone group.	[Pagani, O.] Osped San Giovanni Bellinzona, Inst Oncol Southern Switzerland, CH-6500 Bellinzona, Switzerland; [Francis, P. A.] Univ Melbourne, St Vincents Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Francis, P. A.] Univ Newcastle, Breast Canc Trials Australia & New Zealand, Newcastle, NSW, Australia; [Coates, A. S.] Univ Sydney, Sydney, NSW, Australia; [Ruhstaller, T.] Breast Canc St Gallen, St Gallen, Switzerland; [Maibach, R.; Rabaglio-Poretti, M.; Ruepp, B.; Coates, A. S.] Int Breast Canc Study Grp Coordinating Ctr, Bern, Switzerland; [Rabaglio-Poretti, M.] Inselspital Bern, Univ Hosp, Bern, Switzerland; [Fleming, G. F.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Walley, B. A.] Univ Calgary, Calgary, AB, Canada; [Colleoni, M.; Goldhirsch, A.] European Inst Oncol, Div Med Senol, Milan, Italy; [Goldhirsch, A.] Int Breast Canc Study Grp, Milan, Italy; [Tondini, C.] Osped Papa Giovanni XXIII, Bergamo, Italy; [Pinotti, G.] Osped Circolo Varese, Azienda Socio Sanitaria Terr Sette Laghi, Varese, Italy; [Pinotti, G.] Fdn Macchi, Varese, Italy; [Puglisi, F.; Spazzapan, S.] Natl Canc Inst, IRCCS, Med Oncol & Canc Prevent, Aviano, Italy; [Puglisi, F.] Univ Udine, Sch Med Oncol, Dept Med, Udine, Italy; [Pavesi, L.] Salvatore Maugeri Fdn, Pavia, Italy; [Di Leo, A.] Azienda Unita Sanit Locale Toscana Ctr, Hosp Prato, Prato, Italy; [Lang, I.] Natl Inst Oncol, Budapest, Hungary; [Gomez, H. L.] Inst Nacl Enfermedades Neoplas, Lima, Peru; [Ciruelos, E.] Univ Hosp 12 Octubre, Madrid, Spain; [Bellet, M.] Vall dHebron Inst Oncol, Barcelona, Spain; [Bellet, M.] Vall dHebron Univ Hosp, Barcelona, Spain; [Climent, M. A.] Inst Valenciano Oncol, Valencia, Spain; [Burstein, H. J.; Winer, E. P.] Harvard TH Chan Sch Publ Hlth, Harvard Med Sch, Dana Farber Canc Inst, Susan F Smith Ctr Womens Canc, Boston, MA USA; [Gelber, R. D.; Regan, M. M.] Harvard TH Chan Sch Publ Hlth, Harvard Med Sch, Int Breast Canc Study, Grp Stat Ctr,Dept Biostat & Computat Biol, Boston, MA USA; [Gelber, R. D.] Frontier Sci & Technol Res Fdn Inc, Boston, MA USA; [Bonnefoi, H. R.; Debled, M.] Univ Bordeaux, Comprehens Canc Ctr, Inst Bergonie, Bordeaux, France; [Martino, S.] Angeles Clin & Res Inst, Santa Monica, CA USA; [Geyer, C. E., Jr.] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA USA; [Goetz, M. P.; Ingle, J. N.] Mayo Clin, Rochester, MN USA; [Stearns, V.] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Davidson, N. E.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Coleman, R.] Weston Pk Hosp, Sheffield, S Yorkshire, England; [Buchholz, S.] Univ Med Ctr, Dept Obstet & Gynecol, Regensburg, Germany	Institute of Oncology Research (IOR); Regional Hospital of Bellinzona & Valleys, San Giovanni; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; University of Melbourne; University of Newcastle; University of Sydney; International Breast Cancer Study Group; University of Bern; University Hospital of Bern; University of Chicago; University of Chicago Medical Center; University of Calgary; IRCCS European Institute of Oncology (IEO); ASST Papa Giovanni XXIII; Ospedale Circolo & Fondazione Macchi; University of Udine; Istituti Clinici Scientifici Maugeri IRCCS; Prato Hospital; National Institute of Oncology Hungary; Instituto Nacional de Enfermedades Neoplasicas; Hospital Universitario 12 de Octubre; Vall d'Hebron Institut d'Oncologia (VHIO); Hospital Universitari Vall d'Hebron; Instituto Valenciano De Oncologia; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Frontier Science Foundation; UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; Angeles Clinic & Research Institute; Virginia Commonwealth University; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Weston Park Hospital; University of Regensburg	Francis, PA (corresponding author), Peter MacCallum Canc Ctr, Locked Bag 1,ABeckett St, Melbourne, Vic 8006, Australia.; Pagani, O (corresponding author), Osped San Giovanni Bellinzona, Inst Oncol Southern Switzerland, CH-6500 Bellinzona, Switzerland.	prue.francis@petermac.org; olivia.pagani@ibcsg.org	Geyer, Charles/AGY-0119-2022; Di Leo, Angelo/AAM-1267-2020; Goetz, Matthew P/AAH-2333-2020; Pagani, Olivia/ABF-3164-2020; Francis, Prudence A/J-4003-2012; Puglisi, Fabio/N-3863-2017; Spazzapan, Simon/ABE-1728-2020; TONDINI, CARLO ALBERTO/AAB-7786-2019; Miquel, Josep Maria/AAG-3508-2019; Perren, Timothy/D-5387-2013	Geyer, Charles/0000-0002-2379-5702; Di Leo, Angelo/0000-0002-3665-9056; Francis, Prudence A/0000-0002-7207-9286; Puglisi, Fabio/0000-0003-0573-4938; Spazzapan, Simon/0000-0003-3922-4960; TONDINI, CARLO ALBERTO/0000-0003-0635-8954; Bliss, Judith/0000-0001-7957-7424; Perren, Timothy/0000-0001-8472-8856; Earl, Helena/0000-0003-1549-8094; Llombart Cussac, Antonio/0000-0003-4515-8293; Haba Rodriguez, Juan Rafael de la/0000-0001-5111-1702; Linderholm, Barbro/0000-0003-1531-630X	Pfizer; International Breast Cancer Study Group; National Cancer Institute; Frontier Science and Technology Research Foundation; Swiss Group for Clinical Cancer Research; Cancer Research Switzerland; Oncosuisse; Cancer League Switzerland; Foundation for Clinical Cancer Research of Eastern Switzerland; National Institutes of Health [CA075362]; Breast Cancer Research Foundation [16-185]; NATIONAL CANCER INSTITUTE [U10CA077202, U10CA180821, U10CA180868, U10CA032102, U10CA180834, U10CA180822, U24CA075362, U10CA016116, UG1CA189867, U10CA021115] Funding Source: NIH RePORTER	Pfizer(Pfizer); International Breast Cancer Study Group; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Frontier Science and Technology Research Foundation; Swiss Group for Clinical Cancer Research; Cancer Research Switzerland; Oncosuisse; Cancer League Switzerland; Foundation for Clinical Cancer Research of Eastern Switzerland; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Pfizer, the International Breast Cancer Study Group, and the National Cancer Institute for the conduct of SOFT and TEXT. Pfizer and Ipsen provided the trial drugs. Support for the International Breast Cancer Study Group was provided by the Frontier Science and Technology Research Foundation, Swiss Group for Clinical Cancer Research, Cancer Research Switzerland, Oncosuisse, Cancer League Switzerland, Foundation for Clinical Cancer Research of Eastern Switzerland, a grant (CA075362) from the National Institutes of Health, and a grant (16-185) from the Breast Cancer Research Foundation.	Aebi S, 2000, LANCET, V355, P1869, DOI 10.1016/S0140-6736(00)02292-3; Bartlett JMS, 2017, EUR J CANCER, V79, P129, DOI 10.1016/j.ejca.2017.03.033; Bernhard J, 2015, LANCET ONCOL, V16, P848, DOI 10.1016/S1470-2045(15)00049-2; Burstein HJ, 2016, J CLIN ONCOL, V34, P1689, DOI 10.1200/JCO.2015.65.9573; Cancer Therapy Evaluation Program, 2006, COMM TERM CRIT ADV E; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Colleoni M, 2006, J CLIN ONCOL, V24, P1332, DOI 10.1200/JCO.2005.03.0783; Colleoni M, 2006, ANN ONCOL, V17, P1497, DOI 10.1093/annonc/mdl145; Cuzick J, 2007, LANCET, V369, P1711; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; Gnant M, 2015, ANN ONCOL, V26, P313, DOI 10.1093/annonc/mdu544; Goldhirsch A, 2001, J Natl Cancer Inst Monogr, P44; Pagani O, 2014, NEW ENGL J MED, V371, P107, DOI 10.1056/NEJMoa1404037; Paluch-Shimon S, 2017, BREAST, V35, P203, DOI 10.1016/j.breast.2017.07.017; Pan HC, 2017, NEW ENGL J MED, V377, P1836, DOI 10.1056/NEJMoa1701830; Parker WH, 2013, OBSTET GYNECOL, V121, P709, DOI 10.1097/AOG.0b013e3182864350; Regan MM, 2016, J CLIN ONCOL, V34, P2221, DOI 10.1200/JCO.2015.64.3171; Regan MM, 2013, BREAST, V22, P1094, DOI 10.1016/j.breast.2013.08.009; Ribi K, 2016, J CLIN ONCOL, V34, P1601, DOI 10.1200/JCO.2015.64.8675; Rocca WA, 2006, LANCET ONCOL, V7, P821, DOI 10.1016/S1470-2045(06)70869-5; Rocca WA, 2016, MAYO CLIN PROC, V91, P1577, DOI 10.1016/j.mayocp.2016.08.002; Saha P, 2017, J CLIN ONCOL, V35, P3113, DOI 10.1200/JCO.2016.72.0946; Sorensen SV, 2012, INT J TECHNOL ASSESS, V28, P12, DOI 10.1017/S026646231100064X	26	292	312	3	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2018	379	2					122	137		10.1056/NEJMoa1803164	http://dx.doi.org/10.1056/NEJMoa1803164			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM6DL	29863451	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000438249800009
J	Garcia-Tsao, G				Garcia-Tsao, Guadalupe			Long-term albumin in cirrhosis: is it the ANSWER?	LANCET			English	Editorial Material							ASCITES; SURVIVAL; INFUSION; TRIAL		[Garcia-Tsao, Guadalupe] Yale Univ, Sch Med, Sect Digest Dis, 333 Cedar St, New Haven, CT 06510 USA	Yale University	Garcia-Tsao, G (corresponding author), Yale Univ, Sch Med, Sect Digest Dis, 333 Cedar St, New Haven, CT 06510 USA.	guadalupe.garcia-tsao@yale.edu	Garcia-Tsao, Guadalupe/ABF-7374-2020					Bernardi M, 2012, HEPATOLOGY, V55, P1172, DOI 10.1002/hep.24786; Bureau C, 2017, GASTROENTEROLOGY, V152, P157, DOI 10.1053/j.gastro.2016.09.016; Caraceni P, 2018, LANCET, V391, P2417, DOI 10.1016/S0140-6736(18)30840-7; D'Amico G, 2014, ALIMENT PHARM THER, V39, P1180, DOI 10.1111/apt.12721; Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338; Planas R, 2006, CLIN GASTROENTEROL H, V4, P1385, DOI 10.1016/j.cgh.2006.08.007; Romanelli RG, 2006, WORLD J GASTROENTERO, V12, P1403, DOI 10.3748/wjg.v12.i9.1403; Salerno F, 2010, LIVER INT, V30, P937, DOI 10.1111/j.1478-3231.2010.02272.x; Sola E, 2017, J HEPATOL, V66, pS11, DOI 10.1016/S0168-8278(17)30285-4; Turco L, 2018, J HEPATOL, V68, P949, DOI 10.1016/j.jhep.2017.12.027; Villanueva C, 2017, J HEPATOL, V66, pS97, DOI 10.1016/S0168-8278(17)30455-5	11	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2018	391	10138					2391	2392		10.1016/S0140-6736(18)30948-6	http://dx.doi.org/10.1016/S0140-6736(18)30948-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GK7QC	29861077				2022-12-28	WOS:000436402000005
J	Que, XC; Hung, MY; Yeang, C; Gonen, A; Prohaska, TA; Sun, XL; Diehl, C; Maatta, A; Gaddis, DE; Bowden, K; Pattison, J; MacDonald, JG; Yla-Herttuala, S; Mellon, PL; Hedrick, CC; Ley, K; Miller, YI; Glass, CK; Peterson, KL; Binder, CJ; Tsimikas, S; Witztum, JL				Que, Xuchu; Hung, Ming-Yow; Yeang, Calvin; Gonen, Ayelet; Prohaska, Thomas A.; Sun, Xiaoli; Diehl, Cody; Maatta, Antti; Gaddis, Dalia E.; Bowden, Karen; Pattison, Jennifer; MacDonald, Jeffrey G.; Yla-Herttuala, Seppo; Mellon, Pamela L.; Hedrick, Catherine C.; Ley, Klaus; Miller, Yury I.; Glass, Christopher K.; Peterson, Kirk L.; Binder, Christoph J.; Tsimikas, Sotirios; Witztum, Joseph L.			Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice	NATURE			English	Article							OXIDATION-SPECIFIC EPITOPES; NATURAL ANTIBODIES; ATHEROSCLEROSIS; RECOGNITION; MACROPHAGES; LIPOPROTEIN; IDENTIFICATION; ACCUMULATION; EXPRESSION; LIPIDS	Oxidized phospholipids (OxPL) are ubiquitous, are formed in many inflammatory tissues, including atherosclerotic lesions, and frequently mediate proinflammatory changes(1). Because OxPL are mostly the products of non-enzymatic lipid peroxidation, mechanisms to specifically neutralize them are unavailable and their roles in vivo are largely unknown. We previously cloned the IgM natural antibody E06, which binds to the phosphocholine headgroup of OxPL, and blocks the uptake of oxidized low-density lipoprotein (OxLDL) by macrophages and inhibits the proinflammatory properties of OxPL(2-4). Here, to determine the role of OxPL in vivo in the context of atherogenesis, we generated transgenic mice in the Ldlr(-/-) background that expressed a single-chain variable fragment of E06 (E06-scFv) using the Apoe promoter. E06-scFv was secreted into the plasma from the liver and macrophages, and achieved sufficient plasma levels to inhibit in vivo macrophage uptake of OxLDL and to prevent OxPL-induced inflammatory signalling. Compared to Ldlr(-/-)mice, Ldlr(-/-)E06-scFv mice had 57-28% less atherosclerosis after 4, 7 and even 12 months of 1% high-cholesterol diet. Echocardiographic and histologic evaluation of the aortic valves demonstrated that E06-scFv ameliorated the development of aortic valve gradients and decreased aortic valve calcification. Both cholesterol accumulation and in vivo uptake of OxLDL were decreased in peritoneal macrophages, and both peritoneal and aortic macrophages had a decreased inflammatory phenotype. Serum amyloid A was decreased by 32%, indicating decreased systemic inflammation, and hepatic steatosis and inflammation were also decreased. Finally, the E06-scFv prolonged life as measured over 15 months. Because the E06-scFv lacks the functional effects of an intact antibody other than the ability to bind OxPL and inhibit OxLDL uptake in macrophages, these data support a major proatherogenic role of OxLDL and demonstrate that OxPL are proinflammatory and proatherogenic, which E06 counteracts in vivo. These studies suggest that therapies inactivating OxPL may be beneficial for reducing generalized inflammation, including the progression of atherosclerosis, aortic stenosis and hepatic steatosis.	[Que, Xuchu; Hung, Ming-Yow; Yeang, Calvin; Gonen, Ayelet; Prohaska, Thomas A.; Sun, Xiaoli; Diehl, Cody; Bowden, Karen; Pattison, Jennifer; Miller, Yury I.; Glass, Christopher K.; Peterson, Kirk L.; Tsimikas, Sotirios; Witztum, Joseph L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Maatta, Antti; Yla-Herttuala, Seppo] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland; [Gaddis, Dalia E.; Hedrick, Catherine C.; Ley, Klaus] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [MacDonald, Jeffrey G.] UT Southwestern Med Ctr, Ctr Human Nutr, Dallas, TX USA; [Mellon, Pamela L.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Binder, Christoph J.] Austrian Acad Sci, Ctr Mol Med, Vienna, Austria; [Hung, Ming-Yow] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Hung, Ming-Yow] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Cardiol, New Taipei, Taiwan; [Diehl, Cody] Brigham Young Univ Idaho, Rexburg, ID USA	University of California System; University of California San Diego; University of Eastern Finland; La Jolla Institute for Immunology; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; University of California System; University of California San Diego; Medical University of Vienna; Austrian Academy of Sciences; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Brigham Young University	Witztum, JL (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	jwitztum@ucsd.edu	Que, Xuchu/H-2741-2019; Glass, Christopher/AAI-3933-2021; Sun, Xiaoli/G-3554-2019; Yeang, Calvin/GYV-3875-2022	Glass, Christopher/0000-0003-4344-3592; Yeang, Calvin/0000-0002-5927-9291; Diehl, Cody/0000-0003-3703-8101; Que, Xuchu/0000-0002-6751-5493; Binder, Christoph J./0000-0001-8313-7050; Prohaska, Thomas/0000-0002-1406-692X	NIH [HL088093, HL086559, HL119828, HL136275, R35 HL135737, HL055798, HL112276, HL20948, DRC P30 DK063491, P42 ES010337, P30 CA23100]; Center for Human Nutrition [550015400]; Leducq Foundation Transatlantic Grants; American Heart Association [13POST16990031]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD082567, P50HD012303] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119828, P01HL020948, P01HL136275, P01HL055798, R01HL086559, R01HL112276, P01HL088093, R35HL135737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK044838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Human Nutrition; Leducq Foundation Transatlantic Grants(Leducq Foundation); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH Grants: HL088093 (X.Q., S.T., C.K.G., K.L., Y.I.M. and J.L.W.), HL086559 (J.L.W.), HL119828 (J.L.W. and S.T.), HL055798 (S.T., J.L.W., Y.I.M., K.L. and C.C.H.), HL136275 (S.T., J.L.W. and Y.I.M.), R35 HL135737 (J.L.W. and Y.I.M.), HL055798 and HL112276 (C.C.H.), HL20948 (J.G.M.), DRC P30 DK063491 (P.L.M.), P42 ES010337 (P.L.M.), P30 CA23100 (P.L.M.), Center for Human Nutrition grant 550015400 (J.G.M.) and Leducq Foundation Transatlantic Grants to J.L.W. and C.K.G. X.Q. was supported in part by a Grant-in-Aid from American Heart Association and D.E.G. was supported in part by an American Heart Association post-doctoral grant (13POST16990031).	Ambrogini E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04047-5; Baldan A, 2014, J IMMUNOL, V193, P5637, DOI 10.4049/jimmunol.1400606; Binder CJ, 2016, NAT REV IMMUNOL, V16, P485, DOI 10.1038/nri.2016.63; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Briley-Saebo K, 2014, J CARDIOVASC TRANSL, V7, P719, DOI 10.1007/s12265-014-9590-4; Butcher MJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2848; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Cowling RT, 2014, AM J PHYSIOL-HEART C, V307, pH773, DOI 10.1152/ajpheart.00142.2014; Friedman P, 2002, J BIOL CHEM, V277, P7010, DOI 10.1074/jbc.M108860200; Gonen A, 2014, J LIPID RES, V55, P2137, DOI 10.1194/jlr.M053256; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Houben T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13058-z; Ikura Y, 2006, HEPATOLOGY, V43, P506, DOI 10.1002/hep.21070; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kadl A, 2011, FREE RADICAL BIO MED, V51, P1903, DOI 10.1016/j.freeradbiomed.2011.08.026; Kamstrup PR, 2017, ARTERIOSCL THROM VAS, V37, P1570, DOI 10.1161/ATVBAHA.116.308761; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lee S, 2012, CIRC RES, V111, P778, DOI 10.1161/CIRCRESAHA.111.256859; Lewis KE, 2004, CIRCULATION, V110, P540, DOI 10.1161/01.CIR.0000136819.93989.E1; Liu BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165200; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Montano EN, 2013, J LIPID RES, V54, P3206, DOI 10.1194/jlr.D040923; Nowyhed HN, 2015, SCI REP-UK, V5, DOI 10.1038/srep09059; Oehler B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05348-3; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Popat RJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.87379; Schneider M, 2005, J LIPID RES, V46, P769, DOI 10.1194/jlr.M400467-JLR200; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Senders ML, 2018, J AM COLL CARDIOL, V71, P321, DOI 10.1016/j.jacc.2017.11.036; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Towler DA, 2013, CIRC RES, V113, P198, DOI 10.1161/CIRCRESAHA.113.300155; Tsiantoulas D, 2015, J LIPID RES, V56, P440, DOI 10.1194/jlr.P054569; Tsimikas S, 2017, J AM COLL CARDIOL, V69, P692, DOI 10.1016/j.jacc.2016.11.042; Tsimikas S, 2011, J AM COLL CARDIOL, V58, P1715, DOI 10.1016/j.jacc.2011.07.017; Turner WW, 2012, J MED CHEM, V55, P8178, DOI 10.1021/jm300685s; Zanoni I, 2017, IMMUNITY, V47, P697, DOI 10.1016/j.immuni.2017.09.010	39	249	251	11	161	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 14	2018	558	7709					301	+		10.1038/s41586-018-0198-8	http://dx.doi.org/10.1038/s41586-018-0198-8			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2BI	29875409	Green Submitted, Green Accepted			2022-12-28	WOS:000435071400056
J	Bellono, NW; Leitch, DB; Julius, D				Bellono, Nicholas W.; Leitch, Duncan B.; Julius, David			Molecular tuning of electroreception in sharks and skates	NATURE			English	Article							SHAKER POTASSIUM CHANNELS; ELECTROSENSORY SYSTEM; ELECTRIC SENSE; K+ CHANNELS; HAIR; MECHANISM; SYNAPSE; NOISE	Ancient cartilaginous vertebrates, such as sharks, skates and rays, possess specialized electrosensory organs that detect weak electric fields and relay this information to the central nervous system(1-4). Sharks exploit this sensory modality for predation, whereas skates may also use it to detect signals from conspecifics(5). Here we analyse shark and skate electrosensory cells to determine whether discrete physiological properties could contribute to behaviourally relevant sensory tuning. We show that sharks and skates use a similar low threshold voltage-gated calcium channel to initiate cellular activity but use distinct potassium channels to modulate this activity. Electrosensory cells from sharks express specially adapted voltage gated potassium channels that support large, repetitive membrane voltage spikes capable of driving near-maximal vesicular release from elaborate ribbon synapses. By contrast, skates use a calcium activated potassium channel to produce small, tunable membrane voltage oscillations that elicit stimulus-dependent vesicular release. We propose that these sensory adaptations support amplified indiscriminate signal detection in sharks compared with selective frequency detection in skates, potentially reflecting the electroreceptive requirements of these elasmobranch species. Our findings demonstrate how sensory systems adapt to suit the lifestyle or environmental niche of an animal through discrete molecular and biophysical modifications.	[Bellono, Nicholas W.; Leitch, Duncan B.; Julius, David] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA; [Bellono, Nicholas W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of California System; University of California San Francisco; Harvard University	Bellono, NW; Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	nbellono@harvard.edu; david.julius@ucsf.edu	Leitch, Duncan/AAU-6744-2020	Leitch, Duncan/0000-0002-8513-888X	National Institutes of Health (NIH) Institutional Research Service Award [T32HL007731]; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation; Simons Foundation Postdoctoral Fellowship; NIH [1K99DC016658, K99DK115879, NS055299, NS105038]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK115879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS105038, R01NS055299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC016658] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Institutional Research Service Award; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation(Howard Hughes Medical Institute); Simons Foundation Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank S. Bennett from the Marine Biological Laboratory for supplying animals, J. Wong from the Gladstone/University of California, San Francisco (UCSF) transmission electron microscopy core for performing electron microscopy, A. Zimmerman for help with capacitance measurements, discussion and reading of the manuscript, R. Edwards for discussion, and R. Nicoll for input on the manuscript. This work was supported by a National Institutes of Health (NIH) Institutional Research Service Award to the UCSF CVRI (T32HL007731 to N.W.B.), a Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation (N.W.B.), a Simons Foundation Postdoctoral Fellowship to the Jane Coffin Childs Memorial Fund (D.B.L.) and grants from the NIH (1K99DC016658 to D.B.L., K99DK115879 to N.W.B., and NS055299 and NS105038 to D.J.).	Baker CA, 2015, ELIFE, V4, DOI 10.7554/eLife.08163; Bellono NW, 2017, NATURE, V543, P391, DOI 10.1038/nature21401; CLUSIN WT, 1979, J GEN PHYSIOL, V73, P685, DOI 10.1085/jgp.73.6.685; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; FIELDS RD, 1985, SCIENCE, V228, P197, DOI 10.1126/science.3975637; Gillis JA, 2009, J MORPHOL, V270, P628, DOI 10.1002/jmor.10710; Graydon CW, 2011, J NEUROSCI, V31, P16637, DOI 10.1523/JNEUROSCI.1866-11.2011; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoshi T, 2013, J GEN PHYSIOL, V141, P151, DOI 10.1085/jgp.201210888; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Josberger EE, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600112; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; Kantardzhieva A, 2013, J COMP NEUROL, V521, P3260, DOI 10.1002/cne.23345; Kempster RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052551; King BL, 2016, GENE, V578, P63, DOI 10.1016/j.gene.2015.12.010; Kubota T, 2017, SCI REP-UK, V7, DOI 10.1038/srep45310; Labro AJ, 2012, J GEN PHYSIOL, V140, P481, DOI 10.1085/jgp.201210817; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; MEYER JH, 1982, SCIENCE, V217, P635, DOI 10.1126/science.217.4560.635; Modrell MS, 2017, ELIFE, V6, DOI 10.7554/eLife.24197; Montgomery JC, 1999, J EXP BIOL, V202, P1349; Neiman AB, 2004, J NEUROPHYSIOL, V92, P492, DOI 10.1152/jn.00742.2003; Nouvian R, 2006, J MEMBRANE BIOL, V209, P153, DOI 10.1007/s00232-005-0854-4; PETERS RC, 1985, J EXP BIOL, V118, P99; Rutherford MA, 2009, J NEUROSCI, V29, P10025, DOI 10.1523/JNEUROSCI.1798-09.2009; SEJNOWSKI TJ, 1982, J NEUROCYTOL, V11, P897, DOI 10.1007/BF01148307; SIGG D, 1994, SCIENCE, V264, P578, DOI 10.1126/science.8160016; Sisneros JA, 2002, J PHYSIOL-PARIS, V96, P379, DOI 10.1016/S0928-4257(03)00016-0; Sisneros JA, 1998, J COMP PHYSIOL A, V183, P87, DOI 10.1007/s003590050237; TEETER JH, 1981, J COMP PHYSIOL, V142, P371, DOI 10.1007/BF00605449; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779	31	19	19	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					122	+		10.1038/s41586-018-0160-9	http://dx.doi.org/10.1038/s41586-018-0160-9			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29849147	Green Accepted			2022-12-28	WOS:000434273300049
J	Zapata, CB				Zapata, Carly Benner			Survival Techniques	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Zapata, Carly Benner] Univ Calif San Francisco, Dept Med, Div Hosp Med, 533 Parnassus Ave,POB 1031, San Francisco, CA 94134 USA	University of California System; University of California San Francisco	Zapata, CB (corresponding author), Univ Calif San Francisco, Dept Med, Div Hosp Med, 533 Parnassus Ave,POB 1031, San Francisco, CA 94134 USA.	carly.zapata@ucsf.edu							0	1	1	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2171	2172		10.1001/jama.2018.6069	http://dx.doi.org/10.1001/jama.2018.6069			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29872862				2022-12-28	WOS:000434133400012
J	Iacobucci, G; Limb, M				Iacobucci, Gareth; Limb, Matthew			Scrap the Cap: The scale of the problem in NHS trusts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2018	361								k2367	10.1136/bmj.k2367	http://dx.doi.org/10.1136/bmj.k2367			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MP	29848746				2022-12-28	WOS:000434275800008
J	Rimmer, A				Rimmer, Abi			Review of 10 pound 000 gender pay gap in medicine is launched	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Rimmer A., 2016, BMJ CAREERS; Rimmer A., 2017, BMJ CAREERS	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2018	361								k2366	10.1136/bmj.k2366	http://dx.doi.org/10.1136/bmj.k2366			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MF	29844018				2022-12-28	WOS:000434274800009
J	Horton, R				Horton, Richard			Offline: "The world has been warned"	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2018	391	10135					2092	2092		10.1016/S0140-6736(18)31186-3	http://dx.doi.org/10.1016/S0140-6736(18)31186-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH2UJ	29856335	Bronze			2022-12-28	WOS:000433257200011
J	Garnick, MB				Garnick, Marc B.			Filling in the Gaps	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Garnick, Marc B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Garnick, MB (corresponding author), Harvard Med Sch, 330 Brookline Ave,SCC 9, Boston, MA 02215 USA.	mgarnick@bidmc.harvard.edu							0	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2079	2080		10.1001/jama.2018.5837	http://dx.doi.org/10.1001/jama.2018.5837			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800185				2022-12-28	WOS:000432679400017
J	Slomski, A				Slomski, Anita			Drug Slows Disability Progression in Multiple Sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2069	2069		10.1001/jama.2018.6256	http://dx.doi.org/10.1001/jama.2018.6256			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800176				2022-12-28	WOS:000432679400008
J	Rochford, C; Sridhar, D; Woods, N; Saleh, Z; Hartenstein, L; Ahlawat, H; Whiting, E; Dybul, M; Cars, O; Goosby, E; Cassels, A; Velasquez, G; Hoffman, S; Baris, E; Wadsworth, J; Gyansa-Lutterodt, M; Davies, S				Rochford, Connor; Sridhar, Devi; Woods, Ngaire; Saleh, Zia; Hartenstein, Lars; Ahlawat, Hemant; Whiting, Ed; Dybul, Mark; Cars, Otto; Goosby, Eric; Cassels, Andrew; Velasquez, German; Hoffman, Steven; Baris, Enis; Wadsworth, Jonathan; Gyansa-Lutterodt, Martha; Davies, Sally			Global governance of antimicrobial resistance	LANCET			English	Editorial Material									[Rochford, Connor; Woods, Ngaire; Saleh, Zia] Univ Oxford, Blavatnik Sch Govt, Oxford, England; [Sridhar, Devi] Univ Edinburgh, Global Hlth Governance Programme, Edinburgh, Midlothian, Scotland; [Whiting, Ed] Wellcome Trust Res Labs, London, England; [Hartenstein, Lars; Ahlawat, Hemant] McKinsey & Co Inc, Social Sect Hub, Geneva, Switzerland; [Dybul, Mark] Georgetown Univ, Ctr Global Hlth & Qual, Washington, DC USA; [Cars, Otto] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Goosby, Eric] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Velasquez, German] South Ctr, Special Adviser Hlth & Dev, Geneva, Switzerland; [Cassels, Andrew] Grad Inst, Global Hlth Ctr, Geneva, Switzerland; [Hoffman, Steven] York Univ, Global Strategy Lab, York, N Yorkshire, England; [Baris, Enis; Wadsworth, Jonathan] World Bank Grp, Washington, DC USA; [Gyansa-Lutterodt, Martha] Minist Hlth, Accra, Ghana; [Davies, Sally] Dept Hlth & Social Care, London SW1H 0EU, England	University of Oxford; University of Edinburgh; Georgetown University; Uppsala University; University of California System; University of California San Francisco; University of York - UK; The World Bank	Davies, S (corresponding author), Dept Hlth & Social Care, London SW1H 0EU, England.	sally.davies@dh.gsi.gov.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The Blavatnik School of Government received a grant from the Wellcome Trust to prepare a pre-meeting report and the agenda for the Leeds Castle Meeting and CR, DS, NW, and ZS received personal fees for this work from the Wellcome Trust. LH, HA, EW, MD, OC, EG, AC, GV, SH, EB, JW, MG-L and SD declare no competing interests. The findings, interpretations, and conclusions expressed in this Comment are entirely those of the authors. They do not necessarily represent the views of the International Bank for Reconstruction and Development/World Bank and its affiliated organisations, or those of the Executive Directors of the World Bank or the governments they represent. The Leeds Castle meeting and supporting studies was made available thanks to funding from the Wellcome Trust. Participants at the Leeds Castle meeting included Nana Kuo, Simon Bland, Richard Sibbel, Elizabeth Cousens, Silvia Gold, Arianna Giuliodori, Thomas Cueni, Muzammil Mansuri, Lucy Chen, John Reed, and Peter Sands.	[Anonymous], 2017, AMR FRAM ACT SUPP IA; Barret Scott, 2007, WHY COOPERATE INCENT; Daulaire N, 2015, J LAW MED ETHICS, V43, P17, DOI 10.1111/jlme.12269; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Interagency Coordination Group (IACG) on Antimicrobial Resistance, 2017, WORK PLAN AD HOC INT; OLG Stuttgart, 2017, MDR, P692; ONeill J., 2016, TACKLING DRUG RESIST; Padiyara P, 2018, INFECT DIS AUCKL, V11; Wernli D, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000378; WHO (WorldHealthOrganization), 2018, WHO FACT SHEETS; World Bank, 2016, DRUG RESISTANT INFEC	11	49	50	1	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2018	391	10134					1976	1978		10.1016/S0140-6736(18)31117-6	http://dx.doi.org/10.1016/S0140-6736(18)31117-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GG1IJ	29864011	Green Submitted			2022-12-28	WOS:000432440300010
J	Anderson, I; Cifu, AS				Anderson, Irsk; Cifu, Adam S.			Management of Bleeding in Patients Taking Oral Anticoagulants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROTHROMBIN COMPLEX CONCENTRATE; DABIGATRAN REVERSAL; IDARUCIZUMAB; TRIALS		[Anderson, Irsk; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Chai-Adisaksopha C, 2015, J THROMB HAEMOST, V13, P2012, DOI 10.1111/jth.13139; Connolly SJ, 2016, NEW ENGL J MED, V375, P1131, DOI 10.1056/NEJMoa1607887; Levi M, 2014, J THROMB HAEMOST, V12, P1428, DOI 10.1111/jth.12599; Milling TJ, 2016, ACAD EMERG MED, V23, P466, DOI 10.1111/acem.12911; Nagalla S, 2016, CTS-CLIN TRANSL SCI, V9, P176, DOI 10.1111/cts.12398; Pollack CV, 2017, NEW ENGL J MED, V377, P431, DOI 10.1056/NEJMoa1707278; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Tomaselli GF, 2017, J AM COLL CARDIOL, V70, P3042, DOI 10.1016/j.jacc.2017.09.1085; Zahir H, 2015, CIRCULATION, V131, P82, DOI 10.1161/CIRCULATIONAHA.114.013445	10	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					2032	2033		10.1001/jama.2018.3504	http://dx.doi.org/10.1001/jama.2018.3504			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800198				2022-12-28	WOS:000432238300020
J	[Anonymous]				[Anonymous]			Antibiotic Consumption Increasing Globally	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	8	10	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					1973	1973		10.1001/jama.2018.5711	http://dx.doi.org/10.1001/jama.2018.5711			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800220				2022-12-28	WOS:000432238300004
J	Merchant, FM; Dickert, NW; Howard, DH				Merchant, Faisal M.; Dickert, Neal W., Jr.; Howard, David H.			Mandatory Shared Decision Making by the Centers for Medicare & Medicaid Services for Cardiovascular Procedures and Other Tests	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Merchant, Faisal M.] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; [Dickert, Neal W., Jr.] Emory Univ, Sch Med, Div Cardiol, Emory Clin Cardiovasc Res Inst, Atlanta, GA 30322 USA; [Howard, David H.] Emory Univ, Dept Hlth Policy & Management, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Merchant, FM (corresponding author), Emory Univ, Hosp Midtown, 550 Peachtree St NE, Atlanta, GA 30308 USA.	fmercha@emory.edu						Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Han PKJ, 2013, ANN FAM MED, V11, P306, DOI 10.1370/afm.1539; Incze M, 2018, JAMA INTERN MED, V178, P326, DOI 10.1001/jamainternmed.2017.8217; Jensen TS, FINAL DECISION MEMOR; Jensen TS CJ, NATL COVERAGE DETERM; MCNEIL BJ, 1982, NEW ENGL J MED, V306, P1259, DOI 10.1056/NEJM198205273062103; SCHOEN C, BENDING CURVE OPTION; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5	8	37	40	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2018	320	7					641	642		10.1001/jama.2018.6617	http://dx.doi.org/10.1001/jama.2018.6617			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR1XH	29868828				2022-12-28	WOS:000442348100008
J	Xu, YG; Wang, Q; Shen, C; Lin, QH; Wang, PC; Lu, M				Xu, Yuangang; Wang, Qian; Shen, Cheng; Lin, Qiuhan; Wang, Pengcheng; Lu, Ming			A series of energetic metal pentazolate hydrates (vol 549, pg 78, 2017)	NATURE			English	Correction													Wang, Pengcheng/T-7518-2019	Wang, Pengcheng/0000-0002-5282-236X				Xu YG, 2017, NATURE, V549, P78, DOI 10.1038/nature23662	1	0	0	6	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2018	559	7713					E5	E5		10.1038/s41586-018-0142-y	http://dx.doi.org/10.1038/s41586-018-0142-y			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM6BL	29795341	Bronze			2022-12-28	WOS:000438240900012
J	Yadlowsky, S; Hayward, RA; Sussman, JB; McClelland, RL; Min, YI; Basu, S				Yadlowsky, Steve; Hayward, Rodney A.; Sussman, Jeremy B.; McClelland, Robyn L.; Min, Yuan-, I; Basu, Sanjay			Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk	ANNALS OF INTERNAL MEDICINE			English	Article							CALIBRATION; PREVENTION; VALIDATION; STATINS; MODELS	Background: The 2013 pooled cohort equations (PCEs) are central in prevention guidelines for cardiovascular disease (CVD) but can misestimate CVD risk. Objective: To improve the clinical accuracy of CVD risk prediction by revising the 2013 PCEs using newer data and statistical methods. Design: Derivation and validation of risk equations. Setting: Population-based. Participants: 26 689 adults aged 40 to 79 years without prior CVD from 6 U.S. cohorts. Measurements: Nonfatal myocardial infarction, death from coronary heart disease, or fatal or nonfatal stroke. Results: The 2013 PCEs overestimated 10-year risk for atherosclerotic CVD by an average of 20% across risk groups. Misestimation of risk was particularly prominent among black adults, of whom 3.9 million (33% of eligible black persons) had extreme risk estimates (<70% or >250% those of white adults with otherwise-identical risk factor values). Updating these equations improved accuracy among all race and sex subgroups. Approximately 11.8 million U. S. adults previously labeled high-risk (10year risk >= 7.5%) by the 2013 PCEs would be relabeled lower-risk by the updated equations. Limitations: Updating the 2013 PCEs with data from modern cohorts reduced the number of persons considered to be at high risk. Clinicians and patients should consider the potential benefits and harms of reducing the number of persons recommended aspirin, blood pressure, or statin therapy. Our findings also indicate that risk equations will generally become outdated over time and require routine updating. Conclusion: Revised PCEs can improve the accuracy of CVD risk estimates.	[Yadlowsky, Steve; Basu, Sanjay] Stanford Univ, Ctr Primary Care & Outcomes Res, 616 Serra St,Room E012, Stanford, CA 94305 USA; [Hayward, Rodney A.; Sussman, Jeremy B.] Univ Michigan, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.; Sussman, Jeremy B.] Vet Affairs Ann Arbor Healthcare Syst, Ctr Clin Management Res, Ann Arbor, MI USA; [McClelland, Robyn L.] Univ Washington, 6200 NE 74th St, Seattle, WA 98195 USA; [Min, Yuan-, I] Univ Mississippi, Med Ctr, 350 West Woodrow Wilson Ave,Suite 701, Jackson, MS 39213 USA; [Min, Yuan-, I] Jackson Heart Study, Jackson, MS USA; [Basu, Sanjay] Stanford Univ, Ctr Populat Hlth Sci, Stanford, CA 94305 USA; [Basu, Sanjay] Harvard Med Sch, Ctr Primary Care, Boston, MA USA; [Basu, Sanjay] Stanford Univ, 117 Crothers Way, Stanford, CA 94305 USA; [Hayward, Rodney A.] VA Ann Arbor Hlth Care, 2800 Plymouth Rd,Bldg 14,G100-36, Ann Arbor, MI 48109 USA; [Sussman, Jeremy B.] VA Ann Arbor Hlth Care, 2800 Plymouth Rd,Bldg 16,Room 335E, Ann Arbor, MI 48109 USA	Stanford University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Washington; University of Washington Seattle; University of Mississippi; University of Mississippi Medical Center; Stanford University; Harvard University; Harvard Medical School; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Basu, S (corresponding author), Stanford Univ, 117 Crothers Way, Stanford, CA 94305 USA.	basus@stanford.edu	Sussman, Jeremy/W-3394-2019	Sussman, Jeremy/0000-0002-2158-3618; Min, Yuan-I/0000-0003-2470-0004	National Institute on Minority Health and Health Disparities of the National Institutes of Health [DP2MD010478, U54MD010724]; NHLBI of the National Institutes of Health [K08HL121056]; Stanford University; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK092926]; NHLBI [HHSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, HHSN268201300050C, HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC95168, N01-HC-95169]; National Institute on Minority Health and Health Disparities; National Institute of Biomedical Imaging and Bioengineering; National Center for Advancing Translational Sciences [UL1-TR-000040, UL1-TR-001079, UL1-TR-001420]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001420, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL121056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD010724] Funding Source: NIH RePORTER; Veterans Affairs [I01HX002014, IK2HX001368] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities of the National Institutes of Health; NHLBI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stanford University(Stanford University); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Veterans Affairs(US Department of Veterans Affairs)	By awards DP2MD010478 and U54MD010724 from the National Institute on Minority Health and Health Disparities of the National Institutes of Health and award K08HL121056 from the NHLBI of the National Institutes of Health. Mr. Yadlowsky is supported by the Stanford University Graduate Fellowship. Dr. Hayward is supported by grant P30DK092926 (Michigan Center for Diabetes Translational Research Methods Core) from the National Institute of Diabetes and Digestive and Kidney Diseases. The JHS is supported by contracts HHSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, and HHSN268201300050C from the NHLBI and the National Institute on Minority Health and Health Disparities, with additional support from the National Institute of Biomedical Imaging and Bioengineering. MESA is supported by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC95168, and N01-HC-95169 from the NHLBI and grants UL1-TR-000040, UL1-TR-001079, and UL1-TR-001420 from the National Center for Advancing Translational Sciences.	Basu S., 2017, MODELING PUBLIC HLTH; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Borucka J., 2014, EKONOMETRIA, V45, P85, DOI DOI 10.15611/EKT.2014.3.07; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Cook NR, 2016, ANN INTERN MED, V165, P786, DOI 10.7326/M16-1739; Cook NR, 2014, JAMA INTERN MED, V174, P1964, DOI 10.1001/jamainternmed.2014.5336; Cooper H., 2016, RES SYNTHESIS META A, V5; DeFilippis AP, 2015, ANN INTERN MED, V162, P266, DOI 10.7326/M14-1281; DeFilippis AP, 2017, EUR HEART J, V38, P598, DOI 10.1093/eurheartj/ehw301; Demler OV, 2015, STAT MED, V34, P1659, DOI 10.1002/sim.6428; Eddy DM, 2012, MED DECIS MAKING, V32, P733, DOI 10.1177/0272989X12454579; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hastie TJ, 2011, ELEMENTS STAT LEARNI; Hilden J, 2014, STAT MED, V33, P3405, DOI 10.1002/sim.5804; HILLER L, 2015, TRIALS S2, V16; Hosmer DW, 2013, APPL LOGISTIC REGRES, V398; Jung K, 2015, J BIOMED INFORM, V58, P168, DOI 10.1016/j.jbi.2015.10.006; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Miladinovic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047804; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Muntner P, 2014, JAMA-J AM MED ASSOC, V311, P1406, DOI 10.1001/jama.2014.2630; Pepe MS, 2015, STAT BIOSCI, V7, P282, DOI 10.1007/s12561-014-9118-0; Rana JS, 2016, J AM COLL CARDIOL, V67, P2118, DOI 10.1016/j.jacc.2016.02.055; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Whelton PK, 2017, HYPERTENSION, DOI 10.1016/j.jacc.2017.11.006	30	89	90	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2018	169	1					20	+		10.7326/M17-3011	http://dx.doi.org/10.7326/M17-3011			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL2FB	29868850				2022-12-28	WOS:000436931900004
J	Dimopoulos, MA; Tedeschi, A; Trotman, J; Garcia-Sanz, R; Macdonald, D; Leblond, V; Mahe, B; Herbaux, C; Tam, C; Orsucci, L; Palomba, ML; Matous, JV; Shustik, C; Kastritis, E; Treon, SP; Li, J; Salman, Z; Graef, T; Buske, C				Dimopoulos, M. A.; Tedeschi, A.; Trotman, J.; Garcia-Sanz, R.; Macdonald, D.; Leblond, V.; Mahe, B.; Herbaux, C.; Tam, C.; Orsucci, L.; Palomba, M. L.; Matous, J. V.; Shustik, C.; Kastritis, E.; Treon, S. P.; Li, J.; Salman, Z.; Graef, T.; Buske, C.		INNOVATE Study Grp European Consor	Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstrom's Macroglobulinemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONSENSUS PANEL RECOMMENDATIONS; PREVIOUSLY TREATED PATIENTS; 2ND INTERNATIONAL WORKSHOP; TERM-FOLLOW-UP; OPEN-LABEL; THERAPY; DEXAMETHASONE; MULTICENTER; GUIDELINES; MANAGEMENT	BACKGROUND Single-agent ibrutinib has shown substantial activity in patients with relapsed Waldenstrom's macroglobulinemia, a rare form of B-cell lymphoma. We evaluated the effect of adding ibrutinib to rituximab in patients with this disease, both in those who had not received previous treatment and in those with disease recurrence. METHODS We randomly assigned 150 symptomatic patients to receive ibrutinib plus rituximab or placebo plus rituximab. The primary end point was progression-free survival, as assessed by an independent review committee. Key secondary end points were response rates, sustained hematologic improvement from baseline, and safety. The mutational status of MYD88 and CXCR4 was assessed in bone marrow samples. RESULTS At 30 months, the progression-free survival rate was 82% with ibrutinib-rituximab versus 28% with placebo-rituximab (hazard ratio for progression or death, 0.20; P<0.001). The benefit in the ibrutinib-rituximab group over that in the placebo-rituximab group was independent of the MYD88 or CXCR4 genotype. The rate of major response was higher with ibrutinib-rituximab than with placebo-rituximab (72% vs. 32%, P<0.001). More patients had sustained increases in hemoglobin level with ibrutinib-rituximab than with placebo-rituximab (73% vs. 41%, P<0.001). The most common adverse events of any grade with ibrutinib-rituximab included infusion-related reactions, diarrhea, arthralgia, and nausea. Events of grade 3 or higher that occurred more frequently with ibrutinib-rituximab than with placebo-rituximab included atrial fibrillation (12% vs. 1%) and hypertension (13% vs. 4%); those that occurred less frequently included infusion reactions (1% vs. 16%) and any grade of IgM flare (8% vs. 47%). The major hemorrhage rate was the same in the two trial groups (4%). CONCLUSIONS Among patients with Waldenstrom's macroglobulinemia, the use of ibrutinib-rituximab resulted in significantly higher rates of progression-free survival than the use of placebo-rituximab, both among those who had received no previous treatment and among those with disease recurrence. Atrial fibrillation and hypertension were more common with ibrutinib-rituximab, whereas infusion reactions and IgM flare were more common with placebo-rituximab.	[Dimopoulos, M. A.; Kastritis, E.] Univ Athens, Sch Med, Athens, Greece; [Tedeschi, A.] ASST Grande Osped Metropolitano Niguarda, Milan, Italy; [Orsucci, L.] Citta Salute Hosp & Univ, Turin, Italy; [Trotman, J.] Univ Sydney, Concord Hosp, Concord, NSW, Australia; [Tam, C.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Tam, C.] St Vincents Hosp, Melbourne, Vic, Australia; [Garcia-Sanz, R.] Hosp Univ Salamanca, Salamanca, Spain; [Macdonald, D.] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada; [Shustik, C.] McGill Univ, Hlth Ctr, Royal Victoria Hosp, Montreal, PQ, Canada; [Leblond, V.] Univ Paris 06, AP HP, Hop Pitie Salpetriere, Dept Hematol, Paris, France; [Mahe, B.] CHU Nantes, Nantes, France; [Herbaux, C.] Ctr Hosp Reg Univ Lille, Inst Hematol Tranfus, Lille, France; [Palomba, M. L.] Mem Sloan Kettering Canc Ctr, New York, NY USA; [Matous, J. V.] Colorado Blood Canc Inst, Denver, CO USA; [Treon, S. P.] Dana Farber Canc Inst, Boston, MA USA; [Li, J.; Salman, Z.; Graef, T.] Pharmacyclics, Sunnyvale, CA USA; [Buske, C.] Univ Hosp Ulm, Dept Internal Med 3, Inst Expt Canc Res, Comprehens Canc Ctr Ulm, Ulm, Germany	Athens Medical School; National & Kapodistrian University of Athens; A.O.U. Citta della Salute e della Scienza di Torino; Concord Repatriation General Hospital; University of Sydney; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; University of Salamanca; University of Ottawa; Ottawa Hospital Research Institute; McGill University; Royal Victoria Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Nantes Universite; CHU de Nantes; Universite de Lille - ISITE; CHU Lille; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Pharmacyclics; Ulm University	Dimopoulos, MA (corresponding author), Univ Athens, Alexandra Hosp, Sch Med, Dept Clini Therapeut, Athens 11528, Greece.	mdimop@med.uoa.gr	Kastritis, Efstathios/AAD-3656-2019; Dimopoulos, Meletios Athanasios/AAD-4130-2019; Kastritis, Efstathios/AAE-4483-2020; Trappe, Ralf Ulrich/W-5801-2019; Hatjiharissi, Evdoxia/AAG-7425-2020; Hernandez-Rivas, Jose-Angel/ADF-6441-2022; Symeonidis, Argiris/K-2287-2019; Garcia-Sanz, Ramon/B-7986-2017	Kastritis, Efstathios/0000-0001-8191-5832; Trappe, Ralf Ulrich/0000-0001-7565-7160; Hernandez-Rivas, Jose-Angel/0000-0003-4550-757X; Symeonidis, Argiris/0000-0002-3685-3473; Trotman, Judith/0000-0001-8009-4593; Talaulikar, Dipti/0000-0001-6766-8345; Garcia-Sanz, Ramon/0000-0003-4120-2787	Pharmacyclics; Janssen Research and Development	Pharmacyclics; Janssen Research and Development	Funded by Pharmacyclics and Janssen Research and Development; ClinicalTrials.gov number, NCT02165397.	Buske C, 2013, ANN ONCOL, V24, P155, DOI 10.1093/annonc/mdt298; Buske C, 2015, BLOOD, V126, P2096; Byrd JC, 2015, BLOOD, V125, P2497, DOI 10.1182/blood-2014-10-606038; Castillo JJ, 2016, BRIT J HAEMATOL, V172, P709, DOI 10.1111/bjh.13883; Cella D, 1997, SEMIN HEMATOL, V34, P13; Chang BY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3400; Dimopoulos MA, 2002, J CLIN ONCOL, V20, P2327, DOI 10.1200/JCO.2002.09.039; Dimopoulos MA, 2017, LANCET ONCOL, V18, P241, DOI 10.1016/S1470-2045(16)30632-5; Dimopoulos MA, 2014, BLOOD, V124, P1404, DOI 10.1182/blood-2014-03-565135; Dimopoulos MA, 2013, BLOOD, V122, P3276, DOI 10.1182/blood-2013-05-503862; Dimopoulos MA, 2007, J CLIN ONCOL, V25, P3344, DOI 10.1200/JCO.2007.10.9926; Ghobrial IM, 2013, J CLIN ONCOL, V31, P291, DOI 10.1200/JCO.2012.46.6177; Kyle RA, 2003, SEMIN ONCOL, V30, P116, DOI 10.1053/sonc.2003.50038; Leblond V, 2016, BLOOD, V128, P1321, DOI 10.1182/blood-2016-04-711234; Leblond V, 2013, J CLIN ONCOL, V31, P301, DOI 10.1200/JCO.2012.44.7920; Morel P, 2009, BLOOD, V113, P4163, DOI 10.1182/blood-2008-08-174961; Olszewski AJ, 2016, ONCOLOGIST, V21, P1377, DOI 10.1634/theoncologist.2016-0126; Owen RG, 2003, SEMIN ONCOL, V30, P110, DOI 10.1053/sonc.2003.50082; Owen RG, 2014, BRIT J HAEMATOL, V165, P316, DOI 10.1111/bjh.12760; Rourke M, 2010, LEUKEMIA LYMPHOMA, V51, P1779, DOI 10.3109/10428194.2010.499977; Ruella M, 2017, LEUKEMIA, V31, P246, DOI 10.1038/leu.2016.262; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; Treon SP, 2005, ANN ONCOL, V16, P132, DOI 10.1093/annonc/mdi022; Treon SP, 2017, BLOOD, V130; Treon SP, 2015, BLOOD, V126, P721, DOI 10.1182/blood-2015-01-553974; Treon SP, 2015, NEW ENGL J MED, V372, P1430, DOI 10.1056/NEJMoa1501548; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Wang ML, 2015, BLOOD, V126, P739, DOI 10.1182/blood-2015-03-635326; Zhang L, 2014, BLOOD, V124, P1774	29	205	211	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2018	378	25					2399	2410		10.1056/NEJMoa1802917	http://dx.doi.org/10.1056/NEJMoa1802917			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ8SS	29856685	Bronze			2022-12-28	WOS:000435661600008
J	Perkel, JM				Perkel, Jeffrey M.			MAP-MAKING ON A BUDGET	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008					0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					147	148		10.1038/d41586-018-05331-6	http://dx.doi.org/10.1038/d41586-018-05331-6			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI3LQ	29872206	Bronze			2022-12-28	WOS:000434273300054
J	Torjesen, I				Torjesen, Ingrid			Almost 1.5m emergency hospital admissions could have been avoided last year	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		House of Commons Committee of Public Accounts, 2018, RED EM ADM	1	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2018	361								k2542	10.1136/bmj.k2542	http://dx.doi.org/10.1136/bmj.k2542			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BY	29880540				2022-12-28	WOS:000435073900013
J	Torjesen, I				Torjesen, Ingrid			Recruiting doctors from overseas: managing trusts' expectations	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Torjesen I, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2461	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2018	361								k2470	10.1136/bmj.k2470	http://dx.doi.org/10.1136/bmj.k2470			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BQ	29866651				2022-12-28	WOS:000435072800009
J	Dong, YA; Mu, YJ; Xie, YC; Zhang, YP; Han, YY; Zhou, Y; Wang, WH; Liu, ZH; Wu, M; Wang, H; Pan, M; Xu, N; Xu, CQ; Yang, MJ; Fan, SL; Deng, HT; Tan, TW; Liu, XY; Liu, L; Li, J; Wang, JW; Fang, XY; Feng, Y				Dong, Yanan; Mu, Yajuan; Xie, Yongchao; Zhang, Yupeng; Han, Youyou; Zhou, Yu; Wang, Wenhe; Liu, Zihe; Wu, Mei; Wang, Hao; Pan, Man; Xu, Ning; Xu, Cong-Qiao; Yang, Maojun; Fan, Shilong; Deng, Haiteng; Tan, Tianwei; Liu, Xiaoyun; Liu, Lei; Li, Jun; Wang, Jiawei; Fang, Xianyang; Feng, Yue			Structural basis of ubiquitin modification by the Legionella effector SdeA	NATURE			English	Article							SMALL-ANGLE SCATTERING; ARGININE ADP-RIBOSYLATION; ENDOPLASMIC-RETICULUM; BIOLOGICAL MACROMOLECULES; PK(A) VALUES; IOTA-TOXIN; PNEUMOPHILA; SYSTEM; TRANSLOCATION; RECOGNITION	Protein ubiquitination is a multifaceted post-translational modification that controls almost every process in eukaryotic cells. Recently, the Legionella effector SdeA was reported to mediate a unique phosphoribosyl-linked ubiquitination through successive modifications of the Arg42 of ubiquitin (Ub) by its mono-ADP-ribosyltransferase (mART) and phosphodiesterase (PDE) domains. However, the mechanisms of SdeA-mediated Ub modification and phosphoribosyl-linked ubiquitination remain unknown. Here we report the structures of SdeA in its ligand-free, Ub-bound and Ub-NADH-bound states. The structures reveal that the mART and PDE domains of SdeA form a catalytic domain over its C-terminal region. Upon Ub binding, the canonical ADP-ribosyltransferase toxin turn-turn (ARTT) and phosphate-nicotinamide (PN) loops in the mART domain of SdeA undergo marked conformational changes. The Ub Arg72 might act as a 'probe' that interacts with the mART domain first, and then movements may occur in the side chains of Arg72 and Arg42 during the ADP-ribosylation of Ub. Our study reveals the mechanism of SdeA-mediated Ub modification and provides a framework for further investigations into the phosphoribosyl-linked ubiquitination process.	[Dong, Yanan; Mu, Yajuan; Xie, Yongchao; Han, Youyou; Wang, Wenhe; Liu, Zihe; Wang, Hao; Tan, Tianwei; Feng, Yue] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing Adv Innovat Ctr Soft Matter Sci & Engn, Beijing, Peoples R China; [Zhang, Yupeng; Xu, Ning; Yang, Maojun; Fan, Shilong; Deng, Haiteng; Wang, Jiawei; Fang, Xianyang] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Beijing, Peoples R China; [Zhou, Yu] Natl Inst Biol Sci, Beijing, Peoples R China; [Wu, Mei; Liu, Xiaoyun] Peking Univ, Coll Chem & Mol Engn, Inst Analyt Chem & Synthet, Beijing, Peoples R China; [Wu, Mei; Liu, Xiaoyun] Peking Univ, Coll Chem & Mol Engn, Funct Biomol Ctr, Beijing, Peoples R China; [Pan, Man; Liu, Lei] Tsinghua Univ, Dept Chem, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China; [Xu, Cong-Qiao; Li, Jun] Tsinghua Univ, Minist Educ, Dept Chem, Beijing, Peoples R China; [Xu, Cong-Qiao; Li, Jun] Tsinghua Univ, Minist Educ, Key Lab Organ Optoelect & Mol Engn, Beijing, Peoples R China	Beijing University of Chemical Technology; Tsinghua University; National Institute of Biological Sciences, Beijing; Peking University; Peking University; Tsinghua University; Tsinghua University; Tsinghua University	Feng, Y (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing Adv Innovat Ctr Soft Matter Sci & Engn, Beijing, Peoples R China.	fengyue@mail.buct.edu.cn	Wang, Jiawei/D-1144-2010; Feng, Yue/HGE-4589-2022; Li, Jun/E-5334-2011; PAN, MAN/GLU-5110-2022; Xu, Cong-Qiao/R-3161-2019	Wang, Jiawei/0000-0001-9893-8539; Feng, Yue/0000-0002-1576-1385; Li, Jun/0000-0002-8456-3980; Xu, Cong-Qiao/0000-0003-4593-3288; Deng, Haiteng/0000-0001-9496-1280; Fang, Xianyang/0000-0001-9432-9736; Fan, Shilong/0000-0001-9272-2438; Liu, Zihe/0000-0002-4199-1627	National Key Research and Development Program of China [2017YFA0506500]; National Natural Science Foundation of China [31670766, 21532004, 21475005, 21622501]; Fundamental Research Funds for the Central Universities [buctylkxj03]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank B. Zhou for the gift of the yeast W303 strain and the pYES2 vector; Y. Zhang for help in the yeast experiments; J. Ren, X. Zhang and R. Qiao for discussions about the mechanisms of SdeA; S. Zhang for the electron microscopy tests of the SdeA sample; C. Yan for help with the data collection process; the Tsinghua University Branch of China National Center for Protein Sciences Beijing and Y. Xue for providing facility support for NMR analysis of the protein samples; the Protein Chemistry Facility at the Center for Biomedical Analysis of Tsinghua University and W. Zhang for sample analysis; the staff at beamline BL17U1 and BL19U1 of the Shanghai Synchrotron Radiation Facility for their assistance with data collection and X. Zuo at the Advanced Photon Source (APS), Argonne National Laboratory (ANL) and the staff of BL19U2 beamline at the National Center for Protein Science Shanghai and Shanghai Synchrotron Radiation Facility for assistance during data collection. Use of the scattering beamline 12-ID-B resource at APS, ANL is allocated under the GUP-52757 to X.F. This work was supported by the National Key Research and Development Program of China (2017YFA0506500), the National Natural Science Foundation of China (31670766, 21532004, 21475005, and 21622501) and the Fundamental Research Funds for the Central Universities (buctylkxj03).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akturk A, 2018, NATURE, V557, P729, DOI 10.1038/s41586-018-0147-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bhogaraju S, 2016, CELL, V167, P1636, DOI 10.1016/j.cell.2016.11.019; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dodda LS, 2017, NUCLEIC ACIDS RES, V45, pW331, DOI 10.1093/nar/gkx312; Dodda LS, 2017, J PHYS CHEM B, V121, P3864, DOI 10.1021/acs.jpcb.7b00272; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Hubber A, 2014, CURR TOP MICROBIOL, V376, P227, DOI 10.1007/82_2013_343; Jeong BR, 2011, J BIOL CHEM, V286, P43272, DOI 10.1074/jbc.M111.290122; Jeong KC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004695; Jorgensen WL, 2005, J COMPUT CHEM, V26, P1689, DOI 10.1002/jcc.20297; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kalayil S, 2018, NATURE, V557, P734, DOI 10.1038/s41586-018-0145-8; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kotewicz KM, 2017, CELL HOST MICROBE, V21, P169, DOI 10.1016/j.chom.2016.12.007; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwak MJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.114; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Puvar K, 2017, BIOCHEMISTRY-US, V56, P4762, DOI 10.1021/acs.biochem.7b00664; Qiu JZ, 2017, NAT REV MICROBIOL, V15, P591, DOI 10.1038/nrmicro.2017.67; Qiu JZ, 2016, NATURE, V533, P120, DOI 10.1038/nature17657; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Sakurai J, 2009, TOXINS, V1, P208, DOI 10.3390/toxins1020208; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheedlo MJ, 2015, P NATL ACAD SCI USA, V112, P15090, DOI 10.1073/pnas.1514568112; STORER JW, 1995, J COMPUT AID MOL DES, V9, P87, DOI 10.1007/BF00117280; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; Udier-Blagovic M, 2004, J COMPUT CHEM, V25, P1322, DOI 10.1002/jcc.20059; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Zhang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028882	60	41	43	9	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					674	+		10.1038/s41586-018-0146-7	http://dx.doi.org/10.1038/s41586-018-0146-7			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29795342				2022-12-28	WOS:000433412900043
J	Rothstein, L				Rothstein, Laura			Preserving Access for People with Disabilities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rothstein, Laura] Univ Louisville, Brandeis Sch Law, Louisville, KY 40292 USA	University of Louisville	Rothstein, L (corresponding author), Univ Louisville, Brandeis Sch Law, Louisville, KY 40292 USA.							Iezzoni LI, 2018, NEW ENGL J MED, V378, P1371, DOI 10.1056/NEJMp1800606; Rothstein L, 2017, DISABILITIES LAW	2	1	1	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2018	378	22					2065	2067		10.1056/NEJMp1803649	http://dx.doi.org/10.1056/NEJMp1803649			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH5AL	29847752				2022-12-28	WOS:000433428000004
J	McCartney, M				McCartney, Margaret			Margaret McCartney: We must look at the whole impact of revalidation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				McCartney M, 2015, BMJ-BRIT MED J, V351, ph4982; Pearson K., 2017, TAKING REVALIDATION, DOI [10.1136/bmj.h498226391141, DOI 10.1136/BMJ.H498226391141]; Umbrella, 2018, EV REG IMP MED REV	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2018	361								k2323	10.1136/bmj.k2323	http://dx.doi.org/10.1136/bmj.k2323			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MF	29844015	Green Published, Bronze			2022-12-28	WOS:000434274800002
J	Chattopadhyay, A; Sharma, A; Gupta, K; Jain, S				Chattopadhyay, Arghya; Sharma, Aman; Gupta, Kirti; Jain, Sanjay			The Phemister triad	LANCET			English	Editorial Material									[Chattopadhyay, Arghya; Sharma, Aman; Jain, Sanjay] Dept Internal Med, Clin Immunol & Rheumatol Unit, Chandigarh, Punjab, India; [Gupta, Kirti] Dept Histopathol, Chandigarh, Punjab, India; [Gupta, Kirti] Post Grad Inst Med Educ & Res, Chandigarh, Punjab, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Sharma, A (corresponding author), Post Grad Inst Med Educ & Res, Dept Internal Med, Clin Immunol & Rheumatol Unit, Chandigarh 160012, India.	amansharma74@gmail.com	Chattopadhyay, Arghya/B-4867-2019	Chattopadhyay, Arghya/0000-0003-3917-1977; Jain, Sanjay K/0000-0002-9241-3114					0	5	6	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2018	391	10135					E20	E20		10.1016/S0140-6736(18)30986-3	http://dx.doi.org/10.1016/S0140-6736(18)30986-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH2UJ	29856345				2022-12-28	WOS:000433257200001
J	Chisholm, RA; Fung, T				Chisholm, Ryan A.; Fung, Tak			Comment on "Plant diversity increases with the strength of negative density dependence at the global scale"	SCIENCE			English	Editorial Material							SPECIES ABUNDANCES; FEEDBACK	LaManna et al. (Reports, 30 June 2017, p. 1389) found higher conspecific negative density dependence in tree communities at lower latitudes, yielding a possible mechanistic explanation for the latitudinal diversity gradient. We show that their results are artifacts of a selective data transformation and a forced zero intercept in their fitted model. A corrected analysis shows no latitudinal trend.	[Chisholm, Ryan A.; Fung, Tak] Natl Univ Singapore, Dept Biol Sci, Singapore 117558, Singapore; [Chisholm, Ryan A.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	National University of Singapore; Smithsonian Institution; Smithsonian Tropical Research Institute	Chisholm, RA (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117558, Singapore.; Chisholm, RA (corresponding author), Smithsonian Trop Res Inst, Balboa, Ancon, Panama.	ryan.chis@gmail.com	Chisholm, Ryan/H-8033-2012	Chisholm, Ryan/0000-0002-9847-1710	McDonnell Foundation [220020470]	McDonnell Foundation	Supported by McDonnell Foundation grant 220020470.	Chisholm RA, 2011, THEOR ECOL-NETH, V4, P241, DOI 10.1007/s12080-011-0119-z; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; LaManna JA, 2017, SCIENCE, V356, P1389, DOI 10.1126/science.aam5678; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559	7	17	17	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391							aar4685	10.1126/science.aar4685	http://dx.doi.org/10.1126/science.aar4685			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG9RW	29798854				2022-12-28	WOS:000433039800003
J	Dyer, C				Dyer, Clare			Former editor in chief of RCP journal is struck off for dishonesty	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4537; Dyer C, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1348	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2018	361								k2346	10.1136/bmj.k2346	http://dx.doi.org/10.1136/bmj.k2346			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH4XO	29802166				2022-12-28	WOS:000433416200013
J	Flack, A; Nagy, M; Fiedler, W; Couzin, ID; Wikelski, M				Flack, Andrea; Nagy, Mate; Fiedler, Wolfgang; Couzin, Iain D.; Wikelski, Martin			From local collective behavior to global migratory patterns in white storks	SCIENCE			English	Article							ANIMAL GROUPS; SOCIAL INTERACTIONS; GROUP NAVIGATION; ENERGY; FLIGHT; INFORMATION; STRATEGIES; LEADERSHIP; EVOLUTION; MOVEMENT	Soaring migrant birds exploit columns of rising air (thermals) to cover large distances with minimal energy. Using social information while locating thermals may benefit such birds, but examining collective movements in wild migrants has been a major challenge for researchers. We investigated the group movements of a flock of 27 naturally migrating juvenile white storks by using high-resolution GPS and accelerometers. Analyzing individual and group movements on multiple scales revealed that a small number of leaders navigated to and explored thermals, whereas followers benefited from their movements. Despite this benefit, followers often left thermals earlier and at lower height, and consequently they had to flap considerably more. Followers also migrated less far annually than did leaders. We provide insights into the interactions between freely flying social	[Flack, Andrea; Fiedler, Wolfgang; Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immuno Ecol, Radolfzell am Bodensee, Germany; [Flack, Andrea; Nagy, Mate; Fiedler, Wolfgang; Couzin, Iain D.; Wikelski, Martin] Univ Konstanz, Dept Biol, Constance, Germany; [Nagy, Mate; Couzin, Iain D.] Max Planck Inst Ornithol, Dept Collect Behav, Constance, Germany; [Nagy, Mate] Hungarian Acad Sci, MTA ELTE Stat & Biol Phys Res Grp, Budapest, Hungary	Max Planck Society; University of Konstanz; Max Planck Society; Hungarian Academy of Sciences	Flack, A (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immuno Ecol, Radolfzell am Bodensee, Germany.; Flack, A; Nagy, M (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.; Nagy, M (corresponding author), Max Planck Inst Ornithol, Dept Collect Behav, Constance, Germany.; Nagy, M (corresponding author), Hungarian Acad Sci, MTA ELTE Stat & Biol Phys Res Grp, Budapest, Hungary.	aflack@orn.mpg.de; mnagy@orn.mpg.de	Couzin, Iain D./Q-6862-2018; Flack, Andrea/E-6247-2016; Fiedler, Wolfgang/AAG-4510-2021; Nagy, Mate/B-3180-2011	Couzin, Iain D./0000-0001-8556-4558; Flack, Andrea/0000-0002-9099-2802; Fiedler, Wolfgang/0000-0003-1082-4161; Nagy, Mate/0000-0001-8817-087X	Max Planck Institute for Ornithology; German Aerospace Center (DLR); Christiane Nusslein-Volhard Stiftung; Royal Society Newton Alumni scheme; NSF [IOS-1355061]; ONR [N00014-09-1-1074, N00014-14-1-0635]; ARO [W911NG-11-1-0385, W911NF14-1-0431]; Struktur- und Innovationsfunds fur die Forschung of the State of Baden-Wurttemberg; Max Planck Society	Max Planck Institute for Ornithology(Max Planck Society); German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); Christiane Nusslein-Volhard Stiftung; Royal Society Newton Alumni scheme; NSF(National Science Foundation (NSF)); ONR(Office of Naval Research); ARO; Struktur- und Innovationsfunds fur die Forschung of the State of Baden-Wurttemberg; Max Planck Society(Max Planck Society)	We acknowledge funding from the Max Planck Institute for Ornithology. A.F. was supported by the German Aerospace Center (DLR) and the Christiane Nusslein-Volhard Stiftung. M.N. received funding from the Royal Society Newton Alumni scheme. I.D.C. acknowledges support from the NSF (IOS-1355061), the ONR (N00014-09-1-1074 and N00014-14-1-0635), the ARO (W911NG-11-1-0385 and W911NF14-1-0431), the Struktur- und Innovationsfunds fur die Forschung of the State of Baden-Wurttemberg, and the Max Planck Society.	Akos Z, 2008, P NATL ACAD SCI USA, V105, P4139, DOI 10.1073/pnas.0707711105; Berdahl A, 2013, SCIENCE, V339, P574, DOI 10.1126/science.1225883; Bishop CM, 2015, SCIENCE, V347, P250, DOI 10.1126/science.1258732; Bode NWF, 2012, AM NAT, V179, P621, DOI 10.1086/665005; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Chernetsov N, 2004, J EXP BIOL, V207, P937, DOI 10.1242/jeb.00853; Codling EA, 2007, ECOLOGY, V88, P1864, DOI 10.1890/06-0854.1; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Flack A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500931; Flack A, 2012, ANIM BEHAV, V83, P703, DOI 10.1016/j.anbehav.2011.12.018; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Guttal V, 2010, P NATL ACAD SCI USA, V107, P16172, DOI 10.1073/pnas.1006874107; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Jolles JW, 2017, CURR BIOL, V27, P2862, DOI 10.1016/j.cub.2017.08.004; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; MilnerGulland EJ, 2011, ANIMAL MIGRATION: A SYNTHESIS, P1, DOI 10.1093/acprof:oso/9780199568994.001.0001; Mueller T, 2013, SCIENCE, V341, P999, DOI 10.1126/science.1237139; Nagy M, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0011; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; PENNYCUICK CJ, 1969, IBIS, V111, P525, DOI 10.1111/j.1474-919X.1969.tb02566.x; Portugal SJ, 2014, NATURE, V505, P399, DOI 10.1038/nature12939; Rotics S, 2016, J ANIM ECOL, V85, P938, DOI 10.1111/1365-2656.12525; Sherub S, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0432; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Strandburg-Peshkin A, 2015, SCIENCE, V348, P1358, DOI 10.1126/science.aaa5099; Torney C, 2009, P NATL ACAD SCI USA, V106, P22055, DOI 10.1073/pnas.0907929106; Voelkl B, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0235; Weimerskirch H, 2016, SCIENCE, V353, P74, DOI 10.1126/science.aaf4374	29	77	79	9	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					911	914		10.1126/science.aap7781	http://dx.doi.org/10.1126/science.aap7781			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798883	Green Submitted			2022-12-28	WOS:000433039800049
J	Holmes, RJ				Holmes, Russell J.			Enhancing energy transport in conjugated polymers	SCIENCE			English	Editorial Material							EXCITON DIFFUSION		[Holmes, Russell J.] Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Holmes, RJ (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	rholmes@umn.edu		Holmes, Russell/0000-0001-7183-3673				Akselrod GM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4646; Boott CE, 2017, NAT CHEM, V9, P785, DOI [10.1038/NCHEM.2721, 10.1038/nchem.2721]; Bredas JL, 2017, NAT MATER, V16, P35, DOI [10.1038/nmat4767, 10.1038/NMAT4767]; Fassioli F, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0901; Hedley GJ, 2017, CHEM REV, V117, P796, DOI 10.1021/acs.chemrev.6b00215; Jin XH, 2018, SCIENCE, V360, P897, DOI 10.1126/science.aar8104; Lunt RR, 2010, ADV MATER, V22, P1233, DOI 10.1002/adma.200902827; Menke SM, 2014, ENERG ENVIRON SCI, V7, P499, DOI 10.1039/c3ee42444h; Najafov H, 2010, NAT MATER, V9, P938, DOI 10.1038/nmat2872	9	5	5	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					854	855		10.1126/science.aat6009	http://dx.doi.org/10.1126/science.aat6009			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG9RW	29798868				2022-12-28	WOS:000433039800026
J	Fenton, JJ; Weyrich, MS; Durbin, S; Liu, Y; Bang, H; Melnikow, J				Fenton, Joshua J.; Weyrich, Meghan S.; Durbin, Shauna; Liu, Yu; Bang, Heejung; Melnikow, Joy			Prostate-Specific Antigen-Based Screening for Prostate Cancer Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							QUALITY-OF-LIFE; EXTERNAL-BEAM RADIOTHERAPY; RISK CALCULATOR 2.0; RADICAL PROSTATECTOMY; FOLLOW-UP; ACTIVE SURVEILLANCE; RANDOMIZED PROSTATE; RADIATION-THERAPY; ROTTERDAM SECTION; 30-DAY MORTALITY	IMPORTANCE Prostate cancer is the second leading cause of cancer death among US men. OBJECTIVE To systematically review evidence on prostate-specific antigen (PSA)-based prostate cancer screening, treatments for localized prostate cancer, and prebiopsy risk calculators to inform the US Preventive Services Task Force. DATA SOURCES Searches of PubMed, EMBASE, Web of Science, and Cochrane Registries and Databases from July 1, 2011, through July 15, 2017, with a surveillance search on February 1, 2018. STUDY SELECTION English-language reports of randomized clinical trials (RCTs) of screening; cohort studies reporting harms; RCTs and cohort studies of active localized cancer treatments vs conservative approaches (eg, active surveillance, watchful waiting); external validations of prebiopsy risk calculators to identify aggressive cancers. DATA EXTRACTION AND SYNTHESIS One investigator abstracted data; a second checked accuracy. Two investigators independently rated study quality. MAIN OUTCOMES AND MEASURES Prostate cancer and all-cause mortality; false-positive screening results, biopsy complications, overdiagnosis; adverse effects of active treatments. Random-effects meta-analyses were conducted for treatment harms. RESULTS Sixty-three studies in 104 publications were included (N = 1 904 950). Randomization to PSA screening was not associated with reduced risk of prostate cancer mortality in either a US trial with substantial control group contamination (n = 76 683) or a UK trial with low adherence to a single PSA screen (n = 408 825) but was associated with significantly reduced prostate cancer mortality in a European trial (n = 162 243; relative risk [RR], 0.79 [95% CI, 0.69-0.91]; absolute risk reduction, 1.1 deaths per 10 000 person-years [95% CI, 0.5-1.8]). Of 61 604 men screened in the European trial, 17.8% received false-positive results. In 3 cohorts (n = 15 136), complications requiring hospitalization occurred in 0.5% to 1.6% of men undergoing biopsy after abnormal screening findings. Overdiagnosis was estimated to occur in 20.7% to 50.4% of screen-detected cancers. In an RCT of men with screen-detected prostate cancer (n = 1643), neither radical prostatectomy (hazard ratio [HR], 0.63 [95% CI, 0.21-1.93]) nor radiation therapy (HR, 0.51 [95% CI, 0.15-1.69]) were associated with significantly reduced prostate cancer mortality vs active monitoring, although each was associated with significantly lower risk of metastatic disease. Relative to conservative management, radical prostatectomy was associated with increased risk of urinary incontinence (pooled RR, 2.27 [95% CI, 1.82-2.84]; 3 trials; n = 1796) and erectile dysfunction (pooled RR, 1.82 [95% CI, 1.62-2.04]; 2 trials; n = 883). Relative to conservative management (8 cohort studies; n = 3066), radiation therapy was associated with increased risk of erectile dysfunction (pooled RR, 1.31 [95% CI, 1.20-1.42]). CONCLUSIONS AND RELEVANCE PSA screening may reduce prostate cancer mortality risk but is associated with false-positive results, biopsy complications, and overdiagnosis. Compared with conservative approaches, active treatments for screen-detected prostate cancer have unclear effects on long-term survival but are associated with sexual and urinary difficulties.	[Fenton, Joshua J.; Weyrich, Meghan S.; Durbin, Shauna; Melnikow, Joy] Univ Calif Davis, Ctr Healthcare Policy & Res, Sacramento, CA 95817 USA; [Fenton, Joshua J.; Melnikow, Joy] Univ Calif Davis, Dept Family & Community Med, Sacramento, CA 95817 USA; [Liu, Yu; Bang, Heejung] Univ Calif Davis, Dept Publ Hlth Sci, Div Biostat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Fenton, JJ (corresponding author), Univ Calif Davis, Med Ctr, Dept Family & Community Med, 4860 Y St,Ste 2300, Sacramento, CA 95817 USA.	jjfenton@ucdavis.edu	Fenton, Joshua/AAD-4114-2021	Fenton, Joshua/0000-0002-0581-835X	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2012-00015-I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA-290-2012-00015-I, Task Order 6, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Albertsen PC, 2007, J UROLOGY, V177, P932, DOI 10.1016/j.juro.2006.10.051; Alibhai SMH, 2005, JNCI-J NATL CANCER I, V97, P1525, DOI 10.1093/jnci/dji313; American Cancer Society, 2018, CANC FACTS FIG 2018; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Ankerst DP, 2014, UROLOGY, V83, P1362, DOI 10.1016/j.urology.2014.02.035; Ankerst DP, 2014, WORLD J UROL, V32, P185, DOI 10.1007/s00345-012-0869-2; [Anonymous], AHRQ PUBL; Augustin H, 2003, EUR UROL, V43, P113, DOI 10.1016/S0302-2838(02)00495-5; Bacon CG, 2001, J UROLOGY, V166, P1804, DOI 10.1016/S0022-5347(05)65679-0; Barocas DA, 2017, JAMA-J AM MED ASSOC, V317, P1126, DOI 10.1001/jama.2017.1704; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; Bjorklund J, 2016, BJU INT, V118, P302, DOI 10.1111/bju.13404; Bokhorst LP, 2014, EUR UROL, V65, P329, DOI 10.1016/j.eururo.2013.08.005; Bokhorst LP, 2012, BJU INT, V110, P1654, DOI 10.1111/j.1464-410X.2012.11481.x; Brindle LA, 2006, BJU INT, V98, P777, DOI 10.1111/j.1464-410X.2006.06401.x; Carlsson SV, 2011, BJU INT, V107, P1912, DOI 10.1111/j.1464-410X.2010.09712.x; Carroll PR, 2016, J NATL COMPR CANC NE, V14, P509, DOI 10.6004/jnccn.2016.0060; Carter JL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7773; Chen RC, 2017, JAMA-J AM MED ASSOC, V317, P1141, DOI 10.1001/jama.2017.1652; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Ciatto S, 2003, BJU INT, V92, P97, DOI 10.1111/j.1464-410X.2003.04407.x; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Croswell JM, 2009, ANN FAM MED, V7, P212, DOI 10.1370/afm.942; Cuzick J, 2014, LANCET ONCOL, V15, pE484, DOI 10.1016/S1470-2045(14)70211-6; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Etzioni R, 2002, J NATL CANCER I, V94, P981; Foley RW, 2016, BJU INT, V118, P706, DOI 10.1111/bju.13437; Fowler FJ, 2006, J GEN INTERN MED, V21, P715, DOI 10.1111/j.1525-1497.2006.00464.x; Fransson P, 2001, CANCER-AM CANCER SOC, V92, P3111, DOI 10.1002/1097-0142(20011215)92:12<3111::AID-CNCR10160>3.0.CO;2-E; Fransson P, 2009, SCAND J UROL NEPHROL, V43, P119, DOI 10.1080/00365590802519396; Godtman RA, 2015, EUR UROL, V68, P354, DOI 10.1016/j.eururo.2014.12.006; Gomez-Gomez E, 2017, UROLOGY, V102, P85, DOI 10.1016/j.urology.2016.11.004; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Hernandez DJ, 2009, BJU INT, V103, P609, DOI 10.1111/j.1464-410X.2008.08127.x; Hoffman RM, 2003, CANCER, V97, P1653, DOI 10.1002/cncr.11233; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Katz DA, 2007, UROLOGY, V69, P215, DOI 10.1016/j.urology.2006.09.059; Kicinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027130; Kiellman A, 2009, J UROLOGY, V181, P1615, DOI 10.1016/j.juro.2008.11.115; Kilpelainen TP, 2011, EUR J CANCER, V47, P2698, DOI 10.1016/j.ejca.2011.06.055; Kilpelainen TP, 2017, J UROLOGY, V198, P50, DOI 10.1016/j.juro.2017.01.048; Kilpelainen TP, 2013, JNCI-J NATL CANCER I, V105, P719, DOI 10.1093/jnci/djt038; Labrie F, 2004, PROSTATE, V59, P311, DOI 10.1002/pros.20017; Ladjevardi S, 2010, EUR UROL, V57, P631, DOI 10.1016/j.eururo.2009.03.007; Lin JS, 2017, AHRQ PUBLICATION; Lin K., 2011, AHRQ PUBLICATION; Liss MA, 2015, J UROLOGY, V193, P75, DOI 10.1016/j.juro.2014.07.085; Litwin MS, 2002, CANCER, V95, P54, DOI 10.1002/cncr.10651; LITWIN MS, 1995, JAMA-J AM MED ASSOC, V273, P129, DOI 10.1001/jama.273.2.129; LITWIN MS, 1995, CANCER, V75, P2000, DOI 10.1002/1097-0142(19950401)75:7+<2000::AID-CNCR2820751641>3.0.CO;2-4; Lubeck DP, 1999, UROLOGY, V53, P180, DOI 10.1016/S0090-4295(98)00408-7; Lujan M, 2014, PROSTATE CANCER P D, V17, P187, DOI 10.1038/pcan.2014.7; Lundon DJ, 2015, WORLD J UROL, V33, P827, DOI 10.1007/s00345-014-1365-7; Martin RM, 2018, JAMA-J AM MED ASSOC, V319, P883, DOI 10.1001/jama.2018.0154; Maruf M, 2017, PROSTATE CANCER P D, V20, P179, DOI 10.1038/pcan.2016.46; McNaughton-Collins M, 2004, AM J MED, V117, P719, DOI 10.1016/j.amjmed.2004.06.036; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Moons KGM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001744; Nam RK, 2011, J CLIN ONCOL, V29, P2959, DOI 10.1200/JCO.2010.32.6371; National Cancer Institute, SEER CANC STAT FACTS; National Institute for Health and Care Excellence, 2006, GUID MAN; Ngo TC, 2011, J UROLOGY, V185, P483, DOI 10.1016/j.juro.2010.09.101; Nguyen CT, 2010, J UROLOGY, V183, P529, DOI 10.1016/j.juro.2009.10.007; Park JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168917; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Pinsky PF, 2017, CANCER-AM CANCER SOC, V123, P592, DOI 10.1002/cncr.30474; Pinsky PF, 2014, BJU INT, V113, P254, DOI 10.1111/bju.12368; Pinsky PF, 2010, CLIN TRIALS, V7, P303, DOI 10.1177/1740774510374091; Poyet C, 2016, BJU INT, V117, P401, DOI 10.1111/bju.13314; Raaijmakers R, 2002, UROLOGY, V60, P826, DOI 10.1016/S0090-4295(02)01958-1; Rabbani F, 2010, EUR UROL, V57, P371, DOI 10.1016/j.eururo.2009.11.034; Roobol MJ, 2013, EUR UROL, V64, P530, DOI 10.1016/j.eururo.2013.05.030; Roobol MJ, 2012, EUR UROL, V61, P577, DOI 10.1016/j.eururo.2011.11.012; Rosario DJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7894; Sandblom G, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1539; Schapira MM, 2001, MED CARE, V39, P243, DOI 10.1097/00005650-200103000-00005; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Schroder FH, 2012, EUR UROL, V62, P745, DOI 10.1016/j.eururo.2012.05.068; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schymura MJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-152; Shah C, 2012, AM J CLIN ONCOL-CANC, V35, P566, DOI 10.1097/COC.0b013e3182208262; Siegel T, 2001, J UROLOGY, V165, P430, DOI 10.1097/00005392-200102000-00019; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Smith DS, 2000, CANCER, V88, P1454, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1454::AID-CNCR25>3.3.CO;2-J; Stattin P, 2010, JNCI-J NATL CANCER I, V102, P950, DOI 10.1093/jnci/djq154; Thong MSY, 2010, BJU INT, V105, P652, DOI 10.1111/j.1464-410X.2009.08815.x; Tosoian JJ, 2016, NAT REV UROL, V13, P205, DOI 10.1038/nrurol.2016.45; Trottier G, 2011, BJU INT, V108, pE237, DOI 10.1111/j.1464-410X.2011.10207.x; Tsodikov A, 2017, ANN INTERN MED, V167, P449, DOI 10.7326/M16-2586; Vasarainen H, 2013, ACTA ONCOL, V52, P1615, DOI 10.3109/0284186X.2013.802837; Walter LC, 2013, JAMA INTERN MED, V173, P866, DOI 10.1001/jamainternmed.2013.323; Walz J, 2008, BJU INT, V101, P826, DOI 10.1111/j.1464-410X.2007.07373.x; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278; Wells GA, 2016, NEWCASTLE OTTOWA SCA; Wilt TJ, 2017, NEW ENGL J MED, V377, P132, DOI 10.1056/NEJMoa1615869; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Wolters T, 2010, INT J CANCER, V126, P2387, DOI 10.1002/ijc.24870; Wong YN, 2006, JAMA-J AM MED ASSOC, V296, P2683, DOI 10.1001/jama.296.22.2683; Yao SL, 1999, J NATL CANCER I, V91, P1950, DOI 10.1093/jnci/91.22.1950; Young GJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017729; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zappa M, 1998, ANN ONCOL, V9, P1297, DOI 10.1023/A:1008492013196; Zhou EH, 2009, INT J RADIAT ONCOL, V73, P15, DOI 10.1016/j.ijrobp.2008.04.001	107	236	243	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1914	1931		10.1001/jama.2018.3712	http://dx.doi.org/10.1001/jama.2018.3712			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29801018	Bronze			2022-12-28	WOS:000431668600020
J	Cohen, IG; Mello, MM				Cohen, I. Glenn; Mello, Michelle M.			HIPAA and Protecting Health Information in the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cohen, I. Glenn] Harvard Law Sch, Cambridge, MA USA; [Mello, Michelle M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford Law Sch, Stanford, CA 94305 USA	Harvard University; Stanford University	Mello, MM (corresponding author), Stanford Law Sch, 559 Nathan Abbott Way, Stanford, CA 94305 USA.	mmello@law.stanford.edu		Mello, Michelle/0000-0003-2877-4270	Collaborative Research Program for Biomedical Innovation Law; Novo Nordisk Foundation [NNF17SA0027784]	Collaborative Research Program for Biomedical Innovation Law; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Dr Cohen's research reported in this Viewpoint was supported by the Collaborative Research Program for Biomedical Innovation Law, which is a scientifically independent collaborative research program supported by Novo Nordisk Foundation (grant NNF17SA0027784).	[Anonymous], HLTH INF PRIV HIPAA; [Anonymous], REC DE ID PROT HLTH; Farr C., CNBC; Riley M. F., 2018, BIG DATA HLTH LAW BI; Robbins R., STAT; Terry N.P., 2017, YALE J HLTH POLY L E, V17, P143; Terry Nicolas P, 2014, Health Matrix Clevel, V24, P65; Terry NP, 2012, UMKC LAW REV, V81, P385	8	63	63	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2018	320	3					231	232		10.1001/jama.2018.5630	http://dx.doi.org/10.1001/jama.2018.5630			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN3JE	29800120	Bronze			2022-12-28	WOS:000438900300011
J	Bai, R; Wan, RX; Yan, CY; Lei, JL; Shi, YG				Bai, Rui; Wan, Ruixue; Yan, Chuangye; Lei, Jianlin; Shi, Yigong			Structures of the fully assembled Saccharomyces cerevisiae spliceosome before activation	SCIENCE			English	Article							YEAST U1 SNRNP; DEPENDENT ATPASE ACTIVITY; U4/U6.U5 TRI-SNRNP; GENETIC INTERACTIONS; REQUIRES ATP; RNA; PROTEIN; INSIGHTS; SUBUNIT; COMPLEX	The precatalytic spliceosome (B complex) is preceded by the pre-B complex. Here we report the cryo-electron microscopy structures of the Saccharomyces cerevisiae pre-B and B complexes at average resolutions of 3.3 to 4.6 and 3.9 angstroms, respectively. In the pre-B complex, the duplex between the 5' splice site (5' SS) and U1 small nuclear RNA (snRNA) is recognized by Yhc1, Luc7, and the Sm ring. In the B complex, U1 small nuclear ribonucleoprotein is dissociated, the 5'-exon-5'SS sequences are translocated near U6 snRNA, and three B-specific proteins may orient the precursor messenger RNA. In both complexes, U6 snRNA is anchored to loop I of U5 snRNA, and the duplex between the branch point sequence and U2 snRNA is recognized by the SF3b complex. Structural analysis reveals the mechanism of assembly and activation for the yeast spliceosome.	[Bai, Rui; Wan, Ruixue; Yan, Chuangye; Lei, Jianlin; Shi, Yigong] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Bai, Rui; Wan, Ruixue; Yan, Chuangye; Lei, Jianlin; Shi, Yigong] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Med, Beijing 100084, Peoples R China; [Lei, Jianlin] Tsinghua Univ, Sch Life Sci, Technol Ctr Prot Sci, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Shi, Yigong] Westlake Univ, Inst Biol, Westlake Inst Adv Study, 18 Shilongshan Rd, Hangzhou 310064, Zhejiang, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Westlake University	Shi, YG (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.; Shi, YG (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Med, Beijing 100084, Peoples R China.; Shi, YG (corresponding author), Westlake Univ, Inst Biol, Westlake Inst Adv Study, 18 Shilongshan Rd, Hangzhou 310064, Zhejiang, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X	National Natural Science Foundation of China [31621092, 31430020]; Ministry of Science and Technology [2016YFA0501100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by funds from the National Natural Science Foundation of China (31621092 and 31430020) and the Ministry of Science and Technology (2016YFA0501100 to J.L.).	Agafonov DE, 2011, MOL CELL BIOL, V31, P2667, DOI 10.1128/MCB.05266-11; Agarwal R, 2016, RNA, V22, P1302, DOI 10.1261/rna.056911.116; Boesler C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11997; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; Cordin O, 2012, CURR OPIN CELL BIOL, V24, P431, DOI 10.1016/j.ceb.2012.03.004; DeLano W.L, PYMOL MOL GRAPHICS S; Du H, 2001, RNA, V7, P133, DOI 10.1017/S1355838201001844; Du HS, 2002, NATURE, V419, P86, DOI 10.1038/nature00947; Fica SM, 2017, NAT STRUCT MOL BIOL, V24, P791, DOI 10.1038/nsmb.3463; Fortes P, 1999, GENE DEV, V13, P2425, DOI 10.1101/gad.13.18.2425; Hage R, 2009, MOL CELL BIOL, V29, P3941, DOI 10.1128/MCB.00384-09; Hahn D, 2012, GENE DEV, V26, P2408, DOI 10.1101/gad.199307.112; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; Jacewicz A, 2014, NUCLEIC ACIDS RES, V42, P12885, DOI 10.1093/nar/gku930; Kondo Y, 2015, ELIFE, V4, DOI 10.7554/eLife.04986; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Li XN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01241-9; Lin PC, 2012, EMBO J, V31, P1579, DOI 10.1038/emboj.2012.7; Liu YC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0161-z; Lybarger S, 1999, MOL CELL BIOL, V19, P577; ODay CL, 1996, J BIOL CHEM, V271, P33261, DOI 10.1074/jbc.271.52.33261; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Plaschka C, 2017, NATURE, V546, P617, DOI 10.1038/nature22799; Puig O, 2007, NUCLEIC ACIDS RES, V35, P5874, DOI 10.1093/nar/gkm505; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Rauhut R, 2016, SCIENCE, V353, P1399, DOI 10.1126/science.aag1906; Schwer B, 2015, RNA, V21, P1173, DOI 10.1261/rna.050583.115; Schwer B, 2014, NUCLEIC ACIDS RES, V42, P4697, DOI 10.1093/nar/gku097; Shi YG, 2017, NAT REV MOL CELL BIO, V18, P655, DOI 10.1038/nrm.2017.86; Shi YG, 2017, J MOL BIOL, V429, P2640, DOI 10.1016/j.jmb.2017.07.010; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Stevens SW, 2001, RNA, V7, P1543; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Xie J, 1998, EMBO J, V17, P2938, DOI 10.1093/emboj/17.10.2938; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Zhan XC, 2018, SCIENCE, V359, P537, DOI 10.1126/science.aar6401	41	54	54	10	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2018	360	6396					1423	1428		10.1126/science.aau0325	http://dx.doi.org/10.1126/science.aau0325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9TL	29794219				2022-12-28	WOS:000436598000068
J	Neumann, PJ; Cohen, JT				Neumann, Peter J.; Cohen, Joshua T.			QALYs in 2018-Advantages and Concerns	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VALUE ASSESSMENT FRAMEWORKS; ISPOR		[Neumann, Peter J.; Cohen, Joshua T.] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, 800 Washington St,Ste 63, Boston, MA 02111 USA	Tufts Medical Center	Neumann, PJ (corresponding author), Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, 800 Washington St,Ste 63, Boston, MA 02111 USA.	pneumann@tuftsmedicalcenter.org			CEA; Amgen; Lundbeck; Bill and Melinda Gates Foundation; National Pharmaceutical Council; Alzheimer's Association; National Institutes of Health; Pharmaceutical Research Manufacturers of America; Biogen; GE Healthcare; Genentech; Gilead; Janssen; Merck; Novartis; Otsuka; Pfizer; Partnership for Analytic Research, Precision Health Economics; Purdue Pharma; Sanofi; Vertex	CEA(French Atomic Energy Commission); Amgen(Amgen); Lundbeck(Lundbeck Corporation); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Pharmaceutical Council; Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Research Manufacturers of America; Biogen(Biogen); GE Healthcare(General ElectricGE Healthcare); Genentech(Roche HoldingGenentech); Gilead(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Novartis(Novartis); Otsuka(Otsuka Pharmaceutical); Pfizer(Pfizer); Partnership for Analytic Research, Precision Health Economics; Purdue Pharma; Sanofi; Vertex(Vertex Pharmaceuticals)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Neumann reports membership on advisory boards or consulting for AbbVie, Amgen, Avexis, Axovant, Bayer, the Congressional Budget Office, Boston Health Economics, Vertex, Veritech, Janssen, Merck, Novartis, Novo Nordisk, Pacira, Paratek, and Precision Health Economics, receipt of funding from the CEA Registry Sponsors by various pharmaceutical and medical device companies, and receipt of grants from Amgen, Lundbeck, the Bill and Melinda Gates Foundation, the National Pharmaceutical Council, the Alzheimer's Association, and the National Institutes of Health. Dr Cohen reports receipt of grants and/or personal fees from the National Pharmaceutical Council, the Pharmaceutical Research Manufacturers of America, Amgen, Biogen, GE Healthcare, Genentech, Gilead, Janssen, Lundbeck, Merck, Novartis, Otsuka, Pfizer, the Partnership for Analytic Research, Precision Health Economics, Purdue Pharma, Sanofi, and Vertex.	Coelho T., 2018, HILL; Doshi JA, 2018, NEED FORA NEW PATIEN; Garrison LP, 2018, VALUE HEALTH, V21, P161, DOI 10.1016/j.jval.2017.12.009; Institute for Clinical and Economic Review, 2017, FIN VAL ASS FRAM UPD; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Neumann PJ., 2017, COST EFFECTIVENESS H, V2; Perfetto EM, 2018, VALUE HEALTH, V21, P169, DOI 10.1016/j.jval.2017.12.002; Timmins N, 2016, TERRIBLE BEAUTY SHOR; Ubel P., 2000, PRICING LIFE	9	79	79	3	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2018	319	24					2473	2474		10.1001/jama.2018.6072	http://dx.doi.org/10.1001/jama.2018.6072			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK6ZP	29800152				2022-12-28	WOS:000436342700013
J	Price, GJ; Louys, J; Faith, JT; Lorenzen, E; Westaway, MC				Price, Gilbert J.; Louys, Julien; Faith, J. Tyler; Lorenzen, Eline; Westaway, Michael C.			Big data little help in megafauna mysteries	NATURE			English	Editorial Material									[Price, Gilbert J.] Univ Queensland, Palaeontol, Brisbane, Qld, Australia; [Louys, Julien] Griffith Univ, Nathan, Qld, Australia; [Faith, J. Tyler] Univ Utah, Archaeol, Salt Lake City, UT USA; [Faith, J. Tyler] Univ Utah, Anthropol, Salt Lake City, UT USA; [Lorenzen, Eline] Nat Hist Museum Denmark, Copenhagen, Denmark; [Westaway, Michael C.] Griffith Univ, Griffith, NSW, Australia	University of Queensland; Griffith University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Griffith University	Price, GJ (corresponding author), Univ Queensland, Palaeontol, Brisbane, Qld, Australia.	g.price1@uq.edu.au	Lorenzen, Eline/GRF-1592-2022; Louys, Julien/GLN-6714-2022; Price, Gilbert J/N-3282-2013	Price, Gilbert J/0000-0001-8406-4594; Louys, Julien/0000-0001-7539-0689; Faith, J. Tyler/0000-0002-1101-7161				AHMED SI, 1972, CAN J BOTANY, V50, P419, DOI 10.1139/b72-061; Bartlett LJ, 2016, ECOGRAPHY, V39, P152, DOI 10.1111/ecog.01566; Cooper A, 2015, SCIENCE, V349, P602, DOI 10.1126/science.aac4315; Faith JT, 2012, PALAEOGEOGR PALAEOCL, V361, P84, DOI 10.1016/j.palaeo.2012.08.005; Flannery T., 2012, Q ESSAY, V48, P1; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Johnson CN, 2002, P ROY SOC B-BIOL SCI, V269, P2221, DOI 10.1098/rspb.2002.2130; Rios-Saldana CA, 2018, GLOB ECOL CONSERV, V14, DOI 10.1016/j.gecco.2018.e00389; Saltre F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10511; Sandom C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3254; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Stuart AJ, 2012, QUATERNARY SCI REV, V51, P1, DOI 10.1016/j.quascirev.2012.06.007; Stuart AJ, 2015, GEOL J, V50, P338, DOI 10.1002/gj.2633; Terlato G, 2019, HIST BIOL, V31, P474, DOI 10.1080/08912963.2018.1448395; Turvey ST, 2013, QUATERNARY SCI REV, V76, P156, DOI 10.1016/j.quascirev.2013.06.030; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3; Wan XR, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2438; Westaway MC, 2009, ARCHAEOL OCEAN, V44, P84, DOI 10.1002/j.1834-4453.2009.tb00051.x; Wroe S, 2013, P NATL ACAD SCI USA, V110, P8777, DOI 10.1073/pnas.1302698110	19	28	28	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					23	25		10.1038/d41586-018-05330-7	http://dx.doi.org/10.1038/d41586-018-05330-7			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI3LQ	29872205	Green Submitted, Bronze			2022-12-28	WOS:000434273300022
J	Baghdadi, MB; Castel, D; Machado, L; Fukada, S; Birk, DE; Relaix, F; Tajbakhsh, S; Mourikis, P				Baghdadi, Meryem B.; Castel, David; Machado, Leo; Fukada, So-ichiro; Birk, David E.; Relaix, Frederic; Tajbakhsh, Shahragim; Mourikis, Philippos			Reciprocal signalling by Notch-Collagen V-CALCR retains muscle stem cells in their niche	NATURE			English	Article							TEMPLATE DNA STRANDS; SATELLITE CELLS; SELF-RENEWAL; QUIESCENCE; MOUSE; DIFFERENTIATION; TRANSCRIPTION; REGENERATION; MAINTENANCE; MYOGENESIS	The cell microenvironment, which is critical for stem cell maintenance, contains both cellular and non-cellular components, including secreted growth factors and the extracellular matrix(1-3). Although Notch and other signalling pathways have previously been reported to regulate quiescence of stem cells(4-9), the composition and source of molecules that maintain the stem cell niche remain largely unknown. Here we show that adult muscle satellite (stem) cells in mice produce extracellular matrix collagens to maintain quiescence in a cell-autonomous manner. Using chromatin immunoprecipitation followed by sequencing, we identified NOTCH1/RBPJ-bound regulatory elements adjacent to specific collagen genes, the expression of which is deregulated in Notch-mutant mice. Moreover, we show that Collagen V (COLV) produced by satellite cells is a critical component of the quiescent niche, as depletion of COLV by conditional deletion of the Col5a1 gene leads to anomalous cell cycle entry and gradual diminution of the stem cell pool. Notably, the interaction of COLV with satellite cells is mediated by the Calcitonin receptor, for which COLV acts as a surrogate local ligand. Systemic administration of a calcitonin derivative is sufficient to rescue the quiescence and self-renewal defects found in COLV-null satellite cells. This study reveals a Notch-COLV-Calcitonin receptor signalling cascade that maintains satellite cells in a quiescent state in a cell-autonomous fashion, and raises the possibility that similar reciprocal mechanisms act in diverse stem cell populations.	[Baghdadi, Meryem B.; Tajbakhsh, Shahragim] Inst Pasteur, Dept Dev & Stem Cell Biol, Paris, France; [Baghdadi, Meryem B.; Tajbakhsh, Shahragim] CNRS, Inst Pasteur, UMR 3738, Paris, France; [Baghdadi, Meryem B.] Univ Paris 06, UPMC, Sorbonne Univ, Paris, France; [Castel, David] Univ Paris Saclay, Univ Paris Sud, Gustave Roussy, CNRS,UMR8203, Villejuif, France; [Castel, David] Univ Paris Saclay, Univ Paris Sud, Gustave Roussy, Dept Cancerol Enfant & Adolescent, Villejuif, France; [Machado, Leo; Relaix, Frederic; Mourikis, Philippos] UPEC, EFS, INSERM, IMRB,U955 E10,ENVA, Creteil, France; [Fukada, So-ichiro] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Osaka, Japan; [Birk, David E.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Ecole Nationale Veterinaire d'Alfort (ENVA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Osaka University; State University System of Florida; University of South Florida	Tajbakhsh, S (corresponding author), Inst Pasteur, Dept Dev & Stem Cell Biol, Paris, France.; Tajbakhsh, S (corresponding author), CNRS, Inst Pasteur, UMR 3738, Paris, France.; Mourikis, P (corresponding author), UPEC, EFS, INSERM, IMRB,U955 E10,ENVA, Creteil, France.	shahragim.tajbakhsh@pasteur.fr; philippos.mourikis@inserm.fr	Birk, David/I-4072-2012; Mourikis, Philippos/AAM-2458-2020; Castel, David/D-5353-2018; Fukada, So-ichiro/AAI-9151-2020	Birk, David/0000-0002-4865-9088; Castel, David/0000-0003-0247-080X; Fukada, So-ichiro/0000-0003-4051-5108; Relaix, Frederic/0000-0003-1270-1472; Mourikis, Philippos/0000-0003-3164-7109; Machado, Leo/0000-0002-4919-8762	Association Francaise contre les Myopathies via TRANSLAMUSCLE PROJECT [19507]; Agence Nationale pour la Recherche grant Satnet [ANR-15-CE13-0011-01]; RHU CARMMA [ANR-15-RHUS-0003]; Institut Pasteur; Centre National pour la Recherche Scientific; Agence Nationale de la Recherche [ANR-10-LABX-73]; European Research Council [332893]; Doctoral School grant; Fondation pour la Recherche Medicale	Association Francaise contre les Myopathies via TRANSLAMUSCLE PROJECT; Agence Nationale pour la Recherche grant Satnet(French National Research Agency (ANR)); RHU CARMMA; Institut Pasteur(European Commission); Centre National pour la Recherche Scientific; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Doctoral School grant; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank H. Stunnenberg for the ChIP-seq and RNA sequencing data; D. Castro for the RBPJ ChIP protocol; D. Greenspan for the anti-a3-COLV antibody and Col5a3-knockout muscle samples; C. Moali for the SPR assay; F. Aurade and the Protein Core Facility, Institut Curie, for the production of CalcR proteins; K. Ding for the 7rh DDR1 inhibitor; F. Ruggiero for suggesting the on-cell enzyme-linking immunosorbent assay experiment; and the Cytometry platforms of Institut Pasteur and IMRB, Inserm U955, Creteil. F.R. was funded by the Association Francaise contre les Myopathies via TRANSLAMUSCLE (PROJECT 19507), Agence Nationale pour la Recherche grant Satnet (ANR-15-CE13-0011-01) and RHU CARMMA (ANR-15-RHUS-0003). S.T. was funded by Institut Pasteur, Centre National pour la Recherche Scientific and the Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir; ANR-10-LABX-73) and the European Research Council (Advanced Research Grant 332893). M.B.B. was funded by the Doctoral School grant and Fondation pour la Recherche Medicale.	Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Buas MF, 2010, J BIOL CHEM, V285, P1249, DOI 10.1074/jbc.M109.046441; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Evans BN, 2000, J BIOL CHEM, V275, P31438, DOI 10.1074/jbc.M005604200; Gao MS, 2013, J MED CHEM, V56, P3281, DOI 10.1021/jm301824k; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Machado L, 2017, CELL REP, V21, P1982, DOI 10.1016/j.celrep.2017.10.080; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mourikis P, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-2; Mourikis P, 2012, DEVELOPMENT, V139, P4536, DOI 10.1242/dev.084756; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Paavola KJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005347; Raymond K, 2009, CURR OPIN CELL BIOL, V21, P623, DOI 10.1016/j.ceb.2009.05.004; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Rozo M, 2016, NAT MED, V22, P889, DOI 10.1038/nm.4116; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Sun M, 2015, AM J PATHOL, V185, P1436, DOI 10.1016/j.ajpath.2015.01.031; Sun M, 2011, J CELL SCI, V124, P4096, DOI 10.1242/jcs.091363; Vasconcelos FF, 2016, CELL REP, V17, P469, DOI 10.1016/j.celrep.2016.09.024; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Yamaguchi M, 2015, CELL REP, V13, P302, DOI 10.1016/j.celrep.2015.08.083; Yennek S, 2014, CELL REP, V7, P961, DOI 10.1016/j.celrep.2014.04.016; Yoshida N, 1998, J CELL SCI, V111, P769; Zismanov V, 2016, CELL STEM CELL, V18, P79, DOI 10.1016/j.stem.2015.09.020	40	105	105	6	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					714	+		10.1038/s41586-018-0144-9	http://dx.doi.org/10.1038/s41586-018-0144-9			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29795344	Green Accepted			2022-12-28	WOS:000433412900052
J	Geitmann, A				Geitmann, Anja			Bracing for Abscission	CELL			English	Editorial Material								The detachment of plant organs is highly choreographed, requiring the enzymatic dissolution of the middle lamella between cell layers at the base of the detaching organ. Now, Lee et al. demonstrate that abscission efficiency and plant health rely on the spatial confinement of enzymatic activity and mechanical features that ensure a smooth separation.	[Geitmann, Anja] McGill Univ, Dept Plant Sci, Macdonald Campus,21111 Lakeshore, Ste Anne De Bellevue, PQ H9X 3V9, Canada	McGill University	Geitmann, A (corresponding author), McGill Univ, Dept Plant Sci, Macdonald Campus,21111 Lakeshore, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	geitmann.aes@mcgill.ca	Geitmann, Anja/D-4696-2012	Geitmann, Anja/0000-0003-0390-0517	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair Program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program(Canada Research Chairs)	Research in the Geitmann Lab is supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Research Chair Program.	Addicott F.T, 1982, ABSCISSION; Lee Y, 2018, CELL, V173, P1468, DOI 10.1016/j.cell.2018.03.060; Pickersgill B, 2007, ANN BOT-LONDON, V100, P925, DOI 10.1093/aob/mcm193; Tucker M.L., 2015, STEWART POSTHARV REV, V11, P1, DOI [10.2212/spr.2015.2.1, DOI 10.2212/SPR.2015.2.1]; Zamil MS, 2017, PHYS BIOL, V14, DOI 10.1088/1478-3975/aa5ba5	5	4	4	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1320	1322		10.1016/j.cell.2018.05.025	http://dx.doi.org/10.1016/j.cell.2018.05.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856951	Bronze			2022-12-28	WOS:000433989100006
J	Lo, B				Lo, Bernard			Beyond Legalization - Dilemmas Physicians Confront Regarding Aid in Dying	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ASSISTED SUICIDE; OREGON DEATH; DIGNITY ACT; EXPERIENCES; ATTITUDES; EUTHANASIA; LIFE; END		[Lo, Bernard] Greenwall Fdn, New York, NY 10119 USA		Lo, B (corresponding author), Greenwall Fdn, New York, NY 10119 USA.							Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Emanuel EJ, 2016, JAMA-J AM MED ASSOC, V316, P79, DOI 10.1001/jama.2016.8499; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 2001, JAMA-J AM MED ASSOC, V285, P2363, DOI 10.1001/jama.285.18.2363; Quill TE, 2016, JAMA-J AM MED ASSOC, V315, P245, DOI 10.1001/jama.2015.16210	5	16	16	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2018	378	22					2060	2062		10.1056/NEJMp1802218	http://dx.doi.org/10.1056/NEJMp1802218			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH5AL	29847753				2022-12-28	WOS:000433428000002
J	Simoes, TR; Caldwell, MW; Talanda, M; Bernardi, M; Palci, A; Vernygora, O; Bernardini, F; Mancini, L; Nydam, RL				Simoes, Tiago R.; Caldwell, Michael W.; Talanda, Mateusz; Bernardi, Massimo; Palci, Alessandro; Vernygora, Oksana; Bernardini, Federico; Mancini, Lucia; Nydam, Randall L.			The origin of squamates revealed by a Middle Triassic lizard from the Italian Alps	NATURE			English	Article							PHYLOGENETIC ANALYSIS; REPTILES LIZARDS; MORPHOLOGICAL DATA; SNAKES; TIME; DISTRIBUTIONS; INFERENCE; PATTERN; CHOICE; TAXA	Modern squamates (lizards, snakes and amphisbaenians) are the world's most diverse group of tetrapods along with birds1 and have a long evolutionary history, with the oldest known fossils dating from the Middle Jurassic period-168 million years ago(2-4). The evolutionary origin of squamates is contentious because of several issues: (1) a fossil gap of approximately 70 million years exists between the oldest known fossils and their estimated origin(5-7); (2) limited sampling of squamates in reptile phylogenies; and (3) conflicts between morphological and molecular hypotheses regarding the origin of crown squamates(6,8,9). Here we shed light on these problems by using high-resolution microfocus X-ray computed tomography data from the articulated fossil reptile Megachirella wachtleri (Middle Triassic period, Italian Alps(10)). We also present a phylogenetic dataset, combining fossils and extant taxa, and morphological and molecular data. We analysed this dataset under different optimality criteria to assess diapsid reptile relationships and the origins of squamates. Our results re-shape the diapsid phylogeny and present evidence that M. wachtleri is the oldest known stem squamate. Megachirella is 75 million years older than the previously known oldest squamate fossils, partially filling the fossil gap in the origin of lizards, and indicates a more gradual acquisition of squamatan features in diapsid evolution than previously thought. For the first time, to our knowledge, morphological and molecular data are in agreement regarding early squamate evolution, with geckoes-and not iguanians-as the earliest crown clade squamates. Divergence time estimates using relaxed combined morphological and molecular clocks show that lepidosaurs and most other diapsids originated before the Permian/Triassic extinction event, indicating that the Triassic was a period of radiation, not origin, for several diapsid lineages.	[Simoes, Tiago R.; Caldwell, Michael W.; Vernygora, Oksana] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Caldwell, Michael W.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Talanda, Mateusz] Univ Warsaw, Dept Palaeobiol & Evolut, Biol & Chem Res Ctr, Fac Biol, Warsaw, Poland; [Bernardi, Massimo] Museo Sci Trento, MUSE, Trento, Italy; [Bernardi, Massimo] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Palci, Alessandro] Flinders Univ S Australia, Coll Sci & Engn, Adelaide, SA, Australia; [Bernardini, Federico] Museo Stor Fis, Rome, Italy; [Bernardini, Federico] Ctr Studi & Ric Enr Fermi, Rome, Italy; [Bernardini, Federico] Abdus Salam Int Ctr Theoret Phys, Trieste, Italy; [Mancini, Lucia] Elettra Sincrotrone Trieste SCpA, Trieste, Italy; [Nydam, Randall L.] Midwestern Univ, Arizona Coll Osteopath Med, Dept Anat, Glendale, AZ USA	University of Alberta; University of Alberta; University of Warsaw; University of Bristol; Flinders University South Australia; Abdus Salam International Centre for Theoretical Physics (ICTP); Elettra Sincrotrone Trieste; Midwestern University	Simoes, TR (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	tsimoes@ualberta.ca	Nydam, Randall/AAS-5978-2021	Mancini, Lucia/0000-0003-2416-3464; Bernardini, Federico/0000-0002-3282-8799; Talanda, Mateusz/0000-0003-3358-9539; Simoes, Tiago/0000-0003-4716-649X	Vanier Canada Memorial PhD scholarship; Izaak Walton Killam Memorial PhD scholarship; Euregio Science Fund [IPN16]; Midwestern University Intramural Funds; Natural Science and Engineering Research Council of Canada [23458]; Alberta Ukrainian Centennial Scholarship; National Science Centre [2014/13/N/NZ8/02467]	Vanier Canada Memorial PhD scholarship; Izaak Walton Killam Memorial PhD scholarship; Euregio Science Fund; Midwestern University Intramural Funds; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ukrainian Centennial Scholarship; National Science Centre(National Science Centre, Poland)	We are grateful for funding from the Vanier Canada and the Izaak Walton Killam Memorial PhD scholarships to T.R.S.; Euregio Science Fund (call 2014, IPN16) to M.B.; Midwestern University Intramural Funds to R.L.N.; Natural Science and Engineering Research Council of Canada Discovery Grant to M.W.C. (23458); Alberta Ukrainian Centennial Scholarship to O.V.; and National Science Centre grant 2014/13/N/NZ8/02467 to M.T.; and E. Kustatscher for access to the holotype of M. wachtleri.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; Bernardi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128449; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Butler RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025693; Carroll R. L, 1977, PROBLEMS VERTEBRATE, V4, P1; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102361; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/ngeo1475, 10.1038/NGEO1475]; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; EVANS SE, 1980, ZOOL J LINN SOC-LOND, V70, P203, DOI 10.1111/j.1096-3642.1980.tb00852.x; Evans Susan, 1998, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V250, P123; Fedorov P., 1992, B ST PETERSBURG U GE, V3, P9; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2018, CLADISTICS, V34, P407, DOI 10.1111/cla.12205; Harrison LB, 2015, SYST BIOL, V64, P307, DOI 10.1093/sysbio/syu098; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hohna S, 2011, MOL BIOL EVOL, V28, P2577, DOI 10.1093/molbev/msr095; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Irisarri I, 2017, NAT ECOL EVOL, V1, P1370, DOI 10.1038/s41559-017-0240-5; Jiang DY, 2014, J VERTEBR PALEONTOL, V34, P1044, DOI 10.1080/02724634.2014.846264; Jones MEH, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-208; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; M?ller J., 2004, RECENT ADV ORIGIN EA, P379; MATEER NJ, 1982, PALAEONTOLOGY, V25, P461; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Motani R, 1998, NATURE, V393, P255, DOI 10.1038/30473; NESSOV L A, 1988, Acta Zoologica Cracoviensia, V31, P475; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Reilly JE, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0975; O'Reilly JE, 2015, TRENDS GENET, V31, P637, DOI 10.1016/j.tig.2015.08.001; Ogg JG, 2016, CONCISE GEOLOGIC TIME SCALE 2016, P1; Pyron RA, 2017, SYST BIOL, V66, P38, DOI 10.1093/sysbio/syw068; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Reeder TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118199; Renesto S, 2003, RIV ITAL PALEONTOL S, V109, P463, DOI 10.13130/2039-4942/5517; Renesto S, 2014, PALAEONTOL Z, V88, P197, DOI 10.1007/s12542-013-0194-0; Reynoso VH, 1998, PHILOS T ROY SOC B, V353, P477, DOI 10.1098/rstb.1998.0224; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Simoes TR, 2017, ZOOL J LINN SOC-LOND, V180, P216, DOI 10.1111/zoj.12487; Simoes TR, 2017, CLADISTICS, V33, P198, DOI 10.1111/cla.12163; Stadler T, 2010, J THEOR BIOL, V267, P396, DOI 10.1016/j.jtbi.2010.09.010; Tuniz C, 2013, NUCL INSTRUM METH A, V711, P106, DOI 10.1016/j.nima.2013.01.046; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Wagner PJ, 2012, BIOL LETTERS, V8, P143, DOI 10.1098/rsbl.2011.0523; Wilkinson M, 2006, ZOOL SCR, V35, P109, DOI 10.1111/j.1463-6409.2005.00213.x; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Zhang C, 2016, SYST BIOL, V65, P228, DOI 10.1093/sysbio/syv080; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009	56	98	99	2	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					706	+		10.1038/s41586-018-0093-3	http://dx.doi.org/10.1038/s41586-018-0093-3			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29849156				2022-12-28	WOS:000433412900050
J	Rimmer, A				Rimmer, Abi			Scrap the Cap: Applying for a tier 2 visa	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Home Office, TIER 2 POINTS BAS SY	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2018	361								k2370	10.1136/bmj.k2370	http://dx.doi.org/10.1136/bmj.k2370			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MP	29848503				2022-12-28	WOS:000434275800009
J	Ricci, C; Wood, A; Muller, D; Gunter, MJ; Agudo, A; Boeing, H; van der Schouw, YT; Warnakula, S; Saieva, C; Spijkerman, A; Sluijs, I; Tjonneland, A; Kyro, C; Weiderpass, E; Kuhn, T; Kaaks, R; Sanchez, MJ; Panico, S; Agnoli, C; Palli, D; Tumino, R; Engstrom, G; Melander, O; Bonnet, F; Boer, JMA; Key, TJ; Travis, RC; Overvad, K; Verschuren, WMM; Quiros, JR; Trichopoulou, A; Papatesta, EM; Peppa, E; Iribas, CM; Gavrila, D; Forslund, AS; Jansson, JH; Matullo, G; Arriola, L; Freisling, H; Lassale, C; Tzoulaki, I; Sharp, SJ; Forouhi, NG; Langenberg, C; Saracci, R; Sweeting, M; Brennan, P; Butterworth, AS; Riboli, E; Wareham, NJ; Danesh, J; Ferrari, P				Ricci, Cristian; Wood, Angela; Muller, David; Gunter, Marc J.; Agudo, Antonio; Boeing, Heiner; van der Schouw, Yvonne T.; Warnakula, Samantha; Saieva, Calogero; Spijkerman, Annemieke; Sluijs, Ivonne; Tjonneland, Anne; Kyro, Cecilie; Weiderpass, Elisabete; Kuehn, Tilman; Kaaks, Rudolf; Sanchez, Maria-Jose; Panico, Salvatore; Agnoli, Claudia; Palli, Domenico; Tumino, Rosario; Engstrom, Gunnar; Melander, Olle; Bonnet, Fabrice; Boer, Jolanda M. A.; Key, Timothy J.; Travis, Ruth C.; Overvad, Kim; Verschuren, W. M. Monique; Quiros, J. Ramon; Trichopoulou, Antonia; Papatesta, Eleni-Maria; Peppa, Eleni; Iribas, Conchi Moreno; Gavrila, Diana; Forslund, Ann-Sofie; Jansson, Jan-Hakan; Matullo, Giuseppe; Arriola, Larraitz; Freisling, Heinz; Lassale, Camille; Tzoulaki, Ioanna; Sharp, Stephen J.; Forouhi, Nita G.; Langenberg, Claudia; Saracci, Rodolfo; Sweeting, Michael; Brennan, Paul; Butterworth, Adam S.; Riboli, Elio; Wareham, Nick J.; Danesh, John; Ferrari, Pietro			Alcohol intake in relation to non-fatal and fatal coronary heart disease and stroke: EPIC-CVD case-cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INDIVIDUAL-PARTICIPANT DATA; CAUSE-SPECIFIC MORTALITY; CARDIOVASCULAR-DISEASE; SMOKING-CESSATION; RISK-FACTORS; LIFE-STYLE; CONSUMPTION; METAANALYSIS; POLYPHENOLS; CANCER	OBJECTIVE To investigate the association between alcohol consumption (at baseline and over lifetime) and non-fatal and fatal coronary heart disease (CHD) and stroke. DESIGN Multicentre case-cohort study. SETTING A study of cardiovascular disease (CVD) determinants within the European Prospective Investigation into Cancer and nutrition cohort (EPIC-CVD) from eight European countries. PARTICIPANTS 32 549 participants without baseline CVD, comprised of incident CVD cases and a subcohort for comparison. MAIN OUTCOME MEASURES Non-fatal and fatal CHD and stroke (including ischaemic and haemorrhagic stroke). RESULTS There were 9307 non-fatal CHD events, 1699 fatal CHD, 5855 non-fatal stroke, and 733 fatal stroke. Baseline alcohol intake was inversely associated with non-fatal CHD, with a hazard ratio of 0.94 (95% confidence interval 0.92 to 0.96) per 12 g/day higher intake. There was a J shaped association between baseline alcohol intake and risk of fatal CHD. The hazard ratios were 0.83 (0.70 to 0.98), 0.65 (0.53 to 0.81), and 0.82 (0.65 to 1.03) for categories 5.0-14.9 g/day, 15.0-29.9 g/day, and 30.0-59.9 g/day of total alcohol intake, respectively, compared with 0.1-4.9 g/ day. In contrast, hazard ratios for non-fatal and fatal stroke risk were 1.04 (1.02 to 1.07), and 1.05 (0.98 to 1.13) per 12 g/day increase in baseline alcohol intake, respectively, including broadly similar findings for ischaemic and haemorrhagic stroke. Associations with cardiovascular outcomes were broadly similar with average lifetime alcohol consumption as for baseline alcohol intake, and across the eight countries studied. There was no strong evidence for interactions of alcohol consumption with smoking status on the risk of CVD events. CONCLUSIONS Alcohol intake was inversely associated with non-fatal CHD risk but positively associated with the risk of different stroke subtypes. This highlights the opposing associations of alcohol intake with different CVD types and strengthens the evidence for policies to reduce alcohol consumption.	[Ricci, Cristian; Freisling, Heinz; Saracci, Rodolfo; Ferrari, Pietro] World Hlth Org, Int Agcy Res Canc, Nutr Methodol & Biostat Grp, 150 Cours Albert Thomas, F-69372 Lyon 08, France; [Ricci, Cristian] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa; [Wood, Angela; Warnakula, Samantha; Forslund, Ann-Sofie; Sweeting, Michael; Butterworth, Adam S.; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Med Res Council,British Heart Fdn, Cambridge, England; [Muller, David; Lassale, Camille; Tzoulaki, Ioanna; Riboli, Elio] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Gunter, Marc J.] Int Agcy Res Canc, Nutr & Metab Sect, Nutr Epidemiol Grp, Lyon, France; [Agudo, Antonio] Catalan Inst Oncol, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Spain; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [van der Schouw, Yvonne T.; Sluijs, Ivonne; Verschuren, W. M. Monique] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Saieva, Calogero; Palli, Domenico] Canc Res & Prevent Inst, Canc Risk Factors & Lifestyle Epidemiol Unit, Florence, Italy; [Spijkerman, Annemieke; Boer, Jolanda M. A.; Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Tjonneland, Anne; Kyro, Cecilie] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Weiderpass, Elisabete] Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; Inst Populat Based Canc Res, Canc Registry Norway, Dept Res, Oslo, Norway; Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Univ Helsinki, Folkhalsan Res Ctr, Genet Epidemiol Grp, Helsinki, Finland; [Weiderpass, Elisabete] Univ Helsinki, Fac Med, Helsinki, Finland; [Kuehn, Tilman; Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Sanchez, Maria-Jose] Univ Granada, Andaluzian Sch Publ Hlth, Granada, Spain; [Sanchez, Maria-Jose; Gavrila, Diana] Biomed Res Networking Ctr Epidemiol & Publ Hlth C, Madrid, Spain; [Panico, Salvatore] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Agnoli, Claudia] Fdn IRCCS Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy; [Tumino, Rosario] Civ MP Arezzo Hosp, Canc Registry & Histopathol Dept, Ragusa, Italy; [Engstrom, Gunnar; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Bonnet, Fabrice] Rennes Univ Hosp, Rennes, France; [Key, Timothy J.; Travis, Ruth C.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Overvad, Kim] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark; [Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Quiros, J. Ramon] Publ Hlth Directorate Asturias, Oviedo, Spain; [Trichopoulou, Antonia; Peppa, Eleni] Hellen Hlth Fdn, Athens, Greece; [Trichopoulou, Antonia; Papatesta, Eleni-Maria] Univ Athens, WHO Collaborating Ctr Nutr & Hlth, Unit Nutr Epidemiol & Nutr Publ Hlth, Sch Med, Athens, Greece; [Iribas, Conchi Moreno] Inst Hlth Res IdiSNA, Navarre Publ Hlth Inst, Pamplona, Spain; [Iribas, Conchi Moreno] Res Network Hlth Serv Chron Dis REDISSEC, Pamplona, Spain; [Gavrila, Diana] IMIB Arrixaca, Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Forslund, Ann-Sofie] Umea Univ, Sunderby Res Unit, Dept Publ Hlth & Clin Med, Umea, Sweden; [Jansson, Jan-Hakan] Umea Univ, Dept Med, Skelleftea Res Unit, Dept Publ Hlth & Clin Med, Umea, Sweden; [Matullo, Giuseppe] Univ Torino, Dept Med Sci, IIGM, HuGeF, Turin, Italy; [Arriola, Larraitz] Basque Govt, Inst Biodonostia, Publ Hlth Div Gipuzkoa, Gipuzkoa, Spain; [Lassale, Camille] UCL, Dept Epidemiol & Publ Hlth, London, England; [Tzoulaki, Ioanna] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Ioannina, Greece; [Sharp, Stephen J.; Forouhi, Nita G.; Langenberg, Claudia; Wareham, Nick J.] Univ Cambridge, Med Res Council, Epidemiol Unit, Cambridge, England; [Brennan, Paul] Int Agcy Res Canc, Genet Sect, Genet Epidemiol Grp, Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); North West University - South Africa; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Imperial College London; World Health Organization; International Agency for Research on Cancer (IARC); Catalan Institute of Oncology; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Danish Cancer Society; UiT The Arctic University of Tromso; University of Oslo; Karolinska Institutet; Folkhalsan Research Center; University of Helsinki; University of Helsinki; Helmholtz Association; German Cancer Research Center (DKFZ); Escuela Andaluza de Salud Publica; University of Granada; University of Naples Federico II; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; Lund University; CHU Rennes; Universite de Rennes; University of Oxford; Aarhus University; Aalborg University; Aalborg University Hospital; Athens Medical School; National & Kapodistrian University of Athens; Public Health Institute of Navarra; Hospital Clinico Universitario Virgen de la Arrixaca; Murcia Regional Health Council; Umea University; Umea University; Italian Institute for Genomic Medicine (IIGM); University of Turin; Basque Government; Instituto de Investigacion Sanitaria Biodonostia; University of London; University College London; University of Ioannina; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; World Health Organization; International Agency for Research on Cancer (IARC)	Ferrari, P (corresponding author), World Hlth Org, Int Agcy Res Canc, Nutr Methodol & Biostat Grp, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	ferrarip@iarc.fr	Wood, Angela/GZA-5762-2022; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Gunter, Marc/AAP-8621-2020; Weiderpass, Elisabete/M-4029-2016; Agnoli, Claudia/K-5916-2016; Langenberg, Claudia/ABG-9067-2021; Saieva, Calogero/AAC-2611-2019; Sweeting, Michael John/U-3917-2019; van der Schouw, Yvonne T./F-8327-2014; Tzoulaki, Ioanna/ABE-6269-2020; Lassale, Camille/ABE-7813-2020; Ricci, Cristian/AAV-3315-2021; Sánchez, Maria-José/D-1087-2011; Weiderpass, Elisabete/AAP-2747-2021; MATULLO, Giuseppe/K-6383-2016; Muller, David/V-8207-2017	Wood, Angela/0000-0002-7937-304X; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Weiderpass, Elisabete/0000-0003-2237-0128; Agnoli, Claudia/0000-0003-4472-1179; Langenberg, Claudia/0000-0002-5017-7344; Saieva, Calogero/0000-0002-0117-1608; Sweeting, Michael John/0000-0003-0980-8965; van der Schouw, Yvonne T./0000-0002-4605-435X; Tzoulaki, Ioanna/0000-0002-4275-9328; Lassale, Camille/0000-0002-9340-2708; Ricci, Cristian/0000-0003-4113-8682; Sánchez, Maria-José/0000-0003-4817-0757; Weiderpass, Elisabete/0000-0003-2237-0128; Overvad, Kim/0000-0001-6429-7921; Kyro, Cecilie/0000-0002-9083-8960; MATULLO, Giuseppe/0000-0003-0674-7757; Papatesta, Eleni Maria/0000-0002-1600-2882; Forouhi, Nita/0000-0002-5041-248X; Forslund, Ann-Sofie/0000-0001-9410-1985; Gunter, Marc/0000-0001-5472-6761; tumino, rosario/0000-0003-2666-414X; Riboli, Elio/0000-0001-6795-6080; Muller, David/0000-0002-2350-0417; Melander, Olle/0000-0002-2581-484X; Freisling, Heinz/0000-0001-8648-4998	Direction Generale de la Sante (French Ministry of Health) [GR-IARC-2003-09-12-01]; European Union [HEALTH-F2-2012-279233]; European Research Council [268834]; UK Medical Research Council [G0800270, MR/L003120/1]; British Heart Foundation [SP/09/002, RG/08/014, RG13/13/30194]; UK National Institute of Health Research; EU [LSHM_CT_2006_037197]; Medical Research Council Epidemiology Unit [MC_UU_12015/1, MC_UU_12015/5]; MRC [MC_UU_12015/1, MC_UU_12015/5, MR/L003120/1, G0700463] Funding Source: UKRI	Direction Generale de la Sante (French Ministry of Health); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); UK National Institute of Health Research(National Institute for Health Research (NIHR)); EU(European Commission); Medical Research Council Epidemiology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Direction Generale de la Sante (French Ministry of Health) (grant GR-IARC-2003-09-12-01). EPIC-CVD has been supported by the European Union Framework 7 (HEALTH-F2-2012-279233), the European Research Council (268834), the UK Medical Research Council (G0800270 and MR/L003120/1), the British Heart Foundation (SP/09/002 and RG/08/014 and RG13/13/30194), and the UK National Institute of Health Research. The establishment of the random subcohort was supported by the EU Sixth Framework Programme (FP6) (grant LSHM_CT_2006_037197 to the InterAct project) and the Medical Research Council Epidemiology Unit (grants MC_UU_12015/1 and MC_UU_12015/5).	[Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Arranz S, 2012, NUTRIENTS, V4, P759, DOI 10.3390/nu4070759; Arriola L, 2010, HEART, V96, P124, DOI 10.1136/hrt.2009.173419; Bagnardi V, 2008, J EPIDEMIOL COMMUN H, V62, P615, DOI 10.1136/jech.2007.065607; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Bell S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j909; Booyse FM, 2007, ANN EPIDEMIOL, V17, pS24, DOI 10.1016/j.annepidem.2007.01.006; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Danesh J, 2007, EUR J EPIDEMIOL, V22, P129, DOI 10.1007/s10654-006-9096-8; Di Castelnuovo A, 2002, CIRCULATION, V105, P2836, DOI 10.1161/01.CIR.0000018653.19696.01; Ferrari P, 2007, INT J CANCER, V121, P2065, DOI 10.1002/ijc.22966; Ferrari P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005245; Fillmore KM, 2006, ADDICT RES THEORY, V14, P101, DOI 10.1080/16066350500497983; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Hart CL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-789; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS26, DOI 10.1093/ije/26.suppl_1.S26; Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Millwood IY, 2017, INT J EPIDEMIOL, V46, P2103, DOI 10.1093/ije/dyx210; Mons U, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1551; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Sandhu RK, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1091, DOI 10.1161/CIRCEP.112.975219; Slimani N, 2000, EUR J CLIN NUTR, V54, P900, DOI 10.1038/sj.ejcn.1601107; Stata Statistical Software, 2011, REL 12 VERS; Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X; Zheng YL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2081-y	34	47	50	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2018	361								k934	10.1136/bmj.k934	http://dx.doi.org/10.1136/bmj.k934			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MF	29844013	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000434274800011
J	Chen, JG; Crooks, RM; Seefeldt, LC; Bren, KL; Bullock, RM; Darensbourg, MY; Holland, PL; Hoffman, B; Janik, MJ; Jones, AK; Kanatzidis, MG; King, P; Lancaster, KM; Lymar, SV; Pfromm, P; Schneider, WF; Schrock, RR				Chen, Jingguang G.; Crooks, Richard M.; Seefeldt, Lance C.; Bren, Kara L.; Bullock, R. Morris; Darensbourg, Marcetta Y.; Holland, Patrick L.; Hoffman, Brian; Janik, Michael J.; Jones, Anne K.; Kanatzidis, Mercouri G.; King, Paul; Lancaster, Kyle M.; Lymar, Sergei V.; Pfromm, Peter; Schneider, William F.; Schrock, Richard R.			Beyond fossil fuel-driven nitrogen transformations	SCIENCE			English	Review							CHEMICAL-LOOPING COMBUSTION; AMMONIA-SYNTHESIS; CATALYTIC-REDUCTION; MOFE PROTEIN; PLASMA-CATALYSIS; NITRIC-OXIDE; NITRIFICATION; DINITROGEN; DESIGN; INTERMEDIATE	Nitrogen is fundamental to all of life and many industrial processes. The interchange of nitrogen oxidation states in the industrial production of ammonia, nitric acid, and other commodity chemicals is largely powered by fossil fuels. A key goal of contemporary research in the field of nitrogen chemistry is to minimize the use of fossil fuels by developing more efficient heterogeneous, homogeneous, photo-, and electrocatalytic processes or by adapting the enzymatic processes underlying the natural nitrogen cycle. These approaches, as well as the challenges involved, are discussed in this Review.	[Chen, Jingguang G.] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; [Chen, Jingguang G.; Lymar, Sergei V.] Brookhaven Natl Lab, Chem Div, Upton, NY 11973 USA; [Crooks, Richard M.] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA; [Seefeldt, Lance C.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84332 USA; [Bren, Kara L.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; [Bullock, R. Morris] Pacific Northwest Natl Lab, Richland, WA 99352 USA; [Darensbourg, Marcetta Y.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Holland, Patrick L.] Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06511 USA; [Hoffman, Brian; Kanatzidis, Mercouri G.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Janik, Michael J.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Jones, Anne K.] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85282 USA; [King, Paul] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Lancaster, Kyle M.] Cornell Univ, Baker Lab, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Pfromm, Peter] Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Schneider, William F.] Univ Notre Dame, Dept Biomol & Chem Engn, Notre Dame, IN 46556 USA; [Schrock, Richard R.] MIT, Dept Chem, Cambridge, MA 02139 USA	Columbia University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Texas System; University of Texas Austin; Utah System of Higher Education; Utah State University; University of Rochester; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Texas A&M University System; Texas A&M University College Station; Yale University; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Cornell University; Washington State University; University of Notre Dame; Massachusetts Institute of Technology (MIT)	Chen, JG (corresponding author), Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.; Chen, JG (corresponding author), Brookhaven Natl Lab, Chem Div, Upton, NY 11973 USA.; Crooks, RM (corresponding author), Univ Texas Austin, Dept Chem, Austin, TX 78712 USA.; Seefeldt, LC (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84332 USA.	jgchen@columbia.edu; crooks@cm.utexas.edu; lance.seefeldt@usu.edu	Schneider, William F./ABH-6170-2020; Schneider, William F/D-4240-2013; Pfromm, Peter H/Q-6738-2019; Janik, Michael/AAE-7213-2019; Bullock, R. Morris/L-6802-2016	Schneider, William F./0000-0003-0664-2138; Pfromm, Peter H/0000-0003-4869-9503; Bren, Kara/0000-0002-8082-3634; Seefeldt, Lance/0000-0002-6457-9504; King, Paul/0000-0001-5039-654X; Bullock, R. Morris/0000-0001-6306-4851	Council on Chemical Sciences, Geosciences and Biosciences of the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065313] Funding Source: NIH RePORTER	Council on Chemical Sciences, Geosciences and Biosciences of the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This article evolved from presentations and discussions at the workshop "Frontiers, Opportunities, and Challenges in Biochemical and Chemical N<INF>2</INF> Activation" held in October 2016 in Gaithersburg, Maryland. The workshop was sponsored by the Council on Chemical Sciences, Geosciences and Biosciences of the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences. The authors thank the members of the Council for their encouragement and assistance in developing this workshop. In addition, the authors are indebted to the agencies responsible for funding their individual research efforts, without which this article would not have been possible.	Adanez J, 2012, PROG ENERG COMBUST, V38, P215, DOI 10.1016/j.pecs.2011.09.001; ALLEN AD, 1965, CHEM COMMUN, P621, DOI 10.1039/c19650000621; Anderson JS, 2013, NATURE, V501, P84, DOI 10.1038/nature12435; Arashiba K, 2015, J AM CHEM SOC, V137, P5666, DOI 10.1021/jacs.5b02579; Arashiba K, 2011, NAT CHEM, V3, P120, DOI 10.1038/NCHEM.906; Armstrong DA, 2015, PURE APPL CHEM, V87, P1139, DOI 10.1515/pac-2014-0502; Bartholomew C. H., 2006, FUNDAMENTALS OF INDU; Booth G., 2002, ULLMANNS ENCYCLOPEDI, V17; Brown KA, 2016, SCIENCE, V352, P448, DOI 10.1126/science.aaf2091; Caranto JD, 2017, P NATL ACAD SCI USA, V114, P8217, DOI 10.1073/pnas.1704504114; Caranto JD, 2016, P NATL ACAD SCI USA, V113, P14704, DOI 10.1073/pnas.1611051113; Carmo M, 2013, INT J HYDROGEN ENERG, V38, P4901, DOI 10.1016/j.ijhydene.2013.01.151; Center for Industry Education Collaboration, 2016, THE ESSENTIAL CHEMIC; Chalkley MJ, 2017, ACS CENTRAL SCI, V3, P217, DOI 10.1021/acscentsci.7b00014; Chaplin BP, 2012, ENVIRON SCI TECHNOL, V46, P3655, DOI 10.1021/es204087q; CHATT J, 1978, CHEM REV, V78, P589, DOI 10.1021/cr60316a001; Cherkasov N, 2015, CHEM ENG PROCESS, V90, P24, DOI 10.1016/j.cep.2015.02.004; Coric I, 2016, J AM CHEM SOC, V138, P7200, DOI 10.1021/jacs.6b00747; Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461; Danyal K, 2010, J AM CHEM SOC, V132, P13197, DOI 10.1021/ja1067178; Dean A. M., 2000, GAS PHASE COMBUSTION, P125, DOI DOI 10.1007/978-1-4612-1310-9_2; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; Galvez ME, 2007, IND ENG CHEM RES, V46, P2042, DOI 10.1021/ie061550u; Groothaert MH, 2003, J AM CHEM SOC, V125, P7629, DOI 10.1021/ja029684w; Guo CX, 2018, ENERG ENVIRON SCI, V11, P45, DOI 10.1039/c7ee02220d; Gurvich L. V., 1989, THERMOCHEMICAL PROPE, V1; Hamers RJ, 2014, FARADAY DISCUSS, V172, P397, DOI 10.1039/c4fd00039k; Hoffman BM, 2014, CHEM REV, V114, P4041, DOI 10.1021/cr400641x; Hong JM, 2018, ACS SUSTAIN CHEM ENG, V6, P15, DOI 10.1021/acssuschemeng.7b02381; Hooper Alan B., 2004, V16, P121; International Fertilizer Industry Association, 2014, AMMONIA PRODUCTION M; Jacobsen CJH, 2001, J AM CHEM SOC, V123, P8404, DOI 10.1021/ja010963d; Khadka N, 2017, J AM CHEM SOC, V139, P13518, DOI 10.1021/jacs.7b07311; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kyriakou V, 2017, CATAL TODAY, V286, P2, DOI 10.1016/j.cattod.2016.06.014; Lan R, 2013, RSC ADV, V3, P18016, DOI 10.1039/c3ra43432j; Lawton TJ, 2014, PROTEINS, V82, P2263, DOI 10.1002/prot.24535; Leighton P. A., 1961, PHOTOCHEMISTRY OF AI; Licht S, 2014, SCIENCE, V345, P637, DOI 10.1126/science.1254234; Lionetti D, 2016, J AM CHEM SOC, V138, P5008, DOI 10.1021/jacs.6b01083; Liu J, 2016, P NATL ACAD SCI USA, V113, P5530, DOI 10.1073/pnas.1605512113; Logadottir A, 2001, J CATAL, V197, P229, DOI 10.1006/jcat.2000.3087; Lyngfelt A, 2015, APPL ENERG, V157, P475, DOI 10.1016/j.apenergy.2015.04.057; Medford AJ, 2017, ACS CATAL, V7, P2624, DOI 10.1021/acscatal.7b00439; Medford AJ, 2015, J CATAL, V328, P36, DOI 10.1016/j.jcat.2014.12.033; Mehta P, 2018, NAT CATAL, V1, P269, DOI 10.1038/s41929-018-0045-1; Mergler YJ, 1997, APPL CATAL B-ENVIRON, V12, P95, DOI 10.1016/S0926-3373(96)00068-9; Michalsky R, 2015, CHEM SCI, V6, P3965, DOI 10.1039/c5sc00789e; Michalsky R, 2012, J PHYS CHEM C, V116, P23243, DOI 10.1021/jp307382r; MILLER JA, 1989, PROG ENERG COMBUST, V15, P287, DOI 10.1016/0360-1285(89)90017-8; Milton RD, 2017, J AM CHEM SOC, V139, P9044, DOI 10.1021/jacs.7b04893; Milton RD, 2017, ANGEW CHEM INT EDIT, V56, P2680, DOI 10.1002/anie.201612500; Neyts EC, 2015, CHEM REV, V115, P13408, DOI 10.1021/acs.chemrev.5b00362; NRC, 2000, CLEAN COASTAL WATERS; Ober J. A, 2018, MINERAL COMMODITY SU, DOI [10.3133/70194932, DOI 10.3133/70194932]; Paengnakorn P, 2017, CHEM SCI, V8, P1500, DOI 10.1039/c6sc02860h; Parvulescu VI, 1998, CATAL TODAY, V46, P233, DOI 10.1016/S0920-5861(98)00399-X; Patil BS, 2015, CATAL TODAY, V256, P49, DOI 10.1016/j.cattod.2015.05.005; PICKETT CJ, 1985, NATURE, V317, P652, DOI 10.1038/317652a0; Pouvesle JM, 2008, PLASMA CHEMISTRY, P1, DOI 10.1017/CBO9780511546075; Rafiqul I, 2005, ENERGY, V30, P2487, DOI 10.1016/j.energy.2004.12.004; Rosca V, 2009, CHEM REV, V109, P2209, DOI 10.1021/cr8003696; Rusanov V. D., 1981, Soviet Physics - Uspekhi, V24, P447, DOI 10.1070/PU1981v024n06ABEH004884; Schneider W. F., 2004, ENV CATALYSIS, P233; Shelef M, 2000, CATAL TODAY, V62, P35, DOI 10.1016/S0920-5861(00)00407-7; Smil V, 1999, NATURE, V400, P415, DOI 10.1038/22672; Tavares P, 2006, J INORG BIOCHEM, V100, P2087, DOI 10.1016/j.jinorgbio.2006.09.003; Vajrala N, 2013, P NATL ACAD SCI USA, V110, P1006, DOI 10.1073/pnas.1214272110; van Helden JH, 2007, J APPL PHYS, V101, DOI 10.1063/1.2645828; Vicente EJ, 2017, P NATL ACAD SCI USA, V114, P3009, DOI 10.1073/pnas.1701560114; WAGMAN DD, 1982, J PHYS CHEM REF DATA, V11, P1; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Whitehead JC, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/24/243001; Yandulov DV, 2003, SCIENCE, V301, P76, DOI 10.1126/science.1085326; Zammit M., 2013, FUTURE AUTOMOTIVE AF; Zhao X, 2016, APPL CATAL B-ENVIRON, V183, P269, DOI 10.1016/j.apcatb.2015.10.052; Zhou FL, 2017, ENERG ENVIRON SCI, V10, P2516, DOI 10.1039/c7ee02716h	79	967	978	128	1153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391							eaar6611	10.1126/science.aar6611	http://dx.doi.org/10.1126/science.aar6611			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798857	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000433039800037
J	Messing, EM; Tangen, CM; Lerner, SP; Sahasrabudhe, DM; Koppie, TM; Wood, DP; Mack, PC; Svatek, RS; Evans, CP; Hafez, HS; Culkin, DJ; Brand, TC; Karsh, LI; Holzbeierlein, JM; Wilson, SS; Wu, G; Plets, M; Vogelzang, NJ; Thompson, IM				Messing, Edward M.; Tangen, Catherine M.; Lerner, Seth P.; Sahasrabudhe, Deepak M.; Koppie, Theresa M.; Wood, David P., Jr.; Mack, Philip C.; Svatek, Robert S.; Evans, Christopher P.; Hafez, Haled S.; Culkin, Daniel J.; Brand, Timothy C.; Karsh, Lawrence I.; Holzbeierlein, Jeffrey M.; Wilson, Shandra S.; Wu, Guan; Plets, Melissa; Vogelzang, Nicholas J.; Thompson, Ian M., Jr.			Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence SWOG S0337 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BACILLUS-CALMETTE-GUERIN; PHASE-III TRIAL; TRANSURETHRAL RESECTION; MITOMYCIN-C; POSTOPERATIVE INSTILLATION; FLUORESCENCE CYSTOSCOPY; DOUBLE-BLIND; MULTICENTER; CARCINOMA; CHEMOTHERAPY	IMPORTANCE Low-grade non-muscle-invasive urothelial cancer frequently recurs after excision by transurethral resection of bladder tumor (TURBT). OBJECTIVE To determine whether immediate post-TURBT intravesical instillation of gemcitabine reduces recurrence of suspected low-grade non-muscle-invasive urothelial cancer compared with saline. DESIGN, SETTING, AND PARTICIPANTS Randomized double-blind clinical trial conducted at 23 US centers. Patients with suspected low-grade non-muscle-invasive urothelial cancer based on cystoscopic appearance without any high-grade or without more than 2 low-grade urothelial cancer episodes within 18 months before index TURBT were enrolled between January 23, 2008, and August 14, 2012, and followed up every 3 months with cystoscopy and cytology for 2 years and then semiannually for 2 years. Patients were monitored for tumor recurrence, progression to muscle invasion, survival, and toxic effects. The final date of follow-up was August 14, 2016. INTERVENTIONS Participants were randomly assigned to receive intravesical instillation of gemcitabine (2 g in 100 mL of saline) (n = 201) or saline (100 mL) (n = 205) for 1 hour immediately following TURBT. MAIN OUTCOMES AND MEASURES The primary outcome was time to recurrence of cancer. Secondary end points were time to muscle invasion and death due to any cause. RESULTS Among 406 randomized eligible patients (median age, 66 years; 84.7% men), 383 completed the trial. In the intention-to-treat analysis, 67 of 201 patients (4-year estimate, 35%) in the gemcitabine group and 91 of 205 patients (4-year estimate, 47%) in the saline group had cancer recurrence within 4.0 years (hazard ratio, 0.66; 95% CI, 0.48-0.90; P<.001 by 1-sided log-rank test for time to recurrence). Among the 215 patients with low-grade non-muscle-invasive urothelial cancer who underwent TURBT and drug instillation, 34 of 102 patients (4-year estimate, 34%) in the gemcitabine group and 59 of 113 patients (4-year estimate, 54%) in the saline group had cancer recurrence (hazard ratio, 0.53; 95% CI, 0.35-0.81; P = .001 by 1-sided log-rank test for time to recurrence). Fifteen patients had tumors that progressed to muscle invasion (5 in the gemcitabine group and 10 in the saline group; P = .22 by 1-sided log-rank test) and 42 died of any cause (17 in the gemcitabine group and 25 in the saline group; P =.12 by 1-sided log-rank test). There were no grade 4 or 5 adverse events and no significant differences in adverse events of grade 3 or lower. CONCLUSIONS AND RELEVANCE Among patients with suspected low-grade non-muscle-invasive urothelial cancer, immediate postresection intravesical instillation of gemcitabine, compared with instillation of saline, significantly reduced the risk of recurrence over a median of 4.0 years. These findings support using this therapy, but further research is needed to compare gemcitabine with other intravesical agents.	[Messing, Edward M.; Sahasrabudhe, Deepak M.; Wu, Guan] Univ Rochester, Rochester, NY USA; [Tangen, Catherine M.; Plets, Melissa] SWOG Stat Ctr, Seattle, WA USA; [Tangen, Catherine M.; Plets, Melissa] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Lerner, Seth P.] Baylor Coll Med, Houston, TX 77030 USA; [Koppie, Theresa M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Wood, David P., Jr.] Beaumont Hlth, Royal Oak, MI USA; [Mack, Philip C.; Evans, Christopher P.] Univ Calif Davis, Sacramento, CA 95817 USA; [Svatek, Robert S.] Univ Texas San Antonio, San Antonio, TX USA; [Hafez, Haled S.] Univ Michigan, Ann Arbor, MI 48109 USA; [Culkin, Daniel J.] Univ Oklahoma, Oklahoma City, OK USA; [Brand, Timothy C.] Madigan Army Med Ctr, Tacoma, WA 98431 USA; [Karsh, Lawrence I.] Urol Ctr Colorado, Denver, CO USA; [Holzbeierlein, Jeffrey M.] Univ Kansas, Canc Ctr, Kansas City, KS USA; [Wilson, Shandra S.] Univ Colorado, Aurora, CO USA; [Vogelzang, Nicholas J.] Comprehens Canc Ctr Nevada, Las Vegas, NV USA; [Thompson, Ian M., Jr.] CHRISTUS Santa Rosa Med Ctr, San Antonio, TX USA	University of Rochester; Southwest Oncology Group; Fred Hutchinson Cancer Center; Baylor College of Medicine; Oregon Health & Science University; Beaumont Health; University of California System; University of California Davis; University of Texas System; University of Texas at San Antonio (UTSA); University of Michigan System; University of Michigan; University of Oklahoma System; University of Oklahoma Health Sciences Center; Madigan Army Medical Center; University of Kansas; University of Colorado System; University of Colorado Anschutz Medical Campus; Comprehensive Cancer Centers of Nevada	Messing, EM (corresponding author), Univ Rochester, Strong Mem Hosp, 601 Elmwood Ave,Box 656, Rochester, NY 14642 USA.	edward_messing@umc.rochester.edu			National Cancer Institute of the National Institutes of Health [CA180888, CA180819, CA180846, CA180834, CA180858, CA128567, CA180801, CA189953, CA189854, CA180830, CA180818, CA22433, CA35995, CA12644, CA68183, CA11083, CA46282, CA58416, CA46113, CA37981, CA04919]; Eli Lilly; NATIONAL CANCER INSTITUTE [U10CA068183, U10CA180888, U10CA180801, R43CA235995, UG1CA233178, U10CA037981, U10CA180846, U10CA004919, U10CA180834, U10CA180830, U10CA180819, U10CA022433, U10CA058416, U10CA046113, UG1CA189953, U10CA180818, P30CA093373, UG1CA233329, U10CA180858, U10CA046282, U10CA128567, UG1CA189854] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eli Lilly(Eli Lilly); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This trial was supported by the National Cancer Institute of the National Institutes of Health under award numbers CA180888, CA180819, CA180846, CA180834, CA180858, CA128567, CA180801, CA189953, CA189854, CA180830, CA180818, CA22433, CA35995, CA12644, CA68183, CA11083, CA46282, CA58416, CA46113, CA37981, and CA04919 and in part by Eli Lilly (which provided gemcitabine for the study).	Addeo R, 2010, J CLIN ONCOL, V28, P543, DOI 10.1200/JCO.2008.20.8199; Babjuk M, 2017, EUR UROL, V71, P447, DOI 10.1016/j.eururo.2016.05.041; Barocas DA, 2013, J UROLOGY, V190, P2011, DOI 10.1016/j.juro.2013.06.025; Bohle A, 2009, EUR UROL, V56, P495, DOI 10.1016/j.eururo.2009.06.010; Bohle A, 2003, J UROLOGY, V169, P90, DOI 10.1016/S0022-5347(05)64043-8; Bosschieter J, 2018, EUR UROL, V73, P226, DOI 10.1016/j.eururo.2017.06.038; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; BURNAND KG, 1976, BRIT J UROL, V48, P55, DOI 10.1111/j.1464-410X.1976.tb02742.x; Cai T, 2008, J UROLOGY, V180, P110, DOI 10.1016/j.juro.2008.03.038; Cancer Therapy Evaluation Program, 2006, COMM TERM CRIT ADV E; Centers for Medicare and Medicaid Services, 2018, ASP DRUG PRIC FIL; Chang SS, 2016, J UROLOGY, V196, P1021, DOI 10.1016/j.juro.2016.06.049; Cina SJ, 2001, HUM PATHOL, V32, P630, DOI 10.1053/hupa.2001.24999; Cookson MS, 2012, J UROLOGY, V187, P1571, DOI 10.1016/j.juro.2011.12.056; Davies BJ, 2017, NEW ENGL J MED, V376, P1401, DOI 10.1056/NEJMp1615697; Filson CP, 2014, UROL ONCOL, V32; Grossman HB, 2012, J UROLOGY, V188, P58, DOI 10.1016/j.juro.2012.03.007; HEINEMANN V, 1988, CANCER RES, V48, P4024; Madeb R, 2009, CANCER-AM CANCER SOC, V115, P2660, DOI 10.1002/cncr.24311; Messing E, 2006, J UROLOGY, V176, P500, DOI 10.1016/j.juro.2006.03.061; Messing EM, 2006, CANCER-AM CANCER SOC, V107, P2173, DOI 10.1002/cncr.22224; Montironi R, 2003, J CLIN PATHOL, V56, P91, DOI 10.1136/jcp.56.2.91; Mostofi FK, 1973, HISTOLOGICAL TYPING; Naito S, 2016, EUR UROL, V70, P506, DOI 10.1016/j.eururo.2016.03.053; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; OOSTERLINCK W, 1993, J UROLOGY, V149, P749, DOI 10.1016/S0022-5347(17)36198-0; Rajala P, 1999, J UROLOGY, V161, P1133, DOI 10.1016/S0022-5347(01)61609-4; Rink M, 2013, EUR UROL, V64, P624, DOI 10.1016/j.eururo.2013.07.007; Scosyrev E, 2012, CANCER-AM CANCER SOC, V118, P72, DOI 10.1002/cncr.26238; Scosyrev E, 2012, BJU INT, V109, P57, DOI 10.1111/j.1464-410X.2011.10318.x; SEE WA, 1992, J UROLOGY, V147, P1416, DOI 10.1016/S0022-5347(17)37585-7; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Solsona E, 1999, J UROLOGY, V161, P1120, DOI 10.1016/S0022-5347(01)61606-9; Sylvester RJ, 2016, EUR UROL, V69, P231, DOI 10.1016/j.eururo.2015.05.050; Tolley DA, 1996, J UROLOGY, V155, P1233, DOI 10.1016/S0022-5347(01)66226-8; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; von der Maase H, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.30750; Whelan P., 2001, P AM SOC CLIN ONCOL, V20, P708; Xiong Y, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOUMAL.PONE.0170819	39	106	109	3	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1880	1888		10.1001/jama.2018.4657	http://dx.doi.org/10.1001/jama.2018.4657			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29801011	Green Published, Bronze			2022-12-28	WOS:000431668600017
J	Berkman, BE; Miller, WK; Grady, C				Berkman, Benjamin E.; Miller, Wynter K.; Grady, Christine			Is It Ethical to Use Genealogy Data to Solve Crimes?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BIOLOGICAL SAMPLES; CONSENT		[Berkman, Benjamin E.; Miller, Wynter K.; Grady, Christine] NIH, Dept Bioeth, 10 Ctr Dr,Suite 1C118, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Berkman, BE (corresponding author), NIH, Dept Bioeth, 10 Ctr Dr,Suite 1C118, Bethesda, MD 20892 USA.	berkmanbe@mail.nih.gov			National Institutes of Health Intramural Research Program (National Human Genome Research Institute and Clinical Center)	National Institutes of Health Intramural Research Program (National Human Genome Research Institute and Clinical Center)	By the National Institutes of Health Intramural Research Program (National Human Genome Research Institute and Clinical Center).	Epstein J., 2009, U ILL J L TECH POLY, V1, P141; Grady C, 2015, AM J BIOETHICS, V15, P34, DOI 10.1080/15265161.2015.1062162; Greely HT, 2006, J LAW MED ETHICS, V34, P248, DOI 10.1111/j.1748-720X.2006.00031.x; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Joly Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-25; Liberty A. A., 2015, HAMLINE LAW REV, V38, P467; Lipphardt V, OPEN LETT CRITICAL A; Malin B, 2010, J INVEST MED, V58, P11, DOI 10.2310/JIM.0b013e3181c9b2ea; RADIN MARGARET JANE, 2012, BOILERPLATE FINE PRI; Wendler D, 2006, BMJ-BRIT MED J, V332, P544, DOI 10.1136/bmj.332.7540.544	10	20	21	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2018	169	5					333	+		10.7326/M18-1348	http://dx.doi.org/10.7326/M18-1348			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS2MV	29809242	Green Accepted			2022-12-28	WOS:000443385100013
J	Adamsky, A; Kol, A; Kreisel, T; Doron, A; Ozeri-Engelhard, N; Melcer, T; Refaeli, R; Horn, H; Regev, L; Groysman, M; London, M; Goshen, I				Adamsky, Adar; Kol, Adi; Kreisel, Tirzah; Doron, Adi; Ozeri-Engelhard, Nofar; Melcer, Talia; Refaeli, Ron; Horn, Henrike; Regev, Limor; Groysman, Maya; London, Michael; Goshen, Inbal			Astrocytic Activation Generates De Novo Neuronal Potentiation and Memory Enhancement	CELL			English	Article							LONG-TERM POTENTIATION; IN-VIVO; SYNAPTIC PLASTICITY; OPTOGENETIC STIMULATION; TRANSGENIC MICE; VISUAL-CORTEX; DENTATE GYRUS; MODULATION; CALCIUM; RELEASE	Astrocytes respond to neuronal activity and were shown to be necessary for plasticity and memory. To test whether astrocytic activity is also sufficient to generate synaptic potentiation and enhance memory, we expressed the Gq-coupled receptor hM3Dq in CA1 astrocytes, allowing their activation by a designer drug. We discovered that astrocytic activation is not only necessary for synaptic plasticity, but also sufficient to induce NMDA-dependent de novo long-term potentiation in the hippocampus that persisted after astrocytic activation ceased. In vivo, astrocytic activation enhanced memory allocation; i.e., it increased neuronal activity in a task-specific way only when coupled with learning, but not in home-cagedmice. Furthermore, astrocytic activation using either a chemogenetic or an optogenetic tool during acquisition resulted in memory recall enhancement on the following day. Conversely, directly increasing neuronal activity resulted in dramatic memory impairment. Our findings that astrocytes induce plasticity and enhance memory may have important clinical implications for cognitive augmentation treatments.	[Adamsky, Adar; Kol, Adi; Kreisel, Tirzah; Doron, Adi; Ozeri-Engelhard, Nofar; Melcer, Talia; Refaeli, Ron; Horn, Henrike; Regev, Limor; London, Michael; Goshen, Inbal] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci ELSC, IL-91904 Jerusalem, Israel; [Groysman, Maya] Hebrew Univ Jerusalem, ELSC Vector Core Facil, IL-91904 Jerusalem, Israel; [London, Michael] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Goshen, I (corresponding author), Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci ELSC, IL-91904 Jerusalem, Israel.	inbal.goshen@elsc.huji.ac.il	London, Michael/B-4175-2010; Goshen, Inbal/GQI-2230-2022; Core, Vector/CAF-4832-2022	London, Michael/0000-0001-5137-1707; Goshen, Inbal/0000-0001-7578-2615; Kreisel, Tirzah/0000-0001-6757-156X; Sherman, Maya/0000-0002-7421-9844	ELSC; Azrieli Fellowship; Israeli Centers of Research Excellence Program [1916/12]; Israel Science Foundation (ISF) [1946/13]; NARSAD Young Investigator grant; Abisch-Frenkel Foundation; Alon Fellowship; Milton-Rosenbaum Foundation; ISF; Einstein Foundation; National Institute for Psychobiology	ELSC; Azrieli Fellowship; Israeli Centers of Research Excellence Program; Israel Science Foundation (ISF)(Israel Science Foundation); NARSAD Young Investigator grant(NARSAD); Abisch-Frenkel Foundation; Alon Fellowship; Milton-Rosenbaum Foundation; ISF(Israel Science Foundation); Einstein Foundation; National Institute for Psychobiology	We thank the entire Goshen lab for their support. We thank Karl Deisseroth (Stanford University) for the original OptoGq construct. We thank Ami Citri, Yaniv Ziv, Ofer Yizhar, and Raz Yirmiya for critically reading the manuscript. A.A., A.K., and A.D. were supported by an ELSC graduate students scholarship. A.D. was supported by the Azrieli Fellowship. T.K. was supported by an ELSC postdoc scholarship. I.G. was supported by the Israeli Centers of Research Excellence Program (center no. 1916/12), the Israel Science Foundation (ISF) (grant no. 1946/13), the NARSAD Young Investigator grant, the Abisch-Frenkel Foundation, the Alon Fellowship, and the Milton-Rosenbaum Foundation. M.L. is a Sachs Family Lecturer in Brain Science and is supported by the ISF, the Einstein Foundation, and the National Institute for Psychobiology.	Adamsky A, 2018, NEUROSCIENCE, V370, P14, DOI 10.1016/j.neuroscience.2017.05.033; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Agulhon C, 2013, J PHYSIOL-LONDON, V591, P5599, DOI 10.1113/jphysiol.2013.261289; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Allen WE, 2017, SCIENCE, V357, P1149, DOI 10.1126/science.aan6747; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 1998, J NEUROSCI, V18, P6822; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Ben Menachem-Zidon O, 2011, BRAIN BEHAV IMMUN, V25, P1008, DOI 10.1016/j.bbi.2010.11.007; Bonder DE, 2014, J NEUROSCI, V34, P13139, DOI 10.1523/JNEUROSCI.2591-14.2014; Bull C, 2014, NEUROPSYCHOPHARMACOL, V39, P2835, DOI 10.1038/npp.2014.135; Chai H, 2017, NEURON, V95, P531, DOI 10.1016/j.neuron.2017.06.029; Chen NY, 2016, ELIFE, V5, DOI 10.7554/eLife.18716; Chen NY, 2012, P NATL ACAD SCI USA, V109, pE2832, DOI 10.1073/pnas.1206557109; Dallerac G, 2016, PROG NEUROBIOL, V144, P48, DOI 10.1016/j.pneurobio.2016.01.003; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Figueiredo M, 2014, CELL CALCIUM, V56, P208, DOI 10.1016/j.ceca.2014.07.007; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gao V, 2016, P NATL ACAD SCI USA, V113, P8526, DOI 10.1073/pnas.1605063113; GERLAI R, 1995, LEARN MEMORY, V2, P26, DOI 10.1101/lm.2.1.26; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Goshen I, 2014, TRENDS NEUROSCI, V37, P511, DOI 10.1016/j.tins.2014.06.002; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hertz L, 2009, J NEUROCHEM, V109, P10, DOI 10.1111/j.1471-4159.2009.05939.x; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lopez AJ, 2016, J NEUROSCI, V36, P3588, DOI 10.1523/JNEUROSCI.3682-15.2016; Martin-Fernandez M, 2017, NAT NEUROSCI, V20, P1540, DOI 10.1038/nn.4649; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Navarrete M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001259; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; Oliveira JF, 2015, TRENDS NEUROSCI, V38, P535, DOI 10.1016/j.tins.2015.07.006; Orr AG, 2015, NAT NEUROSCI, V18, P423, DOI 10.1038/nn.3930; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pelluru D, 2016, EUR J NEUROSCI, V43, P1298, DOI 10.1111/ejn.13074; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Poskanzer KE, 2016, P NATL ACAD SCI USA, V113, pE2675, DOI 10.1073/pnas.1520759113; Rogerson T, 2014, NAT REV NEUROSCI, V15, P157, DOI 10.1038/nrn3667; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Sasaki T, 2012, P NATL ACAD SCI USA, V109, P20720, DOI 10.1073/pnas.1213458109; Scofield MD, 2015, BIOL PSYCHIAT, V78, P441, DOI 10.1016/j.biopsych.2015.02.016; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; Stehberg J, 2012, FASEB J, V26, P3649, DOI 10.1096/fj.11-198416; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Sweeney P, 2016, GLIA, V64, P2263, DOI 10.1002/glia.23073; Tadi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141568; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Tanaka KZ, 2014, NEURON, V84, P347, DOI 10.1016/j.neuron.2014.09.037; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yang L, 2015, CELL REP, V11, P798, DOI 10.1016/j.celrep.2015.04.002; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	64	229	234	3	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 28	2018	174	1					59	+		10.1016/j.cell.2018.05.002	http://dx.doi.org/10.1016/j.cell.2018.05.002			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GL3CR	29804835	Bronze			2022-12-28	WOS:000437005800011
J	Weinert, BT; Narita, T; Satpathy, S; Srinivasan, B; Hansen, BK; Scholz, C; Hamilton, WB; Zucconi, BE; Wang, WW; Liu, WSR; Brickman, JM; Kesicki, EA; Lai, A; Bromberg, KD; Cole, PA; Choudhary, C				Weinert, Brian T.; Narita, Takeo; Satpathy, Shankha; Srinivasan, Balaji; Hansen, Bogi K.; Schoelz, Christian; Hamilton, William B.; Zucconi, Beth E.; Wang, Wesley W.; Liu, Wenshe R.; Brickman, Joshua M.; Kesicki, Edward A.; Lai, Albert; Bromberg, Kenneth D.; Cole, Philip A.; Choudhary, Chunaram			Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome	CELL			English	Article							LYSINE ACETYLATION; HISTONE ACETYLATION; P300; BROMODOMAIN; ANNOTATION; INHIBITOR; DIVERSITY; PROTEINS; CBP; H3	The acetyltransferases CBP and p300 are multifunctional transcriptional co-activators. Here, we combined quantitative proteomics with CBP/p300-specific catalytic inhibitors, bromodomain inhibitor, and gene knockout to reveal a comprehensive map of regulated acetylation sites and their dynamic turn-over rates. CBP/p300 acetylates thousands of sites, including signature histone sites and a multitude of sites on signaling effectors and enhancer-associated transcriptional regulators. Time-resolved acetylome analyses identified a subset of CBP/p300-regulated sites with very rapid (<30 min) acetylation turnover, revealing a dynamic balance between acetylation and deacetylation. Quantification of acetylation, mRNA, and protein abundance after CBP/p300 inhibition reveals a kinetically competent network of gene expression that strictly depends on CBP/p300-catalyzed rapid acetylation. Collectively, our in-depth acetylome analyses reveal systems attributes of CBP/p300 targets, and the resource dataset provides a framework for investigating CBP/p300 functions and for understanding the impact of small-molecule inhibitors targeting its catalytic and bromodomain activities.	[Weinert, Brian T.; Narita, Takeo; Satpathy, Shankha; Srinivasan, Balaji; Hansen, Bogi K.; Schoelz, Christian; Choudhary, Chunaram] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Dept Prote,Ctr Prot Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Schoelz, Christian] LMU Munchen, Fac Med, Natl Reference Ctr Retroviruses, Max von Pettenkofer Inst,Virol, Feodor Lynen Str 23, D-81377 Munich, Germany; [Hamilton, William B.; Brickman, Joshua M.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Stem Cell Biol DanStem, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Zucconi, Beth E.; Cole, Philip A.] Harvard Med Sch, Div Genet, Dept Med & Biol Chem, Boston, MA 02115 USA; [Zucconi, Beth E.; Cole, Philip A.] Harvard Med Sch, Div Genet, Dept Mol Pharmacol, Boston, MA 02115 USA; [Zucconi, Beth E.; Cole, Philip A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Wang, Wesley W.; Liu, Wenshe R.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Kesicki, Edward A.] Acylin Therapeut Inc, 1616 Eastlake Ave E,200, Seattle, WA 98102 USA; [Kesicki, Edward A.] Petra Pharma Corp, 430 E 29th St,Suite 835, New York, NY 10016 USA; [Lai, Albert; Bromberg, Kenneth D.] AbbVie, Discovery Global Pharmaceut Res & Dev, 1 North Waukegan Rd, N Chicago, IL 60064 USA	Novo Nordisk Foundation; University of Copenhagen; University of Munich; Novo Nordisk Foundation; University of Copenhagen; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Texas A&M University System; Texas A&M University College Station; AbbVie	Choudhary, C (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Dept Prote,Ctr Prot Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	chuna.choudhary@cpr.ku.dk	Schölz, Christian/K-2855-2014; choudhary, chunaram/ABE-6634-2020; Satpathy, Shankha/AAX-6592-2020; Liu, wenshe/O-4425-2014	Schölz, Christian/0000-0002-1633-2072; choudhary, chunaram/0000-0002-9863-433X; Liu, wenshe/0000-0002-7078-6534; Weinert, Brian/0000-0002-1335-9915; Narita, Takeo/0000-0002-2705-7838; Hansen, Bogi/0000-0001-6471-4895; Wang, Wei/0000-0002-7514-539X; Brickman, Joshua/0000-0003-1580-7491; Hamilton, William B/0000-0003-2029-1944	NIH [GM62437]; LLS-SCOR; FAMRI; Novo Nordisk Foundation [NNF15OC0017774, NNF14CC0001]; Novo Nordisk [NNF14OC0008541]; Danish National Research Foundation (DNRF) [116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM124357, R37GM062437] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LLS-SCOR; FAMRI; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk(Novo Nordisk); Danish National Research Foundation (DNRF)(Danmarks Grundforskningsfond); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of our laboratories for their helpful discussions. We thank Elina Maskey for excellent technical assistance. We thank Val Manaves and Mikkel Algire for their expert technical assistance in p300 and CBP histone acetyltransferase assays and Loren Lasko for expert technical assistance in cellular H3K27Ac and H3K9Ac assays. We thank the NIH (GM62437), LLS-SCOR, and FAMRI for funding. The Novo Nordisk Foundation Center for Stem Cell Biology is supported by the Novo Nordisk Foundation (NNF15OC0017774). The Novo Nordisk Foundation Center for Protein Research is financially supported by the Novo Nordisk Foundation (NNF14CC0001). C.C. was supported by the Hallas Moller Investigator Award (NNF14OC0008541) from Novo Nordisk. B.T.W. is supported by a grant from the Novo Nordisk Foundation (NNF15OC0017774). W.B.H. was supported by a grant from the Danish National Research Foundation (DNRF) (116). We thank the CPR Mass Spectrometry Platform and the CPR Big Data Management Platform for their assistance.	Bedford DC, 2012, AGING-US, V4, P247, DOI 10.18632/aging.100453; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Chen HY, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.385.6560; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dancy BM, 2015, CHEM REV, V115, P2419, DOI 10.1021/cr500452k; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Erwin GS, 2017, SCIENCE, V358, P1617, DOI 10.1126/science.aan6414; Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Gnanavel M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-343; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Lasko LM, 2017, NATURE, V550, P128, DOI 10.1038/nature24028; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; McShane E, 2016, CELL, V167, P803, DOI 10.1016/j.cell.2016.09.015; Michaelides MR, 2018, ACS MED CHEM LETT, V9, P28, DOI 10.1021/acsmedchemlett.7b00395; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Picaud S, 2015, CANCER RES, V75, P5106, DOI 10.1158/0008-5472.CAN-15-0236; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Scholz C, 2015, NAT METHODS, V12, P1003, DOI 10.1038/nmeth.3621; Scholz C, 2015, NAT BIOTECHNOL, V33, P415, DOI 10.1038/nbt.3130; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Tienen LM, 2017, ELIFE, V6, DOI [10.7554/eLife.20882.001, 10.7554/eLife.20882]; Venables WN., 2002, MODERN APPL STAT S; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wang L, 2011, SCIENCE, V333, P765, DOI 10.1126/science.1201662; Wang WW, 2016, ACS CHEM BIOL, V11, P1973, DOI 10.1021/acschembio.6b00243; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zheng YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3203; Zucconi BE, 2016, BIOCHEMISTRY-US, V55, P3727, DOI 10.1021/acs.biochem.6b00480	48	172	176	7	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 28	2018	174	1					231	+		10.1016/j.cell.2018.04.033	http://dx.doi.org/10.1016/j.cell.2018.04.033			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GL3CR	29804834	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000437005800023
J	Thomma, BPHJ; Cook, DE				Thomma, Bart P. H. J.; Cook, David E.			Targeting microbial pathogens Plants secrete extracellular vesicles to prevent fungal infection	SCIENCE			English	Editorial Material							IMMUNITY; MICRORNAS; EXCHANGE; RNAS		[Thomma, Bart P. H. J.] Wageningen Univ & Res, Lab Phytopathol, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands; [Cook, David E.] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA	Wageningen University & Research; Kansas State University	Thomma, BPHJ (corresponding author), Wageningen Univ & Res, Lab Phytopathol, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.	bart.thomma@wur.nl	Cook, David E./AAM-9348-2021; Thomma, Bart/ABH-6344-2020	Cook, David E./0000-0002-2719-4701; Thomma, Bart/0000-0003-4125-4181				Buck AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6488; Cai Q, 2018, SCIENCE, V360, P1126, DOI 10.1126/science.aar4142; Cook DE, 2015, ANNU REV PHYTOPATHOL, V53, P541, DOI 10.1146/annurev-phyto-080614-120114; HALPERIN W, 1967, J ULTRA MOL STRUCT R, V18, P428, DOI 10.1016/S0022-5320(67)80128-X; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Nielsen ME, 2012, P NATL ACAD SCI USA, V109, P11443, DOI 10.1073/pnas.1117596109; Nowara D, 2010, PLANT CELL, V22, P3130, DOI 10.1105/tpc.110.077040; Regente M, 2017, J EXP BOT, V68, P5485, DOI 10.1093/jxb/erx355; Rutter BD, 2017, PLANT PHYSIOL, V173, P728, DOI 10.1104/pp.16.01253; Shahid S, 2018, NATURE, V553, P82, DOI 10.1038/nature25027; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang M, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.151, 10.1038/nplants.2016.151]; Wawra S, 2017, PLANT CELL, V29, P1184, DOI 10.1105/tpc.16.00552; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705	15	5	5	3	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1070	1071		10.1126/science.aat9343	http://dx.doi.org/10.1126/science.aat9343			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX0QK	29880672				2022-12-28	WOS:000447416000001
J	Zhang, YY; Fu, ZY; Wei, J; Qi, W; Baituola, G; Luo, J; Meng, YJ; Guo, SY; Yin, HY; Jiang, SY; Li, YF; Miao, HH; Liu, Y; Wang, Y; Li, BL; Ma, YT; Song, BL				Zhang, Ying-Yu; Fu, Zhen-Yan; Wei, Jian; Qi, Wei; Baituola, Gulinaer; Luo, Jie; Meng, Ya-Jie; Guo, Shu-Yuan; Yin, Huiyong; Jiang, Shi-You; Li, Yun-Feng; Miao, Hong-Hua; Liu, Yong; Wang, Yan; Li, Bo-Liang; Ma, Yi-Tong; Song, Bao-Liang			A LIMA1 variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption	SCIENCE			English	Article							HEART-DISEASE; NPC1L1; PROTEIN; HYPERCHOLESTEROLEMIA; EZETIMIBE; RECEPTOR; INTERNALIZATION; COMPARTMENT; MUTATIONS; MEMBRANE	A high concentration of low-density lipoprotein cholesterol (LDL-C) is a major risk factor for cardiovascular disease. Although LDL-C levels vary among humans and are heritable, the genetic factors affecting LDL-C are not fully characterized. We identified a rare frameshift variant in the LIMA1 (also known as EPLIN or SREBP3) gene from a Chinese family of Kazakh ethnicity with inherited low LDL-C and reduced cholesterol absorption. In a mouse model, LIMA1 was mainly expressed in the small intestine and localized on the brush border membrane. LIMA1 bridged NPC1L1, an essential protein for cholesterol absorption, to a transportation complex containing myosin Vb and facilitated cholesterol uptake. Similar to the human phenotype, Lima1-deficient mice displayed reduced cholesterol absorption and were resistant to diet-induced hypercholesterolemia. Through our study of both mice and humans, we identify LIMA1 as a key protein regulating intestinal cholesterol absorption.	[Zhang, Ying-Yu; Miao, Hong-Hua; Li, Bo-Liang] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Zhang, Ying-Yu; Wei, Jian; Luo, Jie; Jiang, Shi-You; Li, Yun-Feng; Liu, Yong; Wang, Yan; Song, Bao-Liang] Wuhan Univ, Inst Adv Studies, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China; [Fu, Zhen-Yan; Baituola, Gulinaer; Meng, Ya-Jie; Ma, Yi-Tong] Xinjiang Med Univ, State Key Lab Pathogenesis Prevent & Treatment Hi, Heart Ctr, Affiliated Hosp 1, Urumqi 830054, Xinjiang, Peoples R China; [Qi, Wei; Guo, Shu-Yuan; Yin, Huiyong] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Guo, Shu-Yuan; Yin, Huiyong] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Wuhan University; Xinjiang Medical University; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, BL (corresponding author), Wuhan Univ, Inst Adv Studies, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China.; Ma, YT (corresponding author), Xinjiang Med Univ, State Key Lab Pathogenesis Prevent & Treatment Hi, Heart Ctr, Affiliated Hosp 1, Urumqi 830054, Xinjiang, Peoples R China.	myt-xj@163.com; blsong@whu.edu.cn		Qi, Wei/0000-0003-0813-5316; Song, Bao-Liang/0000-0002-6397-5935; yin, hui yong/0000-0001-7049-1560; Luo, Jie/0000-0003-1899-3111	MOST of China [2016YFA0500100]; NNSF of China [31690102, 31430044, 81260041, 31771568, 31701030, 91754102, U1403221, 31600651]; Xinjiang Key Research and Development Project [2016B03053]; Science and Technology Support Project of Xinjiang [2017E0269]; 111 Project of Ministry of Education of China [B16036]; Natural Science Foundation of Hubei Province [2016CFA012]	MOST of China(Ministry of Science and Technology, China); NNSF of China(National Natural Science Foundation of China (NSFC)); Xinjiang Key Research and Development Project; Science and Technology Support Project of Xinjiang; 111 Project of Ministry of Education of China(Ministry of Education, China - 111 Project); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by grants from the MOST of China (2016YFA0500100), NNSF of China (31690102, 31430044, 81260041, 31771568, 31701030, 91754102, U1403221, and 31600651), Xinjiang Key Research and Development Project (2016B03053), Science and Technology Support Project of Xinjiang (2017E0269), 111 Project of Ministry of Education of China (B16036), and the Natural Science Foundation of Hubei Province (2016CFA012).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abul-Husn NS, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7000; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; [Anonymous], 2014, NEW ENGL J MED, V371, P2072, DOI DOI 10.1056/NEJMOA1405386; [Anonymous], 2016, CHIN CIRC J, V31, P10; Chu BB, 2009, J BIOL CHEM, V284, P22481, DOI 10.1074/jbc.M109.034355; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Li PS, 2014, NAT MED, V20, P80, DOI 10.1038/nm.3417; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Paksoy H. B., 1992, CENTR ASIAN SURV, V11, P83; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Wang J, 2009, J LIPID RES, V50, P1653, DOI 10.1194/jlr.M800669-JLR200; Wang J, 2015, J LIPID RES, V56, P319, DOI 10.1194/jlr.M054544; Wang LJ, 2011, J BIOL CHEM, V286, P7397, DOI 10.1074/jbc.M110.178368; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Xie C, 2012, J LIPID RES, V53, P2092, DOI 10.1194/jlr.M027359; Xie C, 2011, J BIOL CHEM, V286, P35933, DOI 10.1074/jbc.M111.270199; Xie P, 2014, ATHEROSCLEROSIS, V237, P609, DOI 10.1016/j.atherosclerosis.2014.09.036; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152; Yang YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035270; Zhang JH, 2011, J BIOL CHEM, V286, P25088, DOI 10.1074/jbc.M111.244475; ZILVERSMIT DB, 1972, P SOC EXP BIOL MED, V140, P862, DOI 10.3181/00379727-140-36568	37	43	49	13	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1087	1092		10.1126/science.aao6575	http://dx.doi.org/10.1126/science.aao6575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI6TJ	29880681				2022-12-28	WOS:000434635500038
J	Hayes, AG				Hayes, Alexander G.			Dunes across the Solar System	SCIENCE			English	Editorial Material							RIPPLES; MARS		[Hayes, Alexander G.] Cornell Univ, Spacecraft Planetary Imaging Facil, 412 Space Sci Bldg, Ithaca, NY 14853 USA	Cornell University	Hayes, AG (corresponding author), Cornell Univ, Spacecraft Planetary Imaging Facil, 412 Space Sci Bldg, Ithaca, NY 14853 USA.	hayes@astro.cornell.edu	Hayes, Alexander G/P-2024-2014	Hayes, Alexander G/0000-0001-6397-2630				Ewing RC, 2015, NAT GEOSCI, V8, P15, DOI 10.1038/ngeo2323; GREELEY R, 1992, J GEOPHYS RES-PLANET, V97, P13319, DOI 10.1029/92JE00980; Jia P, 2017, P NATL ACAD SCI USA, V114, P2509, DOI 10.1073/pnas.1612176114; Lamb MP, 2012, SOC SEDIMENT GEOL SP, V102, P139; Lorenz R. D., 2016, DUNE WORLDS WINDBLOW; Moore JM, 2015, ICARUS, V246, P65, DOI 10.1016/j.icarus.2014.04.028; Moore P., 1955, GUIDE TO THE PLANETS, P174; Nicolis G., 1989, EXPLORING COMPLEXITY; Piqueux S, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002007; SAGAN C, 1990, NATURE, V346, P546, DOI 10.1038/346546a0; SAGAN C, 1975, ICARUS, V26, P209, DOI 10.1016/0019-1035(75)90080-9; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815; Telfer MW, 2018, SCIENCE, V360, P992, DOI 10.1126/science.aao2975	13	4	6	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					960	961		10.1126/science.aat7488	http://dx.doi.org/10.1126/science.aat7488			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6SL	29853671				2022-12-28	WOS:000433574200021
J	van Straalen, NM; Legler, J				van Straalen, Nico M.; Legler, Juliette			Decision-making in a storm of discontent	SCIENCE			English	Editorial Material							EUROPEAN-UNION; GLYPHOSATE; TOXICITY		[van Straalen, Nico M.] Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands; [Legler, Juliette] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Legler, Juliette] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Utrecht University; Utrecht University	van Straalen, NM (corresponding author), Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands.	n.m.van.straalen@vu.nl						Benbrook CM, 2016, ENVIRON SCI EUR, V28, DOI 10.1186/s12302-016-0070-0; Brouwer R, 2014, REGUL TOXICOL PHARM, V68, P438, DOI 10.1016/j.yrtph.2014.01.016; Cuhra M, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00028; EPA, 2017, GLYPH DRAFT HUM HLTH; European Commission, 2017, C20178414 EUR COMM; Graven C., 2018, 20170079 RIVM NAT I; IARC, 2017, IARC MON EV CARC RIS, V112; Janssens L, 2017, AQUAT TOXICOL, V193, P210, DOI 10.1016/j.aquatox.2017.10.028; Joint Meeting on Pesticide Residues, 2016, JOINT FAO WHO M PEST; Mesnage R, 2013, TOXICOLOGY, V313, P122, DOI 10.1016/j.tox.2012.09.006; Silva V, 2018, SCI TOTAL ENVIRON, V621, P1352, DOI 10.1016/j.scitotenv.2017.10.093; Tarazona JV, 2017, ARCH TOXICOL, V91, P2723, DOI 10.1007/s00204-017-1962-5; Url B, 2018, NATURE, V553, P381, DOI 10.1038/d41586-018-01071-9; Van Bruggen AHC, 2018, SCI TOTAL ENVIRON, V616, P255, DOI 10.1016/j.scitotenv.2017.10.309	14	14	15	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					958	960		10.1126/science.aat0567	http://dx.doi.org/10.1126/science.aat0567			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6SL	29853670				2022-12-28	WOS:000433574200020
J	Eisenstein, M				Eisenstein, Michael			GENE EDITING To cut is to cure	NATURE			English	Editorial Material							HUNTINGTIN											Merienne N, 2017, CELL REP, V20, P2980, DOI 10.1016/j.celrep.2017.08.075; Monteys AM, 2017, MOL THER, V25, P12, DOI 10.1016/j.ymthe.2016.11.010; SENYAN, 2018, CELL, V173, P989, DOI DOI 10.1016/J.CELL.2018.03.005; Shin JW, 2016, HUM MOL GENET, V25, P4566, DOI 10.1093/hmg/ddw286; Wang GH, 2016, P NATL ACAD SCI USA, V113, P3359, DOI 10.1073/pnas.1524575113; Yang S, 2017, J CLIN INVEST, V127, P2719, DOI 10.1172/JCI92087	6	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					S42	S43		10.1038/d41586-018-05177-y	http://dx.doi.org/10.1038/d41586-018-05177-y			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JG4ZE	29844549	Bronze			2022-12-28	WOS:000492081800001
J	Luis, F; Coronado, E				Luis, Fernando; Coronado, Eugenio			Spinning on the edge of graphene	NATURE			English	Editorial Material							NANORIBBONS; SPINTRONICS; DYNAMICS	Long-sought evidence has been found of magnetism at the edges of graphene, a two-dimensional form of carbon. The findings might enable the development of the logic gates needed for quantum computers.	[Luis, Fernando] Univ Zaragoza, CSIC, Inst Ciencia Mat Aragon, E-50009 Zaragoza, Spain; [Coronado, Eugenio] Univ Valencia, Inst Ciencia Mol, Paterna 46980, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC - Instituto de Ciencia de Materiales de Aragon (ICMA); University of Zaragoza; University of Valencia	Luis, F (corresponding author), Univ Zaragoza, CSIC, Inst Ciencia Mat Aragon, E-50009 Zaragoza, Spain.	fluis@unizar.es; eugenio.coronado@uv.es	Coronado, Eugenio/E-8960-2014; LUIS, Fernando/E-9108-2011	LUIS, Fernando/0000-0001-6284-0521				Cervetti C, 2016, NAT MATER, V15, P164, DOI [10.1038/NMAT4490, 10.1038/nmat4490]; Drogeler M, 2016, NANO LETT, V16, P3533, DOI 10.1021/acs.nanolett.6b00497; Han W, 2014, NAT NANOTECHNOL, V9, P794, DOI [10.1038/nnano.2014.214, 10.1038/NNANO.2014.214]; Min H, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165310; Pesin D, 2012, NAT MATER, V11, P409, DOI [10.1038/nmat3305, 10.1038/NMAT3305]; Rao SS, 2012, ACS NANO, V6, P7615, DOI 10.1021/nn302745x; Recher P, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/30/302001; Ruffieux P, 2016, NATURE, V531, P489, DOI 10.1038/nature17151; Shiddiq M, 2016, NATURE, V531, P348, DOI 10.1038/nature16984; Slota M, 2018, NATURE, V557, P691, DOI 10.1038/s41586-018-0154-7; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180	11	7	8	4	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					645	647		10.1038/d41586-018-05240-8	http://dx.doi.org/10.1038/d41586-018-05240-8			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH4WT	29805174	Green Submitted			2022-12-28	WOS:000433412900037
J	Roach, S				Roach, Simon			Darkness and light	NATURE			English	Editorial Material								The confirmation that a person will develop Huntington's disease can bring them more uncertainty - but also relief.											0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					S38	S38		10.1038/d41586-018-05175-0	http://dx.doi.org/10.1038/d41586-018-05175-0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JJ2UO	29844551				2022-12-28	WOS:000494017700002
J	Obel, N; Dessau, RB; Krogfelt, KA; Bodilsen, J; Andersen, NS; Moller, JK; Roed, C; Omland, LH; Christiansen, CB; Ellermann-Eriksen, S; Bangsborg, JM; Hansen, K; Benfield, TL; Rothman, KJ; Sorensen, HT; Andersen, CO; Lebech, AM				Obel, Niels; Dessau, Ram B.; Krogfelt, Karen A.; Bodilsen, Jacob; Andersen, Nanna S.; Moller, Jens K.; Roed, Casper; Omland, Lars H.; Christiansen, Claus B.; Ellermann-Eriksen, Svend; Bangsborg, Jette M.; Hansen, Klaus; Benfield, Thomas L.; Rothman, Kenneth J.; Sorensen, Henrik T.; Andersen, Christian O.; Lebech, Anne-Mette			Long term survival, health, social functioning, and education in patients with European Lyme neuroborreliosis: nationwide population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BORRELIA-BURGDORFERI; DISEASE; RISK; MENINGITIS; BACTERIAL; SYMPTOMS; PROFILE; SWEDEN	OBJECTIVE To estimate long term survival, health, and educational/social functioning in patients with Lyme neuroborreliosis compared with the general population. DESIGN Nationwide population based cohort study using national registers. SETTING Denmark. PARTICIPANTS All Danish residents diagnosed during 1986-2016 as having Lyme neuroborreliosis (n= 2067), defined as a positive Borrelia burgdorferi intrathecal antibody test and a clinical diagnosis of Lyme borreliosis, and a comparison cohort from the general population matched on sex and date of birth (n= 20 670). MAIN OUTCOME MEASURES Mortality rate ratios, incidence rate ratios of comorbidities, and differences in educational and social outcomes. RESULTS Mortality among patients with Lyme neuroborreliosis was not higher than in the general population (mortality rate ratio 0.90, 95% confidence interval 0.79 to 1.03). Lyme neuroborreliosis patients had increased risk of haematological (incidence rate ratio 3.07, 2.03 to 4.66) and non-melanoma skin cancers (1.49, 1.18 to 1.88). At diagnosis, Lyme neuroborreliosis patients had slightly higher employment and lower disability pension rates. After five years, patients and comparison cohort members had similar numbers of hospital contacts (difference -0.22, 95% confidence interval -0.45 to 0.02, in-hospital days/year; 0.37, -0.10 to 0.83, outpatient visits/year), employment rates (difference 1.5%, -2.1% to 5.1%), income (difference -1000, -20 000 to 18 000, Danish kroner), days of sick leave (difference -0.3, -3.5 to 3.0, per year), rates of receipt of a disability pension (difference -0.9%, -3.2% to 1.3%), and number of children (difference -0.10, -0.27 to 0.08). More patients were married (difference 4.8%, 2.2% to 7.4%) and had completed high school education (difference 7%, 1% to 12%). CONCLUSION A verified diagnosis of Lyme neuroborreliosis had no substantial effect on long term survival, health, or educational/social functioning. Nevertheless, the diagnosis decreased labour market involvement marginally and was associated with increased risk of haematological and non-melanoma skin cancers.	[Obel, Niels; Roed, Casper; Omland, Lars H.; Lebech, Anne-Mette] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Dessau, Ram B.] Slagelse Hosp, Dept Clin Microbiol, Slagelse, Denmark; [Krogfelt, Karen A.] Statens Serum Inst, Bacteria Parasites & Fungi Dept, Copenhagen, Denmark; [Bodilsen, Jacob] Aalborg Univ Hosp, Dept Clin Microbiol & Infect Dis, Aalborg, Denmark; [Andersen, Nanna S.] Odense Univ Hosp, Clin Ctr Emerging & Vector Borne Infect, Odense, Denmark; [Moller, Jens K.] Vejle Hosp, Dept Clin Microbiol, Vejle, Denmark; [Christiansen, Claus B.] Copenhagen Univ Hosp, Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark; [Ellermann-Eriksen, Svend] Aarhus Univ Hosp, Dept Clin Microbiol, Aarhus, Denmark; [Bangsborg, Jette M.; Andersen, Christian O.] Herlev Univ Hosp, Dept Clin Microbiol, Copenhagen, Denmark; [Hansen, Klaus] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Copenhagen, Denmark; [Benfield, Thomas L.] Hvidovre Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Rothman, Kenneth J.; Sorensen, Henrik T.] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Rothman, Kenneth J.] Boston Univ, Dept Epidemiol, Boston, MA USA	Rigshospitalet; University of Copenhagen; Statens Serum Institut; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Lillebaelt Hospital; Rigshospitalet; University of Copenhagen; Aarhus University; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University; Boston University	Obel, N (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	niels.obel@regionh.dk	Sorensen, Henrik Toft/Z-6181-2019; Krogfelt, Karen Angeliki A/O-8145-2016; Andersen, Nanna Skaarup/U-8346-2019; Krogfelt, Karen Angeliki/P-2430-2018	Sorensen, Henrik Toft/0000-0003-4299-7040; Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Andersen, Nanna Skaarup/0000-0002-3927-9294; Omland, Lars Haukali/0000-0002-5338-8948; Lebech, Anne-Mette/0000-0002-0943-3289; Dessau, Ram/0000-0002-1497-6309; Bodilsen, Jacob/0000-0002-7398-814X; Benfield, Thomas/0000-0003-0698-9385; Moller, Jens Kjolseth/0000-0002-5547-5498; Roed, Casper/0000-0001-8987-5230; Obel, Niels/0000-0002-5031-0045	Danish Council for Independent Research [6110-00173B]; PROCRIN program	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); PROCRIN program	The study was sponsored by the Danish Council for Independent Research (grant number: 6110-00173B). HTS was supported by the PROCRIN program. The sponsors had no influence on the preparation, design, analysis, and reporting of this study.	Adrion ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116767; Berglund J, 2002, SCAND J INFECT DIS, V34, P421, DOI 10.1080/00365540110080421; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Chang CM, 2012, INT J CANCER, V131, P2208, DOI 10.1002/ijc.27483; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christen HJ, 1996, ANN MED, V28, P235, DOI 10.3109/07853899609033125; Dersch R, 2016, J NEUROL, V263, P17, DOI 10.1007/s00415-015-7923-0; Dersch R, 2015, J NEUROL, V262, P2572, DOI 10.1007/s00415-015-7891-4; Dessau RB, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.28.21184; Eikeland R, 2012, EUR J NEUROL, V19, P480, DOI 10.1111/j.1468-1331.2011.03563.x; Eikeland R, 2011, ACTA NEUROL SCAND, V124, P349, DOI 10.1111/j.1600-0404.2010.01482.x; Forrester JD, 2015, EMERG INFECT DIS, V21, P2036, DOI 10.3201/eid2111.150778; Garkowski A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00146; Hall JL, 2017, EMERG INFECT DIS, V23, P463, DOI 10.3201/eid2303.161397; HANSEN K, 1991, ANN NEUROL, V30, P197, DOI 10.1002/ana.410300212; HANSEN K, 1992, BRAIN, V115, P399, DOI 10.1093/brain/115.2.399; Hansen K, 2013, HAND CLINIC, V115, P559, DOI 10.1016/B978-0-444-52902-2.00032-1; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Koedel U, 2017, CURR OPIN INFECT DIS, V30, P101, DOI 10.1097/QCO.0000000000000332; KRUGER H, 1989, J NEUROL, V236, P322, DOI 10.1007/BF00314373; Ljostad U, 2010, EUR J NEUROL, V17, P118, DOI 10.1111/j.1468-1331.2009.02756.x; MEENAN RF, 1981, ARTHRITIS RHEUM, V24, P544, DOI 10.1002/art.1780240315; Moreira J, 2013, LEUKEMIA, V27, P136, DOI 10.1038/leu.2012.187; Mygland A, 2010, EUR J NEUROL, V17, P8, DOI 10.1111/j.1468-1331.2009.02862.x; Mygland A, 2010, EUR J NEUROL, V17, pe1, DOI [10.1111/j.1468-1331.2009.02862.x, DOI 10.1111/J.1468-1331.2009.02862.X]; Nicolson GL, 2008, LABMEDICINE, V39, P291, DOI 10.1309/96M3BWYP42L11BFU; Pfleger CCH, 2010, MULT SCLER J, V16, P878, DOI 10.1177/1352458510370978; Roed C, 2013, JAMA-J AM MED ASSOC, V309, P1714, DOI 10.1001/jama.2013.3792; Roed C, 2010, AM J EPIDEMIOL, V172, P309, DOI 10.1093/aje/kwq126; Schollkopf C, 2008, BLOOD, V111, P5524, DOI 10.1182/blood-2007-08-109611; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83	32	36	36	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2018	361								k1998	10.1136/bmj.k1998	http://dx.doi.org/10.1136/bmj.k1998			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MP	29848547	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000434275800001
J	Vazifeh, MM; Santi, P; Resta, G; Strogatz, SH; Ratti, C				Vazifeh, M. M.; Santi, P.; Resta, G.; Strogatz, S. H.; Ratti, C.			Addressing the minimum fleet problem in on-demand urban mobility	NATURE			English	Article								Information and communication technologies have opened the way to new solutions for urban mobility that provide better ways to match individuals with on-demand vehicles. However, a fundamental unsolved problem is how best to size and operate a fleet of vehicles, given a certain demand for personal mobility. Previous studies(1-5) either do not provide a scalable solution or require changes in human attitudes towards mobility. Here we provide a network-based solution to the following 'minimum fleet problem', given a collection of trips (specified by origin, destination and start time), of how to determine the minimum number of vehicles needed to serve all the trips without incurring any delay to the passengers. By introducing the notion of a 'vehicle-sharing network', we present an optimal computationally efficient solution to the problem, as well as a nearly optimal solution amenable to real-time implementation. We test both solutions on a dataset of 150 million taxi trips taken in the city of New York over one year(6). The real-time implementation of the method with near-optimal service levels allows a 30 per cent reduction in fleet size compared to current taxi operation. Although constraints on driver availability and the existence of abnormal trip demands may lead to a relatively larger optimal value for the fleet size than that predicted here, the fleet size remains robust for a wide range of variations in historical trip demand. These predicted reductions in fleet size follow directly from a reorganization of taxi dispatching that could be implemented with a simple urban app; they do not assume ride sharing(7-9), nor require changes to regulations, business models, or human attitudes towards mobility to become effective. Our results could become even more relevant in the years ahead as fleets of networked, self-driving cars become commonplace(10-14).	[Vazifeh, M. M.; Santi, P.; Ratti, C.] MIT, Senseable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Santi, P.; Resta, G.] CNR, Ist Informat & Telemat, Pisa, Italy; [Strogatz, S. H.] Cornell Univ, Dept Math, White Hall, Ithaca, NY 14853 USA; [Ratti, C.] Cornell Tech, New York, NY USA	Massachusetts Institute of Technology (MIT); Consiglio Nazionale delle Ricerche (CNR); Istituto di Informatica e Telematica (IIT-CNR); Cornell University	Vazifeh, MM (corresponding author), MIT, Senseable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mmvazifeh@gmail.com	Resta, Giovanni/AFR-6696-2022; Strogatz, Steven/A-1641-2014	Strogatz, Steven/0000-0003-2923-3118; RESTA, GIOVANNI/0000-0003-1315-2700	USA NSF [DMS-1513179, CCF-1522054]; Division of Computing and Communication Foundations [1522054] Funding Source: National Science Foundation	USA NSF(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	P.S., M.M.V. and C.R. thank all sponsors and partners of the MIT Senseable City Laboratory including Allianz, the Amsterdam Institute for Advanced Metropolitan Solutions, the Fraunhofer Institute, Kuwait-MIT Center for Natural Resources and the Environment, Singapore-MIT Alliance for Research and Technology (SMART) and all the members of the Consortium. The research of S.H.S. was supported by USA NSF grant numbers DMS-1513179 and CCF-1522054.	Alonso-Mora J, 2017, P NATL ACAD SCI USA, V114, P462, DOI 10.1073/pnas.1611675114; Baker BM, 2003, COMPUT OPER RES, V30, P787, DOI 10.1016/S0305-0548(02)00051-5; Barth M., 2011, TRANSPORT RES REC, V2058, P163; Berbeglia G, 2010, EUR J OPER RES, V202, P8, DOI 10.1016/j.ejor.2009.04.024; Bloomberg M. R., 2014, NEW YORK CITY TAXICA; BOESCH FT, 1977, J ACM, V24, P192, DOI 10.1145/322003.322005; Botsman R., 2011, WHATS MINE IS YOURS; Clare GL, 2011, IEEE T INTELL TRANSP, V12, P1000, DOI 10.1109/TITS.2011.2131650; Handke V., 2013, FLEXIBLE RIDESHARING, DOI [10.1007/978-3-642-11345-1, DOI 10.1007/978-3-642-11345-1]; Hopcroft J. E., 1973, SIAM Journal on Computing, V2, P225, DOI 10.1137/0202019; LAPORTE G, 1992, EUR J OPER RES, V59, P345, DOI 10.1016/0377-2217(92)90192-C; Mitchell W. J., 2010, REINVENTING AUTOMOBI; Rosenberg T., 2013, NY TIMES OPINIONATOR; Roughgarden T, 2005, SELFISH ROUTING PRIC; Santi P, 2014, P NATL ACAD SCI USA, V111, P13290, DOI 10.1073/pnas.1403657111; Spieser K, 2014, LECT N MOBIL, P229, DOI 10.1007/978-3-319-05990-7_20; Sundararajan A., 2013, HARVARD BUS REV, V1, P1; Tachet R, 2017, SCI REP-UK, V7, DOI 10.1038/srep42868; United Nations Environment Programme, 2011, UNEP 2010 ANN REP; Yang J, 2004, TRANSPORT SCI, V38, P135, DOI 10.1287/trsc.1030.0068	20	163	179	23	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2018	557	7706					534	+		10.1038/s41586-018-0095-1	http://dx.doi.org/10.1038/s41586-018-0095-1			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6GP	29795256				2022-12-28	WOS:000432794900042
J	Bhatt, DL				Bhatt, Deepak L.			Percutaneous Coronary Intervention in 2018	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL THERAPY; DISEASE; CHOICE; PCI		[Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bhatt, DL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA.	dlbhattmd@post.harvard.edu			Abbott; Amarin; Amgen; AstraZeneca; Bristol-Myers Squibb; Chiesi; Eisai; Ethicon; Forest Laboratories; Ironwood; Ischemix; Lilly; Medtronic; Pfizer; Regeneron; Roche; Sanofi Aventis; The Medicines Company	Abbott(Abbott Laboratories); Amarin; Amgen(Amgen); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Chiesi(Chiesi Pharmaceuticals Inc); Eisai(Eisai Co Ltd); Ethicon; Forest Laboratories; Ironwood; Ischemix; Lilly(Eli Lilly); Medtronic(Medtronic); Pfizer(Pfizer); Regeneron(Regeneron); Roche(Roche Holding); Sanofi Aventis(Sanofi-Aventis); The Medicines Company	Dr Bhatt has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and reports serving on advisory boards for Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, and Regado Biosciences; board of directors for Boston VA Research Institute and the Society of Cardiovascular Patient Care; American Heart Association Quality Oversight Committee; data monitoring committees for Cleveland Clinic, Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine, and Population Health Research Institute; honoraria from American College of Cardiology, Belvoir Publications, Duke Clinical Research Institute, Harvard Clinical Research Institute, HMP Communications, Journal of the American College of Cardiology, Population Health Research Institute, Slack Publications, Society of Cardiovascular Patient Care, and WebMD; other from Clinical Cardiology, NCDR-ACTION Registry Steering Committee, and VA CART Research and Publications Committee; research funding from Abbott, Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Regeneron, Roche, Sanofi Aventis, and The Medicines Company; royalties from Elsevier; site coinvestigator for Biotronik, Boston Scientific, St Jude Medical (now Abbott), and Svelte; trustee for the American College of Cardiology; and unfunded research for FlowCo, Merck, PLx Pharma, and Takeda.	Al-Lamee R, 2018, LANCET, V391, P31, DOI 10.1016/S0140-6736(17)32714-9; Bhatt DL, 2018, LANCET, V391, P913, DOI 10.1016/S0140-6736(18)30424-0; Bhatt DL, 2013, NEW ENGL J MED, V368, P1446, DOI 10.1056/NEJMe1302670; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Bhatt DL, 2005, JAMA-J AM MED ASSOC, V293, P2935, DOI 10.1001/jama.293.23.2935; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Borden WB, 2011, JAMA-J AM MED ASSOC, V305, P1882, DOI 10.1001/jama.2011.601; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Ruel M, 2017, JAMA CARDIOL, V2, P1061, DOI 10.1001/jamacardio.2017.2946	9	53	57	4	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2127	2128		10.1001/jama.2018.5281	http://dx.doi.org/10.1001/jama.2018.5281			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800163				2022-12-28	WOS:000432679400024
J	Slomski, A				Slomski, Anita			Peer Counselors for Formerly Incarcerated People With HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2069	2069		10.1001/jama.2018.6257	http://dx.doi.org/10.1001/jama.2018.6257			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800177				2022-12-28	WOS:000432679400009
J	Clark, WF; Sontrop, JM; Huang, SH; Gallo, K; Moist, L; House, AA; Cuerden, MS; Weir, MA; Bagga, A; Brimble, S; Burke, A; Muirhead, N; Pandeya, S; Garg, AX				Clark, William F.; Sontrop, Jessica M.; Huang, Shih-Han; Gallo, Kerri; Moist, Louise; House, Andrew A.; Cuerden, Meaghan S.; Weir, Matthew A.; Bagga, Amit; Brimble, Scott; Burke, Andrew; Muirhead, Norman; Pandeya, Sanjay; Garg, Amit X.			Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease The CKD WIT Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; VASOPRESSIN; FLUID; NEPHROLITHIASIS; REABSORPTION; PROGRESSION; COMMUNITY; COPEPTIN; VOLUME	IMPORTANCE In observational studies, increased water intake is associated with better kidney function. OBJECTIVE To determine the effect of coaching to increase water intake on kidney function in adults with chronic kidney disease. DESIGN, SETTING, AND PARTICIPANTS The CKD WIT (Chronic Kidney Disease Water Intake Trial) randomized clinical trial was conducted in 9 centers in Ontario, Canada, from 2013 until 2017 (last day of follow-up, May 25, 2017). Patients had stage 3 chronic kidney disease (estimated glomerular filtration rate [eGFR] 30-60 mL/min/1.73m(2) and microalbuminuria or macroalbuminuria) and a 24-hour urine volume of less than 3.0 L. INTERVENTIONS Patients in the hydration group (n = 316) were coached to drink more water, and those in the control group (n = 315) were coached to maintain usual intake. MAIN OUTCOMES AND MEASURES The primary outcome was change in kidney function (eGFR from baseline to 12 months). Secondary outcomes included 1-year change in plasma copeptin concentration, creatinine clearance, 24-hour urine albumin, and patient-reported overall quality of health (0 [ worst possible] to 10 [best possible]). RESULTS Of 631 randomized patients (mean age, 65.0 years; men, 63.4%; mean eGFR, 43 mL/min/1.73m(2); median urine albumin, 123mg/d), 12 died (hydration group [ n = 5]; control group [ n = 7]). Among 590 survivors with 1-year follow-up measurements (95% of 619), the mean change in 24-hour urine volume was 0.6 L per day higher in the hydration group (95% CI, 0.5 to 0.7; P < .001). The mean change in eGFR was -2.2 mL/min/1.73m(2) in the hydration group and -1.9 mL/min/1.73m(2) in the control group (adjusted between-group difference, -0.3 mL/min/1.73m(2) [ 95% CI, -1.8 to 1.2; P =.74]). The mean between-group differences (hydration vs control) in secondary outcomes were as follows: plasma copeptin, -2.2 pmol/L (95% CI, -3.9 to -0.5; P = .01); creatinine clearance, 3.6 mL/min/1.73m(2) (95% CI, 0.8 to 6.4; P =.01); urine albumin, 7mg per day (95% CI, -4 to 51; P = .11); and quality of health, 0.2 points (95% CI, -0.3 to 0.3; P = .22). CONCLUSIONS AND RELEVANCE Among adults with chronic kidney disease, coaching to increase water intake compared with coaching to maintain the same water intake did not significantly slow the decline in kidney function after 1 year. However, the study may have been underpowered to detect a clinically important difference.	[Clark, William F.; Sontrop, Jessica M.; Huang, Shih-Han; Gallo, Kerri; Moist, Louise; House, Andrew A.; Cuerden, Meaghan S.; Weir, Matthew A.; Muirhead, Norman; Garg, Amit X.] London Hlth Sci Ctr, London, ON, Canada; [Clark, William F.; Huang, Shih-Han; Moist, Louise; House, Andrew A.; Weir, Matthew A.; Bagga, Amit; Muirhead, Norman; Garg, Amit X.] Western Univ, Dept Med, London, ON, Canada; [Sontrop, Jessica M.; Moist, Louise; Garg, Amit X.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Bagga, Amit] Hotel Dieu Grace Hosp, Windsor, ON, Canada; [Brimble, Scott] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Burke, Andrew] Guelph Gen Hosp, Guelph, ON, Canada; [Pandeya, Sanjay] Halton Healthcare Serv, Oakville, ON, Canada	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); McMaster University	Clark, WF (corresponding author), Victoria Hosp, 800 Commissioners Rd E,A2-343, London, ON N6A 5W9, Canada.	william.clark@lhsc.on.ca	Garg, Amit X/G-3295-2011; Weir, Matthew/G-3354-2011; Huang, Shih-Han/H-3817-2013; Muirhead, Norman/G-3337-2011; Clark, Bill/G-3287-2011; Moist, Louise/G-3334-2011; House, Andrew/G-3304-2011	Huang, Shih-Han/0000-0002-0848-130X; 	Danone Research; Program of Experimental Medicine, Western University, Canada; Dr Adam Linton Chair in Kidney Health Analytics; Canadian Institutes of Health Research	Danone Research(Danone Nutricia); Program of Experimental Medicine, Western University, Canada; Dr Adam Linton Chair in Kidney Health Analytics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by Danone Research and the Program of Experimental Medicine, Western University, Canada. Thermo Fisher Scientific provided the instrumentation, assay reagent, and disposables for the analysis copeptin. Dr Garg was supported by the Dr Adam Linton Chair in Kidney Health Analytics, and a Clinician Salary Award from the Canadian Institutes of Health Research.	Bankir L, 2013, NAT REV NEPHROL, V9, P223, DOI 10.1038/nrneph.2013.22; Barash I, 2010, CLIN J AM SOC NEPHRO, V5, P693, DOI 10.2215/CJN.04180609; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; BOUBY N, 1990, AM J PHYSIOL, V258, pF973, DOI 10.1152/ajprenal.1990.258.4.F973; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Christ-Crain M, 2016, NAT REV ENDOCRINOL, V12, P168, DOI 10.1038/nrendo.2015.224; Clark William F, 2017, Can J Kidney Health Dis, V4, p2054358117725106, DOI 10.1177/2054358117725106; Clark WF, 2016, AM J NEPHROL, V43, P281, DOI 10.1159/000445959; Clark WF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003666; Clark WF, 2011, CLIN J AM SOC NEPHRO, V6, P2634, DOI 10.2215/CJN.01990211; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Cravedi P, 2012, NAT REV NEPHROL, V8, P301, DOI 10.1038/nrneph.2012.42; Enhorning S, 2019, NEPHROL DIAL TRANSPL, V34, P74, DOI 10.1093/ndt/gfy017; Eriksen BO, 2010, NEPHRON CLIN PRACT, V115, pE41, DOI 10.1159/000286349; Food and Nutrition Board-National Academy of Sciences, 1945, NAT RES COUNC REPR C, P3; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; Hays RD, 1997, KIDNEY DIS QUALITY L; JOPPICH R, 1971, PFLUG ARCH EUR J PHY, V329, P172, DOI 10.1007/BF00586991; Lette F, 2008, LANCET, V372, P782, DOI 10.1016/S0140-6736(08)61316-1; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lorenzo V, 2010, NEPHROL DIAL TRANSPL, V25, P835, DOI 10.1093/ndt/gfp475; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Qaseem A, 2014, ANN INTERN MED, V161, P659, DOI 10.7326/M13-2908; Rosansky SJ, 2012, AM J NEPHROL, V36, P1, DOI 10.1159/000339327; Roussel R, 2014, J CLIN ENDOCR METAB, V99, P4656, DOI 10.1210/jc.2014-2295; Roy J, 2017, CLIN J AM SOC NEPHRO, V12, P1010, DOI 10.2215/CJN.06210616; SJOSTROM PA, 1988, SCAND J UROL NEPHROL, V22, P129; Sontrop JM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008634; Sontrop JM, 2013, AM J NEPHROL, V37, P434, DOI 10.1159/000350377; Spigt MG, 2006, J AM GERIATR SOC, V54, P438, DOI 10.1111/j.1532-5415.2005.00606.x; Strippoli GFM, 2011, NEPHROLOGY, V16, P326, DOI 10.1111/j.1440-1797.2010.01415.x; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Turin TC, 2012, AM J NEPHROL, V36, P41, DOI 10.1159/000339289; Valtin H, 2002, AM J PHYSIOL-REG I, V283, pR993, DOI 10.1152/ajpregu.00365.2002; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; Vreeman RC, 2007, BRIT MED J, V335, P1288, DOI 10.1136/bmj.39420.420370.25; Wang CJ, 2013, KIDNEY INT, V84, P45, DOI 10.1038/ki.2013.23; Wang CJ, 2011, CLIN J AM SOC NEPHRO, V6, P192, DOI 10.2215/CJN.03950510; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865	40	45	45	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1870	1879		10.1001/jama.2018.4930	http://dx.doi.org/10.1001/jama.2018.4930			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29801012	Green Published, Bronze			2022-12-28	WOS:000431668600016
J	Huang, PX; Zheng, SD; Wierbowski, BM; Kim, Y; Nedelcu, D; Aravena, L; Liu, J; Kruse, AC; Salic, A				Huang, Pengxiang; Zheng, Sanduo; Wierbowski, Bradley M.; Kim, Youngchang; Nedelcu, Daniel; Aravena, Laura; Liu, Jing; Kruse, Andrew C.; Salic, Adrian			Structural Basis of Smoothened Activation in Hedgehog Signaling	CELL			English	Article							CRYSTAL-STRUCTURE; RECEPTOR; PROTEIN; PATHWAY; BINDING; OXYSTEROLS; MODULATION; TRANSDUCTION; MUTATIONS; ENCODES	The seven-transmembrane-spanning protein Smoothened is the central transducer in Hedgehog signaling, a pathway fundamental in development and in cancer. Smoothened is activated by cholesterol binding to its extracellular cysteine-rich domain (CRD).How this interaction leads to changes in the transmembrane domain and Smoothened activation is unknown. Here, we report crystal structures of sterol-activated Smoothened. The CRD undergoes a dramatic reorientation, allosterically causing the transmembrane domain to adopt a conformation similar to active G-protein-coupled receptors. We show that Smoothened contains a unique inhibitory p-cation lock, which is broken on activation and is disrupted in constitutively active oncogenic mutants. Smoothened activation opens a hydrophobic tunnel, suggesting a pathway for cholesterol movement from the inner membrane leaflet to the CRD. All Smoothened antagonists bind the transmembrane domain and block tunnel opening, but cyclopamine also binds the CRD, inducing the active transmembrane conformation. Together, these results define the mechanisms of Smoothened activation and inhibition.	[Huang, Pengxiang; Wierbowski, Bradley M.; Nedelcu, Daniel; Aravena, Laura; Liu, Jing; Salic, Adrian] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Zheng, Sanduo; Kruse, Andrew C.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 250 Longwood Ave, Boston, MA 02115 USA; [Kim, Youngchang] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Argonne National Laboratory	Salic, A (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	asalic@hms.harvard.edu	Liu, Jing/C-9666-2014; Salic, Adrian/GXG-1611-2022	Liu, Jing/0000-0001-9513-3591; Kim, Youngchang/0000-0002-1610-4889; Wierbowski, Bradley/0000-0002-1967-5919	NIH [R01 GM110041]; NIH predoctoral fellowship [F31 GM120833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122920, F31GM120833, R01GM110041] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH grant (R01 GM110041) (to A.S.) and an NIH predoctoral fellowship (F31 GM120833) (to B.M.W.). We thank members of the Salic lab for helpful discussions. The authors thank members of the SBC-CAT at Argonne National Laboratory for help with experiments at the 19-ID beam line.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Byrne EFX, 2016, NATURE, V535, P517, DOI 10.1038/nature18934; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; de Graaf C, 2017, TRENDS BIOCHEM SCI, V42, P946, DOI 10.1016/j.tibs.2017.10.003; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gerhart J, 1999, TERATOLOGY, V60, P226; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Huang PX, 2016, CELL, V166, P1176, DOI 10.1016/j.cell.2016.08.003; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Manglik A, 2017, BIOCHEMISTRY-US, V56, P5628, DOI 10.1021/acs.biochem.7b00747; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Myers BR, 2013, DEV CELL, V26, P346, DOI 10.1016/j.devcel.2013.07.015; Nachtergaele S, 2013, ELIFE, V2, DOI 10.7554/eLife.01340; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Nedelcu D, 2013, NAT CHEM BIOL, V9, P557, DOI [10.1038/NCHEMBIO.1290, 10.1038/nchembio.1290]; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tukachinsky H, 2012, CELL REPORTS, V2, P308, DOI 10.1016/j.celrep.2012.07.010; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5355; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Zhang XJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15383; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394	51	88	88	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 12	2018	174	2					312	+		10.1016/j.cell.2018.04.029	http://dx.doi.org/10.1016/j.cell.2018.04.029			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GM8MM	29804838	Green Accepted, Bronze			2022-12-28	WOS:000438482800009
J	Blankestijn, PJ; Bots, ML				Blankestijn, Peter J.; Bots, Michiel L.			Renal denervation in uncontrolled hypertension: the story continues to unfold	LANCET			English	Editorial Material							MEDICATION ADHERENCE		[Blankestijn, Peter J.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3508 GA Utrecht, Netherlands; [Bots, Michiel L.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Blankestijn, PJ (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3508 GA Utrecht, Netherlands.	p.j.blankestijn@umcutrecht.nl			Netherlands Organisation for Health Research and Development (ZonMw); Medtronic; Dutch Kidney Foundation; European Commission (HORIZON program); Applied and Engineering Sciences (NWO); St Jude Medical; Recor Medical	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Medtronic(Medtronic); Dutch Kidney Foundation; European Commission (HORIZON program); Applied and Engineering Sciences (NWO); St Jude Medical(St. Jude Medical); Recor Medical	PJB reports grants paid to his institution from The Netherlands Organisation for Health Research and Development (ZonMw), Medtronic, Dutch Kidney Foundation, European Commission (HORIZON program), Applied and Engineering Sciences (NWO), St Jude Medical, and Recor Medical, outside the area of work commented on here although some grants relate to renal denervation in general. MLB declares no competing interests.	Blankestijn PJ, 2017, NAT REV NEPHROL, V13, P725, DOI 10.1038/nrneph.2017.150; de Beus E, 2014, J HYPERTENS, V32, P1751, DOI 10.1097/HJH.0000000000000210; de Jager RL, 2018, BRIT J CLIN PHARMACO, V84, P18, DOI 10.1111/bcp.13402; de Jager RL, 2018, NEPHROL DIAL TRANSPL, V33, P614, DOI 10.1093/ndt/gfx086; de Jager RL, 2017, HYPERTENSION, V69, P678, DOI 10.1161/HYPERTENSIONAHA.116.08818; Kandzari DE, 2018, LANCET, V391, P2346, DOI 10.1016/S0140-6736(18)30951-6; Sanders MF, 2017, NEPHROL DIAL TRANSPL, V32, P1440, DOI 10.1093/ndt/gfx088; Townsend RR, 2017, LANCET, V390, P2160, DOI 10.1016/S0140-6736(17)32281-X	8	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2018	391	10137					2300	2302		10.1016/S0140-6736(18)31112-7	http://dx.doi.org/10.1016/S0140-6736(18)31112-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI6WF	29803591				2022-12-28	WOS:000434643200007
J	Smyth, D; Croker, R; Goldacre, B				Smyth, Darren; Croker, Richard; Goldacre, Ben			Pregabalin: what the patent litigation means for doctors and drug companies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Smyth, Darren] EIP, London, England; [Croker, Richard; Goldacre, Ben] Univ Oxford, Ctr Evidence Based Med, EBM DataLab, Oxford, England	University of Oxford	Goldacre, B (corresponding author), Univ Oxford, Ctr Evidence Based Med, EBM DataLab, Oxford, England.	ben.goldacre@phc.ox.ac.uk	Croker, Richard/D-2534-2018	Croker, Richard/0000-0002-8114-9186	Laura and John Arnold Foundation; Wellcome Trust; Oxford Biomedical Research Centre; NHS National Institute for Health Research School of Primary Care Research; Health Foundation; World Health Organization; Martindale Pharma; Menarini Farmaceutica Internazionale; Stirling Anglian Pharmaceuticals; BG	Laura and John Arnold Foundation; Wellcome Trust(Wellcome Trust); Oxford Biomedical Research Centre; NHS National Institute for Health Research School of Primary Care Research; Health Foundation; World Health Organization(World Health Organization); Martindale Pharma; Menarini Farmaceutica Internazionale(Menarini Group); Stirling Anglian Pharmaceuticals; BG	We have read and understood BMJ policy on declaration of interests and declare the following: BG has received research funding from the Laura and John Arnold Foundation, the Wellcome Trust, the Oxford Biomedical Research Centre, the NHS National Institute for Health Research School of Primary Care Research, the Health Foundation, and the World Health Organization; he also receives personal income from speaking and writing for lay audiences on the misuse of science. RC is employed on BG's grants for the OpenPrescribing project. RC is employed by a CCG to optimise prescribing and has been a paid member of advisory boards for Martindale Pharma, Menarini Farmaceutica Internazionale, and Stirling Anglian Pharmaceuticals. DS is a patent attorney in private practice and a partner in the intellectual property law firm EIP. He and other patent attorneys and solicitors at EIP act for and advise drug companies as patent holders as well as advising and representing in relation to patents held by other entities. DS has written extensively concerning pregabalin in his capacity as member of the IPKat intellectual property law blog and as member of the editorial committee of the Journal of Intellectual Property Law and Practice; both these roles are part of his general professional activity and are not remunerated. All authors conceived the project, drafted the manuscript, contributed to and approved the final manuscript.	[Anonymous], 2017, GUID PRESCR; [Anonymous], 2018, WHY WER SPCS PREG AL; Aronson JK, 2017, BRIT J CLIN PHARMACO, V83, P2615, DOI 10.1111/bcp.13394; Croker R, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022416; European Federation of Pharmaceutical Industries and Associations, 2015, NEW IND CROSS LAB DI; General Medical Council, 2018, GMC RESP NEW NICE GU; McCartney Margaret, 2015, BMJ, V350, ph2734, DOI 10.1136/bmj.h2734; National Institute for Health and Care Excellence, 2018, AG REL MAC DEG NICE; NHS Business Service Authority, 2021, PRESCRIPTION COST AN; Papadopoulou F, 2016, J INTELLET PROP LAW, V11, P372, DOI 10.1093/jiplp/jpw027; Smyth D, 2015, J INTELLECTUAL PROPE, V10, P488, DOI [10.1093/jiplp/jpv070, DOI 10.1093/JIPLP/JPV070]; Smyth D, 2016, J INTELLET PROP LAW, V11, P569, DOI 10.1093/jiplp/jpw087; UK Intellectual Property Office, 2010, PAYM ANN FEES ADD FE	13	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2018	361								k2318	10.1136/bmj.k2318	http://dx.doi.org/10.1136/bmj.k2318			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BY	29880536				2022-12-28	WOS:000435073900004
J	Van Zee, NJ; Adelizzi, B; Mabesoone, MFJ; Meng, X; Aloi, A; Zha, RH; Lutz, M; Filot, IAW; Palmans, ARA; Meijer, EW				Van Zee, Nathan J.; Adelizzi, Beatrice; Mabesoone, Mathijs F. J.; Meng, Xiao; Aloi, Antonio; Zha, R. Helen; Lutz, Martin; Filot, Ivo A. W.; Palmans, Anja R. A.; Meijer, E. W.			Potential enthalpic energy of water in oils exploited to control supramolecular structure	NATURE			English	Article							CRYSTAL-STRUCTURE; ORGANIC-SOLVENTS; DRIVING-FORCE; HYDROGEN-BOND; POLYMERS; POLYMERIZATION; ASSOCIATION; COMPLEXITY; TRISAMIDES; INTERFACES	Water directs the self-assembly of both natural(1,2) and synthetic(3-9) molecules to form precise yet dynamic structures. Nevertheless, our molecular understanding of the role of water in such systems is incomplete, which represents a fundamental constraint in the development of supramolecular materials for use in biomaterials, nanoelectronics and catalysis(10). In particular, despite the widespread use of alkanes as solvents in supramolecular chemistry(11,12), the role of water in the formation of aggregates in oils is not clear, probably because water is only sparingly miscible in these solvents typical alkanes contain less than 0.01 per cent water by weight at room temperature(13). A notable and unused feature of this water is that it is essentially monomeric(14). It has been determined previously(15) that the free energy cost of forming a cavity in alkanes that is large enough for a water molecule is only just compensated by its interaction with the interior of the cavity; this cost is therefore too high to accommodate clusters of water. As such, water molecules in alkanes possess potential enthalpic energy in the form of unrealized hydrogen bonds. Here we report that this energy is a thermodynamic driving force for water molecules to interact with co-dissolved hydrogen-bond based aggregates in oils. By using a combination of spectroscopic, calorimetric, light-scattering and theoretical techniques, we demonstrate that this interaction can be exploited to modulate the structure of one-dimensional supramolecular polymers.	[Van Zee, Nathan J.; Adelizzi, Beatrice; Mabesoone, Mathijs F. J.; Meng, Xiao; Aloi, Antonio; Zha, R. Helen; Filot, Ivo A. W.; Palmans, Anja R. A.; Meijer, E. W.] Eindhoven Univ Technol, Lab Macromol & Organ Chem, Inst Complex Mol Syst, Eindhoven, Netherlands; [Aloi, Antonio] Eindhoven Univ Technol, Lab Self Organizing Soft Matter, Eindhoven, Netherlands; [Lutz, Martin] Univ Utrecht, Bijvoet Ctr Biomol Res, Crystal & Struct Chem, Utrecht, Netherlands; [Filot, Ivo A. W.] Eindhoven Univ Technol, Inorgan Mat Chem, Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Utrecht University; Eindhoven University of Technology	Meijer, EW (corresponding author), Eindhoven Univ Technol, Lab Macromol & Organ Chem, Inst Complex Mol Syst, Eindhoven, Netherlands.	e.w.meijer@tue.nl	Mabesoone, Mathijs/AAC-8462-2019; Adelizzi, Beatrice/T-8104-2019; Meijer, E.W./K-7632-2013	Mabesoone, Mathijs/0000-0003-1314-7215; Palmans, Anja/0000-0002-7201-1548; Meijer, E.W./0000-0003-4126-7492	European Union's Horizon 2020 research and innovation program [705701]; Dutch Ministry of Education, Culture and Science's Gravitation program [024.001.035]; Netherlands Organization for Scientific Research	European Union's Horizon 2020 research and innovation program; Dutch Ministry of Education, Culture and Science's Gravitation program; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This project received funding from the European Union's Horizon 2020 research and innovation program (no. 705701) and the Dutch Ministry of Education, Culture and Science's Gravitation program (no. 024.001.035). The X-ray diffractometer was financed by the Netherlands Organization for Scientific Research. N.J.V.Z. acknowledges M. L. Sleczkowski for synthesizing the chiral amine precursor for 1, B. F. M. de Waal for assistance with Karl Fischer titrations and R. A. A. Bovee for performing MALDI-TOF MS measurements. We also thank S. C. J. Meskers, R. J. M. Nolte and A. J. Markvoort for discussions.	Adelizzi B, 2017, CHEM-EUR J, V23, P6103, DOI 10.1002/chem.201603938; Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Aloi A, 2016, NANOSCALE, V8, P8712, DOI 10.1039/c6nr00445h; Aloi A, 2016, J AM CHEM SOC, V138, P2953, DOI 10.1021/jacs.5b13585; Appel EA, 2010, J AM CHEM SOC, V132, P14251, DOI 10.1021/ja106362w; Arazoe H, 2016, NAT MATER, V15, P1084, DOI [10.1038/NMAT4693, 10.1038/nmat4693]; Berl V, 2000, NATURE, V407, P720, DOI 10.1038/35037545; Biedermann F, 2014, ANGEW CHEM INT EDIT, V53, P11158, DOI 10.1002/anie.201310958; Boekhoven J, 2010, ANGEW CHEM INT EDIT, V49, P4825, DOI 10.1002/anie.201001511; Brunsveld L, 2000, CHEM LETT, P292, DOI 10.1246/cl.2000.292; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Christian S. D., 1963, J CHEM EDUC, V40, P419; CHRISTIAN SD, 1970, Q REV CHEM SOC, V24, P20, DOI 10.1039/qr9702400020; De Greef TFA, 2009, CHEM REV, V109, P5687, DOI 10.1021/cr900181u; Filot IAW, 2010, J PHYS CHEM B, V114, P13667, DOI 10.1021/jp1072928; Fitie CFC, 2012, J PHYS CHEM B, V116, P3928, DOI 10.1021/jp300008f; Garcia F, 2013, CHEM COMMUN, V49, P8674, DOI 10.1039/c3cc43845g; GILLI G, 1989, J AM CHEM SOC, V111, P1023, DOI 10.1021/ja00185a035; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Iwamoto R, 2010, J PHYS CHEM A, V114, P7398, DOI 10.1021/jp102479t; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Johnson RS, 2007, J AM CHEM SOC, V129, P5735, DOI 10.1021/ja0706192; Lassettre EN, 1937, CHEM REV, V20, P259, DOI 10.1021/cr60066a004; Liu MH, 2015, CHEM REV, V115, P7304, DOI 10.1021/cr500671p; Louhichi A, 2017, J RHEOL, V61, P1173, DOI 10.1122/1.4997600; Markvoort AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1517; Mazik M, 2006, J ORG CHEM, V71, P7854, DOI 10.1021/jo0610309; MOHR SC, 1965, J AM CHEM SOC, V87, P3048, DOI 10.1021/ja01092a004; Nagornova NS, 2012, SCIENCE, V336, P320, DOI 10.1126/science.1218709; Rao KV, 2017, NAT CHEM, V9, P1133, DOI [10.1038/NCHEM.2812, 10.1038/nchem.2812]; Schreurs AMM, 2010, J APPL CRYSTALLOGR, V43, P70, DOI 10.1107/S0021889809043234; Sheldrick G.M., 2008, SADABS; Sheldrick GM, 2015, ACTA CRYSTALLOGR A, V71, P3, DOI 10.1107/S2053273314026370; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Smulders MMJ, 2008, J AM CHEM SOC, V130, P606, DOI 10.1021/ja075987k; Sorrenti A, 2017, CHEM SOC REV, V46, P5476, DOI 10.1039/c7cs00121e; Spek AL, 2009, ACTA CRYSTALLOGR D, V65, P148, DOI 10.1107/S090744490804362X; Suthagar K, 2015, EUR J MED CHEM, V102, P153, DOI 10.1016/j.ejmech.2015.07.050; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; van Gorp JJ, 2002, J AM CHEM SOC, V124, P14759, DOI 10.1021/ja020984n; WOLFENDEN R, 1994, SCIENCE, V265, P936, DOI 10.1126/science.8052849; Zhao DH, 2003, ORG BIOMOL CHEM, V1, P3471, DOI 10.1039/b308788c	44	80	80	13	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					100	+		10.1038/s41586-018-0169-0	http://dx.doi.org/10.1038/s41586-018-0169-0			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29849144				2022-12-28	WOS:000434273300044
J	Drew, L				Drew, Liam			The big hope for Huntington's	NATURE			English	Editorial Material							DISEASE	A quarter of a century after its discovery, researchers are finally unlocking ways to neutralize the gene behind Huntington's disease.										Dietrich P, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006846; DONISKELLER H, 1979, NUCLEIC ACIDS RES, V7, P179, DOI 10.1093/nar/7.1.179; Haque N, 1997, EXP NEUROL, V144, P139, DOI 10.1006/exnr.1996.6400; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Wang GH, 2016, P NATL ACAD SCI USA, V113, P3359, DOI 10.1073/pnas.1524575113; Wild EJ, 2015, J CLIN INVEST, V125, P1979, DOI 10.1172/JCI80743; ZAMECNIK PC, 1978, P NATL ACAD SCI USA, V75, P280, DOI 10.1073/pnas.75.1.280	7	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					S39	S41		10.1038/d41586-018-05176-z	http://dx.doi.org/10.1038/d41586-018-05176-z			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JJ2UO	29844556				2022-12-28	WOS:000494017700003
J	Kruger, RP				Kruger, Robert P.			Tracking Down and Interrogating Cancer's Holdouts	CELL			English	Editorial Material							MINIMAL RESIDUAL DISEASE; LEUKEMIA											Gokbuget N, 2018, BLOOD, V131, P1522, DOI 10.1182/blood-2017-08-798322; Jongen-Lavrencic M, 2018, NEW ENGL J MED, V378, P1189, DOI 10.1056/NEJMoa1716863	2	0	0	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1309	1309		10.1016/j.cell.2018.05.040	http://dx.doi.org/10.1016/j.cell.2018.05.040			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856946	Bronze			2022-12-28	WOS:000433989100001
J	Hawkes, N				Hawkes, Nigel			Changes to sharing medical records could damage research, report warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Evans H, 2018, USING DATA NHS IMPLI	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2018	361								k2371	10.1136/bmj.k2371	http://dx.doi.org/10.1136/bmj.k2371			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MF	29844098				2022-12-28	WOS:000434274800010
J	Adeli, K; Higgins, V; Trajcevski, K; Palmert, MR				Adeli, Khosrow; Higgins, Victoria; Trajcevski, Karin; Palmert, Mark R.			Important considerations for interpreting biochemical tests in children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PEDIATRIC REFERENCE INTERVALS; GERIATRIC AGES ESTABLISHMENT; ADULT REFERENCE INTERVALS; HEALTH MEASURES SURVEY; REFERENCE VALUES; CALIPER COHORT; MARKERS; CHALLENGES; DATABASE; HORMONES		[Adeli, Khosrow; Higgins, Victoria] Hosp Sick Children, Paediat Lab Med, CALIPER Program, Toronto, ON, Canada; [Adeli, Khosrow; Higgins, Victoria; Trajcevski, Karin] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Palmert, Mark R.] Hosp Sick Children, Div Endocrinol, Toronto, ON, Canada; [Palmert, Mark R.] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Palmert, Mark R.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Adeli, K (corresponding author), Hosp Sick Children, Paediat Lab Med, CALIPER Program, Toronto, ON, Canada.; Adeli, K (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	khosrow.adeli@sickkids.ca		Adeli, Khosrow/0000-0002-5839-5709				Adeli K, 2017, CLIN BIOCHEM, V50, P925, DOI 10.1016/j.clinbiochem.2017.06.006; Adeli K, 2015, CLIN CHEM, V61, P1063, DOI 10.1373/clinchem.2015.240523; Adeli K, 2015, CLIN CHEM, V61, P1049, DOI 10.1373/clinchem.2015.240515; Adeli K, 2015, CLIN CHEM, V61, P1075, DOI 10.1373/clinchem.2015.240531; [Anonymous], 2018, TIETZ TXB CLIN CHEM, V6th; [Anonymous], 2009, LAB MED PRACT GUID F; Bailey D, 2014, CLIN CHEM, V60, P518, DOI 10.1373/clinchem.2013.214312; Behrman R., 1992, NELSON TXB PEDIAT; Bidlingmaier M, 2014, J CLIN ENDOCR METAB, V99, P1712, DOI 10.1210/jc.2013-3059; CANDITO M, 1993, J CHROMATOGR-BIOMED, V617, P304, DOI 10.1016/0378-4347(93)80503-V; Cepeda-Lopez AC, 2010, INT J VITAM NUTR RES, V80, P263, DOI 10.1024/0300-9831/a000033; Ceriotti F, 2012, CLIN CHEM, V58, P808, DOI 10.1373/clinchem.2012.183483; Clifford SM, 2011, CLIN CHIM ACTA, V412, P788, DOI 10.1016/j.cca.2011.01.011; CLSI, 2010, EP28 A3C DEFINING ES, VThird; Coffin CM, 2002, AM J CLIN PATHOL, V117, P683; Colantonio DA, 2012, CLIN CHEM, V58, P854, DOI 10.1373/clinchem.2011.177741; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; ELIOT RJ, 1980, J PEDIATR-US, V96, P311; Estey MP, 2013, CLIN BIOCHEM, V46, P1197, DOI 10.1016/j.clinbiochem.2013.04.001; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Guignard JP, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.4.e49; Hilsted L, 2013, SCAND J CLIN LAB INV, V73, P1, DOI 10.3109/00365513.2012.721519; Jones Graham Rd, 2014, Clin Biochem Rev, V35, P243; Kahlmann V, 2017, EUR J PAEDIATR NEURO, V21, P654, DOI 10.1016/j.ejpn.2017.03.006; Kohse KP, 2014, CLIN BIOCHEM, V47, P742, DOI 10.1016/j.clinbiochem.2014.05.039; Konforte D, 2013, CLIN CHEM, V59, P1215, DOI 10.1373/clinchem.2013.204123; Kyriakopoulou L, 2013, CLIN BIOCHEM, V46, P642, DOI 10.1016/j.clinbiochem.2013.01.002; McCudden CR, 2017, CLIN CHEM, V63, P1856, DOI 10.1373/clinchem.2017.278267; PIPKIN FB, 1981, ARCH DIS CHILD, V56, P298, DOI 10.1136/adc.56.4.298; Pulgaron ER, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0508-y; Shaw JLV, 2013, CRIT REV CL LAB SCI, V50, P37, DOI 10.3109/10408363.2013.786673; Soldin OP, 2009, CLIN BIOCHEM, V42, P823, DOI 10.1016/j.clinbiochem.2009.01.015; Southcott EK, 2010, CLIN CHIM ACTA, V411, P1421, DOI 10.1016/j.cca.2010.06.018; Tate Jillian R, 2014, Clin Biochem Rev, V35, P213; Therrell BL, 2015, SEMIN PERINATOL, V39, P171, DOI 10.1053/j.semperi.2015.03.002	35	9	9	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2018	361								k1950	10.1136/bmj.k1950	http://dx.doi.org/10.1136/bmj.k1950			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH4XN	29798834				2022-12-28	WOS:000433416100002
J	Rubin, R				Rubin, Rita			Is Direct Primary Care a Game Changer?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material													Rubin, Rita/AAD-1259-2020						0	4	4	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2064	2066		10.1001/jama.2018.3173	http://dx.doi.org/10.1001/jama.2018.3173			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800153				2022-12-28	WOS:000432679400001
J	Slomski, A				Slomski, Anita			Hypertension Management in Barbershops	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2069	2069		10.1001/jama.2018.5866	http://dx.doi.org/10.1001/jama.2018.5866			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800174				2022-12-28	WOS:000432679400006
J	Rabinowitz, I				Rabinowitz, Ian			Risk for thrombosis in patients with myeloproliferative neoplasms was highest near the time of diagnosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Rabinowitz, Ian] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA	University of New Mexico	Rabinowitz, I (corresponding author), Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA.				Cancer Research Foundations of Radiumhemmet; Blodcancerfonden; Swedish Research Council; Adolf H. Lundin Charitable Foundation; Memorial Sloan Kettering Cancer Center	Cancer Research Foundations of Radiumhemmet; Blodcancerfonden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Adolf H. Lundin Charitable Foundation; Memorial Sloan Kettering Cancer Center	Cancer Research Foundations of Radiumhemmet; Blodcancerfonden; Swedish Research Council; Adolf H. Lundin Charitable Foundation; Memorial Sloan Kettering Cancer Center.	Kaifie A, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0242-9	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					JC57	JC57		10.7326/ACPJC-2018-168-10-057	http://dx.doi.org/10.7326/ACPJC-2018-168-10-057			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3DE	29800433				2022-12-28	WOS:000434250700009
J	Raja, AS				Raja, Ali S.			PERC strategy was noninferior to the usual strategy for ruling out PE in low-risk patients in the ED	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RULE-OUT CRITERIA		[Raja, Ali S.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Raja, AS (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA.		Raja, Ali S./AAE-5103-2019		Programme Hospitalier de Recherche Clinique; Assistance Publique-Hopitaux de Paris	Programme Hospitalier de Recherche Clinique; Assistance Publique-Hopitaux de Paris	Programme Hospitalier de Recherche Clinique and Assistance Publique-Hopitaux de Paris.	Buchanan I, 2017, ACAD EMERG MED, V24, P1369, DOI 10.1111/acem.13270; Carpenter CR, 2015, ACAD EMERG MED, V22, P1484, DOI 10.1111/acem.12820; Raja AS, 2015, ANN INTERN MED, V163, P701, DOI 10.7326/M14-1772; Singh B, 2012, ANN EMERG MED, V59, P517, DOI 10.1016/j.annemergmed.2011.10.022	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					JC54	JC54		10.7326/ACPJC-2018-168-10-054	http://dx.doi.org/10.7326/ACPJC-2018-168-10-054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3DE	29800430				2022-12-28	WOS:000434250700006
J	Griesmann, M; Chang, Y; Liu, X; Song, Y; Haberer, G; Crook, MB; Billault-Penneteau, B; Lauressergues, D; Keller, J; Imanishi, L; Roswanjaya, YP; Kohlen, W; Pujic, P; Battenberg, K; Alloisio, N; Liang, YH; Hilhorst, H; Salgado, MG; Hocher, V; Gherbi, H; Svistoonoff, S; Doyle, JJ; He, SX; Xu, Y; Xu, SY; Qu, J; Gao, Q; Fang, XD; Fu, Y; Normand, P; Berry, AM; Wall, LG; Ane, JM; Pawlowski, K; Xu, X; Yang, HM; Spannagl, M; Mayer, KFX; Wong, GKS; Parniske, M; Delaux, PM; Cheng, SF				Griesmann, Maximilian; Chang, Yue; Liu, Xin; Song, Yue; Haberer, Georg; Crook, Matthew B.; Billault-Penneteau, Benjamin; Lauressergues, Dominique; Keller, Jean; Imanishi, Leandro; Roswanjaya, Yuda Purwana; Kohlen, Wouter; Pujic, Petar; Battenberg, Kai; Alloisio, Nicole; Liang, Yuhu; Hilhorst, Henk; Salgado, Marco G.; Hocher, Valerie; Gherbi, Hassen; Svistoonoff, Sergio; Doyle, Jeff J.; He, Shixu; Xu, Yan; Xu, Shanyun; Qu, Jing; Gao, Qiang; Fang, Xiaodong; Fu, Yuan; Normand, Philippe; Berry, Alison M.; Wall, Luis G.; Ane, Jean-Michel; Pawlowski, Katharina; Xu, Xun; Yang, Huanming; Spannagl, Manuel; Mayer, Klaus F. X.; Wong, Gane Ka-Shu; Parniske, Martin; Delaux, Pierre-Marc; Cheng, Shifeng			Phylogenomics reveals multiple losses of nitrogen-fixing root nodule symbiosis	SCIENCE			English	Article							ARBUSCULAR MYCORRHIZA; PHYLOGENETIC ANALYSIS; SEQUENCE ALIGNMENT; GENOME; EVOLUTION; GENE; INFERENCE; FIXATION; ORIGINS; NIN		[Griesmann, Maximilian; Billault-Penneteau, Benjamin; Parniske, Martin] Ludwig Maximilians Univ Munchen, Fac Biol, Genet, Grosshaderner Str 2-4, D-82152 Martinsried, Germany; [Griesmann, Maximilian; Haberer, Georg; Spannagl, Manuel; Mayer, Klaus F. X.] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, PGSB, D-85764 Neuherberg, Germany; [Chang, Yue; Liu, Xin; Song, Yue; Liang, Yuhu; He, Shixu; Xu, Yan; Xu, Shanyun; Qu, Jing; Gao, Qiang; Fang, Xiaodong; Fu, Yuan; Xu, Xun; Yang, Huanming; Wong, Gane Ka-Shu; Cheng, Shifeng] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Chang, Yue; Liu, Xin; Song, Yue; Liang, Yuhu; He, Shixu; Xu, Yan; Xu, Shanyun; Qu, Jing; Fu, Yuan; Xu, Xun; Cheng, Shifeng] BGI Shenzhen, China Natl GeneBank, Shenzhen 518120, Peoples R China; [Crook, Matthew B.] Weber State Univ, Dept Microbiol, Ogden, UT 84408 USA; [Lauressergues, Dominique; Keller, Jean; Delaux, Pierre-Marc] Univ Toulouse, LRSV, CNRS, UPS, 24 Chemin Borde Rouge,BP42617, F-31326 Castanet Tolosan, France; [Imanishi, Leandro; Wall, Luis G.] Univ Nacl Quilmes, CONICET, Dept Ciencia & Tecnol, LBMIBS, R Saenz Pena 352,B1876BXD, Bernal, Argentina; [Roswanjaya, Yuda Purwana; Kohlen, Wouter] Wageningen Univ, Mol Biol Lab, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands; [Pujic, Petar; Alloisio, Nicole; Normand, Philippe] Univ Lyon 1, Univ Lyon, CNRS, UMR 5557,Ecol Microbienne, F-69622 Villeurbanne, France; [Battenberg, Kai; Berry, Alison M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Hilhorst, Henk] Wageningen Univ, Lab Plant Physiol, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands; [Salgado, Marco G.; Pawlowski, Katharina] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Hocher, Valerie; Gherbi, Hassen; Svistoonoff, Sergio] Univ Montpellier, French Natl Res Inst Sustainable Dev IRD, UMR LSTM, IRD,INRA,CIRAD,Supagro, Campus Int Baillarguet,TA A-82-J, F-34398 Montpellier 5, France; [Doyle, Jeff J.] Cornell Univ, Sch Integrated Plant Sci, Sect Plant Breeding & Genet, Ithaca, NY 14853 USA; [Gao, Qiang; Fang, Xiaodong] BGI Shenzhen, BGI Genom, Shenzhen 518083, Peoples R China; [Ane, Jean-Michel] Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA; [Ane, Jean-Michel] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Mayer, Klaus F. X.] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Wong, Gane Ka-Shu] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Wong, Gane Ka-Shu] Univ Alberta, Dept Med, Edmonton, AB T6G 2E, Canada	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Utah System of Higher Education; Weber State University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Wageningen University & Research; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; University of California System; University of California Davis; Wageningen University & Research; Stockholm University; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Cornell University; Beijing Genomics Institute (BGI); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Technical University of Munich; University of Alberta; University of Alberta	Parniske, M (corresponding author), Ludwig Maximilians Univ Munchen, Fac Biol, Genet, Grosshaderner Str 2-4, D-82152 Martinsried, Germany.; Cheng, SF (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.; Cheng, SF (corresponding author), BGI Shenzhen, China Natl GeneBank, Shenzhen 518120, Peoples R China.; Delaux, PM (corresponding author), Univ Toulouse, LRSV, CNRS, UPS, 24 Chemin Borde Rouge,BP42617, F-31326 Castanet Tolosan, France.	parniske@lmu.de; pierre-marc.delaux@lrsv.ups-tlse.fr; chengshf@genomics.cn	Fang, Xiaodong/K-6743-2018; Hilhorst, Henk/K-1658-2013; Liang, Yuhu/CAH-0791-2022; Parniske, Martin/M-3781-2019; SVISTOONOFF, Sergio/X-9659-2019; Pujic, Petar/ACY-1850-2022; WONG, Gane Ka-Shu/G-5784-2013; Xu, Xun/AAI-6763-2020; Bagher, Saeed/U-1068-2019; Ané, Jean-Michel/G-5921-2010; Normand, Philippe/ABD-2235-2020; Parniske, Martin/F-2202-2011	Fang, Xiaodong/0000-0001-7061-3337; Parniske, Martin/0000-0001-8561-747X; SVISTOONOFF, Sergio/0000-0001-8554-2922; Pujic, Petar/0000-0003-1957-8534; WONG, Gane Ka-Shu/0000-0001-6108-5560; Xu, Xun/0000-0002-5338-5173; Ané, Jean-Michel/0000-0002-3128-9439; Normand, Philippe/0000-0002-2139-2141; Parniske, Martin/0000-0001-8561-747X; Haberer, Georg/0000-0002-6612-6939; GHERBI, Hassen/0000-0001-9473-9364; Crook, Matthew/0000-0002-4023-160X; Spannagl, Manuel/0000-0003-0701-7035; hilhorst, henk/0000-0002-6743-583X; Billault-Penneteau, Benjamin/0000-0002-1886-0557; Liu, Xin/0000-0003-3256-2940; Keller, Jean/0000-0002-5198-0331; Roswanjaya, Yuda Purwana/0000-0002-8195-8100; Pawlowski, Katharina/0000-0003-2693-885X; Delaux, Pierre-Marc/0000-0002-6211-157X; Liang, Yuhu/0000-0001-7489-6928; Song, Yue/0000-0002-2974-6442	Shenzhen Municipal Government of China [JCYJ20150529150409546, JCYJ20150831201643396]; Swedish Research Council Vetenskapsradet [VR 2012-03061]; German Ministry of Education and Research grant [031A536]; Deutsche Forschungsgemeinschaft Project [SFB924]; National Science Foundation [NSF 1237936, 1546742]; French National Research Agency [ANR-12-BSV7-0007-02]; USDA [NIFA 2015-67014-22849, NIFA590 CA-D-PLS-2173-H]; ECOS-SUD [A13B03]; National University of Quilmes, Argentina [PUNQ 1411/15]; NWO-VENI [863.15.010]; Alberta Innovates Technology Futures (AITF) Innovates Centres of Research Excellence (iCORE); ERC Advanced grant [340904]	Shenzhen Municipal Government of China; Swedish Research Council Vetenskapsradet(Swedish Research Council); German Ministry of Education and Research grant; Deutsche Forschungsgemeinschaft Project; National Science Foundation(National Science Foundation (NSF)); French National Research Agency(French National Research Agency (ANR)); USDA(United States Department of Agriculture (USDA)); ECOS-SUD; National University of Quilmes, Argentina; NWO-VENI(Netherlands Organization for Scientific Research (NWO)); Alberta Innovates Technology Futures (AITF) Innovates Centres of Research Excellence (iCORE); ERC Advanced grant(European Research Council (ERC))	This work was partly performed in the LRSV, which belongs to the TULIP LABEX (ANR-10-LABX-41), and was supported by grants from the Shenzhen Municipal Government of China to S.C. (JCYJ20150529150409546) and Y.C. (JCYJ20150831201643396); a grant from the Swedish Research Council Vetenskapsradet (VR 2012-03061) to K.P.; the German Ministry of Education and Research grant 031A536 "de.NBI" and the Deutsche Forschungsgemeinschaft Project SFB924 to K.F.X.M. and M.P.; grants from the National Science Foundation (NSF 1237936 and 1546742) to J.-M.A.; grants from the French National Research Agency (ANR-12-BSV7-0007-02), the USDA (NIFA 2015-67014-22849), and ECOS-SUD (A13B03) to V.H., H.G., and S.S.; a grant from the National University of Quilmes, Argentina (PUNQ 1411/15) to L.G.W.; and by USDA grant NIFA590 CA-D-PLS-2173-H to A.M.B. W.K. is supported by NWO-VENI (863.15.010), and L.G.W. and L.I. are members of CONICET (Argentina). G.K.-S.W. is funded by Alberta Innovates Technology Futures (AITF) Innovates Centres of Research Excellence (iCORE). M.P. acknowledges funding by ERC Advanced grant 340904 (EvolvingNodules), which supported the work of M.G. and B.B.-P. and the sabbatical stay of K.P. at the LMU Munich.	Albalat R, 2016, NAT REV GENET, V17, P379, DOI 10.1038/nrg.2016.39; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Arratia R, 1996, J COMPUT BIOL, V3, P425, DOI 10.1089/cmb.1996.3.425; Arrighi JF, 2008, P NATL ACAD SCI USA, V105, P9817, DOI 10.1073/pnas.0710273105; Azani N, 2017, TAXON, V66, P44, DOI 10.12705/661.3; Beatty PH, 2011, SCIENCE, V333, P416, DOI 10.1126/science.1209467; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Borisov AY, 2003, PLANT PHYSIOL, V131, P1009, DOI 10.1104/pp.102.016071; Bravo A, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2015.208, 10.1038/NPLANTS.2015.208]; Campbell MS, 2014, PLANT PHYSIOL, V164, P513, DOI 10.1104/pp.113.230144; Carro L, 2013, J BIOSCIENCES, V38, P685, DOI 10.1007/s12038-013-9359-y; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CHANDLER MR, 1978, J EXP BOT, V29, P749, DOI 10.1093/jxb/29.3.749; Clavijo F, 2015, NEW PHYTOL, V208, P887, DOI 10.1111/nph.13506; Conn CE, 2015, SCIENCE, V349, P540, DOI 10.1126/science.aab1140; Criscuolo G, 2012, PLANT CELL ENVIRON, V35, P1567, DOI 10.1111/j.1365-3040.2012.02510.x; De Mita S, 2014, NEW PHYTOL, V201, P961, DOI 10.1111/nph.12549; Delaux PM, 2015, CURR OPIN PLANT BIOL, V26, P95, DOI 10.1016/j.pbi.2015.06.003; Delaux PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004487; Hoang DT, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1131-3; Dos Santos PC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-162; Doyle JJ, 2016, AM J BOT, V103, P1865, DOI 10.3732/ajb.1600260; Doyle JJ, 2011, MOL PLANT MICROBE IN, V24, P1289, DOI 10.1094/MPMI-05-11-0114; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 2003, SCIENCE, V300, P1706, DOI 10.1126/science.1086292; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Favre P, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0333-0; Fujita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093670; Gherbi H, 2008, P NATL ACAD SCI USA, V105, P4928, DOI 10.1073/pnas.0710618105; GORBET DW, 1979, CROP SCI, V19, P727, DOI 10.2135/cropsci1979.0011183X001900050045x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Griesmann M., 2018, GIGADB, DOI [10.5524/100300, DOI 10.5524/100300]; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Han MV, 2013, MOL BIOL EVOL, V30, P1987, DOI 10.1093/molbev/mst100; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; He J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-441; Hellriegel H., 1888, UNTERSUCHUNGEN STICK; Hiltner L, 1895, LANDWIRTSCHAFTLICHE, V46, P153; Hubley R., 2013, REPEATMASKER OPEN 40; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Johnson MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033666; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Kistner C, 2002, TRENDS PLANT SCI, V7, P511, DOI 10.1016/S1360-1385(02)02356-7; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Li HL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14023; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Markmann K, 2008, PLOS BIOL, V6, P497, DOI 10.1371/journal.pbio.0060068; Marsh JF, 2007, PLANT PHYSIOL, V144, P324, DOI 10.1104/pp.106.093021; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nagy LG, 2017, CURR BIOL, V27, pR609, DOI 10.1016/j.cub.2017.04.032; Nagy LG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5471; O'Malley MA, 2016, TRENDS ECOL EVOL, V31, P608, DOI 10.1016/j.tree.2016.04.004; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Pawlowski K, 2012, PROTOPLASMA, V249, P967, DOI 10.1007/s00709-012-0388-4; PENG Z, 2017, SCI REP, V7; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Solovyev V., 2008, HDB STAT GENETICS, P97; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Sprent J.I., 2009, LEGUME NODULATION GL; Sprent JI, 2007, NEW PHYTOL, V174, P11, DOI 10.1111/j.1469-8137.2007.02015.x; Sprent JI, 2017, NEW PHYTOL, V215, P40, DOI 10.1111/nph.14474; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; STREETER J, 1988, CRIT REV PLANT SCI, V7, P1, DOI 10.1080/07352688809382257; Svistoonoff S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064515; Swensen S. M., 2008, V6, P73, DOI 10.1007/978-1-4020-3547-0_4; Swensen SM, 1996, AM J BOT, V83, P1503, DOI 10.2307/2446104; Tan G, 2015, SYST BIOL, V64, P778, DOI 10.1093/sysbio/syv033; van Velzen R, 2018, P NATL ACAD SCI USA, V115, pE4700, DOI 10.1073/pnas.1721395115; van Zeijl A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00284; Veeckman E, 2016, PLANT CELL, V28, P1759, DOI 10.1105/tpc.16.00349; Werner GDA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5087; Xi ZX, 2012, P NATL ACAD SCI USA, V109, P17519, DOI 10.1073/pnas.1205818109; Yang Y, 2014, MOL BIOL EVOL, V31, P3081, DOI 10.1093/molbev/msu245; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zgadzaj R, 2016, P NATL ACAD SCI USA, V113, pE7996, DOI 10.1073/pnas.1616564113	95	181	187	20	269	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2018	361	6398							eaat1743	10.1126/science.aat1743	http://dx.doi.org/10.1126/science.aat1743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8DY	29794220				2022-12-28	WOS:000438449200035
J	Reddy, KS				Reddy, K. Srinath			Health Care Reforms in India	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Reddy, K. Srinath] Publ Hlth Fdn India, Delhi, India	Public Health Foundation of India	Reddy, KS (corresponding author), Publ Hlth Fdn India, Bldg 47,Sect 44, Gurugram 122002, India.	ksrinath.reddy@phfi.org		Reddy, K Srinath/0000-0003-3416-3548				Ahuja R, 2018, FINANCIAL EXPRESS; Central Bureau of Health Intelligence, NAT HLTH PROF; Ministry of Health and Family Welfare, NAT HLTH POL 2017; Planning Commission of India, 2011, HIGH LEV EXP GROUP R; Ravi S, 2016, HLTH MORBIDTY INDIA; Reddy KS, 2018, FINANCIAL EXPRESS; Reddy KS, 2018, HINDU	7	13	13	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2018	319	24					2477	2478		10.1001/jama.2018.5284	http://dx.doi.org/10.1001/jama.2018.5284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK6ZP	29800246				2022-12-28	WOS:000436342700015
J	Clayton, JA				Clayton, Janine A.			Dry Eye	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HORMONE REPLACEMENT THERAPY; MEIBOMIAN GLAND DYSFUNCTION; OCULAR SURFACE; POSTMENOPAUSAL WOMEN; ESTROGEN-RECEPTORS; UTILITY-ASSESSMENT; ANDROGEN RECEPTOR; EXTRACELLULAR DNA; MESSENGER-RNA; FATTY-ACIDS		[Clayton, Janine A.] NIH, Off Res Womens Hlth, 6707 Democracy Blvd,Suite 400, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Clayton, JA (corresponding author), NIH, Off Res Womens Hlth, 6707 Democracy Blvd,Suite 400, Bethesda, MD 20892 USA.	Janine.Clayton@nih.gov		Clayton, Janine/0000-0003-2981-3622				Adatia FA, 2004, CAN J OPHTHALMOL, V39, P767, DOI 10.1016/S0008-4182(04)80071-1; Agarwal P, 2016, DRUG DISCOV TODAY, V21, P977, DOI 10.1016/j.drudis.2016.04.002; Anitua E, 2015, ACTA OPHTHALMOL, V93, pE605, DOI 10.1111/aos.12710; Arita R, 2016, INVEST OPHTH VIS SCI, V57, P3928, DOI 10.1167/iovs.16-19788; Askeroglu U, 2013, PLAST RECONSTR SURG, V131, P159, DOI 10.1097/PRS.0b013e318272a00e; Baudouin C, 1999, OPHTHALMOLOGY, V106, P556, DOI 10.1016/S0161-6420(99)90116-1; Benitez-Del-Castillo J, 2017, OCUL SURF, V15, P169, DOI 10.1016/j.jtos.2016.11.003; Bremond-Gignac D, 2014, EXPERT OPIN DRUG MET, V10, P905, DOI 10.1517/17425255.2014.915026; Bron A J, 2004, Ocul Surf, V2, P149; Bron AJ, 2014, OCUL SURF, V12, pS1, DOI 10.1016/j.jtos.2014.02.002; Buchholz P, 2006, OCUL SURF, V4, P155, DOI 10.1016/S1542-0124(12)70043-5; Colligris B, 2014, EXPERT OPIN PHARMACO, V15, P1371, DOI 10.1517/14656566.2014.914492; Coursey TG, 2015, J CONTROL RELEASE, V213, P168, DOI 10.1016/j.jconrel.2015.07.007; Coursey TG, 2014, J IMMUNOL, V193, P5264, DOI 10.4049/jimmunol.1400016; Craig JP, 2017, OCUL SURF, V15, P802, DOI 10.1016/j.jtos.2017.08.003; Craig JP, 2017, OCUL SURF, V15, P276, DOI 10.1016/j.jtos.2017.05.008; Cumberland PM, 2015, J CATARACT REFR SURG, V41, P2466, DOI 10.1016/j.jcrs.2015.05.040; De Paiva CS, 2006, EXP EYE RES, V83, P526, DOI 10.1016/j.exer.2006.02.004; Deinema LA, 2017, OPHTHALMOLOGY, V124, P43, DOI 10.1016/j.ophtha.2016.09.023; Dogru M, 2013, EXPERT OPIN INV DRUG, V22, P1581, DOI 10.1517/13543784.2013.838557; Dry Eye Assessment Management Stud, 2018, NEW ENGL J MED, V378, P1681, DOI 10.1056/NEJMoa1709691; Esmaeli B, 2000, OPHTHALMOLOGY, V107, P180, DOI 10.1016/S0161-6420(99)00040-8; Fini ME, 2016, EXP EYE RES, V147, P57, DOI 10.1016/j.exer.2016.04.019; Fogt JS, 2016, CLIN OPHTHALMOL, V10, P2237, DOI 10.2147/OPTH.S120158; Foulks Gary N, 2003, Ocul Surf, V1, P107; Fraunfelder FT, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/285851; Fuchsjager-Mayri G, 2002, INVEST OPHTH VIS SCI, V43, P2841; Galor A, 2015, EYE, V29, P301, DOI 10.1038/eye.2014.263; Golebiowski B, 2012, OPTOMETRY VISION SCI, V89, P1443, DOI 10.1097/OPX.0b013e3182693cef; Goyal S, 2016, SEMIN OPHTHALMOL, V31, P59, DOI 10.3109/08820538.2015.1114853; Hartstein I, 2005, CURR MED RES OPIN, V21, P255, DOI 10.1185/030079905X26252; Hessen Michelle, 2014, J Ophthalmic Vis Res, V9, P240; Kaiserman I, 2005, AM J OPHTHALMOL, V139, P498, DOI 10.1016/j.ajo.2004.10.022; KARSON CN, 1984, NEUROLOGY, V34, P677, DOI 10.1212/WNL.34.5.677; Kim YJ, 2016, CORNEA, V35, P536, DOI 10.1097/ICO.0000000000000756; Lee YB, 2014, INVEST OPHTH VIS SCI, V55, P3525, DOI 10.1167/iovs.14-13881; Li DQ, 2004, INVEST OPHTH VIS SCI, V45, P4302, DOI 10.1167/iovs.04-0299; Lim A, 2015, TRENDS MOL MED, V21, P736, DOI 10.1016/j.molmed.2015.10.001; Ljubimov AV, 2017, VISION RES, V139, P138, DOI 10.1016/j.visres.2017.03.002; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; Marin-Castano ME, 2003, INVEST OPHTH VIS SCI, V44, P50, DOI 10.1167/iovs.01-1276; Marshall Leisa L, 2016, Consult Pharm, V31, P96, DOI 10.4140/TCP.n.2016.96; Mastrota KM, 2008, OPTOMETRY VISION SCI, V85, P814, DOI 10.1097/OPX.0b013e3181852777; Mcmonnies Charles W, 2017, J Optom, V10, P5, DOI 10.1016/j.optom.2016.06.002; McNamara NA, 2014, INVEST OPHTH VIS SCI, V55, P7079, DOI 10.1167/iovs.14-14828; Messmer EM, 2016, OPHTHALMOLOGY, V123, P2300, DOI 10.1016/j.ophtha.2016.07.028; Messmer EM, 2015, DTSCH ARZTEBL INT, V112, P71, DOI 10.3238/arztebl.2015.0071; Miljanovic B, 2005, AM J CLIN NUTR, V82, P887, DOI 10.1093/ajcn/82.4.887; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Morgan PB, 2013, CONT LENS SPECTR, V28, P31; Morrow GL, 1998, AM FAM PHYSICIAN, V57, P735; Moshirfar M, 2014, CLIN OPHTHALMOL, V8, P1419, DOI 10.2147/OPTH.S65263; Nakamori K, 1997, AM J OPHTHALMOL, V124, P24, DOI 10.1016/S0002-9394(14)71639-3; Narayanaswamy A, 2015, JAMA OPHTHALMOL, V133, P206, DOI 10.1001/jamaophthalmol.2014.4893; Nassiri Nariman, 2013, J Ophthalmic Vis Res, V8, P351; Nelson JD, 2011, INVEST OPHTH VIS SCI, V52, P1930, DOI 10.1167/iovs.10-6997b; Ogawa Y, 2003, INVEST OPHTH VIS SCI, V44, P1888, DOI 10.1167/iovs.02-0699; Pinheiro Jr. Manuel Neuzimar, 2007, Arq. Bras. Oftalmol., V70, P649, DOI 10.1590/S0004-27492007000400016; Rocha EM, 2013, CURR OPIN OPHTHALMOL, V24, P348, DOI 10.1097/ICU.0b013e32836227bf; Rocha EM, 2000, BRIT J OPHTHALMOL, V84, P76, DOI 10.1136/bjo.84.1.76; Rosin LM, 2013, CLIN OPHTHALMOL, V7, P2131, DOI 10.2147/OPTH.S41358; Sall K, 2000, OPHTHALMOLOGY, V107, P631, DOI 10.1016/S0161-6420(99)00176-1; Savini G, 2008, CLIN OPHTHALMOL, V2, P31; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2001, JAMA-J AM MED ASSOC, V286, P2114, DOI 10.1001/jama.286.17.2114; Schiffman RM, 2003, OPHTHALMOLOGY, V110, P1412, DOI 10.1016/S0161-6420(03)00462-7; Scuderi G, 2012, CAN J OPHTHALMOL, V47, P489, DOI 10.1016/j.jcjo.2012.08.019; Seifart U., 1994, Ophthalmologe, V91, P235; Sj_ogren H.., 1933, ACTA OPHTHALMOL, P1; Smith JA, 2004, ARCH OPHTHALMOL-CHIC, V122, P151, DOI 10.1001/archopht.122.2.151; Smith JA, 2007, OCUL SURF, V5, P93; Smith RE, 1999, CURR EYE RES, V18, P300, DOI 10.1076/ceyr.18.4.300.5362; Sonawane S, 2012, INVEST OPHTH VIS SCI, V53, P8253, DOI 10.1167/iovs.12-10430; Sriprasert I, 2016, MENOPAUSE, V23, P343, DOI 10.1097/GME.0000000000000530; Stern ME, 2004, EXP EYE RES, V78, P409, DOI 10.1016/j.exer.2003.09.003; Sullivan BD, 2002, ARCH OPHTHALMOL-CHIC, V120, P1689; Sullivan BD, 2000, J CLIN ENDOCR METAB, V85, P4866, DOI 10.1210/jc.85.12.4866; Sullivan BD, 2012, CORNEA, V31, P1000, DOI 10.1097/ICO.0b013e318242fd60; Sullivan DA, 2002, ANN NY ACAD SCI, V966, P211, DOI 10.1111/j.1749-6632.2002.tb04217.x; Suzuki T, 2001, CURR EYE RES, V22, P28, DOI 10.1076/ceyr.22.1.28.6980; Tachibana M, 2000, INVEST OPHTH VIS SCI, V41, P64; Tibrewal S, 2014, INVEST OPHTH VIS SCI, V55, P7961, DOI 10.1167/iovs.14-15332; Tibrewal S, 2013, INVEST OPHTH VIS SCI, V54, P8051, DOI 10.1167/iovs.13-12844; TSUBOTA K, 1995, ARCH OPHTHALMOL-CHIC, V113, P155, DOI 10.1001/archopht.1995.01100020037025; Uncu G, 2006, GYNECOL ENDOCRINOL, V22, P501, DOI 10.1080/09513590600917919; Vehof J, 2014, INVEST OPHTH VIS SCI, V55, P7278, DOI 10.1167/iovs.14-15200; Vora GK, 2015, CURR OPIN OPHTHALMOL, V26, P314, DOI 10.1097/ICU.0000000000000166; Wang MTM, 2015, OPTOMETRY VISION SCI, V92, pE321, DOI 10.1097/OPX.0000000000000601; Wojtowicz JC, 2011, CORNEA, V30, P308, DOI 10.1097/ICO.0b013e3181f22e03; Wolffsohn JS, 2017, OCUL SURF, V15, P539, DOI 10.1016/j.jtos.2017.05.001; Yu JH, 2011, CORNEA, V30, P379, DOI 10.1097/ICO.0b013e3181f7f363; Zhu W, 2014, NUTR REV, V72, P662, DOI 10.1111/nure.12145	92	121	127	10	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2018	378	23					2212	2223		10.1056/NEJMra1407936	http://dx.doi.org/10.1056/NEJMra1407936			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3HS	29874529				2022-12-28	WOS:000434263000009
J	Seneviratne, SI; Rogelj, J; Seferian, R; Wartenburger, R; Allen, MR; Cain, M; Millar, RJ; Ebi, KL; Ellis, N; Hoegh-Guldberg, O; Payne, AJ; Schleussner, CF; Tschakert, P; Warren, RF				Seneviratne, Sonia, I; Rogelj, Joeri; Seferian, Roland; Wartenburger, Richard; Allen, Myles R.; Cain, Michelle; Millar, Richard J.; Ebi, Kristie L.; Ellis, Neville; Hoegh-Guldberg, Ove; Payne, Antony J.; Schleussner, Carl-Friedrich; Tschakert, Petra; Warren, Rachel F.			The many possible climates from the Paris Agreement's aim of 1.5 degrees C warming	NATURE			English	Article							CUMULATIVE CARBON EMISSIONS; GLOBAL MEAN TEMPERATURE; EXTREMES; MITIGATION; MODELS; CONSEQUENCES; MANAGEMENT; SCENARIOS; PATHWAYS; INCREASE	The United Nations' Paris Agreement includes the aim of pursuing efforts to limit global warming to only 1.5 degrees C above pre-industrial levels. However, it is not clear what the resulting climate would look like across the globe and over time. Here we show that trajectories towards a '1.5 degrees C warmer world' may result in vastly different outcomes at regional scales, owing to variations in the pace and location of climate change and their interactions with society's mitigation, adaptation and vulnerabilities to climate change. Pursuing policies that are considered to be consistent with the 1.5 degrees C aim will not completely remove the risk of global temperatures being much higher or of some regional extremes reaching dangerous levels for ecosystems and societies over the coming decades.	[Seneviratne, Sonia, I; Rogelj, Joeri; Wartenburger, Richard] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Zurich, Switzerland; [Rogelj, Joeri] Int Inst Appl Syst Anal, Laxenburg, Austria; [Rogelj, Joeri; Allen, Myles R.; Cain, Michelle; Millar, Richard J.] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford, England; [Rogelj, Joeri] Imperial Coll London, Grantham Inst, London, England; [Seferian, Roland] CNRS, Ctr Natl Rech Meteorol, Meteo France, Toulouse, France; [Ebi, Kristie L.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Ellis, Neville; Tschakert, Petra] Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia; [Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, Brisbane, Qld, Australia; [Payne, Antony J.] Univ Bristol, Bristol, Avon, England; [Schleussner, Carl-Friedrich] Climate Analyt, Berlin, Germany; [Schleussner, Carl-Friedrich] Humboldt Univ, IRITHESys, Berlin, Germany; [Schleussner, Carl-Friedrich] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Warren, Rachel F.] Univ East Anglia, Sch Environm Sci, Tyndall Ctr Climate Change, Norwich, Norfolk, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; International Institute for Applied Systems Analysis (IIASA); University of Oxford; Imperial College London; Centre National de la Recherche Scientifique (CNRS); University of Washington; University of Washington Seattle; University of Western Australia; University of Queensland; University of Bristol; Humboldt University of Berlin; Potsdam Institut fur Klimafolgenforschung; University of East Anglia	Seneviratne, SI (corresponding author), Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Zurich, Switzerland.	sonia.seneviratne@ethz.ch; roland.seferian@meteo.fr; richard.wartenburger@env.ethz.ch	Cain, Michelle/AAX-4672-2021; Rogelj, Joeri/I-7108-2012; payne, antony/A-8916-2008; Seneviratne, Sonia I./G-8761-2011; Hoegh-Guldberg, Ove/ABA-5420-2020; Séférian, Roland/ABD-5465-2021	Cain, Michelle/0000-0003-2062-6556; Rogelj, Joeri/0000-0003-2056-9061; payne, antony/0000-0001-8825-8425; Seneviratne, Sonia I./0000-0001-9528-2917; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Séférian, Roland/0000-0002-2571-2114; Schleussner, Carl-Friedrich/0000-0001-8471-848X; Warren, Rachel/0000-0002-0122-1599; Tschakert, Petra/0000-0002-4268-3378	European Community's Seventh Framework Programme [FP7-IDEAS-ERC-617518]; Oxford Martin School Visiting Fellowship programme; European Union's H2020 project CRESCENDO "Coordinated Research in Earth Systems and Climate: Experiments, kNowledge, Dissemination and Outreach" [H2020-641816]; Australia Research Council Laureate program; NERC [NE/F016107/1] Funding Source: UKRI	European Community's Seventh Framework Programme(European Commission); Oxford Martin School Visiting Fellowship programme; European Union's H2020 project CRESCENDO "Coordinated Research in Earth Systems and Climate: Experiments, kNowledge, Dissemination and Outreach"; Australia Research Council Laureate program; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	S.I.S. and R.W. acknowledge the European Research Council (ERC) 'DROUGHT-HEAT' project funded by the European Community's Seventh Framework Programme (grant agreement FP7-IDEAS-ERC-617518). J.R. acknowledges the Oxford Martin School Visiting Fellowship programme for support. R.S. acknowledges the European Union's H2020 project CRESCENDO "Coordinated Research in Earth Systems and Climate: Experiments, kNowledge, Dissemination and Outreach" (grant agreement H2020-641816). O.H.G. acknowledges support of the Australia Research Council Laureate program. This work contributes to the World Climate Research Programme (WCRP) Grand Challenge on Extremes. We acknowledge the WCRP Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups for producing and making available their model output. For CMIP the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	Adger WN, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P755; AghaKouchak A, 2014, GEOPHYS RES LETT, V41, P8847, DOI 10.1002/2014GL062308; Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Beckage B, 2018, NAT CLIM CHANGE, V8, P79, DOI 10.1038/s41558-017-0031-7; Boucher O, 2009, CLIMATIC CHANGE, V92, P261, DOI 10.1007/s10584-008-9489-7; Bowerman NHA, 2011, PHILOS T R SOC A, V369, P45, DOI 10.1098/rsta.2010.0288; Boysen LR, 2017, EARTHS FUTURE, V5, P463, DOI 10.1002/2016EF000469; Byers E, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabf45; Clark PU, 2016, NAT CLIM CHANGE, V6, P360, DOI 10.1038/NCLIMATE2923; Clarke L, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P413; Cowtan K, 2014, Q J ROY METEOR SOC, V140, P1935, DOI 10.1002/qj.2297; Davis NA, 2016, ATMOS CHEM PHYS, V16, P10083, DOI 10.5194/acp-16-10083-2016; Denton F, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1101; Deryng D, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034011; Deser C, 2012, NAT CLIM CHANGE, V2, P775, DOI 10.1038/NCLIMATE1562; Ferraro AJ, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/034012; Fleurbaey M, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P283; Fuglestvedt J, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2016.0445; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Goodwin P, 2018, NAT GEOSCI, V11, P102, DOI 10.1038/s41561-017-0054-8; Haustein K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14828-5; Heck V, 2018, NAT CLIM CHANGE, V8, P151, DOI 10.1038/s41558-017-0064-y; Hirsch AL, 2017, J GEOPHYS RES-ATMOS, V122, P2269, DOI 10.1002/2016JD026125; Hirsch AL, 2018, EARTHS FUTURE, V6, P396, DOI 10.1002/2017EF000744; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jenkins S, 2018, GEOPHYS RES LETT, V45, P2795, DOI 10.1002/2017GL076173; Keenan TF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13428; Keith DW, 2015, NAT CLIM CHANGE, V5, P201, DOI 10.1038/NCLIMATE2493; Lawrence DM, 2016, GEOSCI MODEL DEV, V9, P2973, DOI 10.5194/gmd-9-2973-2016; Le Quere C, 2016, EARTH SYST SCI DATA, V8, P605, DOI 10.5194/essd-8-605-2016; Lo YTE, 2016, SCI REP-UK, V6, DOI 10.1038/srep39169; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Long OM, 2017, J ANIM ECOL, V86, P108, DOI 10.1111/1365-2656.12594; LoPresti A, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/9/095001; Marzeion B, 2018, NAT CLIM CHANGE, V8, P305, DOI 10.1038/s41558-018-0093-1; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; Matthews HD, 2017, CURR CLIM CHANGE REP, V3, P69, DOI 10.1007/s40641-017-0055-0; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; Medhaug I, 2017, NATURE, V545, P41, DOI 10.1038/nature22315; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Millar RJ, 2017, NAT GEOSCI, V10, P741, DOI 10.1038/NGEO3031; Muratori M, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/095004; Muri H, 2014, J GEOPHYS RES-ATMOS, V119, P4174, DOI 10.1002/2013JD021063; O'Brien K, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P437; O'Neill BC, 2017, GLOBAL ENVIRON CHANG, V42, P169, DOI 10.1016/j.gloenvcha.2015.01.004; O'Neill DW, 2018, NAT SUSTAIN, V1, P88, DOI 10.1038/s41893-018-0021-4; Obersteiner M, 2018, NAT CLIM CHANGE, V8, P7, DOI 10.1038/s41558-017-0045-1; Pitman AJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039076; Popp A, 2017, GLOBAL ENVIRON CHANG, V42, P331, DOI 10.1016/j.gloenvcha.2016.10.002; Richardson M, 2016, NAT CLIM CHANGE, V6, P931, DOI [10.1038/NCLIMATE3066, 10.1038/nclimate3066]; Robinson A, 2012, NAT CLIM CHANGE, V2, P429, DOI 10.1038/NCLIMATE1449; Rogelj J, 2018, NAT CLIM CHANGE, V8, P325, DOI 10.1038/s41558-018-0091-3; Rogelj J, 2017, GEOPHYS RES LETT, V44, P10662, DOI 10.1002/2017GL075612; Rogelj J, 2015, NAT CLIM CHANGE, V5, P519, DOI 10.1038/nclimate2572; Schleussner CF, 2016, NAT CLIM CHANGE, V6, P827, DOI 10.1038/NCLIMATE3096; Seneviratne SI, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2016.0450; Seneviratne SI, 2018, NAT GEOSCI, V11, P88, DOI 10.1038/s41561-017-0057-5; Seneviratne SI, 2016, NATURE, V529, P477, DOI 10.1038/nature16542; Settele J, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P271; Smith P, 2016, NAT CLIM CHANGE, V6, P42, DOI [10.1038/NCLIMATE2870, 10.1038/nclimate2870]; Smith WK, 2016, NAT CLIM CHANGE, V6, P306, DOI [10.1038/nclimate2879, 10.1038/NCLIMATE2879]; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Tilmes S, 2016, GEOPHYS RES LETT, V43, P8222, DOI 10.1002/2016GL070122; Trisos CH, 2018, NAT ECOL EVOL, V2, P475, DOI 10.1038/s41559-017-0431-0; UNFCCC, 2015, ADOPTION PARIS AGREE; UNFCCC (U. N. Framew. Conv. Clim. Change), 2015, REP STRUCT EXP DIAL; van Vuuren DP, 2018, NAT CLIM CHANGE, V8, P391, DOI 10.1038/s41558-018-0119-8; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vogel MM, 2017, GEOPHYS RES LETT, V44, P1511, DOI 10.1002/2016GL071235; Wang GJ, 2017, NAT CLIM CHANGE, V7, P568, DOI [10.1038/nclimate3351, 10.1038/NCLIMATE3351]; Wang ZL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46432; Wartenburger R, 2017, GEOSCI MODEL DEV, V10, P3609, DOI 10.5194/gmd-10-3609-2017; Zscheischler J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700263	74	82	85	4	121	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					41	49		10.1038/s41586-018-0181-4	http://dx.doi.org/10.1038/s41586-018-0181-4			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29875489	Green Submitted, Green Accepted			2022-12-28	WOS:000434273300035
J	Fiddes, IT; Lodewijk, GA; Mooring, M; Bosworth, CM; Ewing, AD; Mantalas, GL; Novak, AM; van den Bout, A; Bishara, A; Rosenkrantz, JL; Lorig-Roach, R; Field, AR; Haeussler, M; Russo, L; Bhaduri, A; Nowakowski, TJ; Pollen, AA; Dougherty, ML; Nuttle, X; Addor, MC; Zwolinski, S; Katzman, S; Kriegstein, A; Eichler, EE; Salama, SR; Jacobs, FMJ; Haussler, D				Fiddes, Ian T.; Lodewijk, Gerrald A.; Mooring, Meghan; Bosworth, Colleen M.; Ewing, Adam D.; Mantalas, Gary L.; Novak, Adam M.; van den Bout, Anouk; Bishara, Alex; Rosenkrantz, Jimi L.; Lorig-Roach, Ryan; Field, Andrew R.; Haeussler, Maximilian; Russo, Lotte; Bhaduri, Aparna; Nowakowski, Tomasz J.; Pollen, Alex A.; Dougherty, Max L.; Nuttle, Xander; Addor, Marie-Claude; Zwolinski, Simon; Katzman, Sol; Kriegstein, Arnold; Eichler, Evan E.; Salama, Sofie R.; Jacobs, Frank M. J.; Haussler, David			Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis	CELL			English	Article							CHROMOSOME 1Q21.1; GENOME SEQUENCE; RADIAL GLIA; GENE; EVOLUTION; DUPLICATIONS; AMPLIFICATION; NEANDERTHAL; PROTEOLYSIS; EXPRESSION	Genetic changes causing brain size expansion in human evolution have remained elusive. Notch signaling is essential for radial glia stem cell proliferation and is a determinant of neuronal number in the mammalian cortex. We find that three paralogs of human-specific NOTCH2NL are highly expressed in radial glia. Functional analysis reveals that different alleles of NOTCH2NL have varying potencies to enhance Notch signaling by interacting directly with NOTCH receptors. Consistent with a role in Notch signaling, NOTCH2NL ectopic expression delays differentiation of neuronal progenitors, while deletion accelerates differentiation into cortical neurons. Furthermore, NOTCH2NL genes provide the breakpoints in 1q21.1 distal deletion/duplication syndrome, where duplications are associated with macrocephaly and autism and deletions with microcephaly and schizophrenia. Thus, the emergence of human-specific NOTCH2NL genes may have cor.tributed to the rapid evolution of the larger human neocortex, accompanied by loss of genomic stability at the 1q21.1 locus and resulting recurrent neurodevelopmental disorders.	[Fiddes, Ian T.; Mooring, Meghan; Bosworth, Colleen M.; Ewing, Adam D.; Mantalas, Gary L.; Novak, Adam M.; Rosenkrantz, Jimi L.; Lorig-Roach, Ryan; Field, Andrew R.; Haeussler, Maximilian; Katzman, Sol; Salama, Sofie R.; Jacobs, Frank M. J.; Haussler, David] UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA; [Lodewijk, Gerrald A.; van den Bout, Anouk; Russo, Lotte; Jacobs, Frank M. J.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Mantalas, Gary L.; Field, Andrew R.] UC Santa Cruz, Mol Cell & Dev Biol Dept, Santa Cruz, CA USA; [Bishara, Alex] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Rosenkrantz, Jimi L.; Salama, Sofie R.; Haussler, David] UC Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Bhaduri, Aparna; Nowakowski, Tomasz J.; Pollen, Alex A.; Kriegstein, Arnold] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Bhaduri, Aparna; Nowakowski, Tomasz J.; Pollen, Alex A.; Kriegstein, Arnold] Univ Calif San Francisco, Eli & Edythe Brd Ctr Regenerat Med & Stem Cell Re, San Francisco, CA 94143 USA; [Dougherty, Max L.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Nuttle, Xander] Massachusetts Gen Hosp, Ctr Gen Med, Boston, MA 02114 USA; [Nuttle, Xander] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Nuttle, Xander] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Nuttle, Xander] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Addor, Marie-Claude] Serv Genet Med, Lausanne, Switzerland; [Zwolinski, Simon] Inst Genet Med, Northern Genet Serv, Dept Cytogenet, Newcastle Upon Tyne, Tyne & Wear, England; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Ewing, Adam D.] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia	University of Amsterdam; University of California System; University of California Santa Cruz; Stanford University; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Newcastle University - UK; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Mater Research; University of Queensland	Jacobs, FMJ; Haussler, D (corresponding author), UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA.; Jacobs, FMJ (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.; Haussler, D (corresponding author), UC Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA.	F.M.J.Jacobs@uva.nl; haussler@ucsc.edu	Ewing, Adam D/M-3164-2014; Rosenkrantz, Jimi L/C-3260-2016; Jacobs, Frank/GSD-3616-2022; Haeussler, Maximilian/AAY-1649-2021; Salama, Sofie/K-6412-2019; Jacobs, Frank/O-1809-2014	Ewing, Adam D/0000-0002-4544-994X; Rosenkrantz, Jimi L/0000-0003-4425-884X; Salama, Sofie/0000-0001-6999-7193; Field, Andrew/0000-0002-9016-7917; Novak, Adam/0000-0001-5828-047X; Lodewijk, Gerrald/0000-0002-4143-0432; Lorig-Roach, Ryan/0000-0002-8183-9611; Jacobs, Frank/0000-0003-4423-1479; Mooring, Meghan/0000-0002-8513-7430; Bosworth, Colleen/0000-0001-6241-3554	Human Frontier Science Program [LT000689/2010-L, CDA00030/2016C]; ERC starting grant [ERC-2016-StG-716035]; NWO Earth and Life Sciences project [834.12.003]; EMBO [ALTF 292-2011]; Edward Schulak; NIH [HG002385, F30HG009478, R01 GM109031, U41HG002371, U54HG007990]; CIRM [GC1R-06673-A, GC1R-06673-B, T3-00006, EDUC2-08394, TG2-01157]; NCI Cloud award fund [24074-443720]; NIST/JIMB training program; California QB3 Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007396] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F30HG009478, R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, R01GM109031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097305] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); ERC starting grant(European Research Council (ERC)); NWO Earth and Life Sciences project; EMBO(European Molecular Biology Organization (EMBO)); Edward Schulak; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NCI Cloud award fund; NIST/JIMB training program; California QB3 Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to all families participating in the Simons Variation in Individuals Project (Simons VIP), the Simons VIP Consortium, and SFARI base. We thank Frank Nothaft (Simons Diversity Project), Robert Kuhn, Mark Diekhans, Brain Raney, Hiram Clawson (UCSC Genome Browser), and Raphael Bernier (Simons VIP phenotype data) for assistance with resources; Mari Olsen, Stefany Rubio (Haussler lab), Bari Nazario, Ben Abrams (UCSC Institute for the Biology of Stem Cells), Nader Pourmand (UCSC Genome Sequencing Center), Shana McDevitt (UC Berkeley-QB3 Genomics Sequencing Laboratory), and Martijs Jonker (SILS, University of Amsterdam) for technical support; Arjan Groot and Marc Vooijs (Maastricht Radiation Oncology Lab) for reagents and support for Notch reporter assays; Richard Baldwin (UCSC Anthropology) for providing primate skulls; Pierre Vanderhaeghen, Bin Chen, Benedict Paten, Ed Green, and the Haussler and Jacobs labs for helpful discussions and manuscript comments. This work was supported by CIRM Predoctoral T3-00006 (A.R.F.), EDUC2-08394 (M.M.), and CIRM Postdoctoral TG2-01157 (F.M.J.J.) fellowships; Human Frontier Science Program LT000689/2010-L fellowship and CDA00030/2016C award (F.M.J.J.); ERC starting grant ERC-2016-StG-716035 (F.M.J.J.); NWO Earth and Life Sciences project 834.12.003; EMBO ALTF 292-2011 (M.H.); a fellowship from Edward Schulak (A.D.E.); NIH HG002385 (E.E.E.); NIH F30HG009478 (M.L.D.); CIRM GC1R-06673-A; CIRM GC1R-06673-B; NIH R01 GM109031, U41HG002371, and U54HG007990 (D.H.); NCI Cloud award fund #24074-443720 (D.H.); NIST/JIMB training program (A.B.); and the California QB3 Institute. D.H. and E.E.E. are Howard Hughes Medical Institute Investigators.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bernier R, 2016, GENET MED, V18, P341, DOI 10.1038/gim.2015.78; Boareto M, 2017, DEVELOPMENT, V144, P3465, DOI 10.1242/dev.152520; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Byrne A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16027; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Cheng W, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-170; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Dennis MY, 2016, CURR OPIN GENET DEV, V41, P44, DOI 10.1016/j.gde.2016.08.001; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dougherty ML, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1163-9; Duan ZJ, 2004, MOL CELL BIOL, V24, P58, DOI 10.1128/MCB.24.1.58-70.2004; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Habets RAJ, 2015, J BIOL CHEM, V290, P14705, DOI 10.1074/jbc.M115.643676; Haldeman-Englert C.R., 1993, GENEREVIEWS; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Holloway R. L., 2004, HUMAN FOSSIL RECORD, V3; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Karlstrom H, 2002, P NATL ACAD SCI USA, V99, P17119, DOI 10.1073/pnas.252624099; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Mace A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00556-x; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Nothaft F., 2017, THESIS; Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809; Nuttle X, 2016, NATURE, V536, P205, DOI 10.1038/nature19075; Nuttle X, 2013, NAT METHODS, V10, P903, DOI [10.1038/NMETH.2572, 10.1038/nmeth.2572]; O'Bleness M, 2012, NAT REV GENET, V13, P853, DOI 10.1038/nrg3336; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rabouille C, 2017, TRENDS CELL BIOL, V27, P230, DOI 10.1016/j.tcb.2016.11.007; Ramsay L, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3568-y; Rosenfeld JA, 2012, EUR J HUM GENET, V20, P754, DOI 10.1038/ejhg.2012.6; Steinberg KM, 2014, GENOME RES, V24, P2066, DOI 10.1101/gr.180893.114; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Suzuki IK, 2018, CELL, V173, P1370, DOI 10.1016/j.cell.2018.03.067; Szamalek JM, 2006, HUM GENET, V120, P126, DOI 10.1007/s00439-006-0209-y; Van Dijck A, 2015, EUR J MED GENET, V58, P503, DOI 10.1016/j.ejmg.2015.08.004; Varki A, 2008, NAT REV GENET, V9, P749, DOI 10.1038/nrg2428; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zerbino DR, 2014, BIOINFORMATICS, V30, P1008, DOI 10.1093/bioinformatics/btt737	57	221	227	5	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1356	+		10.1016/j.cell.2018.03.051	http://dx.doi.org/10.1016/j.cell.2018.03.051			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856954	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000433989100010
J	Magiera, MM; Singh, P; Janke, C				Magiera, Maria M.; Singh, Puja; Janke, Carsten			SnapShot: Functions of Tubulin Posttranslational Modifications	CELL			English	Editorial Material									[Magiera, Maria M.; Singh, Puja; Janke, Carsten] Inst Curie, F-91405 Orsay, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Magiera, MM (corresponding author), Inst Curie, F-91405 Orsay, France.		Magiera, Maria M./Y-8754-2019; Janke, Carsten/A-7279-2011; SINGH, PUJA/AGE-0583-2022	Magiera, Maria M./0000-0003-4847-3053; Janke, Carsten/0000-0001-7053-2000; SINGH, PUJA/0000-0003-1011-7221				Aillaud C, 2017, SCIENCE, V358, P1448, DOI 10.1126/science.aao4165; Janke C, 2017, CURR BIOL, V27, pR1287, DOI 10.1016/j.cub.2017.10.044; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Magiera M. M., 2018, CELL, V173; Nieuwenhuis J, 2017, SCIENCE, V358, P1453, DOI 10.1126/science.aao5676; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Wloga D, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028159	8	16	16	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1552	+		10.1016/j.cell.2018.05.032	http://dx.doi.org/10.1016/j.cell.2018.05.032			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856960	Bronze, Green Published			2022-12-28	WOS:000433989100026
J	Simpson, JM				Simpson, Julian M.			Where are UK trained doctors? The migrant care law and its implications for the NHS-an essay by Julian M Simpson	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Locally trained doctors tend not to want to work in areas of high deprivation and need, and we continue to rely on foreign trained doctors to fill massive gaps. Medicine should acknowledge this historical trend and tackle the dysfunction arising from its contemporary manifestations, writes Julian M Simpson				simpsonjm@icloud.com						Album D, 2008, SOC SCI MED, V66, P182, DOI 10.1016/j.socscimed.2007.07.003; Esmail A, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0953-y; Gilles MT, 2008, AUST HEALTH REV, V32, P655, DOI 10.1071/AH080655; Goldacre MJ, 2004, BRIT MED J, V329, P597, DOI 10.1136/bmj.38202.364271.BE; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; HUISH R, 2013, NO DOCTOR HAS GONE C; Levi Carlo, 2000, CHRIST STOPPED EBOLI; Seale C, 2010, J MED ETHICS, V36, P677, DOI 10.1136/jme.2010.036194; Simpson JM, 2018, SOC HIST MEDIC, P1; Social Mobility Commission. Social mobility, 2017, SOC MOB CLASS PAY GA; Taylor DH, 1999, BRIT MED J, V318, P306, DOI 10.1136/bmj.318.7179.306; Verghese Abraham, 1994, MY OWN COUNTRY DOCTO	12	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2018	361								k2336	10.1136/bmj.k2336	http://dx.doi.org/10.1136/bmj.k2336			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MT	29853447				2022-12-28	WOS:000434276300007
J	Macartney, K; Gershon, AA				Macartney, Kristine; Gershon, Anne A.			Shingles vaccine after auto-HSCT decreases risk	LANCET			English	Editorial Material							CELL TRANSPLANT RECIPIENTS; INACTIVATED VARICELLA VACCINE; HERPES-ZOSTER; SUBUNIT VACCINE; ADULTS; IMMUNOGENICITY; PROPHYLAXIS; SAFETY		[Macartney, Kristine] Univ Sydney, Sydney Med Sch, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia; [Macartney, Kristine] Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance, Sydney, NSW 2145, Australia; [Macartney, Kristine] Childrens Hosp Westmead, Dept Microbiol & Infect Dis, Sydney, NSW 2145, Australia; [Gershon, Anne A.] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA	University of Sydney; University of Sydney; University of Sydney; Columbia University	Macartney, K (corresponding author), Univ Sydney, Sydney Med Sch, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia.; Macartney, K (corresponding author), Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance, Sydney, NSW 2145, Australia.; Macartney, K (corresponding author), Childrens Hosp Westmead, Dept Microbiol & Infect Dis, Sydney, NSW 2145, Australia.	kristine.macartney@health.nsw.gov.au						Cunningham AL, 2016, NEW ENGL J MED, V375, P1019, DOI 10.1056/NEJMoa1603800; Eberhardson M, 2017, CLIN INFECT DIS, V65, P1174, DOI 10.1093/cid/cix484; GlaxoSmithKline, 2018, STUD EV EFF SAF IMM; Hata A, 2002, NEW ENGL J MED, V347, P26, DOI 10.1056/NEJMoa013441; Levin MJ, 2018, PLOTKINS VACCINES, V7, P1268; Mullane KM, 2013, J INFECT DIS, V208, P1375, DOI 10.1093/infdis/jit344; Redman RL, 1997, J INFECT DIS, V176, P578, DOI 10.1086/514077; Sahoo F, 2017, BIOL BLOOD MARROW TR, V23, P505, DOI 10.1016/j.bbmt.2016.12.620; Seo HM, 2017, ANTIVIR RES, V140, P106, DOI 10.1016/j.antiviral.2017.01.011; Stadtmauer EA, 2014, BLOOD, V124, P2921, DOI 10.1182/blood-2014-04-573048; Winston DJ, 2018, LANCET, V391, P2116, DOI 10.1016/s0140-6736(18)30631-7	11	0	0	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2018	391	10135					2082	2084		10.1016/S0140-6736(18)30909-7	http://dx.doi.org/10.1016/S0140-6736(18)30909-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH2UJ	29856333				2022-12-28	WOS:000433257200006
J	Gonazlez-Forero, M; Gardner, A				Gonzalez-Forero, Mauricio; Gardner, Andy			Inference of ecological and social drivers of human brain-size evolution	NATURE			English	Article							CULTURAL INTELLIGENCE; LIFE-HISTORY; COGNITION	The human brain is unusually large. It has tripled in size from Australopithecines to modern humans(1) and has become almost six times larger than expected for a placental mammal of human size(2). Brains incur high metabolic costs(3) and accordingly a long-standing question is why the large human brain has evolved(4). The leading hypotheses propose benefits of improved cognition for overcoming ecological(5-7), social(8-10) or cultural(11-14) challenges. However, these hypotheses are typically assessed using correlative analyses, and establishing causes for brain-size evolution remains difficult(15,16). Here we introduce a metabolic approach that enables causal assessment of social hypotheses for brain-size evolution. Our approach yields quantitative predictions for brain and body size from formalized social hypotheses given empirical estimates of the metabolic costs of the brain. Our model predicts the evolution of adult Homo sapiens-sized brains and bodies when individuals face a combination of 60% ecological, 30% cooperative and 10% between-group competitive challenges, and suggests that between-individual competition has been unimportant for driving human brain-size evolution. Moreover, our model indicates that brain expansion in Homo was driven by ecological rather than social challenges, and was perhaps strongly promoted by culture. Our metabolic approach thus enables causal assessments that refine, refute and unify hypotheses of brain-size evolution.	[Gonzalez-Forero, Mauricio; Gardner, Andy] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	University of St Andrews	Gardner, A (corresponding author), Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland.	mgf3@st-andrews.ac.uk	Gardner, Andy/K-5353-2013; González-Forero, Mauricio/J-2676-2015; González-Forero, Mauricio/ADE-9670-2022	Gardner, Andy/0000-0002-1304-3734; González-Forero, Mauricio/0000-0003-1015-3089; González-Forero, Mauricio/0000-0003-1015-3089	Marie Sklodowska-Curie Individual Fellowship [701464]; NERC Independent Research Fellowship [NE/K009524/1]; NERC [NE/K009524/1] Funding Source: UKRI	Marie Sklodowska-Curie Individual Fellowship; NERC Independent Research Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank L. Lehmann for advice on the model set- up and for support at the University of Lausanne, where this project was initiated; P. Avila, S. H. Montgomery, S. B. Laughlin, M. Falcone, T. Clutton-Brock, and M. B. Morrissey for discussions; and A. Whiten for feedback. M. G.-F. was funded by a Marie Sklodowska-Curie Individual Fellowship (No 701464) and A. G. was funded by a NERC Independent Research Fellowship (NE/K009524/1). The contents of this paper reflect only the authors' view and not the views of their funders.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Bartol TM, 2015, ELIFE, V4, DOI 10.7554/eLife.10778; Byrne R., 1988, MACHIAVELLIAN INTELL; Byrne RW, 2004, P ROY SOC B-BIOL SCI, V271, P1693, DOI 10.1098/rspb.2004.2780; Clutton-Brock T., 2016, MAMMAL SOC; CLUTTONBROCK TH, 1980, J ZOOL, V190, P309; Darwin C., 1871, P475; DeCasien AR, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0112; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Dunbar RIM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0244; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Fedorova N, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0008; Fox KCR, 2017, NAT ECOL EVOL, V1, P1699, DOI 10.1038/s41559-017-0336-y; Gibson K.R., 1986, P93; Gonzalez-Forero M, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005380; Henrich J, 2016, SECRET OF OUR SUCCESS: HOW CULTURE IS DRIVING HUMAN EVOLUTION, DOMESTICATING OUR SPECIES, AND MAKING US SMARTER, P1; Howarth C, 2010, J CEREBR BLOOD F MET, V30, P403, DOI 10.1038/jcbfm.2009.231; Humphrey NK., 1976, GROWING POINTS ETHOL, P303; Isler K, 2012, J HUM EVOL, V63, P52, DOI 10.1016/j.jhevol.2012.03.009; Klein R., 2009, HUMAN CAREER; Kruska DCT, 2009, MAMM BIOL, V74, P298, DOI 10.1016/j.mambio.2008.04.002; Kuzawa CW, 2014, P NATL ACAD SCI USA, V111, P13010, DOI 10.1073/pnas.1323099111; Laland K., 2017, DARWINS UNFINISHED S; Lehmann L, 2016, EVOLUTION, V70, DOI 10.1111/evo.12980; Lion S, 2018, AM NAT, V191, P21, DOI 10.1086/694865; MARTIN RD, 1981, NATURE, V293, P57, DOI 10.1038/293057a0; Moll H, 2007, PHILOS T R SOC B, V362, P639, DOI 10.1098/rstb.2006.2000; Patterson MA, 2014, ACM T MATH SOFTWARE, V41, DOI 10.1145/2558904; Powell LE, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1765; Rosati AG, 2017, TRENDS COGN SCI, V21, P691, DOI 10.1016/j.tics.2017.05.011; Schniter E, 2015, AM J PHYS ANTHROPOL, V158, P3, DOI 10.1002/ajpa.22757; Street SE, 2017, P NATL ACAD SCI USA, V114, P7908, DOI 10.1073/pnas.1620734114; Thornton A, 2015, J ZOOL, V295, P12, DOI 10.1111/jzo.12198; van Schaik CP, 2011, PHILOS T R SOC B, V366, P1008, DOI 10.1098/rstb.2010.0304; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076	36	68	68	4	102	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2018	557	7706					554	+		10.1038/s41586-018-0127-x	http://dx.doi.org/10.1038/s41586-018-0127-x			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG6GP	29795254	Green Accepted			2022-12-28	WOS:000432794900046
J	Leeming, J				Leeming, Jack			Building the future	NATURE			English	Editorial Material									[Leeming, Jack] Naturejobs, Heidelberg, Germany		Leeming, J (corresponding author), Naturejobs, Heidelberg, Germany.								0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2018	557	7706					S31	S33		10.1038/d41586-018-05213-x	http://dx.doi.org/10.1038/d41586-018-05213-x			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG6GP	29795259	Bronze			2022-12-28	WOS:000432794900010
J	Hibbs, AM; Ross, K; Kerns, LA; Wagner, C; Fuloria, M; Groh-Wargo, S; Zimmerman, T; Minich, N; Tatsuoka, C				Hibbs, Anna Maria; Ross, Kristie; Kerns, Leigh Ann; Wagner, Carol; Fuloria, Mamta; Groh-Wargo, Sharon; Zimmerman, Teresa; Minich, Nori; Tatsuoka, Curtis			Effect of Vitamin D Supplementation on Recurrent Wheezing in Black Infants Who Were Born Preterm The D-Wheeze Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							D DEFICIENCY; ASTHMA; ASSOCIATION; PREVENTION; RATIONALE; SEVERITY; EXPOSURE; INDEX; RISK	IMPORTANCE Black infants born preterm face high rates of recurrent wheezing throughout infancy. Vitamin D supplementation has the potential to positively or negatively affect wheezing through modulation of the pulmonary and immune systems. OBJECTIVE To assess the effectiveness of 2 vitamin D dosing strategies in preventing recurrent wheezing. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial enrolled 300 black infants born at 28 to 36 weeks' gestation between January 2013 and January 2016 at 4 sites in the United States, and followed them up through March 2017. Randomization was stratified by site and maternal milk exposure. INTERVENTIONS Patients were enrolled prior to discharge from the neonatal intensive care unit or newborn nursery and received open-label multivitamin until they were consuming 200 IU/d of cholecalciferol from formula or fortifier added to human milk, after which they received either 400 IU/d of cholecalciferol until 6 months of age adjusted for prematurity (sustained supplementation) or placebo (diet-limited supplementation). One-hundred fifty three infants were randomized to the sustained group, and 147 were randomized to the diet-limited group. MAIN OUTCOMES AND MEASURES Recurrent wheezing by 12 months' adjusted age was the primary outcome. RESULTS Among 300 patients who were randomized (mean gestational age, 33 weeks; median birth weight, 1.9 kg), 277 (92.3%) completed the trial. Recurrent wheezing was experienced by 31.1% of infants in the sustained supplementation group and 41.8% of infants in the diet-limited supplementation group (difference, -10.7%[95% CI, -27.4% to -2.9%]; relative risk, 0.66 [95% CI, 0.47 to 0.94]). Upper and lower respiratory tract infections were among the most commonly reported adverse events. Upper respiratory infections were experienced by 84 of 153 infants (54.9%) in the sustained group and 83 of 147 infants (56.5%) in the diet-limited group (difference, -1.6%[95% CI, -17.1% to 7.0%]). Lower respiratory infections were experienced by 33 of 153 infants (21.6%) in the sustained group and 37 of 147 infants (25.2%) in the diet-limited group (difference, -3.6%[95% CI, -16.4% to 4.4%]). CONCLUSIONS AND RELEVANCE Among black infants born preterm, sustained supplementation with vitamin D, compared with diet-limited supplementation, resulted in a reduced risk of recurrent wheezing by 12 months' adjusted age. Future research is needed to better understand the mechanisms and longer-term effects of vitamin D supplementation on wheezing in children born preterm.	[Hibbs, Anna Maria; Ross, Kristie; Kerns, Leigh Ann; Groh-Wargo, Sharon; Zimmerman, Teresa; Minich, Nori; Tatsuoka, Curtis] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Hibbs, Anna Maria; Ross, Kristie; Kerns, Leigh Ann; Zimmerman, Teresa; Minich, Nori; Tatsuoka, Curtis] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA; [Wagner, Carol] Med Univ South Carolina, Shawn Jenkins Childrens Hosp, Columbia, SC USA; [Fuloria, Mamta] Childrens Hosp Montefiore, Albert Einstein Coll Med, Bronx, NY USA; [Groh-Wargo, Sharon] MetroHlth Med Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Medical University of South Carolina; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; MetroHealth System	Hibbs, AM (corresponding author), Rainbow Babies & Childrens Hosp, Div Neonatol, 11100 Euclid Ave,Ste 3100, Cleveland, OH 44106 USA.	annamaria.hibbs@cwru.edu			NHLBI; ODS [R01HL109293]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109293] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ODS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the NHLBI and ODS (grant R01HL109293).	Abrams SA, 2013, PEDIATRICS, V131, pE1676, DOI 10.1542/peds.2013-0420; Aglipay M, 2017, JAMA-J AM MED ASSOC, V318, P245, DOI 10.1001/jama.2017.8708; Alyasin S, 2011, ALLERGY ASTHMA IMMUN, V3, P251, DOI 10.4168/aair.2011.3.4.251; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Belderbos ME, 2011, PEDIATRICS, V127, pE1513, DOI 10.1542/peds.2010-3054; Boggs Elizabeth, 2013, Open J Pediatr, V3, P260; Bosse Y, 2007, PHYSIOL GENOMICS, V29, P161, DOI 10.1152/physiolgenomics.00134.2006; Brehm JM, 2009, AM J RESP CRIT CARE, V179, P765, DOI 10.1164/rccm.200808-1361OC; Castro M, 2014, JAMA-J AM MED ASSOC, V311, P2083, DOI 10.1001/jama.2014.5052; Chang TS, 2013, J ALLER CL IMM-PRACT, V1, P152, DOI 10.1016/j.jaip.2012.10.008; EDELSON JD, 1994, BBA-MOL CELL RES, V1221, P159, DOI 10.1016/0167-4889(94)90008-6; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Foong RE, 2015, AM J RESP CELL MOL, V53, P664, DOI 10.1165/rcmb.2014-0356OC; Fort P, 2016, J PEDIATR-US, V174, P132, DOI 10.1016/j.jpeds.2016.03.028; Freishtat RJ, 2010, J PEDIATR-US, V156, P948, DOI 10.1016/j.jpeds.2009.12.033; Halvorsen R, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/460737; Hibbs AM, 2015, J PERINATOL, V35, P192, DOI 10.1038/jp.2014.176; Hollis BW, 2013, J CLIN ENDOCR METAB, V98, P4619, DOI 10.1210/jc.2013-2653; Hypponen E, 2004, ANN NY ACAD SCI, V1037, P84, DOI 10.1196/annals.1337.013; Koroglu OA, 2014, PEDIATR RES, V76, P171, DOI 10.1038/pr.2014.63; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Litonjua AA, 2016, JAMA-J AM MED ASSOC, V315, P362, DOI 10.1001/jama.2015.18589; Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4; MARTINEAU AR, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.I6583; Matheu V, 2003, J ALLERGY CLIN IMMUN, V112, P585, DOI [10.1016/S0091-6749(03)01855-4, 10.1037/mai.2003.1703]; Maxwell CS, 2012, NUTR REV, V70, P548, DOI 10.1111/j.1753-4887.2012.00517.x; McEvoy CT, 2017, CONTEMP CLIN TRIALS, V58, P66, DOI 10.1016/j.cct.2017.05.008; Milner JD, 2004, PEDIATRICS, V114, P27, DOI 10.1542/peds.114.1.27; Nguyen TM, 1996, AM J PHYSIOL-LUNG C, V271, pL392, DOI 10.1152/ajplung.1996.271.3.L392; Oranje AP, 2007, BRIT J DERMATOL, V157, P645, DOI 10.1111/j.1365-2133.2007.08112.x; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Saadoon A, 2017, AM J RESP CELL MOL, V56, P383, DOI 10.1165/rcmb.2014-0482OC; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862; Yurt M, 2014, AM J PHYSIOL-LUNG C, V307, pL859, DOI 10.1152/ajplung.00032.2014; Zadik Z, 2003, OSTEOPOROSIS INT, V14, P857, DOI 10.1007/s00198-003-1456-6; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	38	50	52	4	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2086	2094		10.1001/jama.2018.5729	http://dx.doi.org/10.1001/jama.2018.5729			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800180	Bronze, Green Published			2022-12-28	WOS:000432679400020
J	Kuehn, B				Kuehn, Bridget			Postdisaster Pharmacy Needs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2070	2070		10.1001/jama.2018.6144	http://dx.doi.org/10.1001/jama.2018.6144			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800188				2022-12-28	WOS:000432679400012
J	Slomski, A				Slomski, Anita			Tai Chi for Fibromyalgia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	2	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2069	2069		10.1001/jama.2018.6255	http://dx.doi.org/10.1001/jama.2018.6255			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800175				2022-12-28	WOS:000432679400007
J	Yao, XX; Gersh, BJ; Holmes, DR; Melduni, RM; Johnsrud, DO; Sangaralingham, LR; Shah, ND; Noseworthy, PA				Yao, Xiaoxi; Gersh, Bernard J.; Holmes, David R., Jr.; Melduni, Rowlens M.; Johnsrud, Daniel O.; Sangaralingham, Lindsey R.; Shah, Nilay D.; Noseworthy, Peter A.			Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FIBRILLATION; RISK; ALGORITHMS; OUTCOMES; IMPACT	IMPORTANCE Surgical occlusion of the left atrial appendage (LAAO) may be performed during concurrent cardiac surgery. However, few data exist on the association of LAAO with long-term risk of stroke, and some evidence suggests that this procedure may be associated with subsequent development of atrial fibrillation (AF). OBJECTIVE To evaluate the association of surgical LAAO performed during cardiac surgery with risk of stroke, mortality, and development of subsequent AF. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study using a large US administrative database that contains data from adult patients (>= 18 years) with private insurance or Medicare Advantage who underwent coronary artery bypass graft (CABG) or valve surgery between January 1, 2009, and March 30, 2017, with final follow-up on March 31, 2017. One-to-one propensity score matching was used to balance patients on 76 dimensions to compare those with vs without LAAO, stratified by history of prior AF at the time of surgery. EXPOSURES Surgical LAAO vs no surgical LAAO during cardiac surgery. MAIN OUTCOMES AND MEASURES The primary outcomes were stroke (ie, ischemic stroke or systemic embolism) and all-cause mortality. The secondary outcomes were postoperative AF (AF within 30 days after surgery among patients without prior AF) and long-term AF-related health utilization (event rates of outpatient visits and hospitalizations). RESULTS Among 75 782 patients who underwent cardiac surgery (mean age, 66.0 [SD, 11.2] years; 2 2091 [29.2%] women, 25 721 [33.9%] with preexisting AF), 4374 (5.8%) underwent concurrent LAAO, and mean follow-up was 2.1 (SD, 1.9) years. In the 8590 propensity score-matched patients, LAAO was associated with a reduced risk of stroke (1.14 vs 1.59 events per 100 person-years; hazard ratio [HR], 0.73 [95% CI, 0.56-0.96]; P =.03) and mortality (3.01 vs 4.30 events per 100 person-years; HR, 0.71 [95% CI, 0.60-0.84]; P <.001). LAAO was associated with higher rates of AF-related outpatient visits (11.96 vs 10.26 events per person-year; absolute difference, 1.70 [95% CI, 1.60-1.80] events per person-year; rate ratio, 1.17 [95% CI, 1.10-1.24]; P <.001) and hospitalizations (0.36 vs 0.32 event per person-year; absolute difference, 0.04 [95% CI, 0.02-0.06] event per person-year; rate ratio, 1.13 [95% CI, 1.05-1.21]; P =.002). In patients with prior AF (6438/8590 [74.9%]) with vs without LAAO, risk of stroke was 1.11 vs 1.71 events per 100 person-years (HR, 0.68 [95% CI, 0.50-0.92]; P =.01) and risk of mortality was 3.22 vs 4.93 events per 100 person-years (HR, 0.67 [95% CI, 0.56-0.80]; P <.001), respectively. In patients without prior AF (2152/8590 [25.1%]) with vs without LAAO, risk of stroke was 1.23 vs 1.26 events per 100 person-years (HR, 0.95 [95% CI, 0.54-1.68]), risk of mortality was 2.30 vs 2.49 events per 100 person-years (HR, 0.92 [95% CI, 0.61-1.37]), and risk of postoperative AF was 27.7% vs 20.2% events per 100 person-years (HR, 1.46 [95% CI, 1.22-1.73]; P <.001). The interaction term between prior AF and LAAO was not significant (P =.29 for stroke and P =.16 for mortality). CONCLUSIONS AND RELEVANCE Among patients undergoing cardiac surgery, concurrent surgical LAAO, compared with no surgical LAAO, was associated with reduced risk of subsequent stroke and all-cause mortality. Further research, including from randomized clinical trials, is needed to more definitively determine the role of surgical LAAO.	[Yao, Xiaoxi; Sangaralingham, Lindsey R.; Shah, Nilay D.; Noseworthy, Peter A.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA; [Yao, Xiaoxi; Shah, Nilay D.] Mayo Clin, Dept Hlth Sci Res, Div Hlth Care Policy & Res, Rochester, MN USA; [Gersh, Bernard J.; Holmes, David R., Jr.; Melduni, Rowlens M.; Noseworthy, Peter A.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA; [Johnsrud, Daniel O.] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Shah, Nilay D.] OptumLabs, Cambridge, MA USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Optum	Yao, XX (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	yao.xiaoxi@mayo.edu			Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; National Institutes of Health [HL 135288]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL135288] Funding Source: NIH RePORTER	Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. Dr Melduni is supported by National Institutes of Health grant K01 (HL 135288).	Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X; DAVIS CA, 1990, AM J PHYSIOL, V259, pH1006, DOI 10.1152/ajpheart.1990.259.4.H1006; Fan J, 2013, J AM MED INFORM ASSN, V20, pE349, DOI 10.1136/amiajnl-2013-001827; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Friedman DJ, 2018, JAMA-J AM MED ASSOC, V319, P365, DOI 10.1001/jama.2017.20125; Gayat E, 2012, PHARM STAT, V11, P222, DOI 10.1002/pst.537; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greenberg JW, 2017, EUR J CARDIO-THORAC, V52, P665, DOI 10.1093/ejcts/ezx039; Hershman DL, 2015, J CLIN ONCOL, V33, P1053, DOI 10.1200/JCO.2014.58.3062; HOIT BD, 1993, CIRC RES, V72, P167, DOI 10.1161/01.RES.72.1.167; HOIT BD, 1992, AM J PHYSIOL, V262, pH1356, DOI 10.1152/ajpheart.1992.262.5.H1356; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; KANNEL WB, 1998, AM J CARDIOL, V82; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Kumamaru H, 2014, CIRC-CARDIOVASC QUAL, V7, P611, DOI 10.1161/CIRCOUTCOMES.113.000743; Li F, 2018, J AM STAT ASSOC, V113, P390, DOI 10.1080/01621459.2016.1260466; Maisel WH, 2001, ANN INTERN MED, V135, P1061, DOI 10.7326/0003-4819-135-12-200112180-00010; Melduni RM, 2017, CIRCULATION, V135, P366, DOI 10.1161/CIRCULATIONAHA.116.021952; Noseworthy PA, 2016, CHEST, V150, P1302, DOI 10.1016/j.chest.2016.07.013; O'Brien EC, 2015, JAMA INTERN MED, V175, P848, DOI 10.1001/jamainternmed.2015.13; O'Brien EC, 2014, AM HEART J, V167, P601, DOI 10.1016/j.ahj.2013.12.014; Park-Hansen J, LEFT ATRIAL APPENDAG; Piccini JP, 2017, EUR HEART J, V38, P869, DOI 10.1093/eurheartj/ehw330; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Tsai YC, 2015, EUR J CARDIO-THORAC, V47, P847, DOI 10.1093/ejcts/ezu291; Wallace PJ, 2014, HEALTH AFFAIR, V33, P1187, DOI 10.1377/hlthaff.2014.0038; Wallace PJ, 2014, HLTH AFF MILLWOOD, V33, P1703; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yao XX, 2017, J AM COLL CARDIOL, V70, P2621, DOI 10.1016/j.jacc.2017.09.1087; Yao XX, 2017, J AM COLL CARDIOL, V69, P2779, DOI 10.1016/j.jacc.2017.03.600; Yao XX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003074	36	80	84	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2116	2126		10.1001/jama.2018.6024	http://dx.doi.org/10.1001/jama.2018.6024			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800182	Green Accepted, Bronze			2022-12-28	WOS:000432679400023
J	Dodick, DW; Silberstein, SD; Bigal, ME; Yeung, PP; Goadsby, PJ; Blankenbiller, T; Grozinski-Wolff, M; Yang, RH; Ma, YJ; Aycardi, E				Dodick, David W.; Silberstein, Stephen D.; Bigal, Marcelo E.; Yeung, Paul P.; Goadsby, Peter J.; Blankenbiller, Tricia; Grozinski-Wolff, Melissa; Yang, Ronghua; Ma, Yuju; Aycardi, Ernesto			Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; EFFICACY; SAFETY; TEV-48125; BURDEN; TOLERABILITY; MULTICENTER; PREVALENCE; ANTIBODY; PHASE-2	IMPORTANCE Fremanezumab, a fully humanized monoclonal antibody that targets calcitonin gene-related peptide, may be effective for treating episodic migraine. OBJECTIVE To assess the efficacy of fremanezumab compared with placebo for prevention of episodic migraine with a monthly dosing regimen or a single higher dose. DESIGN AND SETTING Randomized, double-blind, placebo-controlled, parallel-group trial conducted at 123 sites in 9 countries from March 23, 2016 (first patient randomized), to April 10, 2017, consisting of a screening visit, 28-day pretreatment period, 12-week treatment period, and final evaluation at week 12. PARTICIPANTS Study participants were aged 18 to 70 years with episodic migraine (6-14 headache days, with at least 4 migraine days, during 28-day pretreatment period). Patients who had previous treatment failure with 2 classes of migraine-preventive medication were excluded. INTERVENTIONS Patients were randomized 1: 1: 1 to receive subcutaneous monthly dosing of fremanezumab (n = 290; 225 mg at baseline, week 4, and week 8); a single higher dose of fremanezumab, as intended to support a quarterly dose regimen (n = 291; 675 mg of fremanezumab at baseline; placebo at weeks 4 and 8); or placebo (n = 294; at baseline, week 4, and week 8). MAIN OUTCOMES AND MEASURES The primary end point was mean change in mean number of monthly migraine days during the 12-week period after the first dose. RESULTS Among 875 patients who were randomized (mean age, 41.8 [SD, 12.1] years; 742 women [85%]), 791 (90.4%) completed the trial. From baseline to 12 weeks, mean migraine days per month decreased from 8.9 days to 4.9 days in the fremanezumab monthly dosing group, from 9.2 days to 5.3 days in the fremanezumab single-higher-dose group, and from 9.1 days to 6.5 days in the placebo group. This resulted in a difference with monthly dosing vs placebo of -1.5 days (95% CI, -2.01 to -0.93 days; P<.001) and with single higher dosing vs placebo of -1.3 days (95% CI, -1.79 to -0.72 days; P<.001). The most common adverse events that led to discontinuation were injection site erythema (n = 3), injection site in duration (n = 2), diarrhea (n = 2), anxiety (n = 2), and depression (n = 2). CONCLUSIONS AND RELEVANCE Among patients with episodic migraine in whom multiple medication classes had not previously failed, subcutaneous fremanezumab, compared with placebo, resulted in a statistically significant 1.3- to 1.5-day reduction in the mean number of monthly migraine days over a 12-week period. Further research is needed to assess effectiveness against other preventive medications and in patients in whom multiple preventive drug classes have failed and to determine long-term safety and efficacy.	[Dodick, David W.] Mayo Clin Arizona, Phoenix, AZ USA; [Silberstein, Stephen D.] Thomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA 19107 USA; [Bigal, Marcelo E.; Yeung, Paul P.; Blankenbiller, Tricia; Grozinski-Wolff, Melissa; Yang, Ronghua; Ma, Yuju; Aycardi, Ernesto] Teva Pharmaceut, Frazer, PA USA; [Goadsby, Peter J.] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England	Mayo Clinic; Mayo Clinic Phoenix; Jefferson University; University of London; King's College London	Dodick, DW (corresponding author), Mayo Clin, Dept Neurol, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA.	dodick.david@mayo.edu	Goadsby, Peter J/Z-1970-2019	Goadsby, Peter J/0000-0003-3260-5904	Teva Pharmaceuticals, Petach Tikva, Israel	Teva Pharmaceuticals, Petach Tikva, Israel	This study was funded by Teva Pharmaceuticals, Petach Tikva, Israel.	Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal ME, 2008, NEUROLOGY, V71, P848, DOI 10.1212/01.wnl.0000325565.63526.d2; Bigal ME, 2015, LANCET NEUROL, V14, P1081, DOI 10.1016/S1474-4422(15)00249-5; Bigal ME, 2015, LANCET NEUROL, V14, P1091, DOI 10.1016/S1474-4422(15)00245-8; Blumenfeld AM, 2013, HEADACHE, V53, P644, DOI 10.1111/head.12055; Burstein R, 2015, J NEUROSCI, V35, P6619, DOI 10.1523/JNEUROSCI.0373-15.2015; Buse DC, 2016, MAYO CLIN PROC, V91, P596, DOI 10.1016/j.mayocp.2016.02.013; Dodick DW, 2014, LANCET NEUROL, V13, P885, DOI 10.1016/S1474-4422(14)70128-0; Estemalik E, 2013, NEUROPSYCH DIS TREAT, V9, P709, DOI 10.2147/NDT.S33769; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Goadsby PJ, 2017, NEW ENGL J MED, V377, P2123, DOI 10.1056/NEJMoa1705848; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Lipton RB, 2001, HEADACHE, V41, P854; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Lipton RB, 2015, HEADACHE, V55, P103, DOI 10.1111/head.12505_2; Peng Kuan-Po, 2012, Acta Anaesthesiol Taiwan, V50, P69, DOI 10.1016/j.aat.2012.05.002; Silberstein SD, 2017, NEW ENGL J MED, V377, P2113, DOI 10.1056/NEJMoa1709038; Sun H, 2016, LANCET NEUROL, V15, P382, DOI 10.1016/S1474-4422(16)00019-3; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Walter S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0476-1	23	242	254	4	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					1999	2008		10.1001/jama.2018.4853	http://dx.doi.org/10.1001/jama.2018.4853			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800211	Green Published, Bronze			2022-12-28	WOS:000432238300017
J	Nishtar, S; Niinisto, S; Sirisena, M; Vazquez, T; Skvortsova, V; Rubinstein, A; Mogae, FG; Mattila, P; Hashemi, SHG; Kariuki, S; Robles, JN; Adewole, IF; Sarr, AD; Yong, GK; Piukala, SM; Al Owais, ARB; Hargan, E; Alleyne, SG; Alwan, A; Bernaert, A; Bloomberg, M; Dain, K; Frieden, T; Patel, VH; Kennedy, A; Kickbusch, I				Nishtar, Sania; Niinisto, Sauli; Sirisena, Maithripala; Vazquez, Tabare; Skvortsova, Veronika; Rubinstein, Adolfo; Mogae, Festus Gontebanye; Mattila, Pirkko; Hashemi, Sewed Hassan Ghazizadeh; Kariuki, Sicily; Robles, Jose Narro; Adewole, Isaac F.; Sarr, Adboulaye Diouf; Yong, Gan Kim; Piukala, Saia Ma'u; Al Owais, Abdul Rahman Bin Mohammed; Hargan, Eric; Alleyne, Sir George; Alwan, Ala; Bernaert, Arnaud; Bloomberg, Michael; Dain, Katie; Frieden, Tom; Patel, Vikram Harshad; Kennedy, Annette; Kickbusch, Ilona		Commissioners WHO Independent High	Time to deliver: report of the WHO Independent High-Level Commission on NCDs	LANCET			English	Editorial Material									[Nishtar, Sania] Heartfile, Islamabad 44000, Pakistan; [Skvortsova, Veronika] Hlth Care, Moscow, Russia; [Rubinstein, Adolfo] Hlth, Buenos Aires, DF, Argentina; [Mogae, Festus Gontebanye] UNSG, High Level Panel Access Med, Geneva, Switzerland; [Mattila, Pirkko] Social Affairs & Hlth, Helsinki, Finland; [Hashemi, Sewed Hassan Ghazizadeh] Hlth & Med Educ, Tehran, Iran; [Kariuki, Sicily] Hlth Kenya, Nairobi, Kenya; [Robles, Jose Narro] Hlth, Cdmx, Mexico; [Adewole, Isaac F.] Hlth, Abuja, Nigeria; [Sarr, Adboulaye Diouf] Hlth & Social Care, Dakar, Senegal; [Yong, Gan Kim] Hlth, Singapore, Singapore; [Piukala, Saia Ma'u] Hlth, Nukualofa, Tonga; [Al Owais, Abdul Rahman Bin Mohammed] Hlth & Prevent, Dubai, U Arab Emirates; [Hargan, Eric] Hlth & Human Serv, Washington, DC USA; [Alleyne, Sir George] PAHO, Washington, DC USA; [Alleyne, Sir George] UNSG Special Envoy HIV AIDS Caribbean, Geneva, Switzerland; [Alwan, Ala] WHO, EMRO, Cairo, Egypt; [Alwan, Ala] WHO, NCDs & Mental Hlth, Cairo, Egypt; [Bernaert, Arnaud] World Econ Forum, Global Hlth & Healthcare, Geneva, Switzerland; [Bloomberg, Michael] Bloomberg Philanthropies, New York, NY USA; [Bloomberg, Michael] WHO, NCDs & Injuries, Geneva, Switzerland; [Dain, Katie] NCD Alliance, Geneva, Switzerland; [Dain, Katie] WHO, Civil Soc Working Grp High Level Meeting NCDs 3, Geneva, Switzerland; [Frieden, Tom] Vital Strategies, Resolve, New York, NY USA; [Frieden, Tom] US CDCP, Atlanta, GA USA; [Patel, Vikram Harshad] Harvard Med Sch, Global Hlth & Social Med, Boston, MA USA; [Kennedy, Annette] Int Council Nurses, Geneva, Switzerland; [Kickbusch, Ilona] Global Hlth Inst, Grad Inst, Geneva, Switzerland	Pan American Health Organization; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; World Health Organization; World Health Organization; Centers for Disease Control & Prevention - USA; Harvard University; Harvard Medical School	Nishtar, S (corresponding author), Heartfile, Islamabad 44000, Pakistan.	sania@heartfile.org	Kovrazhkina, Elena/AAR-2425-2021	Frieden, Thomas/0000-0002-4759-2256; Hashemi, Hassan/0000-0002-6086-1537					0	62	62	2	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2018	392	10143					245	252		10.1016/S0140-6736(18)31258-3	http://dx.doi.org/10.1016/S0140-6736(18)31258-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN7FE	29866374				2022-12-28	WOS:000439294700026
J	Sinha, MS; Curfman, GD; Carrier, MA				Sinha, Michael S.; Curfman, Gregory D.; Carrier, Michael A.			Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sinha, Michael S.; Curfman, Gregory D.] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Sinha, Michael S.; Curfman, Gregory D.] Harvard Med Sch, Boston, MA USA; [Curfman, Gregory D.] Northeastern Univ, Ctr Hlth Policy & Law, Sch Law, Boston, MA 02115 USA; [Carrier, Michael A.] Rutgers State Univ, Rutgers Law Sch, Camden, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Northeastern University; Rutgers State University Camden; Rutgers State University New Brunswick	Carrier, MA (corresponding author), Rutgers Law Sch, JD,217 N Fifth St, Camden, NJ 08102 USA.	mcarrier@law.rutgers.edu			Laura and John Arnold Foundation; Engelberg Foundation; Harvard Program in Therapeutic Science	Laura and John Arnold Foundation; Engelberg Foundation; Harvard Program in Therapeutic Science	Drs Sinha and Curfman are members of the Program On Regulation Therapeutics, And Law, which receives funding from the Laura and John Arnold Foundation, with additional support from the Engelberg Foundation and the Harvard Program in Therapeutic Science.	[Anonymous], 2017, REGENERIC PHARM PRIC; Carrier Michael A., 2017, BERKELEY TECH LJ, V31, P1379; Kan D, 2017, REEPIPEN EPINEPHRINE	3	6	6	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2018	319	22					2271	2272		10.1001/jama.2018.3478	http://dx.doi.org/10.1001/jama.2018.3478			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2UP	29801104				2022-12-28	WOS:000435129300010
J	DeFilippis, EM; Sobieszczyk, P; Lakdawala, NK; Miller, AL; Loscalzo, J				DeFilippis, Ersilia M.; Sobieszczyk, Piotr; Lakdawala, Neal K.; Miller, Amy L.; Loscalzo, Joseph			A Shocking Turn of Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROGRAMMED ELECTRICAL-STIMULATION; VENA-CAVA SYNDROME; BRUGADA-SYNDROME; CLINICAL CHARACTERISTICS; RISK STRATIFICATION; REGISTRY		[DeFilippis, Ersilia M.; Sobieszczyk, Piotr; Lakdawala, Neal K.; Miller, Amy L.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Miller, AL (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	almiller@bwh.harvard.edu	Loscalzo, Joseph/ABD-8980-2021	DeFilippis, Ersilia/0000-0002-0493-1326				Adler A, 2016, HEART RHYTHM, V13, P299, DOI 10.1016/j.hrthm.2015.08.038; Brugada P, 2003, J CARDIOVASC ELECTR, V14, P455, DOI 10.1046/j.1540-8167.2003.02517.x; Paul M, 2007, EUR HEART J, V28, P2126, DOI 10.1093/eurheartj/ehm116; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Priori SG, 2012, J AM COLL CARDIOL, V59, P37, DOI 10.1016/j.jacc.2011.08.064; Probst V, 2010, CIRCULATION, V121, P635, DOI 10.1161/CIRCULATIONAHA.109.887026; Rice TW, 2006, MEDICINE, V85, P37, DOI 10.1097/01.md.0000198474.99876.f0; Sacher F, 2006, CIRCULATION, V114, P2317, DOI 10.1161/CIRCULATIONAHA.106.628537; Wilson LD, 2007, NEW ENGL J MED, V356, P1862, DOI 10.1056/NEJMcp067190	9	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2018	378	23					2225	2230		10.1056/NEJMcps1714590	http://dx.doi.org/10.1056/NEJMcps1714590			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3HS	29874538				2022-12-28	WOS:000434263000012
J	Iacobucci, G				Iacobucci, Gareth			NHS England failed to disclose full amount of lost clinical correspondence, say MPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		House of Commons Committee of Public Accounts, 2018, CLIN CORR HANDL NHS; House of Commons Committee of Public Accounts, 2017, CLIN CORR HANDL NHS; Iacobucci G, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4822; O'Dowd A, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1059	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2018	361								k2533	10.1136/bmj.k2533	http://dx.doi.org/10.1136/bmj.k2533			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BY	29880548				2022-12-28	WOS:000435073900010
J	Merckx, T; Souffreau, C; Kaiser, A; Baardsen, LF; Backeljau, T; Bonte, D; Brans, KI; Cours, M; Dahirel, M; Debortoli, N; De Wolf, K; Engelen, JMT; Fontaneto, D; Gianuca, AT; Govaert, L; Hendrickx, F; Higuti, J; Lens, L; Martens, K; Matheve, H; Matthysen, E; Piano, E; Sablon, R; Schon, I; Van Doninck, K; De Meester, L; Van Dyck, H				Merckx, Thomas; Souffreau, Caroline; Kaiser, Aurelien; Baardsen, Lisa F.; Backeljau, Thierry; Bonte, Dries; Brans, Kristien, I; Cours, Marie; Dahirel, Maxime; Debortoli, Nicolas; De Wolf, Katrien; Engelen, Jessie M. T.; Fontaneto, Diego; Gianuca, Andros T.; Govaert, Lynn; Hendrickx, Frederik; Higuti, Janet; Lens, Luc; Martens, Koen; Matheve, Hans; Matthysen, Erik; Piano, Elena; Sablon, Rose; Schon, Isa; Van Doninck, Karine; De Meester, Luc; Van Dyck, Hans			Body-size shifts in aquatic and terrestrial urban communities	NATURE			English	Article							DISPERSAL ABILITY; METABOLIC THEORY; URBANIZATION; BIODIVERSITY; BUTTERFLIES; ORGANISMS; RESPONSES; ECOLOGY; MOTHS; PLANT	Body size is intrinsically linked to metabolic rate and life-history traits, and is a crucial determinant of food webs and community dynamics(1,2). The increased temperatures associated with the urban-heat-island effect result in increased metabolic costs and are expected to drive shifts to smaller body sizes'. Urban environments are, however, also characterized by substantial habitat fragmentation', which favours mobile species. Here, using a replicated, spatially nested sampling design across ten animal taxonomic groups, we show that urban communities generally consist of smaller species. In addition, although we show urban warming for three habitat types and associated reduced community-weighted mean body sizes for four taxa, three taxa display a shift to larger species along the urbanization gradients. Our results show that the general trend towards smaller-sized species is overruled by filtering for larger species when there is positive covariation between size and dispersal, a process that can mitigate the low connectivity of ecological resources in urban settings(5). We thus demonstrate that the urban-heat-island effect and urban habitat fragmentation are associated with contrasting community-level shifts in body size that critically depend on the association between body size and dispersal. Because body size determines the structure and dynamics of ecological networks(1), such shifts may affect urban ecosystem function.	[Merckx, Thomas; Kaiser, Aurelien; Van Dyck, Hans] Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, Behav Ecol & Conservat Grp, Louvain La Neuve, Belgium; [Souffreau, Caroline; Brans, Kristien, I; Engelen, Jessie M. T.; Gianuca, Andros T.; Govaert, Lynn; De Meester, Luc] Katholieke Univ Leuven, Lab Aquat Ecol Evolut & Conservat, Leuven, Belgium; [Baardsen, Lisa F.; Backeljau, Thierry; Matthysen, Erik] Univ Antwerp, Evolutionary Ecol Grp, Antwerp, Belgium; [Backeljau, Thierry; De Wolf, Katrien; Hendrickx, Frederik; Piano, Elena; Sablon, Rose] Royal Belgian Inst Nat Sci, Directorate Taxon & Phylogeny, Brussels, Belgium; [Bonte, Dries; Dahirel, Maxime; Hendrickx, Frederik; Lens, Luc; Matheve, Hans] Univ Ghent, Biol Dept, Terr Ecol Unit, Ghent, Belgium; [Cours, Marie; Martens, Koen; Schon, Isa] Royal Belgian Inst Nat Sci, Directorate Nat Environm, Brussels, Belgium; [Dahirel, Maxime] Univ Rennes, CNRS, ECOBIO Ecosyst Biodiversite Evolut, Rennes, France; [Debortoli, Nicolas; Van Doninck, Karine] Univ Namur, Lab Evolutionary Genet & Ecol, NAXYS, URBE, Namur, Belgium; [Fontaneto, Diego] CNR, Inst Ecosyst Study, Verbania, Italy; [Gianuca, Andros T.] German Ctr Integrat Biodivers Res iDiv, Halle, Germany; [Gianuca, Andros T.] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Higuti, Janet] Univ Estadual Maringa, Ctr Res Limnol Ichthyol & Aquaculture PEA, Maringa, Parana, Brazil; [Martens, Koen] Univ Ghent, Biol Dept, Limnol Res Unit, Ghent, Belgium; [Piano, Elena] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Schon, Isa] Univ Hasselt, Zool Res Grp, Hasselt, Belgium	Universite Catholique Louvain; KU Leuven; University of Antwerp; Royal Belgian Institute of Natural Sciences; Ghent University; Royal Belgian Institute of Natural Sciences; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; University of Namur; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Universidade Estadual de Maringa; Ghent University; University of Turin; Hasselt University	Merckx, T (corresponding author), Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, Behav Ecol & Conservat Grp, Louvain La Neuve, Belgium.	th.merckx@gmail.com	Higuti, Janet/A-7492-2017; Piano, Elena/AAJ-4672-2020; Fontaneto, Diego/B-9710-2008; Brans, Kristien/L-2130-2019; Hendrickx, Frederik/F-3149-2013; Kaiser, Aurélien/AAA-3260-2020; Merckx, Thomas/HHN-5979-2022; Bonte, Dries/AAH-3913-2021; De Meester, Luc/F-3832-2015; Van Doninck, Karine/B-3218-2016; Gianuca, Andros/N-3758-2013	Piano, Elena/0000-0002-4685-7240; Fontaneto, Diego/0000-0002-5770-0353; Kaiser, Aurélien/0000-0001-7552-8748; Bonte, Dries/0000-0002-3320-7505; Dahirel, Maxime/0000-0001-8077-7765; De Meester, Luc/0000-0001-5433-6843; De Wolf, Katrien/0000-0002-9255-913X; Van Doninck, Karine/0000-0002-4790-8951; Lens, Luc/0000-0002-0241-2215; Cours, Marie/0000-0002-2376-245X; Gianuca, Andros/0000-0001-9639-3846; Merckx, Thomas/0000-0002-6195-3302	Interuniversity Attraction Poles program of the Belgian Science Policy Office BELSPO (IAP) [P7/04]	Interuniversity Attraction Poles program of the Belgian Science Policy Office BELSPO (IAP)	We thank M. De Cock, J. Dierick, P. Limbourg, E. van den Berg, M. Van Kerckvoorde and P. Vantieghem for help with sampling and identification of species. This is publication BRC419 of the Biodiversity Research Centre (UCL/ELI). This research is part of the SPEEDY-project, funded by the Interuniversity Attraction Poles program of the Belgian Science Policy Office BELSPO (IAP-grant P7/04).	Agosta SJ, 2005, OIKOS, V108, P183, DOI 10.1111/j.0030-1299.2005.13504.x; Alberti M, 2017, P NATL ACAD SCI USA, V114, P8951, DOI 10.1073/pnas.1606034114; Alberti M, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0029; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Auguie B, 2017, GRIDEXTRA MISCELLANE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Bink F.A., 1992, ECOLOGISCHE ATLAS DA; Bonte D, 2017, OIKOS, V126, P472, DOI 10.1111/oik.03801; Brans KI, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0030; Brose U, 2017, BIOL REV, V92, P684, DOI 10.1111/brv.12250; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K P, 2003, MODEL SELECT MULTIMO; Cheptou PO, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0037; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Concepcion ED, 2015, OIKOS, V124, P1571, DOI 10.1111/oik.02166; D Fontaneto, 2011, BIOGEOGRAPHY MICROSC; Dahirel M, 2017, ECOLOGY, V98, P2379, DOI 10.1002/ecy.1915; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; De Saeger S., 2016, BIOL WAARDERINGSKAAR; Donner J, 1965, BESTIMMUNGSBUCHER BO; Duff A. G., 2016, BEETLES BRITAIN IREL, V4; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Forster J, 2012, P NATL ACAD SCI USA, V109, P19310, DOI 10.1073/pnas.1210460109; Gianuca AT, 2018, ECOGRAPHY, V41, P183, DOI 10.1111/ecog.02926; Gianuca AT, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0487; Horne CR, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0238; IBZ, 2017, BEV PROV GEM; Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327; Kalinkat G, 2013, ECOL LETT, V16, P1126, DOI 10.1111/ele.12147; Malerba ME, 2018, ECOL LETT, V21, P54, DOI 10.1111/ele.12870; MANLEY C, 2008, BRIT MOTHS BUTTERFLI; McDonnell MJ, 2015, ANNU REV ECOL EVOL S, V46, P261, DOI 10.1146/annurev-ecolsys-112414-054258; Meisch C., 2000, SUSSWASSERFAUNA MITT, V8/3, P1; Niemela J, 2011, URBAN ECOLOGY: PATTERNS, PROCESSES, AND APPLICATIONS, P1, DOI 10.1093/acprof:oso/9780199563562.001.0001; Nieminen M, 1999, ECOGRAPHY, V22, P697, DOI 10.1111/j.1600-0587.1999.tb00519.x; Osmond MM, 2017, AM NAT, V189, P718, DOI 10.1086/691387; Packet J, 2017, WATERVLAKKEN VERSIE; Piano E, 2017, GLOBAL CHANGE BIOL, V23, P2554, DOI 10.1111/gcb.13606; Reinhardt K, 2005, ECOGRAPHY, V28, P593, DOI 10.1111/j.2005.0906-7590.04285.x; Roberts M. J., 2009, SPIDERS GREAT BRITAI; Scheffers BR, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7671; Schramski JR, 2015, P NATL ACAD SCI USA, V112, P2617, DOI 10.1073/pnas.1423502112; Sekar S, 2012, J ANIM ECOL, V81, P174, DOI 10.1111/j.1365-2656.2011.01909.x; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Slade EM, 2013, ECOLOGY, V94, P1519, DOI 10.1890/12-1366.1; Stevens VM, 2014, ECOL LETT, V17, P1039, DOI 10.1111/ele.12303; Stevens VM, 2012, ECOL LETT, V15, P74, DOI 10.1111/j.1461-0248.2011.01709.x; Threlfall CG, 2017, J APPL ECOL, V54, P1874, DOI 10.1111/1365-2664.12876; Turin H, 2000, NEDERLANDSE LOOPKEVE; Ward K, 2016, SCI TOTAL ENVIRON, V569, P527, DOI 10.1016/j.scitotenv.2016.06.119; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Youngsteadt E, 2015, GLOBAL CHANGE BIOL, V21, P97, DOI 10.1111/gcb.12692	56	132	136	28	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					113	+		10.1038/s41586-018-0140-0	http://dx.doi.org/10.1038/s41586-018-0140-0			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29795350	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000434273300047
J	Zwierzyna, M; Davies, M; Hingorani, AD; Hunter, J				Zwierzyna, Magdalena; Davies, Mark; Hingorani, Aroon D.; Hunter, Jackie			Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; CROSS-SECTIONAL ANALYSIS; DELAYED PUBLICATION; REGISTRATION; INNOVATION; RETRIEVAL; DISCOVERY; MEDICINE; ONCOLOGY; LESSONS	Objective To investigate the distribution, design characteristics, and dissemination of clinical trials by funding organisation and medical specialty. Design Cross sectional descriptive analysis. Data sources Trial protocol information from clinicaltrials.gov, metadata of journal articles in which trial results were published (PubMed), and quality metrics of associated journals from SCImago Journal and Country Rank database. Selection criteria All 45 620 clinical trials evaluating small molecule therapeutics, biological drugs, adjuvants, and vaccines, completed after January 2006 and before July 2015, including randomised controlled trials and non-randomised studies across all clinical phases. Results Industry was more likely than non-profit funders to fund large international randomised controlled trials, although methodological differences have been decreasing with time. Among 27 835 completed efficacy trials (phase II-IV), 15 084 (54.2%) had disclosed their findings publicly. Industry was more likely than non-profit trial funders to disseminate trial results (59.3% (10 444/17 627) v 45.3% (4555/10 066)), and large drug companies had higher disclosure rates than small ones (66.7% (7681/11 508) v 45.2% (2763/6119)). Trials funded by the National Institutes of Health (NIH) were disseminated more often than those of other nonprofit institutions (60.0% (1451/2417) v 40.6% (3104/7649)). Results of studies funded by large drug companies and NIH were more likely to appear on clinicaltrials. gov than were those from non-profit funders, which were published mainly as journal articles. Trials reporting the use of randomisation were more likely than non-randomised studies to be published in a journal article (6895/19 711 (34.9%) v 1408/7748 (18.2%)), and journal publication rates varied across disease areas, ranging from 42% for autoimmune diseases to 20% for oncology. Conclusions Trial design and dissemination of results vary substantially depending on the type and size of funding institution as well as the disease area under study.	[Zwierzyna, Magdalena; Davies, Mark; Hunter, Jackie] BenevolentBio Ltd, London NW1 1LW, England; [Zwierzyna, Magdalena; Hingorani, Aroon D.] UCL, Inst Cardiovasc Sci, London, England; [Hingorani, Aroon D.] Farr Inst Hlth Informat, London, England; [Hunter, Jackie] St George Hosp, Med Sch, London, England	University of London; University College London; St Georges University London	Zwierzyna, M (corresponding author), BenevolentBio Ltd, London NW1 1LW, England.; Zwierzyna, M (corresponding author), UCL, Inst Cardiovasc Sci, London, England.	magda.zwierzyna@benevolent.ai		Hingorani, Aroon/0000-0001-8365-0081; Zwierzyna, Magdalena/0000-0002-7445-6030; Crawley, Francis P./0000-0002-6893-5916	UCL Hospitals NIHR Biomedical Research Centre	UCL Hospitals NIHR Biomedical Research Centre	This study received no specific external funding from any institution in the public, commercial, or not for profit sectors and was conducted by Benevolent Bio as part of its normal business. ADH is supported by the UCL Hospitals NIHR Biomedical Research Centre and is an NIHR senior investigator.	Anderson ML, 2015, NEW ENGL J MED, V372, P1031, DOI 10.1056/NEJMsa1409364; [Anonymous], 2017, TOP 50 GLOB PHARM CO; Bala MM, 2013, J CLIN EPIDEMIOL, V66, P286, DOI 10.1016/j.jclinepi.2012.10.005; Barden CJ, 2010, DRUG DISCOV TODAY, V15, P84, DOI 10.1016/j.drudis.2009.10.001; Bradshaw J., 2017, SMALL DRUG CO GROW B; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chen RJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i637; Chondrogiannis E, 2017, J BIOMED INFORM, V69, P10, DOI 10.1016/j.jbi.2017.03.013; ClinicalTrials.gov, GLOSS COMM SIT TERMS; ClinicalTrials.gov, 2017, CLINICALTRIALS GOV P; Coletti MH, 2001, J AM MED INFORM ASSN, V8, P317, DOI 10.1136/jamia.2001.0080317; Ehlers MD, 2016, CELL, V165, P1043, DOI 10.1016/j.cell.2016.05.005; GlaxoSmithKline, 2014, DAT TRANSP; Hakala A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1116; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Hirsch BR, 2013, JAMA INTERN MED, V173, P972, DOI 10.1001/jamainternmed.2013.627; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Huser V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068409; International Committee of Medical Journal Editors, CLIN TRIALS REG; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Jones CW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6104; Kendall JM, 2003, EMERG MED J, V20, P164, DOI 10.1136/emj.20.2.164; Laine C, 2007, LANCET, V369, P1909, DOI 10.1016/S0140-6736(07)60894-0; Laterre PF, 2015, CLIN MICROBIOL INFEC, V21, P906, DOI 10.1016/j.cmi.2015.07.004; Lindsay MA, 2003, NAT REV DRUG DISCOV, V2, P831, DOI 10.1038/nrd1202; Lokker C, 2011, J AM MED INFORM ASSN, V18, P652, DOI 10.1136/amiajnl-2011-000233; Manzoli L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3058; Martin L, 2017, NAT REV DRUG DISCOV, V16, P381, DOI 10.1038/nrd.2017.70; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Miller JE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017917; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Munos BH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002273; National Institutes of Health, 2016, NIH POL DISS NIH FUN; Novartis Public Affairs, 2016, NOV POS CLIN STUD TR; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405; Pfizer, TRIAL DAT RES; Powell-Smith Anna, 2016, F1000Res, V5, P2629, DOI 10.12688/f1000research.10010.1; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Ramsey S, 2008, ONCOLOGIST, V13, P925, DOI 10.1634/theoncologist.2008-0133; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Schmucker C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114023; Sibbald B, 1998, BRIT MED J, V316, P201; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; Viergever RF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008932; WHO, INT CLIN TRIALS REG; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; Yamey, 1999, BMJ, V319, p939A; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; Zarin DA, 2016, NEW ENGL J MED, V375, P1998, DOI 10.1056/NEJMsr1611785	56	53	54	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2018	361								k2130	10.1136/bmj.k2130	http://dx.doi.org/10.1136/bmj.k2130			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BX	29875212	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000435073600002
J	Driver, BE; Prekker, ME; Klein, LR; Reardon, RF; Miner, JR; Fagerstrom, ET; Cleghorn, MR; McGill, JW; Cole, JB				Driver, Brian E.; Prekker, Matthew E.; Klein, Lauren R.; Reardon, Robert F.; Miner, James R.; Fagerstrom, Erik T.; Cleghorn, Mitchell R.; McGill, John W.; Cole, Jon B.			Effect of Use of a Bougie vs Endotracheal Tube and Stylet on First-Attempt Intubation Success Among Patients With Difficult Airways Undergoing Emergency Intubation A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine (SAEM)	MAY 15-18, 2018	Indianapolis, IN	Soc Acad Emergency Med			GUM-ELASTIC BOUGIE; TRACHEAL INTUBATION; OROTRACHEAL INTUBATION; DIRECT LARYNGOSCOPY; VIDEO LARYNGOSCOPY; 1ST-PASS SUCCESS; ADVERSE EVENTS; MANAGEMENT; DEVICES; TRAUMA	IMPORTANCE The tracheal tube introducer, known as the bougie, is typically used to aid tracheal intubation in poor laryngoscopic views or after intubation attempts fail. The effect of routine bougie use on first-attempt intubation success is unclear. OBJECTIVE To compare first attempt intubation success facilitated by the bougie vs the endotracheal tube + stylet. DESIGN, SETTING, AND PATIENTS The Bougie Use in Emergency Airway Management (BEAM) trial was a randomized clinical trial conducted from September 2016 through August 2017 in the emergency department at Hennepin County Medical Center, an urban, academic department in Minneapolis, Minnesota, where emergency physicians perform all endotracheal intubations. Included patients were 18 years and older who were consecutively admitted to the emergency department and underwent emergency orotracheal intubation with a Macintosh laryngoscope blade for respiratory arrest, difficulty breathing, or airway protection. INTERVENTIONS Patients were randomly assigned to undergo the initial intubation attempt facilitated by bougie (n = 381) or endotracheal tube + stylet (n = 376). MAIN OUTCOMES AND MEASURES The primary outcome was first-attempt intubation success in patients with at least 1 difficult airway characteristic (body fluids obscuring the laryngeal view, airway obstruction or edema, obesity, short neck, small mandible, large tongue, facial trauma, or the need for cervical spine immobilization). Secondary outcomes were first-attempt success in all patients, first-attempt intubation success without hypoxemia, first-attempt duration, esophageal intubation, and hypoxemia. RESULTS Among 757 patients who were randomized (mean age, 46 years; women, 230 [30%]), 757 patients (100%) completed the trial. Among the 380 patients with at least 1 difficult airway characteristic, first-attempt intubation success was higher in the bougie group (96%) than in the endotracheal tube + stylet group (82%) (absolute between-group difference, 14% [95% Cl, 8% to 20%]). Among all patients, first-attempt intubation success in the bougie group (98%) was higher than the endotracheal tube + stylet group (87%) (absolute difference, 11% [95% Cl, 7% to 14%]). The median duration of the first intubation attempt (38 seconds vs 36 seconds) and the incidence of hypoxemia (13% vs 14%) did not differ significantly between the bougie and endotracheal tube + stylet groups. CONCLUSIONS AND RELEVANCE In this emergency department, use of a bougie compared with an endotracheal tube + stylet resulted in significantly higher first-attempt intubation success among patients undergoing emergency endotracheal intubation. However, these findings should be considered provisional until the generalizability is assessed in other institutions and settings.	[Driver, Brian E.; Prekker, Matthew E.; Klein, Lauren R.; Reardon, Robert F.; Miner, James R.; Fagerstrom, Erik T.; McGill, John W.; Cole, Jon B.] Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA; [Prekker, Matthew E.] Hennepin Cty Med Ctr, Dept Med, Div Pulm & Crit Care, Minneapolis, MN 55415 USA; [Cleghorn, Mitchell R.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	Hennepin County Medical Center; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Driver, BE (corresponding author), Dept Emergency Med, 701 Pk Ave,Mail Stop R2, Minneapolis, MN 55415 USA.	briandriver@gmail.com	Cole, Jon B/J-5788-2019; Miner, James/AAI-4801-2020	Cole, Jon B/0000-0002-7714-8826; 	Securisyn Medical	Securisyn Medical	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Miner reported grant funding from Securisyn Medical. No other disclosures were reported.	Amathieu R, 2011, ANESTHESIOLOGY, V114, P25, DOI 10.1097/ALN.0b013e318201c44f; Angerman S, 2018, ANAESTHESIA, V73, P348, DOI 10.1111/anae.14182; Arndt GA, 2008, ANESTH ANALG, V107, P603, DOI 10.1213/ane.0b013e318176fe36; Brown CA, 2015, ANN EMERG MED, V65, P363, DOI 10.1016/j.annemergmed.2014.10.036; Combes X, 2004, ANESTHESIOLOGY, V100, P1146, DOI 10.1097/00000542-200405000-00016; Cook T, 2012, CURR OPIN ANESTHESIO, V25, P461, DOI 10.1097/ACO.0b013e32835528b1; DOGRA S, 1990, ANAESTHESIA, V45, P774, DOI 10.1111/j.1365-2044.1990.tb14454.x; Driver B, 2017, ANN EMERG MED, V70, P473, DOI 10.1016/j.annemergmed.2017.04.033; Driver BE, 2017, ANN EMERG MED, V69, P635, DOI 10.1016/j.annemergmed.2016.11.027; Duggan LV., 2014, J CLIN ANESTH, V26, P167, DOI [10.1016/j.jclinane.2013.12.005, DOI 10.1016/J.JCLINANE.2013.12.005]; Gataure PS, 1996, ANAESTHESIA, V51, P935, DOI 10.1111/j.1365-2044.1996.tb14961.x; Hasegawa K, 2012, ANN EMERG MED, V60, P749, DOI 10.1016/j.annemergmed.2012.04.005; Hodzovic I, 2003, ANAESTHESIA, V58, P192; Jabre P, 2005, AM J EMERG MED, V23, P552, DOI 10.1016/j.ajem.2004.12.005; Joshi R, 2017, ANN AM THORAC SOC, V14, P368, DOI 10.1513/AnnalsATS.201606-472OC; Kadry M, 1999, ANAESTHESIA, V54, P404, DOI 10.1046/j.1365-2044.1999.00876.x; KIDD JF, 1988, ANAESTHESIA, V43, P437, DOI 10.1111/j.1365-2044.1988.tb06625.x; Latto IP, 2002, ANAESTHESIA, V57, P379, DOI 10.1046/j.1365-2044.2002.02411.x; Levitan RM, 2006, ACAD EMERG MED, V13, P1255, DOI 10.1197/j.aem.2006.06.058; Levitan RM, 2011, ANN EMERG MED, V57, P240, DOI 10.1016/j.annemergmed.2010.05.035; Levitan RM, EMERGENCY PHYS MONTH; MACINTOSH RR, 1949, BRIT MED J, V1, P28; Marson BA, 2014, ANAESTHESIA, V69, P219, DOI 10.1111/anae.12534; McGill J., DIFFICULTY PASSING B; McGill JW, 2000, ACAD EMERG MED, V7, P526; Mort TC, 2004, ANESTH ANALG, V99, P607, DOI 10.1213/01.ANE.0000122825.04923.15; NOLAN JP, 1993, ANAESTHESIA, V48, P630, DOI 10.1111/j.1365-2044.1993.tb07133.x; NOLAN JP, 1992, ANAESTHESIA, V47, P878, DOI 10.1111/j.1365-2044.1992.tb03154.x; Ozcan ATD, 2017, UPPER AIRWAY INJURY, P8; Park L, 2017, EMERG MED AUSTRALAS, V29, P40, DOI 10.1111/1742-6723.12704; Prabhu A, 2003, ANAESTHESIA, V58, P811, DOI 10.1046/j.1365-2044.2003.03295_14.x; Rai MR, 2014, ANAESTHESIA, V69, P199, DOI 10.1111/anae.12600; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; Rui, NATL HOSP AMBULATORY; Sakles JC, 2013, ACAD EMERG MED, V20, P71, DOI 10.1111/acem.12055; Sakles JC, 2012, ANN EMERG MED, V60, P739, DOI 10.1016/j.annemergmed.2012.03.031; Sakles JC, 2014, INTERN EMERG MED, V9, P93, DOI 10.1007/s11739-013-0995-x; SMITH BL, 1994, ANAESTHESIA, V49, P91, DOI 10.1111/j.1365-2044.1994.tb03355.x	38	129	130	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2179	2189		10.1001/jama.2018.6496	http://dx.doi.org/10.1001/jama.2018.6496			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	GI1MA	29800096	Bronze, Green Published			2022-12-28	WOS:000434133400016
J	Iacobucci, G				Iacobucci, Gareth			Syphilis and gonorrhoea cases rose by a fifth in England last year	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Public Health England, 2018, SEX TRANSM INF SCREE	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2018	361								k2502	10.1136/bmj.k2502	http://dx.doi.org/10.1136/bmj.k2502			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BU	29871938				2022-12-28	WOS:000435073300012
J	Rimmer, A				Rimmer, Abi			Backing the Scrap the Cap campaign: Five minutes with . . . Chandra Kanneganti	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2018	361								k2455	10.1136/bmj.k2455	http://dx.doi.org/10.1136/bmj.k2455			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BU	29871864				2022-12-28	WOS:000435073300007
J	Chen, B; Yang, YT; Bennett, C				Chen, Brian; Yang, Y. Tony; Bennett, Charles			Friction in the Path to Use of Biosimilar Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Chen, Brian; Bennett, Charles] Univ South Carolina, Columbia, SC 29208 USA; [Yang, Y. Tony] George Mason Univ, Fairfax, VA 22030 USA	University of South Carolina System; University of South Carolina Columbia; George Mason University	Chen, B (corresponding author), Univ South Carolina, Columbia, SC 29208 USA.	bchen@mailbox.sc.edu						Bennett CL, 2014, LANCET ONCOL, V15, pE594, DOI 10.1016/S1470-2045(14)70365-1; Chen B, 2017, JAMA-J AM MED ASSOC, V318, P1186, DOI 10.1001/jama.2017.11930; Hakim A, 2017, JAMA-J AM MED ASSOC, V317, P2163, DOI 10.1001/jama.2017.5202; Moorkens E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190147; Yang YT, 2017, JAMA ONCOL, V3, P1467, DOI 10.1001/jamaoncol.2017.1530	5	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2018	378	22					2148	2148						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH5AL	29847904				2022-12-28	WOS:000433428000030
J	Kardol, P; Fanin, N; Wardle, DA				Kardol, Paul; Fanin, Nicolas; Wardle, David A.			Long-term effects of species loss on community properties across contrasting ecosystems	NATURE			English	Article							TEMPORAL STABILITY; PLANT DIVERSITY; BIODIVERSITY EXPERIMENTS; CARBON SEQUESTRATION; ISLAND ECOSYSTEMS; PRODUCTIVITY; COMPLEMENTARITY; REMOVAL; IMPACTS; FOREST	Biodiversity loss can heavily affect the functioning of ecosystems, and improving our understanding of how ecosystems respond to biodiversity decline is one of the main challenges in ecology(1-4). Several important aspects of the longer-term effects of biodiversity loss on ecosystems remain unresolved, including how these effects depend on environmental context(5-7). Here we analyse data from an across-ecosystem biodiversity manipulation experiment that, to our knowledge, represents the world's longest-running experiment of this type. This experiment has been set up on 30 lake islands in Sweden that vary considerably in productivity and soil fertility owing to differences in fire history(8,9). We tested the effects of environmental context on how plant species loss affected two fundamental community attributes-plant community biomass and temporal variability-over 20 years. In contrast to findings from artificially assembled communities(10-12), we found that the effects of species loss on community biomass decreased over time; this decrease was strongest on the least productive and least fertile islands. Species loss generally also increased temporal variability, and these effects were greatest on the most productive and most fertile islands. Our findings highlight that the ecosystem-level consequences of biodiversity loss are not constant across ecosystems and that understanding and forecasting these consequences necessitates taking into account the overarching role of environmental context.	[Kardol, Paul; Fanin, Nicolas; Wardle, David A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, Umea, Sweden; [Fanin, Nicolas] Bordeaux Sci Agro, INRA, ISPA, UMR 1391, Villenave Dornon, France; [Wardle, David A.] Nanyang Technol Univ, Asian Sch Environm, Singapore, Singapore	Swedish University of Agricultural Sciences; INRAE; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kardol, P (corresponding author), Swedish Univ Agr Sci, Dept Forest Ecol & Management, Umea, Sweden.	Paul.Kardol@slu.se	Wardle, David A./F-6031-2011; Kardol, Paul/N-8383-2015; Fanin, Nicolas/H-5501-2019	Wardle, David A./0000-0002-0476-7335; Kardol, Paul/0000-0001-7065-3435; Fanin, Nicolas/0000-0003-4195-855X	Swedish Research Council (Vetenskapsradet); Wallenberg Scholars award	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Wallenberg Scholars award	We thank numerous assistants for help in the field. This work was supported by grants to D.A.W. from the Swedish Research Council (Vetenskapsradet) and a Wallenberg Scholars award.	Bezemer TM, 2007, NATURE, V446, pE6, DOI 10.1038/nature05749; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2013, ECOLOGY, V94, P1697, DOI 10.1890/12-1334.1; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Craven D, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0277; de Mazancourt C, 2013, ECOL LETT, V16, P617, DOI 10.1111/ele.12088; Diaz S, 2003, TRENDS ECOL EVOL, V18, P140, DOI 10.1016/S0169-5347(03)00007-7; Duffy JE, 2017, NATURE, V549, P261, DOI 10.1038/nature23886; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; FLOWERELLIS JGK, 1971, AGE STRUCTURE DYNAMI; Fowler MS, 2012, ECOL LETT, V15, P1387, DOI 10.1111/j.1461-0248.2012.01862.x; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Gross K, 2014, AM NAT, V183, P1, DOI 10.1086/673915; Guerrero-Ramirez NR, 2017, NAT ECOL EVOL, V1, P1639, DOI 10.1038/s41559-017-0325-1; Gundale MJ, 2012, ECOLOGY, V93, P1695, DOI 10.1890/11-1877.1; Hautier Y, 2014, NATURE, V508, P521, DOI 10.1038/nature13014; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 1998, OIKOS, V82, P597, DOI 10.2307/3546380; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; Isbell F, 2017, NATURE, V546, P65, DOI 10.1038/nature22899; Isbell FI, 2009, ECOL LETT, V12, P443, DOI 10.1111/j.1461-0248.2009.01299.x; Lagerstrom A, 2009, BIOGEOCHEMISTRY, V95, P199, DOI 10.1007/s10533-009-9331-y; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Morin X, 2014, ECOL LETT, V17, P1526, DOI 10.1111/ele.12357; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Symstad AJ, 2001, OIKOS, V92, P424, DOI 10.1034/j.1600-0706.2001.920304.x; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van Ruijven J, 2007, OIKOS, V116, P1323, DOI [10.1111/j.2007.0030-1299.16005.x, 10.1111/j.0030-1299.2007.16005.x]; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Wardle DA, 2005, NATURE, V435, P806, DOI 10.1038/nature03611; Wardle DA, 2014, ECOLOGY, V95, P1836, DOI 10.1890/13-1666.1; Wardle DA, 2012, ECOLOGY, V93, P521, DOI 10.1890/11-0930.1; Wardle DA, 2012, J ECOL, V100, P16, DOI 10.1111/j.1365-2745.2011.01907.x	45	59	60	12	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					710	+		10.1038/s41586-018-0138-7	http://dx.doi.org/10.1038/s41586-018-0138-7			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29795345	Green Accepted			2022-12-28	WOS:000433412900051
J	Wilson, C; Elshimy, N				Wilson, Claire; Elshimy, Noha			An unusual rash on the feet	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wilson, Claire] Leeds Hosp Teaching Trust, Leeds, W Yorkshire, England; [Elshimy, Noha] Mid Yorks Hosp Trust, Wakefield, England		Wilson, C (corresponding author), Leeds Hosp Teaching Trust, Leeds, W Yorkshire, England.	claire.wilson29@nhs.net						Bower M, 2014, HIV MED, V15, P1, DOI 10.1111/hiv.12136; Bunker CB, 2016, ROOKS TXB DERMATOLOG, V319, P15; Curtiss P, 2016, DERMATOLOGY THER, V6, P465, DOI 10.1007/s13555-016-0152-3; Grayson W, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-31; Tsai K, 2016, ROOKS TXB DERMATOLOG, V139, P1	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2018	361								k1406	10.1136/bmj.k1406	http://dx.doi.org/10.1136/bmj.k1406			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH4XN	29794084				2022-12-28	WOS:000433416100001
J	Salm-Reifferscheidt, L				Salm-Reifferscheidt, Laura			Tramadol: Africa's opioid crisis	LANCET			English	Editorial Material																			0	36	36	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2018	391	10134					1982	1983		10.1016/S0140-6736(18)31073-0	http://dx.doi.org/10.1016/S0140-6736(18)31073-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GG1IJ	29864013				2022-12-28	WOS:000432440300013
J	Kuehn, B				Kuehn, Bridget			Workplace Noise and Heart Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1854	1854		10.1001/jama.2018.5096	http://dx.doi.org/10.1001/jama.2018.5096			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29801019				2022-12-28	WOS:000431668600007
J	Haug, CJ				Haug, Charlotte J.			Turning the Tables - The New European General Data Protection Regulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Haug, Charlotte Johanne/0000-0001-8217-7376				Azaria A, 2016, 2016 2 INT C OP BIG; Czeschik C., 2017, DOTMAGAZINE      JUN	2	13	13	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2018	379	3					207	209		10.1056/NEJMp1806637	http://dx.doi.org/10.1056/NEJMp1806637			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GN5CX	29874143				2022-12-28	WOS:000439063900002
J	Cervantes, L; Richardson, S; Raghavan, R; Hou, N; Hasnain-Wynia, R; Wynia, MK; Kleiner, C; Chonchol, M; Tong, A				Cervantes, Lilia; Richardson, Sara; Raghavan, Rajeev; Hou, Nova; Hasnain-Wynia, Romana; Wynia, Matthew K.; Kleiner, Catherine; Chonchol, Michel; Tong, Allison			Clinicians' Perspectives on Providing Emergency-Only Hemodialysis to Undocumented Immigrants A Qualitative Study	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; HEALTH-CARE; DIALYSIS; SATISFACTION; BURNOUT; STRESS; ACCESS; LAW	Background: In the United States, nearly half of undocumented immigrants with end-stage kidney disease receive hemodialysis only when they are evaluated in an emergency department and are found to have life-threatening renal failure ("emergency-only hemodialysis" [EOHD]). These patients experience psychosocial distress and much higher mortality than patients receiving regularly scheduled hemodialysis, but little is known about how providing EOHD affects the clinicians involved. Objective: To understand clinicians' experiences providing EOHD. Design: Qualitative study using semistructured interviews. Setting: A safety-net hospital in Denver, Colorado, and a safety-net system in Houston, Texas. Participants: Fifty interdisciplinary clinicians experienced in providing EOHD. Measurements: Interviews were analyzed using thematic analysis. Outcomes included themes and subthemes. Results: Four themes and 13 subthemes (in parentheses) were identified: 1) drivers of professional burnout (emotional exhaustion from witnessing needless suffering and high mortality, jeopardizing patient trust, detaching from patients, perceived lack of control over EOHD criteria, and physical exhaustion from over-extending to bridge care), 2) moral distress from propagating injustice (altered care based on nonmedical factors, focus on volume at the expense of quality, and need to game the system), 3) confusing and perverse financial incentives (wasting resources, confusing financial incentives, and concerns about sustainability), and 4) inspiration toward advocacy (deriving inspiration from patients and strengthened altruism). Limitation: Whether the findings apply to other settings is unknown, and social desirability response bias might have reduced reporting of negative perceptions and experiences. Conclusion: Clinicians in safety-net settings who provide EOHD to undocumented patients describe experiencing moral distress and being driven toward professional burnout. The burden of EOHD on clinicians should inform discussions of systemic approaches to support provision of adequate care based on medical need.	[Cervantes, Lilia; Wynia, Matthew K.; Kleiner, Catherine; Chonchol, Michel] Denver Hlth, 777 Bannock,MC 4000, Denver, CO 80204 USA; [Richardson, Sara] Denver Hlth, 601 Broadway,4th Floor, Denver, CO 80204 USA; [Hasnain-Wynia, Romana] Denver Hlth, 777 Bannock St,MC 6551, Denver, CO 80204 USA; [Cervantes, Lilia; Wynia, Matthew K.; Tong, Allison] Univ Colorado, Anschutz Med Campus,13080 East 19th Ave, Denver, CO 80045 USA; [Chonchol, Michel] Univ Colorado, Div Renal Dis & Hypertens, Anschutz Med Campus,12700 East 19th Ave,Room 7015, Denver, CO 80045 USA; [Raghavan, Rajeev] Harris Hlth, Houston, TX USA; [Raghavan, Rajeev] Baylor Coll Med, Med Ctr, 7200 Cambridge St,8th Floor, Houston, TX 77030 USA; [Hou, Nova] Univ Texas McGovern Med Sch, 3011 Bell St, Houston, TX 77003 USA; [Tong, Allison] Univ Sydney, Sydney, NSW, Australia; [Tong, Allison] Childrens Hosp Westmead, Ctr Kidney Res, Corner Hawkesbury & Hainsworth St, Westmead, NSW 2145, Australia; [Kleiner, Catherine] 3921 Lions Paw St, Castle Rock, CO 80104 USA	Denver Health Medical Center; Denver Health Medical Center; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Baylor College of Medicine; University of Sydney; University of Sydney	Cervantes, L (corresponding author), Denver Hlth, 777 Bannock,MC 4000, Denver, CO 80204 USA.	lilia.cervantes@dhha.org	Wynia, Matthew/T-2210-2019	Hasnain-Wynia, Romana/0000-0001-6009-3569; Tong, Allison/0000-0001-8973-9538	Robert Wood Johnson Foundation; Doris Duke Charitable Foundation [2015212]; University of Colorado School of Medicine	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); University of Colorado School of Medicine	This study was made possible by a Harold Amos Medical Faculty Development Award from the Robert Wood Johnson Foundation. The project was also supported by grant 2015212 from the Doris Duke Charitable Foundation and the University of Colorado School of Medicine.	American Medical Association (AMA), 2001, AMA PRINC MED ETH; American Nurses Association, 2015, COD ETH NURS; Ansell D, 2015, HEALTH AFFAIR, V34, P781, DOI 10.1377/hlthaff.2014.1192; Berlinger N, 2017, HLTH CARE ACCESS UND; Birt L, 2016, QUAL HLTH RES; Campbell GA, 2010, AM J KIDNEY DIS, V55, P181, DOI 10.1053/j.ajkd.2009.06.039; Cervantes L, 2018, JAMA INTERN MED, V178, P188, DOI 10.1001/jamainternmed.2017.7039; Cervantes L, 2017, JAMA INTERN MED, V177, P529, DOI 10.1001/jamainternmed.2016.8865; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Coritsidis GN, 2004, AM J KIDNEY DIS, V43, P424, DOI 10.1053/j.ajkd.2003.11.004; Crigger BJ, 2017, AMA J ETHICS, V19, P564, DOI [10.1001/journalofethics.2017.19.6.coet1-1706, DOI 10.1001/JOURNALOFETHICS.2017.19.6.COET1-1706]; Earnest MA, 2010, ACAD MED, V85, P63, DOI 10.1097/ACM.0b013e3181c40d40; Fernandez A, 2017, JAMA INTERN MED, V177, P536, DOI 10.1001/jamainternmed.2016.9209; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P478, DOI 10.1001/jama.284.4.478; Hayashi AS, 2009, J HEALTH CARE POOR U, V20, P597, DOI 10.1353/hpu.0.0163; Hurley L, 2009, AM J KIDNEY DIS, V53, P940, DOI 10.1053/j.ajkd.2008.12.029; Jameton A., 1984, NURSING PRACTICE ETH, DOI 10.1002/chp.4760040110; Johnson TL, 2015, HEALTH AFFAIR, V34, P1312, DOI 10.1377/hlthaff.2014.1186; Liamputtong P., 2009, QUALITATIVE RES METH; Linden EA, 2012, AM J KIDNEY DIS, V60, P354, DOI 10.1053/j.ajkd.2012.05.016; Munnangi S, 2018, J TRAUMA NURS, V25, P4, DOI 10.1097/JTN.0000000000000335; Perni S., 2017, AMA J ETHICS, V19, P533, DOI [10.1001/journalofethics.2017.19.6.fred1-1706, DOI 10.1001/JOURNALOFETHICS.2017.19.6.FRED1-1706]; Raghavan R, 2012, SEMIN DIALYSIS, V25, P267, DOI 10.1111/j.1525-139X.2012.01066.x; Raghavan R, 2011, NEW ENGL J MED, V364, P2183, DOI 10.1056/NEJMp1101195; Rodriguez RA, 2015, ADV CHRONIC KIDNEY D, V22, P60, DOI 10.1053/j.ackd.2014.07.003; Rushton CH, 2017, AM J NURS, V117, P52, DOI 10.1097/01.NAJ.0000512203.08844.1d; Sheikh-Hamad D, 2007, TEX MED, V; 103, P53; Sher SJ, 2017, CLIN NEPHROL, V88, P181, DOI 10.5414/CN109137; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Strauss A., 1998, BASICS QUALITATIVE R; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Whitebird RR, 2017, GEN HOSP PSYCHIAT, V44, P91, DOI 10.1016/j.genhosppsych.2016.03.004; Wynia MK, 2000, JAMA-J AM MED ASSOC, V283, P1858, DOI 10.1001/jama.283.14.1858	33	40	40	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2018	169	2					78	+		10.7326/M18-0400	http://dx.doi.org/10.7326/M18-0400			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GN0TI	29800062				2022-12-28	WOS:000438689200013
J	Nakamura, N; Huang, CSY				Nakamura, Noboru; Huang, Clare S. Y.			Atmospheric blocking as a traffic jam in the jet stream	SCIENCE			English	Article							NORTHERN-HEMISPHERE BLOCKING; AMPLITUDE WAVE ACTIVITY; MEAN FLOW; SOUTHERN-HEMISPHERE; POTENTIAL VORTICITY; EDDY; CIRCULATION; EDDIES; SYSTEM; ONSET	Atmospheric blocking due to anomalous, persistent meandering of the jet stream often causes weather extremes in the mid-latitudes. Despite the ubiquity of blocking, the onset mechanism is not well understood. Here we demonstrate a close analogy between blocking and traffic congestion on a highway by using meteorological data and show that blocking and traffic congestion can be described by a common mathematical theory. The theory predicts that the jet stream has a capacity for the flux of wave activity (a measure of meandering), just as the highway has traffic capacity, and when the capacity is exceeded, blocking manifests as congestion. Stationary waves modulate the jet stream's capacity for transient waves and localize block formation. Climate change likely affects blocking frequency by modifying the jet stream's proximity to capacity.	[Nakamura, Noboru; Huang, Clare S. Y.] Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA	University of Chicago	Nakamura, N (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	nnn@uchicago.edu		Huang, Clare S. Y./0000-0002-8505-466X	NSF [AGS1563307]; Div Atmospheric & Geospace Sciences [1563307] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work has been supported by NSF grant AGS1563307.	Barnes EA, 2014, GEOPHYS RES LETT, V41, P638, DOI 10.1002/2013GL058745; Barnes EA, 2012, CLIM DYNAM, V38, P2467, DOI 10.1007/s00382-011-1243-6; Barriopedro D, 2006, J CLIMATE, V19, P1042, DOI 10.1175/JCLI3678.1; Berggren R., 1949, TELLUS, V1, P14, DOI [10.3402/tellusa.v1i2.8501, DOI 10.1111/J.2153-3490.1949.TB01257.X]; Cash BA, 2000, J ATMOS SCI, V57, P3202, DOI 10.1175/1520-0469(2000)057<3202:DPOBE>2.0.CO;2; Charney J. G., 1948, GEOFYS PUBL, V17; CHARNEY JG, 1979, J ATMOS SCI, V36, P1205, DOI 10.1175/1520-0469(1979)036<1205:MFEITA>2.0.CO;2; COLUCCI SJ, 1985, J ATMOS SCI, V42, P2701, DOI 10.1175/1520-0469(1985)042<2701:ECALSC>2.0.CO;2; Colucci SJ, 2001, J ATMOS SCI, V58, P933, DOI 10.1175/1520-0469(2001)058<0933:PSPFTO>2.0.CO;2; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Garcia-Herrera R, 2010, CRIT REV ENV SCI TEC, V40, P267, DOI 10.1080/10643380802238137; Geroliminis N, 2008, TRANSPORT RES B-METH, V42, P759, DOI 10.1016/j.trb.2008.02.002; Greenshields B., 1935, P HIGHWAY RES BOARD, V14, P448; HAINES K, 1987, Q J ROY METEOR SOC, V113, P681, DOI 10.1256/smsqj.47612; Huang CSY, 2017, GEOPHYS RES LETT, V44, P5673, DOI 10.1002/2017GL073760; Huang CSY, 2016, J ATMOS SCI, V73, P211, DOI 10.1175/JAS-D-15-0194.1; Jia XL, 2014, J METEOROL RES-PRC, V28, P76, DOI 10.1007/s13351-014-3085-8; LeVeque RJ, 2002, CAMBRIDGE TEXTS APPL, V31, DOI DOI 10.1017/CBO9780511791253; LIGHTHILL MJ, 1955, PROC R SOC LON SER-A, V229, P317, DOI 10.1098/rspa.1955.0089; Luo DH, 2005, J ATMOS SCI, V62, P5, DOI 10.1175/1186.1; MULLEN SL, 1987, J ATMOS SCI, V44, P3, DOI 10.1175/1520-0469(1987)044<0003:TEFOBF>2.0.CO;2; NAKAMURA H, 1993, MON WEATHER REV, V121, P1892, DOI 10.1175/1520-0493(1993)121<1892:SBOBED>2.0.CO;2; Nakamura H, 1997, MON WEATHER REV, V125, P2074, DOI 10.1175/1520-0493(1997)125<2074:TROHAL>2.0.CO;2; Nakamura N, 2017, J ATMOS SCI, V74, P2341, DOI 10.1175/JAS-D-17-0029.1; Nakamura N, 2010, J ATMOS SCI, V67, P2701, DOI 10.1175/2010JAS3432.1; Pelly JL, 2003, Q J ROY METEOR SOC, V129, P1683, DOI 10.1256/qj.01.173; Pelly JL, 2003, J ATMOS SCI, V60, P743, DOI 10.1175/1520-0469(2003)060<0743:ANPOB>2.0.CO;2; PLATZMAN GW, 1968, Q J ROY METEOR SOC, V94, P225, DOI 10.1002/qj.49709440102; PLUMB RA, 1986, J ATMOS SCI, V43, P1657, DOI 10.1175/1520-0469(1986)043<1657:TDPOTQ>2.0.CO;2; Rex D. F., 1950, TELLUS, V2, P275, DOI DOI 10.1111/J.2153-3490.1950.TB00339.X; RICHARDS PI, 1956, OPER RES, V4, P42, DOI 10.1287/opre.4.1.42; Rossby CG, 1939, J MAR RES, V2, P38, DOI 10.1357/002224039806649023; SHUTTS GJ, 1983, Q J ROY METEOR SOC, V109, P737, DOI 10.1002/qj.49710946204; Sobel A, 2014, STORM SURGE; Swanson KL, 2001, Q J ROY METEOR SOC, V127, P1341, DOI 10.1002/qj.49712757412; Treiber M., 2013, TRAFFIC FLOW DYNAMIC; TRENBERTH KE, 1986, J ATMOS SCI, V43, P2061, DOI 10.1175/1520-0469(1986)043<2061:TSOABE>2.0.CO;2; Wang L, 2015, GEOPHYS RES LETT, V42, P8192, DOI 10.1002/2015GL065830; Woollings T, 2010, Q J ROY METEOR SOC, V136, P856, DOI 10.1002/qj.625	39	74	75	4	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2018	361	6397					42	47		10.1126/science.aat0721	http://dx.doi.org/10.1126/science.aat0721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL8JR	29794217				2022-12-28	WOS:000437467100056
J	Lien, AD; Scanziani, M				Lien, Anthony D.; Scanziani, Massimo			Cortical direction selectivity emerges at convergence of thalamic synapses	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; CATS STRIATE CORTEX; SIMPLE CELLS; RECEPTIVE-FIELDS; IN-VIVO; THALAMOCORTICAL SYNAPSES; RESPONSE PROPERTIES; SPATIAL SUMMATION; AREA 17	Detecting the direction of motion of an object is essential for our representation of the visual environment. The visual cortex is one of the main stages in the mammalian nervous system in which the direction of motion may be computed de novo. Experiments and theories indicate that cortical neurons respond selectively to motion direction by combining inputs that provide information about distinct spatial locations with distinct time delays. Despite the importance of this spatiotemporal offset for direction selectivity, its origin and cellular mechanisms are not fully understood. We show that approximately 80 +/- 10 thalamic neurons, which respond with distinct time courses to stimuli in distinct locations, excite mouse visual cortical neurons during visual stimulation. The integration of thalamic inputs with the appropriate spatiotemporal offset provides cortical neurons with a primordial bias for direction selectivity. These data show how cortical neurons selectively combine the spatiotemporal response diversity of thalamic neurons to extract fundamental features of the visual world.	[Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Neurosci Grad Program, La Jolla, CA 92093 USA; [Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94117 USA; [Scanziani, Massimo] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94117 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Lien, AD; Scanziani, M (corresponding author), Univ Calif San Diego, Neurosci Grad Program, La Jolla, CA 92093 USA.; Lien, AD; Scanziani, M (corresponding author), Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA.; Lien, AD; Scanziani, M (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.; Lien, AD; Scanziani, M (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94117 USA.; Scanziani, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94117 USA.	anthony.d.lien@gmail.com; massimo@ucsf.edu			Gatsby Charitable Foundation; Howard Hughes Medical Institute; Jane Coffin Childs Fellowship; NATIONAL EYE INSTITUTE [P30EY002162] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Jane Coffin Childs Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Evora for help with genotyping and mouse husbandry, S. Hestrin for allowing us to perform some of the experiments in his laboratory, R. Beltramo for helping with extracellular recordings, J. S. Isaacson, B. L. Bloodgood and R. A. Nicoll for comments on the manuscript, E. J. Chichilnisky and members of the Scanziani and Isaacson laboratories for discussions of this project. This research was supported by the Gatsby Charitable Foundation, the Howard Hughes Medical Institute and the Jane Coffin Childs Fellowship to A.D.L.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; EMERSON RC, 1977, J NEUROPHYSIOL, V40, P136, DOI 10.1152/jn.1977.40.1.136; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; GANZ L, 1984, J NEUROPHYSIOL, V51, P294, DOI 10.1152/jn.1984.51.2.294; GOODWIN AW, 1975, J NEUROPHYSIOL, V38, P1500, DOI 10.1152/jn.1975.38.6.1500; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Hillier D, 2017, NAT NEUROSCI, V20, P960, DOI 10.1038/nn.4566; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu H, 2016, J NEUROSCI, V36, P6906, DOI 10.1523/JNEUROSCI.0739-16.2016; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; Li YT, 2018, CEREB CORTEX, V28, P2059, DOI 10.1093/cercor/bhx111; Li YT, 2015, CEREB CORTEX, V25, P2466, DOI 10.1093/cercor/bhu049; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Maex R, 1996, J NEUROPHYSIOL, V75, P1515, DOI 10.1152/jn.1996.75.4.1515; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MARROCCO RT, 1976, J NEUROPHYSIOL, V39, P340, DOI 10.1152/jn.1976.39.2.340; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; MASTRONARDE DN, 1987, J NEUROPHYSIOL, V57, P357, DOI 10.1152/jn.1987.57.2.357; MCLEAN J, 1989, VISION RES, V29, P675, DOI 10.1016/0042-6989(89)90029-1; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Reichardt W, 1961, SENS COMMUN, P303; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; Saleem AB, 2017, NEURON, V93, P315, DOI 10.1016/j.neuron.2016.12.028; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; SAUL AB, 1992, J NEUROPHYSIOL, V68, P1190, DOI 10.1152/jn.1992.68.4.1190; Sedigh-Sarvestani M, 2017, J NEUROSCI, V37, P5250, DOI 10.1523/JNEUROSCI.3370-16.2017; SILLITO AM, 1977, J PHYSIOL-LONDON, V271, P699, DOI 10.1113/jphysiol.1977.sp012021; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; Stanley GB, 2012, J NEUROSCI, V32, P9073, DOI 10.1523/JNEUROSCI.4968-11.2012; SUAREZ H, 1995, J NEUROSCI, V15, P6700; Sun WZ, 2016, NAT NEUROSCI, V19, P308, DOI 10.1038/nn.4196; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668; Zhao XY, 2013, J NEUROSCI, V33, P12751, DOI 10.1523/JNEUROSCI.0095-13.2013	51	65	65	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					80	+		10.1038/s41586-018-0148-5	http://dx.doi.org/10.1038/s41586-018-0148-5			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29795349	Green Submitted			2022-12-28	WOS:000434273300040
J	Aside, LM; Darlow, BA; Finer, N; Schmidt, B; Stenson, B; Tarnow-Mordi, W; Davis, PG; Carlo, WA; Brocklehurst, P; Davies, LC; Das, A; Rich, W; Gantz, MG; Roberts, RS; Whyte, RK; Costantini, L; Poets, C; Asztalos, E; Battin, M; Halliday, HL; Marlow, N; Tin, W; King, A; Juszczak, E; Morley, CJ; Doyle, LW; Gebski, V; Hunter, KE; Simes, RJ				Aside, Lisa M.; Darlow, Brian A.; Finer, Neil; Schmidt, Barbara; Stenson, Ben; Tarnow-Mordi, William; Davis, Peter G.; Carlo, Waldemar A.; Brocklehurst, Peter; Davies, Lucy C.; Das, Abhik; Rich, Wade; Gantz, Marie G.; Roberts, Robin S.; Whyte, Robin K.; Costantini, Lorrie; Poets, Christian; Asztalos, Elizabeth; Battin, Malcolm; Halliday, Henry L.; Marlow, Neil; Tin, Win; King, Andrew; Juszczak, Edmund; Morley, Colin J.; Doyle, Lex W.; Gebski, Val; Hunter, Kylie E.; Simes, Robert J.		Neonatal Oxygenation Prospectiv	Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PULSE OXIMETRY; GESTATIONAL-AGE; BIRTH-WEIGHT; OUTCOMES; TRIALS; RETINOPATHY; BENEFITS; GROWTH	IMPORTANCE There are potential benefits and harms of hyperoxemia and hypoxemia for extremely preterm infants receiving more vs less supplemental oxygen. OBJECTIVE To compare the effects of different target ranges for oxygen saturation as measured by pulse oximetry (Spo(2)) on death or major morbidity. DESIGN, SETTING, AND PARTICIPANTS Prospectively planned meta-analysis of individual participant data from 5 randomized clinical trials (conducted from 2005-2014) enrolling infants born before 28 weeks' gestation. EXPOSURES Spo(2) target range that was lower (85%-89%) vs higher (91%-95%). MAIN OUTCOMES AND MEASURES The primary outcome was a composite of death or major disability (bilateral blindness, deafness, cerebral palsy diagnosed as >= 2 level on the Gross Motor Function Classification System, or Bayley-III cognitive or language score <85) at a corrected age of 18 to 24 months. There were 16 secondary outcomes including the components of the primary outcome and other major morbidities. RESULTS A total of 4965 infants were randomized (2480 to the lower Spo(2) target range and 2485 to the higher Spo(2) range) and had a median gestational age of 26 weeks (interquartile range, 25-27 weeks) and a mean birth weight of 832 g (SD, 190 g). The primary outcome occurred in 1191 of 2228 infants (53.5%) in the lower Spo(2) target group and 1150 of 2229 infants (51.6%) in the higher Spo(2) target group (risk difference, 1.7% [95% Cl, -1.3% to 4.6%]; relative risk [RR], 1.04 [95% Cl, 0.98 to 1.09], P = .21). Of the 16 secondary outcomes, 11 were null, 2 significantly favored the lower Spo(2) target group, and 3 significantly favored the higher Spo(2) target group. Death occurred in 484 of 2433 infants (19.9%) in the lower Spo(2) target group and 418 of 2440 infants (17.1%) in the higher Spo(2) target group (risk difference, 2.8% [95% Cl, 0.6% to 5.0%]; RR, 1.17 [95% Cl, 1.04 to 1.31], P = .01). Treatment for retinopathy of prematurity was administered to 220 of 2020 infants (10.9%) in the lower Spo(2) target group and 308 of 2065 infants (14.9%) in the higher Spo(2) target group (risk difference, -4.0% [95% Cl, -6.1% to -2.0%]; RR, 0.74 [95% Cl, 0.63 to 0.86], P < .001). Severe necrotizing enterocolitis occurred in 227 of 2464 infants (9.2%) in the lower Spo(2) target group and 170 of 2465 infants (6.9%) in the higher Spo(2) target group (risk difference, 2.3% [95% Cl, 0.8% to 3.8%]; RR, 1.33 [95% Cl, 1.10 to 1.61], P = .003). CONCLUSIONS AND RELEVANCE In this prospectively planned meta-analysis of individual participant data from extremely preterm infants, there was no significant difference between a lower Spo(2) target range compared with a higher Spo(2) target range on the primary composite outcome of death or major disability at a corrected age of 18 to 24 months. The lower Spo(2) target range was associated with a higher risk of death and necrotizing enterocolitis, but a lower risk of retinopathy of prematurity treatment.	[Aside, Lisa M.; Tarnow-Mordi, William; Davis, Peter G.; Gebski, Val; Hunter, Kylie E.; Simes, Robert J.] Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Med Fdn Bldg,Level 6,92-94 Parramatta Rd, Camperdown, NSW 2050, Australia; [Darlow, Brian A.] Univ Otago, Dept Paediat, Christchurch, New Zealand; [Finer, Neil; Rich, Wade] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Schmidt, Barbara] Univ Penn, Div Neonatol, Philadelphia, PA 19104 USA; [Schmidt, Barbara; Roberts, Robin S.; Costantini, Lorrie] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Stenson, Ben] Royal Infirm Edinburgh NHS Trust, Dept Neonatol, Edinburgh, Midlothian, Scotland; [Davis, Peter G.; Doyle, Lex W.] Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Newborn Res, Melbourne, Vic, Australia; [Davis, Peter G.; Doyle, Lex W.] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Carlo, Waldemar A.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Brocklehurst, Peter] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham, W Midlands, England; [Brocklehurst, Peter; King, Andrew; Juszczak, Edmund] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England; [Das, Abhik] RTI Int, Stat & Epidemiol Unit, Rockville, MD USA; [Gantz, Marie G.] RTI Int, Stat & Epidemiol Unit, Res Triangle Pk, NC USA; [Whyte, Robin K.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Poets, Christian] Tuebingen Univ Hosp, Dept Neonatol, Tubingen, Germany; [Asztalos, Elizabeth] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Battin, Malcolm] Auckland City Hosp, Newborn Serv, Auckland, New Zealand; [Halliday, Henry L.] Royal Matern Hosp, Belfast, Ireland; [Halliday, Henry L.] Queens Univ, Dept Child Hlth, Belfast, Ireland; [Marlow, Neil] UCL, EGA Inst Womens Hlth, London, England; [Tin, Win] James Cook Univ, Dept Neonatal Med, Middlesbrough, Cleveland, England; [Morley, Colin J.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England	University of Sydney; University of Otago; University of California System; University of California San Diego; University of Pennsylvania; McMaster University; Royal Infirmary of Edinburgh; University of Edinburgh; University of Melbourne; Murdoch Children's Research Institute; University of Alabama System; University of Alabama Birmingham; University of Birmingham; University of Oxford; Research Triangle Institute; Research Triangle Institute; Dalhousie University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Toronto; Auckland City Hospital; Queens University Belfast; University of London; University College London; University of Cambridge	Aside, LM (corresponding author), Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Med Fdn Bldg,Level 6,92-94 Parramatta Rd, Camperdown, NSW 2050, Australia.	lisa.askie@ctc.usyd.edu.au	Doyle, Lex/AAJ-5205-2021; Das, Abhik/AAF-1883-2020; Asztalos, Elizabeth/L-8834-2019; Hunter, Kylie/AAD-6102-2019; Marlow, Neil/D-2918-2009	Doyle, Lex/0000-0002-7667-7312; Das, Abhik/0000-0003-2722-0479; Asztalos, Elizabeth/0000-0002-9468-2860; Hunter, Kylie/0000-0002-2796-9220; Marlow, Neil/0000-0001-5890-2953; Gantz, Marie/0000-0001-8528-0184; Gebski, Val/0000-0001-8748-1844	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services [RO3HD 079867]; NHMRC [1037786]; UK Department of Health's National Institute for Health Research Biomedical Research Centre at University College London Hospital; University College London; Eunice Kennedy Shrivel-National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; National Institutes of Health [U10 HD21364, U10 HD21373, U10 HD21385, U10 HD21397, U10 HD27851, U10 HD27853, U10 HD27856, U10 HD27880, U10 HD27871, U10 HD27904, U10 HD34216, U10 HD36790, U10 HD40461, U10 HD40492, U10 HD40498, U10 HD40521, U10 HD40689, U10 HD53089, U10 HD53109, U10 HD53119, U10 HD53124]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood InstituteNational Institutes of Health [MO1 RR30, MO1 RR32, MO1 RR39, MO1 RR44, MO1 RR54, MO1 RR59, MO1 RR64, MO1 RR70, MO1 RR80, MO1 RR125, MO1 RR633, MO1 RR750, MO1 RR997, MO1 RR6022, MO1 RR7122, MO1 RR8084, MO1 RR16587, UL1 RR25008, UL1 RR24139, UL1 RR24979, UL1 RR25744]; Canadian Institutes of Health Research [MCT-79217]; New Zealand Health Research Council [05/145]; Child Health Research Foundation; UK Medical Research Council; Australian NHMRC [352386]; MRC [G0400415] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD021373, U10HD053119, U10HD021385, U10HD053124, U10HD036790, U10HD027871, R03HD079867, U10HD027851, U10HD027853, U10HD040461, U10HD027880, U10HD034216, U10HD053109, U10HD040492, U10HD021364, U10HD027856, U10HD027904, U10HD053089, U10HD040689] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD021397, U10HD040498, U10HD040521] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000059, UL1RR025008, M01RR000997, M01RR000032, M01RR000080, UL1RR025744, M01RR000044, M01RR000039, M01RR000750, M01RR000064, M01RR000070, M01RR007122, M01RR000633, M01RR016587, M01RR008084, M01RR000054, M01RR000125, M01RR000030, M01RR006022, UL1RR024139, UL1RR024979] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); UK Department of Health's National Institute for Health Research Biomedical Research Centre at University College London Hospital; University College London(General Electric); Eunice Kennedy Shrivel-National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood InstituteNational Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); New Zealand Health Research Council(Health Research Council of New Zealand); Child Health Research Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The data analysis was supported by grant RO3HD 079867 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services. Support for staff of the National Health and Medical Research Council (NHMRC) Clinical Trials Centre (University of Sydney, Sydney, Australia) was partly funded by NHMRC program grant 1037786. Dr Marlow receives funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme at University College London Hospital and the University College London. The SUPPORT trial was supported by grants from the Eunice Kennedy Shrivel-National Institute of Child Health and Human Development, and the National Heart, Lung, and Blood Institute, and from the National Institutes of Health (U10 HD21364, U10 HD21373, U10 HD21385, U10 HD21397, U10 HD27851, U10 HD27853, U10 HD27856, U10 HD27880, U10 HD27871, U10 HD27904, U10 HD34216, U10 HD36790, U10 HD40461, U10 HD40492, U10 HD40498, U10 HD40521, U10 HD40689, U10 HD53089, U10 HD53109, U10 HD53119, and U10 HD53124); and by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, cofunding from the National Heart, Lung, and Blood Institute, and grants from the National Institutes of Health (MO1 RR30, MO1 RR32, MO1 RR39, MO1 RR44, MO1 RR54, MO1 RR59, MO1 RR64, MO1 RR70, MO1 RR80, MO1 RR125, MO1 RR633, MO1 RR750, MO1 RR997, MO1 RR6022, MO1 RR7122, MO1 RR8084, MO1 RR16587, UL1 RR25008, UL1 RR24139, UL1 RR24979, and UL1 RR25744). The Canadian Oxygen Trial was funded by the Canadian Institutes of Health Research (MCT-79217). The BOOST New Zealand trial was funded by th New Zealand Health Research Council (05/145) and the Child Health Research Foundation. The BOOST II UK trial was funded by the UK Medical Research Council and managed by the National Institute for Health Research (NIHR) on behalf of the MRC-NIHR partnership. The BOOST II Australia trial was supported by Australian NHMRC project grant 352386.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Askie LM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011190.pub2; Askie LM, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-6; Askie LM, 2003, NEW ENGL J MED, V349, P959, DOI 10.1056/NEJMoa023080; Askie LM, 2001, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001077; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Bayley N., 2019, BAYLEY SCALES INFANT; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Cole CH, 2003, PEDIATRICS, V112, P1415, DOI 10.1542/peds.112.6.1415; Cummings JJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1576; Cummings JJ, 2016, NEW ENGL J MED, V375, P186, DOI 10.1056/NEJMc1604023; Darlow BA, 2014, J PEDIAT, V165, P30; Ghersi D, 2011, COCHRANE HDB SYSTEMA; Hellstrom A, 2013, LANCET, V382, P1445, DOI 10.1016/S0140-6736(13)60178-6; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, COCHRANE HDB SYSTEMA; Ioannidis J, 2017, BRIT J SPORT MED, V51, P1456, DOI 10.1136/bjsports-2017-097621; Johnston ED, 2011, ARCH DIS CHILD-FETAL, V96, pF429, DOI 10.1136/adc.2010.206011; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Palisano RJ, 2000, PHYS THER, V80, P974, DOI 10.1093/ptj/80.10.974; Phelps DL, 2000, PEDIATRICS, V105, P295; Rich W, 2012, PEDIATRICS, V129, P480, DOI 10.1542/peds.2011-2121; Schmidt B, 2014, PEDIATRICS, V165, P666; Schmidt B, 2014, J PEDIATR-US, V165, P6, DOI 10.1016/j.jpeds.2014.03.004; Schmidt B, 2013, JAMA-J AM MED ASSOC, V309, P2111, DOI 10.1001/jama.2013.5555; Schou IM, 2013, STAT MED, V32, P4859, DOI 10.1002/sim.5893; SIMES RJ, 1995, AM J CARDIOL, V76, pC122; Stenson B, 2011, NEW ENGL J MED, V364, P1680, DOI 10.1056/NEJMc1101319; Stenson BJ, 2013, NEW ENGL J MED, V368, P2094, DOI 10.1056/NEJMoa1302298; Stenson BJ, 2013, NEONATOLOGY, V103, P341, DOI 10.1159/000349936; Tarnow-Mordi W, 2016, NEW ENGL J MED, V374, P749, DOI 10.1056/NEJMoa1514212; Tin W, 2001, ARCH DIS CHILD-FETAL, V84, pF106, DOI 10.1136/fn.84.2.F106; Vaucher YE, 2012, NEW ENGL J MED, V367, P2495, DOI 10.1056/NEJMoa1208506; Walsh MC, 2016, JAMA PEDIATR, V170, P292, DOI 10.1001/jamapediatrics.2015.3794; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Whyte RK, 2017, J PEDIATR-US, V182, P382, DOI 10.1016/j.jpeds.2016.11.076	37	189	195	2	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2190	2201		10.1001/jama.2018.5725	http://dx.doi.org/10.1001/jama.2018.5725			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29872859	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000434133400017
J	Moore, GT				Moore, Gordon T.			Let's Provide Primary Care to All Uninsured Americans Now! (Reprinted from JAMA, vol 265, pg 2108-2109, 1991)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		MOORE GT, 1991, JAMA-J AM MED ASSOC, V265, P2108	1	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2240	2240		10.1001/jama.2017.12402	http://dx.doi.org/10.1001/jama.2017.12402			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29872849				2022-12-28	WOS:000434133400033
J	Waytz, J; Cifu, AS; Stern, SDC				Waytz, Josh; Cifu, Adam S.; Stern, Scott D. C.			Evaluation and Management of Patients With Syncope	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EMERGENCY-DEPARTMENT		[Waytz, Josh] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Cifu, Adam S.; Stern, Scott D. C.] Univ Chicago, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Cifu, AS (corresponding author), Univ Chicago, Gen Internal Med Sect, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Perez-Rodon J, 2014, HEART RHYTHM, V11, P2035, DOI 10.1016/j.hrthm.2014.06.037; Prandoni P, 2016, NEW ENGL J MED, V375, P1524, DOI 10.1056/NEJMoa1602172; Shen WK, 2017, CIRCULATION, V136, pE60, DOI 10.1161/CIR.0000000000000499; Shen WK, 2004, CIRCULATION, V110, P3636, DOI 10.1161/01.CIR.0000149236.92822.07; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; Sun BC, 2014, ANN EMERG MED, V64, P167, DOI 10.1016/j.annemergmed.2013.10.029; van Dijk N, 2008, J CARDIOVASC ELECTR, V19, P48, DOI 10.1111/j.1540-8167.2007.00984.x; Yasa E, 2018, HEART, V104, P487, DOI 10.1136/heartjnl-2017-311857	8	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2227	2228		10.1001/jama.2017.21992	http://dx.doi.org/10.1001/jama.2017.21992			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29872846				2022-12-28	WOS:000434133400022
J	Achilli, A; Olivieri, A; Semino, O; Torroni, A				Achilli, Alessandro; Olivieri, Anna; Semino, Ornella; Torroni, Antonio			Ancient human genomes-keys to understanding our past	SCIENCE			English	Editorial Material							POPULATION; AMERICANS		[Achilli, Alessandro; Olivieri, Anna; Semino, Ornella; Torroni, Antonio] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy	University of Pavia	Torroni, A (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy.	antonio.torroni@unipv.it	Achilli, Alessandro/I-9236-2012; OLIVIERI, ANNA/I-9235-2012; Torroni, Antonio/E-1557-2011	Achilli, Alessandro/0000-0001-6871-3451; OLIVIERI, ANNA/0000-0002-3941-8098; Torroni, Antonio/0000-0002-4163-4478				Achilli A, 2013, P NATL ACAD SCI USA, V110, P14308, DOI 10.1073/pnas.1306290110; Braje TJ, 2017, SCIENCE, V358, P592, DOI 10.1126/science.aao5473; Ebenesersdottir SS, 2018, SCIENCE, V360, P1028, DOI 10.1126/science.aar2625; Kashani BH, 2012, AM J PHYS ANTHROPOL, V147, P35, DOI 10.1002/ajpa.21614; Moreno-Mayar JV, 2018, NATURE, V553, P203, DOI 10.1038/nature25173; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Posth C, 2016, CURR BIOL, V26, P827, DOI 10.1016/j.cub.2016.01.037; Potter BA, 2018, SCIENCE, V359, P1224, DOI 10.1126/science.aar8233; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Renfrew A. C., 2000, ARCHAEOGENETICS DNA; Scheib CL, 2018, SCIENCE, V360, P1024, DOI 10.1126/science.aar6851; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; van de Loosdrecht M, 2018, SCIENCE, V360, P548, DOI 10.1126/science.aar8380	15	9	9	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					964	965		10.1126/science.aat7257	http://dx.doi.org/10.1126/science.aat7257			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6SL	29853673				2022-12-28	WOS:000433574200023
J	Rajab, TK; Bordeianou, LG; von Keudell, A; Rajab, H; Zhou, HY				Rajab, Taufiek K.; Bordeianou, Liliana G.; von Keudell, Arvind; Rajab, Hanna; Zhou, Haiyang			Digital Rectal Examination and Anoscopy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rajab, Taufiek K.; von Keudell, Arvind] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Bordeianou, Liliana G.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Rajab, Hanna] Univ Tubingen, Tubingen, Germany; [Zhou, Haiyang] Second Military Med Univ, Changzheng Hosp, Shanghai, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Eberhard Karls University of Tubingen; Naval Medical University	Zhou, HY (corresponding author), Shanghai Changzheng Hosp, 415 Fengyang Rd, Shanghai 200003, Peoples R China.	haiyang1985_1@aliyun.com						Barleben A, 2010, SURG CLIN N AM, V90, P1, DOI 10.1016/j.suc.2009.09.001; HENNIGAN TW, 1990, BRIT MED J, V301, P478, DOI 10.1136/bmj.301.6750.478; Long KC, 2016, CLIN COLON RECT SURG, V29, P57, DOI 10.1055/s-0035-1570394; Manimaran N, 2004, ANN ROY COLL SURG, V86, P292, DOI 10.1308/147870804218; MURIS JWM, 1993, FAM PRACT, V10, P34, DOI 10.1093/fampra/10.1.34; NG DPK, 1991, POSTGRAD MED J, V67, P904, DOI 10.1136/pgmj.67.792.904; Talley NJ, 2008, AM J GASTROENTEROL, V103, P820, DOI 10.1111/j.1572-0241.2008.01832.x	7	4	4	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2018	378	22							e30	10.1056/NEJMvcm1510280	http://dx.doi.org/10.1056/NEJMvcm1510280			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH5AL	29847759				2022-12-28	WOS:000433428000010
J	Slota, M; Keerthi, A; Myers, WK; Tretyakov, E; Baumgarten, M; Ardavan, A; Sadeghi, H; Lambert, CJ; Narita, A; Mullen, K; Bogani, L				Slota, Michael; Keerthi, Ashok; Myers, William K.; Tretyakov, Evgeny; Baumgarten, Martin; Ardavan, Arzhang; Sadeghi, Hatef; Lambert, Colin J.; Narita, Akimitsu; Muellen, Klaus; Bogani, Lapo			Magnetic edge states and coherent manipulation of graphene nanoribbons	NATURE			English	Article							COMPREHENSIVE SOFTWARE PACKAGE; SPIN QUBITS; EPR; SPECTROSCOPY; SIMULATION; DEVICES; DIAMOND; ZIGZAG; BAND	Graphene, a single-layer network of carbon atoms, has outstanding electrical and mechanical properties(1). Graphene ribbons with nanometre-scale widths(2,3) (nanoribbons) should exhibit half-metallicity(4) and quantum confinement. Magnetic edges in graphene nanoribbons(5,6) have been studied extensively from a theoretical standpoint because their coherent manipulation would be a milestone for spintronic(7) and quantum computing devices(8). However, experimental investigations have been hampered because nanoribbon edges cannot be produced with atomic precision and the graphene terminations that have been proposed are chemically unstable(9). Here we address both of these problems, by using molecular graphene nanoribbons functionalized with stable spin-bearing radical groups. We observe the predicted delocalized magnetic edge states and test theoretical models of the spin dynamics and spin-environment interactions. Comparison with a non-graphitized reference material enables us to clearly identify the characteristic behaviour of the radical-functionalized graphene nanoribbons. We quantify the parameters of spin-orbit coupling, define the interaction patterns and determine the spin decoherence channels. Even without any optimization, the spin coherence time is in the range of microseconds at room temperature, and we perform quantum inversion operations between edge and radical spins. Our approach provides a way of testing the theory of magnetism in graphene nanoribbons experimentally. The coherence times that we observe open up encouraging prospects for the use of magnetic nanoribbons in quantum spintronic devices.	[Slota, Michael; Bogani, Lapo] Univ Oxford, Dept Mat, Oxford, England; [Slota, Michael; Myers, William K.; Ardavan, Arzhang; Bogani, Lapo] Univ Oxford, Ctr Adv ESR, Oxford, England; [Keerthi, Ashok; Baumgarten, Martin; Narita, Akimitsu; Muellen, Klaus] Max Planck Inst Polymer Res, Mainz, Germany; [Tretyakov, Evgeny] NN Vorozhtsov Novosibirsk Inst Organ Chem, Novosibirsk, Russia; [Ardavan, Arzhang] Univ Oxford, Clarendon Lab, Oxford, England; [Sadeghi, Hatef; Lambert, Colin J.] Univ Lancaster, Phys Dept, Quantum Technol Ctr, Lancaster, England	University of Oxford; University of Oxford; Max Planck Society; Russian Academy of Sciences; Vorozhtsov Novosibirsk Institute of Organic Chemistry; University of Oxford; Lancaster University	Bogani, L (corresponding author), Univ Oxford, Dept Mat, Oxford, England.; Bogani, L (corresponding author), Univ Oxford, Ctr Adv ESR, Oxford, England.	lapo.bogani@materials.ox.ac.uk	Narita, Akimitsu/AAD-2005-2019; Ardavan, Arzhang/AAY-9214-2020; Keerthi, Ashok/T-4643-2018; Tretyakov, Evgeny/A-7163-2014; Bogani, Lapo/ABE-6209-2020; Sadeghi, Hatef/P-2407-2019; Lambert, Colin/A-7025-2009; Keerthi, Ashok/J-1291-2014; Baumgarten, Martin/U-8468-2019	Narita, Akimitsu/0000-0002-3625-522X; Keerthi, Ashok/0000-0002-8479-4762; Tretyakov, Evgeny/0000-0003-1540-7033; Bogani, Lapo/0000-0002-4926-5048; Sadeghi, Hatef/0000-0001-5398-8620; Lambert, Colin/0000-0003-2332-9610; Myers, William/0000-0001-5935-9112	European Research Council [ERC-StG 338258]; EU [COST-CA15128, MOLESCO-606728]; EPSRC; Royal Society; RFBR [17-53-50043]; Max Planck Society; German DAAD Bilateral Exchange of Academics [2015/50015739]; EPSRC [EP/J013501/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); EU(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); RFBR(Russian Foundation for Basic Research (RFBR)); Max Planck Society(Max Planck SocietyFoundation CELLEX); German DAAD Bilateral Exchange of Academics; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the European Research Council (ERC-StG 338258 OptoQMol), the EU (COST-CA15128, MOLESCO-606728 and Graphene Flagship), the EPSRC (QuEEN grant), the Royal Society (University Research Fellowship and URF grant), the RFBR (17-53-50043), the Max Planck Society and the German DAAD Bilateral Exchange of Academics (2015/50015739) for financial support.	[Anonymous], 2016, GAUSSIAN 09 REVISION; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Barone V, 2006, NANO LETT, V6, P2748, DOI 10.1021/nl0617033; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; CANESCHI A, 1991, PROG INORG CHEM, V39, P331, DOI 10.1002/9780470166406.ch6; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Collauto A, 2012, J MATER CHEM, V22, P22272, DOI 10.1039/c2jm35076a; Cox N, 2013, MOL PHYS, V111, P2788, DOI 10.1080/00268976.2013.830783; Drogeler M, 2016, NANO LETT, V16, P3533, DOI 10.1021/acs.nanolett.6b00497; Eaton G. R., 2011, MULTIFREQUENCY ELECT; Fischer J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155401; Foletti S, 2009, NAT PHYS, V5, P903, DOI 10.1038/NPHYS1424; Golor M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.046601; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jia XT, 2009, SCIENCE, V323, P1701, DOI 10.1126/science.1166862; Jiao LY, 2009, NATURE, V458, P877, DOI 10.1038/nature07919; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Keerthi A, 2016, CHEM-ASIAN J, V11, P2710, DOI 10.1002/asia.201600638; KLAUDER JR, 1962, PHYS REV, V125, P912, DOI 10.1103/PhysRev.125.912; Meunier V, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.025005; Min H, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165310; Narita A, 2015, CHEM SOC REV, V44, P6616, DOI 10.1039/c5cs00183h; Narita A, 2014, ACS NANO, V8, P11622, DOI 10.1021/nn5049014; Narita A, 2014, NAT CHEM, V6, P126, DOI [10.1038/NCHEM.1819, 10.1038/nchem.1819]; Pesin D, 2012, NAT MATER, V11, P409, DOI [10.1038/nmat3305, 10.1038/NMAT3305]; Rao SS, 2012, ACS NANO, V6, P7615, DOI 10.1021/nn302745x; Recher P, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/30/302001; Rintoul L, 2008, SPECTROCHIM ACTA A, V70, P713, DOI 10.1016/j.saa.2007.08.017; Ruffieux P, 2016, NATURE, V531, P489, DOI 10.1038/nature17151; Schweiger A., 2001, PRINCIPLES PULSE ELE; Shiddiq M, 2016, NATURE, V531, P348, DOI 10.1038/nature16984; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; Son YW, 2007, NATURE, V446, P342, DOI 10.1038/nature05686; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Struck PR, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.125401; WACKER T, 1992, ISRAEL J CHEM, V32, P305; ZHELUDEV A, 1994, J AM CHEM SOC, V116, P2019, DOI 10.1021/ja00084a048	39	170	174	29	378	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					691	+		10.1038/s41586-018-0154-7	http://dx.doi.org/10.1038/s41586-018-0154-7			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29849157	Green Accepted			2022-12-28	WOS:000433412900047
J	Thornton, J				Thornton, Jacqui			Nine in 10 children who die from TB went untreated	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Union against Tuberculosis and Lung Disease, SIL EP CALL ACT CHIL	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2018	361								k2345	10.1136/bmj.k2345	http://dx.doi.org/10.1136/bmj.k2345			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MP	29848481				2022-12-28	WOS:000434275800006
J	Gardner, C				Gardner, Caleb			Neglected encounters: addiction and the meaning of pain	LANCET			English	Editorial Material									[Gardner, Caleb] Cambridge Hlth Alliance, Cambridge, MA 02139 USA	Harvard University; Cambridge Health Alliance	Gardner, C (corresponding author), Cambridge Hlth Alliance, Cambridge, MA 02139 USA.	cgardner@cha.harvard.edu						Ballantyne JC, 2015, NEW ENGL J MED, V373, P2098, DOI 10.1056/NEJMp1507136; Carver R., 1990, FIRES; Morris David B., 1993, CULTURE PAIN	3	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2018	391	10135					2100	2101		10.1016/S0140-6736(18)31087-0	http://dx.doi.org/10.1016/S0140-6736(18)31087-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH2UJ	29856338				2022-12-28	WOS:000433257200017
J	Kirby, T				Kirby, Tony			Catherine Karr: improving paediatric respiratory health	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2018	391	10135					2099	2099		10.1016/S0140-6736(18)31086-9	http://dx.doi.org/10.1016/S0140-6736(18)31086-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH2UJ	29856337				2022-12-28	WOS:000433257200016
J	Dyer, C				Dyer, Clare			Hunt's ACOs could undermine NHS principles, judge hears	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1125	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2018	361								k2342	10.1136/bmj.k2342	http://dx.doi.org/10.1136/bmj.k2342			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH4XO	29802133				2022-12-28	WOS:000433416200011
J	Nevitt, GA				Nevitt, Gabrielle A.			Following the leader, for better or worse	SCIENCE			English	Editorial Material							WHITE STORKS; FLIGHT; BEHAVIOR; BIRDS		[Nevitt, Gabrielle A.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis	Nevitt, GA (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	ganevitt@ucdavis.edu			NSF [1142084, 1258828]	NSF(National Science Foundation (NSF))	The author gratefully acknowledges support from the NSF (grants 1142084 and 1258828).	Chernetsov N, 2004, J EXP BIOL, V207, P937, DOI 10.1242/jeb.00853; Flack A, 2018, SCIENCE, V360, P911, DOI 10.1126/science.aap7781; Harel R, 2016, SCI REP-UK, V6, DOI 10.1038/srep27865; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; Pennycuick CJ, 1998, J AVIAN BIOL, V29, P33, DOI 10.2307/3677338; Rotics S, 2016, J ANIM ECOL, V85, P938, DOI 10.1111/1365-2656.12525; Voelkl B, 2015, P NATL ACAD SCI USA, V112, P2115, DOI 10.1073/pnas.1413589112; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670	8	0	0	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					852	853		10.1126/science.aat7920	http://dx.doi.org/10.1126/science.aat7920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG9RW	29798867				2022-12-28	WOS:000433039800025
J	Stafford, N				Stafford, Ned			Medicinal cannabis should not be used ahead of approved drugs, says German review	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Glaeske G, CANNABIS REPORT; Stafford N, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j706; Stafford N, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5999	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2018	361								k2326	10.1136/bmj.k2326	http://dx.doi.org/10.1136/bmj.k2326			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH4XN	29794116				2022-12-28	WOS:000433416100008
J	Walton, ZE; Patel, CH; Brooks, RC; Yu, YJ; Ibrahim-Hashim, A; Riddle, M; Porcu, A; Jiang, TY; Ecker, BL; Tameire, F; Koumenis, C; Weeraratna, AT; Welsh, DK; Gillies, R; Alwine, JC; Zhang, L; Powell, JD; Dang, CV				Walton, Zandra E.; Patel, Chirag H.; Brooks, Rebekah C.; Yu, Yongjun; Ibrahim-Hashim, Arig; Riddle, Malini; Porcu, Alessandra; Jiang, Tianying; Ecker, Brett L.; Tameire, Feven; Koumenis, Constantinos; Weeraratna, Ashani T.; Welsh, David K.; Gillies, Robert; Alwine, James C.; Zhang, Lin; Powell, Jonathan D.; Dang, Chi V.			Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR	CELL			English	Article							CYTOPLASMIC PH; TUMOR MICROENVIRONMENT; MOLECULAR-MECHANISM; MAMMALIAN TARGET; INTRACELLULAR PH; GENE-EXPRESSION; METABOLISM; LOCALIZATION; FIBROBLASTS; LYSOSOME	Recent reports indicate that hypoxia influences the circadian clock through the transcriptional activities of hypoxia-inducible factors (HIFs) at clock genes. Unexpectedly, we uncover a profound disruption of the circadian clock and diurnal transcriptome when hypoxic cells are permitted to acidify to recapitulate the tumor microenvironment. Buffering against acidification or inhibiting lactic acid production fully rescues circadian oscillation. Acidification of several human and murine cell lines, as well as primary murine T cells, suppresses mechanistic target of rapamycin complex 1 (mTORC1) signaling, a key regulator of translation in response to metabolic status. We find that acid drives peripheral redistribution of normally perinuclear lysosomes away from perinuclear RHEB, thereby inhibiting the activity of lyso-some-bound mTOR. Restoring mTORC1 signaling and the translation it governs rescues clock oscillation. Our findings thus reveal a model in which acid produced during the cellular metabolic response to hypoxia suppresses the circadian clock through diminished translation of clock constituents.	[Walton, Zandra E.; Brooks, Rebekah C.; Yu, Yongjun; Alwine, James C.; Dang, Chi V.] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Walton, Zandra E.; Brooks, Rebekah C.; Yu, Yongjun; Alwine, James C.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Patel, Chirag H.; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Sidney Kimmel Comprehens Canc Res Ctr,Dept Oncol, Baltimore, MD 21231 USA; [Ibrahim-Hashim, Arig; Gillies, Robert] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Physiol, Tampa, FL 33612 USA; [Ibrahim-Hashim, Arig; Gillies, Robert] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL 33612 USA; [Riddle, Malini; Porcu, Alessandra; Welsh, David K.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Riddle, Malini; Porcu, Alessandra; Welsh, David K.] Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA; [Riddle, Malini; Porcu, Alessandra; Welsh, David K.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Jiang, Tianying; Ecker, Brett L.; Weeraratna, Ashani T.; Dang, Chi V.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Ecker, Brett L.] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Tameire, Feven; Koumenis, Constantinos] Univ Penn, Perelman Univ Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Zhang, Lin] Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; [Zhang, Lin] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Dang, Chi V.] Ludwig Inst Canc Res, New York, NY 10017 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; The Wistar Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Ludwig Institute for Cancer Research	Walton, ZE; Dang, CV (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.; Walton, ZE (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA.; Dang, CV (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.; Dang, CV (corresponding author), Ludwig Inst Canc Res, New York, NY 10017 USA.	zandrawalton@alumni.upenn.edu; cdang@licr.org	Dang, Chi/Y-3375-2019; Koumenis, Constantinos/B-2002-2008	Yu, Yongjun/0000-0002-4376-8269; Walton, Zandra/0000-0002-0465-0153; Brooks, Rebekah/0000-0002-9795-5748; Gillies, Robert/0000-0002-8888-7747; Riddle, Malini/0000-0002-6493-2734; Koumenis, Costas/0000-0001-5945-4726	NIH; NCI [F30CA200347, 5T32CA009140, R01CA051497, R01CA57341, R01CA157846, R01AI077610, R01AI091481, R01CA077575, U54CA193489, P30CA010815, R01CA174746]; Veterans Affairs Merit Award [I01BX001146]; Patel Scholar Award; Bloomberg-Kimmel Institute of Cancer Immunotherapy; Tissue Core Facility at the H. Lee Moffitt Cancer Center and Research Institute [P30CA076292]; NATIONAL CANCER INSTITUTE [R01CA157846, R01CA057341, P30CA076292, P30CA010815, U54CA193489, R01CA077575, T32CA009140, R01CA174746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077610] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs Merit Award(US Department of Veterans Affairs); Patel Scholar Award; Bloomberg-Kimmel Institute of Cancer Immunotherapy; Tissue Core Facility at the H. Lee Moffitt Cancer Center and Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	We thank David Sabatini, Pedro Enriques-Navas, Veronica Estrella, Robert Gatenby, James Hayden, Frederick Keeney, Todd Ridky, John Hogenesch, Celeste Simon, Brian Keith, and Dang lab members for their help. This work is supported by NIH and NCI grants (F30CA200347 and 5T32CA009140 to Z.E.W.; R01CA051497 and R01CA57341 to C.V.D.; R01CA157846 to J.C.A.; R01AI077610 and R01AI091481 to J.D.P.; R01CA077575 and U54CA193489 to R.G.; and P30CA010815 and R01CA174746 to A.T.W.), a Veterans Affairs Merit Award (I01BX001146) (to D.K.W.), a Patel Scholar Award (to Z.E.W.), the Bloomberg-Kimmel Institute of Cancer Immunotherapy (J.D.P.), and the Tissue Core Facility at the H. Lee Moffitt Cancer Center and Research Institute (R.G., P30CA076292).	Adamovich Y, 2017, CELL METAB, V25, P93, DOI 10.1016/j.cmet.2016.09.014; Altman BJ, 2015, CELL METAB, V22, P1009, DOI 10.1016/j.cmet.2015.09.003; Balgi AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021549; Boudreau A, 2016, NAT CHEM BIOL, V12, P779, DOI 10.1038/nchembio.2143; Cao RF, 2010, J NEUROSCI, V30, P6302, DOI 10.1523/JNEUROSCI.5482-09.2010; CHAMBARD JC, 1986, EXP CELL RES, V164, P282, DOI 10.1016/0014-4827(86)90029-7; Clippinger AJ, 2012, GENE DEV, V26, P2015, DOI 10.1101/gad.196147.112; Clippinger AJ, 2011, J VIROL, V85, P9369, DOI 10.1128/JVI.05102-11; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dibner C, 2015, J INTERN MED, V277, P513, DOI 10.1111/joim.12347; Dmitriev AV, 2001, J NEUROSCI, V21, P2897, DOI 10.1523/JNEUROSCI.21-08-02897.2001; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; Hanker AB, 2010, ONCOGENE, V29, P380, DOI 10.1038/onc.2009.336; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; Ibrahim-Hashim A, 2017, CANCER RES, V77, P2242, DOI 10.1158/0008-5472.CAN-16-2844; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; Jongsma MLM, 2016, CELL, V166, P152, DOI 10.1016/j.cell.2016.05.078; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Lipton JO, 2015, CELL, V161, P1138, DOI 10.1016/j.cell.2015.04.002; Manifava M, 2016, ELIFE, V5, DOI 10.7554/eLife.19960; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; Mortola JP, 2007, RESP PHYSIOL NEUROBI, V158, P274, DOI 10.1016/j.resp.2007.02.005; Peek CB, 2017, CELL METAB, V25, P86, DOI 10.1016/j.cmet.2016.09.010; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; POUYSSEGUR J, 1985, FEBS LETT, V190, P115, DOI 10.1016/0014-5793(85)80439-7; Raghunand N, 1999, BRIT J CANCER, V80, P1005, DOI 10.1038/sj.bjc.6690455; Rainero E, 2015, CELL REP, V10, P398, DOI 10.1016/j.celrep.2014.12.037; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Walton ZE, 2018, ANNU REV CANC BIOL, V2, P133, DOI 10.1146/annurev-cancerbio-030617-050216; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Wolfson RL, 2017, NATURE, V543, P438, DOI 10.1038/nature21423; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Wu YL, 2017, CELL METAB, V25, P73, DOI 10.1016/j.cmet.2016.09.009; Xie JL, 2015, MOL CELL BIOL, V35, P1805, DOI 10.1128/MCB.00012-15; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yang R, 2010, BIOINFORMATICS, V26, pi168, DOI 10.1093/bioinformatics/btq189; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zheng XZ, 2010, CURR BIOL, V20, P1203, DOI 10.1016/j.cub.2010.05.027	51	111	115	4	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 28	2018	174	1					72	+		10.1016/j.cell.2018.05.009	http://dx.doi.org/10.1016/j.cell.2018.05.009			48	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GL3CR	29861175	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000437005800012
J	Fraietta, JA; Nobles, CL; Sammons, MA; Lundh, S; Carty, SA; Reich, TJ; Cogdill, AP; Morrissette, JJD; DeNizio, JE; Reddy, S; Hwang, Y; Gohil, M; Kulikovskaya, I; Nazimuddin, F; Gupta, M; Chen, F; Everett, JK; Alexander, KA; Lin-Shiao, E; Gee, MH; Liu, XJ; Young, RM; Ambrose, D; Wang, Y; Xu, J; Jordan, MS; Marcucci, KT; Levine, BL; Garcia, KC; Zhao, YB; Kalos, M; Porter, DL; Kohli, RM; Lacey, SF; Berger, SL; Bushman, FD; June, CH; Melenhorst, JJ				Fraietta, Joseph A.; Nobles, Christopher L.; Sammons, Morgan A.; Lundh, Stefan; Carty, Shannon A.; Reich, Tyler J.; Cogdill, Alexandria P.; Morrissette, Jennifer J. D.; DeNizio, Jamie E.; Reddy, Shantan; Hwang, Young; Gohil, Mercy; Kulikovskaya, Irina; Nazimuddin, Farzana; Gupta, Minnal; Chen, Fang; Everett, John K.; Alexander, Katherine A.; Lin-Shiao, Enrique; Gee, Marvin H.; Liu, Xiaojun; Young, Regina M.; Ambrose, David; Wang, Yan; Xu, Jun; Jordan, Martha S.; Marcucci, Katherine T.; Levine, Bruce L.; Garcia, K. Christopher; Zhao, Yangbing; Kalos, Michael; Porter, David L.; Kohli, Rahul M.; Lacey, Simon F.; Berger, Shelley L.; Bushman, Frederic D.; June, Carl H.; Melenhorst, J. Joseph			Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells	NATURE			English	Article							CD28 COSTIMULATION; DNA INTEGRATION; B-CELL; 5-METHYLCYTOSINE; MUTATIONS; PROTEINS; 5-HYDROXYMETHYLCYTOSINE; 5-FORMYLCYTOSINE; LYMPHOCYTES; CONVERSION	Cancer immunotherapy based on genetically redirecting T cells has been used successfully to treat B cell malignancies(1-3). In this strategy, the T cell genome is modified by integration of viral vectors or transposons encoding chimaeric antigen receptors (CARs) that direct tumour cell killing. However, this approach is often limited by the extent of expansion and persistence of CAR T cells(4,5). Here we report mechanistic insights from studies of a patient with chronic lymphocytic leukaemia treated with CAR T cells targeting the CD19 protein. Following infusion of CAR T cells, anti-tumour activity was evident in the peripheral blood, lymph nodes and bone marrow; this activity was accompanied by complete remission. Unexpectedly, at the peak of the response, 94% of CAR T cells originated from a single clone in which lentiviral vector-mediated insertion of the CAR transgene disrupted the methylcytosine dioxygenase TET2 gene. Further analysis revealed a hypomorphic mutation in this patient's second TET2 allele. TET2-disrupted CAR T cells exhibited an epigenetic profile consistent with altered T cell differentiation and, at the peak of expansion, displayed a central memory phenotype. Experimental knockdown of TET2 recapitulated the potency-enhancing effect of TET2 dysfunction in this patient's CAR T cells. These findings suggest that the progeny of a single CAR T cell induced leukaemia remission and that TET2 modification may be useful for improving immunotherapies.	[Fraietta, Joseph A.; Lundh, Stefan; Reich, Tyler J.; Cogdill, Alexandria P.; Gohil, Mercy; Kulikovskaya, Irina; Nazimuddin, Farzana; Gupta, Minnal; Chen, Fang; Liu, Xiaojun; Young, Regina M.; Ambrose, David; Wang, Yan; Xu, Jun; Marcucci, Katherine T.; Levine, Bruce L.; Zhao, Yangbing; Kalos, Michael; Porter, David L.; Lacey, Simon F.; June, Carl H.; Melenhorst, J. Joseph] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA; [Fraietta, Joseph A.; Lundh, Stefan; Carty, Shannon A.; Reich, Tyler J.; Cogdill, Alexandria P.; Gohil, Mercy; Kulikovskaya, Irina; Nazimuddin, Farzana; Gupta, Minnal; Chen, Fang; Liu, Xiaojun; Young, Regina M.; Ambrose, David; Wang, Yan; Xu, Jun; Jordan, Martha S.; Marcucci, Katherine T.; Levine, Bruce L.; Zhao, Yangbing; Kalos, Michael; Porter, David L.; Lacey, Simon F.; June, Carl H.; Melenhorst, J. Joseph] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Fraietta, Joseph A.; Morrissette, Jennifer J. D.; Jordan, Martha S.; Levine, Bruce L.; Kalos, Michael; Lacey, Simon F.; June, Carl H.; Melenhorst, J. Joseph] Univ Penn, Perelman Sch Med, Pathol & Lab Med, Philadelphia, PA 19104 USA; [Fraietta, Joseph A.; June, Carl H.; Melenhorst, J. Joseph] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Nobles, Christopher L.; Reddy, Shantan; Hwang, Young; Everett, John K.; Kohli, Rahul M.; Bushman, Frederic D.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sammons, Morgan A.; Alexander, Katherine A.; Lin-Shiao, Enrique; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Epigenet Program, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [DeNizio, Jamie E.; Porter, David L.; Kohli, Rahul M.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [DeNizio, Jamie E.; Kohli, Rahul M.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gee, Marvin H.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA; [Sammons, Morgan A.] SUNY Albany, Dept Biol, Albany, NY 12222 USA; [Carty, Shannon A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Carty, Shannon A.] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	June, CH; Melenhorst, JJ (corresponding author), Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA.; June, CH; Melenhorst, JJ (corresponding author), Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA.; June, CH; Melenhorst, JJ (corresponding author), Univ Penn, Perelman Sch Med, Pathol & Lab Med, Philadelphia, PA 19104 USA.; June, CH; Melenhorst, JJ (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.	cjune@upenn.edu; mej@upenn.edu	Carty, Shannon/ABF-9536-2020; Melenhorst, Jan/AAW-2546-2020	Carty, Shannon/0000-0003-2286-8014; Melenhorst, Jan/0000-0001-7677-537X; Lin Shiao, Enrique/0000-0001-5396-9614; Cogdill, Alexandria/0000-0001-8917-9462; Reich, Tyler/0000-0003-0178-1411	NCI [T32CA009140, P01CA214278, AI104400, AI 082020, AI045008, AI117950]; NIAID [K08AI101008]; NIGMS [R01GM118501, R01CA165206]; Stand Up to Cancer Phillip A. Sharp Innovation in Collaboration Award; Novartis; NATIONAL CANCER INSTITUTE [R01CA078831, T32CA009140, R01CA165206, P01CA214278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104400, P30AI045008, K08AI101008, U01AI104400, R01AI082020, U19AI117950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118501] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stand Up to Cancer Phillip A. Sharp Innovation in Collaboration Award; Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	L. Tian, V. Gonzalez, N. Kengle, J. Scholler, Y. Wu, A. Bagg, C. Pletcher, B. Carreno, A. Bigdeli and A. Chew are acknowledged for research support. D. Campana and C. Imai provided the CD19-directed CAR under material transfer agreements. B. Jena and L. Cooper provided the CAR anti- idiotypic antibody. The OSU-CLL cell line was a kind gift from J. C. Byrd. This work was supported by funding from NCI T32CA009140 (J.A.F.), P01CA214278 (C.H.J.), AI104400, AI 082020, AI045008, AI117950 (F.D.B), NIAID K08AI101008 (S.A.C.), NIGMS R01GM118501 (R.M.K.), R01CA165206 (D.L.P. and C.H.J.), a Stand Up to Cancer Phillip A. Sharp Innovation in Collaboration Award (S.L.B. and C.H.J.) and Novartis.	Aslanyan MG, 2014, ANN HEMATOL, V93, P1401, DOI 10.1007/s00277-014-2055-7; Barrett DM, 2011, HUM GENE THER, V22, P1575, DOI 10.1089/hum.2011.070; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Berry CC, 2014, BIOINFORMATICS, V30, P1493, DOI 10.1093/bioinformatics/btu035; Berry CC, 2012, BIOINFORMATICS, V28, P755, DOI 10.1093/bioinformatics/bts004; Brady T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr140; Brady T, 2009, GENE DEV, V23, P633, DOI 10.1101/gad.1762309; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Carty SA, 2018, J IMMUNOL, V200, P82, DOI 10.4049/jimmunol.1700559; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Daber R, 2013, CANCER GENET-NY, V206, P441, DOI 10.1016/j.cancergen.2013.11.005; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Fraietta JA, 2016, BLOOD, V127, P1117, DOI 10.1182/blood-2015-11-679134; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hertlein E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076607; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jena B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057838; Jin JJ, 2012, J IMMUNOTHER, V35, P283, DOI 10.1097/CJI.0b013e31824e801f; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Laport GG, 2003, BLOOD, V102, P2004, DOI 10.1182/blood-2003-01-0095; Liu MY, 2016, METHOD ENZYMOL, V573, P365, DOI 10.1016/bs.mie.2015.12.006; Liu MY, 2017, NAT CHEM BIOL, V13, P181, DOI [10.1038/NCHEMBIO.2250, 10.1038/nchembio.2250]; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Moskowitz DM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag0192; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tefferi A, 2009, LEUKEMIA, V23, P1343, DOI 10.1038/leu.2009.59; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Xu J, 2017, NAT GENET, V49, P377, DOI 10.1038/ng.3769; Yeh CH, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0500-z; Zang SB, 2017, J CLIN INVEST, V127, P2998, DOI 10.1172/JCI92026; Zhang H, 2007, J IMMUNOL, V179, P4910, DOI 10.4049/jimmunol.179.7.4910	47	386	403	9	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2018	558	7709					307	+		10.1038/s41586-018-0178-z	http://dx.doi.org/10.1038/s41586-018-0178-z			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2BI	29849141	Green Accepted			2022-12-28	WOS:000435071400057
J	Schmidt, H; Hoffman, AK				Schmidt, Harald; Hoffman, Allison K.			The Ethics of Medicaid's Work Requirements and Other Personal Responsibility Policies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Schmidt, Harald] Univ Penn, Dept Med Eth & Hlth Policy, Ctr Hlth Incent & Behav Econ, Perelman Sch Med,Leonard Davis Inst, Philadelphia, PA 19104 USA; [Hoffman, Allison K.] Univ Penn, Sch Law, Leonard Davis Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Schmidt, H (corresponding author), Univ Penn, Dept Med Eth & Hlth Policy, Ctr Hlth Incent & Behav Econ, Perelman Sch Med, 423 Guardian Dr,Blockley Hall 1410, Philadelphia, PA 19104 USA.	schmidth@mail.med.upenn.edu						Bagley N, 2018, JAMA-J AM MED ASSOC, V319, P763, DOI 10.1001/jama.2018.0958; Bevin MG, 2018, RELATING MEDICAID EX; Centers for Medicare & Medicaid Services, SMD 18 002 OPP PROM; Centers for Medicare & Medicaid Services, STAT PLAN AM 1915 WA; Gangopadhyaya A, WHO COULD BE AFFECTE; Gurley-Calvez T, MEDICAID REFORM EMER; Kentucky Cabinet for Health and Family Services, KENT HLTH HELP ENG A; Rosenbaum S., 2018, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20180204.524941/full/, DOI 10.1377/HBLOG20180204.524941/FULL/]; Sommers BD, 2017, NEW ENGL J MED, V377, P586, DOI 10.1056/NEJMsb1706645	9	7	7	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2018	319	22					2265	2266		10.1001/jama.2018.3384	http://dx.doi.org/10.1001/jama.2018.3384			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2UP	29801097	Green Submitted			2022-12-28	WOS:000435129300007
J	Kronenberg, ZN; Fiddes, IT; Gordon, D; Murali, S; Cantsilieris, S; Meyerson, OS; Underwood, JG; Nelson, BJ; Chaisson, MJP; Dougherty, ML; Munson, KM; Hastie, AR; Diekhans, M; Hormozdiari, F; Lorusso, N; Hoekzema, K; Qiu, R; Clark, K; Raja, A; Welch, AE; Sorensen, M; Baker, C; Fulton, RS; Armstrong, J; Graves-Lindsay, TA; Denli, AM; Hoppe, ER; Hsieh, P; Hill, CM; Pang, AWC; Lee, J; Lam, ET; Dutcher, SK; Gage, FH; Warren, WC; Shendure, J; Haussler, D; Schneider, VA; Cao, H; Ventura, M; Wilson, RK; Paten, B; Pollen, A; Eichler, EE				Kronenberg, Zev N.; Fiddes, Ian T.; Gordon, David; Murali, Shwetha; Cantsilieris, Stuart; Meyerson, Olivia S.; Underwood, Jason G.; Nelson, Bradley J.; Chaisson, Mark J. P.; Dougherty, Max L.; Munson, Katherine M.; Hastie, Alex R.; Diekhans, Mark; Hormozdiari, Fereydoun; Lorusso, Nicola; Hoekzema, Kendra; Qiu, Ruolan; Clark, Karen; Raja, Archana; Welch, AnneMarie E.; Sorensen, Melanie; Baker, Carl; Fulton, Robert S.; Armstrong, Joel; Graves-Lindsay, Tina A.; Denli, Ahmet M.; Hoppe, Emma R.; Hsieh, PingHsun; Hill, Christopher M.; Pang, Andy Wing Chun; Lee, Joyce; Lam, Ernest T.; Dutcher, Susan K.; Gage, Fred H.; Warren, Wesley C.; Shendure, Jay; Haussler, David; Schneider, Valerie A.; Cao, Han; Ventura, Mario; Wilson, Richard K.; Paten, Benedict; Pollen, Alex; Eichler, Evan E.			High-resolution comparative analysis of great ape genomes	SCIENCE			English	Article							STRUCTURAL VARIATION; MICROSATELLITE EVOLUTION; MOLECULAR CLOCK; LONG-READ; SEQUENCE; HUMANS; DNA; ASSEMBLIES; CELL; BIOSYNTHESIS	Genetic studies of human evolution require high-quality contiguous ape genome assemblies that are not guided by the human reference. We coupled long-read sequence assembly and full-length complementary DNA sequencing with a multiplatform scaffolding approach to produce ab initio chimpanzee and orangutan genome assemblies. By comparing these with two long-read de novo human genome assemblies and a gorilla genome assembly, we characterized lineage-specific and shared great ape genetic variation ranging from single- to mega-base pair-sized variants. We identified similar to 17,000 fixed human-specific structural variants identifying genic and putative regulatory changes that have emerged in humans since divergence from nonhuman apes. Interestingly, these variants are enriched near genes that are down-regulated in human compared to chimpanzee cerebral organoids, particularly in cells analogous to radial glial neural progenitors.	[Kronenberg, Zev N.; Murali, Shwetha; Cantsilieris, Stuart; Underwood, Jason G.; Nelson, Bradley J.; Chaisson, Mark J. P.; Dougherty, Max L.; Munson, Katherine M.; Hoekzema, Kendra; Qiu, Ruolan; Raja, Archana; Welch, AnneMarie E.; Sorensen, Melanie; Baker, Carl; Hoppe, Emma R.; Hsieh, PingHsun; Hill, Christopher M.; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Fiddes, Ian T.; Diekhans, Mark; Armstrong, Joel; Paten, Benedict] Univ Calif Santa Cruz, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA; [Gordon, David; Murali, Shwetha; Raja, Archana; Shendure, Jay; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Meyerson, Olivia S.; Pollen, Alex] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Underwood, Jason G.] California Inc, Pacific Biosci PacBio, Menlo Pk, CA 94025 USA; [Chaisson, Mark J. P.] Univ Southern Calif, Computat Biol & Bioinformat, Los Angeles, CA 90089 USA; [Hastie, Alex R.; Pang, Andy Wing Chun; Lee, Joyce; Lam, Ernest T.; Cao, Han] Bionano Genom, San Diego, CA 92121 USA; [Hormozdiari, Fereydoun] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95817 USA; [Lorusso, Nicola; Ventura, Mario] Univ Bari, Dept Biol, I-70121 Bari, Italy; [Clark, Karen; Schneider, Valerie A.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Fulton, Robert S.; Graves-Lindsay, Tina A.; Dutcher, Susan K.; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, Dept Med, McDonnell Genome Inst, St Louis, MO 63108 USA; [Fulton, Robert S.; Graves-Lindsay, Tina A.; Dutcher, Susan K.; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, McDonnell Genome Inst, St Louis, MO 63108 USA; [Denli, Ahmet M.; Gage, Fred H.] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Pollen, Alex] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of Southern California; University of California System; University of California Davis; Universita degli Studi di Bari Aldo Moro; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Washington University (WUSTL); Washington University (WUSTL); Salk Institute; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California San Francisco	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.; Eichler, EE (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	eee@gs.washington.edu	Wilson, Richard K./AAF-4139-2019; Ventura, Mario/E-6420-2011; Munson, Katherine M/P-2462-2015; Shendure, Jay/AAU-3684-2021	Wilson, Richard K./0000-0002-1992-1358; Ventura, Mario/0000-0001-7762-8777; Munson, Katherine M/0000-0001-8413-6498; Lorusso, Nicola/0000-0001-5878-6403; Harringmeyer, Olivia/0000-0003-4040-2226; Cao, Han/0000-0003-3612-6169; Dougherty, Max/0000-0002-0841-0675; Sorensen, Melanie/0000-0002-1525-9707; Schneider, Valerie/0000-0002-3442-1888	NIH [HG002385, HG007635, HG003079, HG007990, HG006283, HG009081, HG007234, HG008742, HG009478]; Ministero dell'Universita e Ricerca (MIUR), Italy [RBFR103CE3]; California Institute for Regenerative Medicine (CIRM) [GC1R-06673-A]; National Health and Medical Research Council (NHMRC) CJ Martin Biomedical Fellowship [1073726]; Intramural Research Program of the NIH, National Library of Medicine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F30HG009478, U54HG003079, U24HG009081, U54HG007990, R01HG002385, U41HG007234, R01HG008742, U41HG007635, R01HG006283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero dell'Universita e Ricerca (MIUR), Italy(Ministry of Education, Universities and Research (MIUR)); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Health and Medical Research Council (NHMRC) CJ Martin Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Intramural Research Program of the NIH, National Library of Medicine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in part, by grants from the NIH (HG002385 to E.E.E.; HG007635 to R.K.W. and E.E.E.; HG003079 to R.K.W.; HG007990 to D.H., M.D., and B.P.; HG006283 to J.S.; HG009081 to S.K.D. and E.E.E.; HG007234 to D.H., B.P., J. A., and M.D.; HG008742 to B.P.; and HG009478 to M.L.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was also partially supported by RBFR103CE3 by Ministero dell'Universita e Ricerca (MIUR), Italy to M.V. and GC1R- 06673-A by California Institute for Regenerative Medicine (CIRM) to I.T.F. and D.H.S.C. was supported by a National Health and Medical Research Council (NHMRC) CJ Martin Biomedical Fellowship (no. 1073726). The work carried out by NCBI was supported by the Intramural Research Program of the NIH, National Library of Medicine. E.E.E., J. S., and D.H. are investigators of the Howard Hughes Medical Institute.	Ameur A, 2012, AM J HUM GENET, V90, P809, DOI 10.1016/j.ajhg.2012.03.014; Bickhart DM, 2017, NAT GENET, V49, P643, DOI 10.1038/ng.3802; Boyd JL, 2015, CURR BIOL, V25, P772, DOI 10.1016/j.cub.2015.01.041; Buckley MT, 2017, MOL BIOL EVOL, V34, P1307, DOI 10.1093/molbev/msx103; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Cardone MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r28; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Dennis MY, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0069; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Feuk L, 2005, PLOS GENET, V1, P489, DOI 10.1371/journal.pgen.0010056; Fiddes I.T., BIORXIV; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; Gordon D, 2016, SCIENCE, V352, DOI 10.1126/science.aae0344; He ZS, 2017, NAT NEUROSCI, V20, P886, DOI 10.1038/nn.4548; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; JAIN M, 2016, GENOME BIOL, V17; Ju XC, 2016, ELIFE, V5, DOI 10.7554/eLife.18197; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Korlach J, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix085; Kuderna LFK, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix098; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; LI WH, 1987, J MOL EVOL, V25, P330, DOI 10.1007/BF02603118; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Mak ACY, 2016, GENETICS, V202, P351, DOI 10.1534/genetics.115.183483; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Moorjani P, 2016, P NATL ACAD SCI USA, V113, P10607, DOI 10.1073/pnas.1600374113; Mora-Bermudez F, 2016, ELIFE, V5, DOI 10.7554/eLife.18683; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809; Nuttle X, 2016, NATURE, V536, P205, DOI 10.1038/nature19075; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/nmeth.3454, 10.1038/NMETH.3454]; Perez-Rico YA, 2017, GENOME RES, V27, P259, DOI 10.1101/gr.203679.115; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Polavarapu N, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r51; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Reno PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084258; Rodriguez O, 2018, BIORXIV, DOI [10. 1101/193144, DOI 10.1101/193144]; RUBINSZTEIN DC, 1995, NAT GENET, V10, P337, DOI 10.1038/ng0795-337; Sanders AD, 2016, GENOME RES, V26, P1575, DOI 10.1101/gr.201160.115; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Sturgill ER, 2012, GLYCOBIOLOGY, V22, P1289, DOI 10.1093/glycob/cws103; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Szamalek JM, 2006, HUM GENET, V119, P103, DOI 10.1007/s00439-005-0117-6; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Varki A, 2008, NAT REV GENET, V9, P749, DOI 10.1038/nrg2428; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Webster MT, 2002, P NATL ACAD SCI USA, V99, P8748, DOI 10.1073/pnas.122067599; Ye KX, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0167; Yohn CT, 2005, PLOS BIOL, V3, P577, DOI 10.1371/journal.pbio.0030110; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	65	163	164	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1085	+	eaar6343	10.1126/science.aar6343	http://dx.doi.org/10.1126/science.aar6343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI6TJ	29880660	Green Accepted, Green Published			2022-12-28	WOS:000434635500036
J	Kossin, JP				Kossin, James P.			A global slowdown of tropical-cyclone translation speed	NATURE			English	Article							PRECIPITATION EXTREMES; HURRICANE INTENSITY; CIRCULATION; CLIMATE; TEMPERATURE; RESPONSES	As the Earth's atmosphere warms, the atmospheric circulation changes. These changes vary by region and time of year, but there is evidence that anthropogenic warming causes a general weakening of summertime tropical circulation(1-8). Because tropical cyclones are carried along within their ambient environmental wind, there is a plausible a priori expectation that the translation speed of tropical cyclones has slowed with warming. In addition to circulation changes, anthropogenic warming causes increases in atmospheric water-vapour capacity, which are generally expected to increase precipitation rates'. Rain rates near the centres of tropical cyclones are also expected to increase with increasing global temperatures(10-12). The amount of tropical-cyclone-related rainfall that any given local area will experience is proportional to the rain rates and inversely proportional to the translation speeds of tropical cyclones. Here I show that tropical-cyclone translation speed has decreased globally by 10 per cent over the period 1949-2016, which is very likely to have compounded, and possibly dominated, any increases in local rainfall totals that may have occurred as a result of increased tropical-cyclone rain rates. The magnitude of the slowdown varies substantially by region and by latitude, but is generally consistent with expected changes in atmospheric circulation forced by anthropogenic emissions. Of particular importance is the slowdown of 30 per cent and 20 per cent over land areas affected by western North Pacific and North Atlantic tropical cyclones, respectively, and the slowdown of 19 per cent over land areas in the Australian region. The unprecedented rainfall totals associated with the 'stall' of Hurricane Harve(13-15) over Texas in 2017 provide a notable example of the relationship between regional rainfall amounts and tropical cyclone translation speed. Any systematic past or future change in the translation speed of tropical cyclones, particularly over land, is therefore highly relevant when considering potential changes in local rainfall totals.	[Kossin, James P.] NOAA, Natl Ctr Environm Informat, Ctr Weather & Climate, Madison, WI 53706 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Kossin, JP (corresponding author), NOAA, Natl Ctr Environm Informat, Ctr Weather & Climate, Madison, WI 53706 USA.	james.kossin@noaa.gov			NOAA's National Centers for Environmental Information	NOAA's National Centers for Environmental Information	This work was supported by NOAA's National Centers for Environmental Information.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Coumou D, 2015, SCIENCE, V348, P324, DOI 10.1126/science.1261768; DeMaria M, 2005, WEATHER FORECAST, V20, P531, DOI 10.1175/WAF862.1; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Emanuel K, 2017, P NATL ACAD SCI USA, V114, P12681, DOI 10.1073/pnas.1716222114; Grise KM, 2017, J CLIMATE, V30, P8497, DOI [10.1175/jcli-d-16-0849.1, 10.1175/JCLI-D-16-0849.1]; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; He C, 2017, J CLIMATE, V30, P6465, DOI [10.1175/JCLI-D-16-0529.1, 10.1175/jcli-d-16-0529.1, 10.1175/JCLI-D-16-0529.s1]; He J, 2015, J CLIMATE, V28, P8728, DOI 10.1175/JCLI-D-15-0205.1; Hegerl GC, 2015, B AM METEOROL SOC, V96, P1097, DOI 10.1175/BAMS-D-13-00212.1; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Kharin VV, 2013, CLIMATIC CHANGE, V119, P345, DOI 10.1007/s10584-013-0705-8; Kitoh A, 2016, WEATHER CLIM EXTREME, V11, P41, DOI 10.1016/j.wace.2015.09.001; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Knutson TR, 2015, J CLIMATE, V28, P7203, DOI 10.1175/JCLI-D-15-0129.1; Kossin JP, 2016, J CLIMATE, V29, P5725, DOI 10.1175/JCLI-D-16-0076.1; Kossin JP, 2014, NATURE, V509, P349, DOI 10.1038/nature13278; Kossin JP, 2013, J CLIMATE, V26, P9960, DOI 10.1175/JCLI-D-13-00262.1; Kossin JP, 2012, WEATHER FORECAST, V27, P484, DOI 10.1175/WAF-D-11-00106.1; Lonfat M, 2004, MON WEATHER REV, V132, P1645, DOI 10.1175/1520-0493(2004)132<1645:PDITCU>2.0.CO;2; Pendergrass AG, 2014, J CLIMATE, V27, P757, DOI 10.1175/JCLI-D-13-00163.1; Prein AF, 2017, NAT CLIM CHANGE, V7, P48, DOI [10.1038/NCLIMATE3168, 10.1038/nclimate3168]; Rappaport EN, 2000, B AM METEOROL SOC, V81, P2065, DOI 10.1175/1520-0477(2000)081<2065:LOLITU>2.3.CO;2; Risser MD, 2017, GEOPHYS RES LETT, V44, P12457, DOI 10.1002/2017GL075888; Sampson CR, 2000, B AM METEOROL SOC, V81, P1231, DOI 10.1175/1520-0477(2000)081<1231:TATCFS>2.3.CO;2; Schreck CJ, 2014, MON WEATHER REV, V142, P3881, DOI 10.1175/MWR-D-14-00021.1; SMITH RB, 1993, J ATMOS SCI, V50, P3213, DOI 10.1175/1520-0469(1993)050<3213:AHBDL>2.0.CO;2; van Oldenborgh GJ, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa9ef2; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; Walsh KJE, 2016, WIRES CLIM CHANGE, V7, P65, DOI 10.1002/wcc.371; Wong B, 2011, NAT METHODS, V8, P441, DOI 10.1038/nmeth.1618; Wuebbles D.J, 2017, CLIMATE SCI SPECIAL, VI, P257, DOI [10. 7930/J07S7KXX, DOI 10.7930/J07S7KXX]	36	273	279	18	180	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					104	+		10.1038/s41586-018-0158-3	http://dx.doi.org/10.1038/s41586-018-0158-3			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29875485				2022-12-28	WOS:000434273300045
J	Maskell, G				Maskell, Giles			Impossible errors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												gilesmaskell@nhs.net	Thimbleby, Harold W/D-4389-2013	Thimbleby, Harold W/0000-0003-2222-4243					0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2018	361								k2427	10.1136/bmj.k2427	http://dx.doi.org/10.1136/bmj.k2427			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BU	29871942				2022-12-28	WOS:000435073300003
J	Telfer, MW; Parteli, EJR; Radebaugh, J; Beyer, RA; Bertrand, T; Forget, F; Nimmo, F; Grundy, WM; Moore, JM; Stern, SA; Spencer, J; Lauer, TR; Earle, AM; Binzel, RP; Weaver, HA; Olkin, CB; Young, LA; Ennico, K; Runyon, K				Telfer, Matt W.; Parteli, Eric J. R.; Radebaugh, Jani; Beyer, Ross A.; Bertrand, Tanguy; Forget, Francois; Nimmo, Francis; Grundy, Will M.; Moore, Jeffrey M.; Stern, S. Alan; Spencer, John; Lauer, Tod R.; Earle, Alissa M.; Binzel, Richard P.; Weaver, Hal A.; Olkin, Cathy B.; Young, Leslie A.; Ennico, Kimberly; Runyon, Kirby		New Horizons Geology Geophysics Im	Dunes on Pluto	SCIENCE			English	Article							NITROGEN-ICE; HORIZONS; SURFACE; TRITON; SNOW; STATE; SUBLIMATION; CONVECTION; ENCOUNTER; BEDFORMS	The surface of Pluto is more geologically diverse and dynamic than had been expected, but the role of its tenuous atmosphere in shaping the landscape remains unclear. We describe observations from the New Horizons spacecraft of regularly spaced, linear ridges whose morphology, distribution, and orientation are consistent with being transverse dunes. These are located close to mountainous regions and are orthogonal to nearby wind streaks. We demonstrate that the wavelength of the dunes (-0.4 to 1 kilometer) is best explained by the deposition of sand-sized (-200 to -300 micrometer) particles of methane ice in moderate winds (<10 meters per second). The undisturbed morphology of the dunes, and relationships with the underlying convective glacial ice, imply that the dunes have formed in the very recent geological past.	[Telfer, Matt W.] Plymouth Univ, Sch Geog Earth & Environm Sci, Plymouth PL4 8AA, Devon, England; [Parteli, Eric J. R.] Univ Cologne, Dept Geosci, Pohligstr 3, D-50969 Cologne, Germany; [Radebaugh, Jani] Brigham Young Univ, Dept Geol Sci, Coll Phys & Math Sci, Provo, UT 84602 USA; [Beyer, Ross A.] SETI Inst, Sagan Ctr, Mountain View, CA 94043 USA; [Beyer, Ross A.; Moore, Jeffrey M.; Ennico, Kimberly] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Bertrand, Tanguy; Forget, Francois] Univ Paris 06, Lab Meteorol Dynam, Paris, France; [Nimmo, Francis] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Grundy, Will M.] Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA; [Stern, S. Alan; Spencer, John; Young, Leslie A.] Southwest Res Inst, Boulder, CO USA; [Lauer, Tod R.] Natl Opt Astron Observ, Tucson, AZ 85726 USA; [Earle, Alissa M.; Binzel, Richard P.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Weaver, Hal A.; Olkin, Cathy B.; Runyon, Kirby] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA	University of Plymouth; University of Cologne; Brigham Young University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Santa Cruz; Southwest Research Institute; National Optical Astronomy Observatory; Massachusetts Institute of Technology (MIT); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Telfer, MW (corresponding author), Plymouth Univ, Sch Geog Earth & Environm Sci, Plymouth PL4 8AA, Devon, England.	matt.telfer@plymouth.ac.uk	Runyon, Kirby D/J-2878-2017; Weaver, Harold A/D-9188-2016; Parteli, Eric/K-7085-2014; UzK, IGMK/HGU-4003-2022; Olkin, Catherine/AAF-5160-2019; Telfer, Matt/K-7596-2015	Runyon, Kirby D/0000-0001-6361-6548; Weaver, Harold A/0000-0003-0951-7762; Parteli, Eric/0000-0003-1925-6412; Olkin, Catherine/0000-0002-5846-716X; Grundy, Will/0000-0002-8296-6540; Lauer, Tod/0000-0003-3234-7247; Radebaugh, Jani/0000-0002-7022-892X; Beyer, Ross/0000-0003-4503-3335; Telfer, Matt/0000-0002-8562-7720	German Research Foundation [RI2497/3-1]; NASA New Horizons Project	German Research Foundation(German Research Foundation (DFG)); NASA New Horizons Project	E.J.R.P. thanks the German Research Foundation for grant RI2497/3-1. All New Horizons team member authors are funded by the NASA New Horizons Project.	Bagnold R. A., 1941, PHYS BLOWN SAND DESE, P16; Bertrand T, 2016, NATURE, V540, P86, DOI 10.1038/nature19337; Cathles LM, 2014, J GLACIOL, V60, P147, DOI 10.3189/2014JoG13J124; Cheng AF, 2008, SPACE SCI REV, V140, P189, DOI 10.1007/s11214-007-9271-6; Cruikshank D., 2017, 49 DIV PLAN SCI M PR; ELUSZKIEWICZ J, 1990, GEOPHYS RES LETT, V17, P1753, DOI 10.1029/GL017i010p01753; ELUSZKIEWICZ J, 1991, J GEOPHYS RES-PLANET, V96, P19217, DOI 10.1029/91JA01858; Filhol S, 2015, J GEOPHYS RES-EARTH, V120, P1645, DOI 10.1002/2015JF003529; Forget F, 2017, ICARUS, V287, P54, DOI 10.1016/j.icarus.2016.11.038; Fourriere A, 2010, J FLUID MECH, V649, P287, DOI 10.1017/S0022112009993466; Fray N, 2009, PLANET SPACE SCI, V57, P2053, DOI 10.1016/j.pss.2009.09.011; Frezzotti M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000673; Gladstone GR, 2016, SCIENCE, V351, DOI 10.1126/science.aad8866; Greeley R., 1985, WIND GEOLOGICAL PROC, V4, P67; Grundy WM, 2016, SCIENCE, V351, DOI 10.1126/science.aad9189; HANSEN CJ, 1990, SCIENCE, V250, P421, DOI 10.1126/science.250.4979.421; Howard AD, 2017, ICARUS, V287, P287, DOI 10.1016/j.icarus.2016.07.006; Jia P, 2017, P NATL ACAD SCI USA, V114, P2509, DOI 10.1073/pnas.1612176114; Kaufmann E, 2006, ICARUS, V185, P274, DOI 10.1016/j.icarus.2006.07.009; Kok JF, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043646; Kok JF, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.074502; Lorenz RD, 1995, J GEOPHYS RES-PLANET, V100, P26377, DOI 10.1029/95JE02708; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; McKinnon WB, 2016, NATURE, V534, P82, DOI 10.1038/nature18289; Moore JM, 2017, ICARUS, V287, P320, DOI 10.1016/j.icarus.2016.08.025; Moore JM, 2016, SCIENCE, V351, P1284, DOI 10.1126/science.aad7055; Moore JM, 2015, ICARUS, V246, P65, DOI 10.1016/j.icarus.2014.04.028; Moores JE, 2017, NATURE, V541, P188, DOI 10.1038/nature20779; NASA/Johns Hopkins University Applied Physics Laboratory/South West Research Institute, IC MOUNT PLAINS; NASA/Johns Hopkins University Applied Physics Laboratory/South West Research Institute, PLUT CLOS UP NOW COL; NASA/Johns Hopkins University Applied Physics Laboratory/South West Research Institute, PLUT IC PLAINS CAPT; NASA/ Johns Hopkins University Applied Physics Laboratory/South West Research Institute, RICH COL VAR PLUT; Pahtz T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.218002; Reuter DC, 2008, SPACE SCI REV, V140, P129, DOI 10.1007/s11214-008-9375-7; Robbins SJ, 2017, ICARUS, V287, P187, DOI 10.1016/j.icarus.2016.09.027; SAGAN C, 1990, NATURE, V346, P546, DOI 10.1038/346546a0; Schmitt B, 2017, ICARUS, V287, P229, DOI 10.1016/j.icarus.2016.12.025; SODERBLOM LA, 1990, SCIENCE, V250, P410, DOI 10.1126/science.250.4979.410; Soderblom LA, 2007, PLANET SPACE SCI, V55, P2025, DOI 10.1016/j.pss.2007.04.014; Stern SA, 2017, ICARUS, V287, P47, DOI 10.1016/j.icarus.2016.11.022; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815; Telfer MW, 2017, GEOMORPHOLOGY, V290, P85, DOI 10.1016/j.geomorph.2017.03.024; Thomas N, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526049; Thomas N, 2010, ICARUS, V205, P296, DOI 10.1016/j.icarus.2009.05.030; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440; Toigo AD, 2015, ICARUS, V254, P306, DOI 10.1016/j.icarus.2015.03.034; Trowbridge AJ, 2016, NATURE, V534, P79, DOI 10.1038/nature18016; Warren SG, 1998, J GEOPHYS RES-PLANET, V103, P25789, DOI 10.1029/98JE01898; ZENT AP, 1989, GEOPHYS RES LETT, V16, P965, DOI 10.1029/GL016i008p00965	49	59	60	4	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					992	997		10.1126/science.aao2975	http://dx.doi.org/10.1126/science.aao2975			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6SL	29853681				2022-12-28	WOS:000433574200036
J	Innes, R				Innes, Roger			The Positives and Negatives of NPR: A Unifying Model for Salicylic Acid Signaling in Plants	CELL			English	Editorial Material							PROTEIN	Salicylic acid (SA) is a potent inducer of defense gene expression in plants, but how SA activates transcription has been controversial. In this issue of Cell, Ding et al. show that the SA-binding proteins NPR3 and NPR4 function as transcriptional co-repressors, with this activity being blocked by SA.	[Innes, Roger] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Innes, R (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	rinnes@indiana.edu						CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Ding YL, 2018, CELL, V173, P1454, DOI 10.1016/j.cell.2018.03.044; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Wu Y, 2012, CELL REPORTS, V1, P639, DOI 10.1016/j.celrep.2012.05.008; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523	5	23	25	3	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1314	1315		10.1016/j.cell.2018.05.034	http://dx.doi.org/10.1016/j.cell.2018.05.034			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856948	Bronze			2022-12-28	WOS:000433989100003
J	Main, R; Yang, IS; Chan, V; Li, DZ; Lin, FX; Mahajan, N; Pen, UL; Vanderlinde, K; van Kerkwijk, MH				Main, Robert; Yang, I-Sheng; Chan, Victor; Li, Dongzi; Lin, Fang Xi; Mahajan, Nikhil; Pen, Ue-Li; Vanderlinde, Keith; van Kerkwijk, Marten H.			Pulsar emission amplified and resolved by plasma lensing in an eclipsing binary	NATURE			English	Article							FAST RADIO-BURST; FRB 121102; MILLISECOND PULSAR; HOST GALAXY; ASTROMETRY; MECHANISMS	Radio pulsars scintillate because their emission travels through the ionized interstellar medium along multiple paths, which interfere with each other. It has long been realized that, independent of their nature, the regions responsible for the scintillation could be used as 'interstellar lenses' to localize pulsar emission regions(1,2). Most such lenses, however, resolve emission components only marginally, limiting results to statistical inferences and detections of small positional shifts(3-5). As lenses situated close to their source offer better resolution, it should be easier to resolve emission regions of pulsars located in high-density environments such as supernova remnants(6) or binaries in which the pulsar's companion has an ionized outflow. Here we report observations of extreme plasma lensing in the 'black widow' pulsar, B1957+20, near the phase in its 9.2-hour orbit at which its emission is eclipsed by its companion's outflow(7-9). During the lensing events, the observed radio flux is enhanced by factors of up to 70-80 at specific frequencies. The strongest events clearly resolve the emission regions: they affect the narrow main pulse and parts of the wider interpulse differently. We show that the events arise naturally from density fluctuations in the outer regions of the outflow, and we infer a resolution of our lenses that is comparable to the pulsar's radius, about 10 kilometres. Furthermore, the distinct frequency structures imparted by the lensing are reminiscent of what is observed for the repeating fast radio burst FRB 121102, providing observational support for the idea that this source is observed through, and thus at times strongly magnified by, plasma lenses(10).	[Main, Robert; Chan, Victor; Mahajan, Nikhil; Vanderlinde, Keith; van Kerkwijk, Marten H.] Univ Toronto, Dept Astron & Astrophys, Toronto, ON, Canada; [Main, Robert; Pen, Ue-Li; Vanderlinde, Keith] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON, Canada; [Main, Robert; Yang, I-Sheng; Li, Dongzi; Lin, Fang Xi; Pen, Ue-Li] Univ Toronto, Canadian Inst Theoret Astrophys, Toronto, ON, Canada; [Yang, I-Sheng; Pen, Ue-Li] Perimeter Inst Theoret Phys, Waterloo, ON, Canada; [Li, Dongzi; Lin, Fang Xi] Univ Toronto, Dept Phys, Toronto, ON, Canada; [Pen, Ue-Li] Canadian Inst Adv Res, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Perimeter Institute for Theoretical Physics; University of Toronto; Canadian Institute for Advanced Research (CIFAR)	Main, R (corresponding author), Univ Toronto, Dept Astron & Astrophys, Toronto, ON, Canada.; Main, R (corresponding author), Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON, Canada.; Main, R (corresponding author), Univ Toronto, Canadian Inst Theoret Astrophys, Toronto, ON, Canada.	main@astro.utoronto.ca	Pen, Ue-Li/GWV-1294-2022	Pen, Ue-Li/0000-0003-2155-9578; Li, Dongzi/0000-0001-7931-0607; Mahajan, Nikhil/0000-0002-6317-3190; Lin, Fang Xi/0000-0002-6820-4275	NSERC; SOSCIP Consortium Postdoctoral Fellowship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); SOSCIP Consortium Postdoctoral Fellowship	We thank A. Bilous for sharing and discussing her results which motivated this analysis. We thank the rest of our scintillometry group for discussions and support throughout. R.M., M.H.v.K., U.-L.P. and K.V. are funded through NSERC. I-S.Y was supported by a SOSCIP Consortium Postdoctoral Fellowship.	BACKER DC, 1975, ASTRON ASTROPHYS, V43, P395; Bassa CG, 2017, ASTROPHYS J LETT, V843, DOI 10.3847/2041-8213/aa7a0c; Bilous AV, 2011, AIP CONF PROC, V1357, P140, DOI 10.1063/1.3615100; Born M., 2000, PRINCIPLES OPTICS EL; Cordes JM, 2017, ASTROPHYS J, V842, DOI 10.3847/1538-4357/aa74da; FRUCHTER AS, 1990, ASTROPHYS J, V351, P642, DOI 10.1086/168502; FRUCHTER AS, 1988, NATURE, V333, P237, DOI 10.1038/333237a0; GINZBURG VL, 1975, ANNU REV ASTRON ASTR, V13, P511, DOI 10.1146/annurev.aa.13.090175.002455; Gwinn CR, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/7; Johnson MD, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/8; Law CJ, 2017, ASTROPHYS J, V850, DOI 10.3847/1538-4357/aa9700; Lovelace R. V. E., 1970, THESIS; Main R., 2017, PREPRINT; Main R, 2017, ASTROPHYS J LETT, V840, DOI 10.3847/2041-8213/aa6f03; MANCHESTER RN, 1972, ASTROPHYS LETT COMM, V10, P67; Masui K, 2015, NATURE, V528, P523, DOI 10.1038/nature15769; Michilli D, 2018, NATURE, V553, P182, DOI 10.1038/nature25149; Nye JF, 1999, NATURAL FOCUSING FIN; Pen UL, 2014, MON NOT R ASTRON SOC, V440, pL36, DOI 10.1093/mnrasl/slu010; Reynolds MT, 2007, MON NOT R ASTRON SOC, V379, P1117, DOI 10.1111/j.1365-2966.2007.11991.x; RYBA MF, 1991, ASTROPHYS J, V380, P557, DOI 10.1086/170613; Scholz P, 2016, ASTROPHYS J, V833, DOI 10.3847/1538-4357/833/2/177; Spitler LG, 2016, NATURE, V531, P202, DOI 10.1038/nature17168; Tendulkar SP, 2017, ASTROPHYS J LETT, V834, DOI 10.3847/2041-8213/834/2/L7; THOMPSON C, 1994, ASTROPHYS J, V422, P304, DOI 10.1086/173728; van Kerkwijk MH, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/2/95; VANPARADIJS J, 1988, NATURE, V334, P684, DOI 10.1038/334684a0	27	48	49	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2018	557	7706					522	+		10.1038/s41586-018-0133-z	http://dx.doi.org/10.1038/s41586-018-0133-z			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6GP	29795253	Green Submitted			2022-12-28	WOS:000432794900039
J	[Anonymous]				[Anonymous]			Factors Linked to Depression in Sexual Minority Youth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2068	2068		10.1001/jama.2018.6253	http://dx.doi.org/10.1001/jama.2018.6253			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800160				2022-12-28	WOS:000432679400004
J	Brainin, M				Brainin, Michael			Stroke units around the world: the success story continues	LANCET			English	Editorial Material							MANAGEMENT; CARE		[Brainin, Michael] Danube Univ Krems, Dept Clin Neurosci & Prevent, A-3500 Krems, Austria	Danube University Krems	Brainin, M (corresponding author), Danube Univ Krems, Dept Clin Neurosci & Prevent, A-3500 Krems, Austria.	michael.brainin@donau-uni.ac.at						Ali AN, 2018, TOP STROKE REHABIL, V25, P214, DOI 10.1080/10749357.2017.1398482; Brainin M, 2007, LANCET NEUROL, V6, P553, DOI 10.1016/S1474-4422(07)70005-4; Department of Health, PHIL HLTH STAT 2013; Langhorne P, 2002, AGE AGEING, V31, P365, DOI 10.1093/ageing/31.5.365; Langhorne P, 2018, LANCET, V391, P2019, DOI [10.1016/S0140-6736(18)30802-X, 10.1016/s0140-6736(18)30802-x]; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Middleton S, 2011, LANCET, V378, P1699, DOI 10.1016/S0140-6736(11)61485-2; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Urimubenshi G, 2017, EUR STROKE J, V2, P287, DOI 10.1177/2396987317735426	9	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2018	391	10134					1970	1971		10.1016/S0140-6736(18)30908-5	http://dx.doi.org/10.1016/S0140-6736(18)30908-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GG1IJ	29864010				2022-12-28	WOS:000432440300006
J	Caverly, TJ; Cao, PP; Hayward, RA; Meza, R				Caverly, Tanner J.; Cao, Pianpian; Hayward, Rodney A.; Meza, Rafael			Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive A Microsimulation Study	ANNALS OF INTERNAL MEDICINE			English	Article							COMPUTED-TOMOGRAPHY; COST-EFFECTIVENESS; RISK; MORTALITY; SELECTION; PROSTATE; BENEFITS; CRITERIA; OUTCOMES; MODELS	Background: Many health systems are exploring how to implement low-dose computed tomography (LDCT) screening programs that are effective and patient-centered. Objective: To examine factors that influence when LDCT screening is preference-sensitive. Design: State-transition microsimulation model. Data Sources: Two large randomized trials, published decision analyses, and the SEER (Surveillance, Epidemiology, and End Results) cancer registry. Target Population: U.S.-representative sample of simulated patients meeting current U.S. Preventive Services Task Force criteria for screening eligibility. Time Horizon: Lifetime. Perspective: Individual. Intervention: LDCT screening annually for 3 years. Outcome Measures: Lifetime quality-adjusted life-year gains and reduction in lung cancer mortality. To examine the effect of preferences on net benefit, disutilities (the "degree of dislike") quantifying the burden of screening and follow-up were varied across a likely range. The effect of varying the rate of false-positive screening results and overdiagnosis associated with screening was also examined. Results of Base-Case Analysis: Moderate differences in preferences about the downsides of LDCT screening influenced whether screening was appropriate for eligible persons with annual lung cancer risk less than 0.3% or life expectancy less than 10.5 years. For higher-risk eligible persons with longer life expectancy (roughly 50% of the study population), the benefits of LDCT screening overcame even highly negative views about screening and its downsides. Results of Sensitivity Analysis: Rates of false-positive findings and overdiagnosed lung cancer were not highly influential. Limitation: The quantitative thresholds that were identified may vary depending on the structure of the microsimulation model. Conclusion: Identifying circumstances in which LDCT screening is more versus less preference-sensitive may help clinicians personalize their screening discussions, tailoring to both preferences and clinical benefit.	[Caverly, Tanner J.] VA Ctr Clin Management Res, 2800 Plymouth Rd,Bldg 16,Room 331W, Ann Arbor, MI 48109 USA; [Caverly, Tanner J.] Univ Michigan, Med Sch, 2800 Plymouth Rd,Bldg 16,Room 331W, Ann Arbor, MI 48109 USA; [Cao, Pianpian; Meza, Rafael] Univ Michigan, Sch Publ Hlth, M5336 SPH II,1415 Washington Hts, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] VA Ctr Clin Management Res, 2800 Plymouth Rd,Bldg 10,Room G016-4A, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] Univ Michigan, Med Sch, 2800 Plymouth Rd,Bldg 10,Room G016-4A, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Caverly, TJ (corresponding author), VA Ctr Clin Management Res, 2800 Plymouth Rd,Bldg 16,Room 331W, Ann Arbor, MI 48109 USA.; Caverly, TJ (corresponding author), Univ Michigan, Med Sch, 2800 Plymouth Rd,Bldg 16,Room 331W, Ann Arbor, MI 48109 USA.	tcaverly@med.umich.edu			Veterans Affairs Quality Enhancement Research Initiative [QUE 15-286]; National Cancer Institute [U01CA199284]; NATIONAL CANCER INSTITUTE [U01CA199284] Funding Source: NIH RePORTER	Veterans Affairs Quality Enhancement Research Initiative; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Development of the provider-facing Web tool that uses the results of this study was supported by a grant from the Veterans Affairs Quality Enhancement Research Initiative (QUE 15-286). Ms. Cao and Dr. Meza were supported by National Cancer Institute grant U01CA199284.	Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; American Joint Committee on Cancer, 2018, AJCC CANC STAGING MA; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Black WC, 2014, NEW ENGL J MED, V371, P1793, DOI 10.1056/NEJMoa1312547; Brock University, 2018, LUNG CANC RISK CALC; Caverly TJ, 2018, JAMA INTERN MED, V178, P426, DOI 10.1001/jamainternmed.2017.8170; Center for Clinical Management Research; Ann Arbor Veterans Health Administration Medical Center; The Regents of the University of Michigan, LUNG CANC SCREEN; Centers for Medicare & Medicaid Services, 2016, BEN ENG INC MOD SHAR; Cheung LC, 2018, ANN INTERN MED, V168, P229, DOI 10.7326/M17-2067; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Fritz A., 2013, ICD O INT CLASSIFICA, DOI DOI 10.12970/2310-984X.2013.01.01.4; Han SS, 2017, INT J CANCER, V140, P2436, DOI 10.1002/ijc.30602; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Katki HA, 2016, JAMA-J AM MED ASSOC, V315, P2300, DOI 10.1001/jama.2016.6255; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kinsinger LS, 2017, JAMA INTERN MED, V177, P399, DOI 10.1001/jamainternmed.2016.9022; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Kumar V, 2018, ANN INTERN MED, V168, P161, DOI 10.7326/M17-1401; Mahadevia PJ, 2003, JAMA-J AM MED ASSOC, V289, P313, DOI 10.1001/jama.289.3.313; Memorial Sloan Kettering Cancer Center, 2014, LUNG CANC SCREEN DEC; Meza R, 2014, CANCER-AM CANCER SOC, V120, P1713, DOI 10.1002/cncr.28623; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; National Cancer Institute, CANC STAT FACTS LUNG, DOI DOI 10.1001/JAMAINTERNMED.2016.9022; National Cancer Institute, RISK BAS NLST OUTC T; National Cancer Institute (NCI), NCI DICT CANC TERMS; National Center for Health Statistics, 2018, NHIS NAT HLTH INT SU; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Othus M, 2012, CLIN CANCER RES, V18, P3731, DOI 10.1158/1078-0432.CCR-11-2859; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Pinsky PF, 2015, ANN INTERN MED, V162, P485, DOI 10.7326/M14-2086; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Sox HC, 2014, JAMA-J AM MED ASSOC, V312, P1206, DOI 10.1001/jama.2014.12921; Tammemagi MC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001764; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; ten Haaf K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002277; ten Haaf K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002225; ten Haaf K, 2015, CANCER EPIDEM BIOMAR, V24, P154, DOI 10.1158/1055-9965.EPI-14-0745; The R Project for Statistical Computing, R 3 3 1 WIND; Tramontano AC, 2015, MED DECIS MAKING, V35, P371, DOI 10.1177/0272989X15570364; University of Michigan, 2018, SHOULD I SCREEN LUNG; Volk RJ, 2014, JAMA-J AM MED ASSOC, V312, P1193, DOI 10.1001/jama.2014.12709; Wever EM, 2011, MED DECIS MAKING, V31, P550, DOI 10.1177/0272989X10396717; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	46	50	50	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2018	169	1					1	+		10.7326/M17-2561	http://dx.doi.org/10.7326/M17-2561			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL2FB	29809244	Green Accepted			2022-12-28	WOS:000436931900002
J	Katki, HA; Kovalchik, SA; Petito, LC; Cheung, LC; Jacobs, E; Jemal, A; Berg, CD; Chaturvedi, AK				Katki, Hormuzd A.; Kovalchik, Stephanie A.; Petito, Lucia C.; Cheung, Li C.; Jacobs, Eric; Jemal, Ahmedin; Berg, Christine D.; Chaturvedi, Anil K.			Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Article							MORTALITY; BENEFITS; CRITERIA; DESIGN; COHORT	Background: Lung cancer screening guidelines recommend using individualized risk models to refer ever-smokers for screening. However, different models select different screening populations. The performance of each model in selecting ever-smokers for screening is unknown. Objective: To compare the U.S. screening populations selected by 9 lung cancer risk models (the Bach model; the Spitz model; the Liverpool Lung Project [LLP] model; the LLP Incidence Risk Model [LLPi]; the Hoggart model; the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Model 2012 [PLCOM2012]; the Pittsburgh Predictor; the Lung Cancer Risk Assessment Tool [LCRAT]; and the Lung Cancer Death Risk Assessment Tool [LCDRAT]) and to examine their predictive performance in 2 cohorts. Design: Population-based prospective studies. Setting: United States. Participants: Models selected U.S. screening populations by using data from the National Health Interview Survey from 2010 to 2012. Model performance was evaluated using data from 337 388 ever-smokers in the National Institutes of Health-AARP Diet and Health Study and 72 338 ever-smokers in the CPS-II (Cancer Prevention Study II) Nutrition Survey cohort. Measurements: Model calibration (ratio of model-predicted to observed cases [expected-observed ratio]) and discrimination (area under the curve [AUC]). Results: At a 5-year risk threshold of 2.0%, the models chose U. S. screening populations ranging from 7.6 million to 26 million ever-smokers. These disagreements occurred because, in both validation cohorts, 4 models (the Bach model, PLCOM2012, LCRAT, and LCDRAT) were well-calibrated (expected-observed ratio range, 0.92 to 1.12) and had higher AUCs (range, 0.75 to 0.79) than 5 models that generally overestimated risk (expected-observed ratio range, 0.83 to 3.69) and had lower AUCs (range, 0.62 to 0.75). The 4 best-performing models also had the highest sensitivity at a fixed specificity (and vice versa) and similar discrimination at a fixed risk threshold. These models showed better agreement on size of the screening population (7.6 million to 10.9 million) and achieved consensus on 73% of persons chosen. Limitation: No consensus on risk thresholds for screening. Conclusion: The 9 lung cancer risk models chose widely differing U.S. screening populations. However, 4 models (the Bach model, PLCOM2012, LCRAT, and LCDRAT) most accurately predicted risk and performed best in selecting ever-smokers for screening.	[Katki, Hormuzd A.] NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr,Room 7E592, Bethesda, MD 20892 USA; [Kovalchik, Stephanie A.] Victoria Univ, Inst Sport Exercise & Act Living, POB 14428, Melbourne, Vic 8001, Australia; [Petito, Lucia C.] Harvard Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave,Boston, Boston, MA 02115 USA; [Jacobs, Eric; Jemal, Ahmedin] Amer Canc Soc, 250 Williams St NW, Atlanta, GA 30303 USA; [Cheung, Li C.] NCI, NIH, US Dept Hlth & Human Serv, 9609 Med Ctr Dr,Room 7E612, Bethesda, MD 20892 USA; [Berg, Christine D.] NCI, NIH, US Dept Hlth & Human Serv, 9609 Med Ctr Dr, Bethesda, MD 20892 USA; [Chaturvedi, Anil K.] NCI, NIH, US Dept Hlth & Human Serv, 9609 Med Ctr Dr,Room 6E238, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Victoria University; Harvard University; Harvard T.H. Chan School of Public Health; American Cancer Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Katki, HA (corresponding author), NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr,Room 7E592, Bethesda, MD 20892 USA.	katkih@mail.nih.gov	Cheung, Li/AAY-3594-2020; Petito, Lucia/AAP-8794-2021	Petito, Lucia/0000-0002-0156-1219; Cheung, Li/0000-0003-1625-4331	Intramural Research Program of the National Institutes of Health/National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010181] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Intramural Research Program of the National Institutes of Health/National Cancer Institute.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; [Anonymous], 2014, LANG ENV STAT COMP; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bach PB, 2004, CHEST, V126, P1742, DOI 10.1378/chest.126.6.1742; Bach PB, 2014, LUNG CANC SCREENING; Bach PB, 2014, ANN INTERN MED, V160, P365, DOI 10.7326/M13-2926; Bach PB, 2012, ANN INTERN MED, V157, P571, DOI 10.7326/0003-4819-157-8-201210160-00524; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Boiselle PM, 2013, JAMA-J AM MED ASSOC, V309, P1163, DOI 10.1001/jama.2012.216988; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; Cronin KA, 2006, JNCI-J NATL CANCER I, V98, P637, DOI 10.1093/jnci/djj163; D'Amelio AM, 2010, BRIT J CANCER, V103, P423, DOI 10.1038/sj.bjc.6605759; Gould MK, 2016, JAMA-J AM MED ASSOC, V315, P2279, DOI 10.1001/jama.2016.5986; Gould MK, 2014, NEW ENGL J MED, V371, P1813, DOI 10.1056/NEJMcp1404071; Hoggart C, 2012, CANCER PREV RES, V5, P834, DOI 10.1158/1940-6207.CAPR-11-0237; Jemal A, 2017, JAMA ONCOL, V3, P1278, DOI 10.1001/jamaoncol.2016.6416; Katki HA, 2016, JAMA-J AM MED ASSOC, V315, P2300, DOI 10.1001/jama.2016.6255; Kovalchik SA, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-143; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Lau YK, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.4039; Li KR, 2015, CANCER PREV RES, V8, P777, DOI 10.1158/1940-6207.CAPR-14-0424; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Marcus MW, 2015, CANCER PREV RES, V8, P570, DOI 10.1158/1940-6207.CAPR-14-0438; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Ministry of Health and Welfare, 2013, NATL HLTH INTERVIEW; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; National Comprehensive Cancer Network, 2018, NCCN CLIN PRAC GUID; Pinsky PF, 2007, AM J EPIDEMIOL, V165, P874, DOI 10.1093/aje/kwk075; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Tammemagi MC, 2015, J THORAC IMAG, V30, P88, DOI 10.1097/RTI.0000000000000142; Tammemagi MC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001764; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; ten Haaf K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002277; Wilson DO, 2015, LUNG CANCER, V89, P31, DOI 10.1016/j.lungcan.2015.03.021	36	90	93	25	123	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2018	169	1					10	+		10.7326/M17-2701	http://dx.doi.org/10.7326/M17-2701			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL2FB	29800127	Green Accepted			2022-12-28	WOS:000436931900003
J	Chan, LN; Chen, ZS; Braas, D; Lee, JW; Xiao, G; Geng, HM; Cosgun, KN; Hurtz, C; Shojaee, S; Cazzaniga, V; Schjerven, H; Ernst, T; Hochhaus, A; Kornblau, SM; Konopleva, M; Pufall, MA; Cazzaniga, G; Liu, GJ; Milne, TA; Koeffler, HP; Ross, TS; Sanchez-Garcia, I; Borkhardt, A; Yamamoto, KR; Dickins, RA; Graeber, TG; Muschen, M				Chan, Lai N.; Chen, Zhengshan; Braas, Daniel; Lee, Jae-Woong; Xiao, Gang; Geng, Huimin; Cosgun, Kadriye Nehir; Hurtz, Christian; Shojaee, Seyedmehdi; Cazzaniga, Valeria; Schjerven, Hilde; Ernst, Thomas; Hochhaus, Andreas; Kornblau, Steven M.; Konopleva, Marina; Pufall, Miles A.; Cazzaniga, Giovanni; Liu, Grace J.; Milne, Thomas A.; Koeffler, H. Phillip; Ross, Theodora S.; Sanchez-Garcia, Isidro; Borkhardt, Arndt; Yamamoto, Keith R.; Dickins, Ross A.; Graeber, Thomas G.; Muschen, Markus			Metabolic gatekeeper function of B-lymphoid transcription factors (vol 542, pg 479, 2017)	NATURE			English	Correction													Dickins, Ross A/K-2852-2012; Cazzaniga, Giovanni/K-6338-2016	Dickins, Ross A/0000-0003-4112-5304; Pufall, Miles/0000-0002-7022-6916; Cosgun, Kadriye/0000-0003-4181-744X; Cazzaniga, Giovanni/0000-0003-2955-4528	NCI NIH HHS [R01 CA020535] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chan LN, 2017, NATURE, V542, P479, DOI 10.1038/nature21076	1	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2018	558	7711					E5	E5		10.1038/s41586-018-0164-5	http://dx.doi.org/10.1038/s41586-018-0164-5			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9SN	29849140	Green Submitted, Bronze			2022-12-28	WOS:000436594300012
J	Stamatelopoulos, K; Mueller-Hennessen, M; Georgiopoulos, G; Sachse, M; Boeddinghaus, J; Sopova, K; Gatsiou, A; Amrhein, C; Biener, M; Vafaie, M; Athanasouli, F; Stakos, D; Pateras, K; Twerenbold, R; Badertscher, P; Nestelberger, T; Dimmeler, S; Katus, HA; Zeiher, AM; Mueller, C; Giannitsis, E; Stellos, K				Stamatelopoulos, Kimon; Mueller-Hennessen, Matthias; Georgiopoulos, Georgios; Sachse, Marco; Boeddinghaus, Jasper; Sopova, Kateryna; Gatsiou, Aikaterini; Amrhein, Carolin; Biener, Moritz; Vafaie, Mehrshad; Athanasouli, Fani; Stakos, Dimitrios; Pateras, Konstantinos; Twerenbold, Raphael; Badertscher, Patrick; Nestelberger, Thomas; Dimmeler, Stefanie; Katus, Hugo A.; Zeiher, Andreas M.; Mueller, Christian; Giannitsis, Evangelos; Stellos, Konstantinos			Amyloid-beta (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM MORTALITY; PRECURSOR PROTEIN 770; ALZHEIMERS-DISEASE; MYOCARDIAL-INFARCTION; GLOBAL REGISTRY; RISK SCORES; ENDOTHELIAL-CELLS; HEART-DISEASE; MOUSE MODEL; ASSOCIATION	Background: Amyloid-beta (1-40) (A beta 40) is implicated in mechanisms related to plaque destabilization and correlates with adverse outcomes in stable coronary artery disease. Objective: To determine the prognostic and reclassification value of baseline circulating levels of A beta 40 after adjustment for the Global Registry of Acute Coronary Events (GRACE) score, which is widely recommended for risk stratification in non-ST segment elevation acute coronary syndrome (NSTE-ACS). Design: Retrospective cohort study using data from 2 independent prospective cohorts, the Heidelberg study (n = 1145) and the validation multicenter international APACE (Advantageous Predictors of Acute Coronary Syndrome Evaluation) study (n = 734). Setting: Academic hospitals in 7 European countries. Participants: Patients with adjudicated NSTE-ACS followed for a median of 21.9 and 24.9 months in the Heidelberg and APACE studies, respectively. Measurements: All-cause mortality was the primary end point. Results: Amyloid-beta (1-40) was associated with mortality after multivariate adjustment for age, sex, diabetes mellitus, high-sensitivity cardiac troponin T and C-reactive protein, revascularization, and ACS type (Heidelberg cohort hazard ratio [HR] for 80th vs. 20th percentiles, 1.66 [95% CI, 1.06 to 2.61; P = 0.026]; APACE cohort HR, 1.50 [CI, 1.15 to 1.96; P = 0.003]). It was also associated with mortality after adjustment for the GRACE score (Heidelberg cohort HR for 80th vs. 20th percentiles, 1.11 [CI, 1.04 to 1.18; P = 0.001]; APACE cohort HR, 1.39 [CI, 1.02 to 1.88; P = 0.036]). Amyloid-beta (1-40) correctly reclassified risk for death over the GRACE score (net reclassification index, 33.4% and 47.1% for the Heidelberg and APACE cohorts, respectively) (P < 0.05). Limitation: At low concentrations of A beta 40, dose-response associations with mortality differed between cohorts, possibly because of varying blood preparations used to measure A beta 40. Conclusion: Circulating A beta 40 is a predictor of mortality and improves risk stratification of patients with NSTE-ACS over the GRACE score recommended by clinical guidelines. The clinical application of A beta 40 as a novel biomarker in NSTE-ACS should be further explored and validated.	[Stamatelopoulos, Kimon; Georgiopoulos, Georgios; Athanasouli, Fani] Univ Athens, Alexandra Hosp, Athens, Greece; [Mueller-Hennessen, Matthias; Biener, Moritz; Vafaie, Mehrshad; Katus, Hugo A.; Giannitsis, Evangelos] Univ Hosp Heidelberg, Heidelberg, Germany; [Mueller-Hennessen, Matthias; Biener, Moritz; Vafaie, Mehrshad; Katus, Hugo A.; Giannitsis, Evangelos] German Ctr Cardiovasc Res, Heidelberg, Germany; [Sachse, Marco; Gatsiou, Aikaterini; Amrhein, Carolin; Dimmeler, Stefanie] Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Sachse, Marco; Sopova, Kateryna; Gatsiou, Aikaterini; Dimmeler, Stefanie; Zeiher, Andreas M.] German Ctr Cardiovasc Res, Frankfurt, Germany; [Boeddinghaus, Jasper; Twerenbold, Raphael; Badertscher, Patrick; Nestelberger, Thomas; Mueller, Christian] Cardiovasc Res Inst Basel, Basel, Switzerland; [Boeddinghaus, Jasper; Twerenbold, Raphael; Badertscher, Patrick; Nestelberger, Thomas; Mueller, Christian] Univ Hosp Basel, Basel, Switzerland; [Sopova, Kateryna; Zeiher, Andreas M.] Goethe Univ Frankfurt, Frankfurt, Germany; [Stakos, Dimitrios] Democritus Univ Thrace, Alexandroupolis, Greece; [Pateras, Konstantinos] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Stellos, Konstantinos] Newcastle Univ, Inst Genet Med, Cardiovasc Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Stellos, Konstantinos] Newcastle Upon Tyne Hosp NHS Fdn Trust, Cardiothorac Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Stellos, Konstantinos] Inst Genet Med, Cardiovasc Res Ctr, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Stamatelopoulos, Kimon; Georgiopoulos, Georgios; Athanasouli, Fani] Alexandra Hosp, Vasc Lab, Dept Clin Therapeut, 80 Vasilissis Sofias,POB 11528, Athens, Greece; [Mueller-Hennessen, Matthias; Biener, Moritz; Vafaie, Mehrshad; Katus, Hugo A.; Giannitsis, Evangelos] Univ Hosp Heidelberg, Cardiol, Dept Internal Med 3, Neuenheimer Feld 400, D-69120 Heidelberg, Germany; [Boeddinghaus, Jasper; Twerenbold, Raphael; Badertscher, Patrick; Nestelberger, Thomas; Mueller, Christian] Univ Basel, Univ Hosp Basel, Cardiovasc Res Inst Basel, Spitalstr 2, CH-4056 Basel, Switzerland; [Boeddinghaus, Jasper; Twerenbold, Raphael; Badertscher, Patrick; Nestelberger, Thomas; Mueller, Christian] Univ Basel, Univ Hosp Basel, Dept Cardiol, Spitalstr 2, CH-4056 Basel, Switzerland; [Sopova, Kateryna; Zeiher, Andreas M.] Goethe Univ Frankfurt, Dept Cardiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Stakos, Dimitrios] Democritus Univ Thrace, Dept Cardiol, Alexandroupolis 68100, Greece; [Pateras, Konstantinos] Univ Med Ctr Utrecht, Dept Biostat & Res Support, Julius Ctr Hlth Sci & Primary Care, Huispost STR 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands	Alexandra Hospital; National & Kapodistrian University of Athens; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Goethe University Frankfurt; German Centre for Cardiovascular Research; University of Basel; Goethe University Frankfurt; Democritus University of Thrace; Utrecht University; Utrecht University Medical Center; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Alexandra Hospital; Ruprecht Karls University Heidelberg; University of Basel; University of Basel; Goethe University Frankfurt; Democritus University of Thrace; Utrecht University; Utrecht University Medical Center	Stellos, K (corresponding author), Inst Genet Med, Cardiovasc Res Ctr, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	konstantinos.stellos@ncl.ac.uk	Müller, Christian/AAB-4783-2022; Stamatelopoulos, Kimon/AAD-6993-2019; GEORGIOPOULOS, GEORGIOS/AAH-7442-2020; Stellos, Konstantinos/ABH-1523-2021; Stakos, Dimitrios/AAO-8728-2021; Badertscher, Patrick/ABA-7212-2020; Pateras, Konstantinos/J-4172-2019; Stellos, Konstantinos/AAF-2711-2020	Müller, Christian/0000-0002-1120-6405; Stamatelopoulos, Kimon/0000-0001-6444-8734; GEORGIOPOULOS, GEORGIOS/0000-0001-7661-5253; Pateras, Konstantinos/0000-0002-6005-9798; Stellos, Konstantinos/0000-0002-0194-0825; Badertscher, Patrick/0000-0001-9751-0557	German Cardiac Society	German Cardiac Society	By an Inge-Edler Research Scholarship from the German Cardiac Society.	Abdullah L, 2007, NEUROSCI LETT, V428, P53, DOI 10.1016/j.neulet.2007.09.058; Abu-Assi E, 2010, AM HEART J, V160, P826, DOI 10.1016/j.ahj.2010.06.053; Ahn HJ, 2014, J EXP MED, V211, P1049, DOI 10.1084/jem.20131751; Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Aragam KG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007947; Bawamia B, 2013, AM HEART J, V165, P441, DOI 10.1016/j.ahj.2012.12.020; Bibl M, 2012, ELECTROPHORESIS, V33, P445, DOI 10.1002/elps.201100455; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Chisari M, 2010, PHARMACOL RES, V61, P157, DOI 10.1016/j.phrs.2009.09.004; Chong YH, 2001, J BIOL CHEM, V276, P23511, DOI 10.1074/jbc.M009466200; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; De Meyer GRY, 2002, CIRC RES, V90, P1197, DOI 10.1161/01.RES.0000020017.84398.61; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Farooq V, 2013, JACC-CARDIOVASC INTE, V6, P737, DOI 10.1016/j.jcin.2013.04.004; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Fox CS, 2005, AM J CARDIOL, V95, P856, DOI 10.1016/j.amjcard.2004.12.011; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Goncalves PDA, 2005, EUR HEART J, V26, P865, DOI 10.1093/eurheartj/ehi187; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Hall M, 2016, JAMA-J AM MED ASSOC, V316, P1073, DOI 10.1001/jama.2016.10766; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Kitazume S, 2012, J BIOL CHEM, V287, P40817, DOI 10.1074/jbc.M112.398578; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Li L, 2003, AM J PATHOL, V163, P2155, DOI 10.1016/S0002-9440(10)63572-9; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; Liu YH, 2015, MOL NEUROBIOL, V52, P115, DOI 10.1007/s12035-014-8854-y; Liu Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000981; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Mueller C, 2002, CIRCULATION, V105, P1412, DOI 10.1161/01.CIR.0000012625.02748.62; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nestelberger T, 2017, J AM COLL CARDIOL, V70, P1558, DOI 10.1016/j.jacc.2017.07.774; Ng LL, 2014, J AM COLL CARDIOL, V64, P1698, DOI 10.1016/j.jacc.2014.05.074; Ng LL, 2014, J AM COLL CARDIOL, V63, P280, DOI 10.1016/j.jacc.2013.09.037; Niwa K, 2001, AM J PHYSIOL-HEART C, V281, pH2417, DOI 10.1152/ajpheart.2001.281.6.H2417; Ohman EM, 2014, J AM COLL CARDIOL, V63, P2258, DOI 10.1016/j.jacc.2014.03.009; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubio I, 2006, J ALZHEIMERS DIS, V10, P439; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Smith CCT, 1997, NEUROSCI LETT, V235, P157, DOI 10.1016/S0304-3940(97)00738-6; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sonkar VK, 2014, FASEB J, V28, P1819, DOI 10.1096/fj.13-243691; Stamatelopoulos K, 2015, J AM COLL CARDIOL, V65, P904, DOI 10.1016/j.jacc.2014.12.035; Stellos K, 2016, NAT MED, V22, P1140, DOI 10.1038/nm.4172; Stone C, 1985, ADD SPLIN STAT P STA; Tang EW, 2007, AM HEART J, V153, P29, DOI 10.1016/j.ahj.2006.10.004; Thygesen K, 2007, EUR HEART J, V28, P2525; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Van De Parre TJL, 2011, ATHEROSCLEROSIS, V216, P54, DOI 10.1016/j.atherosclerosis.2011.01.032; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; WALD A, 1945, ANN MATH STAT, V16, P117, DOI 10.1214/aoms/1177731118; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065232; Widera C, 2012, EUR HEART J, V33, P1095, DOI 10.1093/eurheartj/ehr444; Wildi K, 2017, CLIN CHEM, V63, P1227, DOI 10.1373/clinchem.2016.268359; Wright RS, 2011, CIRCULATION, V123, P2022, DOI 10.1161/CIR.0b013e31820f2f3e	68	22	22	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2018	168	12					855	+		10.7326/M17-1540	http://dx.doi.org/10.7326/M17-1540			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK1TE	29799975				2022-12-28	WOS:000435903500015
J	Lowery, CM; Bralower, TJ; Owens, JD; Rodriguez-Tovar, FJ; Jones, H; Smit, J; Whalen, MT; Claeys, P; Farley, K; Gulick, SPS; Morgan, JV; Green, S; Chenot, E; Christeson, GL; Cockell, CS; Coolen, MJL; Ferriere, L; Gebhardt, C; Goto, K; Kring, DA; Lofi, J; Ocampo-Torres, R; Perez-Cruz, L; Pickersgill, AE; Poelchau, MH; Rae, ASP; Rasmussen, C; Rebolledo-Vieyra, M; Riller, U; Sato, H; Tikoo, SM; Tomioka, N; Urrutia-Fucugauchi, J; Vellekoop, J; Wittmann, A; Xiao, L; Yamaguchi, KE; Zylberman, W				Lowery, Christopher M.; Bralower, Timothy J.; Owens, Jeremy D.; Rodriguez-Tovar, Francisco J.; Jones, Heather; Smit, Jan; Whalen, Michael T.; Claeys, Phillipe; Farley, Kenneth; Gulick, Sean P. S.; Morgan, Joanna V.; Green, Sophie; Chenot, Elise; Christeson, Gail L.; Cockell, Charles S.; Coolen, Marco J. L.; Ferriere, Ludovic; Gebhardt, Catalina; Goto, Kazuhisa; Kring, David A.; Lofi, Johanna; Ocampo-Torres, Ruben; Perez-Cruz, Ligia; Pickersgill, Annemarie E.; Poelchau, Michael H.; Rae, Auriol S. P.; Rasmussen, Cornelia; Rebolledo-Vieyra, Mario; Riller, Ulrich; Sato, Honami; Tikoo, Sonia M.; Tomioka, Naotaka; Urrutia-Fucugauchi, Jaime; Vellekoop, Johan; Wittmann, Axel; Xiao, Long; Yamaguchi, Kosei E.; Zylberman, William			Rapid recovery of life at ground zero of the end-Cretaceous mass extinction	NATURE			English	Article							GULF-OF-MEXICO; TERTIARY BOUNDARY; EXTRATERRESTRIAL HE-3; BENTHIC FORAMINIFERA; INTERPLANETARY DUST; PALEOGENE BOUNDARY; CHICXULUB CRATER; IMPACT CRATER; NANNOPLANKTON; ACCRETION	The Cretaceous/Palaeogene mass extinction eradicated 76% of species on Earth(1,2). It was caused by the impact of an asteroid(3,4) on the Yucatan carbonate platform in the southern Gulf of Mexico 66 million years ago(5), forming the Chicxulub impact crater(6,7). After the mass extinction, the recovery of the global marine ecosystem-measured as primary productivity-was geographically heterogeneous(8); export production in the Gulf of Mexico and North Atlantic-western Tethys was slower than in most other regions(8-11), taking 300 thousand years (kyr) to return to levels similar to those of the Late Cretaceous period. Delayed recovery of marine productivity closer to the crater implies an impact-related environmental control, such as toxic metal poisoning(12), on recovery times. If no such geographic pattern exists, the best explanation for the observed heterogeneity is a combination of ecological factors-trophic interactions(13), species incumbency and competitive exclusion by opportunists(14)-and 'chance'(8,15,16). The question of whether the post-impact recovery of marine productivity was delayed closer to the crater has a bearing on the predictability of future patterns of recovery in anthropogenically perturbed ecosystems. If there is a relationship between the distance from the impact and the recovery of marine productivity, we would expect recovery rates to be slowest in the crater itself. Here we present a record of foraminifera, calcareous nannoplankton, trace fossils and elemental abundance data from within the Chicxulub crater, dated to approximately the first 200 kyr of the Palaeocene. We show that life reappeared in the basin just years after the impact and a high-productivity ecosystem was established within 30 kyr, which indicates that proximity to the impact did not delay recovery and that there was therefore no impact-related environmental control on recovery. Ecological processes probably controlled the recovery of productivity after the Cretaceous/Palaeogene mass extinction and are therefore likely to be important for the response of the ocean ecosystem to other rapid extinction events.	[Lowery, Christopher M.; Gulick, Sean P. S.; Christeson, Gail L.; Rasmussen, Cornelia] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, 8701 Mopac Blvd, Austin, TX 78712 USA; [Bralower, Timothy J.; Jones, Heather] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Owens, Jeremy D.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Owens, Jeremy D.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Rodriguez-Tovar, Francisco J.] Univ Granada, Dept Estratig & Paleontol, Granada, Spain; [Smit, Jan] Vrije Univ Amsterdam, Fac Earth & Life Sci FALW, Amsterdam, Netherlands; [Whalen, Michael T.] Univ Alaska Fairbanks, Dept Geosci, Fairbanks, AK USA; [Claeys, Phillipe; Vellekoop, Johan] Vrije Univ Brussel, Analyt Environm & Geochem, Brussels, Belgium; [Farley, Kenneth] CALTECH, Div Geol & Planetary Sci, MS 170-25, Pasadena, CA 91125 USA; [Morgan, Joanna V.; Rae, Auriol S. P.] Imperial Coll London, Dept Earth Sci & Engn, London, England; [Green, Sophie] British Geol Survey, Edinburgh, Midlothian, Scotland; [Chenot, Elise] Univ Bourgogne Franche Comte, Biogeosci Lab, Dijon, France; [Cockell, Charles S.] Univ Edinburgh, Sch Phys & Astron, UK Ctr Astrobiol, Edinburgh, Midlothian, Scotland; [Coolen, Marco J. L.] Curtin Univ, WA Organ & Isotope Geochem Ctr WA OIGC, Sch Earth & Planetary Sci, Bentley, WA, Australia; [Ferriere, Ludovic] Nat Hist Museum, Vienna, Austria; [Gebhardt, Catalina] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Goto, Kazuhisa] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi, Japan; [Kring, David A.] Lunar & Planetary Inst, 3303 NASA Rd 1, Houston, TX 77058 USA; [Lofi, Johanna] Univ Montpellier, CNRS, Geosci Montpellier, Montpellier, France; [Ocampo-Torres, Ruben] Univ Strasbourg, ICPEES, Grp Phys Chim Atmosphere, Strasbourg, France; [Perez-Cruz, Ligia; Urrutia-Fucugauchi, Jaime] Univ Nacl Autonoma Mexico, Inst Geofis, Mexico City, DF, Mexico; [Pickersgill, Annemarie E.] Univ Glasgow, Sch Geog & Earth Sci, Glasgow, Lanark, Scotland; [Pickersgill, Annemarie E.] SUERC, Argon Isotope Facil, E Kilbride, Lanark, Scotland; [Poelchau, Michael H.] Univ Freiburg, Dept Geol, Freiburg, Germany; [Rebolledo-Vieyra, Mario] Independent Consultant, Cancun, Mexico; [Riller, Ulrich] Univ Hamburg, Inst Geol, Hamburg, Germany; [Sato, Honami] Chiba Inst Technol, Ocean Resources Res Ctr Next Generat, Chiba, Japan; [Tikoo, Sonia M.] Rutgers State Univ, Earth & Planetary Sci, New Brunswick, NJ USA; [Tomioka, Naotaka] Japan Agcy Marine Earth Sci & Technol, Kochi Inst Core Sample Res, Kochi, Kerala, India; [Wittmann, Axel] Arizona State Univ, LeRoy Eyring Ctr Solid State Sci Phys Sci, Tempe, AZ USA; [Xiao, Long] China Univ Geosci, Sch Earth Sci, Plant Sci Inst, Wuhan, Hubei, Peoples R China; [Yamaguchi, Kosei E.] Toho Univ, Dept Chem, Chiba, Japan; [Yamaguchi, Kosei E.] NASA, Astrobiol Inst, Mountain View, CA USA; [Zylberman, William] Aix Marseille Univ, CNRS, Inst Rech & Dev, Marseille, France	University of Texas System; University of Texas Austin; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Granada; Vrije Universiteit Amsterdam; University of Alaska System; University of Alaska Fairbanks; Vrije Universiteit Brussel; California Institute of Technology; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; Universite de Bourgogne; University of Edinburgh; Curtin University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Tohoku University; National Aeronautics & Space Administration (NASA); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidad Nacional Autonoma de Mexico; University of Glasgow; Scottish Universities Research & Reactor Center; University of Freiburg; University of Hamburg; Chiba Institute of Technology; Rutgers State University New Brunswick; Arizona State University; Arizona State University-Tempe; China University of Geosciences; Toho University; National Aeronautics & Space Administration (NASA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Lowery, CM (corresponding author), Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, 8701 Mopac Blvd, Austin, TX 78712 USA.	cmlowery@utexas.edu	Gulick, Sean/GNH-2042-2022; Tomioka, Naotaka/B-1888-2011; Farley, Kenneth/AAE-7735-2020; Rodríguez-Tovar, Francisco/AAA-9041-2020; Rae, Auriol/ABB-1816-2021; Yamaguchi, Kosei E/B-2882-2008; (VUB), VRIJE UNIVERSITEIT BRUSSEL/B-4895-2008; Goto, Kazuhisa/O-2060-2018; Vellekoop, Johan/L-1805-2019; Lofi, Johanna/I-5159-2018; Xiao, Long/R-1343-2017; Christeson, Gail/B-9967-2008; Christeson, Gail/R-3777-2019; Whalen, Michael T/N-6503-2014; Coolen, Marco/B-8263-2015; Pickersgill, Annemarie/N-1871-2017	Gulick, Sean/0000-0003-4740-9068; Tomioka, Naotaka/0000-0001-5725-9513; Rodríguez-Tovar, Francisco/0000-0002-1400-2715; Yamaguchi, Kosei E/0000-0001-8728-6918; (VUB), VRIJE UNIVERSITEIT BRUSSEL/0000-0002-4585-7687; Goto, Kazuhisa/0000-0002-5351-7383; Vellekoop, Johan/0000-0001-6977-693X; Lofi, Johanna/0000-0002-0602-595X; Xiao, Long/0000-0002-5271-8554; Christeson, Gail/0000-0002-4749-4429; Christeson, Gail/0000-0002-4749-4429; Whalen, Michael T/0000-0003-0556-7471; Smit, Jan/0000-0002-6070-4865; Coolen, Marco/0000-0002-0417-920X; Ocampo Torres, Ruben/0000-0003-3107-8954; Wittmann, Axel/0000-0001-7572-0801; Owens, Jeremy/0000-0002-0530-2177; Ferriere, Ludovic/0000-0002-9082-6230; Pickersgill, Annemarie/0000-0001-5452-2849; Rae, Auriol/0000-0003-3420-4135; Riller, Ulrich/0000-0002-3803-6792; Perez Cruz, Ligia Lucina/0000-0001-6991-5143	European Consortium for Ocean Research Drilling (ECORD); International Continental Drilling Program (ICDP); US Science Support Program; NSF [OCE 1737351]; NASA [NNX16AJ60G]; Secretaria de Estado de I+D+I, Spain [CGL2015-66835-P]; Scientific Excellence Unit (Universidad de Granada) [UCE-2016-05]; Directorate For Geosciences [1624895] Funding Source: National Science Foundation; Natural Environment Research Council [NE/P006736/1] Funding Source: researchfish; NERC [bgs05019, NE/P005217/1, NE/P006736/1] Funding Source: UKRI	European Consortium for Ocean Research Drilling (ECORD); International Continental Drilling Program (ICDP); US Science Support Program; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Secretaria de Estado de I+D+I, Spain; Scientific Excellence Unit (Universidad de Granada); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research used samples and data provided by the International Ocean Discovery Program (IODP). IODP Expedition 364 was jointly funded by the European Consortium for Ocean Research Drilling (ECORD) and International Continental Drilling Program (ICDP), with contributions and logistical support from the Yucatan State Government and Universidad Nacional Autonoma de Mexico (UNAM). We thank T. Cayton for assistance with crushing and washing samples; S. Dameron, R. Moura de Mello and M. Leckie for helpful discussions on benthic foraminifer taxonomy; J. Maner for assistance with the UT ESEM laboratory and R. Martindale for assistance with petrographic microscope imaging. We are particularly grateful for assistance of the staff of the IODP Core Repository in Bremen, Germany for their assistance taking these samples and running shipboard analyses. The authors acknowledge Post-Expedition Awards from the US Science Support Program for C.M.L. and T.J.B., NSF OCE 1737351, and NASA NNX16AJ60G. Funding for F.J.R.-T. was provided by Project CGL2015-66835-P (Secretaria de Estado de I+D+I, Spain), and Scientific Excellence Unit UCE-2016-05 (Universidad de Granada).	Abramov O, 2007, METEORIT PLANET SCI, V42, P93, DOI 10.1111/j.1945-5100.2007.tb00220.x; Alegret L, 2005, PALAEOGEOGR PALAEOCL, V224, P53, DOI 10.1016/j.palaeo.2005.03.031; Alegret L, 2004, NEUES JAHRB GEOL P-A, V234, P25; Alegret L, 2001, MICROPALEONTOLOGY, V47, P269, DOI 10.2113/47.4.269; Alegret L, 2001, GEOLOGY, V29, P891, DOI 10.1130/0091-7613(2001)029<0891:BFATCT>2.0.CO;2; ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; [Anonymous], 2017, EXPEDITION 364 PRELI; Berggren WA, 2005, J FORAMIN RES, V35, P279, DOI 10.2113/35.4.279; Bralower TJ, 1998, GEOLOGY, V26, P331, DOI 10.1130/0091-7613(1998)026<0331:TCTBCC>2.3.CO;2; BUZAS MA, 1990, J PALEONTOL, V64, P842, DOI 10.1017/S002233600001903X; Cockell CS, 2006, PHILOS T R SOC B, V361, P1845, DOI 10.1098/rstb.2006.1908; Dorador J, 2016, MAR GEOL, V377, P118, DOI 10.1016/j.margeo.2015.09.008; Dorador J, 2014, FACIES, V60, P39, DOI 10.1007/s10347-013-0383-z; Farley KA, 2003, EARTH PLANET SC LETT, V208, P135, DOI 10.1016/S0012-821X(03)00017-7; Gulick SPS, 2008, NAT GEOSCI, V1, P131, DOI 10.1038/ngeo103; Hardisty DS, 2017, EARTH PLANET SC LETT, V463, P159, DOI 10.1016/j.epsl.2017.01.032; HILDEBRAND AR, 1991, GEOLOGY, V19, P867, DOI 10.1130/0091-7613(1991)019<0867:CCAPCT>2.3.CO;2; Hull PM, 2011, NAT GEOSCI, V4, P856, DOI 10.1038/NGEO1302; Hull PM, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002082; Jablonski David, 1995, P25; Jiang SJ, 2010, NAT GEOSCI, V3, P280, DOI 10.1038/NGEO775; Knaust D, 2017, ATLAS TRACE FOSSILS; Leckie R.M., 2003, SEPM SPECIAL PUB, V75, P5, DOI DOI 10.2110/pec.03.75.0005; Lu ZL, 2010, GEOLOGY, V38, P1107, DOI 10.1130/G31145.1; Morgan J., 2017, P INT OC DISC PROGR; Morgan JV, 2016, SCIENCE, V354, P878, DOI 10.1126/science.aah6561; Mukhopadhyay S, 2001, SCIENCE, V291, P1952, DOI 10.1126/science.291.5510.1952; Mukhopadhyay S, 2001, GEOCHIM COSMOCHIM AC, V65, P653, DOI 10.1016/S0016-7037(00)00555-X; Olsson D. K., 1999, ATLAS PALEOCENE PLAN; Patterson DB, 1998, GEOCHIM COSMOCHIM AC, V62, P3669, DOI 10.1016/S0016-7037(98)00263-4; Poag CW, 2009, GEOL SOC AM SPEC PAP, V458, P747, DOI 10.1130/2009.2458(32); Renne PR, 2013, SCIENCE, V339, P684, DOI 10.1126/science.1230492; Salvador, 1991, GULF MEXICO BASIN, VJ, P205, DOI 10.1130/DNAG-GNA-J.205; Schueth JD, 2015, PALEOBIOLOGY, V41, P661, DOI 10.1017/pab.2015.28; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; SMIT J, 1980, NATURE, V285, P198, DOI 10.1038/285198a0; Sole RV, 2002, PHILOS T R SOC B, V357, P697, DOI 10.1098/rstb.2001.0987; Wade BS, 2011, EARTH-SCI REV, V104, P111, DOI 10.1016/j.earscirev.2010.09.003; Yedid G, 2009, AM NAT, V173, pE139, DOI 10.1086/597228	39	81	82	3	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2018	558	7709					288	+		10.1038/s41586-018-0163-6	http://dx.doi.org/10.1038/s41586-018-0163-6			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2BI	29849143	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000435071400053
J	ten Kate, IL				ten Kate, Inge Loes			Organic molecules on Mars	SCIENCE			English	Editorial Material							DELIVERY; IMPACT		[ten Kate, Inge Loes] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands	Utrecht University	ten Kate, IL (corresponding author), Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands.	i.l.tenkate@uu.nl						BIEMANN K, 1979, J GEOPHYS RES, V84, P8385, DOI 10.1029/JB084iB14p08385; Carr MH, 2010, EARTH PLANET SC LETT, V294, P185, DOI 10.1016/j.epsl.2009.06.042; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; Crismani MMJ, 2017, NAT GEOSCI, V10, P401, DOI [10.1038/NGEO2958, 10.1038/ngeo2958]; Ehrenfreund P, 2011, PHILOS T R SOC A, V369, P538, DOI 10.1098/rsta.2010.0231; Eigenbrode JL, 2018, SCIENCE, V360, P1096, DOI 10.1126/science.aas9185; Frantseva K, 2018, ICARUS, V309, P125, DOI 10.1016/j.icarus.2018.03.006; Freissinet C, 2015, J GEOPHYS RES-PLANET, V120, P495, DOI 10.1002/2014JE004737; Grotzinger JP, 2014, SCIENCE, V343, DOI 10.1126/science.1242777; Keil RG, 2014, TREATISE GEOCHEMISTR, P337, DOI DOI 10.1016/B978-0-08-095975-7.01024-X; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; Pavlov AA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052166; ten Kate IL, 2008, ASTROBIOLOGY, V8, P571, DOI 10.1089/ast.2007.0160; ten Kate IL, 2010, ASTROBIOLOGY, V10, P589, DOI 10.1089/ast.2010.0498; Webster CR, 2018, SCIENCE, V360, P1093, DOI 10.1126/science.aaq0131	15	10	10	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1068	1069		10.1126/science.aat2662	http://dx.doi.org/10.1126/science.aat2662			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI6TJ	29880670				2022-12-28	WOS:000434635500025
J	Dayan, S				Dayan, Steven			Revision Plastic Surgery Reality Television What's Good About Botched?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TV		[Dayan, Steven] DeNova Res, 845 N Michigan Ave,Ste 923E, Chicago, IL 60611 USA; [Dayan, Steven] Univ Illinois, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Dayan, S (corresponding author), DeNova Res, 845 N Michigan Ave,Ste 923E, Chicago, IL 60611 USA.	sdayan@drdayan.com			Allergan; Galderma; MErz; Revance; Nutrafol; AOBiome	Allergan(AbbVieAllergan); Galderma; MErz; Revance; Nutrafol; AOBiome	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Dayan reported receiving grant funding from Allergan, Galderma, MErz, Revance, Nutrafol, and AOBiome.	Crockett RJ, 2007, PLAST RECONSTR SURG, V120, P316, DOI 10.1097/01.prs.0000264339.67451.71; Dorfman RG, 2018, AESTHET SURG J, V38, P332, DOI [10.1093/asj/sjx120, 10.1093/asj/sjx210]; Rey Robert, 2007, Virtual Mentor, V9, P229, DOI 10.1001/virtualmentor.2007.9.3.oped1-0703; Sperry S, 2009, ANN PLAS SURG, V62, P7, DOI 10.1097/SAP.0b013e31817e2cb8	4	1	1	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2156	2157		10.1001/jama.2018.5756	http://dx.doi.org/10.1001/jama.2018.5756			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29872838				2022-12-28	WOS:000434133400001
J	Dmitrienko, A; D'Agostino, RB				Dmitrienko, Alex; D'Agostino, Ralph B., Sr.			Multiplicity Considerations in Clinical Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							METASTATIC PROSTATE-CANCER; END-POINTS; ADJUSTMENT METHODS; PLACEBO; SCHIZOPHRENIA; CHEMOTHERAPY; LURASIDONE; ISSUES		[Dmitrienko, Alex; D'Agostino, Ralph B., Sr.] Mediana, Overland Pk, KS 66213 USA		Dmitrienko, A (corresponding author), Mediana, Overland Pk, KS 66213 USA.	alex.dmitrienko@gmail.com						BAUER P, 1991, STAT MED, V10, P871, DOI 10.1002/sim.4780100609; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Brechenmacher T, 2011, J BIOPHARM STAT, V21, P748, DOI 10.1080/10543406.2011.551334; Bretz F, 2005, BIOMETRICS, V61, P738, DOI 10.1111/j.1541-0420.2005.00344.x; CAPPUZZO F, 2009, J CLIN ONCOL S, V27; Chuang-Stein C, 2009, J BIOPHARM STAT, V19, P14, DOI 10.1080/10543400802541719; Cohen AT, 2016, NEW ENGL J MED, V375, P534, DOI 10.1056/NEJMoa1601747; D'Agostino RB, 2000, STAT MED, V19, P763, DOI 10.1002/(SICI)1097-0258(20000330)19:6<763::AID-SIM517>3.0.CO;2-8; D'Agostino RB, 1993, DRUG INF J, p[27, 625]; DAGOSTINO RB, 1991, STAT MED, V10, P1, DOI 10.1002/sim.4780100102; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dmitrienko A., 2009, MULTIPLE TESTING PRO, P165; Dmitrienko A., 2009, MULTIPLE TESTING PRO, P35, DOI [10.1201/9781584889854-c2, DOI 10.1201/9781584889854-C2]; Dmitrienko A, 2013, STAT MED, V32, P5172, DOI 10.1002/sim.5990; Dmitrienko A, 2013, BIOMETRICAL J, V55, P402, DOI 10.1002/bimj.201100258; Dmitrienko A, 2013, STAT MED, V32, P1079, DOI 10.1002/sim.5642; Dmitrienko A, 2011, STAT MED, V30, P1473, DOI 10.1002/sim.4008; European Medicines Agency, 2016, GUID MULT ISS CLIN T; European medicines agency, 2002, POINTS CONS MULT ISS; Huque M, 2010, CH CRC BIOSTAT SER, V33, P1; Huque MF, 2013, STAT BIOPHARM RES, V5, P321, DOI 10.1080/19466315.2013.807749; Huque MF, 2011, J BIOPHARM STAT, V21, P610, DOI 10.1080/10543406.2011.551327; Mehrotra DV, 2004, STAT METHODS MED RES, V13, P227, DOI 10.1191/0962280204sm363ra; Meltzer HY, 2011, AM J PSYCHIAT, V168, P957, DOI 10.1176/appi.ajp.2011.10060907; Millen BA, 2012, DRUG INF J, V46, P647, DOI 10.1177/0092861512454116; Nasrallah HA, 2013, J PSYCHIATR RES, V47, P670, DOI 10.1016/j.jpsychires.2013.01.020; Offen W, 2007, DRUG INF J, V41, P31, DOI 10.1177/009286150704100105; Pulkstenis, 2017, CLIN TRIAL OPTIMIZAT; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Sankoh AJ, 2014, STAT MED, V33, P4709, DOI 10.1002/sim.6205; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; U.S. Food and Drug Administration, 2017, GUIDANCE DOCUMENT MU	33	65	66	3	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2018	378	22					2115	2122		10.1056/NEJMra1709701	http://dx.doi.org/10.1056/NEJMra1709701			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH5AL	29847757				2022-12-28	WOS:000433428000009
J	Dyer, C				Dyer, Clare			GP is struck off for wrongly charging patients and lying to colleagues	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2018	361								k2437	10.1136/bmj.k2437	http://dx.doi.org/10.1136/bmj.k2437			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MT	29853445				2022-12-28	WOS:000434276300015
J	Magiera, MM; Singh, P; Gadadhar, S; Janke, C				Magiera, Maria M.; Singh, Puja; Gadadhar, Sudarshan; Janke, Carsten			Tubulin Posttranslational Modifications and Emerging Links to Human Disease	CELL			English	Review							TYROSINE-LIGASE; RETINITIS-PIGMENTOSA; PLATELET ACTIVATION; POOR-PROGNOSIS; POLYGLUTAMYLATION; MICROTUBULES; ACETYLATION; TRANSPORT; MOUSE; AGBL5	Tubulin posttranslational modifications are currently emerging as important regulators of the microtubule cytoskeleton and thus have a strong potential to be implicated in a number of disorders. Here, we review the latest advances in understanding the physiological roles of tubulin modifications and their links to a variety of pathologies.	[Magiera, Maria M.; Singh, Puja; Gadadhar, Sudarshan; Janke, Carsten] PSL Res Univ, CNRS, UMR3348, Inst Curie, Orsay, France; [Magiera, Maria M.; Singh, Puja; Gadadhar, Sudarshan; Janke, Carsten] Univ Paris Saclay, Univ Paris Sud, UMR3348, CNRS, Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Magiera, MM; Janke, C (corresponding author), PSL Res Univ, CNRS, UMR3348, Inst Curie, Orsay, France.; Magiera, MM; Janke, C (corresponding author), Univ Paris Saclay, Univ Paris Sud, UMR3348, CNRS, Orsay, France.	maria.magiera@curie.fr; carsten.janke@curie.fr	Gadadhar, Sudarshan/C-1319-2019; Gadadhar, Sudarshan/O-1770-2019; SINGH, PUJA/AGE-0583-2022; Janke, Carsten/A-7279-2011; Magiera, Maria M./Y-8754-2019	Gadadhar, Sudarshan/0000-0003-4791-2034; Gadadhar, Sudarshan/0000-0003-4791-2034; SINGH, PUJA/0000-0003-1011-7221; Janke, Carsten/0000-0001-7053-2000; Magiera, Maria M./0000-0003-4847-3053	program "Investissements d'Avenir'' [ANR-10-LBX-0038, ANR-10-IDEX-0001-02 PSL]; Institut Curie, ANR [ANR-12-BSV2-0007]; Institut National du Cancer (INCA) [2013-1-PL BIO-02-ICR-1, 2014-PL BIO-11-ICR-1]; EMBO short-term fellowship [ASTF 148-2015]; Fondation Vaincre Alzheimer [FR-16055p]; Ligue contre le Cancer	program "Investissements d'Avenir''(French National Research Agency (ANR)); Institut Curie, ANR; Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); EMBO short-term fellowship(European Molecular Biology Organization (EMBO)); Fondation Vaincre Alzheimer; Ligue contre le Cancer(Ligue nationale contre le cancer)	We would like to thank C. Arnoult (University of Grenoble, France), M. Barisic (Danish Cancer Society Research Center, Copenhagen, Denmark), S. Bodakuntla (Institut Curie), and F. Lanza (Etablissement Francais du Sang, Strasbourg, France) for insightful discussion. This work was supported by the program "Investissements d'Avenir'' launched by the French Government and implemented by the French National Research Agency (ANR), ANR-10-LBX-0038, ANR-10-IDEX-0001-02 PSL, by the Institut Curie, ANR grant ANR-12-BSV2-0007, the Institut National du Cancer (INCA) grants 2013-1-PL BIO-02-ICR-1 and 2014-PL BIO-11-ICR-1. M.M.M. is supported by the EMBO short-term fellowship ASTF 148-2015 and by the Fondation Vaincre Alzheimer grant FR-16055p., and P.S. is supported by a postdoctoral fellowship from the Ligue contre le Cancer.	Aillaud C, 2017, SCIENCE, V358, P1448, DOI 10.1126/science.aao4165; Akera T, 2017, SCIENCE, V358, P668, DOI 10.1126/science.aan0092; Astuti GDN, 2016, INVEST OPHTH VIS SCI, V57, P6180, DOI 10.1167/iovs.16-20148; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Branham K, 2016, PHYSIOL GENOMICS, V48, P922, DOI 10.1152/physiolgenomics.00101.2016; d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396; Diagouraga B, 2014, J CELL BIOL, V204, P177, DOI 10.1083/jcb.201306085; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Du H, 2017, CANCER BIOL THER, V18, P827, DOI 10.1080/15384047.2017.1373217; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; Gadadhar S, 2017, J CELL BIOL, V216, P2701, DOI 10.1083/jcb.201612050; Godena VK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6245; Grau MB, 2017, J CELL SCI, V130, P938, DOI 10.1242/jcs.199091; Grau MB, 2013, J CELL BIOL, V202, P441, DOI 10.1083/jcb.201305041; Huq M.D.M., 2010, P 20 AUSTR U POW ENG, P1; Iancu-Rubin C, 2012, EXP HEMATOL, V40, P564, DOI 10.1016/j.exphem.2012.02.004; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Johnson KA, 1998, J CELL SCI, V111, P313; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962; Kastner S, 2015, INVEST OPHTH VIS SCI, V56, P8045, DOI 10.1167/iovs.15-17473; Kato C, 2004, INT J CANCER, V112, P365, DOI 10.1002/ijc.20431; Kerr JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9526; Kherraf ZE, 2017, EMBO MOL MED, V9, P1132, DOI 10.15252/emmm.201607461; Kim JU, 2016, J NANOMATER, V2016, DOI 10.1155/2016/7602395; Konno A, 2016, J CELL SCI, V129, P2757, DOI 10.1242/jcs.185983; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Maas C, 2009, P NATL ACAD SCI USA, V106, P8731, DOI 10.1073/pnas.0812391106; Magiera MM, 2018, CELL, V173, P1552, DOI 10.1016/j.cell.2018.05.032; Marchena M, 2011, EXP EYE RES, V93, P607, DOI 10.1016/j.exer.2011.07.010; Mialhe A, 2001, CANCER RES, V61, P5024; Morley SJ, 2016, ELIFE, V5, DOI 10.7554/eLife.20813; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Nieuwenhuis J, 2017, SCIENCE, V358, P1453, DOI 10.1126/science.aao5676; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Robison P, 2016, SCIENCE, V352, DOI 10.1126/science.aaf0659; Rocha C, 2014, EMBO J, V33, P2247, DOI 10.15252/embj.201488466; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Sadoul K, 2012, BLOOD, V120, P4215, DOI 10.1182/blood-2012-05-428011; Song YY, 2015, TRENDS CELL BIOL, V25, P125, DOI 10.1016/j.tcb.2014.10.004; Valenstein ML, 2016, CELL, V164, P911, DOI 10.1016/j.cell.2016.01.019; Vogel P, 2010, VET PATHOL, V47, P703, DOI 10.1177/0300985810363485; Wei D., 2017, CEREB CORTEX, DOI DOI 10.1093/CERCOR/BHX1225; Wloga D, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028159; Wu HY, 2017, SCI REP-UK, V7, DOI 10.1038/srep41428; Xu ZJ, 2017, SCIENCE, V356, P328, DOI 10.1126/science.aai8764	49	88	91	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1323	1327		10.1016/j.cell.2018.05.018	http://dx.doi.org/10.1016/j.cell.2018.05.018			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856952	Green Submitted, Bronze			2022-12-28	WOS:000433989100007
J	Sebe-Pedros, A; Saudemont, B; Chomsky, E; Plessier, F; Mailhe, MP; Renno, J; Loe-Mie, Y; Lifshitz, A; Mukamel, Z; Schmutz, S; Novault, S; Steinmetz, PRH; Spitz, F; Tanay, A; Marlow, H				SebePedros, A.; Saudemont, Baptiste; Chomsky, Elad; Plessier, Flora; Mailhe, Marie-Pierre; Renno, Justine; Loe-Mie, Yann; Lifshitz, Aviezer; Mukamel, Zohar; Schmutz, Sandrine; Novault, Sophie; Steinmetz, Patrick R. H.; Spitz, Francois; Tanay, Amos; Marlow, Heather			Cnidarian Cell Type Diversity and Regulation Revealed by Whole-Organism Single-Cell RNA-Seq	CELL			English	Article							ANEMONE NEMATOSTELLA-VECTENSIS; GENE-EXPRESSION; EVOLUTION; GENOME; ORGANIZATION; ENHANCERS; SYSTEMS	The emergence and diversification of cell types is a leading factor in animal evolution. So far, systematic characterization of the gene regulatory programs associated with cell type specificity was limited to few cell types and few species. Here, we perform whole-organism single-cell transcriptomics to map adult and larval cell types in the cnidarian Nematostella vectensis, a non-bilaterian animal with complex tissue-level body-plan organization. We uncover eight broad cell classes in Nematostella, including neurons, cnidocytes, and digestive cells. Each class comprises different subtypes defined by the expression of multiple specific markers. In particular, we characterize a surprisingly diverse repertoire of neurons, which comparative analysis suggests are the result of lineage-specific diversification. By integrating transcription factor expression, chromatin profiling, and sequence motif analysis, we identify the regulatory codes that underlie Nematostella cell-specific expression. Our study reveals cnidarian cell type complexity and provides insights into the evolution of animal cell-specific genomic regulation.	[SebePedros, A.; Chomsky, Elad; Lifshitz, Aviezer; Mukamel, Zohar; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [SebePedros, A.; Chomsky, Elad; Lifshitz, Aviezer; Mukamel, Zohar; Tanay, Amos] Weizmann Inst Sci, Dept Biol Regulat, IL-76100 Rehovot, Israel; [Saudemont, Baptiste; Plessier, Flora; Mailhe, Marie-Pierre; Renno, Justine; Loe-Mie, Yann; Spitz, Francois; Marlow, Heather] Inst Pasteur, Dept Dev & Stem Cell Biol, Epi Genom Anim Dev Unit, F-75015 Paris, France; [Saudemont, Baptiste; Plessier, Flora; Mailhe, Marie-Pierre; Renno, Justine; Loe-Mie, Yann; Spitz, Francois; Marlow, Heather] CNRS, UMR3738, 25 Rue Dr Roux, F-75015 Paris, France; [Plessier, Flora] Ecole Normale Super Lyon, Dept Biol, 46 Allee Italie, F-69364 Lyon 07, France; [Schmutz, Sandrine; Novault, Sophie] Inst Pasteur, Cytometry Platform, Cytometry & Biomarkers UtechS, F-75015 Paris, France; [Steinmetz, Patrick R. H.] Univ Bergen, Sars Int Ctr Marine Mol Biol, Thormohlensgate 55, N-5006 Bergen, Norway	Weizmann Institute of Science; Weizmann Institute of Science; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Bergen	Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.; Tanay, A (corresponding author), Weizmann Inst Sci, Dept Biol Regulat, IL-76100 Rehovot, Israel.; Marlow, H (corresponding author), Inst Pasteur, Dept Dev & Stem Cell Biol, Epi Genom Anim Dev Unit, F-75015 Paris, France.; Marlow, H (corresponding author), CNRS, UMR3738, 25 Rue Dr Roux, F-75015 Paris, France.	amos.tanay@weizmann.ac.il; heather.marlow@pasteur.fr	Sebé-Pedrós, Arnau/B-9268-2011; Steinmetz, Patrick/AAD-4093-2022	Sebé-Pedrós, Arnau/0000-0002-9896-9746; Loe-Mie, Yann/0000-0003-1427-8014; Plessier, Flora/0000-0001-8023-8550; Spitz, Francois/0000-0002-1960-829X; novault, sophie/0000-0001-5708-3597	EMBO [ALTF 841-2014]; Region Ile de France (program SESAME 2016 "Paris Single Cell Centre"); Pasteur Citech ("Single cell genomics"); European Research Council [724824]	EMBO(European Molecular Biology Organization (EMBO)); Region Ile de France (program SESAME 2016 "Paris Single Cell Centre"); Pasteur Citech ("Single cell genomics"); European Research Council(European Research Council (ERC)European Commission)	We thank Yehu Moran for help in the interpretation of the cell clusters, David Lara-Astiaso for critical comments on the manuscript, Manuel Irimia for discussion on cross-species clustering, and all the members of the Tanay and Spitz labs for comments and discussion. We thank Dr. Malte Paulsen for assistance with initial cell-sorting trials. We thank Dr. Fabian Rentzsch for providing the Elav and SoxB2a reporter lines and Dr. Detlev Arendt for allowing the use of the Fez, Lwamide2, and RPamide clones and riboprobes, as well as for constructive discussions. We thanks Elodie Brient-Litzler for tremendous support developing the Pasteur Single Cell Initiative. A. S.-P. was supported by an EMBO long-term fellowship (ALTF 841-2014). Research in the Unit Epigenomics of Animal Development (GEAD) group was supported by the Region Ile de France (program SESAME 2016 "Paris Single Cell Centre") and Pasteur Citech ("Single cell genomics"). Research in the A.T. group was supported by the European Research Council (724824). A.T. is a Kimmel investigator.	Babonis LS, 2017, EVODEVO, V8, DOI 10.1186/s13227-017-0077-7; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Busengdal H, 2017, DEV BIOL, V431, P59, DOI 10.1016/j.ydbio.2017.08.021; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; de Mendoza A, 2013, P NATL ACAD SCI USA, V110, pE4858, DOI 10.1073/pnas.1311818110; FRANK P, 1976, J NAT HIST, V10, P441, DOI 10.1080/00222937600770331; Hartl M, 2010, P NATL ACAD SCI USA, V107, P4051, DOI 10.1073/pnas.0911060107; Havrilak JA, 2017, DEV BIOL, V431, P336, DOI 10.1016/j.ydbio.2017.08.028; Jahnel SM, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-44; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Layden MJ, 2012, DEVELOPMENT, V139, P1013, DOI 10.1242/dev.073221; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liebeskind BJ, 2017, ANNU REV ECOL EVOL S, V48, P377, DOI 10.1146/annurev-ecolsys-110316-023048; Marlow H, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-7; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Matus DQ, 2007, EVOL DEV, V9, P25, DOI 10.1111/j.1525-142X.2006.00135.x; Mazza ME, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-3; Moran Y, 2013, MAR BIOTECHNOL, V15, P329, DOI 10.1007/s10126-012-9491-y; Nakanishi N, 2012, DEVELOPMENT, V139, P347, DOI 10.1242/dev.071902; Nielsen C, 2005, EVOL DEV, V7, P483, DOI 10.1111/j.1525-142X.2005.05051.x; Nowotschin S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-49; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Rentzsch F, 2016, CURR OPIN GENET DEV, V39, P63, DOI 10.1016/j.gde.2016.05.024; Schwaiger M, 2014, GENOME RES, V24, P639, DOI 10.1101/gr.162529.113; Sebe-Pedros A, 2016, CELL, V165, P1224, DOI 10.1016/j.cell.2016.03.034; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sinigaglia C, 2015, DEV BIOL, V398, P120, DOI 10.1016/j.ydbio.2014.11.019; Steinmetz PRH, 2017, NAT ECOL EVOL, V1, P1535, DOI 10.1038/s41559-017-0285-5; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wolenski FS, 2013, NAT PROTOC, V8, P900, DOI 10.1038/nprot.2013.014; Zenkert C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022725	39	133	134	2	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1520	+		10.1016/j.cell.2018.05.019	http://dx.doi.org/10.1016/j.cell.2018.05.019			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856957	Bronze			2022-12-28	WOS:000433989100022
J	Jin, CH; Kim, J; Utama, MIB; Regan, EC; Kleemann, H; Cai, H; Shen, YX; Shinner, MJ; Sengupta, A; Watanabe, K; Taniguchi, T; Tongay, S; Zettl, A; Wang, F				Jin, Chenhao; Kim, Jonghwan; Utama, M. Iqbal Bakti; Regan, Emma C.; Kleemann, Hans; Cai, Hui; Shen, Yuxia; Shinner, Matthew James; Sengupta, Arjun; Watanabe, Kenji; Taniguchi, Takashi; Tongay, Sefaattin; Zettl, Alex; Wang, Feng			Imaging of pure spin-valley diffusion current in WS2-WSe2 heterostructures	SCIENCE			English	Article							MONOLAYER MOS2; POLARIZATION; DYNAMICS	Transition metal dichalcogenide (TMDC) materials are promising for spintronic and valleytronic applications because valley-polarized excitations can be generated and manipulated with circularly polarized photons and the valley and spin degrees of freedom are locked by strong spin-orbital interactions. In this study we demonstrate efficient generation of a pure and locked spin-valley diffusion current in tungsten disulfide (WS2)-tungsten diselenide (WSe2) heterostructures without any driving electric field. We imaged the propagation of valley current in real time and space by pump-probe spectroscopy. The valley current in the heterostructures can live for more than 20 microseconds and propagate over 20 micrometers; both the lifetime and the diffusion length can be controlled through electrostatic gating. The high-efficiency and electric-field-free generation of a locked spin-valley current in TMDC heterostructures holds promise for applications in spin and valley devices.	[Jin, Chenhao; Kim, Jonghwan; Utama, M. Iqbal Bakti; Regan, Emma C.; Kleemann, Hans; Shinner, Matthew James; Sengupta, Arjun; Zettl, Alex; Wang, Feng] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Kim, Jonghwan] Pohang Univ Sci & Technol, Dept Mat Sci & Engn, Pohang 790784, South Korea; [Utama, M. Iqbal Bakti] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Regan, Emma C.] Univ Calif Berkeley, Grad Grp Appl Sci & Technol, Berkeley, CA 94720 USA; [Cai, Hui; Shen, Yuxia; Tongay, Sefaattin] Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ 85287 USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Zettl, Alex; Wang, Feng] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Zettl, Alex; Wang, Feng] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Zettl, Alex; Wang, Feng] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Pohang University of Science & Technology (POSTECH); University of California System; University of California Berkeley; University of California System; University of California Berkeley; Arizona State University; Arizona State University-Tempe; National Institute for Materials Science; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Wang, F (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.; Wang, F (corresponding author), Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.; Wang, F (corresponding author), Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA.; Wang, F (corresponding author), Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	fengwang76@berkeley.edu	Cai, Hui/AAA-3998-2019; JIN, CHENHAO/GYV-5734-2022; Watanabe, Kenji/ABB-2135-2021; Tongay, Sefaattin/E-6388-2011; wang, Feng/I-5727-2015; Tongay, Sefaattin/ACQ-5306-2022; Utama, Iqbal Bakti/AAM-4849-2020	Watanabe, Kenji/0000-0003-3701-8119; wang, Feng/0000-0001-8369-6194; Tongay, Sefaattin/0000-0001-8294-984X; Utama, Iqbal Bakti/0000-0002-4454-8348; Kleemann, Hans/0000-0002-9773-6676; Cai, Hui/0000-0003-0848-3097	Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy [DE-AC02-05-CH11231]; NSF EFRI program [EFMA-1542741]; JSPS KAKENHI [JP15K21722]; NSF DMR CAREER [1552220]; Deutsche Forschungsgemeinschaft [KL 2961/1-1]	Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy(United States Department of Energy (DOE)); NSF EFRI program; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NSF DMR CAREER; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported primarily by the director, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy, under contract no. DE-AC02-05-CH11231 (van der Waals heterostructures program, KCWF16). The device fabrication was supported by the NSF EFRI program (EFMA-1542741). The growth of hBN crystals was supported by the Elemental Strategy Initiative conducted by the MEXT, Japan, and JSPS KAKENHI grant JP15K21722. S.T. acknowledges support from NSF DMR CAREER award 1552220 for the growth of MoS<INF>2</INF> and WSe<INF>2</INF> crystals. H.K. acknowledges fellowship support from the Deutsche Forschungsgemeinschaft (KL 2961/1-1).	Aivazian G, 2015, NAT PHYS, V11, P148, DOI 10.1038/NPHYS3201; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; Ceballos F, 2014, ACS NANO, V8, P12717, DOI 10.1021/nn505736z; Hong XP, 2014, NAT NANOTECHNOL, V9, P682, DOI [10.1038/NNANO.2014.167, 10.1038/nnano.2014.167]; Hsu WT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9963; Kang J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4774090; Kim J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600663; Kim J, 2014, SCIENCE, V346, P1205, DOI 10.1126/science.1258122; Li YL, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.266804; Liu LQ, 2012, SCIENCE, V336, P555, DOI 10.1126/science.1218197; MacNeill D, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.037401; MAIALLE MZ, 1993, PHYS REV B, V47, P15776, DOI 10.1103/PhysRevB.47.15776; Mak KF, 2014, SCIENCE, V344, P1489, DOI 10.1126/science.1250140; Mak KF, 2013, NAT MATER, V12, P207, DOI [10.1038/NMAT3505, 10.1038/nmat3505]; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Pai CF, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4753947; Rivera P, 2016, SCIENCE, V351, P688, DOI 10.1126/science.aac7820; Sie EJ, 2015, NAT MATER, V14, P290, DOI 10.1038/nmat4156; Sinova J, 2015, REV MOD PHYS, V87, P1213, DOI 10.1103/RevModPhys.87.1213; Song XL, 2016, NANO LETT, V16, P5010, DOI 10.1021/acs.nanolett.6b01727; Srivastava A, 2015, NAT PHYS, V11, P141, DOI 10.1038/NPHYS3203; Wang ZF, 2017, NAT NANOTECHNOL, V12, P144, DOI [10.1038/NNANO.2016, 10.1038/nnano.2016.213]; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Xu XD, 2014, NAT PHYS, V10, P343, DOI [10.1038/NPHYS2942, 10.1038/nphys2942]; Yang LY, 2015, NAT PHYS, V11, P830, DOI [10.1038/nphys3419, 10.1038/NPHYS3419]; Ye ZL, 2017, NAT PHYS, V13, P26, DOI [10.1038/nphys3891, 10.1038/NPHYS3891]; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	30	120	120	21	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					893	896		10.1126/science.aao3503	http://dx.doi.org/10.1126/science.aao3503			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798880	Green Submitted			2022-12-28	WOS:000433039800044
J	LaManna, JA; Mangan, SA; Alonso, A; Bourg, NA; Brockelman, WY; Bunyavejchewin, S; Chang, LW; Chiang, JM; Chuyong, GB; Clay, K; Cordell, S; Davies, SJ; Furniss, TJ; Giardina, CP; Gunatilleke, IAUN; Gunatilleke, CVS; He, FL; Howe, RW; Hubbell, SP; Hsieh, CF; Inman-Narahari, FM; Janik, D; Johnson, DJ; Kenfack, D; Korte, L; Kral, K; Larson, AJ; Lutz, JA; McMahon, SM; McShea, WJ; Memiaghe, HR; Nathalang, A; Novotny, V; Ong, PS; Orwig, DA; Ostertag, R; Parker, GG; Phillips, RP; Sack, L; Sun, IF; Tello, JS; Thomas, DW; Turner, BL; Diaz, DMV; Vrska, T; Weiblen, GD; Wolf, A; Yap, S; Myers, JA				LaManna, Joseph A.; Mangan, Scott A.; Alonso, Alfonso; Bourg, Norman A.; Brockelman, Warren Y.; Bunyavejchewin, Sarayudh; Chang, Li-Wan; Chiang, Jyh-Min; Chuyong, George B.; Clay, Keith; Cordell, Susan; Davies, Stuart J.; Furniss, Tucker J.; Giardina, Christian P.; Gunatilleke, I. A. U. Nimal; Gunatilleke, C. V. Savitri; He, Fangliang; Howe, Robert W.; Hubbell, Stephen P.; Hsieh, Chang-Fu; Inman-Narahari, Faith M.; Janik, David; Johnson, Daniel J.; Kenfack, David; Korte, Lisa; Kral, Kamil; Larson, Andrew J.; Lutz, James A.; McMahon, Sean M.; McShea, William J.; Memiaghe, Herve R.; Nathalang, Anuttara; Novotny, Vojtech; Ong, Perry S.; Orwig, David A.; Ostertag, Rebecca; Parker, Geoffrey G.; Phillips, Richard P.; Sack, Lawren; Sun, I-Fang; Tello, J. Sebastian; Thomas, Duncan W.; Turner, Benjamin L.; Diaz, Dilys M. Vela; Vrska, Tomas; Weiblen, George D.; Wolf, Amy; Yap, Sandra; Myers, Jonathan A.			Response to Comment on "Plant diversity increases with the strength of negative density dependence at the global scale"	SCIENCE			English	Editorial Material							TROPICAL FORESTS; SEED DISPERSAL; TEMPERATE	Chisholm and Fung claim that our method of estimating conspecific negative density dependence (CNDD) in recruitment is systematically biased, and present an alternative method that shows no latitudinal pattern in CNDD. We demonstrate that their approach produces strongly biased estimates of CNDD, explaining why they do not detect a latitudinal pattern. We also address their methodological concerns using an alternative distance-weighted approach, which supports our original findings of a latitudinal gradient in CNDD and a latitudinal shift in the relationship between CNDD and species abundance.	[LaManna, Joseph A.; Myers, Jonathan A.] Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA; [LaManna, Joseph A.; Mangan, Scott A.; Diaz, Dilys M. Vela; Myers, Jonathan A.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Alonso, Alfonso; Korte, Lisa] Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Conservat & Sustainabil, Washington, DC USA; [Bourg, Norman A.] US Geol Survey, Water Miss Area, Earth Syst Processes Div, Hydrological Ecol Interact Branch, 959 Natl Ctr, Reston, VA 22092 USA; [Brockelman, Warren Y.; Nathalang, Anuttara] Natl Sci & Technol Dev Agcy, BIOTEC, Ecol Lab, Sci Pk, Pathum Thani, Thailand; [Brockelman, Warren Y.] Mahidol Univ, Inst Mol Biosci, Nakhon, Pathom, Thailand; [Bunyavejchewin, Sarayudh] Wildlife & Plant Conservat, Dept Natl Pk, Res Off, Bangkok, Thailand; [Chang, Li-Wan] Taiwan Forestry Res Inst, Taipei 10066, Taiwan; [Chiang, Jyh-Min] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Chuyong, George B.] Univ Buea, Dept Bot & Plant Physiol, Buea, Cameroon; [Clay, Keith; Phillips, Richard P.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Cordell, Susan; Giardina, Christian P.; Inman-Narahari, Faith M.] US Forest Serv, USDA, Inst Pacific Islands Forestry, Hilo, HI USA; [Davies, Stuart J.; Kenfack, David] Smithsonian Trop Res Inst, Forest Global Earth Observ, Ctr Trop Forest Sci, Panama City, Panama; [Davies, Stuart J.; Kenfack, David] Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Furniss, Tucker J.; Lutz, James A.] Utah State Univ, Wildland Resources Dept, Logan, UT 84322 USA; [Gunatilleke, I. A. U. Nimal; Gunatilleke, C. V. Savitri] Univ Peradeniya, Fac Sci, Dept Bot, Peradeniya, Sri Lanka; [He, Fangliang] SYSU, Univ Alberta, Sch Life Sci, Joint Lab Biodivers Conservat,State Key Lab Bioco, Guangzhou 510275, Guangdong, Peoples R China; [He, Fangliang] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Howe, Robert W.; Wolf, Amy] Univ Wisconsin, Dept Nat & Appl Sci, Green Bay, WI 54302 USA; [Hubbell, Stephen P.; Sack, Lawren] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Hsieh, Chang-Fu] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei, Taiwan; [Janik, David; Kral, Kamil; Vrska, Tomas] Silva Tarouca Res Inst, Dept Forest Ecol, Brno, Czech Republic; [Johnson, Daniel J.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Larson, Andrew J.] Univ Montana, Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA; [McMahon, Sean M.] Smithsonian Environm Res Ctr, Forest Global Earth Observ, Ctr Trop Forest Sci, POB 28, Edgewater, MD 21037 USA; [McMahon, Sean M.; Parker, Geoffrey G.] Smithsonian Environm Res Ctr, Forest Ecol Grp, POB 28, Edgewater, MD 21037 USA; [McShea, William J.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA USA; [Memiaghe, Herve R.] Ctr Natl Rech Sci & Technol, Inst Rech Ecol Tropicale, Libreville, Gabon; [Novotny, Vojtech] New Guinea Binatang Res Ctr, POB 604, Madang, Papua N Guinea; [Novotny, Vojtech] Acad Sci Czech Republ, Biol Ctr, Prague, Czech Republic; [Novotny, Vojtech] Univ South Bohemia, Fac Sci, Branisovska 31, Ceske Budejovice 37005, Czech Republic; [Ong, Perry S.] Univ Philippines Diliman, Inst Biol, Quezon City, Philippines; [Orwig, David A.] Harvard Univ, Harvard Forest, Petersham, MA USA; [Ostertag, Rebecca] Univ Hawaii, Dept Biol, Hilo, HI 96720 USA; [Sun, I-Fang] Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, Hualien, Taiwan; [Tello, J. Sebastian] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, Pob 299, St Louis, MO 63166 USA; [Thomas, Duncan W.] Washington State Univ, Sch Biol Sci, Vancouver, WA USA; [Turner, Benjamin L.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Weiblen, George D.] Univ Minnesota, Dept Plant & Microbial Biol, St Paul, MN 55108 USA; [Wolf, Amy] Univ Wisconsin, Dept Biol, Green Bay, WI 54302 USA; [Yap, Sandra] Far Eastern Univ Manila, Inst Arts & Sci, Manila, Philippines	Washington University (WUSTL); Washington University (WUSTL); Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; United States Department of the Interior; United States Geological Survey; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Tunghai University; Indiana University System; Indiana University Bloomington; United States Department of Agriculture (USDA); United States Forest Service; Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; Utah System of Higher Education; Utah State University; University of Peradeniya; Sun Yat Sen University; University of Alberta; University of Wisconsin System; University of California System; University of California Los Angeles; National Taiwan University; Utah System of Higher Education; Utah State University; University of Montana System; University of Montana; Smithsonian Institution; Smithsonian Environmental Research Center; Smithsonian Institution; Smithsonian Environmental Research Center; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of the Philippines System; University of the Philippines Diliman; Harvard University; University of Hawaii System; University Hawaii Hilo; National Dong Hwa University; Missouri Botanical Gardens; Washington State University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; Far Eastern University	LaManna, JA (corresponding author), Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA.; LaManna, JA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	joe.a.lamanna@gmail.com	Díaz, Dilys M Vela/N-4481-2018; Lutz, James/AAA-9574-2019; Kral, Kamil/E-4415-2014; Ostertag, Rebecca/B-1756-2013; Novotny, Vojtech/G-9434-2014; Phillips, Richard P/C-6429-2009; Janík, David/H-1334-2018; Nathalang, Anuttara/P-3925-2018; Turner, Benjamin L/E-5940-2011; Giardina, Christian P/C-3120-2011; Sack, Lawren/A-5492-2008; Johnson, Daniel J./L-4899-2019	Díaz, Dilys M Vela/0000-0002-5332-1305; Novotny, Vojtech/0000-0001-7918-8023; Phillips, Richard P/0000-0002-1345-4138; Janík, David/0000-0002-8271-7456; Nathalang, Anuttara/0000-0003-2780-0289; Turner, Benjamin L/0000-0002-6585-0722; Giardina, Christian P/0000-0002-3431-5073; Sack, Lawren/0000-0002-7009-7202; Johnson, Daniel J./0000-0002-8585-2143; LaManna, Joseph/0000-0002-8229-7973; Chiang, Jyh-Min/0000-0002-6293-1551; Kenfack, David/0000-0001-8208-3388; Lutz, James/0000-0002-2560-0710; Orwig, David/0000-0001-7822-3560; Ong, Perry/0000-0002-1597-1921; Bourg, Norman/0000-0002-7443-1992; McShea, William/0000-0002-8102-0200; Ostertag, Rebecca/0000-0002-5747-3285; Chuyong, George/0000-0002-0235-211X; Alonso, Alfonso/0000-0001-6860-8432; Kral, Kamil/0000-0002-3848-2119	NSF [DEB-1545761, DEB-1256788, DEB-1557094, DEB-1257989]; Tyson Research Center; Division Of Environmental Biology [1237491] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Tyson Research Center; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank an anonymous reviewer for suggesting the distance-weighted approach. We also thank everyone involved in the collection of the vast quantity of data in the CTFS-ForestGEO network; see table S20 in our original paper for site-specific acknowledgments. Supported by NSF grant DEB-1545761 (S.J.D.), NSF grants DEB-1256788 and DEB-1557094 (J.A.M.), NSF grant DEB-1257989 (S.A.M.), and the Tyson Research Center. We declare no conflicts of interest. The data and R code for analyses are available at the Smithsonian Institution's ForestGEO database portal: https://forestgeo.si.edu/explore-data and https://forestgeo.si.edu/plant-diversity-increases-strength-negative-densitydependence-global-scale.	Bennett JA, 2017, SCIENCE, V355, P181, DOI 10.1126/science.aai8212; Bolker B, 2008, ECOLOGICAL MODELS DA; Chisholm RA, 2018, SCIENCE, V360, DOI 10.1126/science.aar4685; Clark F, 2010, METHODS ECOL EVOL, V1, P253, DOI 10.1111/j.2041-210X.2010.00029.x; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; CONNELL J H, 1971, P298; Dickie IA, 2012, SCIENCE, V338, DOI 10.1126/science.1225520; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; LaManna JA, 2018, SCIENCE, V360, DOI 10.1126/science.aar3824; LaManna JA, 2017, SCIENCE, V356, P1389, DOI 10.1126/science.aam5678; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x	14	7	7	5	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391							aar5245	10.1126/science.aar5245	http://dx.doi.org/10.1126/science.aar5245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG9RW	29798855	Green Submitted			2022-12-28	WOS:000433039800004
J	Barnett, R				Barnett, Richard			Case histories Osteoarthritis	LANCET			English	Editorial Material												richard@richardbarnettwriter.com							0	58	65	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2018	391	10134					1985	1985		10.1016/S0140-6736(18)31064-X	http://dx.doi.org/10.1016/S0140-6736(18)31064-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GG1IJ	29864015				2022-12-28	WOS:000432440300015
J	Sparano, JA; Gray, RJ; Makower, DF; Pritchard, KI; Albain, KS; Hayes, DF; Geyer, CE; Dees, EC; Goetz, MP; Olson, JA; Lively, T; Badve, SS; Saphner, TJ; Wagner, LI; Whelan, TJ; Ellis, MJ; Paik, S; Wood, WC; Ravdin, PM; Keane, MM; Moreno, HLG; Reddy, PS; Goggins, TF; Mayer, IA; Brufsky, AM; Toppmeyer, DL; Kaklamani, VG; Berenberg, JL; Abrams, J; Sledge, GW				Sparano, J. A.; Gray, R. J.; Makower, D. F.; Pritchard, K. I.; Albain, K. S.; Hayes, D. F.; Geyer, C. E., Jr.; Dees, E. C.; Goetz, M. P.; Olson, J. A., Jr.; Lively, T.; Badve, S. S.; Saphner, T. J.; Wagner, L. I.; Whelan, T. J.; Ellis, M. J.; Paik, S.; Wood, W. C.; Ravdin, P. M.; Keane, M. M.; Moreno, H. L. Gomez; Reddy, P. S.; Goggins, T. F.; Mayer, I. A.; Brufsky, A. M.; Toppmeyer, D. L.; Kaklamani, V. G.; Berenberg, J. L.; Abrams, J.; Sledge, G. W., Jr.			Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-PRACTICE; AMERICAN SOCIETY; SYSTEMIC THERAPY; GENE-EXPRESSION; RISK; SURVIVAL; WOMEN; RECOMMENDATIONS; RECURRENCE; DECISIONS	BACKGROUND The recurrence score based on the 21-gene breast cancer assay predicts chemotherapy benefit if it is high and a low risk of recurrence in the absence of chemotherapy if it is low; however, there is uncertainty about the benefit of chemotherapy for most patients, who have a midrange score. METHODS We performed a prospective trial involving 10,273 women with hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, axillary node-negative breast cancer. Of the 9719 eligible patients with follow-up information, 6711 (69%) had a midrange recurrence score of 11 to 25 and were randomly assigned to receive either chemoendocrine therapy or endocrine therapy alone. The trial was designed to show noninferiority of endocrine therapy alone for invasive disease-free survival (defined as freedom from invasive disease recurrence, second primary cancer, or death). RESULTS Endocrine therapy was noninferior to chemoendocrine therapy in the analysis of invasive disease-free survival (hazard ratio for invasive disease recurrence, second primary cancer, or death [endocrine vs. chemoendocrine therapy], 1.08; 95% confidence interval, 0.94 to 1.24; P = 0.26). At 9 years, the two treatment groups had similar rates of invasive disease-free survival (83.3% in the endocrine-therapy group and 84.3% in the chemoendocrine-therapy group), freedom from disease recurrence at a distant site (94.5% and 95.0%) or at a distant or local-regional site (92.2% and 92.9%), and overall survival (93.9% and 93.8%). The chemotherapy benefit for invasive disease-free survival varied with the combination of recurrence score and age (P = 0.004), with some benefit of chemotherapy found in women 50 years of age or younger with a recurrence score of 16 to 25. CONCLUSIONS Adjuvant endocrine therapy and chemoendocrine therapy had similar efficacy in women with hormone-receptor-positive, HER2-negative, axillary node-negative breast cancer who had a midrange 21-gene recurrence score, although some benefit of chemotherapy was found in some women 50 years of age or younger.	[Sparano, J. A.; Makower, D. F.] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Gray, R. J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Pritchard, K. I.] Sunnybrook Res Inst, Toronto, ON, Canada; [Whelan, T. J.] McMaster Univ, Hamilton, ON, Canada; [Albain, K. S.] Loyola Univ Chicago, Stritch Sch Med, Maywood, LA USA; [Wagner, L. I.; Kaklamani, V. G.] Northwestern Univ, Chicago, IL 60611 USA; [Hayes, D. F.] Univ Michigan, Ann Arbor, MI 48109 USA; [Geyer, C. E., Jr.] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA; [Geyer, C. E., Jr.] Massey Canc Ctr, Richmond, VA USA; [Dees, E. C.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Olson, J. A., Jr.] Duke Univ, Med Ctr, Durham, NC USA; [Goetz, M. P.] Mayo Clin, Jacksonville, FL 32224 USA; [Lively, T.; Abrams, J.] NCI, NIH, Bethesda, MD USA; [Badve, S. S.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Sledge, G. W., Jr.] Indiana Univ Hosp, 550 N Univ Blvd, Indianapolis, IN 46202 USA; [Saphner, T. J.] Vince Lombardi Canc Clin, Two Rivers, WI USA; [Goggins, T. F.] Fox Valley Hematol & Oncol, Appleton, WI USA; [Ellis, M. J.] Washington Univ, St Louis, MO USA; [Paik, S.] Natl Surg Adjuvant Breast & Bowel Project Pathol, Pittsburgh, PA USA; [Brufsky, A. M.] Univ Pittsburgh, Pittsburgh, PA USA; [Wood, W. C.] Emory Univ, Atlanta, GA 30322 USA; [Ravdin, P. M.] Univ Texas San Antonio, San Antonio, TX USA; [Keane, M. M.] Canc Trials Ireland, Dublin, Ireland; [Moreno, H. L. Gomez] Inst Nacl Enfermedades Neoplas, Lima, Peru; [Reddy, P. S.] Canc Ctr Kansas, Wichita, KS USA; [Mayer, I. A.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Toppmeyer, D. L.] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA; [Berenberg, J. L.] Univ Hawaii, Canc Ctr, Honolulu, HI 96822 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Dana-Farber Cancer Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; Northwestern University; University of Michigan System; University of Michigan; Virginia Commonwealth University; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Indiana University System; Indiana University Bloomington; Indiana University System; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; University of Texas System; University of Texas at San Antonio (UTSA); Instituto Nacional de Enfermedades Neoplasicas; Cancer Center of Kansas; Vanderbilt University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Cancer Research Center of Hawaii; University of Hawaii System	Sparano, JA (corresponding author), Montefiore Med Ctr, 1695 Eastchester Rd, Bronx, NY 10461 USA.	jsparano@-montefiore.org	Hayes, Daniel/ABE-1129-2020; Whelan, Timothy/D-3185-2017; Goetz, Matthew P/AAH-2333-2020; Geyer, Charles/AGY-0119-2022; Brufsky, Adam/AAE-7470-2020	Whelan, Timothy/0000-0001-9844-2023; Geyer, Charles/0000-0002-2379-5702; Brufsky, Adam/0000-0001-8080-7960; Badve, Sunil/0000-0001-8861-9980; Sparano, Joseph/0000-0002-9031-2010	National Cancer Institute of the National Institutes of Health [CA180820, CA180794, CA189828, CA180790, CA180795, CA180799, CA180801, CA180816, CA180821, CA180838, CA180822, CA180844, CA180847, CA180857, CA180864, CA189867, CA180868, CA189869, CA180888, CA189808, CA189859, CA189804, CA190140, CA180863]; Canadian Cancer Society Research Institute [015469, 021039]; Breast Cancer Research Foundation; Komen Foundation; Genomic Health; NATIONAL CANCER INSTITUTE [U10CA180833, UG1CA189828, UG1CA232760, UG1CA189859, U10CA180820, U10CA180821, U10CA180864, UG1CA190140, U10CA180888, U10CA180838, U10CA180801, U10CA180847, U10CA180863, U24CA196172, UG1CA189869, UG1CA189804, U10CA180795, U10CA180868, UG1CA233184, U10CA180857, U10CA180822, U10CA180799, U10CA063844, UG1CA189808, U10CA180816, U10CA180794, U10CA180790, UG1CA189867, U10CA180844] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Breast Cancer Research Foundation; Komen Foundation(Susan G. Komen Breast Cancer Foundation); Genomic Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the National Cancer Institute of the National Institutes of Health (award numbers CA180820, CA180794, CA189828, CA180790, CA180795, CA180799, CA180801, CA180816, CA180821, CA180838, CA180822, CA180844, CA180847, CA180857, CA180864, CA189867, CA180868, CA189869, CA180888, CA189808, CA189859, CA189804, CA190140, and CA180863), the Canadian Cancer Society Research Institute (grants 015469 and 021039), the Breast Cancer Research Foundation, the Komen Foundation, the Breast Cancer Research Stamp issued by the U.S. Postal Service, and Genomic Health.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abrams J S, 2001, Breast Cancer, V8, P298, DOI 10.1007/BF02967528; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Bartlett J, 2013, CLIN ONCOL-UK, V25, P109, DOI 10.1016/j.clon.2012.10.005; Bertelsen L, 2008, JNCI-J NATL CANCER I, V100, P32, DOI 10.1093/jnci/djm267; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Carlson Robert W, 2006, J Natl Compr Canc Netw, V4 Suppl 1, pS1; Early Breast Cancer Trialists' Collab- orative Group (EBCTCG), 1997, CANCER J SCI AM, V3, P6; Fisher B, 1997, JNCI-J NATL CANCER I, V89, P1673, DOI 10.1093/jnci/89.22.1673; FISHER B, 1985, NEW ENGL J MED, V312, P665, DOI 10.1056/NEJM198503143121101; Fleming G, 2017, CANC RES S, V78, pGS4; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Howlader N, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju055; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Krop I, 2017, J CLIN ONCOL, V35, P2838, DOI 10.1200/JCO.2017.74.0472; Kurian AW, 2018, JNCI-J NATL CANCER I, V110, P493, DOI 10.1093/jnci/djx239; Kwa M, 2017, NAT REV CLIN ONCOL, V14, P595, DOI 10.1038/nrclinonc.2017.74; LACHIN JM, 1986, BIOMETRICS, V42, P507, DOI 10.2307/2531201; Mamounas EP, 2014, J SURG ONCOL, V110, P45, DOI 10.1002/jso.23609; MANSOUR EG, 1989, NEW ENGL J MED, V320, P485, DOI 10.1056/NEJM198902233200803; Mansour EG, 1998, J CLIN ONCOL, V16, P3486, DOI 10.1200/JCO.1998.16.11.3486; Munoz D, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju289; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Petkov VI, 2016, NPJ BREAST CANCER, V2, DOI 10.1038/npjbcancer.2016.17; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Stemmer SM, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0034-6; Swain SM, 2010, NEW ENGL J MED, V362, P2053, DOI 10.1056/NEJMoa0909638; Tallman MS, 2003, NEW ENGL J MED, V349, P17, DOI 10.1056/NEJMoa030684; Wong WB, 2012, CONTEMP CLIN TRIALS, V33, P1117, DOI 10.1016/j.cct.2012.08.006	35	1022	1042	4	151	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2018	379	2					111	121		10.1056/NEJMoa1804710	http://dx.doi.org/10.1056/NEJMoa1804710			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM6DL	29860917	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000438249800008
J	Saavedra, HG; Wrabl, JO; Anderson, JA; Li, J; Hilser, VJ				Saavedra, Harry G.; Wrabl, James O.; Anderson, Jeremy A.; Li, Jing; Hilser, Vincent J.			Dynamic allostery can drive cold adaptation in enzymes	NATURE			English	Article							ADENYLATE-KINASE; ESCHERICHIA-COLI; SUBSTRATE-BINDING; TRANSITION-STATE; LID DOMAIN; CATALYSIS; MOTIONS; PROTEINS; FLUCTUATIONS; TEMPERATURES	Adaptation of organisms to environmental niches is a hallmark of evolution. One prevalent example is that of thermal adaptation, in which two descendants evolve at different temperature extremes(1,2). Underlying the physiological differences between such organisms are changes in enzymes that catalyse essential reactions(3), with orthologues from each organism undergoing adaptive mutations that preserve similar catalytic rates at their respective physiological temperatures(4,5). The sequence changes responsible for these adaptive differences, however, are often at surface-exposed sites distant from the substrate-binding site, leaving the active site of the enzyme structurally unperturbed(6,7). How such changes are allosterically propagated to the active site, to modulate activity, is not known. Here we show that entropy-tuning changes can be engineered into distal sites of Escherichia coli adenylate kinase, allowing us to quantitatively assess the role of dynamics in determining affinity, turnover and the role in driving adaptation. The results not only reveal a dynamics-based allosteric tuning mechanism, but also uncover a spatial separation of the control of key enzymatic parameters. Fluctuations in one mobile domain (the LID) control substrate affinity, whereas dynamic attenuation in the other domain (the AMP-binding domain) affects rate-limiting conformational changes that govern enzyme turnover. Dynamics-based regulation may thus represent an elegant, widespread and previously unrealized evolutionary adaptation mechanism that fine-tunes biological function without altering the ground state structure. Furthermore, because rigid-body conformational changes in both domains were thought to be rate limiting for turnover(8,9), these adaptation studies reveal a new model for understanding the relationship between dynamics and turnover in adenylate kinase.	[Saavedra, Harry G.; Wrabl, James O.; Anderson, Jeremy A.; Li, Jing; Hilser, Vincent J.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Saavedra, Harry G.; Wrabl, James O.; Anderson, Jeremy A.; Li, Jing; Hilser, Vincent J.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Hilser, VJ (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.; Hilser, VJ (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA.	hilser@jhu.edu		Saavedra, Harry/0000-0002-8896-5020	NIH [R01-GM063747]; NSF [MCB-1330211]; Johns Hopkins University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008403, R01GM063747] Funding Source: NIH RePORTER; Direct For Biological Sciences [1330211] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Johns Hopkins University(Johns Hopkins University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Mujamdar, A. Schon, and K. Tripp for technical assistance and instrumentation. Funding from NIH (R01-GM063747), NSF (MCB-1330211), and Johns Hopkins University is acknowledged.	Aden J, 2012, J AM CHEM SOC, V134, P16562, DOI 10.1021/ja3032482; Arrhenius S, 1902, TXB ELECTROCHEMISTRY; Beckstein O, 2009, J MOL BIOL, V394, P160, DOI 10.1016/j.jmb.2009.09.009; Beers JM, 2015, J EXP BIOL, V218, P1834, DOI 10.1242/jeb.116129; Counago R, 2005, EXTREMOPHILES, V9, P135, DOI 10.1007/s00792-004-0428-x; Daily MD, 2012, CHEM PHYS, V396, P84, DOI 10.1016/j.chemphys.2011.08.015; DAquino JA, 1996, PROTEINS, V25, P143, DOI 10.1002/(SICI)1097-0134(199606)25:2<143::AID-PROT1>3.0.CO;2-J; Elias M, 2014, TRENDS BIOCHEM SCI, V39, P1, DOI 10.1016/j.tibs.2013.11.001; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Fersht AR., 1977, ENZYME STRUCTURE MEC; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; Fields PA, 2015, J EXP BIOL, V218, P1801, DOI 10.1242/jeb.114298; Hansen DF, 2008, J PHYS CHEM B, V112, P5898, DOI 10.1021/jp074793o; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Kerns SJ, 2015, NAT STRUCT MOL BIOL, V22, P124, DOI 10.1038/nsmb.2941; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; LAIDLER KJ, 1983, J PHYS CHEM-US, V87, P2657, DOI 10.1021/j100238a002; Lisi GP, 2016, CHEM REV, V116, P6323, DOI 10.1021/acs.chemrev.5b00541; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Murray V, 2012, METHODS MOL BIOL, V831, P1, DOI 10.1007/978-1-61779-480-3_1; Olsson U, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1106; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; RHOADS DG, 1968, J BIOL CHEM, V243, P3963; Rogne P, 2016, BIOPHYS J, V111, P1385, DOI 10.1016/j.bpj.2016.08.028; Rundqvist L, 2009, BIOCHEMISTRY-US, V48, P1911, DOI 10.1021/bi8018042; Schrank TP, 2013, TOP CURR CHEM, V337, P95, DOI 10.1007/128_2012_410; Schrank TP, 2011, METHOD ENZYMOL, V492, P253, DOI 10.1016/B978-0-12-381268-1.00020-3; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; Siddiqui KS, 2017, CRIT REV BIOTECHNOL, V37, P309, DOI 10.3109/07388551.2016.1144045; Somero GN, 2004, COMP BIOCHEM PHYS B, V139, P321, DOI 10.1016/j.cbpc.2004.05.003; Tattersall GJ, 2012, COMPR PHYSIOL, V2, P2151, DOI 10.1002/cphy.c110055; Nguyen V, 2017, SCIENCE, V355, P289, DOI 10.1126/science.aah3717; Warshel A, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4947037; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821	37	100	101	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2018	558	7709					324	+		10.1038/s41586-018-0183-2	http://dx.doi.org/10.1038/s41586-018-0183-2			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2BI	29875414	Green Accepted			2022-12-28	WOS:000435071400060
J	Socinski, MA; Jotte, RM; Cappuzzo, F; Orlandi, F; Stroyakovskiy, D; Nogami, N; Rodriguez-Abreu, D; Moro-Sibilot, D; Thomas, CA; Barlesi, F; Finley, G; Kelsch, C; Lee, A; Coleman, S; Deng, Y; Shen, Y; Kowanetz, M; Lopez-Chavez, A; Sandler, A; Reck, M; Ahualli, A; Jarchum, G; Kaen, DL; Kahl, S; Kotliar, M; Kowalyszyn, RD; Lerzo, G; Magri, I; Martin, C; Pastor, A; Picon, P; Streich, G; Varela, M; Blinman, P; Boyer, M; Crombie, C; Gauden, S; Gill, S; Hughes, B; John, T; Joshi, A; Kosmider, S; Lewis, C; Millward, M; Nordman, I; Nott, L; O'Byrne, K; Parnis, F; Potasz, N; Richardson, G; Singhal, N; Eckmayr, J; Greil, R; Goeminne, JC; Paulus, A; Aragao, B; Bruno, LA; Campos, C; Costamilan, RD; Dettino, A; Faccio, A; Girotto, G; Matias, D; Murad, AM; Schwartsmann, G; Silva, C; Tadokoro, H; Dimitrov, B; Ilieva, R; Kalev, D; Kanarev, V; Koleva, M; Koynov, K; Mihaylova, Z; Cohen, V; Cournoyer, G; Rorke, S; Rothenstein, J; Spadafora, S; Aren, O; Ulunque, EO; Yanez, E; Valette, CA; Bennouna, J; Berard, H; Coudert, B; Dayen, C; Denis, F; Guillevin, EF; Foa, C; Gazaille, V; Le Moulec, S; Mazieres, J; Morere, JF; Veillon, R; Bargon, J; Behringer, D; Dickgreber, NJ; Engel-Riedel, W; Fischer, JR; Hackanson, B; Kokowski, K; Kollmeier, J; Loges, S; Schulz, C; Schutte, W; Serke, M; Stauder, H; Steppert, C; Wehler, T; Weissinger, F; Wermke, M; Wesseler, C; Allegrini, G; Amoroso, D; Barone, C; Borra, G; Carteni, G; Defraia, E; Falcone, A; Grossi, F; Mencoboni, M; Migliorino, MR; Pazzola, A; Parra, HS; Tonini, G; Azuma, K; Fukuhara, T; Ichiki, M; Ikeda, S; Kawaguchi, T; Kim, YH; Kishi, K; Otani, S; Seto, T; Takeda, Y; Tanaka, H; Yamamoto, N; Yokota, S; Yokoyama, T; Purkalne, G; Zvirbule, Z; Cicenas, S; Filipauskiene, J; Dominguez, A; Gomez, A; Leon, JML; Lopez, Y; Aerts, JGJV; Barlo, N; Biesma, B; Dingemans, AM; Hashemi, S; Keizer-van't Westeinde, S; Lammers, E; Mansour, K; Schramel, F; Snijders, D; van Haarst, JM; van Lindert, A; Wilschut, F; Aleman, D; Tipismana, RC; Kobashigawa, A; Mas, L; Escobar, HDM; Almodovar, T; Araujo, A; Azevedo, I; Barata, F; Queiroga, H; de Brito, USD; Teixeira, E; Biakhov, M; Galiulin, R; Gorbunova, V; Karaseva, N; Kovalenko, N; Penkov, K; Poltoratskiy, A; Vasiliev, A; Zhiltsova, E; Leong, SS; Lim, D; Beniak, J; Chovanec, J; Godal, R; Kasan, P; Porubska, M; Alvarez, R; Manrique, MDA; Aranda, ICB; Carpeno, JD; Gomez, JHCNNMD; Font, EF; Garcia, YG; Lopez, PG; Sarrio, RG; Larriba, JLG; Molla, AI; Munarriz, BJ; Piqueras, MLB; Nadal, E; Aix, SP; Garcia, AT; Pons, JT; Estevez, SV; Segarra, NV; Vikstrom, A; Frueh, M; Gautschi, O; Lohri, A; Ochsenbein, A; Chang, GC; Chen, CH; Chen, WT; Chen, YM; Ho, CL; Hsia, TC; Hsieh, RK; Huang, MS; Li, CT; Lin, YC; Liu, CY; Su, WC; Yu, CJ; Adamchuk, H; Andrusenko, O; Bondarenko, I; Chornobai, A; Hotko, Y; Ivashchuk, O; Kolesnik, O; Kryzhanivska, A; Odarchenko, S; Ogorodnikova, N; Rusyn, A; Shamrai, V; Shapovalov, D; Vasylyev, L; Vynnychenko, I; Karim, NA; Almubarak, M; Al-Nsour, M; Assikis, V; Baker, S; Batus, M; Beatty, P; Becker, K; Belman, N; Bernicker, E; Braiteh, F; Bui, L; Carr, L; Chaudhry, A; Cheng, H; Chitneni, S; Cohenuram, M; Daniels, G; Dean-Colomb, W; DeVore, R; DiStefano, A; Dobrescu, A; Drew, DZ; Eisenberg, P; Erickson, B; Eskander, E; Fabregas, J; Faller, B; Fiorillo, J; Goldschmidt, J; Goueli, B; Gurubhagavatula, S; Halibey, B; Hamm, J; Herman, J; Hoffman, P; Hooberman, A; Jhangiani, H; Kabbinavar, F; Karnad, A; Keogh, GP; Kirshner, E; Koh, H; Kono, S; Kosty, M; Kotiah, S; Kozloff, M; Kuzma, C; Lakhani, N; Lukas, J; Martin, W; Masood, N; Matthews-Smith, V; McCann, J; Menefee, M; Mitchell, BR; Naidu, S; Narang, M; Natale, R; Niederman, T; Nissenblatt, M; Ou, SH; Paschold, JC; Raez, LE; Rafiyath, S; Rodriguez, E; Rosales, J; Rothman, J; Sabbath, K; Sanz-Altamira, P; Schnell, FM; Shtivelband, M; Silberberg, J; Socoteanu, M; Spira, AI; Stella, P; Subramanian, J; Swanson, PM; Telivala, B; Tsai, F; Tummala, M; VanderWalde, A; Velcheti, V; West, H; Yanagihara, R; Zylla, D				Socinski, M. A.; Jotte, R. M.; Cappuzzo, F.; Orlandi, F.; Stroyakovskiy, D.; Nogami, N.; Rodriguez-Abreu, D.; Moro-Sibilot, D.; Thomas, C. A.; Barlesi, F.; Finley, G.; Kelsch, C.; Lee, A.; Coleman, S.; Deng, Y.; Shen, Y.; Kowanetz, M.; Lopez-Chavez, A.; Sandler, A.; Reck, M.; Ahualli, A.; Jarchum, G.; Kaen, D. L.; Kahl, S.; Kotliar, M.; Kowalyszyn, R. D.; Lerzo, G.; Magri, I; Martin, C.; Pastor, A.; Picon, P.; Streich, G.; Varela, M.; Blinman, P.; Boyer, M.; Crombie, C.; Gauden, S.; Gill, S.; Hughes, B.; John, T.; Joshi, A.; Kosmider, S.; Lewis, C.; Millward, M.; Nordman, I; Nott, L.; O'Byrne, K.; Parnis, F.; Potasz, N.; Richardson, G.; Singhal, N.; Eckmayr, J.; Greil, R.; Goeminne, J. C.; Paulus, A.; Aragao, B.; Bruno, L. A.; Campos, C.; Costamilan, RdC; Dettino, A.; Faccio, A.; Girotto, G.; Matias, D.; Murad, A. M.; Schwartsmann, G.; Silva, C.; Tadokoro, H.; Dimitrov, B.; Ilieva, R.; Kalev, D.; Kanarev, V; Koleva, M.; Koynov, K.; Mihaylova, Z.; Cohen, V; Cournoyer, G.; Rorke, S.; Rothenstein, J.; Spadafora, S.; Aren, O.; Ulunque, Orellana E.; Yanez, E.; Valette, Audigier C.; Bennouna, J.; Berard, H.; Coudert, B.; Dayen, C.; Denis, F.; Guillevin, Fabre E.; Foa, C.; Gazaille, V; Le Moulec, S.; Mazieres, J.; Morere, J. F.; Veillon, R.; Bargon, J.; Behringer, D.; Dickgreber, N. J.; Engel-Riedel, W.; Fischer, J. R.; Hackanson, B.; Kokowski, K.; Kollmeier, J.; Loges, S.; Schulz, C.; Schutte, W.; Serke, M.; Stauder, H.; Steppert, C.; Wehler, T.; Weissinger, F.; Wermke, M.; Wesseler, C.; Allegrini, G.; Amoroso, D.; Barone, C.; Borra, G.; Carteni, G.; Defraia, E.; Falcone, A.; Grossi, F.; Mencoboni, M.; Migliorino, M. R.; Pazzola, A.; Parra, Soto H.; Tonini, G.; Azuma, K.; Fukuhara, T.; Ichiki, M.; Ikeda, S.; Kawaguchi, T.; Kim, Y. H.; Kishi, K.; Otani, S.; Seto, T.; Takeda, Y.; Tanaka, H.; Yamamoto, N.; Yokota, S.; Yokoyama, T.; Purkalne, G.; Zvirbule, Z.; Cicenas, S.; Filipauskiene, J.; Dominguez, A.; Gomez, A.; Leon, Lazaro J. M.; Lopez, Y.; Aerts, J. G. J., V; Barlo, N.; Biesma, B.; Dingemans, A. M.; Hashemi, S.; Keizer-van't Westeinde, S.; Lammers, E.; Mansour, K.; Schramel, F.; Snijders, D.; van Haarst, J. M.; van Lindert, A.; Wilschut, F.; Aleman, D.; Tipismana, Cisneros R.; Kobashigawa, A.; Mas, L.; Escobar, Moron H. D.; Almodovar, T.; Araujo, A.; Azevedo, I; Barata, F.; Queiroga, H.; de Brito, Saturnino Duarte U.; Teixeira, E.; Biakhov, M.; Galiulin, R.; Gorbunova, V; Karaseva, N.; Kovalenko, N.; Penkov, K.; Poltoratskiy, A.; Vasiliev, A.; Zhiltsova, E.; Leong, S. S.; Lim, D.; Beniak, J.; Chovanec, J.; Godal, R.; Kasan, P.; Porubska, M.; Alvarez, R.; Manrique, Areses MdC; Aranda, Barneto I. C.; Carpeno, De Castro J.; Gomez, Domine J. H. C. N. N. M.; Font, Felip E.; Garcia, Garcia Y.; Lopez, Garrido P.; Sarrio, Girones R.; Larriba, Gonzalez J. L.; Molla, Insa A.; Munarriz, Jimenez B.; Piqueras, Lopez-Brea M.; Nadal, E.; Aix, Ponce S.; Garcia, Taus A.; Pons, Terrasa J.; Estevez, Vazquez S.; Segarra, Vinolas N.; Vikstrom, A.; Frueh, M.; Gautschi, O.; Lohri, A.; Ochsenbein, A.; Chang, G. C.; Chen, C. H.; Chen, W. T.; Chen, Y. M.; Ho, C. L.; Hsia, T. C.; Hsieh, R. K.; Huang, M. S.; Li, C. T.; Lin, Y. C.; Liu, C. Y.; Su, W. C.; Yu, C. J.; Adamchuk, H.; Andrusenko, O.; Bondarenko, I; Chornobai, A.; Hotko, Y.; Ivashchuk, O.; Kolesnik, O.; Kryzhanivska, A.; Odarchenko, S.; Ogorodnikova, N.; Rusyn, A.; Shamrai, V; Shapovalov, D.; Vasylyev, L.; Vynnychenko, I; Karim, Abdel N.; Almubarak, M.; Al-Nsour, M.; Assikis, V; Baker, S.; Batus, M.; Beatty, P.; Becker, K.; Belman, N.; Bernicker, E.; Braiteh, F.; Bui, L.; Carr, L.; Chaudhry, A.; Cheng, H.; Chitneni, S.; Cohenuram, M.; Daniels, G.; Dean-Colomb, W.; DeVore, R., III; DiStefano, A.; Dobrescu, A.; Drew, D. Z.; Eisenberg, P.; Erickson, B.; Eskander, E.; Fabregas, J.; Faller, B.; Fiorillo, J.; Goldschmidt, J., Jr.; Goueli, B.; Gurubhagavatula, S.; Halibey, B.; Hamm, J.; Herman, J.; Hoffman, P.; Hooberman, A.; Jhangiani, H.; Kabbinavar, F.; Karnad, A.; Keogh, G. P.; Kirshner, E.; Koh, H.; Kono, S.; Kosty, M.; Kotiah, S.; Kozloff, M.; Kuzma, C.; Lakhani, N.; Lukas, J.; Martin, W.; Masood, N.; Matthews-Smith, V; McCann, J.; Menefee, M.; Mitchell, B. R.; Naidu, S.; Narang, M.; Natale, R.; Niederman, T.; Nissenblatt, M.; Ou, S. H.; Paschold, J. C.; Raez, L. E.; Rafiyath, S.; Rodriguez, E.; Rosales, J.; Rothman, J.; Sabbath, K.; Sanz-Altamira, P.; Schnell, F. M.; Shtivelband, M.; Silberberg, J.; Socoteanu, M.; Spira, A., I; Stella, P.; Subramanian, J.; Swanson, P. M.; Telivala, B.; Tsai, F.; Tummala, M.; VanderWalde, A.; Velcheti, V.; West, H.; Yanagihara, R.; Zylla, D.		IMpower150 Study Grp	Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; OPEN-LABEL; CANCER; BEVACIZUMAB; THERAPY; DOCETAXEL; ANTIBODY; CELLS; CHEMOTHERAPY; MULTICENTER	BACKGROUND The cancer-cell-killing property of atezolizumab may be enhanced by the blockade of vascular endothelial growth factor-mediated immunosuppression with bevacizumab. This open-label, phase 3 study evaluated atezolizumab plus bevacizumab plus chemotherapy in patients with metastatic nonsquamous non-small-cell lung cancer (NSCLC) who had not previously received chemotherapy. METHODS We randomly assigned patients to receive atezolizumab plus carboplatin plus paclitaxel (ACP), bevacizumab plus carboplatin plus paclitaxel (BCP), or atezolizumab plus BCP (ABCP) every 3 weeks for four or six cycles, followed by maintenance therapy with atezolizumab, bevacizumab, or both. The two primary end points were investigator-assessed progression-free survival both among patients in the intention-to-treat population who had a wild-type genotype (WT population; patients with EGFR or ALK genetic alterations were excluded) and among patients in the WT population who had high expression of an effector T-cell (Teff) gene signature in the tumor (Teff-high WT population) and overall survival in the WT population. The ABCP group was compared with the BCP group before the ACP group was compared with the BCP group. RESULTS In the WT population, 356 patients were assigned to the ABCP group, and 336 to the BCP group. The median progression-free survival was longer in the ABCP group than in the BCP group (8.3 months vs. 6.8 months; hazard ratio for disease progression or death, 0.62; 95% confidence interval [CI], 0.52 to 0.74; P<0.001); the corresponding values in the Teff-high WT population were 11.3 months and 6.8 months (hazard ratio, 0.51 [95% CI, 0.38 to 0.68]; P<0.001). Progression-free survival was also longer in the ABCP group than in the BCP group in the entire intention-to-treat population (including those with EGFR or ALK genetic alterations) and among patients with low or negative programmed death ligand 1 (PD-L1) expression, those with low Teff gene-signature expression, and those with liver metastases. Median overall survival among the patients in the WT population was longer in the ABCP group than in the BCP group (19.2 months vs. 14.7 months; hazard ratio for death, 0.78; 95% CI, 0.64 to 0.96; P = 0.02). The safety profile of ABCP was consistent with previously reported safety risks of the individual medicines. CONCLUSIONS The addition of atezolizumab to bevacizumab plus chemotherapy significantly improved progression-free survival and overall survival among patients with metastatic nonsquamous NSCLC, regardless of PD-L1 expression and EGFR or ALK genetic alteration status.	[Socinski, M. A.] Florida Hosp Canc Inst, Orlando, FL USA; [Jotte, R. M.] Rocky Mt Canc Ctr, Denver, CO USA; [Jotte, R. M.] US Oncol, Houston, TX USA; [Cappuzzo, F.] Azienda Unita Sanit Locale Romagna, Ravenna, Italy; [Orlandi, F.] Inst Nacl Torax, Santiago, Chile; [Stroyakovskiy, D.] Moscow City Oncol Hosp, Moscow, Russia; [Nogami, N.] Shikoku Canc Ctr, Natl Hosp Org, Matsuyama, Ehime, Japan; [Rodriguez-Abreu, D.] Univ Las Palmas Gran Canaria, Complejo Hosp Univ Insular Maternoinfantil Gran, Las Palmas Gran Canaria, Spain; [Moro-Sibilot, D.] Ctr Hosp Univ Grenoble Alpes, Grenoble, France; [Barlesi, F.] Aix Marseille Univ, AP HM, Marseille, France; [Thomas, C. A.] New England Canc Specialists, Scarborough, ME USA; [Finley, G.] Allegheny Hlth Network Canc Inst, Pittsburgh, PA USA; [Kelsch, C.; Lee, A.; Coleman, S.; Deng, Y.; Shen, Y.; Kowanetz, M.; Lopez-Chavez, A.; Sandler, A.] Genentech Inc, San Francisco, CA USA; [Reck, M.] German Ctr Lung Res, Airway Res Ctr North, Lung Clin Grosshansdorf, Grosshansdorf, Germany	Adventist Health Services; AdventHealth; Rocky Mountain Cancer Centers; US Oncology Network; Universidad de Las Palmas de Gran Canaria; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Roche Holding; Genentech	Reck, M (corresponding author), German Ctr Lung Res, Airway Res Ctr North, Lung Clin Grosshansdorf, Dept Thorac Oncol, Wohrendamm 80, D-22927 Grosshansdorf, Germany.	m.reck@lungenclinic.de	Raez, Luis/AAL-8829-2020; Vynnychenko, Ihor O/E-1684-2012; Hotko, Yevhen/F-9068-2019; SOTO PARRA, HECTOR J/ABC-6273-2021; GARRIDO, PILAR/D-5187-2017; Wehler, Thomas Christian/AAY-6362-2020; Kovalenko, Nadezhda/AAG-6298-2021; Cappuzzo, federico/R-2827-2016; Kosty, Michael/AAR-6169-2021; Kryzhanivska, Anna/ABG-4997-2020; LA DETTINO, Aldo/A-1288-2014; Thomas, Christian/AAI-6276-2020; Rusyn, Andriy/AFS-4172-2022; Reck, Martin/ABF-5721-2020; Shtivelband, Mikhail/GXN-0194-2022; Grossi, Francesco/AAL-5024-2021	Raez, Luis/0000-0003-2669-5771; Vynnychenko, Ihor O/0000-0002-2339-6509; Hotko, Yevhen/0000-0002-4533-4210; SOTO PARRA, HECTOR J/0000-0001-7966-4472; GARRIDO, PILAR/0000-0002-5899-6125; Cappuzzo, federico/0000-0002-6295-6767; Kryzhanivska, Anna/0000-0001-7720-7374; LA DETTINO, Aldo/0000-0002-1186-941X; Reck, Martin/0000-0002-5348-4462; Grossi, Francesco/0000-0001-8412-3136; Stroyakovskiy, Daniil/0000-0003-1973-1092; Bennouna, Jaafar/0000-0002-5034-1108; Kollmeier, Jens/0000-0002-8048-3895; Rodriguez-Abreu, Delvys/0000-0003-0506-1366; MORO-SIBILOT, Denis/0000-0001-6776-8610; O'Byrne, Kenneth/0000-0002-6754-5633; Nadal, Ernest/0000-0002-9674-5554; Vikstrom, Anders/0000-0003-3549-3944; , CLARISSE/0000-0002-9518-9162; INSA, AMELIA/0000-0002-3438-6170; Ochsenbein, Adrian/0000-0003-1773-5436	F. Hoffmann-La Roche/Genentech	F. Hoffmann-La Roche/Genentech(Hoffmann-La RocheRoche HoldingGenentech)	Funded by F. Hoffmann-La Roche/Genentech; IMpower150 ClinicalTrials.gov number, NCT02366143.	Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen DS, 2012, CLIN CANCER RES, V18, P6580, DOI 10.1158/1078-0432.CCR-12-1362; Dmitrienko A, 2013, STAT MED, V32, P5172, DOI 10.1002/sim.5990; Dmitrienko A, 2013, STAT MED, V32, P1079, DOI 10.1002/sim.5642; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Gabrilovich DI, 1996, CELL IMMUNOL, V170, P101, DOI 10.1006/cimm.1996.0139; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gadgeel S, 2017, ANN ONCOL, V28, pv460, DOI DOI 10.1093/annonc/mdx380.001; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Hegde PS, 2017, SEMIN CANC BIOL; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hodi FS, 2014, CANCER IMMUNOL RES, V2, P632, DOI 10.1158/2326-6066.CIR-14-0053; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Kim JM, 2016, ANN ONCOL, V27, P1492, DOI 10.1093/annonc/mdw217; Kowanetz M, 2017, J THORAC ONCOL, V12, pS1817, DOI 10.1016/j.jtho.2017.09.485; Liu SV, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9092; Motz GT, 2014, NAT MED, V20, P607, DOI 10.1038/nm.3541; National Comprehensive Cancer Net-work, 2018, NCCN CLIN PRACT GUID, V2; Novello S, 2016, ANN ONCOL, V27, pv1, DOI 10.1093/annonc/mdw326; Oyama T, 1998, J IMMUNOL, V160, P1224; Paz-Ares LG, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.3038; Peters S, 2017, J CLIN ONCOL, V35, P2781, DOI 10.1200/JCO.2016.71.9476; Pillai RN, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_supll.e20665; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Roland CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007669; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Syrigos K, 2017, ANN ONCOL          S, V28, P468; Tumeh PC, 2017, CANCER IMMUNOL RES, V5, P417, DOI 10.1158/2326-6066.CIR-16-0325; Voron T, 2015, J EXP MED, V212, P139, DOI 10.1084/jem.20140559; Wallin JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12624	38	1867	1950	22	207	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2018	378	24					2288	2301		10.1056/NEJMoa1716948	http://dx.doi.org/10.1056/NEJMoa1716948			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2KR	29863955	Bronze, Green Published			2022-12-28	WOS:000435099900006
J	Raghu, G; van den Blink, B; Hamblin, MJ; Brown, AW; Golden, JA; Ho, LA; Wijsenbeek, MS; Vasakova, M; Pesci, A; Antin-Ozerkis, DE; Meyer, KC; Kreuter, M; Santin-Janin, H; Mulder, GJ; Bartholmai, B; Gupta, R; Richeldi, L				Raghu, Ganesh; van den Blink, Bernt; Hamblin, Mark J.; Brown, A. Whitney; Golden, Jeffrey A.; Ho, Lawrence A.; Wijsenbeek, Marlies S.; Vasakova, Martina; Pesci, Alberto; Antin-Ozerkis, Danielle E.; Meyer, Keith C.; Kreuter, Michael; Santin-Janin, Hugues; Mulder, Geert-Jan; Bartholmai, Brian; Gupta, Renu; Richeldi, Luca			Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SERUM-AMYLOID-P; IMPORTANT DIFFERENCE; MORTALITY; EFFICACY; DIAGNOSIS; SAFETY	IMPORTANCE Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with poor prognosis. Approved therapies do not halt disease progression. OBJECTIVE To determine the effect of recombinant human pentraxin 2 vs placebo on change from baseline to week 28 in mean forced vital capacity (FVC) percentage of predicted value. DESIGN, SETTING, AND PARTICIPANTS Phase 2, randomized, double-blind, placebo-controlled trial conducted at 18 sites in 7 countries of eligible patients with IPF (N = 117; aged 40-80 years; FVC >= 50% and >= 90% predicted; ratio of forced expiratory volume in the first second/FVC >0.70; diffusing capacity for carbon monoxide [DLCO] >= 25% and >= 90% predicted; and distance of >= 150 m on the 6-minute walk test). Study period was August 2015-May 2017. INTERVENTIONS Patients were randomized to receive either recombinant human pentraxin 2 (10 mg/kg intravenous every 4 weeks, n = 77) or placebo (n = 39) for 24 weeks, and stratified by concurrent IPF treatment status. MAIN OUTCOMES AND MEASURES The primary end pointwas the least-squares mean change in FVC percentage of predicted value from baseline to week 28 (minimal clinically important difference, decline of 2%-6%). Secondary end points included mean change in lung volumes (total, normal, and interstitial lung abnormalities) on high-resolution computed tomography (HRCT) and 6-minute walk distance (minimal clinically important difference, 24-45 m). RESULTS Of 117 randomized patients, 116 received at least 1 dose of study drug (mean age, 68.6 years; 81.0% men; mean time since IPF diagnosis, 3.8 years), and 111 (95.7%) completed the study. The least-squares mean change in FVC percentage of predicted value from baseline to week 28 in patients treated with recombinant human pentraxin 2 was -2.5 vs -4.8 for those in the placebo group (difference, + 2.3[90% CI, 1.1 to 3.5]; P =.001). No significant treatment differences were observed in total lung volume (difference, 93.5mL[90% CI, -27.7 to 214.7]), quantitative parenchymal features on HRCT (normal lung volume difference, -1.2%[90% CI, -4.4 to 1.9]; interstitial lung abnormalities difference, 1.1%[90% CI, -2.2 to 4.3]), or measurement of DLCO (difference, -0.4[90% CI, -2.6 to 1.7]). The change in 6-minute walk distance was -0.5m for patients treated with recombinant human pentraxin 2 vs -31.8 m for those in the placebo group (difference, + 31.3 m[90% CI, 17.4 to 45.1]; P < .001). The most common adverse events in the recombinant human pentraxin 2 vs placebo group were cough (18% vs 5%), fatigue (17% vs 10%), and nasopharyngitis (16% vs 23%). CONCLUSIONS AND RELEVANCE In this preliminary study, recombinant human pentraxin 2 vs placebo resulted in a slower decline in lung function over 28 weeks for patients with idiopathic pulmonary fibrosis. Further research should more fully assess efficacy and safety.	[Raghu, Ganesh; Ho, Lawrence A.] Univ Washington, Seattle, WA 98195 USA; [van den Blink, Bernt; Mulder, Geert-Jan; Gupta, Renu] Promedior Inc, Lexington, MA USA; [Hamblin, Mark J.] Univ Kansas, Kansas City, KS USA; [Brown, A. Whitney] Inova Fairfax Hosp, Falls Church, VA USA; [Golden, Jeffrey A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Wijsenbeek, Marlies S.] Erasmus Univ, Med Ctr, Dept Resp Med, Rotterdam, Netherlands; [Vasakova, Martina] Charles Univ Prague, Med Fac 1, Prague, Czech Republic; [Vasakova, Martina] Thomayer Hosp, Prague, Czech Republic; [Pesci, Alberto] Univ Milano Bicocca, Monza, Italy; [Antin-Ozerkis, Danielle E.] Yale Sch Med, New Haven, CT USA; [Meyer, Keith C.] Univ Wisconsin, Madison, WI 53706 USA; [Kreuter, Michael] Heidelberg Univ, Thoraxklin, Ctr Rare & Interstitial Lung Dis, Heidelberg, Germany; [Santin-Janin, Hugues] Venn Life Sci, Paris, France; [Bartholmai, Brian] Mayo Clin, Rochester, MN USA; [Richeldi, Luca] Univ Cattolica Sacro Cuore, IRCCS Fdn Policlin Univ A Gemelli, Unita Operat Complessa Pneumol, Rome, Italy	University of Washington; University of Washington Seattle; University of Kansas; Inova Fairfax Hospital; University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC; Charles University Prague; Thomayer Hospital; University of Milano-Bicocca; Yale University; University of Wisconsin System; University of Wisconsin Madison; Ruprecht Karls University Heidelberg; Mayo Clinic; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Raghu, G (corresponding author), Univ Washington, Med Ctr, Ctr Interstitial Lung Dis, 1959 NE Pacific,Campus Box 356175, Seattle, WA 98195 USA.	graghu@uw.edu	Richeldi, Luca/B-6243-2019; Richeldi, Luca/ABF-2486-2020	Richeldi, Luca/0000-0001-8594-1448; Wijsenbeek, Marlies/0000-0002-4527-6962	Promedior; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Promedior; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was funded by Promedior.	Ayele BT, 2014, J BIOPHARM STAT, V24, P211, DOI 10.1080/10543406.2013.859148; Chung JH, 2016, AM J ROENTGENOL, V206, P463, DOI 10.2214/AJR.15.15627; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; De Biasi S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0515-0; Dillingh MR, 2013, PULM PHARMACOL THER, V26, P672, DOI 10.1016/j.pupt.2013.01.008; du Bois RM, 2014, EUR RESPIR J, V43, P1421, DOI 10.1183/09031936.00131813; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P1382, DOI 10.1164/rccm.201105-0840OC; du Bois RM, 2011, AM J RESP CRIT CARE, V183, P1231, DOI [10.1164/rccm.201007.1179OC, 10.1164/rccm.201007-1179OC]; Hutchinson J, 2015, EUR RESPIR J, V46, P795, DOI 10.1183/09031936.00185114; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Moreira AP, 2010, J ALLERGY CLIN IMMUN, V126, P712, DOI 10.1016/j.jaci.2010.06.010; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; Naik-Mathuria B, 2008, WOUND REPAIR REGEN, V16, P266, DOI 10.1111/j.1524-475X.2008.00366.x; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Raghu G, 2016, EUR RESPIR J, V48, P179, DOI 10.1183/13993003.01653-2015; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2017, LANCET, V389, P1941, DOI 10.1016/S0140-6736(17)30866-8; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; van den Blink B, 2016, EUR RESPIR J, V47, P889, DOI 10.1183/13993003.00850-2015	23	108	109	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2018	319	22					2299	2307		10.1001/jama.2018.6129	http://dx.doi.org/10.1001/jama.2018.6129			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2UP	29800034	Bronze, Green Published			2022-12-28	WOS:000435129300016
J	Kandzari, DE; Bohm, M; Mahfoud, F; Townsend, RR; Weber, MA; Pocock, S; Tsioufis, K; Tousoulis, D; Choi, JW; East, C; Brar, S; Cohen, SA; Fahy, M; Pilcher, G; Kario, K				Kandzari, David E.; Boehm, Michael; Mahfoud, Felix; Townsend, Raymond R.; Weber, Michael A.; Pocock, Stuart; Tsioufis, Konstantinos; Tousoulis, Dimitrios; Choi, James W.; East, Cara; Brar, Sandeep; Cohen, Sidney A.; Fahy, Martin; Pilcher, Garrett; Kario, Kazuomi		SPYRAL HTN-ON MED Trial Investigat	Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial	LANCET			English	Article							TREATMENT-RESISTANT HYPERTENSION; SYMPLICITY HTN-3; PROGNOSTIC VALUE; HEART-RATE; ADHERENCE; HOME; PRODUCT; ABSENCE; DESIGN; PART	Background Previous catheter-based renal denervation studies have reported variable efficacy results. We aimed to evaluate safety and blood pressure response after renal denervation or sham control in patients with uncontrolled hypertension on antihypertensive medications with drug adherence testing. Methods In this international, randomised, single-blind, sham-control, proof-of-concept trial, patients with uncontrolled hypertension (aged 20-80 years) were enrolled at 25 centres in the USA, Germany, Japan, UK, Australia, Austria, and Greece. Eligible patients had an office systolic blood pressure of between 150 mm Hg and 180 mm Hg and a diastolic blood pressure of 90 mm Hg or higher; a 24 h ambulatory systolic blood pressure of between 140 mm Hg and 170 mm Hg at second screening; and were on one to three antihypertensive drugs with stable doses for at least 6 weeks. Patients underwent renal angiography and were randomly assigned to undergo renal denervation or sham control. Patients, caregivers, and those assessing blood pressure were masked to randomisation assignments. The primary efficacy endpoint was blood pressure change from baseline (measured at screening visit two), based on ambulatory blood pressure measurements assessed at 6 months, as compared between treatment groups. Drug surveillance was used to assess medication adherence. The primary analysis was done in the intention-to-treat population. Safety events were assessed through 6 months as per major adverse events. This trial is registered with ClinicalTrials.gov, number NCT02439775, and follow-up is ongoing. Findings Between July 22, 2015, and June 14, 2017, 467 patients were screened and enrolled. This analysis presents results for the first 80 patients randomly assigned to renal denervation (n=38) and sham control (n=42). Office and 24 h ambulatory blood pressure decreased significantly from baseline to 6 months in the renal denervation group (mean baseline-adjusted treatment differences in 24 h systolic blood pressure -7.0 mm Hg, 95% CI -12 to -2.1; p=0.0059, 24 h diastolic blood pressure -4.3 mm Hg, -7.8 to -0.8; p=0.0174, office systolic blood pressure -6.6 mm Hg, -12.4 to -0.9; p=0.0250, and office diastolic blood pressure -4.2 mm Hg, -7.7 to -0.7; p=0.0190). The change in blood pressure was significantly greater at 6 months in the renal denervation group than the sham-control group for office systolic blood pressure (difference -6.8 mm Hg, 95% CI -12.5 to -1.1; p=0.0205), 24 h systolic blood pressure (difference -7 . 4 mm Hg, -12.5 to -2.3; p=0.0051), office diastolic blood pressure (difference -3.5 mm Hg, -7.0 to -0.0; p=0.0478), and 24 h diastolic blood pressure (difference -4.1 mm Hg, -7.8 to -0.4; p=0.0292). Evaluation of hourly changes in 24 h systolic blood pressure and diastolic blood pressure showed blood pressure reduction throughout 24 h for the renal denervation group. 3 month blood pressure reductions were not significantly different between groups. Medication adherence was about 60% and varied for individual patients throughout the study. No major adverse events were recorded in either group. Interpretation Renal denervation in the main renal arteries and branches significantly reduced blood pressure compared with sham control with no major safety events. Incomplete medication adherence was common. Funding Medtronic. Copyright (C) = 2018 Elsevier Ltd. All rights reserved.	[Kandzari, David E.] Piedmont Heart Inst, Dept Intervent Cardiol, Atlanta, GA USA; [Boehm, Michael; Mahfoud, Felix] Univ Saarland, Univ Klinikum Saarlandes, Dept Internal Med, Homburg, Germany; [Mahfoud, Felix] MIT, Inst Med Engn & Sci, Cambridge, MA USA; [Townsend, Raymond R.; Cohen, Sidney A.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA; [Weber, Michael A.] SUNY Downstate, Coll Med, Dept Med, Brooklyn, NY USA; [Pocock, Stuart] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Tsioufis, Konstantinos; Tousoulis, Dimitrios] Natl & Kapodistrian Univ Athens, Hippocrat Hosp, Dept Cardiol, Athens, Greece; [Choi, James W.; East, Cara] Baylor Jack & Jane Hamilton Heart & Vasc Hosp, Dept Cardiol, Dallas, TX USA; [Brar, Sandeep; Cohen, Sidney A.; Fahy, Martin; Pilcher, Garrett] Medtron PLC, Santa Rosa, CA USA; [Kario, Kazuomi] Jichi Med Univ, Sch Med, Dept Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Kandzari, David E.] Piedmont Heart Inst, Atlanta, GA 30309 USA	Piedmont Heart Institute; Saarland University; Universitatsklinikum des Saarlandes; Massachusetts Institute of Technology (MIT); University of Pennsylvania; Pennsylvania Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of London; London School of Hygiene & Tropical Medicine; National & Kapodistrian University of Athens; Jichi Medical University; Piedmont Heart Institute	Kandzari, DE (corresponding author), Piedmont Heart Inst, Atlanta, GA 30309 USA.	david.kandzari@piedmont.org	Mahfoud, Felix/D-7707-2011; Lurz, Philipp C/B-6558-2009; Böhm, Michael/C-3638-2011	Lurz, Philipp C/0000-0002-5993-4487; Hopper, Ingrid/0000-0002-8805-370X	Medtronic	Medtronic(Medtronic)	Medtronic.	Azizi M, 2016, CIRCULATION, V134, P847, DOI 10.1161/CIRCULATIONAHA.116.022922; Azizi M, 2015, LANCET, V385, P1957, DOI 10.1016/S0140-6736(14)61942-5; Berra E, 2016, HYPERTENSION, V68, P297, DOI 10.1161/HYPERTENSIONAHA.116.07464; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Bundy JD, 2017, JAMA CARDIOL, V2, P775, DOI 10.1001/jamacardio.2017.1421; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Ewen S, 2015, CLIN RES CARDIOL, V104, P1097, DOI 10.1007/s00392-015-0905-5; Inoue R, 2012, AM J HYPERTENS, V25, P568, DOI 10.1038/ajh.2012.3; James KE, 1996, STAT MED, V15, P1421; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kandzari DE, 2016, AM HEART J, V171, P82, DOI 10.1016/j.ahj.2015.08.021; Kandzari DE, 2015, EUR HEART J, V36, P219, DOI 10.1093/eurheartj/ehu441; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Kikuya M, 2000, HYPERTENSION, V36, P901, DOI 10.1161/01.HYP.36.5.901; Mahfoud F, 2017, EUR HEART J, V38, P3272, DOI 10.1093/eurheartj/ehx215; Mahfoud F, 2017, EUR HEART J, V38, P93, DOI 10.1093/eurheartj/ehw325; Mahfoud F, 2015, J AM COLL CARDIOL, V66, P1766, DOI 10.1016/j.jacc.2015.08.018; Mahfoud F, 2015, EUR HEART J, V36, P2219, DOI 10.1093/eurheartj/ehv192; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mompeo B, 2016, CLIN ANAT, V29, P660, DOI 10.1002/ca.22720; Ott C, 2016, J HYPERTENS, V34, P2475, DOI 10.1097/HJH.0000000000001110; Pekarskiy SE, 2017, J HYPERTENS, V35, P369, DOI 10.1097/HJH.0000000000001160; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Schlaich MP, 2009, NEW ENGL J MED, V361, P932, DOI 10.1056/NEJMc0904179; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Stergiou GS, 2002, AM J HYPERTENS, V15, P101, DOI 10.1016/S0895-7061(01)02324-X; Townsend RR, 2017, LANCET, V390, P2160, DOI 10.1016/S0140-6736(17)32281-X; Verdecchia P, 2000, HYPERTENSION, V35, P844, DOI 10.1161/01.HYP.35.3.844; Weber MA, 2015, J CLIN HYPERTENS, V17, P743, DOI 10.1111/jch.12590; Whelton PK, 2018, J AM COLL CARDIOL, V71, P1, DOI [10.22141/2307-1257.7.1.2018.122220, 10.1161/HYP.0000000000000065, DOI 10.1161/HYP.0000000000000065]; White WB, 1999, AM J HYPERTENS, V12, p50S, DOI 10.1016/S0895-7061(98)00280-5; White WB, 2014, J AM SOC HYPERTENS, V8, P743, DOI 10.1016/j.jash.2014.06.005; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3	35	429	456	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2018	391	10137					2346	2355		10.1016/S0140-6736(18)30951-6	http://dx.doi.org/10.1016/S0140-6736(18)30951-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI6WF	29803589	Green Accepted			2022-12-28	WOS:000434643200031
J	Tittl, A; Leitis, A; Liu, MK; Yesilkoy, F; Choi, DY; Neshev, DN; Kivshar, YS; Altug, H				Tittl, Andreas; Leitis, Aleksandrs; Liu, Mingkai; Yesilkoy, Filiz; Choi, Duk-Yong; Neshev, Dragomir N.; Kivshar, Yuri S.; Altug, Hatice			Imaging-based molecular barcoding with pixelated dielectric metasurfaces	SCIENCE			English	Article							SPECTROSCOPY; RESOLUTION; ANTENNAS	Metasurfaces provide opportunities for wavefront control, flat optics, and subwavelength light focusing. We developed an imaging-based nanophotonic method for detecting mid-infrared molecular fingerprints and implemented it for the chemical identification and compositional analysis of surface-bound analytes. Our technique features a two-dimensional pixelated dielectric metasurface with a range of ultrasharp resonances, each tuned to a discrete frequency; this enables molecular absorption signatures to be read out at multiple spectral points, and the resulting information is then translated into a barcode-like spatial absorption map for imaging. The signatures of biological, polymer, and pesticide molecules can be detected with high sensitivity, covering applications such as biosensing and environmental monitoring. Our chemically specific technique can resolve absorption fingerprints without the need for spectrometry, frequency scanning, or moving mechanical parts, thereby paving the way toward sensitive and versatile miniaturized mid infrared spectroscopy devices.	[Tittl, Andreas; Leitis, Aleksandrs; Yesilkoy, Filiz; Altug, Hatice] Ecole Polytech Fed Lausanne, Inst BioEngn, CH-1015 Lausanne, Switzerland; [Liu, Mingkai; Neshev, Dragomir N.; Kivshar, Yuri S.] Australian Natl Univ, Res Sch Phys & Engn, Nonlinear Phys Ctr, Canberra, ACT 2601, Australia; [Choi, Duk-Yong] Australian Natl Univ, Res Sch Phys & Engn, Laser Phys Ctr, Canberra, ACT 2601, Australia	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Australian National University; Australian National University	Altug, H (corresponding author), Ecole Polytech Fed Lausanne, Inst BioEngn, CH-1015 Lausanne, Switzerland.	hatice.altug@epfl.ch	Tittl, Andreas/H-3056-2016; Liu, Mingkai/AAX-7457-2020; Yesilkoy, Filiz/X-4725-2019; Kivshar, Yuri/ABA-7970-2020; Kivshar, Yuri/AAJ-1901-2020; Neshev, Dragomir/A-3759-2008; Choi, Duk-Yong/E-6542-2013	Tittl, Andreas/0000-0003-3191-7164; Liu, Mingkai/0000-0001-9444-8794; Yesilkoy, Filiz/0000-0001-8483-3285; Kivshar, Yuri/0000-0002-3410-812X; Neshev, Dragomir/0000-0002-4508-8646; Leitis, aleksandrs.leitis@epfl.ch/0000-0003-4855-5876; Choi, Duk-Yong/0000-0002-5339-3085	European Research Council [682167 VIBRANT-B10]; European Union [665667, 777714, FETOPEN-737071, 644956]; Australian Research Council	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Australian Research Council(Australian Research Council)	The research leading to these results has received funding from the European Research Council under grant agreement no. 682167 VIBRANT-B10 and the European Union Horizon 2020 Framework Programme for Research and Innovation under grant agreements no. 665667 (call 2015), no. 777714 (NOCTURNO project), no. FETOPEN-737071 (ULTRACHIRAL project), and no. 644956 (RAIS project). The authors acknowledge the support of the Australian Research Council.	Arbabi A, 2015, NAT NANOTECHNOL, V10, P937, DOI [10.1038/nnano.2015.186, 10.1038/NNANO.2015.186]; Bagheri S, 2015, ACS PHOTONICS, V2, P779, DOI 10.1021/acsphotonics.5b00141; Caldwell MW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6996; Campione S, 2016, ACS PHOTONICS, V3, P2362, DOI 10.1021/acsphotonics.6b00556; Cerjan B, 2016, ACS PHOTONICS, V3, P354, DOI 10.1021/acsphotonics.6b00024; Chen K, 2012, ACS NANO, V6, P7998, DOI 10.1021/nn3026468; Decker M, 2015, ADV OPT MATER, V3, P813, DOI 10.1002/adom.201400584; Dong LL, 2017, NANO LETT, V17, P5768, DOI 10.1021/acs.nanolett.7b02736; Dregely D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3237; Harrer A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21795; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Huck C, 2014, ACS NANO, V8, P4908, DOI 10.1021/nn500903v; Jiang S, 2013, NANOSCALE, V5, P3127, DOI 10.1039/c3nr34005h; Khorasaninejad M, 2016, SCIENCE, V352, P1190, DOI 10.1126/science.aaf6644; Kuznetsov AI, 2016, SCIENCE, V354, DOI 10.1126/science.aag2472; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Limaj O, 2016, NANO LETT, V16, P1502, DOI 10.1021/acs.nanolett.5b05316; Limonov MF, 2017, NAT PHOTONICS, V11, P543, DOI 10.1038/NPHOTON.2017.142; Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213; Lin HT, 2018, NANOPHOTONICS-BERLIN, V7, P393, DOI 10.1515/nanoph-2017-0085; Neubrech F, 2017, CHEM REV, V117, P5110, DOI 10.1021/acs.chemrev.6b00743; Rybin M, 2017, NATURE, V541, P164, DOI 10.1038/541164a; Schwarz B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5085; Sieger M, 2016, ANAL CHEM, V88, P5562, DOI 10.1021/acs.analchem.5b04143; Stuart, 2005, INFRARED SPECTROSCOP, P76; Tittel FK, 2003, TOP APPL PHYS, V89, P445; Wu CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4892; Wu CH, 2012, NAT MATER, V11, P69, DOI [10.1038/NMAT3161, 10.1038/nmat3161]; Zhu A. Y., 2017, NANOPHOTONICS, V6, P1	29	427	439	78	410	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1105	+		10.1126/science.aas9768	http://dx.doi.org/10.1126/science.aas9768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI6TJ	29880685	Green Submitted			2022-12-28	WOS:000434635500042
J	Abbott, A				Abbott, Alison			Scientists criticize handling of animal-welfare charges	NATURE			English	News Item																			0	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					13	14		10.1038/d41586-018-05187-w	http://dx.doi.org/10.1038/d41586-018-05187-w			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29872188	Bronze			2022-12-28	WOS:000434273300014
J	Mello, MM; Lieou, V; Goodman, SN				Mello, Michelle M.; Lieou, Van; Goodman, Steven N.			Clinical Trial Participants' Views of the Risks and Benefits of Data Sharing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATTITUDES; CONSENT; ACCESS; PERSPECTIVES; WILLINGNESS; PRIVACY; PROJECT	BACKGROUND Sharing of participant-level clinical trial data has potential benefits, but concerns about potential harms to research participants have led some pharmaceutical sponsors and investigators to urge caution. Little is known about clinical trial participants' perceptions of the risks of data sharing. METHODS We conducted a structured survey of 771 current and recent participants from a diverse sample of clinical trials at three academic medical centers in the United States. Surveys were distributed by mail (350 completed surveys) and in clinic waiting rooms (421 completed surveys) (overall response rate, 79%). RESULTS Less than 8% of respondents felt that the potential negative consequences of data sharing outweighed the benefits. A total of 93% were very or somewhat likely to allow their own data to be shared with university scientists, and 82% were very or somewhat likely to share with scientists in for-profit companies. Willingness to share data did not vary appreciably with the purpose for which the data would be used, with the exception that fewer participants were willing to share their data for use in litigation. The respondents' greatest concerns were that data sharing might make others less willing to enroll in clinical trials (37% very or somewhat concerned), that data would be used for marketing purposes (34%), or that data could be stolen (30%). Less concern was expressed about discrimination (22%) and exploitation of data for profit (20%). CONCLUSIONS In our study, few clinical trial participants had strong concerns about the risks of data sharing. Provided that adequate security safeguards were in place, most participants were willing to share their data for a wide range of uses.	[Mello, Michelle M.; Lieou, Van; Goodman, Steven N.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Law Sch, 559 Nathan Abbott Way, Stanford, CA 94305 USA	Stanford University; Stanford University	Mello, MM (corresponding author), Stanford Law Sch, 559 Nathan Abbott Way, Stanford, CA 94305 USA.	mmello@law.stanford.edu		Mello, Michelle/0000-0003-2877-4270; Goodman, Steven/0000-0002-3872-5723	Greenwall Foundation; National Center for Research Resources, National Institutes of Health [UL1 TR001085]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER	Greenwall Foundation; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by a grant from the Greenwall Foundation. Research information technology used in the study was funded by a grant from the National Center for Research Resources, National Institutes of Health (Clinical and Translational Sciences Award UL1 TR001085, to Stanford University).	Alemayehu D, 2014, CONTEMP CLIN TRIALS, V39, P28, DOI 10.1016/j.cct.2014.07.002; [Anonymous], 2012, NAT BIOTECHNOL, V30, P371, DOI 10.1038/nbt.2237; Bauchner H, 2016, JAMA-J AM MED ASSOC, V315, P1237, DOI 10.1001/jama.2016.2420; Berlin JA, 2014, CLIN TRIALS, V11, P7, DOI 10.1177/1740774513514497; Bertagnolli MM, 2017, NEW ENGL J MED, V376, P1178, DOI 10.1056/NEJMsb1702054; Beskow LM, 2008, CANCER EPIDEM BIOMAR, V17, P1440, DOI 10.1158/1055-9965.EPI-08-0086; Bierer BE, 2016, NEW ENGL J MED, V374, P2411, DOI 10.1056/NEJMp1605348; Castellani J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f1881; Coady SA, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-201; Davis AL, 2017, JAMA-J AM MED ASSOC, V317, P905, DOI 10.1001/jama.2017.0918; Eichler HG, 2013, NEW ENGL J MED, V369, P1577, DOI 10.1056/NEJMp1310771; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; European Medicines Agency, CLIN DAT PUBL; Food and Drug Administration, 2013, FED REGISTER, V78, P33421; Garrison NA, 2016, GENET MED, V18, P663, DOI 10.1038/gim.2015.138; Gornick MC, 2014, J EMPIR RES HUM RES, V9, P22, DOI 10.1177/1556264614544277; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Grande D, 2013, JAMA INTERN MED, V173, P1798, DOI 10.1001/jamainternmed.2013.9166; Green AK, 2015, ONCOLOGIST, V20, P464, DOI 10.1634/theoncologist.2014-0431; Hapgood R, 2004, 0405 HEDS; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Haug CJ, 2017, NEW ENGL J MED, V376, P2203, DOI 10.1056/NEJMp1704485; Helft PR, 2007, J EMPIR RES HUM RES, V2, P15, DOI 10.1525/jer.2007.2.3.15; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; Johnsson L, 2010, EUR J HUM GENET, V18, P1261, DOI 10.1038/ejhg.2010.106; Jumbe NL, 2016, NEW ENGL J MED, V374, P2415, DOI 10.1056/NEJMp1605441; Kaufman DJ, 2009, AM J HUM GENET, V85, P643, DOI 10.1016/j.ajhg.2009.10.002; Krumholz HM, 2016, NEW ENGL J MED, V375, P403, DOI 10.1056/NEJMp1607342; Krumholz HM, 2014, CIRC-CARDIOVASC QUAL, V7, P499, DOI 10.1161/CIRCOUTCOMES.114.001166; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Lemmens T, 2013, J LAW MED ETHICS, V41, P163, DOI 10.1111/jlme.12012; Loder E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4794; Long MD, 2015, INFLAMM BOWEL DIS, V21, P132, DOI 10.1097/MIB.0000000000000263; Luchenski SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2701; Majumder MA, 2017, GENET MED, V19, P1289, DOI 10.1038/gim.2017.59; Melas PA, 2010, J MED ETHICS, V36, P93, DOI 10.1136/jme.2009.032367; Mello MM, 2013, NEW ENGL J MED, V369, P1651, DOI 10.1056/NEJMhle1309073; Oliver JM, 2012, PUBLIC HEALTH GENOM, V15, P106, DOI 10.1159/000334718; Pentz RD, 2006, AM J MED GENET A, V140A, P733, DOI 10.1002/ajmg.a.31154; PhRMA, 2014, PRINC RESP CLIN TRIA; Rathi V, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7570; Rockhold F, 2016, NEW ENGL J MED, V375, P1115, DOI 10.1056/NEJMp1608086; Rogith D, 2014, J AM MED INFORM ASSN, V21, pE320, DOI 10.1136/amiajnl-2013-002579; Rosenblatt M, 2015, ANN INTERN MED, V162, P306, DOI 10.7326/M14-1299; Sample I., 2013, GUARDIAN; Sanderson SC, 2017, AM J HUM GENET, V100, P414, DOI 10.1016/j.ajhg.2017.01.021; Shabani M, 2014, EXPERT REV MOL DIAGN, V14, P1053, DOI 10.1586/14737159.2014.961917; Storr CL, 2014, J COMMUN GENET, V5, P363, DOI 10.1007/s12687-014-0191-3; Strom BL, 2016, NEW ENGL J MED, V375, P1608, DOI 10.1056/NEJMp1610336; Stunkel L, 2011, CONTEMP CLIN TRIALS, V32, P342, DOI 10.1016/j.cct.2010.12.003; Taichman DB, 2017, NEW ENGL J MED, V376, P2277, DOI 10.1056/NEJMe1705439; Trinidad SB, 2010, GENET MED, V12, P486, DOI 10.1097/GIM.0b013e3181e38f9e; Truong TH, 2011, CLIN TRIALS, V8, P616, DOI 10.1177/1740774511414444; Truven Health Analytics National Public Radio, 2014, HLTH POLL DAT PRIV; Walport M, 2011, LANCET, V377, P537, DOI 10.1016/S0140-6736(10)62234-9; Warren E, 2016, NEW ENGL J MED, V375, P401, DOI 10.1056/NEJMp1607282; Whitty CJM, 2015, LANCET, V386, P1797, DOI 10.1016/S0140-6736(15)00758-8; Zarin DA, 2013, NEW ENGL J MED, V369, P468, DOI 10.1056/NEJMe1307268	60	96	97	4	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2018	378	23					2202	2211		10.1056/NEJMsa1713258	http://dx.doi.org/10.1056/NEJMsa1713258			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3HS	29874542	Green Accepted			2022-12-28	WOS:000434263000008
J	Richardson, J				Richardson, Jennifer			General practice needs new models: here are some ideas	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jrichardson@bmj.com						Baird B, 2018, INNOVATIVE MODELS GE	1	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2018	361								k2460	10.1136/bmj.k2460	http://dx.doi.org/10.1136/bmj.k2460			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BX	29875092				2022-12-28	WOS:000435073600005
J	Christie, B				Christie, Bryan			Non-medical health professionals get chance to train as GPs in Scotland	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2018	361								k2468	10.1136/bmj.k2468	http://dx.doi.org/10.1136/bmj.k2468			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BQ	29866708				2022-12-28	WOS:000435072800008
J	Elmassry, M				Elmassry, Moamen			What I learned from teaching	SCIENCE			English	Editorial Material								When I started my Ph.D. program, 3 years ago, I was excited to conduct cutting-edge research. But I wasn't so sure about the teaching that I would have to do every semester to fund my education. I saw it as a waste of time and energy that I could otherwise spend in the lab. The stereotype of the teaching assistant (TA) rushing between classes and spending weekends grading while guzzling coffee did not help. I had no experience teaching, and the idea of being in front of a class made me anxious. But if you ask me now, I would say that teaching has been one of the most rewarding parts of my Ph.D. experience.	[Elmassry, Moamen] Texas Tech Univ, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Elmassry, M (corresponding author), Texas Tech Univ, Lubbock, TX 79409 USA.		Elmassry, Moamen M/J-9335-2015	Elmassry, Moamen M/0000-0002-1193-7822					0	0	0	2	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					934	934		10.1126/science.360.6391.934	http://dx.doi.org/10.1126/science.360.6391.934			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG9RW	29798885				2022-12-28	WOS:000433039800053
J	Hartmann, N; Kronenberg, M				Hartmann, Nadine; Kronenberg, Mitchell			Cancer immunity thwarted by the microbiome	SCIENCE			English	Editorial Material							BILE-ACIDS; T-CELLS; TOLERANCE; LIVER		[Hartmann, Nadine; Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA; [Kronenberg, Mitchell] Univ Calif San Diego, Div Biol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA.; Kronenberg, M (corresponding author), Univ Calif San Diego, Div Biol, La Jolla, CA 92037 USA.	mitch@lji.org	Kronenberg, Mitchell/AAT-6078-2021		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI137230] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI137230, R01 AI105215] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; Chandra S, 2015, ADV IMMUNOL, V127, P145, DOI 10.1016/bs.ai.2015.03.003; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; Doherty DG, 2016, J AUTOIMMUN, V66, P60, DOI 10.1016/j.jaut.2015.08.020; Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931; Mehrfeld C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00635; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Shaler CR, 2017, CANCER IMMUNOL IMMUN, V66, P1563, DOI 10.1007/s00262-017-2050-7; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zitvogel L, 2018, SCIENCE, V359, P1366, DOI 10.1126/science.aar6918	14	11	16	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					858	859		10.1126/science.aat8289	http://dx.doi.org/10.1126/science.aat8289			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG9RW	29798871				2022-12-28	WOS:000433039800029
J	Banerjee, M; Heiblum, M; Umansky, V; Feldman, DE; Oreg, Y; Stern, A				Banerjee, Mitali; Heiblum, Moty; Umansky, Vladimir; Feldman, Dima E.; Oreg, Yuval; Stern, Ady			Observation of half-integer thermal Hall conductance	NATURE			English	Article							QUANTUM HALL; STATES	Topological states of matter are characterized by topological invariants, which are physical quantities whose values are quantized and do not depend on the details of the system (such as its shape, size and impurities). Of these quantities, the easiest to probe is the electrical Hall conductance, and fractional values (in units of e(2)/h, where e is the electronic charge and h is the Planck constant) of this quantity attest to topologically ordered states, which carry quasiparticles with fractional charge and anyonic statistics. Another topological invariant is the thermal Hall conductance, which is harder to measure. For the quantized thermal Hall conductance, a fractional value in units of kappa(0) (kappa(0) = pi(2)kB(2)/(3h), where k(B) is the Boltzmann constant) proves that the state of matter is non-Abelian. Such non-Abelian states lead to ground-state degeneracy and perform topological unitary transformations when braided, which can be useful for topological quantum computation. Here we report measurements of the thermal Hall conductance of several quantum Hall states in the first excited Landau level and find that the thermal Hall conductance of the 5/2 state is compatible with a half-integer value of 2.5 kappa(0), demonstrating its non-Abelian nature.	[Banerjee, Mitali; Heiblum, Moty; Umansky, Vladimir; Oreg, Yuval; Stern, Ady] Weizmann Inst Sci, Dept Condensed Matter Phys, Braun Ctr Submicron Phys, Rehovot, Israel; [Feldman, Dima E.] Brown Univ, Dept Phys, Providence, RI 02912 USA	Weizmann Institute of Science; Brown University	Heiblum, M (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, Braun Ctr Submicron Phys, Rehovot, Israel.	moty.heiblum@weizmann.ac.il	heiblum, moty/Q-1193-2019; Umansky, Vladimir/P-1334-2019; Banerjee, Mitali/AAX-7506-2021	Umansky, Vladimir/0000-0001-5727-2064; 	European Research Council under the European Community's Seventh Framework Program (FP7)/ERC [339070]; Minerva foundation [711752]; Israeli Science Foundation ISF [459/16]; German Israeli Foundation (GIF) [I-1241-303.10/2014]; European Research Council under the European Union's Seventh Framework Program (FP7)/ERC Project MUNATOP; DFG [CRC/Transregi 183, EI 519/7-1]; Israel Science Foundation; National Science Foundation [DMR-1607451]	European Research Council under the European Community's Seventh Framework Program (FP7)/ERC(European Research Council (ERC)); Minerva foundation; Israeli Science Foundation ISF(Israel Science Foundation); German Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); European Research Council under the European Union's Seventh Framework Program (FP7)/ERC Project MUNATOP; DFG(German Research Foundation (DFG)); Israel Science Foundation(Israel Science Foundation); National Science Foundation(National Science Foundation (NSF))	We acknowledge B. Halperin and S. Simon for discussions. M.B. acknowledges the help and advice of Y. Gross regarding fabrication processes and R. Bhattacharyya for help with the cold amplifiers and Y. C. Chung and H.K. Choi for their help with the dilution refrigerator. M.H. acknowledges the continuous support of the Sub-Micron Center staff, and in particular Y. Rotblat, without whom this work would not be possible. M.H. acknowledges the support of the European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC under grant agreement number 339070, the partial support of the Minerva foundation under grant number 711752, the Israeli Science Foundation ISF under grant number 459/16 and, together with V.U., the German Israeli Foundation (GIF) under grant number I-1241-303.10/2014. A.S and Y.O. acknowledge support from the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC Project MUNATOP, the DFG (CRC/Transregi 183, EI 519/7-1) and the Israel Science Foundation. Y.O. acknowledges the Binational Science Foundation (BSF). D.E.F.'s research was supported in part by the National Science Foundation under grant number DMR-1607451.	Banerjee M, 2017, NATURE, V545, P75, DOI 10.1038/nature22052; Bid A, 2010, NATURE, V466, P585, DOI 10.1038/nature09277; Bonderson P, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.125323; Dahlem F, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.121305; Son DT, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031027; Dolev M, 2008, NATURE, V452, P829, DOI [10.1038/nature06855, 10.1038/natureO6855]; Dolev M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.036805; Dolev M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161303; Fidkowski L, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041016; GELFAND BY, 1994, PHYS REV B, V49, P1862, DOI 10.1103/PhysRevB.49.1862; GREITER M, 1991, PHYS REV LETT, V66, P3205, DOI 10.1103/PhysRevLett.66.3205; HALPERIN BI, 1983, HELV PHYS ACTA, V56, P75; Jain JK, 2007, COMPOSITE FERMIONS, P1; Jezouin S, 2013, SCIENCE, V342, P601, DOI 10.1126/science.1241912; Kane CL, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.031009; Kane CL, 1997, PHYS REV B, V55, P15832, DOI 10.1103/PhysRevB.55.15832; Lee SS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236807; Levin M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236806; Lian BA, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.165124; Meschke M, 2006, NATURE, V444, P187, DOI 10.1038/nature05276; MOONEY PM, 1990, J APPL PHYS, V67, pR1, DOI 10.1063/1.345628; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; Morf RH, 1998, PHYS REV LETT, V80, P1505, DOI 10.1103/PhysRevLett.80.1505; Mross D. F., 2017, THEORY DISORDER INDU; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; Read N, 1999, PHYS REV B, V59, P8084, DOI 10.1103/PhysRevB.59.8084; Rezayi EH, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.026801; Rossler C, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043007; Samani M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.121405; Schwab K, 2000, NATURE, V404, P974, DOI 10.1038/35010065; Slobodeniuk AO, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.165307; Steven S. H., 2018, PHYS REV B, V97; Storni M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.076803; Umansky V, 2013, MOLECULAR BEAM EPITAXY: FROM RESEARCH TO MASS PRODUCTION, P121, DOI 10.1016/B978-0-12-387839-7.00006-3; Wang C., 2017, TOPOLOGICAL ORDER DI; WELLSTOOD FC, 1994, PHYS REV B, V49, P5942, DOI 10.1103/PhysRevB.49.5942; Wen X.G., 2004, QUANTUM FIELD THEORY; WEN XG, 1991, PHYS REV LETT, V66, P802, DOI 10.1103/PhysRevLett.66.802; WILLETT R, 1987, PHYS REV LETT, V59, P1776, DOI 10.1103/PhysRevLett.59.1776; Willett RL, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/7/076501; Yang G, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.161306; Yang G, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.085317; Zucker PT, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.096802	46	187	187	7	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2018	559	7713					205	+		10.1038/s41586-018-0184-1	http://dx.doi.org/10.1038/s41586-018-0184-1			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM6BL	29867160	Green Submitted			2022-12-28	WOS:000438240900046
J	Ram, N; Guerrini, CJ; McGuire, AL				Ram, Natalie; Guerrini, Christi J.; McGuire, Amy L.			Genealogy databases and the future of criminal investigation	SCIENCE			English	Editorial Material									[Ram, Natalie] Univ Baltimore, Sch Law, Baltimore, MD 21201 USA; [Guerrini, Christi J.; McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA	University System of Maryland; University of Baltimore; Baylor College of Medicine	Ram, N (corresponding author), Univ Baltimore, Sch Law, Baltimore, MD 21201 USA.	nram@ubalt.edu; amcguire@bcm.edu	Guerrini, Christi/HGF-0227-2022	Ram, Natalie/0000-0002-6681-5400	National Institutes of Health, National Human Genome Research Institute [K01HG009355, R01HG008918]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG009355, R01HG008918] Funding Source: NIH RePORTER	National Institutes of Health, National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding was provided by the National Institutes of Health, National Human Genome Research Institute (K01HG009355 and R01HG008918). We thank M. Majumder, D. Peterson, S. Pereira, R. Hsu, A. Gutierrez, and J. Robinson for contributions and assistance on this project.	Cassidy M., 2016, ARIZONA REPUBLIC; Hsu J., 2011, I S J LAW POLICY INF, V6, P557; Ram N, 2011, STANFORD LAW REV, V63, P751	3	55	55	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1078	1079		10.1126/science.aau1083	http://dx.doi.org/10.1126/science.aau1083			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI6TJ	29880677	Green Accepted			2022-12-28	WOS:000434635500032
J	Du, XR; Wen, J; Wang, YY; Karmaus, PWF; Khatamian, A; Tan, HY; Li, YX; Guy, C; Nguyen, TLM; Dhungana, Y; Neale, G; Peng, JM; Yu, JY; Chi, HB				Du, Xingrong; Wen, Jing; Wang, Yanyan; Karmaus, Peer W. F.; Khatamian, Alireza; Tan, Haiyan; Li, Yuxin; Guy, Cliff; Nguyen, Thanh-Long M.; Dhungana, Yogesh; Neale, Geoffrey; Peng, Junmin; Yu, Jiyang; Chi, Hongbo			Hippo/Mst signalling couples metabolic state and immune function of CD8 alpha(+) dendritic cells	NATURE			English	Article							SET ENRICHMENT ANALYSIS; IN-VIVO; MITOCHONDRIAL DYNAMICS; T-CELLS; B-CELLS; PATHWAY; CD8(+); RECONSTRUCTION; INFLAMMATION; CHECKPOINT	Dendritic cells orchestrate the crosstalk between innate and adaptive immunity. CD8 alpha(+) dendritic cells present antigens to CD8(+) T cells and elicit cytotoxic T cell responses to viruses, bacteria and tumours(1). Although lineage-specific transcriptional regulators of CD8 alpha(+) dendritic cell development have been identified(2), the molecular pathways that selectively orchestrate CD8 alpha(+) dendritic cell function remain elusive. Moreover, metabolic reprogramming is important for dendritic cell development and activation(3,4), but metabolic dependence and regulation of dendritic cell subsets are largely uncharacterized. Here we use a data-driven systems biology algorithm (NetBID) to identify a role of the Hippo pathway kinases Mst1 and Mst2 (Mst1/2) in selectively programming CD8 alpha(+) dendritic cell function and metabolism. Our NetBID analysis reveals a marked enrichment of the activities of Hippo pathway kinases in CD8 alpha(+) dendritic cells relative to CD8 alpha-dendritic cells. Dendritic cell-specific deletion of Mst1/2-but not Lats1 and Lats2 (Lats1/2) or Yap and Taz (Yap/Taz), which mediate canonical Hippo signalling-disrupts homeostasis and function of CD8(+) T cells and anti-tumour immunity. Mst1/2-deficient CD8 alpha(+) dendritic cells are impaired in presentation of extracellular proteins and cognate peptides to prime CD8(+) T cells, while CD8 alpha(+)-dendritic cells that lack Mst1/2 have largely normal function. Mechanistically, compared to CD8 alpha-adendritic cells, CD8a+ dendritic cells exhibit much stronger oxidative metabolism and critically depend on Mst1/2 signalling to maintain bioenergetic activities and mitochondrial dynamics for their functional capacities. Further, selective expression of IL-12 by CD8 alpha(+) dendritic cells depends on Mst1/2 and the crosstalk with non-canonical NF-kappa B signalling. Our findings identify Mst1/2 as selective drivers of CD8 alpha(+) dendritic cell function by integrating metabolic activity and cytokine signalling, and highlight that the interplay between immune signalling and metabolic reprogramming underlies the unique functions of dendritic cell subsets.	[Du, Xingrong; Wen, Jing; Wang, Yanyan; Karmaus, Peer W. F.; Guy, Cliff; Nguyen, Thanh-Long M.; Dhungana, Yogesh; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Khatamian, Alireza; Yu, Jiyang] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Tan, Haiyan; Li, Yuxin; Peng, Junmin] St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Tan, Haiyan; Li, Yuxin; Peng, Junmin] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Tan, Haiyan; Li, Yuxin; Peng, Junmin] St Jude Childrens Res Hosp, St Jude Prote Facil, 332 N Lauderdale St, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Yu, JY (corresponding author), St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jiyang.yu@stjude.org; hongbo.chi@stjude.org	li, yu/HGL-9518-2022; Chi, Hongbo/M-9397-2018; Yu, Jiyang/N-8113-2018; Du, Xinrong/GWU-9803-2022; li, Yu/HCI-9086-2022; Peng, Junmin/N-2614-2018; Li, yuxin/GSD-1668-2022; Li, yu/HHZ-5236-2022	Chi, Hongbo/0000-0002-9997-2496; Yu, Jiyang/0000-0003-3629-4330; Peng, Junmin/0000-0003-0472-7648; Du, Xingrong/0000-0001-6427-9600; Dhungana, Yogesh/0000-0002-4021-0075	NIH [AI105887, AI101407, CA176624, CA221290, NS064599, AG047928]; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA176624, R01CA221290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105887, R37AI105887, R01AI101407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047928] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors acknowledge N. Chapman for critical reading of the manuscript, R. Johnson for Stk4 and Stk3 floxed mice, E. Olson for Yap1 and Taz floxed mice, S.C. Sun for the NIK(Delta 78-84) construct, M. Hendren and A. KC for animal work, SJCRH Electron Microscopy core resource for electron microscopy, and Immunology FACS core facility for cell sorting. This work was supported by NIH AI105887, AI101407, CA176624, CA221290, NS064599 (to H.C.), and AG047928 (to J.P.).	Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; [Anonymous], 2013, TEXTS STAT SCI SERIE; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Fan FQ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2304; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Irizarry RA, 2009, STAT METHODS MED RES, V18, P565, DOI 10.1177/0962280209351908; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Katakam AK, 2015, P NATL ACAD SCI USA, V112, P14664, DOI 10.1073/pnas.1520627112; Kretzer NM, 2016, J EXP MED, V213, P2871, DOI 10.1084/jem.20160597; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Liedmann S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6645; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Putcha P, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0658-0; Riley JW, 1949, AM SOCIOL REV, V14, P557, DOI 10.2307/2087216; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez-Barrueco R, 2015, GENE DEV, V29, P1631, DOI 10.1101/gad.262642.115; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Valenzuela J, 2002, J IMMUNOL, V169, P6842, DOI 10.4049/jimmunol.169.12.6842; Wang DL, 2012, ANGEW CHEM INT EDIT, V51, P9302, DOI 10.1002/anie.201204589; Wang H, 2015, J PROTEOME RES, V14, P829, DOI 10.1021/pr500882h; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang YY, 2013, P NATL ACAD SCI USA, V110, pE4894, DOI 10.1073/pnas.1308905110; Wang YY, 2012, P NATL ACAD SCI USA, V109, pE343, DOI 10.1073/pnas.1115635109; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	47	96	102	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					141	+		10.1038/s41586-018-0177-0	http://dx.doi.org/10.1038/s41586-018-0177-0			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29849151	Green Accepted			2022-12-28	WOS:000434273300053
J	Richardson, J				Richardson, Jennifer			King's Fund warns that access must not trump other essential attributes of general practice	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Baird B, 2018, INNOVATIVE MODELS GE; Iacobucci G, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k955; Rimmer A, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1045	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2018	361								k2490	10.1136/bmj.k2490	http://dx.doi.org/10.1136/bmj.k2490			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BX	29875182				2022-12-28	WOS:000435073600007
J	Suzuki, IK; Gacquer, D; Van Heurck, R; Kumar, D; Wojno, M; Bilheu, A; Herpoel, A; Lambert, N; Cheron, J; Polleux, F; Detours, V; Vanderhaeghen, P				Suzuki, Ikuo K.; Gacquer, David; Van Heurck, Roxane; Kumar, Devesh; Wojno, Marta; Bilheu, Angeline; Herpoel, Adele; Lambert, Nelle; Cheron, Julian; Polleux, Franck; Detours, Vincent; Vanderhaeghen, Pierre			Human-Specific NOTCH2NL Genes Expand Cortical Neurogenesis through Delta/Notch Regulation	CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN BRAIN EVOLUTION; COPY NUMBER VARIATION; RADIAL GLIA; SEGMENTAL DUPLICATIONS; PYRAMIDAL NEURONS; PROGENITOR CELLS; MOUSE NEOCORTEX; CEREBRAL-CORTEX; NERVOUS-SYSTEM	The cerebral cortex underwent rapid expansion and increased complexity during recent hominid evolution. Gene duplications constitute a major evolutionary force, but their impact on human brain development remains unclear. Using tailored RNA sequencing (RNA-seq), we profiled the spatial and temporal expression of hominid-specific duplicated (HS) genes in the human fetal cortex and identified a repertoire of 35 HS genes displaying robust and dynamic patterns during cortical neurogenesis. Among them NOTCH2NL, human-specific paralogs of the NOTCH2 receptor, stood out for their ability to promote cortical progenitor maintenance. NOTCH2NL promote the clonal expansion of human cortical progenitors, ultimately leading to higher neuronal output. At the molecular level, NOTCH2NL function by activating the Notch pathway through inhibition ofcisDelta/Notch interactions. Our study uncovers a large repertoire of recently evolved genes active during human corticogenesis and reveals how human-specific NOTCH paralogs may have contributed to the expansion of the human cortex.	[Suzuki, Ikuo K.; Gacquer, David; Van Heurck, Roxane; Kumar, Devesh; Wojno, Marta; Bilheu, Angeline; Herpoel, Adele; Lambert, Nelle; Cheron, Julian; Detours, Vincent; Vanderhaeghen, Pierre] ULB, Inst Interdisciplinary Res IRIBHM, B-1070 Brussels, Belgium; [Suzuki, Ikuo K.; Van Heurck, Roxane; Kumar, Devesh; Wojno, Marta; Bilheu, Angeline; Herpoel, Adele; Lambert, Nelle; Cheron, Julian; Vanderhaeghen, Pierre] ULB, Neurosci Inst UNI, B-1070 Brussels, Belgium; [Suzuki, Ikuo K.; Kumar, Devesh; Wojno, Marta; Vanderhaeghen, Pierre] VIB KULeuven Ctr Brain & Dis Res, B-3000 Leuven, Belgium; [Suzuki, Ikuo K.; Kumar, Devesh; Wojno, Marta; Vanderhaeghen, Pierre] Katholieke Univ Leuven, Dept Neurosci, Leuven Brain Inst, B-3000 Leuven, Belgium; [Polleux, Franck] Columbia Univ, Dept Neurosci, Med Ctr, New York, NY 10027 USA; [Vanderhaeghen, Pierre] ULB, WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); KU Leuven; Columbia University; Universite Libre de Bruxelles; WELBIO	Vanderhaeghen, P (corresponding author), ULB, Inst Interdisciplinary Res IRIBHM, B-1070 Brussels, Belgium.; Vanderhaeghen, P (corresponding author), ULB, Neurosci Inst UNI, B-1070 Brussels, Belgium.; Vanderhaeghen, P (corresponding author), VIB KULeuven Ctr Brain & Dis Res, B-3000 Leuven, Belgium.; Vanderhaeghen, P (corresponding author), Katholieke Univ Leuven, Dept Neurosci, Leuven Brain Inst, B-3000 Leuven, Belgium.; Vanderhaeghen, P (corresponding author), ULB, WELBIO, B-1070 Brussels, Belgium.	pierre.vanderhaeghen@kuleuven.vib.be	Suzuki, Ikuo/N-7399-2018	Suzuki, Ikuo/0000-0003-2896-0292; Polleux, Franck/0000-0003-4313-0481; , Marta/0000-0003-2711-1264; Vanderhaeghen, Pierre/0000-0001-7899-5720	Belgian FRS/FNRS; European Research Council (ERC Adv Grant GENDEVOCORTEX); FMRE; Interuniversity Attraction Poles Program (IUAP); WELBIO Program of the Walloon Region; AXA Research Fund; Foundation ULB; ERA-net "Microkin"; Vlaams Instituut voor Biotechnologie (VIB); EMBO Fellowships; L'Oreal-Unesco for Women in Sciences fellowship	Belgian FRS/FNRS(Fonds de la Recherche Scientifique - FNRS); European Research Council (ERC Adv Grant GENDEVOCORTEX)(European Research Council (ERC)); FMRE; Interuniversity Attraction Poles Program (IUAP)(Belgian Federal Science Policy Office); WELBIO Program of the Walloon Region(WELBIO); AXA Research Fund(AXA Research Fund); Foundation ULB; ERA-net "Microkin"; Vlaams Instituut voor Biotechnologie (VIB); EMBO Fellowships; L'Oreal-Unesco for Women in Sciences fellowship(L'Oreal Group)	We thank Philippe Thibaudeau for initiation of this project, members of the lab and IRIBHM for helpful feedback, and Jean-Marie Vanderwinden of the Light Microscopy Facility (LiMiF) for support with imaging. We thank Dr. Lambot and the clinics of obstetrics and gynecology of Erasme hospital for help with collection of fetal material. We thank Drs. Evan Eichler and Mirko Schmidt for insightful advice and Drs. Michael Elowitz, Yukiko Gotoh, and Franz Van Roy for providing crucial reagents. This work was funded by the Belgian FRS/FNRS, the European Research Council (ERC Adv Grant GENDEVOCORTEX), the FMRE, the Interuniversity Attraction Poles Program (IUAP), the WELBIO Program of the Walloon Region, the AXA Research Fund, the Foundation ULB, the ERA-net "Microkin," and the Vlaams Instituut voor Biotechnologie (VIB) (to P.V.). I.K.S. and D.K. were supported by EMBO Fellowships. I.K.S. was a postdoctoral Fellow of the FNRS, R.V.H. is an Aspirant of the FNRS and supported by a L'Oreal-Unesco for Women in Sciences fellowship, and M.W. is a PhD Fellow of the FRIA.	Amadio JP, 2006, CELL, V126, P1033, DOI 10.1016/j.cell.2006.09.007; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Boyd JL, 2015, CURR BIOL, V25, P772, DOI 10.1016/j.cub.2015.01.041; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Coe BP, 2012, AM J MED GENET C, V160C, P118, DOI 10.1002/ajmg.c.31327; Dang L, 2006, DEV NEUROSCI-BASEL, V28, P58, DOI 10.1159/000090753; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Dennis MY, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0069; Dennis MY, 2016, CURR OPIN GENET DEV, V41, P44, DOI 10.1016/j.gde.2016.08.001; Dimidschstein J, 2013, NEURON, V79, P1123, DOI 10.1016/j.neuron.2013.07.015; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duan ZJ, 2004, MOL CELL BIOL, V24, P58, DOI 10.1128/MCB.24.1.58-70.2004; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2016, CURR BIOL, V26, pR1109, DOI 10.1016/j.cub.2016.09.030; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fiddes IT, 2018, CELL, V173, P1356, DOI 10.1016/j.cell.2018.03.051; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Goidts V, 2006, HUM GENET, V120, P270, DOI 10.1007/s00439-006-0217-y; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Ju XC, 2016, ELIFE, V5, DOI 10.7554/eLife.18197; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Kawaguchi D, 2008, DEVELOPMENT, V135, P3849, DOI 10.1242/dev.024570; Klein T, 1997, DEV BIOL, V189, P123, DOI 10.1006/dbio.1997.8564; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lambert N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017753; Lambot MA, 2005, J NEUROSCI, V25, P7232, DOI 10.1523/JNEUROSCI.0802-05.2005; LeBon L, 2014, ELIFE, V3, DOI 10.7554/eLife.02950; Lui JH, 2014, NATURE, V515, P264, DOI 10.1038/nature13973; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mefford HC, 2009, CURR OPIN GENET DEV, V19, P196, DOI 10.1016/j.gde.2009.04.003; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; Mora-Bermudez F, 2016, ELIFE, V5, DOI 10.7554/eLife.18683; Nelson BR, 2013, J NEUROSCI, V33, P9122, DOI 10.1523/JNEUROSCI.0791-13.2013; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Nord AS, 2015, NEURON, V85, P27, DOI 10.1016/j.neuron.2014.11.011; Nuttle X, 2016, NATURE, V536, P205, DOI 10.1038/nature19075; O'Bleness M, 2012, NAT REV GENET, V13, P853, DOI 10.1038/nrg3336; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rani N, 2016, NEURON, V90, P1174, DOI 10.1016/j.neuron.2016.05.005; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Reilly SK, 2015, SCIENCE, V347, P1155, DOI 10.1126/science.1260943; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Sousa AMM, 2017, CELL, V170, P226, DOI 10.1016/j.cell.2017.06.036; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Suzuki IK, 2015, DEVELOPMENT, V142, P3138, DOI 10.1242/dev.120568; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tiberi L, 2012, NAT NEUROSCI, V15, P1627, DOI 10.1038/nn.3264; Tiberi L, 2012, CURR OPIN CELL BIOL, V24, P269, DOI 10.1016/j.ceb.2012.01.010; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Valdes- Dapena M. A., 1983, PERINATAL AUTOPSY MA; Varki A, 2008, NAT REV GENET, V9, P749, DOI 10.1038/nrg2428; Wang L, 2016, NAT NEUROSCI, V19, P888, DOI 10.1038/nn.4307; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Zhang YE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001179	83	171	175	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1370	+		10.1016/j.cell.2018.03.067	http://dx.doi.org/10.1016/j.cell.2018.03.067			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856955	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000433989100011
J	Tumino, A; Spitaleri, C; La Cognata, M; Cherubini, S; Guardo, GL; Gulino, M; Hayakawa, S; Indelicato, I; Lamia, L; Petrascu, H; Pizzone, RG; Puglia, SMR; Rapisarda, GG; Romano, S; Sergi, ML; Sparta, R; Trache, L				Tumino, A.; Spitaleri, C.; La Cognata, M.; Cherubini, S.; Guardo, G. L.; Gulino, M.; Hayakawa, S.; Indelicato, I.; Lamia, L.; Petrascu, H.; Pizzone, R. G.; Puglia, S. M. R.; Rapisarda, G. G.; Romano, S.; Sergi, M. L.; Sparta, R.; Trache, L.			An increase in the C-12+C-12 fusion rate from resonances at astrophysical energies	NATURE			English	Article							CROSS-SECTIONS; SCATTERING; MG-24; SUPERBURST; STATES	Carbon burning powers scenarios that influence the fate of stars, such as the late evolutionary stages of massive stars(1) (exceeding eight solar masses) and superbursts from accreting neutron stars(2,3). It proceeds through the C-12 + C-12 fusion reactions that produce an alpha particle and neon-20 or a proton and sodium-23-that is, C-12(C-12, a) Ne-20 and C-12(C-12, p) Na-23-at temperatures greater than 0.4 x 10(9) kelvin, corresponding to astrophysical energies exceeding a megaelectronvolt, at which such nuclear reactions are more likely to occur in stars. The cross-sections(4) for those carbon fusion reactions (probabilities that are required to calculate the rate of the reactions) have hitherto not been measured at the Gamow peaks(4) below 2 megaelectronvolts because of exponential suppression arising from the Coulomb barrier. The reference rate(5) at temperatures below 1.2 x 10(9) kelvin relies on extrapolations that ignore the effects of possible low-lying resonances. Here we report the measurement of the C-12(C-12, a(0,1)) Ne-20 and C-12(C-12, p(0,1)) Na-23 reaction rates (where the subscripts 0 and 1 stand for the ground and first excited states of Ne-20 and Na-23, respectively) at centre-of-mass energies from (2.7) to 0.8 megaelectronvolts using the Trojan Horse method(6,7) and the deuteron in N-14. The cross-sections deduced exhibit several resonances that are responsible for very large increases of the reaction rate at relevant temperatures. In particular, around 5 x 10(8) kelvin, the reaction rate is boosted to more than 25 times larger than the reference value(5). This finding may have implications such as lowering the temperatures and densities(8) required for the ignition of carbon burning in massive stars and decreasing the superburst ignition depth in accreting neutron stars to reconcile observations with theoretical models(3).	[Tumino, A.; Gulino, M.] Univ Enna Kore, Fac Ingn & Architettura, Enna, Italy; [Tumino, A.; Spitaleri, C.; La Cognata, M.; Cherubini, S.; Guardo, G. L.; Gulino, M.; Hayakawa, S.; Indelicato, I.; Lamia, L.; Pizzone, R. G.; Puglia, S. M. R.; Rapisarda, G. G.; Romano, S.; Sergi, M. L.; Sparta, R.] Ist Nazl Fis Nucl, Lab Nazl Sud, Catania, Italy; [Spitaleri, C.; Cherubini, S.; Lamia, L.; Romano, S.] Univ Catania, Dipartimento Fis & Astron, Catania, Italy; [Guardo, G. L.; Petrascu, H.; Trache, L.] Horia Hulubei Natl Inst R&D Phys & Nucl Engn, Bucharest, Romania; [Hayakawa, S.] Univ Tokyo, Ctr Nucl Studies, Tokyo, Japan	Universita Kore di ENNA; Istituto Nazionale di Fisica Nucleare (INFN); University of Catania; Horia Hulubei National Institute of Physics & Nuclear Engineering; University of Tokyo	Tumino, A (corresponding author), Univ Enna Kore, Fac Ingn & Architettura, Enna, Italy.; Tumino, A (corresponding author), Ist Nazl Fis Nucl, Lab Nazl Sud, Catania, Italy.	tumino@lns.infn.it	Sergi, Maria Letizia/K-2321-2015; Petrascu, Horia M/Q-6470-2017; LAMIA, LIVIO/N-7937-2019; Guardo, Giovanni Luca/ABA-3851-2021; Trache, Livius/M-6265-2016; Pizzone, Rosario G./I-4527-2015; Gulino, Marisa/AAC-4620-2021; La Cognata, Marco/B-9641-2013; LAMIA, LIVIO/J-9381-2015; Spitaleri, Claudio/K-3215-2015	Sergi, Maria Letizia/0000-0002-6631-0015; Petrascu, Horia M/0000-0001-5453-5228; LAMIA, LIVIO/0000-0002-4055-0811; Trache, Livius/0000-0002-5074-7431; Pizzone, Rosario G./0000-0003-2436-6640; La Cognata, Marco/0000-0002-1819-4814; LAMIA, LIVIO/0000-0002-4055-0811; Spitaleri, Claudio/0000-0001-6256-9727; Sparta', Roberta/0000-0002-9986-1518; Romano, Stefano/0000-0001-6271-2992				ABEGG R, 1991, PHYS REV C, V43, P2523, DOI 10.1103/PhysRevC.43.2523; Aguilera EF, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.064601; Barron-Palos L, 2006, NUCL PHYS A, V779, P318, DOI 10.1016/j.nuclphysa.2006.09.004; BECKER HW, 1981, Z PHYS A-HADRON NUCL, V303, P305, DOI 10.1007/BF01421528; Belyaeva TL, 2002, PHYS ATOM NUCL+, V65, P1616, DOI 10.1134/1.1508693; BERTRAND FE, 1978, PHYS REV LETT, V40, P635, DOI 10.1103/PhysRevLett.40.635; BLATT JM, 1952, REV MOD PHYS, V24, P258, DOI 10.1103/RevModPhys.24.258; Bravo E, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201117814; Caciolli A, 2008, NUCL INSTRUM METH B, V266, P1392, DOI 10.1016/j.nimb.2007.11.025; CAUGHLAN GR, 1988, ATOM DATA NUCL DATA, V40, P283, DOI 10.1016/0092-640X(88)90009-5; Cooper RL, 2009, ASTROPHYS J, V702, P660, DOI 10.1088/0004-637X/702/1/660; HIGH MD, 1977, NUCL PHYS A, V282, P181, DOI 10.1016/0375-9474(77)90179-8; Iliadis C., 2007, NUCL PHYS STARS; ITOH K, 1981, PHYS REV C, V23, P945, DOI 10.1103/PhysRevC.23.945; Jiang CL, 2018, PHYS REV C, V97, DOI 10.1103/PhysRevC.97.012801; Jiang CL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.072701; Keek L, 2008, ASTRON ASTROPHYS, V479, P177, DOI 10.1051/0004-6361:20078464; KETTNER KU, 1980, Z PHYS A-HADRON NUCL, V298, P65, DOI 10.1007/BF01416030; La Cognata M, 2017, ASTROPHYS J, V846, DOI 10.3847/1538-4357/aa845f; La Cognata M, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/2/143; La Cognata M, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L54; La Cognata M, 2010, ASTROPHYS J, V723, P1512, DOI 10.1088/0004-637X/723/2/1512; Lamia L, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/65; LANE AM, 1958, REV MOD PHYS, V30, P257, DOI 10.1103/RevModPhys.30.257; MAZARAKIS MG, 1973, PHYS REV C, V7, P1280, DOI 10.1103/PhysRevC.7.1280; Mukhamedzhanov AM, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.044616; Mukhamedzhanov AM, 2008, J PHYS G NUCL PARTIC, V35, DOI 10.1088/0954-3899/35/1/014016; PATTERSON JR, 1969, ASTROPHYS J, V157, P367, DOI 10.1086/150073; Pignatari M, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/31; Pizzone RG, 2017, ASTROPHYS J, V836, DOI 10.3847/1538-4357/836/1/57; Schatz H, 2014, NATURE, V505, P62, DOI 10.1038/nature12757; Spillane T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.122501; Spitaleri C, 1999, PHYS REV C, V60, DOI 10.1103/PhysRevC.60.055802; Spitaleri C, 2017, PHYS REV C, V95, DOI 10.1103/PhysRevC.95.035801; Spitaleri C, 2011, PHYS ATOM NUCL+, V74, P1725, DOI 10.1134/S1063778811110184; Straniero O, 2016, J PHYS CONF SER, V665, DOI 10.1088/1742-6596/665/1/012008; Strieder F, 2001, NATURWISSENSCHAFTEN, V88, P461, DOI 10.1007/s001140100267; Tribble RE, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/10/106901; Truran J. W., 1987, ADVANCES IN NUCLEAR, V525; Tumino A, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/96; VANHOY JR, 1987, PHYS REV C, V36, P920, DOI 10.1103/PhysRevC.36.920; Woosley SE, 2002, REV MOD PHYS, V74, P1015, DOI 10.1103/RevModPhys.74.1015; YANG GC, 1976, PHYS REV C, V13, P1376, DOI 10.1103/PhysRevC.13.1376; Zickefoose J., 2011, THESIS; ZURMUHLE RW, 1994, PHYS REV C, V49, P2549, DOI 10.1103/PhysRevC.49.2549	45	80	82	5	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					687	+		10.1038/s41586-018-0149-4	http://dx.doi.org/10.1038/s41586-018-0149-4			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29795352	Green Submitted			2022-12-28	WOS:000433412900046
J	Gibson, PR; Burgell, RE				Gibson, Peter R.; Burgell, Rebecca E.			Illuminating dark depths	SCIENCE			English	Editorial Material							CAPSULE ENDOSCOPY; ARTICLE		[Gibson, Peter R.] Alfred Hosp, Dept Gastroenterol, Melbourne, Vic 3004, Australia; Monash Univ, Melbourne, Vic 3004, Australia	Florey Institute of Neuroscience & Mental Health; Monash University	Gibson, PR (corresponding author), Alfred Hosp, Dept Gastroenterol, Melbourne, Vic 3004, Australia.	peter.gibson@monash.edu						Bernstein CN, 2017, ALIMENT PHARM THER, V46, P911, DOI 10.1111/apt.14338; Canavan C, 2014, ALIMENT PHARM THER, V40, P1023, DOI 10.1111/apt.12938; Clemente JC, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5145; Farmer AD, 2013, UNITED EUR GASTROENT, V1, P413, DOI 10.1177/2050640613510161; Hale MF, 2014, WORLD J GASTROENTERO, V20, P7752, DOI 10.3748/wjg.v20.i24.7752; Jain A, 2015, BIOTECHNOL J, V10, P447, DOI 10.1002/biot.201400168; Kalantar-Zadeh K, 2016, GASTROENTEROLOGY, V150, P37, DOI 10.1053/j.gastro.2015.07.072; Lanas A, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.20; Mapara SS, 2017, J CONTROL RELEASE, V261, P337, DOI 10.1016/j.jconrel.2017.07.005; Mimee M, 2018, SCIENCE, V360, P915, DOI 10.1126/science.aas9315; Ou BM, 2016, APPL MICROBIOL BIOT, V100, P8693, DOI 10.1007/s00253-016-7829-5; Ou JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33387; Rondonotti E, 2018, ENDOSCOPY, V50, P423, DOI 10.1055/a-0576-0566; Zarate N, 2010, AM J PHYSIOL-GASTR L, V299, pG1276, DOI 10.1152/ajpgi.00127.2010	15	6	6	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					856	857		10.1126/science.aat8658	http://dx.doi.org/10.1126/science.aat8658			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG9RW	29798870				2022-12-28	WOS:000433039800028
J	[Anonymous]				[Anonymous]			The Conscientious Objector (Reprinted from JAMA, vol 122, pg 178-179, 1943)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Hoag D. E., 1920, PSYCHOL CONSCIENTIOU, V111, P187; May MA, 1920, AM J PSYCHOL, V31, P152, DOI 10.2307/1413492; Schulthess Peter, 1934, ARCH NEUROL PSYCHIAT, V33, P95; Stalker H, 1943, J MENT SCI, V89, P52; 1943, JAMA, V122, P178	5	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					2047	2047		10.1001/jama.2017.12380	http://dx.doi.org/10.1001/jama.2017.12380			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800200				2022-12-28	WOS:000432238300032
J	Mehta, T; Allison, DB				Mehta, Tapan; Allison, David B.			How Much Variation in Outcomes Is Too Much in a Center of Excellence for Bariatric Surgery?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MODELS	QUESTION How much variation in surgical outcomes exists among bariatric centers of excellence in the United States? FINDINGS In this analysis of claims data from 145'527 patients who underwerit bariatric procedures, there was a 17-fold variation in rates of serious complications across accredited Pariatric centers nationally and up 9.5-fold variation across individual states. Significant;variation was also seen in low-volume, medium-volume, and high-volume bariatric centers. MEANING Accreditation alone does not ensure taniform high-quality care for bariatric procedures and further quality improvement efforts should be considered.	[Mehta, Tapan] Univ Alabama Birmingham, Sch Hlth Profess, Dept Hlth Serv Adm, Birmingham, AL USA; [Mehta, Tapan] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA; [Allison, David B.] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Indiana University System; Indiana University Bloomington	Mehta, T (corresponding author), Univ Alabama Birmingham, Hlth Serv Adm, 1716 Ninth Ave S,SHP 590D, Birmingham, AL 35294 USA.	tapan@uab.edu			National Institutes of Health [P30DK056336, R25GM116167, R25HL124208]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported in part by grants P30DK056336, R25GM116167, and R25HL124208 from the National Institutes of Health.	American College of Surgeons, 2016, MET BAR SURG ACCR QU; Azagury D, 2016, J AM COLL SURGEONS, V223, P469, DOI 10.1016/j.jamcollsurg.2016.06.014; Bae J, 2015, JAMA SURG, V150, P644, DOI 10.1001/jamasurg.2015.74; Dimick JB, 2013, JAMA-J AM MED ASSOC, V309, P792, DOI 10.1001/jama.2013.755; Ibrahim AM, 2017, JAMA SURG, V152, P629, DOI 10.1001/jamasurg.2017.0542; Keith Scott W, 2014, Front Nutr, V2014, P00016; Lin XH, 1997, BIOMETRIKA, V84, P309, DOI 10.1093/biomet/84.2.309; Livingston EH, 2010, ARCH SURG-CHICAGO, V145, P993, DOI 10.1001/archsurg.2010.218; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545	9	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1932	1933		10.1001/jamasurg.2017.0542	http://dx.doi.org/10.1001/jamasurg.2017.0542			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29801000	Green Published			2022-12-28	WOS:000431668600021
J	Beyaz, S; Mana, MD; Roper, J; Kedrin, D; Saadatpour, A; Hong, SJ; Bauer-Rowe, KE; Xifaras, ME; Akkad, A; Arias, E; Pinello, L; Katz, Y; Shinagare, S; Abu-Remaileh, M; Mihaylova, MM; Lamming, DW; Dogum, R; Guo, GJ; Bell, GW; Selig, M; Nielsen, GP; Gupta, N; Ferrone, CR; Deshpande, V; Yuan, GC; Orkin, SH; Sabatini, DM; Yilmaz, OH				Beyaz, Semir; Mana, Miyeko D.; Roper, Jatin; Kedrin, Dmitriy; Saadatpour, Assieh; Hong, Sue-Jean; Bauer-Rowe, Khristian E.; Xifaras, Michael E.; Akkad, Adam; Arias, Erika; Pinello, Luca; Katz, Yarden; Shinagare, Shweta; Abu-Remaileh, Monther; Mihaylova, Maria M.; Lamming, Dudley W.; Dogum, Rizkullah; Guo, Guoji; Bell, George W.; Selig, Martin; Nielsen, G. Petur; Gupta, Nitin; Ferrone, Cristina R.; Deshpande, Vikram; Yuan, Guo-Cheng; Orkin, Stuart H.; Sabatini, David M.; Yilmaz, Omer H.			High-fat diet enhances stemness and tumorigenicity of intestinal progenitors (vol 531, pg 53, 2016)	NATURE			English	Correction													Mihaylova, Maria M./ACZ-4949-2022	Mihaylova, Maria M./0000-0002-2725-767X				Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173	1	6	6	4	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2018	560	7717					E26	E26		10.1038/s41586-018-0187-y	http://dx.doi.org/10.1038/s41586-018-0187-y			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP7UJ	29849139	Bronze			2022-12-28	WOS:000441115200013
J	MacLeod, KG; Quinton, PC; Sepulveda, J; Negra, MH				MacLeod, K. G.; Quinton, P. C.; Sepulveda, J.; Negra, M. H.			Postimpact earliest Paleogene warming shown by fish debris oxygen isotopes (El Kef, Tunisia)	SCIENCE			English	Article							CRETACEOUS-TERTIARY BOUNDARY; CHICXULUB ASTEROID IMPACT; K-PG BOUNDARY; EVENT; EXTINCTION; PHOSPHATE; WINTER; HYPOTHESIS; WILDFIRES; RECORDS	Greenhouse warming is a predicted consequence of the Chicxulub impact, but supporting data are sparse. This shortcoming compromises understanding of the impact's effects, and it has persisted due to an absence of sections that both contain suitable material for traditional carbonate-or organic-based paleothermometry and are complete and expanded enough to resolve changes on short time scales. We address the problem by analyzing the oxygen isotopic composition of fish debris, phosphatic microfossils that are relatively resistant to diagenetic alteration, from the Global Stratotype Section and Point for the Cretaceous/Paleogene boundary at El Kef, Tunisia. We report an similar to 1 per mil decrease in oxygen isotopic values (similar to 5 degrees C warming) beginning at the boundary and spanning similar to 300 centimeters of section (similar to 100,000 years). The pattern found matches expectations for impact-initiated greenhouse warming.	[MacLeod, K. G.] Univ Missouri, Dept Geol Sci, Columbia, MO 65211 USA; [Quinton, P. C.] SUNY Coll Potsdam, Dept Geol, Potsdam, NY 13676 USA; [Sepulveda, J.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Sepulveda, J.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Negra, M. H.] Univ Tunis El Manar, Fac Sci Tunis, Dept Geol, 2092 Manar 2, Tunis, Tunisia	University of Missouri System; University of Missouri Columbia; State University of New York (SUNY) System; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST)	MacLeod, KG (corresponding author), Univ Missouri, Dept Geol Sci, Columbia, MO 65211 USA.	macleodk@missouri.edu	MacLeod, Kenneth G./C-4042-2017; Negra, Mohamed/ABE-9978-2020; MacLeod, Kenneth/GWU-8940-2022; Sepúlveda, Julio/AAC-9956-2020	MacLeod, Kenneth G./0000-0002-6016-0837; Sepúlveda, Julio/0000-0002-8251-6937; Negra, Mohamed Hedi/0000-0001-9246-1995	NSF-EAR [1323444]; MU Undergraduate Research Fund; MIT MISTI-Spain Program	NSF-EAR(National Science Foundation (NSF)); MU Undergraduate Research Fund; MIT MISTI-Spain Program	NSF-EAR 1323444 (K.G.M.), MU Undergraduate Research Fund (K.G.M.), and the MIT MISTI-Spain Program (J.S.).	Abramovich S, 2002, PALAEOGEOGR PALAEOCL, V178, P145, DOI 10.1016/S0031-0182(01)00394-7; Arenillas I, 2002, GFF, V124, P121, DOI 10.1080/11035890201243121; Bassett D, 2007, PALAIOS, V22, P98, DOI 10.2110/palo.2005.p05-089r; Beerling DJ, 2002, P NATL ACAD SCI USA, V99, P7836, DOI 10.1073/pnas.122573099; Bell MS, 2016, METEORIT PLANET SCI, V51, P619, DOI 10.1111/maps.12613; Galeotti S, 2004, GEOLOGY, V32, P529, DOI 10.1130/G20439.1; Huang CM, 2013, PALAEOGEOGR PALAEOCL, V385, P95, DOI 10.1016/j.palaeo.2013.01.005; KELLER G, 1989, PALAEOGEOGR PALAEOCL, V73, P243, DOI 10.1016/0031-0182(89)90007-2; Kring DA, 2000, GSA TODAY, V10, P1; Kring DA, 2007, PALAEOGEOGR PALAEOCL, V255, P4, DOI 10.1016/j.palaeo.2007.02.037; Lecuyer C, 2013, CHEM GEOL, V347, P217, DOI 10.1016/j.chemgeo.2013.03.008; Molina E, 2006, EPISODES, V29, P263, DOI 10.18814/epiiugs/2006/v29i4/004; Morgan J, 2013, J GEOPHYS RES-BIOGEO, V118, P1508, DOI 10.1002/2013JG002428; Mukhopadhyay S, 2001, SCIENCE, V291, P1952, DOI 10.1126/science.291.5510.1952; Pierazzo E, 1998, J GEOPHYS RES-PLANET, V103, P28607, DOI 10.1029/98JE02496; POPE KO, 1994, EARTH PLANET SC LETT, V128, P719, DOI 10.1016/0012-821X(94)90186-4; Renne PR, 2013, SCIENCE, V339, P684, DOI 10.1126/science.1230492; Robertson DS, 2013, J GEOPHYS RES-BIOGEO, V118, P329, DOI 10.1002/jgrg.20018; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Scotese C.R., 2014, PALEOMAP ATLAS ARCGI, V2; Vellekoop J, 2016, GEOLOGY, V44, P619; Vellekoop J, 2015, PALAEOGEOGR PALAEOCL, V426, P216, DOI 10.1016/j.palaeo.2015.03.021; Vellekoop J, 2014, P NATL ACAD SCI USA, V111, P7537, DOI 10.1073/pnas.1319253111; Wade BS, 2011, EARTH-SCI REV, V104, P111, DOI 10.1016/j.earscirev.2010.09.003; Wenzel B, 2000, GEOCHIM COSMOCHIM AC, V64, P1859, DOI 10.1016/S0016-7037(00)00337-9; WOLBACH WS, 1985, SCIENCE, V230, P167, DOI 10.1126/science.230.4722.167	26	30	31	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2018	360	6396					1467	+		10.1126/science.aap8525	http://dx.doi.org/10.1126/science.aap8525			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9TL	29794216				2022-12-28	WOS:000436598000079
J	Patriarchi, T; Cho, JR; Merten, K; Howe, MW; Marley, A; Xiong, WH; Folk, RW; Broussard, GJ; Liang, RQ; Jang, MJ; Zhong, HN; Dombeck, D; von Zastrow, M; Nimmerjahn, A; Gradinaru, V; Williams, JT; Tian, L				Patriarchi, Tommaso; Cho, Jounhong Ryan; Merten, Katharina; Howe, Mark W.; Marley, Aaron; Xiong, Wei-Hong; Folk, Robert W.; Broussard, Gerard Joey; Liang, Ruqiang; Jang, Min Jee; Zhong, Haining; Dombeck, Daniel; von Zastrow, Mark; Nimmerjahn, Axel; Gradinaru, Viviana; Williams, John T.; Tian, Lin			Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; ADRENERGIC-RECEPTOR; ACTION INITIATION; REWARD; TRANSMISSION; RELEASE; NEUROMODULATION; PREDICTION; CIRCUITS	Neuromodulatory systems exert profound influences on brain function. Understanding how these systems modify the operating mode of target circuits requires spatiotemporally precise measurement of neuromodulator release. We developed dLight1, an intensity-based genetically encoded dopamine indicator, to enable optical recording of dopamine dynamics with high spatiotemporal resolution in behaving mice. We demonstrated the utility of dLight1 by imaging dopamine dynamics simultaneously with pharmacological manipulation, electrophysiological or optogenetic stimulation, and calcium imaging of local neuronal activity. dLight1 enabled chronic tracking of learning-induced changes in millisecond dopamine transients in mouse striatum. Further, we used dLight1 to image spatially distinct, functionally heterogeneous dopamine transients relevant to learning and motor control in mouse cortex. We also validated our sensor design platform for developing norepinephrine, serotonin, melatonin, and opioid neuropeptide indicators.	[Patriarchi, Tommaso; Broussard, Gerard Joey; Liang, Ruqiang; Tian, Lin] Univ Calif Davis, Dept Biochem & Mol Med, 2700 Stockton Blvd, Sacramento, CA 95817 USA; [Cho, Jounhong Ryan; Jang, Min Jee; Gradinaru, Viviana] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Merten, Katharina; Folk, Robert W.; Nimmerjahn, Axel] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Howe, Mark W.; Dombeck, Daniel] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Marley, Aaron; von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94131 USA; [Xiong, Wei-Hong; Zhong, Haining; Williams, John T.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Howe, Mark W.] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA	University of California System; University of California Davis; California Institute of Technology; Salk Institute; Northwestern University; University of California System; University of California San Francisco; Oregon Health & Science University; Boston University	Tian, L (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, 2700 Stockton Blvd, Sacramento, CA 95817 USA.	lintian@ucdavis.edu	Patriarchi, Tommaso/AAK-8653-2020; Jang, Min Jee/AAO-2892-2020	Patriarchi, Tommaso/0000-0001-9351-3734; Broussard, Gerard/0000-0003-1636-2615; Folk, Robert/0000-0002-2434-1913; Dombeck, Daniel/0000-0003-2576-5918	NIH BRAIN Initiative [U01NS090604, U01NS013522, DP2MH107056, DP2NS083038, R01NS085938, P30CA014195]; BRAIN Initiative [U01NS013522, U01NS094247, R01NS104944]; NIH [1R01MH110556, DP2NS087949]; NIH/NIA [R01AG047664]; Heritage Medical Research Institute; Catharina Foundation postdoctoral scholar award; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110556, DP2MH107056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090604, U01NS103522, R01NS104944, R01NS085938, DP2NS087949, DP2NS083038, U01NS094247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004523, R01DA010711] Funding Source: NIH RePORTER	NIH BRAIN Initiative; BRAIN Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Heritage Medical Research Institute; Catharina Foundation postdoctoral scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by NIH BRAIN Initiative U01NS090604 and U01NS013522, DP2MH107056 (L.T.); DP2NS083038, R01NS085938, P30CA014195 (A.N.); BRAIN Initiative U01NS013522 (J.T.W. and M.v.Z.); BRAIN Initiative U01NS094247 and R01NS104944 (H.Z.); NIH 1R01MH110556 (D.D.); and NIH DP2NS087949, NIH/NIA R01AG047664 (V.G.). K.M. is a DFG research fellow and recipient of a Catharina Foundation postdoctoral scholar award. V.G. is a Heritage Principal Investigator supported by the Heritage Medical Research Institute.	Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Courtney NA, 2014, J NEUROSCI, V34, P7645, DOI 10.1523/JNEUROSCI.0166-14.2014; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; da Silva JA, 2018, NATURE, V554, P244, DOI 10.1038/nature25457; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Dudman JT, 2016, CURR OPIN NEUROBIOL, V37, P158, DOI 10.1016/j.conb.2016.02.005; Ford CP, 2010, J NEUROSCI, V30, P6975, DOI 10.1523/JNEUROSCI.1020-10.2010; Ford CP, 2009, J NEUROSCI, V29, P13344, DOI 10.1523/JNEUROSCI.3546-09.2009; Ganesana M, 2017, ANAL CHEM, V89, P314, DOI 10.1021/acs.analchem.6b04278; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Howe MW, 2016, NATURE, V535, P505, DOI 10.1038/nature18942; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jaquins-Gerstl A, 2015, ANALYST, V140, P3696, DOI 10.1039/c4an02065k; Lee D, 2017, NAT METHODS, V14, P495, DOI [10.1038/nmeth.4234, 10.1038/NMETH.4234]; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; Mamaligas AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep37834; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Muller A, 2014, NAT METHODS, V11, P1245, DOI [10.1038/nmeth.3151, 10.1038/NMETH.3151]; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Piatkevich KD, 2018, NAT CHEM BIOL, V14, P352, DOI 10.1038/s41589-018-0004-9; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2016, NAT REV NEUROSCI, V17, P183, DOI 10.1038/nrn.2015.26; STRADER CD, 1988, J BIOL CHEM, V263, P10267; Taha SA, 2005, J NEUROSCI, V25, P1193, DOI 10.1523/JNEUROSCI.3975-04.2005; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yorgason JT, 2017, J NEUROSCI, V37, P2086, DOI 10.1523/JNEUROSCI.3064-16.2017	36	399	405	21	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2018	360	6396					1420	+	eaat4422	10.1126/science.aat4422	http://dx.doi.org/10.1126/science.aat4422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9TL	29853555	Green Accepted			2022-12-28	WOS:000436598000065
J	Degirmenci, B; Valenta, T; Dimitrieva, S; Hausmann, G; Basler, K				Degirmenci, Bahar; Valenta, Tomas; Dimitrieva, Slavica; Hausmann, George; Basler, Konrad			GLI1-expressing mesenchymal cells form the essential Wnt-secreting niche for colon stem cells	NATURE			English	Article							LGR5; INTESTINE; PROGENITORS; HOMEOSTASIS; ABSENCE; MARKER	Wnt-beta-catenin signalling plays a pivotal role in the homeostasis of the intestinal epithelium by promoting stem cell renewal(1,2). In the small intestine, epithelial Paneth cells secrete Wnt ligands and thus adopt the function of the stem cell niche to maintain epithelial homeostasis(3,4). It is unclear which cells comprise the stem cell niche in the colon. Here we show that subepithelial mesenchymal GLI1-expressing cells form this essential niche. Blocking Wnt secretion from GLI1-expressing cells prevents colonic stem cell renewal in mice: the stem cells are lost and, as a consequence, the integrity of the colonic epithelium is corrupted, leading to death. GLI1-expressing cells also play an important role in the maintenance of the small intestine, where they serve as a reserve Wnt source that becomes critical when Wnt secretion from epithelial cells is prevented. Our data suggest a mechanism by which the stem cell niche is adjusted to meet the needs of the intestine via adaptive changes in the number of mesenchymal GLI1-expressing cells.	[Degirmenci, Bahar; Valenta, Tomas; Hausmann, George; Basler, Konrad] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Valenta, Tomas] Inst Mol Genet ASCR, Prague, Czech Republic; [Dimitrieva, Slavica] ETH Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland	University of Zurich; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich	Valenta, T; Basler, K (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.; Valenta, T (corresponding author), Inst Mol Genet ASCR, Prague, Czech Republic.	tomas.valenta@imls.uzh.ch; konrad.basler@imls.uzh.ch		Valenta, Tomas/0000-0002-3043-1835; Basler, Konrad/0000-0003-3534-1529	Swiss National Science Foundation; Swiss Cancer League; University of Zurich Research Priority Program (URPP) 'Translational Cancer Research'; Kanton of Zurich; Czech Science Foundation [18-21466S]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; University of Zurich Research Priority Program (URPP) 'Translational Cancer Research'; Kanton of Zurich; Czech Science Foundation(Grant Agency of the Czech Republic)	We thank O. Sansom for providing us with the Gli1-Cre<SUP>ERT2</SUP> and Pdgfra<SUP>EGFP</SUP> strains and for suggestions; S. Robine for the Villin-Cre<SUP>ERT2</SUP> strain; F. Greten, L. Sommer, M. Aguet and G. Christofori for comments; members of the Basler laboratory, in particular C. Cantu, V.S. Salazar and D. Zimmerli, for discussions; E. Escher, E. Tuncer, L. Zurkirchen and V. Parfejevs for technical help; J. Duarte, C. Ewald and A. Henning for help with cell sorting; and C. Aquino and the Functional Genomics Center Zurich for performing scRNA-seq. This work was supported by the Swiss National Science Foundation, the Swiss Cancer League, the University of Zurich Research Priority Program (URPP) 'Translational Cancer Research' and the Kanton of Zurich. T.V. is supported by Czech Science Foundation grant 18-21466S and is a fellow of the URPP Translational Cancer Research.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Aoki R, 2016, CELL MOL GASTROENTER, V2, P175, DOI 10.1016/j.jcmgh.2015.12.004; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Degirmenci B, 2018, PROG MOL BIOL TRANSL, V153, P1, DOI 10.1016/bs.pmbts.2017.11.011; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fafilek B, 2013, GASTROENTEROLOGY, V144, P381, DOI 10.1053/j.gastro.2012.10.048; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Farin HF, 2016, NATURE, V530, P340, DOI 10.1038/nature16937; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; Koliaraki V., 2016, BIOPROTOC, V6, pe1940; Kramann R, 2016, CELL STEM CELL, V19, P628, DOI 10.1016/j.stem.2016.08.001; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Sasaki N, 2016, P NATL ACAD SCI USA, V113, pE5399, DOI 10.1073/pnas.1607327113; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stzepourginski I, 2017, P NATL ACAD SCI USA, V114, pE506, DOI 10.1073/pnas.1620059114; Valenta T, 2016, CELL REP, V15, P911, DOI 10.1016/j.celrep.2016.03.088; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035	30	174	176	3	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2018	558	7710					449	+		10.1038/s41586-018-0190-3	http://dx.doi.org/10.1038/s41586-018-0190-3			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3IU	29875413				2022-12-28	WOS:000436037800051
J	Reingold, RB; Gostin, LO				Reingold, Rebecca B.; Gostin, Lawrence O.			Banning Abortion in Cases of Down Syndrome Important Lessons for Advances in Genetic Diagnosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Reingold, Rebecca B.; Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Center for Reproductive Rights, SHIFT FRAM DIS RIGHT; Centers for Disease Control and Prevention, DAT STAT OCC SYNDR U; Generations Ahead, DIS RIGHTS AN GEN TE; Giric S, 2016, J LAW BIOSCI, V3, P736, DOI 10.1093/jlb/lsw056; Kaposy C., ETHICAL CASE HAVING	5	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2018	319	23					2375	2376		10.1001/jama.2018.6118	http://dx.doi.org/10.1001/jama.2018.6118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ7JX	29800223				2022-12-28	WOS:000435564100012
J	Hainmueller, T; Bartos, M				Hainmueller, Thomas; Bartos, Marlene			Parallel emergence of stable and dynamic memory engrams in the hippocampus	NATURE			English	Article							DENTATE GYRUS INTERNEURONS; GRANULE CELLS; CELLULAR RESOLUTION; SYNAPTIC PLASTICITY; SPATIAL NAVIGATION; PATTERN SEPARATION; BASKET CELLS; AWAKE; TIME; OSCILLATIONS	During our daily life, we depend on memories of past experiences to plan future behaviour. These memories are represented by the activity of specific neuronal groups or 'engrams'(1,2). Neuronal engrams are assembled during learning by synaptic modification, and engram reactivation represents the memorized experience(1). Engrams of conscious memories are initially stored in the hippocampus for several days and then transferred to cortical areas(2). In the dentate gyrus of the hippocampus, granule cells transform rich inputs from the entorhinal cortex into a sparse output, which is forwarded to the highly interconnected pyramidal cell network in hippocampal area CA33. This process is thought to support pattern separation(4) ( but see refs. 5,6). CA3 pyramidal neurons project to CA1, the hippocampal output region. Consistent with the idea of transient memory storage in the hippocampus, engrams in CA1 and CA2 do not stabilize over time(7-10). Nevertheless, reactivation of engrams in the dentate gyrus can induce recall of artificial memories even after weeks(2). Reconciliation of this apparent paradox will require recordings from dentate gyrus granule cells throughout learning, which has so far not been performed for more than a single day(6,11,12). Here, we use chronic two-photon calcium imaging in head-fixed mice performing a multiple-day spatial memory task in a virtual environment to record neuronal activity in all major hippocampal subfields. Whereas pyramidal neurons in CA1-CA3 show precise and highly context-specific, but continuously changing, representations of the learned spatial sceneries in our behavioural paradigm, granule cells in the dentate gyrus have a spatial code that is stable over many days, with low place-or context-specificity. Our results suggest that synaptic weights along the hippocampal trisynaptic loop are constantly reassigned to support the formation of dynamic representations in downstream hippocampal areas based on a stable code provided by the dentate gyrus.	[Hainmueller, Thomas; Bartos, Marlene] Univ Freiburg, Inst Physiol Syst & Cellular Neurophysiol 1, Freiburg, Germany; [Hainmueller, Thomas] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany; [Hainmueller, Thomas] Univ Freiburg, Fac Biol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Bartos, M (corresponding author), Univ Freiburg, Inst Physiol Syst & Cellular Neurophysiol 1, Freiburg, Germany.	marlene.bartos@physiologie.uni-freiburg.de	Core, Vector/CAF-4832-2022	Bartos, Marlene/0000-0001-9741-1946; Hainmueller, Thomas/0000-0002-7824-5927	German Research Foundation [FOR2143]; Excellence Initiative of the German Research Foundation (Spemann Graduate School) [GSC-4];  [ERC-AdG 787450]	German Research Foundation(German Research Foundation (DFG)); Excellence Initiative of the German Research Foundation (Spemann Graduate School); 	We thank H.-J. Weber, C. Paun and C. Schmidt-Hieber for advice and help with setting up the virtual environment system; K. Winterhalter and K. Semmler for technical support; and J. Sauer, M. Strueber and M. Eyre for comments on earlier versions of the manuscript. This work was funded by the German Research Foundation (FOR2143, M.B.) and ERC-AdG 787450 (M.B.). This work was supported in part by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School; T.H.).	Aghajan ZM, 2015, NAT NEUROSCI, V18, P121, DOI 10.1038/nn.3884; Arriaga M, 2017, J NEUROSCI, V37, P9222, DOI 10.1523/JNEUROSCI.1076-17.2017; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bernier BE, 2017, J NEUROSCI, V37, P6359, DOI 10.1523/JNEUROSCI.3029-16.2017; Bittner KC, 2017, SCIENCE, V357, P1033, DOI 10.1126/science.aan3846; Brandalise F, 2014, P NATL ACAD SCI USA, V111, P4303, DOI 10.1073/pnas.1317667111; Burgalossi A, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00074; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Danielson NB, 2016, NEURON, V91, P652, DOI 10.1016/j.neuron.2016.06.020; Danielson NB, 2016, NEURON, V90, P101, DOI 10.1016/j.neuron.2016.02.019; Diamantaki M, 2016, ELIFE, V5, DOI 10.7554/eLife.20252; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Driscoll LN, 2017, CELL, V170, P986, DOI 10.1016/j.cell.2017.07.021; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Garcia-Junco-Clemente P, 2017, NAT NEUROSCI, V20, P389, DOI 10.1038/nn.4483; GoodSmith D, 2017, NEURON, V93, P677, DOI 10.1016/j.neuron.2016.12.026; Hainmuller T, 2014, P NATL ACAD SCI USA, V111, P13211, DOI 10.1073/pnas.1409394111; Hosp JA, 2014, HIPPOCAMPUS, V24, P189, DOI 10.1002/hipo.22214; Kaifosh P, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00080; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kitamura T, 2017, SCIENCE, V356, P73, DOI 10.1126/science.aam6808; Lee SH, 2014, NEURON, V82, P1129, DOI 10.1016/j.neuron.2014.03.034; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Malvache A, 2016, SCIENCE, V353, P1280, DOI 10.1126/science.aaf3319; Mankin EA, 2015, NEURON, V85, P190, DOI 10.1016/j.neuron.2014.12.001; Mankin EA, 2012, P NATL ACAD SCI USA, V109, P19462, DOI 10.1073/pnas.1214107109; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; Pernia-Andrade AJ, 2014, NEURON, V81, P140, DOI 10.1016/j.neuron.2013.09.046; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Rajasethupathy P, 2015, NATURE, V526, P653, DOI 10.1038/nature15389; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Roy DS, 2016, NATURE, V531, P508, DOI 10.1038/nature17172; Rubin A, 2015, ELIFE, V4, DOI 10.7554/eLife.12247; Schmidt-Hieber C, 2013, NAT NEUROSCI, V16, P325, DOI 10.1038/nn.3340; Senzai Y, 2017, NEURON, V93, P691, DOI 10.1016/j.neuron.2016.12.011; Sheffield MEJ, 2017, NEURON, V96, P490, DOI 10.1016/j.neuron.2017.09.029; Sheffield MEJ, 2015, NATURE, V517, P200, DOI 10.1038/nature13871; Skaggs WE, 1993, ADV NEURAL INFORM PR, V5, P1030, DOI DOI 10.1109/PROC.1977.10559; Stefanelli T, 2016, NEURON, V89, P1074, DOI 10.1016/j.neuron.2016.01.024; Tsao A, 2017, INTEGRATING TIME ENT; Tukker JJ, 2013, J NEUROSCI, V33, P6809, DOI 10.1523/JNEUROSCI.5052-12.2013; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109	48	128	129	9	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2018	558	7709					292	+		10.1038/s41586-018-0191-2	http://dx.doi.org/10.1038/s41586-018-0191-2			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2BI	29875406	Green Accepted			2022-12-28	WOS:000435071400054
J	Wade, L				Wade, Lizzie			She studied Mexico City. Can she lead it, too?	SCIENCE			English	News Item																			0	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1052	1053		10.1126/science.360.6393.1052	http://dx.doi.org/10.1126/science.360.6393.1052			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI6TJ	29880663				2022-12-28	WOS:000434635500010
J	McMahon, AW; Dal Pan, G				McMahon, Ann W.; Dal Pan, Gerald			Assessing Drug Safety in Children - The Role of Real-World Data	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McMahon, Ann W.] US FDA, Off Pediat Therapeut, Silver Spring, MD 20993 USA; [Dal Pan, Gerald] US FDA, Off Surveillance & Epidemiol, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	McMahon, AW (corresponding author), US FDA, Off Pediat Therapeut, Silver Spring, MD 20993 USA.				Intramural FDA HHS [FD999999] Funding Source: Medline	Intramural FDA HHS		Avant D, 2018, J PEDIATR-US, V192, P8, DOI 10.1016/j.jpeds.2017.08.048; Chai G, 2012, PEDIATRICS, V130, P23, DOI 10.1542/peds.2011-2879; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Olen O, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3951	5	28	29	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2018	378	23					2155	2157		10.1056/NEJMp1802197	http://dx.doi.org/10.1056/NEJMp1802197			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3HS	29874532	Green Accepted			2022-12-28	WOS:000434263000002
J	Dyer, O				Dyer, Owen			Colorectal cancer: US guidelines urge screening from age 45 as incidence soars in younger adults	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Siegel RL, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw322; Wolf AMD, 2018, CA-CANCER J CLIN, DOI [10.3322/caac.21457, 10.3322/caac.21457%20, DOI 10.3322/CAAC.21457%20]	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2018	361								k2452	10.1136/bmj.k2452	http://dx.doi.org/10.1136/bmj.k2452			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MZ	29858248				2022-12-28	WOS:000434276900004
J	DeWeerdt, S				DeWeerdt, Sarah			Chain of mystery	NATURE			English	Editorial Material							REPEAT; EXON-1; GENE											Barbaro BA, 2015, HUM MOL GENET, V24, P913, DOI 10.1093/hmg/ddu504; Guo Q, 2018, NATURE, V555, P117, DOI 10.1038/nature25502; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Huntington G., 1872, MED SURG REP, V26, P320; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0	6	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					S36	S37		10.1038/d41586-018-05174-1	http://dx.doi.org/10.1038/d41586-018-05174-1			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JJ2UO	29844552				2022-12-28	WOS:000494017700001
J	Kim, MY; Yu, KR; Kenderian, SS; Ruella, M; Chen, S; Shin, TH; Aljanahi, AA; Schreeder, D; Klichinsky, M; Shestova, O; Kozlowski, MS; Cummins, KD; Shan, XH; Shestov, M; Bagg, A; Morrissette, JJD; Sekhri, P; Lazzarotto, CR; Calvo, KR; Kuhns, DB; Donahue, RE; Behbehani, GK; Tsai, SQ; Dunbar, CE; Gill, S				Kim, Miriam Y.; Yu, Kyung-Rok; Kenderian, Saad S.; Ruella, Marco; Chen, Shirley; Shin, Tae-Hoon; Aljanahi, Aisha A.; Schreeder, Daniel; Klichinsky, Michael; Shestova, Olga; Kozlowski, Miroslaw S.; Cummins, Katherine D.; Shan, Xinhe; Shestov, Maksim; Bagg, Adam; Morrissette, Jennifer J. D.; Sekhri, Palak; Lazzarotto, Cicera R.; Calvo, Katherine R.; Kuhns, Douglas B.; Donahue, Robert E.; Behbehani, Gregory K.; Tsai, Shengdar Q.; Dunbar, Cynthia E.; Gill, Saar			Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia	CELL			English	Article							CHIMERIC ANTIGEN RECEPTORS; CLONAL TRACKING; CYTOMETRY DATA; SPECIFICITY; TARGET; CAS9; PHOSPHATASES; BINDING; LECTIN; SHP-1	The absence of cancer-restricted surface markers is a major impediment to antigen-specific immunotherapy using chimeric antigen receptor (CAR) T cells. For example, targeting the canonical myeloid marker CD33 in acute myeloid leukemia (AML) results in toxicity from destruction of normal myeloid cells. We hypothesized that a leukemia-specific antigen could be created by deleting CD33 from normal hematopoietic stem and progenitor cells (HSPCs), thereby generating a hematopoietic system resistant to CD33-targeted therapy and enabling specific targeting of AML with CAR T cells. We generated CD33-deficient human HSPCs and demonstrated normal engraftment and differentiation in immunodeficient mice. Autologous CD33 KO HSPC transplantation in rhesus macaques demonstrated long-term multilineage engraftment of gene-edited cells with normal myeloid function. CD33-deficient cells were impervious to CD33-targeting CAR T cells, allowing for efficient elimination of leukemia without myelotoxicity. These studies illuminate a novel approach to antigen-specific immunotherapy by genetically engineering the host to avoid on-target, off-tumor toxicity.	[Kim, Miriam Y.; Ruella, Marco; Klichinsky, Michael; Shestova, Olga; Kozlowski, Miroslaw S.; Cummins, Katherine D.; Shan, Xinhe; Gill, Saar] Hosp Univ Penn, Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA; [Yu, Kyung-Rok; Chen, Shirley; Shin, Tae-Hoon; Aljanahi, Aisha A.; Donahue, Robert E.; Dunbar, Cynthia E.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Kenderian, Saad S.] Mayo Clin, Div Hematol, Rochester, MN 55905 USA; [Aljanahi, Aisha A.] Georgetown Univ, Dept Chem & Mol & Cellular Biol, Washington, DC 20057 USA; [Schreeder, Daniel; Gill, Saar] Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Shestov, Maksim] Univ Penn, Genom & Computat Biol Grad Grp, Philadelphia, PA 19104 USA; [Bagg, Adam; Morrissette, Jennifer J. D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Sekhri, Palak; Behbehani, Gregory K.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Lazzarotto, Cicera R.; Tsai, Shengdar Q.] St Jude Childrens Res Hosp, Dept Hematol, 332 N Lauderdale, Memphis, TN 38105 USA; [Calvo, Katherine R.] NIH, Dept Lab Med, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA; [Kuhns, Douglas B.] Frederick Natl Lab Canc Res, Leidos Biomed Res, Clin Serv Program, Frederick, MD 21701 USA; [Behbehani, Gregory K.] Ohio State Univ, Dept Med, Div Hematol, Columbus, OH 43210 USA; [Kim, Miriam Y.] Washington Univ, Sch Med, Dept Med, Oncol Div, St Louis, MO 63110 USA	University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Mayo Clinic; Georgetown University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; Washington University (WUSTL)	Gill, S (corresponding author), Hosp Univ Penn, Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA.; Dunbar, CE (corresponding author), NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA.; Gill, S (corresponding author), Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA.	dunbarc@nhlbi.nih.gov; saargill@pennmedicine.upenn.edu	Ruella, Marco/GQP-8473-2022; Sekhri, Palak/AAF-3636-2021; Lazzarotto, Cicera/AAG-4259-2020; Tsai, Shengdar Q./G-4600-2012; Bagg, Adam/R-8450-2019; Yu, Kyung-Rok/AAR-6227-2021	Sekhri, Palak/0000-0001-8178-8562; Tsai, Shengdar Q./0000-0001-9161-3993; Yu, Kyung-Rok/0000-0002-4685-3223; Calvo, Katherine/0000-0002-0771-4191; Ruella, Marco/0000-0003-4301-5811; AlJanahi, Aisha/0000-0002-2345-5070; Cummins, Katherine/0000-0001-9041-0828; Kim, Miriam Yunhee/0000-0001-9609-0685	Leukemia & Lymphoma Society (SCOR grant); National Institute of Health [1 K08 CA194256-01]; Korean Visiting Scientist Training Award; Intramural Research Program of the NHLBI; NATIONAL CANCER INSTITUTE [K08CA194256, P30CA016058] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002339, ZICHL002338, ZIGHL006020] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090025] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society (SCOR grant); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Visiting Scientist Training Award; Intramural Research Program of the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CLINICAL CENTER	We thank Peter Klein, Robert Vonderheide, and Carl June for constructive comments; Yangbing Zhao, Jiangtao Ren, and Jian Huang for technical assistance; Sam Sadigh for photomicroscopy; Amy Ziober and Li Ping for immunocytochemistry; Vania Aikawa for cytogenetic analysis; Taehyong Kim, Zhiping (Paul) Wang, and Jonathan Schug for assistance with analysis of NGS; Mary Sell and Sam Mignogno for providing human apheresis specimens; NHLBI DNA Sequencing and Genomics and the NHLBI Flow Cytometry Cores; Naoya Uchida and John Tisdale for providing control bone marrow; Mark Raffeld, Liqiang Xi, and Chingiz Underbayev for ddPCR consultation and technical assistance; Keyvan Keyvanfar, Stephanie Sellers, Lemlem Alemu, and Jun Zhu for technical assistance; Ilker Tunc for off-target prediction; Aylin Bonifacino for RM CD34+ immunoselections; and Allen Krouse, Mark Metzger, Sandra Price, and the veterinary staff for care of the macaques. This work was supported by the Leukemia & Lymphoma Society (SCOR grant; S.G.), the National Institute of Health (1 K08 CA194256-01; S.G.), the Korean Visiting Scientist Training Award (K.-R.Y.), and the Intramural Research Program of the NHLBI.	Appelbaum FR, 2017, BLOOD, V130, P2373, DOI 10.1182/blood-2017-09-797712; Brinkman-Vand der Linden ECM, 2003, MOL CELL BIOL, V23, P4199, DOI 10.1128/MCB.23.12.4199-4206.2003; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Donahue Robert E, 2005, Curr Protoc Immunol, VChapter 22, DOI 10.1002/0471142735.im22a01s69; Dutour A, 2012, Adv Hematol, V2012, P683065, DOI 10.1155/2012/683065; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gill S, 2014, BLOOD, V123, P2343, DOI 10.1182/blood-2013-09-529537; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ishida A, 2014, J BIOL CHEM, V289, P25341, DOI 10.1074/jbc.M113.523480; Kenderian SS, 2015, LEUKEMIA, V29, P1637, DOI 10.1038/leu.2015.52; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kotecha N., 2010, CURR PROTOC CYTOM, DOI DOI 10.1002/0471142956.CY1017S53; Laszlo GS, 2014, BLOOD REV, V28, P143, DOI 10.1016/j.blre.2014.04.001; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Leong SR, 2017, BLOOD, V129, P609, DOI 10.1182/blood-2016-08-735365; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Mardiros A, 2013, BLOOD, V122, P3138, DOI 10.1182/blood-2012-12-474056; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624; Nguyen DH, 2006, EXP HEMATOL, V34, P728, DOI 10.1016/j.exphem.2006.03.003; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Ornatsky OI, 2008, J ANAL ATOM SPECTROM, V23, P463, DOI 10.1039/b710510j; Paul SP, 2000, BLOOD, V96, P483; Peterson CW, 2016, BLOOD, V127, P2416, DOI 10.1182/blood-2015-09-672337; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Pizzitola I, 2014, LEUKEMIA, V28, P1596, DOI 10.1038/leu.2014.62; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Saleheen D, 2017, NATURE, V544, P235, DOI 10.1038/nature22034; Scott DA, 2017, NAT MED, V23, P1095, DOI 10.1038/nm.4377; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Sotillo E, 2015, CANCER DISCOV, V5, P1282, DOI 10.1158/2159-8290.CD-15-1020; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Tashiro H, 2017, MOL THER, V25, P2202, DOI 10.1016/j.ymthe.2017.05.024; Taylor VC, 1999, J BIOL CHEM, V274, P11505, DOI 10.1074/jbc.274.17.11505; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Ulyanova T, 1999, EUR J IMMUNOL, V29, P3440, DOI 10.1002/(SICI)1521-4141(199911)29:11<3440::AID-IMMU3440>3.3.CO;2-3; Wang QS, 2015, MOL THER, V23, P184, DOI 10.1038/mt.2014.164; Wu CF, 2018, J EXP MED, V215, P217, DOI 10.1084/jem.20171341; Wu CF, 2014, CELL STEM CELL, V14, P486, DOI 10.1016/j.stem.2014.01.020; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	49	213	235	3	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1439	+		10.1016/j.cell.2018.05.013	http://dx.doi.org/10.1016/j.cell.2018.05.013			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29856956	Green Accepted, Bronze			2022-12-28	WOS:000433989100016
J	Sabbatini, AK; Wright, B				Sabbatini, Amber K.; Wright, Brad			Excluding Observation Stays from Readmission Rates - What Quality Measures Are Missing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							REDUCTION PROGRAM		[Sabbatini, Amber K.] Univ Washington, Dept Emergency Med, Seattle, WA 98195 USA; [Wright, Brad] Univ Iowa, Dept Hlth Management & Policy, Iowa City, IA USA	University of Washington; University of Washington Seattle; University of Iowa	Sabbatini, AK (corresponding author), Univ Washington, Dept Emergency Med, Seattle, WA 98195 USA.		Wright, Brad/AAA-5844-2019; Wright, Brad/H-1330-2013	Wright, Brad/0000-0002-2674-4951				Burke RE, 2013, JAMA INTERN MED, V173, P695, DOI 10.1001/jamainternmed.2013.171; Gupta A, 2018, JAMA CARDIOL, V3, P44, DOI 10.1001/jamacardio.2017.4265; Micklos J, 2017, EC INVESTMENT JOURNE; Nuckols TK, 2017, J HOSP MED, V12, P443, DOI 10.12788/jhm.2751; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024	5	25	25	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2018	378	22					2062	2065		10.1056/NEJMp1800732	http://dx.doi.org/10.1056/NEJMp1800732			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH5AL	29847758				2022-12-28	WOS:000433428000003
J	Kneebone, R				Kneebone, Roger			Improvising medicine	LANCET			English	Editorial Material												r.kneebone@imperial.ac.uk							0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2018	391	10135					2097	2097		10.1016/S0140-6736(18)31084-5	http://dx.doi.org/10.1016/S0140-6736(18)31084-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH2UJ	29856336	Green Submitted			2022-12-28	WOS:000433257200015
J	Winston, DJ; Mullane, KM; Cornely, OA; Boeckh, MJ; Brown, JW; Pergam, SA; Trociukas, I; Zak, P; Craig, MD; Papanicolaou, GA; Velez, JD; Panse, J; Hurtado, K; Fernsler, DA; Stek, JE; Pang, L; Su, SC; Zhao, YL; Chan, ISF; Kaplan, SS; Parrino, J; Lee, I; Popmihajlov, Z; Annunziato, PW; Arvin, A				Winston, Drew J.; Mullane, Kathleen M.; Cornely, Oliver A.; Boeckh, Michael J.; Brown, Janice Wes; Pergam, Steven A.; Trociukas, Igoris; Zak, Pavel; Craig, Michael D.; Papanicolaou, Genovefa A.; Velez, Juan D.; Panse, Jens; Hurtado, Kimberly; Fernsler, Doreen A.; Stek, Jon E.; Pang, Lei; Su, Shu-Chih; Zhao, Yanli; Chan, Ivan S. F.; Kaplan, Susan S.; Parrino, Janie; Lee, Ingi; Popmihajlov, Zoran; Annunziato, Paula W.; Arvin, Ann		V212 Protocol 001 Trial Team	Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							HERPES-ZOSTER; BONE-MARROW; POSTHERPETIC NEURALGIA; IMMUNE RECONSTITUTION; VIRUS VACCINE; IMMUNOGENICITY; SAFETY; PROPHYLAXIS; ADULTS; ASSAY	Background Recipients of autologous haemopoietic stem-cell transplants (auto-HSCT) have an increased risk of herpes zoster and herpes zoster-related complications. The aim of this study was to establish the efficacy and safety of an inactivated varicella zoster vaccine for the prevention of herpes zoster after auto-HSCT. Methods In this randomised, double-blind, placebo-controlled phase 3 trial, participants were recruited from 135 medical centres (ie, stem-cell transplant centres and hospitals) in North America, South America, Europe, and Asia. Patients were eligible if they were aged 18 years or older, scheduled to receive an auto-HSCT within 60 days of enrolment, and had a history of varicella infection or were seropositive for antibodies to varicella zoster virus, or both. Exclusion criteria included a history of herpes zoster within the previous year of enrolment, and intended antiviral prophylaxis for longer than 6 months after transplantation. Participants were randomly assigned according to a central randomisation schedule generated by the trial statistician, to receive either the inactivated-virus vaccine from one of three consistency lots, a high-antigen lot, or placebo, stratified by age (< 50 vs >= 50 years) and intended duration of antiviral prophylaxis after transplantation (<= 3 months vs > 3 to <= 6 months). Participants, investigators, trial staff, and the funder's clinical and laboratory personnel were masked to group assignment. Participants were given four doses of inactivated vaccine or placebo, with the first dose 5-60 days before auto-HSCT, and the second, third, and fourth doses at about 30, 60, and 90 days after transplantation. The primary efficacy endpoint was the incidence of herpes zoster, confirmed by PCR or adjudication by a masked clinical committee, or both, assessed in all participants randomly assigned to the vaccine consistency lot group or placebo group who received at least one dose of vaccine and had auto-HSCT. Safety was assessed in all randomised participants who received at least one dose of vaccine and had follow-up data. A prespecified vaccine efficacy success criterion required the lower bound of the 95% CI be higher than 25% for the relative reduction of the hazard ratio of herpes zoster infection in participants given the vaccine from one of the consistency lots compared with those given placebo. This trial is registered on ClinicalTrials. gov (NCT01229267) and EudraCT (2010-020150-34). Findings Between Dec 7, 2010, and April 25, 2013, 560 participants were randomly assigned to the vaccine consistency lot group, 106 to the high-antigen lot group, and 564 to the placebo group. 249 (44%) of patients in the vaccine consistency lot group, 35 (33%) in the high-antigen lot group, and 220 (39%) in the placebo group discontinued before study end, mostly because of death or withdrawal. 51 participants were excluded from the primary efficacy endpoint analyses because they did not undergo auto-HSCT or were not vaccinated, or both (22 [4%] in the vaccine consistency lot group, and 29 [5%] in the placebo group). Mean follow-up for efficacy was 2 . 4 years (SD 1.3) in the vaccine consistency lot group and 2.3 years (SD 1.3) in the placebo group. 42 (8%) of 538 participants in the vaccine consistency lot group (32.9 per 1000 person-years) and 113 (21%) of 535 in the placebo group (91.9 per 1000 person-years) had a confirmed case of herpes zoster. The estimated vaccine efficacy was 63.8% (95% CI 48.4-74.6), meeting the pre-specified success criterion. For the combined vaccine groups versus the placebo group, the proportion of patients with serious adverse events (216 [33%] of 657 vs 181 [33%] of 554; risk difference 0.2%, 95% CI -5.1 to 5.5) and serious vaccine-related adverse events (five [1%] vs five [1%]; risk difference 0.1%, -1.4 to 1.1) were similar. Vaccine-related injection-site adverse events occurred more frequently in participants given vaccine than those given placebo (191 [29%] vs 36 [7%]; risk difference 22.6%, 95% CI 18.5-26.6; p<0.0001). Interpretation This study shows for the first time in a large phase 3 trial that early vaccination of auto-HSCT recipients during the peri-transplant period can be effective for the prevention of an opportunistic infection like herpes zoster and that the vaccine is well tolerated. Funding Merck & Co., Inc. Copyright (C) 2018 Elsevier Ltd. All rights reserved.	[Winston, Drew J.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Winston, Drew J.] Univ Calif Los Angeles, Med Ctr, Dept Med, Los Angeles, CA 90024 USA; [Mullane, Kathleen M.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Cornely, Oliver A.] Cologne Excellence Cluster Cellular Stress Respon, Clin Trials Ctr, Dept Internal Med, Cologne, Germany; [Cornely, Oliver A.] Univ Cologne, Ctr Infect Res DZIF, Cologne, Germany; [Boeckh, Michael J.; Pergam, Steven A.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Brown, Janice Wes; Arvin, Ann] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Trociukas, Igoris] Vilnius Univ Hosp, Vilnius, Lithuania; [Zak, Pavel] Fak Nemocnice Hradec Kralove, Dept Med, Hradec Kralove, Czech Republic; [Craig, Michael D.] West Virginia Univ Hosp, Morgantown, WV USA; [Papanicolaou, Genovefa A.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Velez, Juan D.] Fdn Valle Lili, Cali, Colombia; [Panse, Jens] Univ Hosp RWTH Aachen, Med Fac, Dept Oncol Hematol Hemostaseol & Stem Cell Transp, Aachen, Germany; [Hurtado, Kimberly; Fernsler, Doreen A.; Stek, Jon E.; Pang, Lei; Su, Shu-Chih; Zhao, Yanli; Chan, Ivan S. F.; Kaplan, Susan S.; Parrino, Janie; Lee, Ingi; Popmihajlov, Zoran; Annunziato, Paula W.] Merck & Co Inc, Kenilworth, NJ USA	University of California System; University of California Los Angeles; University of Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Chicago; University of Cologne; University of Cologne; Fred Hutchinson Cancer Center; Stanford University; Vilnius University Hospital Santariskiu Klinikos; University Hospital Hradec Kralove; West Virginia University; Memorial Sloan Kettering Cancer Center; Fundacion Valle del Lili; RWTH Aachen University; RWTH Aachen University Hospital; Merck & Company	Winston, DJ (corresponding author), Univ Calif Los Angeles, Ctr Hlth Sci, Dept Med, Los Angeles, CA 90095 USA.	dwinston@mednet.ucla.edu	Rambaldi, Alessandro/P-2603-2018; Boeckh, Michael/AAA-1607-2022; Pergam, Steven A/C-2286-2008; Cornely, Oliver A./J-5095-2013; zhao, yan/GWC-9174-2022	Rambaldi, Alessandro/0000-0002-3739-7502; Pergam, Steven A/0000-0002-6333-5196; Cornely, Oliver A./0000-0001-9599-3137; Cherif, Honar/0000-0001-7582-4002; Sloan, John/0000-0001-7069-4528; Sossa-Melo, Claudia/0000-0001-9876-222X; Papanicolaou, Genovefa/0000-0002-2891-079X; Onida, Francesco/0000-0002-2991-3474; Castro, M.D., Januario E./0000-0003-2785-0892	Merck Co., Inc.; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Merck Co., Inc.(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding Merck & Co., Inc.	[Anonymous], 2009, ZOST ZOST VACC LIV P; Arvin AM, 2000, BIOL BLOOD MARROW TR, V6, P219, DOI 10.1016/S1083-8791(00)70004-8; Bosch M, 2012, CURR OPIN HEMATOL, V19, P324, DOI 10.1097/MOH.0b013e328353bc7d; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Coplan PM, 2004, J PAIN, V5, P344, DOI 10.1016/j.jpain.2004.06.001; DEGAST GC, 1985, BLOOD, V66, P428; Eberhardson M, 2017, CLIN INFECT DIS, V65, P1174, DOI 10.1093/cid/cix484; Gilderman LI, 2009, CLIN VACCINE IMMUNOL, V16, P1381; Hata A, 2002, NEW ENGL J MED, V347, P26, DOI 10.1056/NEJMoa013441; Issa NC, 2014, BIOL BLOOD MARROW TR, V20, P285, DOI 10.1016/j.bbmt.2013.11.013; KELLER PM, 1986, J VIROL METHODS, V14, P177, DOI 10.1016/0166-0934(86)90048-0; Ljungman P, 2009, BONE MARROW TRANSPL, V44, P521, DOI 10.1038/bmt.2009.263; Marty FM, 2011, LANCET INFECT DIS; MEYERS JD, 1980, J INFECT DIS, V141, P479, DOI 10.1093/infdis/141.4.479; Mullane KM, 2013, J INFECT DIS, V208, P1375, DOI 10.1093/infdis/jit344; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Parrino J, 2017, VACCINE, V35, P1764, DOI 10.1016/j.vaccine.2016.10.055; Pollack M, 2011, BIOL BLOOD MARROW TR, V17, P664, DOI 10.1016/j.bbmt.2010.07.026; Redman RL, 1997, J INFECT DIS, V176, P578, DOI 10.1086/514077; Reimer P, 2003, ANN HEMATOL, V82, P263, DOI 10.1007/s00277-003-0630-4; Sahoo F, 2017, BIOL BLOOD MARROW TR, V23, P505, DOI 10.1016/j.bbmt.2016.12.620; SCHUCHTER LM, 1989, BLOOD, V74, P1424; Smith JG, 2001, CLIN DIAGN LAB IMMUN, V8, P871, DOI 10.1128/CDLI.8.5.871-879.2001; Stadtmauer EA, 2014, BLOOD, V124, P2921, DOI 10.1182/blood-2014-04-573048; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; van Burik JAH, 2004, CLIN INFECT DIS, V39, P1407, DOI 10.1086/422312; VOSE JM, 1992, CANCER, V69, P784, DOI 10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M; WASMUTH EH, 1990, J MED VIROL, V32, P189, DOI 10.1002/jmv.1890320310	29	54	56	2	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2018	391	10135					2116	2127		10.1016/S0140-6736(18)30631-7	http://dx.doi.org/10.1016/S0140-6736(18)30631-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH2UJ	29856344				2022-12-28	WOS:000433257200027
J	Langhorne, P; O'Donnell, MJ; Chin, SL; Zhang, HY; Xavier, D; Avezum, A; Mathur, N; Turner, M; MacLeod, MJ; Lopez-Jaramillo, P; Damasceno, A; Hankey, GJ; Dans, AL; Elsayed, A; Mondo, C; Wasay, M; Czlonkowska, A; Weimar, C; Yusufali, AH; Al Hussain, F; Liu, LS; Diener, HC; Ryglewicz, D; Pogosova, N; Iqbal, R; Diaz, R; Yusoff, K; Oguz, A; Wang, XY; Penaherrera, E; Lanas, F; Ogah, OS; Ogunniyi, A; Iversen, HK; Malaga, G; Rumboldt, Z; Magazi, D; Nilanont, Y; Rosengren, A; Oveisgharan, S; Yusuf, S				Langhorne, Peter; O'Donnell, Martin J.; Chin, Siu Lim; Zhang, Hongye; Xavier, Denis; Avezum, Alvaro; Mathur, Nandini; Turner, Melanie; MacLeod, Mary Joan; Lopez-Jaramillo, Patricio; Damasceno, Albertino; Hankey, Graeme J.; Dans, Antonio L.; Elsayed, Ahmed; Mondo, Charles; Wasay, Mohammad; Czlonkowska, Anna; Weimar, Christian; Yusufali, Afzal Hussein; Al Hussain, Fawaz; Liu Lisheng; Diener, Hans-Christoph; Ryglewicz, Danuta; Pogosova, Nana; Iqbal, Romana; Diaz, Rafael; Yusoff, Khalid; Oguz, Aytekin; Wang, Xingyu; Penaherrera, Ernesto; Lanas, Fernando; Ogah, Okechukwu S.; Ogunniyi, Adesola; Iversen, Helle K.; Malaga, German; Rumboldt, Zvonko; Magazi, Daliwonga; Nilanont, Yongchai; Rosengren, Annika; Oveisgharan, Shahram; Yusuf, Salim		INTERSTROKE Collaborators	Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study	LANCET			English	Article							TRANSIENT ISCHEMIC ATTACK; UNIT CARE; INCOME COUNTRIES; GLOBAL BURDEN; RISK-FACTORS; RIKS-STROKE; QUALITY; MANAGEMENT; MORTALITY; REGISTER	Background Stroke disproportionately affects people in low-income and middle-income countries. Although improvements in stroke care and outcomes have been reported in high-income countries, little is known about practice and outcomes in low and middle-income countries. We aimed to compare patterns of care available and their association with patient outcomes across countries at different economic levels. Methods We studied the patterns and effect of practice variations (ie, treatments used and access to services) among participants in the INTERSTROKE study, an international observational study that enrolled 13447 stroke patients from 142 clinical sites in 32 countries between Jan 11, 2007, and Aug 8, 2015. We supplemented patient data with a questionnaire about health-care and stroke service facilities at all participating hospitals. Using univariate and multivariate regression analyses to account for patient casemix and service clustering, we estimated the association between services available, treatments given, and patient outcomes (death or dependency) at 1 month. Findings We obtained full information for 12342 (92%) of 13447 INTERSTROKE patients, from 108 hospitals in 28 countries; 2576 from 38 hospitals in ten high-income countries and 9766 from 70 hospitals in 18 low and middle-income countries. Patients in low-income and middle-income countries more often had severe strokes, intracerebral haemorrhage, poorer access to services, and used fewer investigations and treatments (p<0.0001) than those in high-income countries, although only differences in patient characteristics explained the poorer clinical outcomes in low and middle-income countries. However across all countries, irrespective of economic level, access to a stroke unit was associated with improved use of investigations and treatments, access to other rehabilitation services, and improved survival without severe dependency (odds ratio [OR] 1.29; 95% CI 1.14-1.44; all p<0.0001), which was independent of patient casemix characteristics and other measures of care. Use of acute antiplatelet treatment was associated with improved survival (1.39; 1.12-1.72) irrespective of other patient and service characteristics. Interpretation Evidence-based treatments, diagnostics, and stroke units were less commonly available or used in low and middle-income countries. Access to stroke units and appropriate use of antiplatelet treatment were associated with improved recovery. Improved care and facilities in low-income and middle-income countries are essential to improve outcomes.	[Langhorne, Peter] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [O'Donnell, Martin J.; Chin, Siu Lim; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [O'Donnell, Martin J.; Chin, Siu Lim; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON, Canada; [O'Donnell, Martin J.] NUI Galway, Dept Med, Hlth Res Board Clin Res Facil, Galway, Ireland; [Zhang, Hongye; Wang, Xingyu] Beijing Hypertens League Inst, Beijing, Peoples R China; [Xavier, Denis; Mathur, Nandini] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India; [Avezum, Alvaro] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Turner, Melanie; MacLeod, Mary Joan] Univ Aberdeen, Div Appl Med, Aberdeen, Scotland; [Lopez-Jaramillo, Patricio] Univ Santander, Escuela Med, Inst Invest FOSCAL, Bucaramanga, Colombia; [Damasceno, Albertino] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique; [Hankey, Graeme J.] Univ Western Australia, Sch Med, Perth, WA, Australia; [Dans, Antonio L.] Univ Philippines, Coll Med, Manila, Philippines; [Elsayed, Ahmed] Alzaeim Alazhari Univ, Khartoum, Sudan; [Mondo, Charles] Mulago Hosp, Uganda Heart Inst, Kampala, Uganda; [Wasay, Mohammad; Iqbal, Romana] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Czlonkowska, Anna; Ryglewicz, Danuta] Inst Psychiat & Neurol, Warsaw, Poland; [Weimar, Christian; Diener, Hans-Christoph] Univ Hosp, Dept Neurol, Essen, Germany; [Yusufali, Afzal Hussein] Dubai Med Coll, Dubai Hlth Author, Dubai, U Arab Emirates; [Al Hussain, Fawaz] King Saud Univ, Riyadh, Saudi Arabia; [Liu Lisheng] Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Pogosova, Nana] Russian Federat, Minist Healthcare, Natl Res Ctr Prevent Med, Moscow, Russia; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Santa Fe, Argentina; [Yusoff, Khalid] UCSI Univ, Kuala Lumpur, Malaysia; [Oguz, Aytekin] Istanbul Medeniyet Univ, Istanbul, Turkey; [Penaherrera, Ernesto] Hosp Luis Vernaza, Dept Cardiol, Guayaquil, Ecuador; [Lanas, Fernando] Univ La Frontera, Fac Med, Temuco, Chile; [Ogah, Okechukwu S.] Univ Coll Hosp, Div Cardiovasc Med, Ibadan, Nigeria; [Ogunniyi, Adesola] Univ Coll Hosp, Dept Med, Ibadan, Nigeria; [Iversen, Helle K.] Univ Copenhagen, Rigshosp, Dept Neurol, Copenhagen, Denmark; [Malaga, German] Univ Peruana Cayetano Heredia, Lima, Peru; [Rumboldt, Zvonko] Univ Split, Split, Croatia; [Magazi, Daliwonga] Univ Limpopo, Pretoria, South Africa; [Nilanont, Yongchai] Mahidol Univ, Siriraj Hosp, Dept Med, Neurol Div, Bangkok, Thailand; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Rosengren, Annika] Univ Gothenburg, Univ Hosp, Gothenburg, Sweden; [Oveisgharan, Shahram] Rush Alzheimer Dis Res Ctr Chicago, Chicago, IL USA	University of Glasgow; McMaster University; Population Health Research Institute; McMaster University; Ollscoil na Gaillimhe-University of Galway; Chinese Hypertension League; St. John's National Academy of Health Sciences; St. John's Medical College; Instituto Dante Pazzanese de Cardiologia; University of Aberdeen; Universidad Industrial de Santander; Eduardo Mondlane University; University of Western Australia; University of the Philippines System; University of the Philippines Manila; Mulago National Referral Hospital; Aga Khan University; Institute of Psychiatry & Neurology; University of Duisburg Essen; King Saud University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; National Medical Research Center for Therapy & Preventive Medicine; UCSI University; Istanbul Medeniyet University; Universidad de La Frontera; University of Ibadan; University College Hospital, Ibadan; University of Ibadan; University College Hospital, Ibadan; Rigshospitalet; University of Copenhagen; Universidad Peruana Cayetano Heredia; University of Split; University of Limpopo; Mahidol University; University of Gothenburg; University of Gothenburg	Langhorne, P (corresponding author), Royal Infirm, Acad Sect Geriatr Med, Glasgow G31 2ER, Lanark, Scotland.	peter.langhorne@glasgow.ac.uk	Avezum, Alvaro/AAP-7687-2020; Boytsov, Sergey/AAK-5354-2021; Hankey, Graeme J/H-4968-2014; Lanas, Fernando/AAE-8842-2022; Yusoff, Khalid/I-7029-2019; Kelishadi, Roya/E-6154-2012; Pogosova, Nana/ABG-1633-2021; Boytsov, Sergey A/M-4486-2014; Agrawal, Amit/C-1511-2011; Oguz, Aytekin/AAJ-2732-2021; Pogosova, Nana/G-7470-2016; O'Donnell, Martin/ABE-7459-2020; Senadim, Songul/B-7732-2019; Kalantri, Shriprakash/ABG-9318-2021; Iversen, Helle Klingenberg/P-5726-2019; Diener, Hans-Christoph/AAF-7275-2019; Elsayed, Ahmed/AAC-9689-2020; Oveisgharan, Shahram/AAI-5971-2021; Muengtaweepongsa, Sombat/C-1402-2010; Rumboldt, Zvonko/D-6274-2017; Friedrich, Matthias/H-8474-2015; Doney, Alexander/P-7437-2017; Gomez-Arbelaez, Diego/K-1883-2013	Boytsov, Sergey/0000-0001-6998-8406; Hankey, Graeme J/0000-0002-6044-7328; Yusoff, Khalid/0000-0001-5669-5188; Kelishadi, Roya/0000-0001-7455-1495; Boytsov, Sergey A/0000-0001-6998-8406; Agrawal, Amit/0000-0002-3287-5448; Oguz, Aytekin/0000-0002-2595-5167; Pogosova, Nana/0000-0002-4165-804X; O'Donnell, Martin/0000-0002-7347-7761; Senadim, Songul/0000-0001-8359-7057; Kalantri, Shriprakash/0000-0002-1633-1029; Iversen, Helle Klingenberg/0000-0002-5880-6352; Muengtaweepongsa, Sombat/0000-0003-3715-4428; Rumboldt, Zvonko/0000-0002-6811-275X; Sobral Sousa, Antonio Carlos/0000-0002-4158-9726; Yusufali, Afzalhussein/0000-0003-3378-2646; Yusuf, Salim/0000-0003-4776-5601; SIGAMANI, ALBEN/0000-0002-6927-1947; Dayan, Colin/0000-0002-6557-3462; Collantes Estevez, Eduardo/0000-0002-7647-6289; Czlonkowska, Anna/0000-0002-1956-1866; Macleod, Mary Joan/0000-0003-2115-8184; Pandian, Jeyaraj/0000-0003-0028-1968; Malaga, German/0000-0002-7828-300X; Lanas, Fernando/0000-0003-3595-9759; Konopko, Magdalena/0000-0002-0484-4468; DUARTE VERA, YAN CARLOS/0000-0003-4685-6907; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Owolabi, Mayowa/0000-0003-1146-3070; ElSayed, Ahmed/0000-0001-7422-7169; Bochynska, Anna/0000-0003-0616-5482; Akinyemi, Rufus/0000-0001-5286-428X; Prabhakaran, Dorairaj/0000-0002-3172-834X; Rao, Purnima/0000-0002-7537-9057; AVEZUM, ALVARO/0000-0002-3073-6890; Friedrich, Matthias/0000-0003-1204-5647; Camacho, Paul Anthony/0000-0002-6233-9582; Dowlatshahi, Dar/0000-0003-1379-3612; Joshi, Rajnish/0000-0002-4702-0522; Doney, Alexander/0000-0002-6210-5620; Joshi, Rohina/0000-0002-3374-401X; Gomez-Arbelaez, Diego/0000-0001-6150-0066	Chest, Heart and Stroke Scotland	Chest, Heart and Stroke Scotland	Chest, Heart and Stroke Scotland.	Asplund K, 2011, INT J STROKE, V6, P99, DOI 10.1111/j.1747-4949.2010.00557.x; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Brainin M, 2007, LANCET NEUROL, V6, P553, DOI 10.1016/S1474-4422(07)70005-4; Cadilhac DA, 2016, INT J STROKE, V11, P28, DOI 10.1177/1747493015607523; Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Gilligan AK, 2005, CEREBROVASC DIS, V20, P239, DOI 10.1159/000087705; Govan L, 2009, STROKE, V40, P3396, DOI 10.1161/STROKEAHA.109.557645; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hankey GJ, 2017, LANCET, V389, P641, DOI 10.1016/S0140-6736(16)30962-X; Ingeman A, 2008, MED CARE, V46, P63, DOI 10.1097/MLR.0b013e3181484b91; Intercollegiate Stroke Working Party, 2011, NAT SENT STROK CLIN; Caballero PEJ, 2013, J STROKE CEREBROVASC, V22, pE214, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.014; Langhorne P, 2002, AGE AGEING, V31, P365, DOI 10.1093/ageing/31.5.365; Langhorne P, 2012, LANCET NEUROL, V11, P341, DOI 10.1016/S1474-4422(12)70024-8; Lindsay MP, 2010, CANADIAN BEST PRACTI, P85; Lopez AD, 2006, ANN TROP MED PARASIT, V100, P481, DOI 10.1179/136485906X97417; National Stroke Foundation, 2010, GUID STROK MAN; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Rodrigues FB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1754; Rothwell PM, 2016, LANCET, V388, P365, DOI 10.1016/S0140-6736(16)30468-8; Saposnik G, 2009, STROKE, V40, P3321, DOI 10.1161/STROKEAHA.109.554907; Scottish Stroke Care Audit National Report, 2010, STROK SERV SCOTT HOS; Summers D, 2009, STROKE, V40, P2911, DOI 10.1161/STROKEAHA.109.192362; Terent A, 2009, J NEUROL NEUROSUR PS, V80, P881, DOI 10.1136/jnnp.2008.169102; The Intercollegiate Working Party for Stroke Royal College of Physicians, 2008, NAT CLIN GUID STROK; Turner M, 2015, STROKE, V46, P1065, DOI 10.1161/STROKEAHA.114.007608; Wade DT., 1992, MEASUREMENT NEUROLOG; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890	29	61	64	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2018	391	10134					2019	2027		10.1016/S0140-6736(18)30802-X	http://dx.doi.org/10.1016/S0140-6736(18)30802-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG1IJ	29864018	Green Submitted, Green Accepted			2022-12-28	WOS:000432440300028
J	Hurley, K; O'Connor, GT				Hurley, Killian; O'Connor, George T.			Serum alpha(1)-Antitrypsin Concentration in the Diagnosis of alpha(1)-Antitrypsin Deficiency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALPHA-1-ANTITRYPSIN; DISEASE		[Hurley, Killian; O'Connor, George T.] Boston Univ, Sch Med, Ctr Pulm, Div Pulm Allergy Sleep & Crit Care Med,Boston Med, Boston, MA 02118 USA	Boston University	O'Connor, GT (corresponding author), Boston Univ, Sch Med, Ctr Pulm, 72 E Concord St,Rm R-304, Boston, MA 02118 USA.	goconnor@bu.edu		Hurley, Killian/0000-0003-4755-5559	AstraZeneca; Janssen Pharmaceuticals	AstraZeneca(AstraZeneca); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr O'Connor reports receipt of consulting fees from AstraZeneca and grants from Janssen Pharmaceuticals. No other disclosures were reported.	Bornhorst JA, 2013, CHEST, V143, P1000, DOI 10.1378/chest.12-0564; Center for Medicare and Medicaid Services, 2020, CLIN LAB FEE SCHED; Miravitlles M, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00610-2017; Molloy K, 2014, AM J RESP CRIT CARE, V189, P419, DOI 10.1164/rccm.201311-1984OC; Sandhaus RA, 2016, CHRON OBSTR PULM DIS, V3, P668, DOI 10.15326/jcopdf.3.3.2015.0182; de Serres F, 2014, J INTERN MED, V276, P311, DOI 10.1111/joim.12239; SILVERMAN EK, 1992, GENET EPIDEMIOL, V9, P317, DOI 10.1002/gepi.1370090504	7	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					2034	2035		10.1001/jama.2018.3888	http://dx.doi.org/10.1001/jama.2018.3888			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800192				2022-12-28	WOS:000432238300021
J	Mejean, A; Ravaud, A; Thezenas, S; Colas, S; Beauval, JB; Bensalah, K; Geoffrois, L; Thiery-Vuillemin, A; Cormier, L; Lang, H; Guy, L; Gravis, G; Rolland, F; Linassier, C; Lechevallier, E; Beisland, C; Aitchison, M; Oudard, S; Patard, JJ; Theodore, C; Chevreau, C; Laguerre, B; Hubert, J; Gross-Goupil, M; Bernhard, JC; Albiges, L; Timsit, MO; Lebret, T; Escudier, B				Mejean, A.; Ravaud, A.; Thezenas, S.; Colas, S.; Beauval, J. -B.; Bensalah, K.; Geoffrois, L.; Thiery-Vuillemin, A.; Cormier, L.; Lang, H.; Guy, L.; Gravis, G.; Rolland, F.; Linassier, C.; Lechevallier, E.; Beisland, C.; Aitchison, M.; Oudard, S.; Patard, J. -J.; Theodore, C.; Chevreau, C.; Laguerre, B.; Hubert, J.; Gross-Goupil, M.; Bernhard, J. -C.; Albiges, L.; Timsit, M. -O.; Lebret, T.; Escudier, B.			Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINES; CYTOREDUCTIVE NEPHRECTOMY; TARGETED THERAPY; RADICAL NEPHRECTOMY; CANCER; SURVIVAL; CLASSIFICATION; COMPLICATIONS; TRIAL	BACKGROUND Cytoreductive nephrectomy has been the standard of care in metastatic renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies. However, the efficacy of targeted therapies has challenged this standard. We assessed the role of nephrectomy in patients with metastatic renal-cell carcinoma who were receiving targeted therapies. METHODS In this phase 3 trial, we randomly assigned, in a 1: 1 ratio, patients with confirmed metastatic clear-cell renal-cell carcinoma at presentation who were suitable candidates for nephrectomy to undergo nephrectomy and then receive sunitinib (standard therapy) or to receive sunitinib alone. Randomization was stratified according to prognostic risk (intermediate or poor) in the Memorial Sloan Kettering Cancer Center prognostic model. Patients received sunitinib at a dose of 50 mg daily in cycles of 28 days on and 14 days off every 6 weeks. The primary end point was overall survival. RESULTS A total of 450 patients were enrolled from September 2009 to September 2017. At this planned interim analysis, the median follow-up was 50.9 months, with 326 deaths observed. The results in the sunitinib-alone group were noninferior to those in the nephrectomy-sunitinib group with regard to overall survival (stratified hazard ratio for death, 0.89; 95% confidence interval, 0.71 to 1.10; upper boundary of the 95% confidence interval for noninferiority, <= 1.20). The median overall survival was 18.4 months in the sunitinib-alone group and 13.9 months in the nephrectomy-sunitinib group. No significant differences in response rate or progression-free survival were observed. Adverse events were as anticipated in each group. CONCLUSIONS Sunitinib alone was not inferior to nephrectomy followed by sunitinib in patients with metastatic renal-cell carcinoma who were classified as having intermediate-risk or poor-risk disease. (Funded by Assistance Publique-Hopitaux de Paris and others; CARMENA ClinicalTrials.gov number, NCT00930033.)	[Mejean, A.; Timsit, M. -O.] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Dept Urol, Paris, France; [Oudard, S.] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Dept Med Oncol, Paris, France; [Colas, S.] AP HP, Paris Descartes Necker Cochin Clin Res Unit, Paris, France; [Ravaud, A.] Bordeaux Univ Hosp, Dept Med Oncol, Bordeaux, France; [Gross-Goupil, M.] Ctr Hosp Univ CHU Bordeaux, Hop St Andre, Dept Med Oncol, Bordeaux, France; [Bernhard, J. -C.] CHU Bordeaux, Dept Urol, Bordeaux, France; [Bernhard, J. -C.] Univ Bordeaux, Bordeaux, France; [Thezenas, S.] Univ Montpellier, Canc Inst Montpellier, Biometr Unit, Montpellier, France; [Beauval, J. -B.] CHU Rangueil, Dept Urol, Toulouse, France; [Chevreau, C.] Inst Univ Canc Toulouse Oncopole, Dept Med Oncol, Toulouse, France; [Bensalah, K.] Univ Rennes, Dept Urol, Rennes, France; [Laguerre, B.] Ctr Eugene Marquis, Dept Med Oncol, Rennes, France; [Geoffrois, L.] Inst Cancerol Lorraine, Dept Med Oncol, Vandoeuvre Les Nancy, France; [Thiery-Vuillemin, A.] CHU Besancon, Dept Med Oncol, Oncol, Besancon, France; [Thiery-Vuillemin, A.] Univ Franche Comte, INSERM, Struct Federat Rech Ingn & Biol Cellulaire & Tiss, Unite Mixte Rech UMR 1098, Besancon, France; [Cormier, L.] CHU Francois Mitterrand, Dept Urol, Dijon, France; [Lang, H.] CHU Strasbourg, Translat Med Federat Strasbourg, Dept Urol, Strasbourg, France; [Guy, L.] Gabriel Montpied Hosp, Dept Urol, Clermont Ferrand, France; [Guy, L.] Clermont Auvergne Univ, Clermont Ferrand, France; [Gravis, G.] CNRS, Ctr Rech Cancerol Marseille, Dept Med Oncol, INSERM,UMR 1068,UMR 7258, Marseille, France; [Gravis, G.] Inst Paoli Calmettes, Marseille, France; [Lechevallier, E.] Aix Marseille Univ, Hop Concept, Dept Urol, Marseille, France; [Rolland, F.] Inst Cancerol Ouest, Dept Med Oncol, Nantes, France; [Linassier, C.] CHU Bretonneau, Dept Med Oncol, Tours, France; [Linassier, C.] Univ Tours, Dept Med, Tours, France; [Patard, J. -J.] Mt de Marsan Gen Hosp, Dept Urol, Mt De Marsan, France; [Theodore, C.] Hop Foch, Dept Med Oncol, Suresnes, France; [Lebret, T.] Hop Foch, Dept Urol, Suresnes, France; [Hubert, J.] CHU Nancy, INSERM, Imagerie Adaptat Diagnost & Intervent, Dept Urol,U1254, Brabois, France; [Albiges, L.; Escudier, B.] Gustave Roussy Inst, Dept Med Oncol, 114 Rue Edouard Vaillant, F-94800 Villejuif, France; [Albiges, L.; Escudier, B.] Univ Paris Saclay, Villejuif, France; [Lebret, T.] Univ Versailles, St Quentin En Yvelines, France; [Beisland, C.] Haukeland Hosp, Dept Urol, Bergen, Norway; [Beisland, C.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Aitchison, M.] Royal Free Hosp, Dept Urol, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Universite de Montpellier; CHU de Toulouse; Universite de Rennes; UNICANCER; Centre Eugene Marquis; UNICANCER; Institut de cancerologie de Lorraine (ICL); Universite de Franche-Comte; CHU Besancon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Dijon Bourgogne; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); CHU Tours; Universite de Tours; Hospital Foch; Hospital Foch; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Bergen; Haukeland University Hospital; University of Bergen; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Escudier, B (corresponding author), Gustave Roussy Inst, Dept Med Oncol, 114 Rue Edouard Vaillant, F-94800 Villejuif, France.	escudier@gustaveroussy.fr	Bensalah, Karim/ABD-7954-2020; Gravis, Gwenaelle/CAG-3019-2022; BERNHARD, Jean-Christophe/GWQ-9119-2022; Beisland, Christian/R-6046-2019	Gravis, Gwenaelle/0000-0002-3127-1554; BERNHARD, Jean-Christophe/0000-0001-8564-1699; Beisland, Christian/0000-0002-3216-4937; thiery-vuillemin, antoine/0000-0001-6822-3401; Ravaud, Alain/0000-0001-9455-6744; Laurent, GUY/0000-0001-9561-9356; OUDARD, Stephane/0000-0003-0893-285X	Assistance Publique-Hopitaux de Paris (Clinical Research and Innovation Delegation); Programme Hospitalier de Recherche Clinique Cancer-Ministere de la Sante; Pfizer; Bristol-Myers Squibb; Roche; Janssen; Ferring Pharmaceuticals; Novartis; Ipsen; Laboratoires Bouchara Recordati; Astellas Pharma; Sanofi; Eisai; Bayer; Merck Sharp Dohme; Intuitive Surgical	Assistance Publique-Hopitaux de Paris (Clinical Research and Innovation Delegation); Programme Hospitalier de Recherche Clinique Cancer-Ministere de la Sante; Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Ferring Pharmaceuticals(Ferring Pharmaceuticals); Novartis(Novartis); Ipsen(Ipsen); Laboratoires Bouchara Recordati; Astellas Pharma(Astellas Pharmaceuticals); Sanofi; Eisai(Eisai Co Ltd); Bayer(Bayer AG); Merck Sharp Dohme(Merck & Company); Intuitive Surgical	Supported by Assistance Publique-Hopitaux de Paris (Clinical Research and Innovation Delegation), by a grant (PHRC-K 2007) from the Programme Hospitalier de Recherche Clinique Cancer-Ministere de la Sante, and by an unrestricted grant from Pfizer.; Dr. Mejean reports receiving consulting fees and travel support from Bristol-Myers Squibb, Roche, Janssen, and Ferring Pharmaceuticals, consulting fees, fees for serving on an advisory board, and travel support from Novartis and Ipsen, and travel support from Sanofi and Pfizer; Dr. Ravaud, receiving fees for serving on an advisory board and travel support from Pfizer, Novartis, Bristol-Myers Squibb, Roche, and Ipsen; Dr. Beauval, receiving consulting fees, lecture fees, and travel support from Janssen and Laboratoires Bouchara Recordati, travel support from Ipsen and Ferring Pharmaceuticals, and consulting fees and travel support from Astellas Pharma; Dr. Thiery-Vuillemin, receiving grant support and consulting fees from Pfizer, consulting fees from Sanofi, and consulting fees and travel support from Astellas Pharma, Novartis, Bristol-Myers Squibb, Roche, and Ipsen; Dr. Rolland, receiving consulting fees from Pfizer; Dr. Beisland, receiving lecture fees and travel support from Pfizer; Dr. Oudard, receiving honoraria, consulting fees, and travel support from Pfizer, Novartis, Bristol-Myers Squibb, Eisai, Bayer, and Ipsen; Dr. Chevreau, receiving fees for serving on an advisory board from Bristol-Myers Squibb, Ipsen, Novartis, and Pfizer; Dr. Laguerre, receiving honoraria and travel support from Bristol-Myers Squibb and Novartis; Dr. Gross-Goupil, receiving honoraria and travel support from Pfizer, consulting fees and travel support from Novartis and Bristol-Myers Squibb, and honoraria, consulting fees, and travel support from Ipsen and Merck Sharp & Dohme; Dr. Bernhard, receiving consulting fees and travel support from Pfizer, grant support, consulting fees, and travel support from Novartis, grant support, consulting fees, and lecture fees from Bristol-Myers Squibb, lecture fees and travel support from Ipsen, grant support, consulting fees, and writing assistance from Intuitive Surgical, and provision of equipment from Fujifilm; Dr. Albiges, receiving consulting fees from Pfizer, Novartis, Roche, Bristol-Myers Squibb, and Ipsen; and Dr. Lebret, receiving honoraria from Pfizer, Ipsen, and Merck Sharp & Dohme and consulting fees from Novartis, Bristol-Myers Squibb, and Bayer. No other potential conflict of interest relevant to this article was reported.	Bamias A, 2017, ONCOLOGIST, V22, P667, DOI 10.1634/theoncologist.2016-0435; Bex A, 2018, EUR UROL SUPPL, V17, pe1; Bhindi B, 2018, J UROL; BHINDI B, 2018, J CLIN ONCOL S, V36; Brigitte Laguerre M. D, JEAN; Choueiri TK, 2017, J CLIN ONCOL, V35, P591, DOI 10.1200/JCO.2016.70.7398; Choueiri TK, 2017, NEW ENGL J MED, V376, P354, DOI 10.1056/NEJMra1601333; CLAVIEN PA, 1992, SURGERY, V111, P518; Culp SH, 2015, THER ADV UROL, V7, P275, DOI 10.1177/1756287215585501; Escudier B, 2016, ANN ONCOL, V27, pv58, DOI 10.1093/annonc/mdw328; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Garcia-Perdomo HA, 2018, INVESTIG CLIN UROL, V59, P2, DOI 10.4111/icu.2018.59.1.2; [Georges-Pompidou Assistance Publique-Hopitaux de Paris (AP-HP) Universite Paris-Descartes and Paris Descartes Necker-Cochin Clinical Research Unit AP-HP (S. C.) Paris the Department of Medical Oncology Bordeaux University Hospital (A. R.) Department of Medical Oncology Hopital Saint Andre Centre Hospitalier Universitaire (CHU) de Bordeaux (M. G.-G.) Department of Urology CHU de Bordeaux and Universite de Bordeaux (J.-C. B.) Bordeaux Biometrics Unit Cancer Institute of Montpellier University of Montpellier Montpellier (S. T.) Department of Urology CHU Rangueil (J.-B. B.) and the Department of Medical Oncology Institut Universitaire du Cancer Toulouse-Oncopole (C. C.) Toulouse the Department of Urology University of Rennes (K. B.) and the Department of Medical Oncology Centre Eugene Marquis (B. L.) Rennes the Department of Medical Oncology Institut de Cancerologie de Lorraine Vandoeuvre les Nancy (L. Geoffrois) the Department of Medical Oncology CHU Besancon Oncologie and Universite de Franche-Comte INSERM Unite Mixte de Recherche (UMR) Structure Federative de Recherche Ingenierie et Biologie Cellulaire et Tissulaire Besancon (A. T.-V.) Department of Urology CHU Francois Mitterrand Dijon (L. C.) the Department of Urology CHU Strasbourg Translational Medicine Federation Strasbourg Strasbourg (H. L.) the Department of Urology Gabriel Montpied Hospital and Clermont Auvergne University Clermont-Ferrand (L. Guy) the Department of Medical Oncology Centre de Recherche en Cancer-ologie de Marseille INSERM UMR 1068 Centre National de la Recherche Scientifique UMR Institut Paoli-Calmettes (G. G.) and the Department of Urology Hopital la Conception (E. L.) Aix Marseille Universite Marseille the Department of Medical Oncology Institut de Cancerologie de l'Ouest Nantes (F. R.) the Department of Medical Oncology CHU Bretonneau and the Department of Medicine Universite Francois Rabelais Tours (C. L.) the Department of Urology Mont de Marsan General Hospital Mont de Marsan (J.-J. P.) the Departments of Medical Oncology (C. T.) and Urology (T. L.) Hopital Foch Suresnes the Department of Urology Imagerie Adaptative Diagnostique et Interventionnelle INSERM Unite 1254 CHU de Nancy Brabois (J. H.) the Department of Medical Oncology Institut Gustave Roussy and Universite Paris-Saclay Villejuif (L. A. B. E.) and Universite Versailles St.-Quentin-en-Yvelines (T. L.)-all in France; the Department of Urology Haukeland University Hospital (C. B.) and the Department of Clinical Medicine University of Bergen (C. B.) Bergen Norway; and the Department of Urology Royal Free Hospital London (M. A.)ology Royal Free Hospital London (M. A.)ology Royal Free Hospital London (M. A.)ology Royal Free Hospital London (M. A.)], 1098, LONDON; Hanna N, SUR; Hanna N, 2016, J CLIN ONCOL, V34, P3267, DOI 10.1200/JCO.2016.66.7931; Heng DYC, 2014, EUR UROL, V66, P704, DOI 10.1016/j.eururo.2014.05.034; Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; NEVES RJ, 1988, J UROLOGY, V139, P1173, DOI 10.1016/S0022-5347(17)42851-5; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Siegel RL, CANCER; Silberstein JL, 2012, BJU INT, V110, P1276, DOI 10.1111/j.1464-410X.2012.11103.x; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; statistics, 2018, ONCOLOGIST, V22, P667; Stewart GD, 2017, EUR UROL, V71, P845, DOI 10.1016/j.eururo.2016.10.029; The authors' affiliations are as follows: the Departments of Urology (A. M. M.-O. T.), MED ONCOLOGY	27	458	470	2	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2018	379	5					417	427		10.1056/NEJMoa1803675	http://dx.doi.org/10.1056/NEJMoa1803675			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GO9HB	29860937	Bronze			2022-12-28	WOS:000440415800005
J	Wachter, RM; Howell, MD				Wachter, Robert M.; Howell, Michael D.			Resolving the Productivity Paradox of Health Information Technology A Time for Optimism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wachter, Robert M.] Univ Calif San Francisco, Dept Med, 505 Parnassus Ave, San Francisco, CA 94143 USA; [Howell, Michael D.] Google LLC, Mountain View, CA USA	University of California System; University of California San Francisco	Wachter, RM (corresponding author), Univ Calif San Francisco, Dept Med, 505 Parnassus Ave, San Francisco, CA 94143 USA.	robert.wachter@ucsf.edu						Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Jones SS, 2014, ANN INTERN MED, V160, P48, DOI 10.7326/M13-1531; Jones SS, 2012, NEW ENGL J MED, V366, P2243, DOI 10.1056/NEJMp1204980; Rushakoff RJ, 2017, ANN INTERN MED, V166, P621, DOI 10.7326/M16-1413	5	16	16	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2018	320	1					25	26		10.1001/jama.2018.5605	http://dx.doi.org/10.1001/jama.2018.5605			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL5PC	29813165				2022-12-28	WOS:000437219400007
J	Komaroff, AL				Komaroff, Anthony L.			The Microbiome and Risk for Atherosclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GUT MICROBIOTA; METABOLISM		[Komaroff, Anthony L.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Komaroff, AL (corresponding author), Brigham & Womens Hosp, 1620 Tremont St, Boston, MA 02120 USA.	komaroff@hms.harvard.edu						Boorstin DJ, 1983, THE DISCOVERERS, P330; Heianza Y, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004947; Komaroff AL, 2017, JAMA-J AM MED ASSOC, V317, P355, DOI 10.1001/jama.2016.20099; Li DY, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0675-9; Loscalzo J, 2013, NEW ENGL J MED, V368, P1647, DOI 10.1056/NEJMe1302154; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628	10	47	52	2	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2018	319	23					2381	2382		10.1001/jama.2018.5240	http://dx.doi.org/10.1001/jama.2018.5240			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ7JX	29800043				2022-12-28	WOS:000435564100015
J	Schreiber, CA; Creinin, MD; Atrio, J; Sonalkar, S; Ratcliffe, SJ; Barnhart, KT				Schreiber, Courtney A.; Creinin, Mitchell D.; Atrio, Jessica; Sonalkar, Sarita; Ratcliffe, Sarah J.; Barnhart, Kurt T.			Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MISOPROSTOL TREATMENT; MISSED ABORTION; MISCARRIAGE; FAILURE; ROUTES; TRIAL	BACKGROUND Medical management of early pregnancy loss is an alternative to uterine aspiration, but standard medical treatment with misoprostol commonly results in treatment failure. We compared the efficacy and safety of pretreatment with mifepristone followed by treatment with misoprostol with the efficacy and safety of misoprostol use alone for the management of early pregnancy loss. METHODS We randomly assigned 300 women who had an anembryonic gestation or in whom embryonic or fetal death was confirmed to receive pretreatment with 200 mg of mifepristone, administered orally, followed by 800 mu g of misoprostol, administered vaginally (mifepristone-pretreatment group), or 800 mu g of misoprostol alone, administered vaginally (misoprostol-alone group). Participants returned 1 to 4 days after misoprostol use for evaluation, including ultrasound examination, by an investigator who was unaware of the treatment-group assignments. Women in whom the gestational sac was not expelled were offered expectant management, a second dose of misoprostol, or uterine aspiration. We followed all participants for 30 days after randomization. Our primary outcome was gestational sac expulsion with one dose of misoprostol by the first follow-up visit and no additional intervention within 30 days after treatment. RESULTS Complete expulsion after one dose of misoprostol occurred in 124 of 148 women (83.8%; 95% confidence interval (CI), 76.8 to 89.3) in the mifepristone-pretreatment group and in 100 of 149 women (67.1%; 95% CI, 59.0 to 74.6) in the misoprostol-alone group (relative risk, 1.25; 95% CI, 1.09 to 1.43). Uterine aspiration was performed less frequently in the mifepristone-pretreatment group than in the misoprostol-alone group (8.8% vs. 23.5%; relative risk, 0.37; 95% CI, 0.21 to 0.68). Bleeding that resulted in blood transfusion occurred in 2.0% of the women in the mifepristone-pretreatment group and in 0.7% of the women in the misoprostolalone group (P=0.31); pelvic infection was diagnosed in 1.3% of the women in each group. CONCLUSIONS Pretreatment with mifepristone followed by treatment with misoprostol resulted in a higher likelihood of successful management of first-trimester pregnancy loss than treatment with misoprostol alone.	[Schreiber, Courtney A.; Sonalkar, Sarita] Univ Penn, Pregnancy Early Access Ctr PEACE, Div Family Planning, Philadelphia, PA 19104 USA; [Schreiber, Courtney A.; Sonalkar, Sarita; Barnhart, Kurt T.] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Ratcliffe, Sarah J.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Creinin, Mitchell D.] Univ Calif Davis, Dept Obstet & Gynecol, Sacramento, CA 95817 USA; [Atrio, Jessica] Montefiore Hosp, Dept Obstet & Gynecol, Bronx, NY USA; [Atrio, Jessica] Albert Einstein Coll Med, Bronx, NY 10467 USA	University of Pennsylvania; University of Pennsylvania; University of Virginia; University of California System; University of California Davis; Yeshiva University; Albert Einstein College of Medicine	Schreiber, CA (corresponding author), Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA.	schreibe@upenn.edu	Creinin, Mitchell/AAH-3488-2020; Ratcliffe, Sarah J/GYR-1110-2022; Atrio, Jessica/F-4440-2016	Creinin, Mitchell/0000-0001-5967-8180; Ratcliffe, Sarah J/0000-0002-6644-8284; Atrio, Jessica/0000-0002-3505-643X	National Institute of Child Health and Human Development of the National Institutes of Health (Eunice Kennedy Shriver award) [R01-HD0719-20]; Danco Laboratories; National Institute of Child Health and Human Development of the National Institutes of Health (Women's Reproductive Health Research award) [K12-HD001265-18]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071920, K12HD001265] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development of the National Institutes of Health (Eunice Kennedy Shriver award); Danco Laboratories(Randox Laboratories); National Institute of Child Health and Human Development of the National Institutes of Health (Women's Reproductive Health Research award); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by the National Institute of Child Health and Human Development of the National Institutes of Health (Eunice Kennedy Shriver award number R01-HD0719-20 [to Dr. Schreiber] and Women's Reproductive Health Research award number K12-HD001265-18 [to Dr. Sonalkar]).; Dr. Creinin reports receiving consulting fees from Danco Laboratories. No other potential conflict of interest relevant to this article was reported.	[Anonymous], OBSTET GYNECOL, DOI DOI 10.1097/01.AOG.0000465191.27155.25; Baulieu EE., 1991, ANN NY ACAD SCI, V626, P545, DOI 10.1111/j.1749-6632.1991.tb37946.x; CASTERLINE JB, 1989, STUD FAMILY PLANN, V20, P81, DOI 10.2307/1966462; Chen BA, 2007, CLIN OBSTET GYNECOL, V50, P67, DOI 10.1097/GRF.0b013e31802f1233; CHENG LN, 1993, J CLIN ENDOCR METAB, V77, P873, DOI 10.1210/jc.77.3.873; Chia K V, 2002, J Obstet Gynaecol, V22, P184; Cleland K, 2015, CONTRACEPTION, V92, P179, DOI 10.1016/j.contraception.2015.06.016; Creinin MD, 2004, OBSTET GYNECOL, V103, P851, DOI 10.1097/01.AOG.0000124271.23499.84; Creinin MD, 2001, BRIT J OBSTET GYNAEC, V108, P469, DOI 10.1016/S0306-5456(00)00117-0; Creinin MD, 2007, OBSTET GYNECOL, V109, P885, DOI 10.1097/01.AOG.0000258298.35143.d2; Creinin MD, 2006, OBSTET GYNECOL, V107, P901, DOI 10.1097/01.AOG.0000206737.68709.3e; Gemzell-Danielsson K, 2006, CONTRACEPTION, V74, P31, DOI 10.1016/j.contraception.2006.03.009; Gronlund A, 2002, ACTA OBSTET GYN SCAN, V81, P1060, DOI 10.1034/j.1600-0412.2002.811111.x; Hertig AT, 1944, NEW ENGL J MED, V230, P797; Jurkovic D, 1998, ULTRASOUND OBST GYN, V11, P161, DOI 10.1046/j.1469-0705.1998.11030161.x; Kim C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007223.pub4; Kollitz KM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.026; Kulier R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002855.pub4; Lee C, 1996, J PSYCHOSOM RES, V40, P235, DOI 10.1016/0022-3999(95)00579-X; Lohr PA, 2007, CONTRACEPTION, V76, P215, DOI 10.1016/j.contraception.2007.05.088; Meckstroth KR, 2006, OBSTET GYNECOL, V108, P582, DOI 10.1097/01.AOG.0000230398.32794.9d; Neilson JP, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002253.pub3; Ngoc NTN, 2004, INT J GYNECOL OBSTET, V87, P138, DOI 10.1016/j.ijgo.2004.07.015; Raymond EG, 2017, NEW ENGL J MED, V376, P790, DOI 10.1056/NEJMsb1612526; Robledo C, 2007, INT J GYNECOL OBSTET, V99, P46, DOI 10.1016/j.ijgo.2007.04.031; Schreiber CA, 2006, CONTRACEPTION, V74, P458, DOI 10.1016/j.contraception.2006.07.007; Schreiber CA, 2016, OBSTET GYNECOL, V128, P1347, DOI 10.1097/AOG.0000000000001753; Tang OS, 2002, HUM REPROD, V17, P332, DOI 10.1093/humrep/17.2.332; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Ventura Stephanie J, 2012, Natl Vital Stat Rep, V60, P1; Wagaarachchi PT, 2001, HUM REPROD, V16, P1849, DOI 10.1093/humrep/16.9.1849; Wallace RR, 2010, PATIENT EDUC COUNS, V81, P454, DOI 10.1016/j.pec.2010.10.031; Weeks A, 2007, WEEKS MED TREATM EAR; Zhang J, 2005, NEW ENGL J MED, V353, P761, DOI 10.1056/NEJMoa044064	34	87	93	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2018	378	23					2161	2170		10.1056/NEJMoa1715726	http://dx.doi.org/10.1056/NEJMoa1715726			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3HS	29874535	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000434263000004
J	Willink, A; DuGoff, EH				Willink, Amber; DuGoff, Eva H.			Integrating Medical and Nonmedical Services - The Promise and Pitfalls of the CHRONIC Care Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HOME		[Willink, Amber] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [DuGoff, Eva H.] Univ Maryland, Dept Hlth Serv Adm, College Pk, MD 20742 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland College Park	Willink, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA.			DuGoff, Eva/0000-0001-6673-8428				Cooper AL, 2012, NEW ENGL J MED, V366, P150, DOI 10.1056/NEJMsa1104273; Davis K, 2016, AM J MANAG CARE, V22, P764; Kan HJ, 2018, MED CARE, V56, P233, DOI 10.1097/MLR.0000000000000865; Park S, 2017, SERVICE LEVEL SELECT; Ruiz S, 2017, HEALTH AFFAIR, V36, P425, DOI 10.1377/hlthaff.2016.1305	5	34	34	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2018	378	23					2153	2155		10.1056/NEJMp1803292	http://dx.doi.org/10.1056/NEJMp1803292			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3HS	29874539				2022-12-28	WOS:000434263000001
J	Fink, DS; Schleimer, JP; Sarvet, A; Grover, KK; Delcher, C; Castillo-Carniglia, A; Kim, JH; Rivera-Aguirre, AE; Henry, SG; Martins, SS; Cerda, M				Fink, David S.; Schleimer, Julia P.; Sarvet, Aaron; Grover, Kiran K.; Delcher, Chris; Castillo-Carniglia, Alvaro; Kim, June H.; Rivera-Aguirre, Ariadne E.; Henry, Stephen G.; Martins, Silvia S.; Cerda, Magdalena			Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							UNITED-STATES; OPIOIDS; IMPACT; IMPLEMENTATION; MORTALITY; REDUCTIONS; DEATHS; REDUCE; TRENDS; RATES	Background: Prescription drug monitoring programs (PDMPs) are a key component of the president's Prescription Drug Abuse Prevention Plan to prevent opioid overdoses in the United States. Purpose: To examine whether PDMP implementation is associated with changes in nonfatal and fatal overdoses; identify features of programs differentially associated with those outcomes; and investigate any potential unintended consequences of the programs. Data Sources: Eligible publications from MEDLINE, Current Contents Connect (Clarivate Analytics), Science Citation Index (Clarivate Analytics), Social Sciences Citation Index (Clarivate Analytics), and ProQuest Dissertations indexed through 27 December 2017 and additional studies from reference lists. Study Selection: Observational studies (published in English) from U.S. states that examined an association between PDMP implementation and nonfatal or fatal overdoses. Data Extraction: 2 investigators independently extracted data from and rated the risk of bias (ROB) of studies by using established criteria. Consensus determinations involving all investigators were used to grade strength of evidence for each intervention. Data Synthesis: Of 2661 records, 17 articles met the inclusion criteria. These articles examined PDMP implementation only (n = 8), program features only (n = 2), PDMP implementation and program features (n = 5), PDMP implementation with mandated provider review combined with pain clinic laws (n = 1), and PDMP robustness (n = 1). Evidence from 3 studies was insufficient to draw conclusions regarding an association between PDMP implementation and nonfatal overdoses. Low-strength evidence from 10 studies suggested a reduction in fatal overdoses with PDMP implementation. Program features associated with a decrease in overdose deaths included mandatory provider review, provider authorization to access PDMP data, frequency of reports, and monitoring of nonscheduled drugs. Three of 6 studies found an increase in heroin overdoses after PDMP implementation. Limitation: Few studies, high ROB, and heterogeneous analytic methods and outcome measurement. Conclusion: Evidence that PDMP implementation either increases or decreases nonfatal or fatal overdoses is largely insufficient, as is evidence regarding positive associations between specific administrative features and successful programs. Some evidence showed unintended consequences. Research is needed to identify a set of "best practices" and complementary initiatives to address these consequences.	[Fink, David S.; Schleimer, Julia P.; Sarvet, Aaron; Grover, Kiran K.; Martins, Silvia S.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, 722 West 168th St,Room 724, New York, NY 10032 USA; [Delcher, Chris] Univ Florida, Coll Med, Dept Hlth Outcomes & Biomed Informat, Gainesville, FL 32610 USA; [Castillo-Carniglia, Alvaro; Rivera-Aguirre, Ariadne E.; Cerda, Magdalena] Univ Calif Davis, Violence Prevent Res Program, Dept Emergency Med, Sch Med, Sacramento, CA 95817 USA; [Henry, Stephen G.] Univ Calif Davis, Sch Med, Dept Internal Med, Sacramento, CA 95817 USA; [Kim, June H.] NYU, Behav Sci Training Drug Abuse Res, Rory Meyers Coll Nursing, New York, NY 10010 USA	Columbia University; State University System of Florida; University of Florida; University of California System; University of California Davis; University of California System; University of California Davis; New York University	Fink, DS (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, 722 West 168th St,Room 724, New York, NY 10032 USA.	dsf2130@columbia.edu	Rivera-Aguirre, Ariadne/AAW-6652-2021; Castillo-Carniglia, Alvaro/T-4015-2019; Fink, David S./F-1634-2014; Martins, Silvia Saboia/C-9405-2014	Rivera-Aguirre, Ariadne/0000-0003-4860-2791; Castillo-Carniglia, Alvaro/0000-0002-3016-890X; Fink, David S./0000-0003-1531-1525; Martins, Silvia Saboia/0000-0003-3059-9993; Schleimer, Julia/0000-0001-6439-7586	NIDA, National Institutes of Health (NIH) [R01 DA039962]; NIDA [T32DA031099];  [2016-PM-BX-K005];  [2015-PM-BX-K001]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA039962, K23DA043052, T32DA031099] Funding Source: NIH RePORTER	NIDA, National Institutes of Health (NIH); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By grant R01 DA039962 from the NIDA, National Institutes of Health (NIH), and grants 2016-PM-BX-K005 and 2015-PM-BX-K001 from the BJA. Mr. Fink is supported by NIDA training grant T32DA031099. The BJA is a component of the Department of Justice's Office of Justice Programs, which include the Bureau of Justice Statistics, National Institute of Justice, Office of Juvenile Justice and Delinquency Prevention, Office for Victims of Crime, and Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering, and Tracking.	Bachhuber MA, 2016, INT J DRUG POLICY, V28, P120, DOI 10.1016/j.drugpo.2015.08.005; Berkman ND, 2008, GRADING STRENGTH BOD; Birk EG, 2017, RESCRIPTION DRUG MON; Brown R, 2017, DRUG ALCOHOL DEPEN, V178, P348, DOI 10.1016/j.drugalcdep.2017.05.023; Clark JD, 2002, J PAIN SYMPTOM MANAG, V23, P131, DOI 10.1016/S0885-3924(01)00396-7; Delcher C, 2016, AM J PUBLIC HEALTH, V106, pE10, DOI 10.2105/AJPH.2016.303104; Delcher C, 2015, DRUG ALCOHOL DEPEN, V150, P63, DOI 10.1016/j.drugalcdep.2015.02.010; Dowell D, 2016, HEALTH AFFAIR, V35, P1876, DOI 10.1377/hlthaff.2016.0448; Finley EP, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2354-5; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Han B, 2015, JAMA-J AM MED ASSOC, V314, P1468, DOI 10.1001/jama.2015.11859; Islam MM, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-46; Joynt M, 2013, J GEN INTERN MED, V28, P1604, DOI 10.1007/s11606-013-2516-z; Kaucher S, 2017, EUR J EPIDEMIOL, V32, P289, DOI 10.1007/s10654-017-0240-4; Kilby A., 2015, OPIOIDS MASSES WELFA; Kim M., 2013, IMPACT PRESCRIPTION; King NB, 2014, AM J PUBLIC HEALTH, V104, pE32, DOI 10.2105/AJPH.2014.301966; Li Guohua, 2014, Inj Epidemiol, V1, P9; Mars SG, 2014, INT J DRUG POLICY, V25, P257, DOI 10.1016/j.drugpo.2013.10.004; Maughan BC, 2015, DRUG ALCOHOL DEPEN, V156, P282, DOI 10.1016/j.drugalcdep.2015.09.024; McCabe SE, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2387; Meinhofer A., 2017, AM J HLTH EC; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nam YH, 2017, AM J MANAG CARE, V23, P297; National Alliance for Model State Drug Laws, 2004, COMP STRONG PRESCR M; National Center for Injury Prevention and Control, 2013, EP POL PRESCR DRUG O; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Pardo B, 2017, ADDICTION, V112, P1773, DOI 10.1111/add.13741; Patrick SW, 2016, HEALTH AFFAIR, V35, P1324, DOI 10.1377/hlthaff.2015.1496; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Paulozzi LJ, 2011, PAIN MED, V12, P747, DOI 10.1111/j.1526-4637.2011.01062.x; Pauly NJ, 2018, DRUG ALCOHOL DEPEN, V184, P26, DOI 10.1016/j.drugalcdep.2017.12.002; Phillips Elyse, 2017, J Opioid Manag, V13, P229, DOI 10.5055/jom.2017.0391; Radakrishnan S, 2015, ESSAYS EC RISKY HLTH; Reifler LM, 2012, PAIN MED, V13, P434, DOI 10.1111/j.1526-4637.2012.01327.x; Reisman Richard M, 2009, Subst Abuse, V3, P41; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Surratt HL, 2014, PHARMACOEPIDEM DR S, V23, P314, DOI 10.1002/pds.3553; Worley Julie, 2012, Issues Ment Health Nurs, V33, P319, DOI 10.3109/01612840.2011.654046	40	129	129	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2018	168	11					783	+		10.7326/M17-3074	http://dx.doi.org/10.7326/M17-3074			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3EK	29801093	Green Accepted			2022-12-28	WOS:000434254100005
J	Loeb, S; Byrne, N; Makarov, DV; Lepor, H; Walter, D				Loeb, Stacy; Byrne, Nataliya; Makarov, Danil V.; Lepor, Herbert; Walter, Dawn			Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Loeb, Stacy; Makarov, Danil V.] Manhattan Vet Affairs Med Ctr, New York, NY USA; [Byrne, Nataliya; Lepor, Herbert] NYU, Dept Urol, New York, NY USA; [Walter, Dawn] NYU, Dept Populat Hlth, New York, NY USA	New York University; New York University	Loeb, S (corresponding author), 227 E 30th St,Ste 612, New York, NY 10016 USA.	stacyloeb@gmail.com		Makarov, Danil/0000-0002-0565-9272; Loeb, Stacy/0000-0003-3933-9207	Edward Blank and Sharon Cosloy Blank Family Foundation; Gertrude and Louis Feil Family; New York State Department of Health [DOH01-C30697GG-3450000]; Laura and Isaac Perlmutter Cancer Center at New York University Langone Medical Center [P30CA016087]; Prostate Cancer Foundation; National Institutes of Health (NIH) [K07CA178258]; US Department of Veterans Affairs [CDA11-257, COP 11-254]; NATIONAL CANCER INSTITUTE [K07CA178258] Funding Source: NIH RePORTER	Edward Blank and Sharon Cosloy Blank Family Foundation; Gertrude and Louis Feil Family; New York State Department of Health; Laura and Isaac Perlmutter Cancer Center at New York University Langone Medical Center; Prostate Cancer Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Edward Blank and Sharon Cosloy Blank Family Foundation, the Gertrude and Louis Feil Family; and by grants DOH01-C30697GG-3450000 from the New York State Department of Health, P30CA016087 from the Laura and Isaac Perlmutter Cancer Center at New York University Langone Medical Center, the Prostate Cancer Foundation, K07CA178258 from the National Institutes of Health (NIH) (Dr Loeb), and CDA11-257 and COP 11-254 from the US Department of Veterans Affairs (Dr Makarov).		0	44	44	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2231	2233		10.1001/jama.2018.5616	http://dx.doi.org/10.1001/jama.2018.5616			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29800017	Green Published, Bronze			2022-12-28	WOS:000434133400023
J	McCartney, M				McCartney, Margaret			Margaret McCartney: We should stop fuelling anxiety	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Hooper L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009647.pub2; Remes O, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.497; Ronalds C, 2002, FAM PRACT, V19, P23, DOI 10.1093/fampra/19.1.23; Rosling H, 2018, NOT BE IGNORANT WORL; Walters K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041670; World Cancer Research Fund, AR YOU MAK YOURS CAN	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2018	361								k2399	10.1136/bmj.k2399	http://dx.doi.org/10.1136/bmj.k2399			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BQ	29866792	Green Published			2022-12-28	WOS:000435072800005
J	Le, C; Chen, TQ; Liang, T; Zhang, P; MacMillan, DWC				Le, Chip; Chen, Tiffany Q.; Liang, Tao; Zhang, Patricia; MacMillan, David W. C.			A radical approach to the copper oxidative addition problem: Trifluoromethylation of bromoarenes	SCIENCE			English	Article							CATALYZED TRIFLUOROMETHYLATION; ARYL; SELECTIVITIES; COMPLEXES; PALLADIUM; MECHANISM; HALIDES; CUCF3; SALTS; ALKYL	Transition metal-catalyzed arene functionalization has been widely used for molecular synthesis over the past century. In this arena, copper catalysis has long been considered a privileged platform due to the propensity of high-valent copper to undergo reductive elimination with a wide variety of coupling fragments. However, the sluggish nature of oxidative addition has limited copper's capacity to broadly facilitate haloarene coupling protocols. Here, we demonstrate that this copper oxidative addition problem can be overcome with an aryl radical-capture mechanism, wherein the aryl radical is generated through a silyl radical halogen abstraction. This strategy was applied to a general trifluoromethylation of aryl bromides through dual copper-photoredox catalysis. Mechanistic studies support the formation of an open-shell aryl species.	[Le, Chip; Chen, Tiffany Q.; Liang, Tao; Zhang, Patricia; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu	Liang, Tao/O-3387-2019	Musacchio, Patricia/0000-0002-0211-1893; Le, Chi/0000-0002-9614-365X; Chen, Tiffany Q./0000-0001-9096-8856	NIH National Institute of General Medical Sciences [R01 GM103558-03]; Bristol-Myers Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103558] Funding Source: NIH RePORTER	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the NIH National Institute of General Medical Sciences (R01 GM103558-03) and gifts from Merck, Bristol-Myers Squibb, Eli Lilly, Genentech, Pfizer, and Johnson & Johnson. C .L. thanks Bristol-Myers Squibb for a graduate fellowship.	Alonso C, 2015, CHEM REV, V115, P1847, DOI 10.1021/cr500368h; Bhunia S, 2017, ANGEW CHEM INT EDIT, V56, P16136, DOI 10.1002/anie.201701690; Bour JR, 2015, J AM CHEM SOC, V137, P8034, DOI 10.1021/jacs.5b04892; Casitas A, 2013, CHEM SCI, V4, P2301, DOI 10.1039/c3sc21818j; Chatgilialoglu C., 2014, ORGANOSILANES RADICA; CHEN QY, 1989, J CHEM SOC CHEM COMM, P705, DOI 10.1039/c39890000705; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Creutz SE, 2012, SCIENCE, V338, P647, DOI 10.1126/science.1226458; Devery JJ, 2016, ACS CATAL, V6, P5962, DOI 10.1021/acscatal.6b01914; Dubinina GG, 2008, J AM CHEM SOC, V130, P8600, DOI 10.1021/ja802946s; Evano G., 2014, COPPER MEDIATED CROS; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Giri R, 2018, J AM CHEM SOC, V140, P793, DOI 10.1021/jacs.7b11853; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Hegedus L. S., 2010, TRANSITION METALS SY; Hickman AJ, 2012, NATURE, V484, P177, DOI 10.1038/nature11008; Johnson MW, 2016, CHEM SCI, V7, P4091, DOI [10.1039/C5SC04709A, 10.1039/c5sc04709a]; Jones GO, 2010, J AM CHEM SOC, V132, P6205, DOI 10.1021/ja100739h; Joseph PJA, 2017, ORG PROCESS RES DEV, V21, P1889, DOI 10.1021/acs.oprd.7b00285; Jover J, 2014, ACS CATAL, V4, P4389, DOI 10.1021/cs500872m; Konovalov AI, 2014, J AM CHEM SOC, V136, P13410, DOI 10.1021/ja507564p; Leas DA, 2017, ORG LETT, V19, P2518, DOI 10.1021/acs.orglett.7b00771; Lishchynskyi A, 2014, CHEM COMMUN, V50, P10237, DOI 10.1039/c4cc04930f; Lucarini M, 1998, J ORG CHEM, V63, P1687, DOI 10.1021/jo972178i; Morimoto H, 2011, ANGEW CHEM INT EDIT, V50, P3793, DOI 10.1002/anie.201100633; Oishi M, 2009, CHEM COMMUN, P1909, DOI 10.1039/b823249k; Petrone DA, 2016, CHEM REV, V116, P8003, DOI 10.1021/acs.chemrev.6b00089; Schareina T, 2012, TOP CATAL, V55, P426, DOI 10.1007/s11244-012-9824-0; Tasker SZ, 2014, NATURE, V509, P299, DOI 10.1038/nature13274; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293; Tsuji J., 2005, PALLADIUM REAGENTS C; Twilton J, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0052; Uneyama K., 2006, ORGANOFLUORINE CHEM; Xia ZH, 2013, ORG LETT, V15, P4110, DOI 10.1021/ol4017244; Yi H, 2017, CHEM REV, V117, P9016, DOI 10.1021/acs.chemrev.6b00620; Yu HZ, 2010, J AM CHEM SOC, V132, P18078, DOI 10.1021/ja104264v; Zanardi A, 2011, J AM CHEM SOC, V133, P20901, DOI 10.1021/ja2081026; Zhang P, 2016, J AM CHEM SOC, V138, P8084, DOI 10.1021/jacs.6b04818	38	225	227	19	251	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					1010	+		10.1126/science.aat4133	http://dx.doi.org/10.1126/science.aat4133			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6SL	29853683	Green Accepted			2022-12-28	WOS:000433574200040
J	Crisp, N				Crisp, Nigel			Nursing-the wave of the future	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Crisp, Nigel] All Party Parliamentary Grp Global Hlth, London, England		Crisp, N (corresponding author), All Party Parliamentary Grp Global Hlth, London, England.	crisp@parliament.uk		Crisp, Nigel/0000-0002-9452-095X				All-Party Parliamentary Group on Global Health, 2016, TRIPL IMP DEV NURS W; Calouste Gulbenkian Foundation, 2014, FUT HLTH EV HAS ROL, P148; Salvage J, 2018, J CLIN NURS, V27, P1301, DOI 10.1111/jocn.14306; United Nations, 2018, TRANSF OUR WORLD 203	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2018	361								k2355	10.1136/bmj.k2355	http://dx.doi.org/10.1136/bmj.k2355			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MT	29853442				2022-12-28	WOS:000434276300008
J	Munoz, JB; Loeb, A				Munoz, Julian B.; Loeb, Abraham			A small amount of mini-charged dark matter could cool the baryons in the early Universe	NATURE			English	Article							RECOMBINATION; PARTICLES; SEARCH; RANGE	The dynamics of our Universe is strongly influenced by pervasive-albeit elusive-dark matter, with a total mass about five times the mass of all the baryons(1,2). Despite this, its origin and composition remain a mystery. All evidence for dark matter relies on its gravitational pull on baryons, and thus such evidence does not require any non-gravitational coupling between baryons and dark matter. Nonetheless, some small coupling would explain the comparable cosmic abundances of dark matter and baryons(3), as well as solving structure-formation puzzles in the pure cold-dark-matter models(4). A vast array of observations has been unable to find conclusive evidence for any non-gravitational interactions of baryons with dark matter(5-9). Recent observations by the EDGES collaboration, however, suggest that during the cosmic dawn, roughly 200 million years after the Big Bang, the baryonic temperature was half of its expected value(10). This observation is difficult to reconcile with the standard cosmological model but could be explained if baryons are cooled down by interactions with dark matter, as expected if their interaction rate grows steeply at low velocities(11). Here we report that if a small fraction-less than one per cent-of the dark matter has a mini-charge, a million times smaller than the charge on the electron, and a mass in the range of 1-100 times the electron mass, then the data(10) from the EDGES experiment can be explained while remaining consistent with all other observations. We also show that the entirety of the dark matter cannot have a mini-charge.	[Munoz, Julian B.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Loeb, Abraham] Harvard Univ, Dept Astron, Cambridge, MA 02138 USA	Harvard University; Harvard University	Munoz, JB (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	julianmunoz@fas.harvard.edu			Black Hole Initiative; JTF grant	Black Hole Initiative; JTF grant	We thank P. Agrawal, Y. Ali-Haimoud, C. Dvorkin, M. Kamionkowski, D. Pinner, C. Stubbs and S. Westerdale for discussions. This research is supported in part by the Black Hole Initiative, which is funded by a JTF grant.	Ackermann M, 2017, ASTROPHYS J, V840, DOI 10.3847/1538-4357/aa6cab; Ade PAR, 2016, ASTRON ASTROPHYS, V594, DOI 10.1051/0004-6361/201525830; Akerib DS, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.021303; Ali-Haimoud Y, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.043513; Ali-Haimoud Y, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.063521; Barkana R., 2017, PREPRINT; Batell B, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.045016; Bovy J, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/89; Brust C, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2013)058; Chluba J, 2011, MON NOT R ASTRON SOC, V412, P748, DOI 10.1111/j.1365-2966.2010.17940.x; Clarke TE, 2001, ASTROPHYS J, V547, pL111, DOI 10.1086/318896; Cline JM, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.101302; Davidson S., 2000, J HIGH ENERGY PHYS, V05; DeBoer DR, 2017, PUBL ASTRON SOC PAC, V129, DOI 10.1088/1538-3873/129/974/045001; Dolgov AD, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.117701; Dvorkin C, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.023519; Erickcek AL, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.042007; Essig R., 2013, WORKING GROUP REPORT; Fox PJ, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.014028; Furlanetto SR, 2006, PHYS REP, V433, P181, DOI 10.1016/j.physrep.2006.08.002; HOLDOM B, 1986, PHYS LETT B, V166, P196, DOI 10.1016/0370-2693(86)91377-8; Jaeckel J, 2010, ANNU REV NUCL PART S, V60, P405, DOI 10.1146/annurev.nucl.012809.104433; Jansson R, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/14; Kadota K., 2016, PREPRINT; KAPLAN DB, 1992, PHYS REV LETT, V68, P741, DOI 10.1103/PhysRevLett.68.741; Knapen S, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.115021; LINDHARD J, 1961, PHYS REV, V124, P128, DOI 10.1103/PhysRev.124.128; Loeb A., 2013, 1 GALAXIES UNIVERSE; MA CP, 1995, ASTROPHYS J, V455, P7, DOI 10.1086/176550; Madau P, 1997, ASTROPHYS J, V475, P429, DOI 10.1086/303549; McDermott SD, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.063509; Munoz J. B., 2017, J COSMOL ASTROPART P, V1711; Munoz JB, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.083528; PEEBLES PJE, 1968, ASTROPHYS J, V153, P1, DOI 10.1086/149628; Pritchard JR, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.103511; Pritchard JR, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.023006; RUBIN VC, 1980, ASTROPHYS J, V238, P471, DOI 10.1086/158003; Slatyer TR, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.123513; STUBBS CW, 1987, PHYS REV LETT, V58, P1070, DOI 10.1103/PhysRevLett.58.1070; Tashiro H, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.083522; Vogel H, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/02/029; Wagner TA, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/18/184002; Weinberg DH, 2015, P NATL ACAD SCI USA, V112, P12249, DOI 10.1073/pnas.1308716112; WOUTHUYSEN SA, 1952, ASTRON J, V57, P31, DOI 10.1086/106661	53	152	152	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					684	+		10.1038/s41586-018-0151-x	http://dx.doi.org/10.1038/s41586-018-0151-x			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29849153	Green Submitted			2022-12-28	WOS:000433412900045
J	Iacobucci, G				Iacobucci, Gareth			Scrap the Cap: BMJ calls for end to cap on non-EEA doctors being allowed to work in NHS	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2367; Limb M, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2224; Rimmer A, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2197	3	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2018	361								k2362	10.1136/bmj.k2362	http://dx.doi.org/10.1136/bmj.k2362			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MP	29848483				2022-12-28	WOS:000434275800007
J	Hand, E				Hand, Eric			Rival giant telescopes join to seek US funding	SCIENCE			English	News Item																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					839	840		10.1126/science.360.6391.839	http://dx.doi.org/10.1126/science.360.6391.839			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798860				2022-12-28	WOS:000433039800018
J	Burke, M; Davis, WM; Diffenbaugh, NS				Burke, Marshall; Davis, W. Matthew; Diffenbaugh, Noah S.			Large potential reduction in economic damages under UN mitigation targets	NATURE			English	Article							CLIMATE-CHANGE; DISTANT FUTURE; TEMPERATURE; GROWTH; STERN; COST; WELL	International climate change agreements typically specify global warming thresholds as policy targets(1), but the relative economic benefits of achieving these temperature targets remain poorly understood(2,3). Uncertainties include the spatial pattern of temperature change, how global and regional economic output will respond to these changes in temperature, and the willingness of societies to trade present for future consumption. Here we combine historical evidence(4) with national-level climate(5) and socioeconomic(6) projections to quantify the economic damages associated with the United Nations (UN) targets of 1.5 degrees C and 2 degrees C global warming, and those associated with current UN national-level mitigation commitments (which together approach 3 degrees C warming(7)). We find that by the end of this century, there is a more than 75% chance that limiting warming to 1.5 degrees C would reduce economic damages relative to 2 degrees C, and a more than 60% chance that the accumulated global benefits will exceed US$20 trillion under a 3% discount rate (2010 US dollars). We also estimate that 71% of countries-representing 90% of the global population-have a more than 75% chance of experiencing reduced economic damages at 1.5 degrees C, with poorer countries benefiting most. Our results could understate the benefits of limiting warming to 1.5 degrees C if unprecedented extreme outcomes, such as large-scale sea level rise(8), occur for warming of 2 degrees C but not for warming of 1.5 degrees C. Inclusion of other unquantified sources of uncertainty, such as uncertainty in secular growth rates beyond that contained in existing socioeconomic scenarios, could also result in less precise impact estimates. We find considerably greater reductions in global economic output beyond 2 degrees C. Relative to a world that did not warm beyond 2000-2010 levels, we project 15%-25% reductions in per capita output by 2100 for the 2.5-3 degrees C of global warming implied by current national commitments(7), and reductions of more than 30% for 4 degrees C warming. Our results therefore suggest that achieving the 1.5 degrees C target is likely to reduce aggregate damages and lessen global inequality, and that failing to meet the 2 degrees C target is likely to increase economic damages substantially.	[Burke, Marshall; Diffenbaugh, Noah S.] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Burke, Marshall; Davis, W. Matthew] Stanford Univ, Ctr Food Secur & Environm, Stanford, CA 94305 USA; [Burke, Marshall] NBER, Cambridge, MA 02138 USA; [Diffenbaugh, Noah S.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA	Stanford University; Stanford University; National Bureau of Economic Research; Stanford University	Burke, M (corresponding author), Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA.; Burke, M (corresponding author), Stanford Univ, Ctr Food Secur & Environm, Stanford, CA 94305 USA.; Burke, M (corresponding author), NBER, Cambridge, MA 02138 USA.	mburke@stanford.edu	Diffenbaugh, Noah S/I-5920-2014	Diffenbaugh, Noah S/0000-0002-8856-4964; Burke, Marshall/0000-0003-4288-5858; Alampay Davis, William Matthew/0000-0002-9502-2450	Erol Foundation	Erol Foundation	We thank L. Goulder, S. Hsiang and D. Lobell for comments. We thank the Erol Foundation for funding.	[Anonymous], 2016, Nature, V537, P585, DOI 10.1038/537585b; Arrow KJ, 2014, REV ENV ECON POLICY, V8, P145, DOI 10.1093/reep/reu008; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Burke M, 2016, SCIENCE, V352, P292, DOI 10.1126/science.aad9634; Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Cai YY, 2016, NAT CLIM CHANGE, V6, P520, DOI [10.1038/nclimate2964, 10.1038/NCLIMATE2964]; Carleton TA, 2016, SCIENCE, V353, DOI 10.1126/science.aad9837; Colacito R., 2016, IDBWP676; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; Deryugina T., 2014, TECHNICAL REPORT; Goulder LH, 2012, CLIM CHANG ECON, V3, DOI 10.1142/S2010007812500248; Greenstone M, 2013, REV ENV ECON POLICY, V7, P23, DOI 10.1093/reep/res015; Groom B, 2007, J APPL ECONOMET, V22, P641, DOI 10.1002/jae.937; Hallegatte S., 2015, SHOCK WAVES MANAGING, DOI 10.1596/978-1-4648-0673-5; Hallegatte S, 2016, NAT CLIM CHANGE, V6, P663, DOI 10.1038/NCLIMATE3057; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Henderson JV, 2012, AM ECON REV, V102, P994, DOI 10.1257/aer.102.2.994; Hof AF, 2017, ENVIRON SCI POLICY, V71, P30, DOI 10.1016/j.envsci.2017.02.008; Hsiang S, 2017, SCIENCE, V356, P1362, DOI 10.1126/science.aal4369; Hsiang SM, 2010, P NATL ACAD SCI USA, V107, P15367, DOI 10.1073/pnas.1009510107; Jean N, 2016, SCIENCE, V353, P790, DOI 10.1126/science.aaf7894; Mastrandrea MD, 2011, CLIMATIC CHANGE, V108, P675, DOI 10.1007/s10584-011-0178-6; Newell RG, 2003, J ENVIRON ECON MANAG, V46, P52, DOI 10.1016/S0095-0696(02)00031-1; Nordhaus W. D., 2008, QUESTION BALANCE WEI; O'Neill BC, 2017, GLOBAL ENVIRON CHANG, V42, P169, DOI 10.1016/j.gloenvcha.2015.01.004; Quiggin J, 2008, CLIMATIC CHANGE, V89, P195, DOI 10.1007/s10584-008-9434-9; Rogelj J, 2016, NATURE, V534, P631, DOI 10.1038/nature18307; Rogelj J, 2013, NATURE, V493, P79, DOI 10.1038/nature11787; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schleussner CF, 2016, NAT CLIM CHANGE, V6, P827, DOI 10.1038/NCLIMATE3096; Seneviratne SI, 2016, NATURE, V529, P477, DOI 10.1038/nature16542; Stern N, 2007, EC CLIMATE CHANGE ST; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tebaldi C, 2007, PHILOS T R SOC A, V365, P2053, DOI 10.1098/rsta.2007.2076; van Vuuren DP, 2017, GLOBAL ENVIRON CHANG, V42, P148, DOI 10.1016/j.gloenvcha.2016.10.009; Weitzman ML, 2007, J ECON LIT, V45, P703, DOI 10.1257/jel.45.3.703; Zhang P, 2018, J ENVIRON ECON MANAG, V88, P1, DOI 10.1016/j.jeem.2017.11.001	38	124	130	17	70	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2018	557	7706					549	+		10.1038/s41586-018-0071-9	http://dx.doi.org/10.1038/s41586-018-0071-9			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG6GP	29795251				2022-12-28	WOS:000432794900045
J	Lee, JS; Somerman, MJ				Lee, Janice S.; Somerman, Martha J.			The Importance of Oral Health in Comprehensive Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lee, Janice S.; Somerman, Martha J.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Lee, JS (corresponding author), Natl Inst Dent & Craniofacial Res, 10 Ctr Dr,5-2531,MSC1470, Bethesda, MD 20892 USA.	janice.lee@nih.gov			National Institute of Dental and Craniofacial Research Intramural Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000746] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research Intramural Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for the video was provided by the National Institute of Dental and Craniofacial Research Intramural Program.	Bernstein J, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160066; Bui AL, 2017, JAMA PEDIATR, V171, P181, DOI 10.1001/jamapediatrics.2016.4086; Crall JJ, 2016, HEALTH AFFAIR, V35, P2216, DOI 10.1377/hlthaff.2016.0880; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Dooley D, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2014-3532; Institute of Medicine, 2011, ADV OR HLTH AM; US Centers for Disease Control and Prevention; National Center for Health Statistics. Data brief 197, DAT BRIEF 197 DENT C; US Centers for Disease Control and Prevention; National Center for Health Statistics. Health United States, 2016, HLTH US 2016 CHARTB; Wu YY, 2015, INT J ORAL SCI, V7, P63, DOI 10.1038/ijos.2015.2	9	17	18	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2018	320	4					339	340		10.1001/jama.2017.19777	http://dx.doi.org/10.1001/jama.2017.19777			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GO0AX	29801162				2022-12-28	WOS:000439581200014
J	Grobner, SN; Worst, BC; Weischenfeldt, J; Buchhalter, I; Kleinheinz, K; Rudneva, VA; Johann, PD; Balasubramanian, GP; Segura-Wang, M; Brabetz, S; Bender, S; Hutter, B; Sturm, D; Pfaff, E; Hubschmann, D; Zipprich, G; Heinold, M; Eils, J; Lawerenz, C; Erkek, S; Lambo, S; Waszak, S; Blattmann, C; Borkhardt, A; Kuhlen, M; Eggert, A; Fulda, S; Gessler, M; Wegert, J; Kappler, R; Baumhoer, D; Burdach, S; Kirschner-Schwabe, R; Kontny, U; Kulozik, AE; Lohmann, D; Hettmer, S; Eckert, C; Bielack, S; Nathrath, M; Niemeyer, C; Richter, GH; Schulte, J; Siebert, R; Westermann, F; Molenaar, JJ; Vassal, G; Witt, H; Burkhardt, B; Kratz, CP; Witt, O; van Tilburg, CM; Kramm, CM; Fleischhack, G; Dirksen, U; Rutkowski, S; Fruhwald, M; von Hoff, K; Wolf, S; Klingebiel, T; Koscielniak, E; Landgraf, P; Koster, J; Resnick, AC; Zhang, JH; Liu, YL; Zhou, X; Waanders, AJ; Zwijnenburg, DA; Raman, P; Brors, B; Weber, UD; Northcott, PA; Pajtler, KW; Kool, M; Piro, RM; Korbel, JO; Schlesner, M; Eils, R; Jones, DTW; Lichter, P; Chavez, L; Zapatka, M; Pfister, SM				Groebner, Susanne N.; Worst, Barbara C.; Weischenfeldt, Joachim; Buchhalter, Ivo; Kleinheinz, Kortine; Rudneva, Vasilisa A.; Johann, Pascal D.; Balasubramanian, Gnana Prakash; Segura-Wang, Maia; Brabetz, Sebastian; Bender, Sebastian; Hutter, Barbara; Sturm, Dominik; Pfaff, Elke; Huebschmann, Daniel; Zipprich, Gideon; Heinold, Michael; Eils, Juergen; Lawerenz, Christian; Erkek, Serap; Lambo, Sander; Waszak, Sebastian; Blattmann, Claudia; Borkhardt, Arndt; Kuhlen, Michaela; Eggert, Angelika; Fulda, Simone; Gessler, Manfred; Wegert, Jenny; Kappler, Roland; Baumhoer, Daniel; Burdach, Stefan; Kirschner-Schwabe, Renate; Kontny, Udo; Kulozik, Andreas E.; Lohmann, Dietmar; Hettmer, Simone; Eckert, Cornelia; Bielack, Stefan; Nathrath, Michaela; Niemeyer, Charlotte; Richter, Guenther H.; Schulte, Johannes; Siebert, Reiner; Westermann, Frank; Molenaar, Jan J.; Vassal, Gilles; Witt, Hendrik; Burkhardt, Birgit; Kratz, Christian P.; Witt, Olaf; van Tilburg, Cornelis M.; Kramm, Christof M.; Fleischhack, Gudrun; Dirksen, Uta; Rutkowski, Stefan; Fruehwald, Michael; von Hoff, Katja; Wolf, Stephan; Klingebiel, Thomas; Koscielniak, Ewa; Landgraf, Pablo; Koster, Jan; Resnick, Adam C.; Zhang, Jinghui; Liu, Yanling; Zhou, Xin; Waanders, Angela J.; Zwijnenburg, Danny A.; Raman, Pichai; Brors, Benedikt; Weber, Ursula D.; Northcott, Paul A.; Pajtler, Kristian W.; Kool, Marcel; Piro, Rosario M.; Korbel, Jan O.; Schlesner, Matthias; Eils, Roland; Jones, David T. W.; Lichter, Peter; Chavez, Lukas; Zapatka, Marc; Pfister, Stefan M.		ICGC PedBrain-Seq Project; ICGC MMML-Seq Project	The landscape of genomic alterations across childhood cancers (vol 555, pg 321, 2018)	NATURE			English	Correction									[Brors, Benedikt] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; German Canc Res Ctr, Heidelberg, Germany	St Jude Children's Research Hospital; Helmholtz Association; German Cancer Research Center (DKFZ)	Brors, B (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.		Hoffmann, Steve/E-1438-2013; Rudneva, Vasilisa/Q-5495-2018; Pfister, Stefan M/F-6860-2013; Dirksen, Uta/AGX-8472-2022; Westermann, Frank/F-7509-2013; Pajtler, Kristian/AAN-9029-2020; Zapatka, Marc/G-9896-2013; Eggert, Angelika/AAE-6907-2022; Zhang, Jing/GWZ-7332-2022; Kratz, Christian/AAC-9726-2021; Kulozik, Andreas/AAO-2432-2020; Lohmann, Dietmar R./X-4895-2019; Northcott, Paul A/N-4022-2018; Weischenfeldt, Joachim/O-3681-2015; Brors, Benedikt/E-5620-2013; Burkhardt, Birgit/AAS-9678-2021; Ammerpohl, Ole/G-2691-2010; Eils, Roland/B-6121-2009; Rausch, Tobias/H-6511-2019; Radlwimmer, Bernhard/I-3229-2013; Schlesner, Matthias/I-4030-2013	Pfister, Stefan M/0000-0002-5447-5322; Zapatka, Marc/0000-0001-8287-5967; Eggert, Angelika/0000-0003-3476-8184; Lohmann, Dietmar R./0000-0002-2624-9889; Northcott, Paul A/0000-0002-1220-5252; Weischenfeldt, Joachim/0000-0002-3917-5524; Brors, Benedikt/0000-0001-5940-3101; Burkhardt, Birgit/0000-0002-1151-829X; Eils, Roland/0000-0002-0034-4036; Rausch, Tobias/0000-0001-5773-5620; Radlwimmer, Bernhard/0000-0002-4553-7800; Schlesner, Matthias/0000-0002-5896-4086; Gessler, Manfred/0000-0002-7915-6045; Kerssemakers, Jules/0000-0002-0460-7032; Kirschner-Schwabe, Renate/0000-0001-6335-3274; Fulda, Simone/0000-0002-0459-6417; Schulte, Johannes Hubertus/0000-0003-0671-1201; Chavez, Lukas/0000-0002-8718-8848; Koster, Jan/0000-0002-0890-7585; Piro, Rosario/0000-0002-3066-7397; Huebschmann, Daniel/0000-0002-6041-7049				Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480	1	15	16	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2018	559	7714					E10	E10		10.1038/s41586-018-0167-2	http://dx.doi.org/10.1038/s41586-018-0167-2			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5BX	29875405	Bronze			2022-12-28	WOS:000439059800012
J	Chen, L; Roake, CM; Freund, A; Batista, PJ; Tian, S; Yin, YA; Gajera, CR; Lin, SD; Lee, B; Pech, MF; Venteicher, AS; Das, R; Chang, HY; Artandi, SE				Chen, Lu; Roake, Caitlin M.; Freund, Adam; Batista, Pedro J.; Tian, Siqi; Yin, Yi A.; Gajera, Chandresh R.; Lin, Shengda; Lee, Byron; Pech, Matthew F.; Venteicher, Andrew S.; Das, Rhiju; Chang, Howard Y.; Artandi, Steven E.			An Activity Switch in Human Telomerase Based on RNA Conformation and Shaped by TCAB1	CELL			English	Article							TERT PROMOTER MUTATIONS; CAJAL BODIES; RECRUITMENT; TRAFFICKING; DOMAIN; CELLS; IDENTIFICATION; LOCALIZATION; MAINTENANCE; ACTIVATION	Ribonucleoprotein enzymes require dynamic conformations of their RNA constituents for regulated catalysis. Human telomerase employs a non-coding RNA (hTR) with a bipartite arrangement of domains-a template-containing core and a distal three-way junction (CR4/5) that stimulates catalysis through unknown means. Here, we show that telomerase activity unexpectedly depends upon the holoenzyme protein TCAB1, which in turn controls conformation of CR4/5. Cells lacking TCAB1 exhibit a marked reduction in telomerase catalysis without affecting enzyme assembly. Instead, TCAB1 inactivation causes unfolding of CR4/5 helices that are required for catalysis and for association with the telomerase reverse-transcriptase (TERT). CR4/5 mutations derived from patients with telomere biology disorders provoke defects in catalysis and TERT binding similar to TCAB1 inactivation. These findings reveal a conformational "activity switch'' in human telomerase RNA controlling catalysis and TERT engagement. The identification of two discrete catalytic states for telomerase suggests an intramolecular means for controlling telomerase in cancers and progenitor cells.	[Chen, Lu; Roake, Caitlin M.; Freund, Adam; Yin, Yi A.; Gajera, Chandresh R.; Lin, Shengda; Pech, Matthew F.; Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Chen, Lu; Roake, Caitlin M.; Freund, Adam; Tian, Siqi; Yin, Yi A.; Gajera, Chandresh R.; Lin, Shengda; Pech, Matthew F.; Venteicher, Andrew S.; Das, Rhiju; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Chen, Lu; Roake, Caitlin M.; Freund, Adam; Yin, Yi A.; Gajera, Chandresh R.; Lin, Shengda; Pech, Matthew F.; Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Batista, Pedro J.; Lee, Byron; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Batista, Pedro J.; Lee, Byron; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University	Artandi, SE (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.; Artandi, SE (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.; Artandi, SE (corresponding author), Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA.	sartandi@stanford.edu	Chen, Lu/AAN-4886-2021; Gajera, Chandresh R/AAN-2454-2021; Venteicher, Andrew/AAN-5666-2021	Chen, Lu/0000-0002-4571-7975; Gajera, Chandresh R/0000-0002-4638-2097; Venteicher, Andrew/0000-0003-0643-0493; Das, Rhiju/0000-0001-7497-0972; Lee, Byron/0000-0001-7132-2662	NIH [CA197563, AG056575, GM122579, GM102519, HG004361]; MSTP Training Grant [GM007365]; Gerald J. Lieberman Fellowship; Stanford Cancer Institute; NATIONAL CANCER INSTITUTE [R35CA197563] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102519, R35GM122579, T32GM007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG056575] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP Training Grant; Gerald J. Lieberman Fellowship; Stanford Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to members of the Artandi laboratory and to D. Herschlag for critical comments. This work was supported by NIH grants CA197563 and AG056575 (S.E.A.), GM122579 and GM102519 (R.D.), and HG004361 (H.Y.C.). C.M.R. was supported by MSTP Training Grant GM007365 and by a Gerald J. Lieberman Fellowship. L.C. was supported by a Stanford Cancer Institute 2018 Fellowship Award.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Berman AJ, 2010, MOL CELL BIOL, V30, P4965, DOI 10.1128/MCB.00827-10; Cash DD, 2017, NUCLEIC ACIDS RES, V45, P482, DOI 10.1093/nar/gkw1153; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen JL, 2002, NUCLEIC ACIDS RES, V30, P592, DOI 10.1093/nar/30.2.592; Chen YL, 2015, NUCLEIC ACIDS RES, V43, P385, DOI 10.1093/nar/gku1277; Chen YN, 2018, EMBO J, V37, DOI 10.15252/embj.201797953; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Flynn RA, 2016, NAT PROTOC, V11, P273, DOI 10.1038/nprot.2016.011; Folco EG, 2012, JOVE-J VIS EXP, DOI 10.3791/4140; Freund A, 2014, CELL, V159, P1389, DOI 10.1016/j.cell.2014.10.059; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huang J, 2014, NAT STRUCT MOL BIOL, V21, P507, DOI 10.1038/nsmb.2819; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kim NK, 2014, NUCLEIC ACIDS RES, V42, P3395, DOI 10.1093/nar/gkt1276; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; Leeper TC, 2005, RNA, V11, P394, DOI 10.1261/rna.7222505; Lemieux B, 2016, CELL, V165, P1171, DOI 10.1016/j.cell.2016.04.018; Mitchell JR, 2000, MOL CELL, V6, P361, DOI 10.1016/S1097-2765(00)00036-8; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Pech MF, 2015, GENE DEV, V29, P2420, DOI 10.1101/gad.271783.115; Pfeiffer V, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010405; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Podlevsky JD, 2016, RNA BIOL, V13, P720, DOI 10.1080/15476286.2016.1205768; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robart AR, 2010, J BIOL CHEM, V285, P4375, DOI 10.1074/jbc.M109.088575; Schmidt JC, 2016, CELL, V166, P1188, DOI 10.1016/j.cell.2016.07.033; Schmidt JC, 2015, GENE DEV, V29, P1095, DOI 10.1101/gad.263863.115; Schroeder R, 2004, NAT REV MOL CELL BIO, V5, P908, DOI 10.1038/nrm1497; Sexton AN, 2014, GENE DEV, V28, P1885, DOI 10.1101/gad.246819.114; Stern JL, 2012, MOL CELL BIOL, V32, P2384, DOI 10.1128/MCB.00379-12; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Vogan JM, 2016, ELIFE, V5, DOI 10.7554/eLife.18221; Vulliamy TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024383; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335; Yoon S, 2011, BIOINFORMATICS, V27, P1798, DOI 10.1093/bioinformatics/btr277; Zaug AJ, 2013, NUCLEIC ACIDS RES, V41, P8969, DOI 10.1093/nar/gkt653; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	51	40	42	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 28	2018	174	1					218	+		10.1016/j.cell.2018.04.039	http://dx.doi.org/10.1016/j.cell.2018.04.039			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GL3CR	29804836	Bronze, Green Accepted			2022-12-28	WOS:000437005800022
J	Webster, CR; Mahaffy, PR; Atreya, SK; Moores, JE; Flesch, GJ; Malespin, C; Mckay, CP; Martinez, G; Smith, CL; Martin-Torres, J; Gomez-Elvira, J; Zorzano, MP; Wong, MH; Trainer, MG; Steele, A; Archer, D; Sutter, B; Coll, PJ; Freissinet, C; Meslin, PY; Gough, RV; House, CH; Pavlov, A; Eigenbrode, JL; Glavin, DP; Pearson, JC; Keymeulen, D; Christensen, LE; Schwenzer, SP; Navarro-Gonzalez, R; Pla-Garcia, J; Rafkin, SCR; Vicente-Retortillo, A; Kahanpaa, H; Viudez-Moreiras, D; Smith, MD; Harri, AM; Genzer, M; Hassler, DM; Lemmon, M; Crisp, J; Sander, SP; Zurek, RW; Vasavada, AR				Webster, Christopher R.; Mahaffy, Paul R.; Atreya, Sushil K.; Moores, John E.; Flesch, Gregory J.; Malespin, Charles; McKay, Christopher P.; Martinez, German; Smith, Christina L.; Martin-Torres, Javier; Gomez-Elvira, Javier; Zorzano, Maria-Paz; Wong, Michael H.; Trainer, Melissa G.; Steele, Andrew; Archer, Doug, Jr.; Sutter, Brad; Coll, Patrice J.; Freissinet, Caroline; Meslin, Pierre-Yves; Gough, Raina V.; House, Christopher H.; Pavlov, Alexander; Eigenbrode, Jennifer L.; Glavin, Daniel P.; Pearson, John C.; Keymeulen, Didier; Christensen, Lance E.; Schwenzer, Susanne P.; Navarro-Gonzalez, Rafael; Pla-Garcia, Jorge; Rafkin, Scot C. R.; Vicente-Retortillo, Alvaro; Kahanpaa, Henrik; Viudez-Moreiras, Daniel; Smith, Michael D.; Harri, Ari-Matti; Genzer, Maria; Hassler, Donald M.; Lemmon, Mark; Crisp, Joy; Sander, Stanley P.; Zurek, Richard W.; Vasavada, Ashwin R.			Background levels of methane in Mars' atmosphere show strong seasonal variations	SCIENCE			English	Article							MARTIAN ATMOSPHERE; COMETARY ORIGIN; LIFE; HABITABILITY; VARIABILITY; ADSORPTION; CLIMATE; SEARCH; ETHANE	Variable levels of methane in the martian atmosphere have eluded explanation partly because the measurements are not repeatable in time or location. We report in situ measurements at Gale crater made over a 5-year period by the Tunable Laser Spectrometer on the Curiosity rover. The background levels of methane have a mean value 0.41 +/- 0.16 parts per billion by volume (ppbv) (95% confidence interval) and exhibit a strong, repeatable seasonal variation (0.24 to 0.65 ppbv). This variation is greater than that predicted from either ultraviolet degradation of impact-delivered organics on the surface or from the annual surface pressure cycle. The large seasonal variation in the background and occurrences of higher temporary spikes (similar to 7 ppbv) are consistent with small localized sources of methane released from martian surface or subsurface reservoirs.	[Webster, Christopher R.; Flesch, Gregory J.; Pearson, John C.; Keymeulen, Didier; Christensen, Lance E.; Crisp, Joy; Sander, Stanley P.; Zurek, Richard W.; Vasavada, Ashwin R.] CALTECH, NASA, Jet Prop Lab, Pasadena, CA 91125 USA; [Mahaffy, Paul R.; Malespin, Charles; Pavlov, Alexander; Eigenbrode, Jennifer L.; Glavin, Daniel P.; Smith, Michael D.] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA; [Atreya, Sushil K.; Martinez, German; Wong, Michael H.; Vicente-Retortillo, Alvaro] Univ Michigan, Dept Climate & Space Sci & Engn, Ann Arbor, MI 48109 USA; [Moores, John E.; McKay, Christopher P.] York Univ, Dept Earth & Space Sci & Engn, Toronto, ON, Canada; [McKay, Christopher P.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Martin-Torres, Javier; Zorzano, Maria-Paz] Lulea Univ Technol, Dept Comp Sci Elect & Space Engn, Lulea, Sweden; [Martin-Torres, Javier] Inst Andaluz Ciencias Tierra, Granada, Spain; [Martin-Torres, Javier; Gomez-Elvira, Javier; Pla-Garcia, Jorge] Inst Natl Tecn Aerosp, Ctr Astrobiol, Madrid, Spain; [Steele, Andrew] Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA; [Steele, Andrew] Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA; [Archer, Doug, Jr.; Sutter, Brad] NASA, Johnson Space Ctr, Jacobs Technol, Houston, TX USA; [Coll, Patrice J.] Lab Interuniv Syst Atmospher, Creteil, France; [Freissinet, Caroline] Lab Atmospheres Milieux Observat Spatiales, Paris 05, France; [Meslin, Pierre-Yves] Inst Rech Astrophys & Planetol, Toulouse, France; [Gough, Raina V.] Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA; [Gough, Raina V.] Univ Colorado, Cooperat Inst Res Environm Sci, Campus Box 215, Boulder, CO 80309 USA; [House, Christopher H.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Schwenzer, Susanne P.] Open Univ, Sch Environm Earth & Ecosyst Sci, Milton Keynes, Bucks, England; [Navarro-Gonzalez, Rafael] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Ciudad Univ, Mexico City, DF, Mexico; [Pla-Garcia, Jorge] Space Sci Inst, Boulder, CO USA; [Viudez-Moreiras, Daniel] Southwest Res Inst Boulder, Dept Space Studies, Boulder, CO USA; [Harri, Ari-Matti; Genzer, Maria] Finnish Meteorol Inst, Helsinki, Finland; [Lemmon, Mark] Texas A&M Univ, Dept Atmospher Sci, College Stn, TX USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Michigan System; University of Michigan; York University - Canada; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Lulea University of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Carnegie Institution for Science; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Open University - UK; Universidad Nacional Autonoma de Mexico; Finnish Meteorological Institute; Texas A&M University System; Texas A&M University College Station	Webster, CR (corresponding author), CALTECH, NASA, Jet Prop Lab, Pasadena, CA 91125 USA.	chris.r.webster@jpl.nasa.gov	Zorzano, María-Paz/F-2184-2015; Crisp, Joy/H-8287-2016; Harri, Ari-Matti/C-7142-2012; Lemmon, Mark T/E-9983-2010; Trainer, Melissa G/E-1477-2012; Martin-Torres, Javier/M-3779-2019; Martin-Torres, Javier/G-6329-2015; Eigenbrode, Jennifer L/D-4651-2012; Gomez-Elvira, Javier/K-5829-2014; Smith, Christina/GXG-6941-2022; Steele, Andrew/A-3573-2013; Moores, John E./AAO-6622-2021; Glavin, Daniel P/D-6194-2012; Kahanpää, Henrik/AAD-4801-2021; Lemmon, Mark/X-2333-2019; Navarro-González, Rafael/D-1748-2009; Webster, Chris/M-9315-2019; Pavlov, Alexander A./F-3779-2012; Mahaffy, Paul/E-4609-2012	Zorzano, María-Paz/0000-0002-4492-9650; Crisp, Joy/0000-0002-3202-4416; Harri, Ari-Matti/0000-0001-8541-2802; Lemmon, Mark T/0000-0002-4504-5136; Martin-Torres, Javier/0000-0001-6479-2236; Eigenbrode, Jennifer L/0000-0003-3089-1986; Gomez-Elvira, Javier/0000-0002-9068-9846; Steele, Andrew/0000-0001-9643-2841; Moores, John E./0000-0001-9435-1095; Glavin, Daniel P/0000-0001-7779-7765; Kahanpää, Henrik/0000-0001-9108-186X; Lemmon, Mark/0000-0002-4504-5136; Navarro-González, Rafael/0000-0002-6078-7621; Pavlov, Alexander A./0000-0001-8771-1646; Schwenzer, Susanne Petra/0000-0002-9608-0759; Vicente-Retortillo, Alvaro/0000-0002-4553-7624; Martinez, German/0000-0001-5885-236X; Mahaffy, Paul/0000-0003-1896-1726; Pla-Garcia, Jorge/0000-0002-8047-3937	NASA's Planetary Science Division; National Autonomous University of Mexico; Consejo Nacional de Ciencia y Tecnologia; Canadian Space Agency MSL participating scientist program; UK Space Agency; Finnish Academy [310509]; Spanish Ministry of Economy and Competitiveness [ESP2016-79612-C3-1-R]	NASA's Planetary Science Division; National Autonomous University of Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Canadian Space Agency MSL participating scientist program; UK Space Agency; Finnish Academy(Academy of Finland); Spanish Ministry of Economy and Competitiveness(Spanish Government)	Funding from NASA's Planetary Science Division is acknowledged by authors C.R.W., P.R.M., S.K.A., G.J.F., C.M., C.P.M., M.H.W., M.G.T., A.S., D.A., C.H.H., R.V.G., A.P., J.L.E., D.P.G., J.C.P., D.K., L.E.C., J.P.-G., S.C.R.R., M.D.S., D.M.H., M.L., J.C., R.W.Z., and A.R.V. R.N.-G. acknowledges funding from the National Autonomous University of Mexico and Consejo Nacional de Ciencia y Tecnologia. J.E.M. and C.L.S. acknowledge funding from the Canadian Space Agency MSL participating scientist program. S.P.Sc. acknowledges funding from the UK Space Agency. A.-M.H. acknowledges funding from the Finnish Academy under grant 310509. J.P.-G. acknowledges funding from the Spanish Ministry of Economy and Competitiveness under contract ESP2016-79612-C3-1-R.	Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Atreya SK, 2006, ASTROBIOLOGY, V6, P439, DOI 10.1089/ast.2006.6.439; Atreya SK, 2011, PLANET SPACE SCI, V59, P133, DOI 10.1016/j.pss.2010.10.008; Chassefiere E, 2009, ICARUS, V204, P137, DOI 10.1016/j.icarus.2009.06.016; Chastain BK, 2007, PLANET SPACE SCI, V55, P1246, DOI 10.1016/j.pss.2007.02.003; Etiope G, 2011, PLANET SPACE SCI, V59, P182, DOI 10.1016/j.pss.2010.06.003; Etiope G., 2015, NATURAL GAS SEEPAGE; Farrell W. M., 2006, J GEOPHYS RES, V33; Fonti S, 2015, ASTRON ASTROPHYS, V581, DOI 10.1051/0004-6361/201526235; Fonti S, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913178; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Fries M, 2016, GEOCHEM PERSPECT LET, V2, P10, DOI 10.7185/geochemlet.1602; Garry JRC, 2006, METEORIT PLANET SCI, V41, P391, DOI 10.1111/j.1945-5100.2006.tb00470.x; Geminale A, 2011, PLANET SPACE SCI, V59, P137, DOI 10.1016/j.pss.2010.07.011; Gough RV, 2010, ICARUS, V207, P165, DOI 10.1016/j.icarus.2009.11.030; HOURDIN F, 1993, J ATMOS SCI, V50, P3625, DOI 10.1175/1520-0469(1993)050<3625:MVATAS>2.0.CO;2; IPCC, 2014, 5 ASSESSMENT REPORT; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; Keppler F, 2012, NATURE, V486, P93, DOI 10.1038/nature11203; Kite ES, 2017, NAT GEOSCI, V10, P737, DOI 10.1038/NGEO3033; Krashnopolsky VA, 2004, ICARUS, V172, P537, DOI 10.1016/j.icarus.2004.07.004; Krasnopolsky VA, 2006, ICARUS, V180, P359, DOI 10.1016/j.icarus.2005.10.015; Krasnopolsky VA, 2012, ICARUS, V217, P144, DOI 10.1016/j.icarus.2011.10.019; Lefevre F, 2009, NATURE, V460, P720, DOI 10.1038/nature08228; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; Martinez GM, 2017, SPACE SCI REV, V212, P295, DOI 10.1007/s11214-017-0360-x; McMahon S, 2013, INT J ASTROBIOL, V12, P113, DOI 10.1017/S1473550412000481; Meslin PY, 2011, PLANET SPACE SCI, V59, P247, DOI 10.1016/j.pss.2010.09.022; Mischna MA, 2011, PLANET SPACE SCI, V59, P227, DOI 10.1016/j.pss.2010.07.005; Mousis O, 2016, ICARUS, V278, P1, DOI 10.1016/j.icarus.2016.05.035; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; Newman CE, 2017, ICARUS, V291, P203, DOI 10.1016/j.icarus.2016.12.016; Oehler DZ, 2017, ASTROBIOLOGY, V17, P1233, DOI 10.1089/ast.2017.1657; Oze C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022691; Pereira PR, 2001, SEP PURIF TECHNOL, V21, P237, DOI 10.1016/S1383-5866(00)00206-9; Roos-Serote M, 2016, J GEOPHYS RES-PLANET, V121, P2108, DOI 10.1002/2016JE005076; Schuerger AC, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE004023; Trainer MG, 2010, ICARUS, V208, P192, DOI 10.1016/j.icarus.2010.02.006; Villanueva GL, 2013, ICARUS, V223, P11, DOI 10.1016/j.icarus.2012.11.013; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; Webster CR, 2015, SCIENCE, V347, P415, DOI 10.1126/science.1261713; Webster CR, 2013, SCIENCE, V342, P355, DOI 10.1126/science.1242902; Webster CR, 2011, PLANET SPACE SCI, V59, P271, DOI 10.1016/j.pss.2010.08.021; Zahnle K, 2015, SCIENCE, V347, P370, DOI 10.1126/science.aaa3687; Zahnle K, 2011, ICARUS, V212, P493, DOI 10.1016/j.icarus.2010.11.027; ZHANG SY, 1991, J PHYS CHEM-US, V95, P1722, DOI 10.1021/j100157a044	46	138	140	11	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1093	+		10.1126/science.aaq0131	http://dx.doi.org/10.1126/science.aaq0131			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI6TJ	29880682				2022-12-28	WOS:000434635500039
J	Chang, CC; Nicholson, AN; Rinaldi, E; Berkowitz, E; Garron, N; Brantley, DA; Monge-Camacho, H; Monahan, CJ; Bouchard, C; Clark, MA; Joo, B; Kurth, T; Orginos, K; Vranas, P; Walker-Loud, A				Chang, C. C.; Nicholson, A. N.; Rinaldi, E.; Berkowitz, E.; Garron, N.; Brantley, D. A.; Monge-Camacho, H.; Monahan, C. J.; Bouchard, C.; Clark, M. A.; Joo, B.; Kurth, T.; Orginos, K.; Vranas, P.; Walker-Loud, A.			A per-cent-level determination of the nucleon axial coupling from quantum chromodynamics	NATURE			English	Article							CHIRAL PERTURBATION-THEORY; DECAY; ASYMMETRY; NEUTRON	The axial coupling of the nucleon, gA, is the strength of its coupling to the weak axial current of the standard model of particle physics, in much the same way as the electric charge is the strength of the coupling to the electromagnetic current. This axial coupling dictates the rate at which neutrons decay to protons, the strength of the attractive long-range force between nucleons and other features of nuclear physics. Precision tests of the standard model in nuclear environments require a quantitative understanding of nuclear physics that is rooted in quantum chromodynamics, a pillar of the standard model. The importance of gA makes it a benchmark quantity to determine theoretically-a difficult task because quantum chromodynamics is non-perturbative, precluding known analytical methods. Lattice quantum chromodynamics provides a rigorous, non-perturbative definition of quantum chromodynamics that can be implemented numerically. It has been estimated that a precision of two per cent would be possible by 2020 if two challenges are overcome(1,2):contamination of gA from excited states must be controlled in the calculations and statistical precision must be improved markedly(2-10). Here we use an unconventional method(11) inspired by the Feynman-Hellmann theorem that overcomes these challenges. We calculate a gA value of 1.271 +/- 0.013, which has a precision of about one per cent.	[Chang, C. C.; Nicholson, A. N.; Rinaldi, E.; Brantley, D. A.; Monge-Camacho, H.; Kurth, T.; Vranas, P.; Walker-Loud, A.] Lawrence Berkeley Natl Lab, Nucl Sci Div, Berkeley, CA 94720 USA; [Chang, C. C.] RIKEN, Interdisciplinary Theoret & Math Sci iTHEMS Progr, Saitama, Japan; [Nicholson, A. N.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Nicholson, A. N.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC USA; [Rinaldi, E.] Brookhaven Natl Lab, RIKEN BNL Res Ctr, Upton, NY 11973 USA; [Rinaldi, E.; Berkowitz, E.; Brantley, D. A.; Vranas, P.; Walker-Loud, A.] Lawrence Livermore Natl Lab, Phys Div, Livermore, CA 94550 USA; [Berkowitz, E.] Forschungszentrum Julich, Inst Kernphys, Julich, Germany; [Berkowitz, E.] Forschungszentrum Julich, Inst Adv Simulat, Julich, Germany; [Garron, N.] Univ Liverpool, Dept Math Sci, Theoret Phys Div, Liverpool, Merseyside, England; [Brantley, D. A.; Monge-Camacho, H.; Bouchard, C.; Orginos, K.] Coll William & Mary, Dept Phys, Williamsburg, VA 23185 USA; [Monahan, C. J.] Rutgers State Univ, Phys Dept & Astron, Piscataway, NJ USA; [Monahan, C. J.] Univ Washington, Inst Nucl Theory, Seattle, WA 98195 USA; [Bouchard, C.] Univ Glasgow, Sch Phys & Astron, Glasgow, Lanark, Scotland; [Clark, M. A.] NVIDIA Corp, Santa Clara, CA USA; [Joo, B.] Thomas Jefferson Natl Accelerator Facil, Sci Comp Grp, Newport News, VA USA; [Kurth, T.] Lawrence Berkeley Natl Lab, NERSC, Berkeley, CA USA; [Orginos, K.] Thomas Jefferson Natl Accelerator Facil, Theory Ctr, Newport News, VA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; RIKEN; University of California System; University of California Berkeley; University of North Carolina; University of North Carolina Chapel Hill; RIKEN; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; University of Liverpool; William & Mary; Rutgers State University New Brunswick; University of Washington; University of Washington Seattle; University of Glasgow; Nvidia Corporation; United States Department of Energy (DOE); Jefferson National Accelerator; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Jefferson National Accelerator	Walker-Loud, A (corresponding author), Lawrence Berkeley Natl Lab, Nucl Sci Div, Berkeley, CA 94720 USA.; Walker-Loud, A (corresponding author), Lawrence Livermore Natl Lab, Phys Div, Livermore, CA 94550 USA.	awalker-loud@lbl.gov	Rinaldi, Enrico/J-8753-2018; Bouchard, Chris/L-4549-2019; Orginos, Kostas/Z-1237-2019; Kurth, Thorsten/Z-2117-2018; Bouchard, Chris/N-3723-2016	Rinaldi, Enrico/0000-0003-4134-809X; Orginos, Kostas/0000-0002-3535-7865; Kurth, Thorsten/0000-0003-0832-6198; Garron, Nicolas/0000-0002-4428-3984; Berkowitz, Evan/0000-0003-1082-1374; Walker-Loud, Andre/0000-0002-4686-3667; Bouchard, Chris/0000-0003-1639-7164; Vranas, Pavlos/0000-0002-8497-6283; Brantley, David/0000-0001-8131-3989; Monge-Camacho, Henry/0000-0002-9257-7813; Clark, Kate/0000-0001-5211-2002	Office of Science of the US Department of Energy at LLNL [DE-AC05-00OR22725]; NVIDIA Corporation; DFG; NSFC Sino-German [CRC110]; LBNL LDRD; RIKEN Special Postdoctoral Researcher Program; Leverhulme Trust; US Department of Energy, Office of Science: Office of Nuclear Physics; Office of Advanced Scientific Computing; Nuclear Physics Double Beta Decay Topical Collaboration; DOE Early Career Award Program; US Department of Energy by LLNL [DE-AC52-07NA27344]; NSF [PHY-1748958]; GPU-enabled Surface cluster at LLNL; RZHasGPU cluster at LLNL; Vulcan, a BG/Q supercomputer at LLNL; STFC [ST/S005781/1] Funding Source: UKRI	Office of Science of the US Department of Energy at LLNL(United States Department of Energy (DOE)); NVIDIA Corporation; DFG(German Research Foundation (DFG)); NSFC Sino-German; LBNL LDRD; RIKEN Special Postdoctoral Researcher Program; Leverhulme Trust(Leverhulme Trust); US Department of Energy, Office of Science: Office of Nuclear Physics(United States Department of Energy (DOE)); Office of Advanced Scientific Computing; Nuclear Physics Double Beta Decay Topical Collaboration; DOE Early Career Award Program(United States Department of Energy (DOE)); US Department of Energy by LLNL(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); GPU-enabled Surface cluster at LLNL; RZHasGPU cluster at LLNL; Vulcan, a BG/Q supercomputer at LLNL; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank C. Bernard, A. Bernstein, P. J. Bickel, C. Detar, A. X. El-Khadra, W. Haxton, Y. Hsia, V. Koch, A. S. Kronfeld, W. T. Lee, G. P. Lepage, E. Mereghetti, G. Miller, A. E. Raftery, D. Toussaint and F. Yuan for discussions. We thank E. Mereghetti for the updated Extended Data Fig. 7<SUP>29</SUP>. We thank the MILC Collaboration for providing their highly improved staggered quark configurations<SUP>30</SUP> without restriction. Computer time was awarded to CalLat (2016) by the Innovative and Novel Computational Impact on Theory and Experiment (INCITE) programme, as well as by the Lawrence Livermore National Laboratory (LLNL) Multiprogrammatic and Institutional Computing programme through a Tier-1 Grand Challenge award. This research used the NVIDIA GPU-accelerated Titan supercomputer at the Oak Ridge Leadership Computing Facility at the Oak Ridge National Laboratory, which is supported by the Office of Science of the US Department of Energy under contract number DE-AC05-00OR22725, the GPU-enabled Surface and RZHasGPU clusters, and Vulcan, a BG/Q supercomputer, all at LLNL. This work was supported by the NVIDIA Corporation (M. A. C.), the DFG and the NSFC Sino-German CRC110 (E.B.), an LBNL LDRD (A.W.-L.), the RIKEN Special Postdoctoral Researcher Program (E.R.), the Leverhulme Trust (N.G.), the US Department of Energy, Office of Science: Office of Nuclear Physics (E.B., C.B., D.A.B., C.C.C., T.K., C.J.M., H.M.-C., A.N.N., E. R., B.J., K.O., P.V. and A.W.-L.); Office of Advanced Scientific Computing (E.B., B.J., T.K. and A.W.-L.); Nuclear Physics Double Beta Decay Topical Collaboration (D.A.B., H.M.-C. and A.W.-L.); and the DOE Early Career Award Program (D.A.B., C.C.C., H.M.-C. and A.W.-L.). This work (E. B., E. R. and P. V.) was performed under the auspices of the US Department of Energy by LLNL under contract number DE-AC52-07NA27344. Part of this work was performed at the Kavli Institute for Theoretical Physics, supported by NSF grant number PHY-1748958.	Abdel-Rehim A, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.039904; Abdel-Rehim A, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.114513; Alexandrou C, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.054507; Alioli S, 2017, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2017)086; Aoki S, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-2890-7; Bali GS, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.054501; Bazavov A, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.054505; Berkowitz E, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.054513; Bhattacharya T, 2016, PHYS REV D, V94, DOI 10.1103/PhysRevD.94.054508; BOPP P, 1986, PHYS REV LETT, V56, P919, DOI 10.1103/PhysRevLett.56.919; Borsanyi S, 2015, SCIENCE, V347, P1452, DOI 10.1126/science.1257050; Bouchard C, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.014504; Capitani S, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.074502; Capitani S., 2017, PREPRINT; Detmold W, 2016, COLD NUCL PHYS USQCD; Durr S, 2008, SCIENCE, V322, P1224, DOI 10.1126/science.1163233; GASSER J, 1988, NUCL PHYS B, V307, P763, DOI 10.1016/0550-3213(88)90107-1; GASSER J, 1984, ANN PHYS-NEW YORK, V158, P142, DOI 10.1016/0003-4916(84)90242-2; Horsley R, 2014, PHYS LETT B, V732, P41, DOI 10.1016/j.physletb.2014.03.002; JENKINS E, 1991, PHYS LETT B, V255, P558, DOI 10.1016/0370-2693(91)90266-S; LHPC Collaboration, 2006, PHYS REV LETT, V96; Liaud P, 1997, NUCL PHYS A, V612, P53, DOI 10.1016/S0375-9474(96)00325-9; Lin HW, 2018, PROG PART NUCL PHYS, V100, P107, DOI 10.1016/j.ppnp.2018.01.007; Mendenhall MP, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.032501; Mostovoi YA, 2001, PHYS ATOM NUCL+, V64, P1955, DOI 10.1134/1.1423745; Mund D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.172502; Patrignani C, 2016, CHINESE PHYS C, V40, DOI 10.1088/1674-1137/40/10/100001; Schumann M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.151801; SYMANZIK K, 1983, NUCL PHYS B, V226, P187, DOI 10.1016/0550-3213(83)90468-6; WEINBERG S, 1979, PHYSICA A, V96, P327, DOI 10.1016/0378-4371(79)90223-1; Yerozolimsky B, 1997, PHYS LETT B, V412, P240, DOI 10.1016/S0370-2693(97)01004-6	31	100	101	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					91	+		10.1038/s41586-018-0161-8	http://dx.doi.org/10.1038/s41586-018-0161-8			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29849150	Green Submitted, Green Accepted			2022-12-28	WOS:000434273300042
J	Mouritsen, H				Mouritsen, Henrik			Long-distance navigation and magnetoreception in migratory animals	NATURE			English	Review							MAGNETIC COMPASS ORIENTATION; LIGHT-DEPENDENT MAGNETORECEPTION; RADICAL-PAIR MECHANISM; MONARCH BUTTERFLIES; STAR COMPASS; CUES; BIRDS; BRAIN; PIGEONS; MAP	For centuries, humans have been fascinated by how migratory animals find their way over thousands of kilometres. Here, I review the mechanisms used in animal orientation and navigation with a particular focus on long-distance migrants and magnetoreception. I contend that any long-distance navigational task consists of three phases and that no single cue or mechanism will enable animals to navigate with pinpoint accuracy over thousands of kilometres. Multiscale and multisensory cue integration in the brain is needed. I conclude by raising twenty important mechanistic questions related to long-distance animal navigation that should be solved over the next twenty years.	[Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, Oldenburg, Germany; [Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Mouritsen, H (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, Oldenburg, Germany.; Mouritsen, H (corresponding author), Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany.	henrik.mouritsen@uol.de	Mouritsen, Henrik/A-5401-2010	Mouritsen, Henrik/0000-0001-7082-4839	Air Force Office of Scientific Research (Air Force Material Command, USAF award) [FA9550-14-1-0095, FA9550-14-1-0242]; DFG [Graduiertenkolleg 1885, SFB 1372]; 'Ministerium fur Wissenschaft und Kultur' (Landesgraduiertenkolleg Nano-Energieforschung); University of Oldenburg	Air Force Office of Scientific Research (Air Force Material Command, USAF award)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); DFG(German Research Foundation (DFG)); 'Ministerium fur Wissenschaft und Kultur' (Landesgraduiertenkolleg Nano-Energieforschung); University of Oldenburg	I am grateful to many of the key scientists working in the field of animal navigation and magnetoreception, including all my colleagues and associated members of the proposed collaborative research centre SFB 1372, for inspiration and discussions, for commenting on earlier drafts of this manuscript, and for providing valuable input to various sections of the review. Funding was provided by the Air Force Office of Scientific Research (Air Force Material Command, USAF award no. FA9550-14-1-0095 and FA9550-14-1-0242), the DFG (Graduiertenkolleg 1885, SFB 1372), the 'Ministerium fur Wissenschaft und Kultur' (Landesgraduiertenkolleg Nano-Energieforschung), and the University of Oldenburg.	Akesson S, 2017, J COMP PHYSIOL A, V203, P475, DOI 10.1007/s00359-017-1171-y; Alerstam T, 2011, P ROY SOC B-BIOL SCI, V278, P3074, DOI 10.1098/rspb.2011.0058; Alert B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119919; Allison JD, 2016, PHEROMONE COMMUNICATION IN MOTHS: EVOLUTION, BEHAVIOR, AND APPLICATION, P1; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Bech M, 2014, CURR BIOL, V24, P2124, DOI 10.1016/j.cub.2014.07.045; Begall S, 2013, MAMM BIOL, V78, P10, DOI 10.1016/j.mambio.2012.05.005; Berthold P, 1999, OSTRICH, V70, P1, DOI 10.1080/00306525.1999.9639744; Bett NN, 2016, BIOL REV, V91, P728, DOI 10.1111/brv.12191; Bjorn L.O., 2015, PHOTOBIOLOGY SCI LIG; Bolte P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147819; Bottesch M, 2016, CURR BIOL, V26, pR1266, DOI 10.1016/j.cub.2016.10.051; Brothers JR, 2015, CURR BIOL, V25, P392, DOI 10.1016/j.cub.2014.12.035; Brower LP, 1996, J EXP BIOL, V199, P93; Burger T, 2010, J R SOC INTERFACE, V7, P1275, DOI 10.1098/rsif.2009.0551; Cadiou H, 2010, J R SOC INTERFACE, V7, pS193, DOI 10.1098/rsif.2009.0423.focus; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Chapman JW, 2015, ECOL LETT, V18, P287, DOI 10.1111/ele.12407; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Cheeseman JF, 2014, P NATL ACAD SCI USA, V111, P8949, DOI 10.1073/pnas.1408039111; Chernetsov N, 2008, CURR BIOL, V18, P188, DOI 10.1016/j.cub.2008.01.018; Chernetsov N, 2017, CURR BIOL, V27, P2647, DOI 10.1016/j.cub.2017.07.024; Chernetsov N, 2011, J EXP BIOL, V214, P2540, DOI 10.1242/jeb.057729; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Dacke M, 2013, CURR BIOL, V23, P298, DOI 10.1016/j.cub.2012.12.034; DeBose JL, 2008, J CHEM ECOL, V34, P867, DOI 10.1007/s10886-008-9493-4; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; Deutschlander ME, 2012, WILSON J ORNITHOL, V124, P467, DOI 10.1676/11-043.1; Edelman NB, 2015, P NATL ACAD SCI USA, V112, P262, DOI 10.1073/pnas.1407915112; Eder SHK, 2012, P NATL ACAD SCI USA, V109, P12022, DOI 10.1073/pnas.1205653109; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Elbers D, 2017, J COMP PHYSIOL A, V203, P591, DOI 10.1007/s00359-017-1167-7; EMLEN ST, 1975, SCI AM, V233, P102, DOI 10.1038/scientificamerican0875-102; Engels S, 2014, NATURE, V509, P353, DOI 10.1038/nature13290; Engels S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043271; Fedele G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5391; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; Gagliardo A, 2013, J EXP BIOL, V216, P2798, DOI 10.1242/jeb.085738; Gagliardo A, 2013, J EXP BIOL, V216, P2165, DOI 10.1242/jeb.070250; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Geva-Sagiv M, 2015, NAT REV NEUROSCI, V16, P94, DOI 10.1038/nrn3888; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; GRIFFIN DR, 1952, BIOL REV, V27, P359, DOI 10.1111/j.1469-185X.1952.tb01509.x; Gunther A, 2018, CURR BIOL, V28, P211, DOI 10.1016/j.cub.2017.12.003; Guerra PA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5164; Guilford T, 2014, J EXP BIOL, V217, P169, DOI 10.1242/jeb.092908; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hagstrum JT, 2000, J EXP BIOL, V203, P1103; Hein CM, 2011, NATURE, V471, pE11, DOI 10.1038/nature09875; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Heinze S, 2015, CURR BIOL, V25, pR1034, DOI 10.1016/j.cub.2015.09.003; Heinze S, 2011, NEURON, V69, P345, DOI 10.1016/j.neuron.2010.12.025; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Heyers D, 2010, P NATL ACAD SCI USA, V107, P9394, DOI 10.1073/pnas.0907068107; Hiscock HG, 2017, BIOPHYS J, V113, P1475, DOI 10.1016/j.bpj.2017.07.031; Hiscock HG, 2016, P NATL ACAD SCI USA, V113, P4634, DOI 10.1073/pnas.1600341113; Holland RA, 2014, J ZOOL, V293, P1, DOI 10.1111/jzo.12107; Holland RA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1047; Hore PJ, 2016, ANNU REV BIOPHYS, V45, P299, DOI 10.1146/annurev-biophys-032116-094545; Horvath G., 2014, POLARIZED LIGHT POLA; Hu G, 2016, SCIENCE, V354, P1584, DOI 10.1126/science.aah4379; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Jorge PE, 2010, P R SOC B, V277, P45, DOI 10.1098/rspb.2009.1521; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; Kamermans M, 2011, PHILOS T R SOC B, V366, P742, DOI 10.1098/rstb.2010.0211; Kattnig DR, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/6/063007; Kavokin K, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0451; Kirschvink JL, 2010, J R SOC INTERFACE, V7, pS179, DOI 10.1098/rsif.2009.0491.focus; Kishkinev D, 2015, CURR BIOL, V25, pR822, DOI 10.1016/j.cub.2015.08.012; Kishkinev Dmitry, 2013, PLoS ONE, V8, pe65847, DOI 10.1371/journal.pone.0065847; Komolkin AV, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.1002; Kullberg C, 2007, P ROY SOC B-BIOL SCI, V274, P2145, DOI 10.1098/rspb.2007.0554; Kutta RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44906; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Liedvogel M, 2010, J R SOC INTERFACE, V7, pS147, DOI 10.1098/rsif.2009.0411.focus; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; Lohmann KJ, 2013, CRC MAR BIOL SER, P59; LOHMANN KJ, 1993, BIOL BULL, V185, P149, DOI 10.2307/1542138; Lohmann KJ, 2001, SCIENCE, V294, P364, DOI 10.1126/science.1064557; Longfellow L, 1985, MAGNETITE BIOMINERAL, P223; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; Maeda K, 2012, P NATL ACAD SCI USA, V109, P4774, DOI 10.1073/pnas.1118959109; Malkemper EP, 2015, SCI REP-UK, V5, DOI 10.1038/srep09917; Meister M, 2016, ELIFE, V5, DOI 10.7554/eLife.17210; Michalik A, 2014, J ORNITHOL, V155, P225, DOI 10.1007/s10336-013-1004-x; Mouritsen H, 2000, J THEOR BIOL, V207, P283, DOI 10.1006/jtbi.2000.2171; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Mouritsen H, 2003, AVIAN MIGRATION, P493; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Mouritsen H, 2001, J EXP BIOL, V204, P3855; Mouritsen H., 2013, NEUROSCIENCES MOL BE, P427; Mouritsen H, 2016, ANNU REV PHYSIOL, V78, P133, DOI 10.1146/annurev-physiol-021115-105054; Mouritsen H, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P113; Mouritsen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066039; Mouritsen H, 2013, P NATL ACAD SCI USA, V110, P7348, DOI 10.1073/pnas.1221701110; Mouritsen H, 2012, NATURE, V484, P320, DOI 10.1038/484320a; Munro U, 1997, NATURWISSENSCHAFTEN, V84, P26, DOI 10.1007/s001140050343; Nemec P, 2001, SCIENCE, V294, P366, DOI 10.1126/science.1063351; Niessner C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150377; Niessner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020091; PAULIN MG, 1995, J THEOR BIOL, V174, P325, DOI 10.1006/jtbi.1995.0102; PERDECK A. C., 1958, ARDEA, V46, P1; Phillips JB, 2002, J COMP PHYSIOL A, V188, P157, DOI 10.1007/s00359-002-0286-x; PHILLIPS JB, 1986, SCIENCE, V233, P765, DOI 10.1126/science.3738508; PHILLIPS JB, 1992, NATURE, V359, P142, DOI 10.1038/359142a0; Phillips JB, 2001, J EXP BIOL, V204, P2543; Putman NF, 2013, CURR BIOL, V23, P312, DOI 10.1016/j.cub.2012.12.041; Qin SY, 2016, NAT MATER, V15, P217, DOI [10.1038/NMAT4484, 10.1038/nmat4484]; Radford CA, 2011, CORAL REEFS, V30, P295, DOI 10.1007/s00338-010-0710-6; Ramos JSL, 2017, J COMP PHYSIOL A, V203, P383, DOI 10.1007/s00359-017-1184-6; Ranvaud R, 1991, ORIENTATION BIRDS, P1, DOI DOI 10.1007/978-3-0348-7208-9_1; Reynolds AM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0392; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Salewski Volker, 2000, Ringing and Migration, V20, P29; Sarel A, 2017, SCIENCE, V355, P176, DOI 10.1126/science.aak9589; Schmaljohann H, 2012, ANIM BEHAV, V84, P623, DOI 10.1016/j.anbehav.2012.06.018; Schmitz H, 1998, J COMP PHYSIOL A, V182, P647, DOI 10.1007/s003590050210; SCHNEIDER T, 1994, J EXP BIOL, V194, P255; SCHOLZ AT, 1976, SCIENCE, V192, P1247, DOI 10.1126/science.1273590; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Schwarze S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33805; Schwarze S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00055; Shaw J, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0499; Sjoberg S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00029; Solov'yov IA, 2014, QUANTUM EFFECTS IN BIOLOGY, P218; Solov'yov IA, 2010, BIOPHYS J, V99, P40, DOI 10.1016/j.bpj.2010.03.053; Stalleicken J, 2006, J COMP PHYSIOL A, V192, P321, DOI 10.1007/s00359-005-0073-6; Stalleicken J, 2005, J EXP BIOL, V208, P2399, DOI 10.1242/jeb.01613; Stanley SA, 2015, NAT MED, V21, P92, DOI 10.1038/nm.3730; Thorup K, 2007, P NATL ACAD SCI USA, V104, P18115, DOI 10.1073/pnas.0704734104; Treiber CD, 2012, NATURE, V484, P367, DOI 10.1038/nature11046; Uebe R, 2016, NAT REV MICROBIOL, V14, P621, DOI 10.1038/nrmicro.2016.99; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Wallraff HG, 2000, TELLUS B, V52, P1138, DOI 10.1034/j.1600-0889.2000.00099.x; Warrant E, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00077; Wehner R, 2014, NEW VISUAL NEUROSCIENCES, P1153; Wheeler MA, 2016, NAT NEUROSCI, V19, P756, DOI 10.1038/nn.4265; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R, 2000, J EXP BIOL, V203, P889; Wiltschko R., 1995, TIEROSYCHOL; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; WILTSCHKO W, 1976, BEHAV ECOL SOCIOBIOL, V1, P229, DOI 10.1007/BF00300066; Wiltschko W, 2002, NATURE, V419, P467, DOI 10.1038/nature00958; WILTSCHKO W, 1987, ETHOLOGY, V74, P285; Wiltschko W, 2011, NATURE, V471, pE12, DOI 10.1038/nature09876; Winklhofer M., MAGNETIC PROTEIN COM; Winklhofer M, 2010, J R SOC INTERFACE, V7, pS273, DOI 10.1098/rsif.2009.0435.focus; Worster S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0405; Wu LQ, 2012, SCIENCE, V336, P1054, DOI 10.1126/science.1216567; Zapka M, 2010, EUR J NEUROSCI, V32, P619, DOI 10.1111/j.1460-9568.2010.07311.x; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528; Zeil J, 2012, CURR OPIN NEUROBIOL, V22, P285, DOI 10.1016/j.conb.2011.12.008; Zufall F., 2016, CHEMOSENSORY TRANSDU	157	200	205	33	391	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					50	59		10.1038/s41586-018-0176-1	http://dx.doi.org/10.1038/s41586-018-0176-1			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29875486				2022-12-28	WOS:000434273300036
J	Dyer, C				Dyer, Clare			Obstetrics registrar gets nine month suspension for poor communication skills	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2018	361								k2453	10.1136/bmj.k2453	http://dx.doi.org/10.1136/bmj.k2453			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MZ	29858220				2022-12-28	WOS:000434276900005
J	Ebenesersdottir, SS; Sandoval-Velasco, M; Gunnarsdottir, ED; Jagadeesan, A; Guomundsdottir, VB; Thordardottir, EL; Einarsdottir, MS; Moore, KHS; Sigurosson, A; Magnusdottir, DN; Jonsson, H; Snorradottir, S; Hovig, E; Moller, P; Kockum, I; Olsson, T; Alfredsson, L; Hansen, TF; Werge, T; Cavalleri, GL; Gilbert, E; Lalueza-Fox, C; Walser, J; Kristjansdottir, S; Gopalakrishnan, S; Arnadottir, L; Magnusson, OP; Gilbert, MTP; Stefansson, K; Helgason, A				Ebenesersdottir, S. Sunna; Sandoval-Velasco, Marcela; Gunnarsdottir, Ellen D.; Jagadeesan, Anuradha; Guomundsdottir, Valdis B.; Thordardottir, Elisabet L.; Einarsdottir, Margret S.; Moore, Kristjan H. S.; Sigurosson, Asgeir; Magnusdottir, Droplaug N.; Jonsson, Hakon; Snorradottir, Steinunn; Hovig, Eivind; Moller, Pal; Kockum, Ingrid; Olsson, Tomas; Alfredsson, Lars; Hansen, Thomas F.; Werge, Thomas; Cavalleri, Gianpiero L.; Gilbert, Edmund; Lalueza-Fox, Carles; Walser, Joew., III; Kristjansdottir, Steinunn; Gopalakrishnan, Shyam; Arnadottir, Lilja; Magnusson, Olafur P.; Gilbert, M. Thomas P.; Stefansson, Kari; Helgason, Agnar			Ancient genomes from Iceland reveal the making of a human population	SCIENCE			English	Article							HISTORY	Opportunities to directly study the founding of a human population and its subsequent evolutionary history are rare. Using genome sequence data from 27 ancient Icelanders, we demonstrate that they are a combination of Norse, Gaelic, and admixed individuals. We further show that these ancient Icelanders are markedly more similar to their source populations in Scandinavia and the British-Irish Isles than to contemporary Icelanders, who have been shaped by 1100 years of extensive genetic drift. Finally, we report evidence of unequal contributions from the ancient founders to the contemporary Icelandic gene pool. These results provide detailed insights into the making of a human population that has proven extraordinarily useful for the discovery of genotype-phenotype associations.	[Ebenesersdottir, S. Sunna; Gunnarsdottir, Ellen D.; Jagadeesan, Anuradha; Guomundsdottir, Valdis B.; Thordardottir, Elisabet L.; Einarsdottir, Margret S.; Moore, Kristjan H. S.; Sigurosson, Asgeir; Magnusdottir, Droplaug N.; Jonsson, Hakon; Snorradottir, Steinunn; Magnusson, Olafur P.; Stefansson, Kari; Helgason, Agnar] AMGEN Inc, DeCODE Genet, Reykjavik, Iceland; [Ebenesersdottir, S. Sunna; Gunnarsdottir, Ellen D.; Jagadeesan, Anuradha; Guomundsdottir, Valdis B.; Thordardottir, Elisabet L.; Einarsdottir, Margret S.; Helgason, Agnar] Univ Iceland, Dept Anthropol, Reykjavik, Iceland; [Sandoval-Velasco, Marcela; Gopalakrishnan, Shyam; Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark; [Hovig, Eivind; Moller, Pal] Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Hovig, Eivind] Oslo Univ Hosp, Inst Canc Genet & Informat, Oslo, Norway; [Hovig, Eivind] Univ Oslo, Dept Informat, Oslo, Norway; [Moller, Pal] Univ Witten Herdecke, Dept Human Med, Witten, Germany; [Moller, Pal] Oslo Univ Hosp, Dept Med Genet, Res Grp Inherited Canc, Oslo, Norway; [Kockum, Ingrid; Olsson, Tomas] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Ctr Mol Med, Stockholm, Sweden; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Hansen, Thomas F.; Werge, Thomas] Copenhagen Mental Hlth Serv, Inst Biol Psychiat, Copenhagen, Denmark; [Hansen, Thomas F.] Copenhagen Univ Hosp, Dept Neurol, Danish Headache Ctr, DK-2600 Glostrup, Denmark; [Werge, Thomas] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Werge, Thomas] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Copenhagen, Denmark; [Cavalleri, Gianpiero L.; Gilbert, Edmund] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, 123 St Stephens Green, Dublin, Ireland; [Lalueza-Fox, Carles] Inst Biol Evolut UPF CSIC, Barcelona, Spain; [Walser, Joew., III; Kristjansdottir, Steinunn; Arnadottir, Lilja] Natl Museum Iceland, Reykjavik, Iceland; [Walser, Joew., III; Kristjansdottir, Steinunn] Univ Iceland, Dept Archaeol, Reykjavik, Iceland; [Gilbert, M. Thomas P.] Norwegian Univ Sci & Techonol, Univ Museum, N-7491 Trondheim, Norway; [Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland	University of Iceland; University of Copenhagen; University of Oslo; University of Oslo; University of Oslo; Witten Herdecke University; University of Oslo; Karolinska Institutet; Karolinska Institutet; University of Copenhagen; University of Copenhagen; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Royal College of Surgeons - Ireland; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); University of Iceland; Norwegian University of Science & Technology (NTNU); University of Iceland	Ebenesersdottir, SS; Stefansson, K; Helgason, A (corresponding author), AMGEN Inc, DeCODE Genet, Reykjavik, Iceland.; Ebenesersdottir, SS; Helgason, A (corresponding author), Univ Iceland, Dept Anthropol, Reykjavik, Iceland.; Stefansson, K (corresponding author), Univ Iceland, Fac Med, Reykjavik, Iceland.	sunna@decode.is; kstefan@deocde.is; agnar@decode.is	Gopalakrishnan, Shyam/J-1546-2019; Kockum, Ingrid/O-8781-2018; LALUEZA-FOX, CARLES/AAG-5341-2020; Sandoval-Velasco, Marcela/AAS-6478-2021; Hovig, Eivind/H-2474-2011; Hansen, Thomas Folkmann/O-5965-2014; Alfredsson, Lars/AAC-9007-2019; Kristjánsdóttir, Steinunn/L-9729-2015; Stefansson, Kari/AAE-7187-2019; Hansen, Thomas/GWZ-2858-2022; Gilbert, Marcus/A-8936-2013	Gopalakrishnan, Shyam/0000-0002-2004-6810; Kockum, Ingrid/0000-0002-0867-4726; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Sandoval-Velasco, Marcela/0000-0002-4635-6171; Hovig, Eivind/0000-0002-9103-1077; Hansen, Thomas Folkmann/0000-0001-6703-7762; Alfredsson, Lars/0000-0003-1688-6697; Kristjánsdóttir, Steinunn/0000-0002-7524-8460; Helgason, Agnar/0000-0002-8545-3767; Jagadeesan, Anuradha/0000-0002-7579-9713; Olsson, Tomas/0000-0002-2938-1877; Gilbert, Marcus/0000-0002-5805-7195; Walser III, Joe/0000-0001-9329-579X; Gilbert, Edmund/0000-0002-5574-4520; Cavalleri, Gianpiero/0000-0002-9802-0506; Ebenesersdottir, Sigridur Sunna/0000-0001-5912-4401; Moore, Kristjan/0000-0002-9579-4362	University of Iceland; EUROTAST Marie Curie Framework Programme 7 Initial Training Network [290344]; Icelandic Research Fund [163428-051]; Science Foundation Ireland [13/CDA/2223]; Swedish Research Council [13/CDA/2223, 2016-02349]; Swedish Research Council for Health, Working Life and Welfare [2013-0194]; Swedish Brain Foundation [FO2017-0076]; Lundbeck Foundation [R155-2014-1724, R248-2017-2003] Funding Source: researchfish	University of Iceland; EUROTAST Marie Curie Framework Programme 7 Initial Training Network; Icelandic Research Fund; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Brain Foundation; Lundbeck Foundation(Lundbeckfonden)	S.S.E. and V.B.G. received grants from The Research Fund of University of Iceland for doctoral studies. M.S.-V. and A.J. received a grant from EUROTAST Marie Curie Framework Programme 7 Initial Training Network (290344). M.S.E. received a grant from the Icelandic Research Fund (163428-051). The work was partly funded (E.G. and G.L.C.) by a Career Development Award (13/CDA/2223) from Science Foundation Ireland and Swedish Research Council (Dnr 2016-02349), Swedish Research Council for Health, Working Life and Welfare (Dnr 2013-0194), and Swedish Brain Foundation (FO2017-0076).	[Anonymous], 1972, BOOK SETTL LANDN; Eldjarn K., 2016, KUML OG HAUGFE; Goodacre S, 2005, HEREDITY, V95, P129, DOI 10.1038/sj.hdy.6800661; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Helgason A, 2003, ANN HUM GENET, V67, P281, DOI 10.1046/j.1469-1809.2003.00046.x; Helgason A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000343; Jnsson G., 1997, HAGSKINNA ICELANDIC; Jones Gwyn, 1984, HIST VIKINGS; Karras R. M., 1998, SLAVERY SOC MEDIEVAL; LONG JC, 1991, GENETICS, V127, P417; Maher R. A., 2007, ARBOK FORNLEIFAFELAG, V2004-2005, P151; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; Steffensen J., 1975, MENNING MEINSEMDIR R	17	37	37	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					1028	1032		10.1126/science.aar2625	http://dx.doi.org/10.1126/science.aar2625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6SL	29853688	Green Submitted			2022-12-28	WOS:000433574200045
J	Kim, Y; Chortos, A; Xu, WT; Liu, YX; Oh, JY; Son, D; Kang, J; Foudeh, AM; Zhu, CX; Lee, Y; Niu, SM; Liu, J; Pfattner, R; Bao, ZN; Lee, TW				Kim, Yeongin; Chortos, Alex; Xu, Wentao; Liu, Yuxin; Oh, Jin Young; Son, Donghee; Kang, Jiheong; Foudeh, Amir M.; Zhu, Chenxin; Lee, Yeongjun; Niu, Simiao; Liu, Jia; Pfattner, Raphael; Bao, Zhenan; Lee, Tae-Woo			A bioinspired flexible organic artificial afferent nerve	SCIENCE			English	Article							TACTILE; MECHANISM; NEURONS	The distributed network of receptors, neurons, and synapses in the somatosensory system efficiently processes complex tactile information. We used flexible organic electronics to mimic the functions of a sensory nerve. Our artificial afferent nerve collects pressure information (1 to 80 kilopascals) from clusters of pressure sensors, converts the pressure information into action potentials (0 to 100 hertz) by using ring oscillators, and integrates the action potentials from multiple ring oscillators with a synaptic transistor. Biomimetic hierarchical structures can detect movement of an object, combine simultaneous pressure inputs, and distinguish braille characters. Furthermore, we connected our artificial afferent nerve to motor nerves to construct a hybrid bioelectronic reflex arc to actuate muscles. Our system has potential applications in neurorobotics and neuroprosthetics.	[Kim, Yeongin; Zhu, Chenxin] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Chortos, Alex] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Xu, Wentao; Lee, Yeongjun; Lee, Tae-Woo] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul, South Korea; [Xu, Wentao] Nankai Univ, Inst Photoelect Thin Film Devices & Technol, Tianjin, Peoples R China; [Liu, Yuxin] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Oh, Jin Young; Son, Donghee; Kang, Jiheong; Foudeh, Amir M.; Niu, Simiao; Liu, Jia; Pfattner, Raphael; Bao, Zhenan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Oh, Jin Young] Kyung Hee Univ, Dept Chem Engn, Yongin, South Korea	Stanford University; Stanford University; Seoul National University (SNU); Nankai University; Stanford University; Stanford University; Kyung Hee University	Xu, WT; Lee, TW (corresponding author), Seoul Natl Univ, Dept Mat Sci & Engn, Seoul, South Korea.; Xu, WT (corresponding author), Nankai Univ, Inst Photoelect Thin Film Devices & Technol, Tianjin, Peoples R China.; Bao, ZN (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	wentao@nankai.edu.cn; zbao@stanford.edu; twlees@snu.ac.kr	Lee, Tae-Woo/AAE-7298-2019; Zhu, Chen/A-5356-2010; Oh, Jin Young/ABG-7154-2020; Pfattner, Raphael/E-9209-2011; Son, Donghee/R-5594-2019; Kim, Yeongin/AAK-3756-2021; Lee, Yeongjun/ABA-5477-2020; Niu, Simiao/D-3019-2012; Bao, Zhenan/AAC-5044-2019	Lee, Tae-Woo/0000-0002-6449-6725; Zhu, Chen/0000-0001-5374-6787; Oh, Jin Young/0000-0003-2260-9960; Pfattner, Raphael/0000-0002-7232-1845; Son, Donghee/0000-0002-3772-8009; Kim, Yeongin/0000-0002-9495-3165; Niu, Simiao/0000-0003-1973-2204; Bao, Zhenan/0000-0002-0972-1715; Liu, Yuxin/0000-0003-0623-9402; Lee, Yeongjun/0000-0002-2488-9903; Chortos, Alex/0000-0003-3976-5257; Liu, Jia/0000-0003-2217-6982	National Research Foundation of Korea (NRF) - Korean government (Ministry of Science and ICT) [NRF-2016R1A3B1908431]; Center for Advanced Soft-Electronics - Ministry of Science and ICT [CASE-2013M3A6A5073175]; Creative-Pioneering Researchers Program through Seoul National University (SNU); Samsung Electronics; Agency for Science, Technology and Research (A*STAR), Singapore; Natural Sciences and Engineering Research Council (NSERC) of Canada; Beatriu de Pinos fellowship from the Marie Curie Cofund [AGAUR 2014 BP-A 00094]; NSF [ECCS-1542152]	National Research Foundation of Korea (NRF) - Korean government (Ministry of Science and ICT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Center for Advanced Soft-Electronics - Ministry of Science and ICT(Ministry of Science, ICT & Future Planning, Republic of Korea); Creative-Pioneering Researchers Program through Seoul National University (SNU); Samsung Electronics(Samsung); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Beatriu de Pinos fellowship from the Marie Curie Cofund; NSF(National Science Foundation (NSF))	This work was supported by a National Research Foundation of Korea (NRF) grant (NRF-2016R1A3B1908431) funded by the Korean government (Ministry of Science and ICT); the Center for Advanced Soft-Electronics, funded by the Ministry of Science and ICT as a Global Frontier Project (CASE-2013M3A6A5073175); and the Creative-Pioneering Researchers Program through Seoul National University (SNU). Research carried out at Stanford University is funded by Samsung Electronics. Y.Li. acknowledges NSS funding support from the Agency for Science, Technology and Research (A*STAR), Singapore. A.M.F. acknowledges postdoctoral fellowship support from the Natural Sciences and Engineering Research Council (NSERC) of Canada. R.P. acknowledges support from a Beatriu de Pinos fellowship (AGAUR 2014 BP-A 00094) from the Marie Curie Cofund. Part of this work was performed in the nano@Stanford labs (part of the National Nanotechnology Coordinated Infrastructure) and at the Stanford Nano Shared Facilities (SNSF), both of which are supported by the NSF under award ECCS-1542152.	Bartolozzi C, 2007, NEURAL COMPUT, V19, P2581, DOI 10.1162/neco.2007.19.10.2581; Beer RD, 1997, COMMUN ACM, V40, P31; Bengtsson F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056630; Bologna LL, 2011, J PHYSIOL-PARIS, V105, P25, DOI 10.1016/j.jphysparis.2011.08.002; Caviglia S., 2016, 2016 IEEE INT S CIRC; Delbruck T., 2010, 2010 IEEE INT S CIRC; Furber S, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/5/051001; Furber SB, 2014, P IEEE, V102, P652, DOI 10.1109/JPROC.2014.2304638; Goldschmidt D, 2014, FRONT NEUROROBOTICS, V8, DOI 10.3389/fnbot.2014.00003; Herlogsson L, 2007, ADV MATER, V19, P97, DOI 10.1002/adma.200600871; Jorntell H, 2014, NEURON, V83, P1444, DOI 10.1016/j.neuron.2014.07.038; Khodagholy D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2573; Lee J, 2009, J PHYS CHEM C, V113, P8972, DOI 10.1021/jp901426e; Lee S, 2016, NAT NANOTECHNOL, V11, P472, DOI [10.1038/nnano.2015.324, 10.1038/NNANO.2015.324]; Lesniak DR, 2014, ELIFE, V3, DOI 10.7554/eLife.01488; Liu S.-C., 2010, 2010 IEEE INT S CIRC; Malmivuo P., 1995, BIOELECTROMAGNETISM, DOI [DOI 10.1093/ACPROF:OSO/9780195058239.001.0001, 10.1093/acprof:oso/9780195058239.001.0001]; Mead C.A., 1989, ANALOG VLSI NEURAL S; Oddo CM, 2016, ELIFE, V5, DOI 10.7554/eLife.09148; Osborn L, 2016, IEEE T HAPTICS, V9, P196, DOI 10.1109/TOH.2016.2564965; Park M, 2012, NAT NANOTECHNOL, V7, P803, DOI [10.1038/nnano.2012.206, 10.1038/NNANO.2012.206]; Pringle JWS, 1939, J EXP BIOL, V16, P220; Pruszynski JA, 2014, NAT NEUROSCI, V17, P1404, DOI 10.1038/nn.3804; Qian C, 2016, ACS APPL MATER INTER, V8, P26169, DOI 10.1021/acsami.6b08866; Qiao N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00141; Schemmel J., 2010, 2010 IEEE INT S CIRC; Simon DT, 2009, NAT MATER, V8, P742, DOI [10.1038/NMAT2494, 10.1038/nmat2494]; Suri M, 2011, 2011 IEEE INTERNATIONAL ELECTRON DEVICES MEETING (IEDM); Takeuchi Y, 2012, J NEUROSCI, V32, P6917, DOI 10.1523/JNEUROSCI.5008-11.2012; Tee BCK, 2015, SCIENCE, V350, P313, DOI 10.1126/science.aaa9306; van de Burgt Y, 2017, NAT MATER, V16, P414, DOI [10.1038/NMAT4856, 10.1038/nmat4856]; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Xu W, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501326; Zaghloul KA, 2006, J NEURAL ENG, V3, P257, DOI 10.1088/1741-2560/3/4/002	34	679	690	135	1282	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					998	+		10.1126/science.aao0098	http://dx.doi.org/10.1126/science.aao0098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6SL	29853682				2022-12-28	WOS:000433574200037
J	Akturk, A; Wasilko, DJ; Wu, XC; Liu, Y; Zhang, Y; Qiu, JZ; Luo, ZQ; Reiter, KH; Brzovic, PS; Klevit, RE; Mao, YX				Akturk, Anil; Wasilko, David J.; Wu, Xiaochun; Liu, Yao; Zhang, Yong; Qiu, Jiazhang; Luo, Zhao-Qing; Reiter, Katherine H.; Brzovic, Peter S.; Klevit, Rachel E.; Mao, Yuxin			Mechanism of phosphoribosyl-ubiquitination mediated by a single Legionella effector	NATURE			English	Article							PROTEIN; SYSTEM; LIGASE; SITES; MODEL	Ubiquitination is a post-translational modification that regulates many cellular processes in eukaryotes(1-4). The conventional ubiquitination cascade culminates in a covalent linkage between the C terminus of ubiquitin (Ub) and a target protein, usually on a lysine side chain(1,5). Recent studies of the Legionella pneumophila SidE family of effector proteins revealed a ubiquitination method in which a phosphoribosyl ubiquitin (PR-Ub) is conjugated to a serine residue on substrates via a phosphodiester bond(6-8). Here we present the crystal structure of a fragment of the SidE family member SdeA that retains ubiquitination activity, and determine the mechanism of this unique post-translational modification. The structure reveals that the catalytic module contains two distinct functional units: a phosphodiesterase domain and a mono-ADP-ribosyltransferase domain. Biochemical analysis shows that the mono-ADP-ribosyltransferase domain-mediated conversion of Ub to ADP-ribosylated Ub (ADPR-Ub) and the phosphodiesterase domain-mediated ligation of PR-Ub to substrates are two independent activities of SdeA. Furthermore, we present two crystal structures of a homologous phosphodiesterase domain from the SidE family member SdeD(9) in complexes with Ub and ADPR-Ub. The structures suggest a mechanism for how SdeA processes ADPR-Ub to PR-Ub and AMP, and conjugates PR-Ub to a serine residue in substrates. Our study establishes the molecular mechanism of phosphoribosy llinked ubiquitination and will enable future studies of this unusual type of ubiquitination in eukaryotes.	[Akturk, Anil; Wasilko, David J.; Wu, Xiaochun; Mao, Yuxin] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14850 USA; [Akturk, Anil; Wasilko, David J.; Wu, Xiaochun; Mao, Yuxin] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Liu, Yao; Zhang, Yong; Qiu, Jiazhang; Luo, Zhao-Qing] Purdue Univ, Purdue Inst Immunol Inflammat & Infect Dis, W Lafayette, IN 47907 USA; [Liu, Yao; Zhang, Yong; Qiu, Jiazhang; Luo, Zhao-Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Reiter, Katherine H.; Brzovic, Peter S.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Cornell University; Cornell University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Washington; University of Washington Seattle	Mao, YX (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14850 USA.; Mao, YX (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	ym253@cornell.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X; Liu, Yao/0000-0002-4330-2389; Mao, Yuxin/0000-0002-5064-1397	National Institute of Health (NIH) [5R01GM116964, R01AI127465, R01GM088055, 1R01GM098503-05, 1 F32 GM120797]; NSF; NIH/National Institute of General Medical Sciences (NIGMS) via NSF award [DMR-1332208]; NIH/NIGMS award [GM-103485]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NIH, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088055, P41GM103485, F32GM120797, P41GM103393, R01GM098503, R01GM116964] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH/National Institute of General Medical Sciences (NIGMS) via NSF award; NIH/NIGMS award; US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge L. Pollack's group for SAXS data collection. This work is supported by National Institute of Health (NIH) grants 5R01GM116964 (Y.M.), R01AI127465 (Z.-Q.L.), R01GM088055 (R.E.K.), 1R01GM098503-05 (P.S.B.), and 1 F32 GM120797 (K.H.R.). The X-ray data were collected at Cornell High Energy Synchrotron Source. CHESS is supported by the NSF and NIH/National Institute of General Medical Sciences (NIGMS) via NSF award DMR-1332208, and the MacCHESS resource is supported by NIH/NIGMS award GM-103485. Some SAXS data were collected at Stanford Synchrotron Radiation Lightsource. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the NIH, NIGMS (including P41GM103393).	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhogaraju S, 2016, CELL, V167, P1636, DOI 10.1016/j.cell.2016.11.019; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Daniels CM, 2014, J PROTEOME RES, V13, P3510, DOI 10.1021/pr401032q; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong YA, 2018, NATURE, V557, P674, DOI 10.1038/s41586-018-0146-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ensminger AW, 2010, INFECT IMMUN, V78, P3905, DOI 10.1128/IAI.00344-10; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hsu FS, 2014, P NATL ACAD SCI USA, V111, P10538, DOI 10.1073/pnas.1402605111; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Jeong BR, 2011, J BIOL CHEM, V286, P43272, DOI 10.1074/jbc.M111.290122; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kalayil S, 2018, NATURE, V557, P734, DOI 10.1038/s41586-018-0145-8; Klumpp S, 2002, EUR J BIOCHEM, V269, P1067, DOI 10.1046/j.1432-1033.2002.02755.x; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kotewicz KM, 2017, CELL HOST MICROBE, V21, P169, DOI 10.1016/j.chom.2016.12.007; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Kubori T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001216; Lin YH, 2017, J CELL SCI, V130, P1985, DOI 10.1242/jcs.188482; Luo X, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004965; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Price CT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000704; Qiu JZ, 2017, NAT REV MICROBIOL, V15, P591, DOI 10.1038/nrmicro.2017.67; Qiu JZ, 2016, NATURE, V533, P120, DOI 10.1038/nature17657; Raasi Shahri, 2005, V301, P47; Rinaldo S, 2015, J BACTERIOL, V197, P1525, DOI 10.1128/JB.02606-14; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Trapani S, 2008, ACTA CRYSTALLOGR D, V64, P11, DOI 10.1107/S0907444907044460; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109; Wong K, 2015, J BIOL CHEM, V290, P24727, DOI 10.1074/jbc.M115.671263; Zhou Y, 2015, CELL MICROBIOL, V17, P26, DOI 10.1111/cmi.12384	45	40	43	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					729	+		10.1038/s41586-018-0147-6	http://dx.doi.org/10.1038/s41586-018-0147-6			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29795346	Green Accepted			2022-12-28	WOS:000433412900055
J	Sparrow, C; Martin-Lopez, E; Maraviglia, N; Neville, A; Harrold, C; Carolan, J; Joglekar, YN; Hashimoto, T; Matsuda, N; O'Brien, JL; Tew, DP; Laing, A				Sparrow, Chris; Martin-Lopez, Enrique; Maraviglia, Nicola; Neville, Alex; Harrold, Christopher; Carolan, Jacques; Joglekar, Yogesh N.; Hashimoto, Toshikazu; Matsuda, Nobuyuki; O'Brien, Jeremy L.; Tew, David P.; Laing, Anthony			Simulating the vibrational quantum dynamics of molecules using photonics	NATURE			English	Article							SINGLE-PHOTON; LINEAR OPTICS; COMPUTATION; LIGHT; WATER; PURE	Advances in control techniques for vibrational quantum states in molecules present new challenges for modelling such systems, which could be amenable to quantum simulation methods. Here, by exploiting a natural mapping between vibrations in molecules and photons in waveguides, we demonstrate a reprogrammable photonic chip as a versatile simulation platform for a range of quantum dynamic behaviour in different molecules. We begin by simulating the time evolution of vibrational excitations in the harmonic approximation for several four-atom molecules, including H2CS, SO3, HNCO, HFHF, N-4 and P-4. We then simulate coherent and dephased energy transport in the simplest model of the peptide bond in proteins-N-methylacetamide-and simulate thermal relaxation and the effect of anharmonicities in H2O. Finally, we use multi-photon statistics with a feedback control algorithm to iteratively identify quantum states that increase a particular dissociation pathway of NH3. These methods point to powerful new simulation tools for molecular quantum dynamics and the field of femtochemistry.	[Sparrow, Chris; Maraviglia, Nicola; Neville, Alex; Harrold, Christopher; O'Brien, Jeremy L.; Laing, Anthony] Univ Bristol, Sch Phys, Quantum Engn & Technol Labs, Bristol, Avon, England; [Sparrow, Chris; Maraviglia, Nicola; Neville, Alex; Harrold, Christopher; O'Brien, Jeremy L.; Laing, Anthony] Univ Bristol, Dept Elect & Elect Engn, Bristol, Avon, England; [Sparrow, Chris] Imperial Coll London, Dept Phys, London, England; [Martin-Lopez, Enrique] Nokia Bell Labs, Cambridge, England; [Carolan, Jacques] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Joglekar, Yogesh N.] Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46205 USA; [Hashimoto, Toshikazu] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa, Japan; [Matsuda, Nobuyuki] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa, Japan; [Tew, David P.] Univ Bristol, Sch Chem, Bristol, Avon, England	University of Bristol; University of Bristol; Imperial College London; Nokia Corporation; Massachusetts Institute of Technology (MIT); Indiana University System; Indiana University-Purdue University Indianapolis; Nippon Telegraph & Telephone Corporation; Nippon Telegraph & Telephone Corporation; University of Bristol	Laing, A (corresponding author), Univ Bristol, Sch Phys, Quantum Engn & Technol Labs, Bristol, Avon, England.; Laing, A (corresponding author), Univ Bristol, Dept Elect & Elect Engn, Bristol, Avon, England.	anthony.laing@bristol.ac.uk	Joglekar, Yogesh/ABD-8584-2021; Tew, David Peter/E-1458-2011; Hashimoto, Toshikazu/W-3455-2019; Matsuda, Nobuyuki/T-2724-2019; Joglekar, Yogesh/U-5645-2018	Joglekar, Yogesh/0000-0002-3222-1436; Tew, David Peter/0000-0002-3220-4177; Joglekar, Yogesh/0000-0002-3222-1436; Martin-Lopez, Enrique/0000-0002-3595-458X; Laing, Anthony/0000-0002-1066-3110; Matsuda, Nobuyuki/0000-0001-6014-3570; Carolan, Jacques/0000-0002-5736-2753	Engineering and Physical Sciences Research Council (EPSRC); European Commission [H2020-FETPROACT-3-2014]; European Research Council (ERC); Wilkinson Foundation; EU [751016]; NSF [DMR-1054020]; Royal Society Wolfson Merit Award; Royal Academy of Engineering Chair in Emerging Technologies; EPSRC [EP/N003470/1]; EPSRC [EP/L024020/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)European Commission); Wilkinson Foundation; EU(European Commission); NSF(National Science Foundation (NSF)); Royal Society Wolfson Merit Award(Royal Society of London); Royal Academy of Engineering Chair in Emerging Technologies(Royal Academy of Engineering - UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank A. Orr-Ewing and R. Santagati for helpful conversations, and J. Barton for assistance with figures. This work was supported by the Engineering and Physical Sciences Research Council (EPSRC), European Commission QUCHIP (H2020-FETPROACT-3-2014: quantum simulation) and the European Research Council (ERC). A.N. is grateful for support from the Wilkinson Foundation. J.C. is supported by EU H2020 Marie Sklodowska-Curie grant number 751016. Y.N.J. was supported by NSF grant number DMR-1054020. J.L.O'B. acknowledges a Royal Society Wolfson Merit Award and a Royal Academy of Engineering Chair in Emerging Technologies. Fellowship support from EPSRC is acknowledged by A.L. (EP/N003470/1).	Aaronson S., 2013, THEORY COMPUT, V9, P143, DOI DOI 10.4086/toc.2013.v009a004; Alnaser AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4800; Arkhipov A., 2012, GEOM TOPOL MONOGR, V18, P1, DOI [10.2140/gtm.2012.18.1, DOI 10.2140/GTM.2012.18.1]; Aspuru-Guzik A, 2012, NAT PHYS, V8, P285, DOI [10.1038/NPHYS2253, 10.1038/nphys2253]; Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Berry DW, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.090502; Campbell ET, 2017, NATURE, V549, P172, DOI 10.1038/nature23460; Clark JB, 2017, NATURE, V541, P191, DOI 10.1038/nature20604; Crespi A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1570; De Santis L, 2017, NAT NANOTECHNOL, V12, P663, DOI [10.1038/nnano.2017.85, 10.1038/NNANO.2017.85]; Dorfman KE, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.045008; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Gatti F, 2014, PHYS CHEM ACTION, P1, DOI 10.1007/978-3-642-45290-1; Georgescu IM, 2014, REV MOD PHYS, V86, P153, DOI 10.1103/RevModPhys.86.153; Harris NC, 2017, NAT PHOTONICS, V11, P447, DOI [10.1038/nphoton.2017.95, 10.1038/NPHOTON.2017.95]; Hause ML, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2363192; Horn R. A., 1991, TOPICS MATRIX ANAL, P57; Huh J, 2015, NAT PHOTONICS, V9, P615, DOI [10.1038/nphoton.2015.153, 10.1038/NPHOTON.2015.153]; Kandala A, 2017, NATURE, V549, P242, DOI 10.1038/nature23879; Karpinski M, 2017, NAT PHOTONICS, V11, P53, DOI [10.1038/nphoton.2016.228, 10.1038/NPHOTON.2016.228]; Kassal I, 2008, P NATL ACAD SCI USA, V105, P18681, DOI 10.1073/pnas.0808245105; Kirchmair G, 2013, NATURE, V495, P205, DOI 10.1038/nature11902; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kobus M, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3574395; Lanyon BP, 2011, SCIENCE, V334, P57, DOI 10.1126/science.1208001; Leitner DM, 2008, ANNU REV PHYS CHEM, V59, P233, DOI 10.1146/annurev.physchem.59.032607.093606; Lidar DA, 1999, PHYS REV E, V59, P2429, DOI 10.1103/PhysRevE.59.2429; Lindner J, 2006, CHEM PHYS LETT, V421, P329, DOI 10.1016/j.cplett.2006.01.081; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Najafi F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6873; Peruzzo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5213; Piddock S., 2017, PREPRINT; Politi A, 2008, SCIENCE, V320, P646, DOI 10.1126/science.1155441; Ramasesha K, 2013, NAT CHEM, V5, P935, DOI [10.1038/NCHEM.1757, 10.1038/nchem.1757]; Russell NJ, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa60ed; Shapiro M, 2003, REP PROG PHYS, V66, P859, DOI 10.1088/0034-4885/66/6/201; SHI SH, 1988, J CHEM PHYS, V88, P6870, DOI 10.1063/1.454384; Shomroni I, 2014, SCIENCE, V345, P903, DOI 10.1126/science.1254699; Silverstone JW, 2014, NAT PHOTONICS, V8, P104, DOI [10.1038/NPHOTON.2013.339, 10.1038/nphoton.2013.339]; Spring JB, 2017, OPTICA, V4, P90, DOI 10.1364/OPTICA.4.000090; Tong X, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143001; Wang H, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.213601; Wolter B, 2016, SCIENCE, V354, P308, DOI 10.1126/science.aah3429	50	107	108	8	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					660	667		10.1038/s41586-018-0152-9	http://dx.doi.org/10.1038/s41586-018-0152-9			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29849155	Green Submitted			2022-12-28	WOS:000433412900041
J	Beck, JW; Zhou, WJ; Li, C; Wu, ZK; White, L; Xian, F; Kong, XH; An, Z				Beck, J. Warren; Zhou, Weijian; Li, Cheng; Wu, Zhenkun; White, Lara; Xian, Feng; Kong, Xianghui; An, Zhisheng			A 550,000-year record of East Asian monsoon rainfall from Be-10 in loess	SCIENCE			English	Article							CROSS-EQUATORIAL FLOWS; ICE-AGE TERMINATIONS; SUMMER MONSOON; INDIAN-OCEAN; INTERANNUAL VARIABILITY; AGULHAS SYSTEM; CIRCULATION; SEA; CLIMATE; PRECIPITATION	Cosmogenic Be-10 flux from the atmosphere is a proxy for rainfall. Using this proxy, we derived a 550,000-year-long record of East Asian summer monsoon (EASM) rainfall from Chinese loess. This record is forced at orbital precession frequencies, with higher rainfall observed during Northern Hemisphere summer insolation maxima, although this response is damped during cold interstadials. The Be-10 monsoon rainfall proxy is also highly correlated with global ice-volume variations, which differs from Chinese cave delta O-18, which is only weakly correlated. We argue that both EASM intensity and Chinese cave delta O-18 are not governed by high-northern-latitude insolation, as suggested by others, but rather by low-latitude interhemispheric insolation gradients, which may also strongly influence global ice volume via monsoon dynamics.	[Beck, J. Warren; White, Lara] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Beck, J. Warren] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA; [Beck, J. Warren; Li, Cheng; Wu, Zhenkun; White, Lara; Kong, Xianghui] Univ Arizona, NSF Arizona Accelerator Mass Spectrometry Lab, Tucson, AZ 85721 USA; [Zhou, Weijian; Wu, Zhenkun; Xian, Feng; Kong, Xianghui; An, Zhisheng] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710075, Shaanxi, Peoples R China; [Zhou, Weijian] Qingdao Natl Lab Marine Sci & Technol, Qingdao, Peoples R China; [An, Zhisheng] Jiaotong Univ, Inst Global Environm Change, Xian 710061, Shaanxi, Peoples R China	University of Arizona; University of Arizona; National Science Foundation (NSF); University of Arizona; Chinese Academy of Sciences; Institute of Earth Environment, CAS; Qingdao National Laboratory for Marine Science & Technology	Beck, JW (corresponding author), Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA.; Beck, JW (corresponding author), Univ Arizona, Dept Phys, Tucson, AZ 85721 USA.; Beck, JW (corresponding author), Univ Arizona, NSF Arizona Accelerator Mass Spectrometry Lab, Tucson, AZ 85721 USA.; Zhou, WJ (corresponding author), Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710075, Shaanxi, Peoples R China.; Zhou, WJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Qingdao, Peoples R China.	wbeck@physics.arizona.edu; weijian@loess.llqg.ac.cn	Xian, Feng/B-1866-2009; Kong, Xianghui/I-9714-2014; AN, Zhisheng/F-8834-2012; Zhou, Weijian/T-1412-2019	Zhou, Weijian/0000-0001-9641-5734; White, Lara/0000-0002-3462-0588	U.S. National Science Foundation [EAR-0908709, EAR-0902633, EAR-0929458]; Ministry of Science and Technology of China; National Science Foundations of China; Chinese Academy of Sciences	U.S. National Science Foundation(National Science Foundation (NSF)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundations of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was jointly supported by the U.S. National Science Foundation through EAR-0908709, EAR-0902633, and EAR-0929458, as well as the Ministry of Science and Technology of China, the National Science Foundations of China, and the Key Research Programs of Frontier Sciences, Chinese Academy of Sciences. We also gratefully acknowledge insightful editorial assistance from J. Russell and P. Goodman, University of Arizona Geosciences Department, and three anonymous reviewers. The data used in this work can be found in the associated supplementary materials.	Backeberg BC, 2012, NAT CLIM CHANGE, V2, P608, DOI 10.1038/NCLIMATE1587; Basha G, 2015, REMOTE SENS ENVIRON, V163, P262, DOI 10.1016/j.rse.2015.03.024; Beal LM, 2011, NATURE, V472, P429, DOI 10.1038/nature09983; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Braby L, 2016, GEOPHYS RES LETT, V43, P8143, DOI 10.1002/2016GL069480; Broccoli AJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024546; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI DOI 10.5670/0CEAN0G.1991.07; Caillet S, 2001, J ENVIRON RADIOACTIV, V53, P241, DOI 10.1016/S0265-931X(00)00130-2; Cao J, 2016, J CLIMATE, V29, P5027, DOI 10.1175/JCLI-D-15-0839.1; Cheng H, 2016, NATURE, V534, P640, DOI 10.1038/nature18591; Cheng H, 2012, CLIM DYNAM, V39, P1045, DOI 10.1007/s00382-012-1363-7; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Chiang J., 2014, QUATERNARY SCI REV, V108, P111; Clemens SC, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2010PA001926; Dima IM, 2005, J ATMOS SCI, V62, P2499, DOI 10.1175/JAS3486.1; Erb MP, 2015, J CLIMATE, V28, P9258, DOI 10.1175/JCLI-D-15-0242.1; Erb MP, 2013, J CLIMATE, V26, P5897, DOI 10.1175/JCLI-D-12-00419.1; GILL AE, 1980, Q J ROY METEOR SOC, V106, P447, DOI 10.1002/qj.49710644905; Grant KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6076; Hitchman MH, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012883; Huang YY, 2015, CLIM DYNAM, V44, P2035, DOI 10.1007/s00382-014-2194-5; Lee SK, 2013, J CLIMATE, V26, P10193, DOI 10.1175/JCLI-D-13-00106.1; Li C, 2014, J CLIMATE, V27, P3966, DOI 10.1175/JCLI-D-13-00288.1; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Liu F, 2013, J CLIMATE, V26, P1791, DOI 10.1175/JCLI-D-12-00243.1; Mantsis DF, 2014, J CLIMATE, V27, P5504, DOI 10.1175/JCLI-D-13-00526.1; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; Schiemann R, 2009, J CLIMATE, V22, P2940, DOI 10.1175/2008JCLI2625.1; Schwendike J, 2014, J GEOPHYS RES-ATMOS, V119, P1322, DOI 10.1002/2013JD020742; Sengupta S, 2006, EARTH PLANET SC LETT, V250, P511, DOI 10.1016/j.epsl.2006.08.011; Shaw TA, 2015, NAT GEOSCI, V8, P560, DOI [10.1038/NGEO2449, 10.1038/ngeo2449]; Shukla RP, 2016, CLIM DYNAM, V46, P1977, DOI 10.1007/s00382-015-2687-x; Walker JM, 2015, J CLIMATE, V28, P3731, DOI 10.1175/JCLI-D-14-00612.1; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Webster P., 2005, HADLEY CIRCULATION P, P9; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220; Zhou WJ, 2007, RADIOCARBON, V49, P139; Zhu YL, 2012, ADV ATMOS SCI, V29, P509, DOI 10.1007/s00376-011-1120-6	38	123	140	19	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					877	+		10.1126/science.aam5825	http://dx.doi.org/10.1126/science.aam5825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798878				2022-12-28	WOS:000433039800041
J	Narevicius, E				Narevicius, Edvardas			Cold chemistry with two atoms	SCIENCE			English	Editorial Material							RESONANCES		[Narevicius, Edvardas] Weizmann Inst Sci, Chem & Biol Phys Dept, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Narevicius, E (corresponding author), Weizmann Inst Sci, Chem & Biol Phys Dept, IL-76100 Rehovot, Israel.	edvardas.narevicius@weizmann.ac.il						Chefdeville S, 2013, SCIENCE, V341, P1094, DOI 10.1126/science.1241395; Cohen-Tannoudji C., 2011, ADV ATOMIC PHYS OVER, DOI 10.11426631; Henson AB, 2012, SCIENCE, V338, P234, DOI 10.1126/science.1229141; Jones KM, 2006, REV MOD PHYS, V78, P483, DOI 10.1103/RevModPhys.78.483; LEE YT, 1969, REV SCI INSTRUM, V40, P1402, DOI 10.1063/1.1683809; Liu LR, 2018, SCIENCE, V360, P900, DOI 10.1126/science.aar7797; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Tizniti M, 2014, NAT CHEM, V6, P141, DOI [10.1038/NCHEM.1835, 10.1038/nchem.1835]	9	0	0	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					855	856		10.1126/science.aat7917	http://dx.doi.org/10.1126/science.aat7917			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG9RW	29798869				2022-12-28	WOS:000433039800027
J	Polymenidou, M				Polymenidou, Magdalini			The RNA face of phase separation	SCIENCE			English	Editorial Material							PROTEIN		[Polymenidou, Magdalini] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich	Polymenidou, M (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	magdalini.polymenidou@imls.uzh.ch	Polymenidou, Magdalini/D-2254-2014		Swiss National Science Foundation; Target ALS, the ALS association; U.S. Department of Defense	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Target ALS, the ALS association; U.S. Department of Defense(United States Department of Defense)	M.P. apologizes to all authors whose relevant papers could not be cited due to space limitations. M.P. is grateful to F. Allain, M. Perez Berlanga, and M. Jambeau for critical reading of the manuscript. M.P. is supported by the Swiss National Science Foundation and holds funding from Target ALS, the ALS association, and the U.S. Department of Defense. She is an EMBO Young Investigator.	Becker LA, 2017, NATURE, V544, P367, DOI 10.1038/nature22038; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Langdon EM, 2018, SCIENCE, V360, P922, DOI 10.1126/science.aar7432; Maharana S, 2018, SCIENCE, V360, P918, DOI 10.1126/science.aar7366; Markmiller S, 2018, CELL, V172, P590, DOI 10.1016/j.cell.2017.12.032; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Murray DT, 2017, CELL, V171, P615, DOI 10.1016/j.cell.2017.08.048; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Van Treeck B, 2018, P NATL ACAD SCI USA, V115, P2734, DOI 10.1073/pnas.1800038115; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	15	26	26	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					859	+		10.1126/science.aat8028	http://dx.doi.org/10.1126/science.aat8028			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG9RW	29798872				2022-12-28	WOS:000433039800030
J	Snyder, RA; Hu, CY; Cuddy, A; Francescatti, AB; Schumacher, JR; Van Loon, K; You, YN; Kozower, BD; Greenberg, CC; Schrag, D; Venook, A; McKellar, D; Winchester, DP; Chang, GJ				Snyder, Rebecca A.; Hu, Chung-Yuan; Cuddy, Amanda; Francescatti, Amanda B.; Schumacher, Jessica R.; Van Loon, Katherine; You, Y. Nancy; Kozower, Benjamin D.; Greenberg, Caprice C.; Schrag, Deborah; Venook, Alan; McKellar, Daniel; Winchester, David P.; Chang, George J.		Alliance Clin Trials Oncology Netw	Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE GUIDELINES; FOLLOW-UP; RECTAL-CANCER; CURATIVE RESECTION; COLON-CANCER; TRIAL; METAANALYSIS; DIAGNOSIS; ONCOLOGY; OUTCOMES	IMPORTANCE Surveillance testing is performed after primary treatment for colorectal cancer (CRC), but it is unclear if the intensity of testing decreases time to detection of recurrence or affects patient survival. OBJECTIVE To determine if intensity of posttreatment surveillance is associated with time to detection of CRC recurrence, rate of recurrence, resection for recurrence, or overall survival. DESIGN, SETTING, AND PARTICIPANTS A retrospective cohort study of patient data abstracted from the medical record as part of a Commission on Cancer Special Study merged with records from the National Cancer Database. A random sample of patients (n= 8529) diagnosed with stage I, II, or III CRC treated at a Commission on Cancer-accredited facilities (2006-2007) with follow-up through December 31, 2014. EXPOSURES Intensity of imaging and carcinoembryonic antigen (CEA) surveillance testing derived empirically at the facility level using the observed to expected ratio for surveillance testing during a 3-year observation period. MAIN OUTCOMES AND MEASURES The primary outcome was time to detection of CRC recurrence; secondary outcomes included rates of resection for recurrent disease and overall survival. RESULTS A total of 8529 patients (49% men; median age, 67 years) at 1175 facilities underwent surveillance imaging and CEA testing within 3 years after their initial CRC treatment. The cohort was distributed by stage as follows: stage I, 25.0%; stage II, 35.2%; and stage III, 39.8%. Patients treated at high-intensity facilities-4188 patients (49.1%) for imaging and 4136 (48.5%) for CEA testing underwent a mean of 2.9 (95% CI, 2.8-2.9) imaging scans and a mean of 4.3 (95% CI, 4.2-4.4) CEA tests. Patients treated at low-intensity facilities-4341 patients (50.8%) for imaging and 4393 (51.5%) for CEA testing-underwent a mean of 1.6 (95% CI, 1.6-1.7) imaging scans and a mean of 1.6 (95% CI, 1.6-1.7) CEA tests. Imaging and CEA surveillance intensity were not associated with a significant difference in time to detection of cancer recurrence. The median time to detection of recurrence was 15.1 months (IQR, 8.2-26.3) for patients treated at facilities with high-intensity imaging surveillance and 16.0 months (IQR, 7.9-27.2) with low-intensity imaging surveillance (difference,-0.95 months; 95% CI,-2.59 to0.68; HR, 0.99; 95% CI, 0.90-1.09) and was 15.9 months (IQR, 8.5-27.5) for patients treated at facilities with high-intensity CEA testing and 15.3 months (IQR, 7.9-25.7) with low-intensity CEA testing (difference, 0.59 months; 95% CI, -1.33 to 2.51; HR, 1.00; 95% CI, 0.90-1.11). No significant difference existed in rates of resection for cancer recurrence (HR for imaging, 1.22; 95% CI, 0.99-1.51 and HR for CEA testing, 1.12; 95% CI, 0.91-1.39) or overall survival (HR for imaging, 1.01; 95% CI, 0.94-1.08 and HR for CEA testing, 0.96; 95% CI, 0.89-1.03) among patients treated at facilities with high-vs low-intensity imaging or CEA testing surveillance. CONCLUSIONS AND RELEVANCE Among patients treated for stage I, II, or III CRC, there was no significant association between surveillance intensity and detection of recurrence.	[Snyder, Rebecca A.; Hu, Chung-Yuan; Cuddy, Amanda; You, Y. Nancy; Chang, George J.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St,FCT 17-5060, Houston, TX 77030 USA; [Snyder, Rebecca A.] Univ South Carolina, Sch Med, Dept Surg, Greenville, SC USA; [Francescatti, Amanda B.] Amer Coll Surg, Canc Programs, Chicago, IL USA; [Schumacher, Jessica R.; Greenberg, Caprice C.; McKellar, Daniel; Winchester, David P.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Surg Outcomes Res Program, Madison, WI USA; [Van Loon, Katherine] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA; [Kozower, Benjamin D.] Washington Univ, Dept Surg, St Louis, MO USA; [Schrag, Deborah] Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02115 USA; [Venook, Alan] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [McKellar, Daniel] Wright State Univ, Dept Surg, Dayton, OH 45435 USA; [Chang, George J.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; American College of Surgeons; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; Washington University (WUSTL); Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University System of Ohio; Wright State University Dayton; University of Texas System; UTMD Anderson Cancer Center	Chang, GJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St,FCT 17-5060, Houston, TX 77030 USA.; Chang, GJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, 1400 Pressler St,FCT 17-5060, Houston, TX 77030 USA.	gchang@mdanderson.org	Snyder, Rebecca A/Y-8302-2019	Schumacher, Jessica/0000-0002-6740-9498; Snyder, Rebecca/0000-0002-2485-2481	Patient-Centered Outcomes Research Institute (PCORI) [CE13-04-6855]; National Cancer Institute of the National Institutes of Health [P30CA016672]; MD Anderson Cancer Center Support Grant; National Cancer Institute [U10CA180821]; NATIONAL CANCER INSTITUTE [U10CA180833, U10CA180821, P30CA016672] Funding Source: NIH RePORTER	Patient-Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MD Anderson Cancer Center Support Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by award CE13-04-6855 from the Patient-Centered Outcomes Research Institute (PCORI) (Dr Chang), and grant P30CA016672 from the National Cancer Institute of the National Institutes of Health to the University of Texas, MD Anderson Cancer Center Support Grant, and U10CA180821 from the National Cancer Institute to the Alliance for Clinical Trials in Oncology.	Benson AB, 2017, J NATL COMPR CANC NE, V15, P370, DOI 10.6004/jnccn.2017.0036; Benson AB, 2015, J NATL COMPR CANC NE, V13, P719, DOI 10.6004/jnccn.2015.0087; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boffa DJ, 2017, JAMA ONCOL, V3, P1722, DOI 10.1001/jamaoncol.2016.6905; Earle C, 2012, VERSION 2, V26-2; Edge SB, 2010, AJCC CANC STAGING MA; Glimelius B, 2013, ANN ONCOL, V24, P81, DOI 10.1093/annonc/mdt240; Jeffery M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002200.pub2; Labianca R, 2013, ANN ONCOL, V24, P64, DOI 10.1093/annonc/mdt354; Leong K, 2017, COLORECTAL DIS, V19, P67, DOI 10.1111/codi.13706; Management of early colorectal cancer, 2011, MAN EARL COL CANC; Meyerhardt JA, 2013, J CLIN ONCOL, V31, P4465, DOI 10.1200/JCO.2013.50.7442; Noone A, 1975, SEER CANC STAT REV; Pita-Fernandez S, 2015, ANN ONCOL, V26, P644, DOI 10.1093/annonc/mdu543; Price RM, 2002, J STAT COMPUT SIM, V72, P119, DOI 10.1080/00949650212140; Primrose JN, 2014, JAMA-J AM MED ASSOC, V311, P263, DOI 10.1001/jama.2013.285718; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI; Renehan AG, 2002, BMJ-BRIT MED J, V324, P813, DOI 10.1136/bmj.324.7341.813; Rosati G, 2016, ANN ONCOL, V27, P274, DOI 10.1093/annonc/mdv541; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Steele SR, 2015, DIS COLON RECTUM, V58, P713, DOI 10.1097/DCR.0000000000000410; Tjandra JJ, 2007, DIS COLON RECTUM, V50, P1783, DOI 10.1007/s10350-007-9030-5; Verberne CJ, 2015, EJSO-EUR J SURG ONC, V41, P1188, DOI 10.1016/j.ejso.2015.06.008; Wille-Jorgensen P, 2009, COLORECTAL DIS, V11, P756, DOI 10.1111/j.1463-1318.2008.01668.x	24	75	75	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2104	2115		10.1001/jama.2018.5816	http://dx.doi.org/10.1001/jama.2018.5816			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800181	Bronze, Green Accepted			2022-12-28	WOS:000432679400022
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			Abuse-Deterrent Opioids (Reprinted from The Medical Letter on Drugs and Therapeutics vol 59, pg 95-96, 2017)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							EXTENDED-RELEASE OXYCODONE; OXYCONTIN						Pflomm, Jean-Marie/HDO-0765-2022					[Anonymous], 2017, MED LETT DRUGS THER, V59, P68; [Anonymous], 2016, MED LETT DRUGS THER, V58, P77; [Anonymous], 2015, MED LETT DRUGS THER, V57, P119; [Anonymous], MED LETT DR IN PRESS; Cassidy TA, 2014, PAIN MED, V15, P440, DOI 10.1111/pme.12295; Cicero TJ, 2012, NEW ENGL J MED, V367, P187, DOI 10.1056/NEJMc1204141; Coplan PM, 2016, CLIN PHARMACOL THER, V100, P275, DOI 10.1002/cpt.390; Coplan PM, 2013, PHARMACOEPIDEM DR S, V22, P1274, DOI 10.1002/pds.3522; Degenhardt L, 2015, DRUG ALCOHOL DEPEN, V151, P56, DOI 10.1016/j.drugalcdep.2015.02.038; FDA, 2015, AB DET OP EV LAB GUI; Hwang CS, 2015, PHARMACOEPIDEM DR S, V24, P197, DOI 10.1002/pds.3723; Larochelle MR, 2015, JAMA INTERN MED, V175, P978, DOI 10.1001/jamainternmed.2015.0914	12	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					2036	+		10.1001/jama.2018.4996	http://dx.doi.org/10.1001/jama.2018.4996			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF8QV	29800210				2022-12-28	WOS:000432238300022
J	Gerstein, H				Gerstein, Hertzel			In high-risk T1DM, real-time continuous glucose monitoring vs self-monitoring reduced hypoglycemic events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Gerstein, Hertzel] McMaster Univ, Hamilton, ON, Canada	McMaster University	Gerstein, H (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Gerstein, Hertzel/ABB-8781-2020; Gerstein, Hertzel C/B-1235-2013	Gerstein, Hertzel/0000-0001-8072-2836; Gerstein, Hertzel C/0000-0001-8072-2836	Dexcom Inc.	Dexcom Inc.	Dexcom Inc.	Pickup JC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3805; Riddle MC, 2017, DIABETES CARE, V40, P1611, DOI 10.2337/dci17-0049	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					JC53	JC53		10.7326/ACPJC-2018-168-10-053	http://dx.doi.org/10.7326/ACPJC-2018-168-10-053			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3DE	29800429				2022-12-28	WOS:000434250700005
J	Voelker, R				Voelker, Rebecca			A Mandate for Opioid Education?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					1974	1974		10.1001/jama.2018.5565	http://dx.doi.org/10.1001/jama.2018.5565			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800195				2022-12-28	WOS:000432238300008
J	Lee, LK; Mannix, R				Lee, Lois K.; Mannix, Rebekah			Increasing Fatality Rates From Preventable Deaths in Teenagers and Young Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lee, Lois K.; Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, BCH 3066,300 Longwood Ave, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Lee, LK (corresponding author), Boston Childrens Hosp, Div Emergency Med, BCH 3066,300 Longwood Ave, Boston, MA 02115 USA.	lois.lee@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020	Mannix, Rebekah/0000-0003-3608-2792				Gaither JR, 2016, JAMA PEDIATR, V170, P1195, DOI 10.1001/jamapediatrics.2016.2154; Hemenway D., 2009, WHILE SLEEPING SUCCE; Lee LK, 2017, JAMA INTERN MED, V177, P106, DOI 10.1001/jamainternmed.2016.7051; National Center for Injury Prevention and Control, WEB BAS INJ STAT QUE; National Highway Transportation Safety Administration Department of Transportation, 2012, YOUNG DRIV REP HIGH; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Santaella-Tenorio J, 2016, EPIDEMIOL REV, V38, P140, DOI 10.1093/epirev/mxv012	7	17	17	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2018	320	6					543	544		10.1001/jama.2018.6566	http://dx.doi.org/10.1001/jama.2018.6566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ4KZ	29852050				2022-12-28	WOS:000441642500003
J	Truog, RD; Pope, TM; Jones, DS				Truog, Robert D.; Pope, Thaddeus Mason; Jones, David S.			The 50-Year Legacy of the Harvard Report on Brain Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Truog, Robert D.] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Ctr Bioeth, Boston, MA USA; [Pope, Thaddeus Mason] Mitchell Hamline Sch Law, St Paul, MN USA; [Jones, David S.] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA; [Jones, David S.] Harvard Univ, Fac Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Mitchell Hamline School of Law; Harvard University; Harvard University	Truog, RD (corresponding author), Boston Childrens Hosp, 300 Longwood Ave,Bader 6, Boston, MA 02115 USA.	robert_truog@hms.harvard.edu			Sanofi-Genzyme	Sanofi-Genzyme	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Truog reports receipt of personal fees from Sanofi-Genzyme for seivice on data monitoring committees. No other disclosures were reported.	[Anonymous], 1968, J AMER MED ASSOC, V205, P337; [Anonymous], 2018, DON DON CIRC DEATH D; BERNAT JL, 1981, ANN INTERN MED, V94, P389, DOI 10.1001/archinte.94.3.389; Capron AM, 2001, NEW ENGL J MED, V344, P1244, DOI 10.1056/NEJM200104193441611; Pope TM, 2017, J LEGAL MED, V37, P265, DOI 10.1080/01947648.2017.1385041; Shewmon DA, 1998, NEUROLOGY, V51, P1538, DOI 10.1212/WNL.51.6.1538; Truog RD, 2018, JAMA-J AM MED ASSOC, V319, P1859, DOI 10.1001/jama.2018.3441	7	20	20	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2018	320	4					335	336		10.1001/jama.2018.6990	http://dx.doi.org/10.1001/jama.2018.6990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GO0AX	29879281				2022-12-28	WOS:000439581200012
J	Ambrogio, S; Narayanan, P; Tsai, HY; Shelby, RM; Boybat, I; di Nolfo, C; Sidler, S; Giordano, M; Bodini, M; Farinha, NCP; Killeen, B; Cheng, C; Jaoudi, Y; Burr, GW				Ambrogio, Stefano; Narayanan, Pritish; Tsai, Hsinyu; Shelby, Robert M.; Boybat, Irem; di Nolfo, Carmelo; Sidler, Severin; Giordano, Massimo; Bodini, Martina; Farinha, Nathan C. P.; Killeen, Benjamin; Cheng, Christina; Jaoudi, Yassine; Burr, Geoffrey W.			Equivalent-accuracy accelerated neural-network training using analogue memory	NATURE			English	Article							SYNAPSES; DEVICES	Neural-network training can be slow and energy intensive, owing to the need to transfer the weight data for the network between conventional digital memory chips and processor chips. Analogue non-volatile memory can accelerate the neural-network training algorithm known as backpropagation by performing parallelized multiply-accumulate operations in the analogue domain at the location of the weight data. However, the classification accuracies of such in situ training using non-volatile-memory hardware have generally been less than those of software-based training, owing to insufficient dynamic range and excessive weight-update asymmetry. Here we demonstrate mixed hardware-software neural-network implementations that involve up to 204,900 synapses and that combine long-term storage in phase-change memory, near-linear updates of volatile capacitors and weight-data transfer with 'polarity inversion' to cancel out inherent device-to-device variations. We achieve generalization accuracies (on previously unseen data) equivalent to those of software-based training on various commonly used machine-learning test datasets (MNIST, MNIST-backrand, CIFAR-10 and CIFAR-100). The computational energy efficiency of 28,065 billion operations per second per watt and throughput per area of 3.6 trillion operations per second per square millimetre that we calculate for our implementation exceed those of today's graphical processing units by two orders of magnitude. This work provides a path towards hardware accelerators that are both fast and energy efficient, particularly on fully connected neural-network layers.	[Ambrogio, Stefano; Narayanan, Pritish; Tsai, Hsinyu; Shelby, Robert M.; di Nolfo, Carmelo; Sidler, Severin; Giordano, Massimo; Bodini, Martina; Farinha, Nathan C. P.; Killeen, Benjamin; Cheng, Christina; Jaoudi, Yassine; Burr, Geoffrey W.] IBM Res Almaden, San Jose, CA 95120 USA; [Boybat, Irem] IBM Res Zurich, Ruschlikon, Switzerland; [Boybat, Irem; di Nolfo, Carmelo; Sidler, Severin; Bodini, Martina] Ecole Polytech Fed Lausanne, Lausanne, Switzerland	International Business Machines (IBM); International Business Machines (IBM); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Burr, GW (corresponding author), IBM Res Almaden, San Jose, CA 95120 USA.	gwburr@us.ibm.com		Killeen, Benjamin/0000-0003-2511-7929	IBM Research Frontiers Institute; IBM RFI	IBM Research Frontiers Institute(International Business Machines (IBM)); IBM RFI(International Business Machines (IBM))	We acknowledge management support from B. Kurdi, C. Lam, W. Wilcke, S. Narayan, T. C. Chen, W. Haensch, R. Divakaruni, J. Welser and D. Gil, and discussions with P. Solomon, S. Kim, A. Sebastian, K. Hosokawa and S. C. Lewis. This work was performed as part of the 'Neuromorphic Devices & Architectures' project under the auspices of the IBM Research Frontiers Institute (https://www.research.ibm.com/frontiers). We acknowledge advice and support from H. Riel, S. Gowda, D. Maynard and the member companies of the IBM RFI.	Agarwal S, 2017, 2017 S VLSI TECHN T1, V13; Alibart F, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/7/075201; Burr G. W., 2014, 2014 IEEE INT EL DEV, V29; Burr GW, 2017, IEEE INT SYMP CIRC S, P23; Burr GW, 2017, ADV PHYS-X, V2, P89, DOI 10.1080/23746149.2016.1259585; Burr GW, 2015, IEEE T ELECTRON DEV, V62, P3498, DOI 10.1109/TED.2015.2439635; Burr GW, 2014, J VAC SCI TECHNOL B, V32, DOI 10.1116/1.4889999; Cao Yu, 2009, ACMSIGDA NEWSLETTER, V39, P1; Cho K., 2014, C EMPIRICAL METHODS, P1724; Coates A., 2013, INT C MACHINE LEARNI, P1337; Donahue J, 2014, PR MACH LEARN RES, V32; Esser SK, 2016, P NATL ACAD SCI USA, V113, P11441, DOI 10.1073/pnas.1604850113; Fuller EJ, 2017, ADV MATER, V29, DOI 10.1002/adma.201604310; Gao LG, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/45/455204; Gokmen T, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00333; Goodfellow I, 2016, DEEP LEARNING; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Gupta S, 2015, PR MACH LEARN RES, V37, P1737; Hu M, 2016, DES AUT CON, DOI 10.1145/2897937.2898010; Ielmini D, 2007, IEEE T ELECTRON DEV, V54, P308, DOI 10.1109/TED.2006.888752; Jang JW, 2015, IEEE ELECTR DEVICE L, V36, P457, DOI 10.1109/LED.2015.2418342; Jeong Y, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4934818; Jouppi NP, 2017, 44TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE (ISCA 2017), P1, DOI 10.1145/3079856.3080246; Kaneko Y, 2014, IEEE T ELECTRON DEV, V61, P2827, DOI 10.1109/TED.2014.2331707; Kim S, 2017, MIDWEST SYMP CIRCUIT, P422, DOI 10.1109/MWSCAS.2017.8052950; Krizhevsky A, 2009, LEARNING MULTIPLE LA; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Merolla P., 2016, PREPRINT; Merolla PA, 2014, SCIENCE, V345, P668, DOI 10.1126/science.1254642; MORIE T, 1994, IEEE J SOLID-ST CIRC, V29, P1086, DOI 10.1109/4.309904; Mujtaba H, 2017, WCCFTECH; Nandakumar S. R, 2017, PREPRINT; Narayanan P, 2017, IBM J RES DEV, V61, DOI 10.1147/JRD.2017.2716579; Nurvitadhi E, 2017, FPGA'17: PROCEEDINGS OF THE 2017 ACM/SIGDA INTERNATIONAL SYMPOSIUM ON FIELD-PROGRAMMABLE GATE ARRAYS, P5, DOI 10.1145/3020078.3021740; Papandreou N, 2011, IEEE INT SYMP CIRC S, P329; PELGROM MJM, 1989, IEEE J SOLID-ST CIRC, V24, P1433, DOI 10.1109/JSSC.1989.572629; Prezioso M, 2015, NATURE, V521, P61, DOI 10.1038/nature14441; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; SZEGEDY C, 2016, PROC CVPR IEEE, P2818, DOI DOI 10.1109/CVPR.2016.308; van de Burgt Y, 2017, NAT MATER, V16, P414, DOI [10.1038/NMAT4856, 10.1038/nmat4856]; Xu ZH, 2014, PROCEDIA COMPUT SCI, V41, P126, DOI 10.1016/j.procs.2014.11.094; Yu S, 2015, 2015 IEEE INT EL DEV, V17	44	540	546	25	254	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					60	+		10.1038/s41586-018-0180-5	http://dx.doi.org/10.1038/s41586-018-0180-5			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29875487				2022-12-28	WOS:000434273300037
J	Martyn, I; Kanno, TY; Ruzo, A; Siggia, ED; Brivanlou, AH				Martyn, I; Kanno, T. Y.; Ruzo, A.; Siggia, E. D.; Brivanlou, A. H.			Self-organization of a human organizer by combined Wnt and Nodal signalling	NATURE			English	Article							EMBRYONIC STEM-CELLS; MOUSE NODE; INDUCTION; MESODERM; POPULATION; PATTERNS; GASTRULA; ACTIVIN	In amniotes, the development of the primitive streak and its accompanying 'organizer' define the first stages of gastrulation. Although these structures have been characterized in detail in model organisms, the human primitive streak and organizer remain a mystery. When stimulated with BMP4, micropatterned colonies of human embryonic stem cells self-organize to generate early embryonic germ layers(1). Here we show that, in the same type of colonies, Wnt signalling is sufficient to induce a primitive streak, and stimulation with Wnt and Activin is sufficient to induce an organizer, as characterized by embryo-like sharp boundary formation, markers of epithelial-to-mesenchymal transition and expression of the organizer-specific transcription factor GSC. Moreover, when grafted into chick embryos, human stem cell colonies treated with Wnt and Activin induce and contribute autonomously to a secondary axis while inducing a neural fate in the host. This fulfils the most stringent functional criteria for an organizer, and its discovery represents a milestone in human embryology.	[Martyn, I; Kanno, T. Y.; Ruzo, A.; Brivanlou, A. H.] Rockefeller Univ, Lab Mol Vertebrate Embryol, 1230 York Ave, New York, NY 10021 USA; [Martyn, I; Siggia, E. D.] Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Brivanlou, AH (corresponding author), Rockefeller Univ, Lab Mol Vertebrate Embryol, 1230 York Ave, New York, NY 10021 USA.; Siggia, ED (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	siggiae@rockefeller.edu; brvnlou@rockefeller.edu	Nakamura Kanno, Tatiane Yumi/ABD-5508-2021	Nakamura Kanno, Tatiane Yumi/0000-0003-3073-1800	Tri-Institutional Starr Foundation [2016-007]; Rockefeller University;  [R01 HD080699];  [R01 GM101653]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101653] Funding Source: NIH RePORTER	Tri-Institutional Starr Foundation; Rockefeller University; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to I. Yan, F. Vieceli and M. Bronner for materials and protocols, to J. Metzger for assistance with 3D image segmentation, and to members of the A.H.B. and E.D.S. laboratories for helpful discussions. This work was supported by grants R01 HD080699, R01 GM101653, the Tri-Institutional Starr Foundation Grant 2016-007, and private funds from the Rockefeller University.	BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Crease DJ, 1998, P NATL ACAD SCI USA, V95, P4398, DOI 10.1073/pnas.95.8.4398; Etoc F, 2016, DEV CELL, V39, P302, DOI 10.1016/j.devcel.2016.09.016; Faial T, 2015, DEVELOPMENT, V142, P2121, DOI 10.1242/dev.117838; Gritsman K, 2000, DEVELOPMENT, V127, P921; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Knoetgen H, 2000, DEV BIOL, V225, P370, DOI 10.1006/dbio.2000.9834; Oppenheimer JM, 1936, J EXP ZOOL, V72, P409, DOI 10.1002/jez.1400720304; Psychoyos Delphine, 2009, J Vis Exp, DOI 10.3791/1027; Robb L, 2004, SEMIN CELL DEV BIOL, V15, P543, DOI 10.1016/j.semcdb.2004.04.005; Spemann H, 2001, INT J DEV BIOL, V45, P13; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Vieceli FM, 2013, GENE EXPR PATTERNS, V13, P189, DOI 10.1016/j.gep.2013.03.004; Waddington CH, 1932, PHILOS T R SOC LON B, V221, P179, DOI 10.1098/rstb.1932.0003; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/NMETH.3016, 10.1038/nmeth.3016]; Williams M, 2012, DEV DYNAM, V241, P270, DOI 10.1002/dvdy.23711; Zhu L, 1999, DEV BIOL, V216, P276, DOI 10.1006/dbio.1999.9508; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	22	126	127	7	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					132	+		10.1038/s41586-018-0150-y	http://dx.doi.org/10.1038/s41586-018-0150-y			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29795348	Green Accepted, Green Submitted			2022-12-28	WOS:000434273300051
J	Poore, J; Nemecek, T				Poore, J.; Nemecek, T.			Reducing food's environmental impacts through producers and consumers	SCIENCE			English	Article							GREENHOUSE-GAS EMISSIONS; OPPORTUNITIES; PROTECTION; FOOTPRINT; SECURITY; CHINA	Food's environmental impacts are created by millions of diverse producers. To identify solutions that are effective under this heterogeneity, we consolidated data covering five environmental indicators; 38,700 farms; and 1600 processors, packaging types, and retailers. Impact can vary 50-fold among producers of the same product, creating substantial mitigation opportunities. However, mitigation is complicated by trade-offs, multiple ways for producers to achieve low impacts, and interactions throughout the supply chain. Producers have limits on how far they can reduce impacts. Most strikingly, impacts of the lowest-impact animal products typically exceed those of vegetable substitutes, providing new evidence for the importance of dietary change. Cumulatively, our findings support an approach where producers monitor their own impacts, flexibly meet environmental targets by choosing from multiple practices, and communicate their impacts to consumers.	[Poore, J.] Univ Oxford, Dept Zool, New Radcliffe House, Oxford OX2 6GG, England; [Poore, J.] Univ Oxford, Sch Geog & Environm, South Parks Rd, Oxford OX1 3QY, England; [Nemecek, T.] LCA Res Grp, Agroscope Agroecol & Environm Res Div, CH-8046 Zurich, Switzerland	University of Oxford; University of Oxford; Swiss Federal Research Station Agroscope	Poore, J (corresponding author), Univ Oxford, Dept Zool, New Radcliffe House, Oxford OX2 6GG, England.; Poore, J (corresponding author), Univ Oxford, Sch Geog & Environm, South Parks Rd, Oxford OX1 3QY, England.	joseph.poore@queens.ox.ac.uk	Poore, Joseph/P-8366-2018	Poore, Joseph/0000-0002-2527-7466; Nemecek, Thomas/0000-0001-8249-1170				Beza E, 2017, EUR J AGRON, V82, P206, DOI 10.1016/j.eja.2016.06.016; Bouwman AF, 2002, WATER AIR SOIL POLL, V141, P349, DOI 10.1023/A:1021398008726; Carlson KM, 2017, NAT CLIM CHANGE, V7, P63, DOI [10.1038/nclimate3158, 10.1038/NCLIMATE3158]; Clark M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6cd5; Clune S, 2017, J CLEAN PROD, V140, P766, DOI 10.1016/j.jclepro.2016.04.082; Cui ZL, 2014, BIOGEOSCIENCES, V11, P2287, DOI 10.5194/bg-11-2287-2014; Cui ZL, 2018, NATURE, V555, P363, DOI 10.1038/nature25785; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Denef K., 2012, GS23F8182H ICF INT U; *FAO, 2010, 2 REP STAT WORLD PLA; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gerber P.J., 2013, TACKLING CLIMATE CHA, P139; German RN, 2017, BIOL REV, V92, P716, DOI 10.1111/brv.12251; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; GSMA, 2017, CREAT SCAL ENG MOB S; Hellweg S, 2014, SCIENCE, V344, P1109, DOI 10.1126/science.1248361; Ladha JK, 2016, GLOBAL CHANGE BIOL, V22, P1054, DOI 10.1111/gcb.13143; Lal R, 2018, GLOBAL CHANGE BIOL, V24, P3285, DOI 10.1111/gcb.14054; Mottet A, 2017, GLOB FOOD SECUR-AGR, V14, P1, DOI 10.1016/j.gfs.2017.01.001; Nepstad DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0167; Nijdam D, 2012, FOOD POLICY, V37, P760, DOI 10.1016/j.foodpol.2012.08.002; OECD, 2017, AGR POL MON EV 2017; Paustian K, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/021001; Roos E, 2013, ECOL INDIC, V24, P573, DOI 10.1016/j.ecolind.2012.08.004; Sara L., 2014, STATE FOOD AGR 2014, DOI [10.18356/579516b5-en, DOI 10.18356/579516B5-EN]; Segerson K, 2013, ANNU REV RESOUR ECON, V5, P161, DOI 10.1146/annurev-resource-091912-151945; Smith P, 2007, AGR ECOSYST ENVIRON, V118, P6, DOI 10.1016/j.agee.2006.06.006; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Song EH, 2016, SIAM-ASA J UNCERTAIN, V4, P1060, DOI 10.1137/15M1048070; Springmann M, 2017, NAT CLIM CHANGE, V7, P69, DOI [10.1038/nclimate3155, 10.1038/NCLIMATE3155]; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Waldman KB, 2014, ANNU REV RESOUR ECON, V6, P429, DOI 10.1146/annurev-resource-100913-012432; West PC, 2014, SCIENCE, V345, P325, DOI 10.1126/science.1246067; Yu QY, 2017, AGR SYST, V153, P212, DOI 10.1016/j.agsy.2017.02.003	35	1421	1438	147	788	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					987	+		10.1126/science.aaq0216	http://dx.doi.org/10.1126/science.aaq0216			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6SL	29853680	Green Submitted			2022-12-28	WOS:000433574200035
J	Mayor, S				Mayor, Susan			Transhumanism: five minutes with . . . Mark O'Connell The winner of the 2018 Wellcome Book Prize for To be a Machine explains what it means to be transhuman	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2018	361								k2327	10.1136/bmj.k2327	http://dx.doi.org/10.1136/bmj.k2327			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MF	29844012				2022-12-28	WOS:000434274800003
J	Friedfeld, MR; Zhong, HY; Ruck, RT; Shevlin, M; Chirik, PJ				Friedfeld, Max R.; Zhong, Hongyu; Ruck, Rebecca T.; Shevlin, Michael; Chirik, Paul J.			Cobalt-catalyzed asymmetric hydrogenation of enamides enabled by single-electron reduction	SCIENCE			English	Article							BIS(PHOSPHINE)COBALT DIALKYL COMPLEXES; ALKENE HYDROGENATION; HOMOGENEOUS HYDROGENATION; OLEFINS; DISCOVERY; IRON	Identifying catalyst activation modes that exploit one-electron chemistry and overcome associated deactivation pathways will be transformative for developing first-row transition metal catalysts with performance equal or, ideally, superior to precious metals. Here we describe a zinc-activation method compatible with high-throughput reaction discovery that identified scores of cobalt-phosphine combinations for the asymmetric hydrogenation of functionalized alkenes. An optimized catalyst prepared from (R, R)-Ph-BPE {Ph-BPE, 1,2bis-[(2R, 5R)-2,5-diphenylphospholano] ethane} and cobalt chloride [CoCl2 center dot 6H(2)O] exhibited high activity and enantioselectivity in protic media and enabled the asymmetric synthesis of the epilepsy medication levetiracetam at 200-gram scale with 0.08 mole % catalyst loading. Stoichiometric studies established that the cobalt (II) catalyst precursor (R, R)-Ph-BPECoCl2 underwent ligand displacement by methanol, and zinc promoted facile one-electron reduction to cobalt (I), which more stably bound the phosphine.	[Friedfeld, Max R.; Zhong, Hongyu; Chirik, Paul J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Ruck, Rebecca T.; Shevlin, Michael] Merck Res Labs, Dept Proc Res & Dev, Rahway, NJ 07065 USA	Princeton University; Merck & Company	Chirik, PJ (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.; Shevlin, M (corresponding author), Merck Res Labs, Dept Proc Res & Dev, Rahway, NJ 07065 USA.	michael_shevlin@merck.com; pchirik@princeton.edu	Zhong, Hongyu/ABB-1501-2021	Zhong, Hongyu/0000-0002-6892-482X; Ruck, Rebecca/0000-0001-9980-9675; Shevlin, Michael/0000-0003-2566-5095; Chirik, Paul/0000-0001-8473-2898	U.S. National Science Foundation (NSF) [CHE-1265988]; NSF [DGE-1148900]	U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	Financial support was from a U.S. National Science Foundation (NSF) Grant Opportunities for Academic Liaison with Industry (GOALI) grant (CHE-1265988) between Princeton and Merck. M.R.F. acknowledges the NSF for a Graduate Research Fellowship (DGE-1148900).	Abou-Khalil Bassel, 2008, Neuropsychiatr Dis Treat, V4, P507; Chirik PJ, 2015, ACCOUNTS CHEM RES, V48, P1687, DOI 10.1021/acs.accounts.5b00134; Crabtree RH, 2015, CHEM REV, V115, P127, DOI 10.1021/cr5004375; Differding E, 2001, Patent No. [2001064637 A1, 2001064637]; Dobbs DA, 2000, ANGEW CHEM INT EDIT, V39, P1992, DOI 10.1002/1521-3773(20000602)39:11<1992::AID-ANIE1992>3.0.CO;2-W; Friedfeld MR, 2014, J AM CHEM SOC, V136, P13178, DOI 10.1021/ja507902z; Friedfeld MR, 2013, SCIENCE, V342, P1076, DOI 10.1126/science.1243550; Ge SZ, 2014, J AM CHEM SOC, V136, P1617, DOI 10.1021/ja411911s; HALLMAN PS, 1967, CHEM COMMUN, P305, DOI 10.1039/c19670000305; Heller D., 2007, HDB HOMOGENEOUS HYDR, P1483; Hilt G, 2012, EUR J ORG CHEM, V2012, P4441, DOI 10.1002/ejoc.201200212; Hoyt JM, 2014, ORGANOMETALLICS, V33, P5781, DOI 10.1021/om500329q; Kim DK, 2017, J AM CHEM SOC, V139, P10208, DOI 10.1021/jacs.7b05327; Knowles WS, 2002, ANGEW CHEM INT EDIT, V41, P1999; Korstanje TJ, 2015, SCIENCE, V350, P298, DOI 10.1126/science.aaa8938; LANDIS CR, 1987, J AM CHEM SOC, V109, P1746, DOI 10.1021/ja00240a025; Mat XL, 2017, J ORG CHEM, V82, P2703, DOI 10.1021/acs.joc.7b00016; OSBORN JA, 1966, J CHEM SOC A, P1711, DOI 10.1039/j19660001711; Prat D, 2013, ORG PROCESS RES DEV, V17, P1517, DOI 10.1021/op4002565; Saudan LA, 2007, ACCOUNTS CHEM RES, V40, P1309, DOI 10.1021/ar700140m; SCHROCK RR, 1976, J AM CHEM SOC, V98, P2134, DOI 10.1021/ja00424a020; Shevlin M, 2016, J AM CHEM SOC, V138, P3562, DOI 10.1021/jacs.6b00519; Shultz CS, 2007, ACCOUNTS CHEM RES, V40, P1320, DOI 10.1021/ar700141v; VINEYARD BD, 1977, J AM CHEM SOC, V99, P5946, DOI 10.1021/ja00460a018; Yoon TP, 2003, SCIENCE, V299, P1691, DOI 10.1126/science.1083622	25	146	148	13	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					888	892		10.1126/science.aar6117	http://dx.doi.org/10.1126/science.aar6117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798879				2022-12-28	WOS:000433039800043
J	Ma, C; Han, MJ; Heinrich, B; Fu, Q; Zhang, QF; Sandhu, M; Agdashian, D; Terabe, M; Berzofsky, JA; Fako, V; Ritz, T; Longerich, T; Theriot, CM; McCulloch, JA; Roy, S; Yuan, WX; Thovarai, V; Sen, SK; Ruchirawat, M; Korangy, F; Wang, XW; Trinchieri, G; Greten, TF				Ma, Chi; Han, Miaojun; Heinrich, Bernd; Fu, Qiong; Zhang, Qianfei; Sandhu, Milan; Agdashian, David; Terabe, Masaki; Berzofsky, Jay A.; Fako, Valerie; Ritz, Thomas; Longerich, Thomas; Theriot, Casey M.; McCulloch, John A.; Roy, Soumen; Yuan, Wuxing; Thovarai, Vishal; Sen, Shurjo K.; Ruchirawat, Mathuros; Korangy, Firouzeh; Wang, Xin Wei; Trinchieri, Giorgio; Greten, Tim F.			Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells	SCIENCE			English	Article							KILLER T-CELLS; INTESTINAL MICROBIOTA; TUMOR SURVEILLANCE; THERAPY	Primary liver tumors and liver metastasis currently represent the leading cause of cancer-related death. Commensal bacteria are important regulators of antitumor immunity, and although the liver is exposed to gut bacteria, their role in antitumor surveillance of liver tumors is poorly understood. We found that altering commensal gut bacteria in mice induced a liver-selective antitumor effect, with an increase of hepatic CXCR6(+) natural killer T (NKT) cells and heightened interferon-gamma production upon antigen stimulation. In vivo functional studies showed that NKT cells mediated liver-selective tumor inhibition. NKT cell accumulation was regulated by CXCL16 expression of liver sinusoidal endothelial cells, which was controlled by gut microbiome-mediated primary-to-secondary bile acid conversion. Our study suggests a link between gut bacteria-controlled bile acid metabolism and liver antitumor immunosurveillance.	[Ma, Chi; Han, Miaojun; Heinrich, Bernd; Fu, Qiong; Zhang, Qianfei; Sandhu, Milan; Agdashian, David; Korangy, Firouzeh; Greten, Tim F.] NCI, Gastrointestinal Malignancy Sect, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Terabe, Masaki; Berzofsky, Jay A.] NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Fako, Valerie; Wang, Xin Wei] NCI, Lab Human Carcinogenesis, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Ritz, Thomas; Longerich, Thomas] Univ Hosp RWTH Aachen, Inst Pathol, D-52074 Aachen, Germany; [Longerich, Thomas] Univ Hosp Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany; [Theriot, Casey M.] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27607 USA; [McCulloch, John A.; Roy, Soumen; Yuan, Wuxing; Thovarai, Vishal; Sen, Shurjo K.; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Yuan, Wuxing; Thovarai, Vishal; Sen, Shurjo K.] NCI, Leidos Biomed Res Inc, Microbiome Sequencing Core, NIH, Bethesda, MD 20892 USA; [Ruchirawat, Mathuros] Chulabhorn Res Inst, Bangkok, Thailand; [Wang, Xin Wei; Greten, Tim F.] NCI CCR Liver Canc Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); RWTH Aachen University; RWTH Aachen University Hospital; Ruprecht Karls University Heidelberg; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chulabhorn Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Greten, TF (corresponding author), NCI, Gastrointestinal Malignancy Sect, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.; Greten, TF (corresponding author), NCI CCR Liver Canc Program, Bethesda, MD 20892 USA.	tim.greten@nih.gov	Wang, Xin Wei/B-6162-2009; Trinchieri, Giorgio/F-9369-2015; Greten, Tim F/B-3127-2015	Wang, Xin Wei/0000-0001-9735-606X; Trinchieri, Giorgio/0000-0001-5892-7464; Greten, Tim F/0000-0002-0806-2535; , Chi/0000-0002-4171-0813; Berzofsky, Jay/0000-0002-0342-3194; Agdashian, David/0000-0001-5912-8031	NIH, NCI [ZIA BC 011345, ZO1 SC 004020, Z01 BC 010876]; Deutsche Forschungsgemeinschaft DFG [SFB/TRR57];  [R35GM119438]; NATIONAL CANCER INSTITUTE [ZIABC011345, Z01SC004020, Z01BC010876, ZIABC011343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119438] Funding Source: NIH RePORTER	NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T.F.G., M.T., J.A.B., X.W.W., and G.T. were supported by the Intramural Research Program of the NIH, NCI (ZIA BC 011345, ZO1 SC 004020, and Z01 BC 010876). C.M.T. was supported by R35GM119438. T.L. was supported by the Deutsche Forschungsgemeinschaft DFG (SFB/TRR57, project Q1).	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bhowmik S, 2016, PROTEINS, V84, P316, DOI 10.1002/prot.24971; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Chaisaingmongkol J, 2017, CANCER CELL, V32, P57, DOI 10.1016/j.ccell.2017.05.009; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Disibio G, 2008, ARCH PATHOL LAB MED, V132, P931, DOI 10.1043/1543-2165(2008)132[931:MPOCRF]2.0.CO;2; Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Kurioka A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.51; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969; Ma C, 2012, J LEUKOCYTE BIOL, V92, P1199, DOI 10.1189/jlb.0212059; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pobezinsky LA, 2015, NAT IMMUNOL, V16, P517, DOI 10.1038/ni.3146; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Sonoda KH, 1999, J EXP MED, V190, P1215, DOI 10.1084/jem.190.9.1215; Staley C, 2017, APPL MICROBIOL BIOT, V101, P47, DOI 10.1007/s00253-016-8006-6; Terabe M., 2016, ENCYCLOPEDIA OF IMMU, V4, P460; Terabe M, 2008, ADV CANCER RES, V101, P277, DOI 10.1016/S0065-230X(08)00408-9; Theriot CM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00045-15; Van Kaer L, 2005, NAT REV IMMUNOL, V5, P31, DOI 10.1038/nri1531; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641	38	584	612	30	369	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391							eaan5931	10.1126/science.aan5931	http://dx.doi.org/10.1126/science.aan5931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29798856	Green Accepted			2022-12-28	WOS:000433039800040
J	Bao, W; Xu, GF; Lu, JC; Snetselaar, LG; Wallace, RB				Bao, Wei; Xu, Guifeng; Lu, Jiachun; Snetselaar, Linda G.; Wallace, Robert B.			Changes in Electronic Cigarette Use Among Adults in the United States, 2014-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Bao, Wei; Xu, Guifeng; Snetselaar, Linda G.; Wallace, Robert B.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA; [Lu, Jiachun] Guangzhou Med Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China	University of Iowa; Guangzhou Medical University	Bao, W (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Epidemiol, CPHB, 145 N Riverside Dr,Room S431, Iowa City, IA 52242 USA.	wei-bao@uiowa.edu	Bao, Wei/AAG-2431-2019	Bao, Wei/0000-0002-7301-5786	NCI NIH HHS [P30 CA086862] Funding Source: Medline; NIEHS NIH HHS [P30 ES005605] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		HARTMANNBOYCE J, 2018, BMJ-BRIT MED J, V360, P12538, DOI DOI 10.1136/BMJ.J5543; Jamal A, 2017, MMWR-MORBID MORTAL W, V66, P597, DOI 10.15585/mmwr.mm6623a1; Leventhal AM, 2016, JAMA-J AM MED ASSOC, V316; McMillen RC, 2015, NICOTINE TOB RES, V17, P1195, DOI 10.1093/ntr/ntu213; Schoenborn CA, 2014, NCHS DATA BRIEF, V2015, P1; Schoenborn CA, 2017, MMWR-MORBID MORTAL W, V66, P892	6	105	107	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					2039	2041		10.1001/jama.2018.4658	http://dx.doi.org/10.1001/jama.2018.4658			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800201	Green Published, Bronze			2022-12-28	WOS:000432238300023
J	Kuehn, B				Kuehn, Bridget			Mass Bat Exposure at National Park	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1854	1854		10.1001/jama.2018.5383	http://dx.doi.org/10.1001/jama.2018.5383			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29801020				2022-12-28	WOS:000431668600006
J	Khera, R; Dorsey, KB; Krumholz, HM				Khera, Rohan; Dorsey, Karen B.; Krumholz, Harlan M.			Transition to the ICD-10 in the United States An Emerging Data Chasm	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Khera, Rohan] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Dorsey, Karen B.] Yale Sch Med, Dept Pediat, Sect Gen Pediat, New Haven, CT 06510 USA; [Dorsey, Karen B.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Krumholz, Harlan M.] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Sch Med, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020; Khera, Rohan/AAQ-6838-2021; Khera, Rohan/P-2378-2019	Khera, Rohan/0000-0001-9467-6199; 	National Heart, Lung, and Blood Institute of the National Institutes of Health [5T32HL125247-02]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001105]; Yale from Medtronic; Johnson Johnson; Medtronic; US Food and Drug Administration	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Yale from Medtronic; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Medtronic(Medtronic); US Food and Drug Administration	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Khera reported being supported by the National Heart, Lung, and Blood Institute (grant 5T32HL125247-02) and the National Center for Advancing Translational Sciences (grant UL1TR001105) of the National Institutes of Health. Drs Dorsey and Krumholz reported working under contracts with the Centers for Medicare & Medicaid Services to develop and maintain performance measures that are publicly reported. Dr Krumholz also reported being the recipient of research grants through Yale from Medtronic and Johnson & Johnson to develop methods of clinical trial data sharing and from Medtronic and the US Food and Drug Administration to develop methods for postmarketing surveillance of medical devices; chairing a cardiac scientific advisory board for United Health; being a participant and participant representative of the IBM Watson Health Life Sciences Board; being a member of the advisory board for element science and the physician advisory board for Aetna; and being the founder of Hugo, which is a personal health information platform.	Centers for Medicare & Medicaid Services, 2017, ICD 10 CM PCS NEXT G; Goyal A, 2017, CIRCULATION, V136, P1180, DOI 10.1161/CIRCULATIONAHA.117.030347; Heslin KC, 2017, MED CARE, V55, P918, DOI 10.1097/MLR.0000000000000805; QualityNet, 2017, MEAS METH REP READM; Romano Teri, 2016, Bull Am Coll Surg, V101, P50; Topaz Maxim, 2013, Perspect Health Inf Manag, V10, p1d; US Centers for Disease Control and Prevention; National Center for Health Statistics, 2017, INT CLASS DIS ICD 10; Yoon J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2504-9	8	54	54	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2018	320	2					133	134		10.1001/jama.2018.6823	http://dx.doi.org/10.1001/jama.2018.6823			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM4MM	29868861				2022-12-28	WOS:000438094900009
J	Carey, CM; Jena, AB; Barnett, ML				Carey, C. M.; Jena, A. B.; Barnett, M. L.			Patterns of Potential Opioid Misuse and Subsequent Adverse Outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													Barnett, Michael/ABA-4159-2021; Barnett, Michael/AAF-4017-2019	Barnett, Michael/0000-0002-4884-6609; Barnett, Michael/0000-0002-4884-6609; carey, colleen/0000-0003-0069-9707					0	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2018	168	12					I18	I18		10.7326/P18-0007	http://dx.doi.org/10.7326/P18-0007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK1TE	29800059				2022-12-28	WOS:000435903500002
J	Caraceni, P; Riggio, O; Angeli, P; Alessandria, C; Neri, S; Foschi, FG; Levantesi, F; Airoldi, A; Boccia, S; Svegliati-Baroni, G; Fagiuoli, S; Romanelli, RG; Cozzolongo, R; Di Marco, V; Sangiovanni, V; Morisco, F; Toniutto, P; Tortora, A; De Marco, R; Angelico, M; Cacciola, I; Elia, G; Federico, A; Massironi, S; Guarisco, R; Galioto, A; Ballardini, G; Rendina, M; Nardelli, S; Piano, S; Elia, C; Prestianni, L; Cappa, FM; Cesarini, L; Simone, L; Pasquale, C; Cavallin, M; Andrealli, A; Fidone, F; Ruggeri, M; Roncadori, A; Baldassarre, M; Tufoni, M; Zaccherini, G; Bernardi, M				Caraceni, Paolo; Riggio, Oliviero; Angeli, Paolo; Alessandria, Carlo; Neri, Sergio; Foschi, Francesco G.; Levantesi, Fabio; Airoldi, Aldo; Boccia, Sergio; Svegliati-Baroni, Gianluca; Fagiuoli, Stefano; Romanelli, Roberto G.; Cozzolongo, Raffaele; Di Marco, Vito; Sangiovanni, Vincenzo; Morisco, Filomena; Toniutto, Pierluigi; Tortora, Annalisa; De Marco, Rosanna; Angelico, Mario; Cacciola, Irene; Elia, Gianfranco; Federico, Alessandro; Massironi, Sara; Guarisco, Riccardo; Galioto, Alessandra; Ballardini, Giorgio; Rendina, Maria; Nardelli, Silvia; Piano, Salvatore; Elia, Chiara; Prestianni, Loredana; Cappa, Federica Mirici; Cesarini, Lucia; Simone, Loredana; Pasquale, Chiara; Cavallin, Marta; Andrealli, Alida; Fidone, Federica; Ruggeri, Matteo; Roncadori, Andrea; Baldassarre, Maurizio; Tufoni, Manuel; Zaccherini, Giacomo; Bernardi, Mauro		ANSWER Study Investigators	Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial	LANCET			English	Article							PERIPHERAL ARTERIAL VASODILATION; PLASMA EXPANDERS; NATURAL-HISTORY; LIVER-DISEASE; ASCITES; INFECTIONS; MANAGEMENT; SURVIVAL; IMPROVES; FAILURE	Background Evidence is scarce on the efficacy of long-term human albumin (HA) administration in patients with decompensated cirrhosis. The human Albumin for the treatmeNt of aScites in patients With hEpatic ciRrhosis (ANSWER) study was designed to clarify this issue. Methods We did an investigator-initiated multicentre randomised, parallel, open-label, pragmatic trial in 33 academic and non-academic Italian hospitals. We randomly assigned patients with cirrhosis and uncomplicated ascites who were treated with anti-aldosteronic drugs (>= 200 mg/day) and furosemide (>= 25 mg/day) to receive either standard medical treatment (SMT) or SMT plus HA (40 g twice weekly for 2 weeks, and then 40 g weekly) for up to 18 months. The primary endpoint was 18-month mortality, evaluated as difference of events and analysis of survival time in patients included in the modified intention-to-treat and per-protocol populations. This study is registered with EudraCT, number 2008-000625-19, and ClinicalTrials. gov, number NCT01288794. Findings From April 2, 2011, to May 27, 2015, 440 patients were randomly assigned and 431 were included in the modified intention-to-treat analysis. 38 of 218 patients died in the SMT plus HA group and 46 of 213 in the SMT group. Overall 18-month survival was significantly higher in the SMT plus HA than in the SMT group (Kaplan-Meier estimates 77% vs 66%; p=0.028), resulting in a 38% reduction in the mortality hazard ratio (0.62 [95% CI 0.40-0.95]). 46 (22%) patients in the SMT group and 49 (22%) in the SMT plus HA group had grade 3-4 non-liver related adverse events. Interpretation In this trial, long-term HA administration prolongs overall survival and might act as a disease modifying treatment in patients with decompensated cirrhosis. (C) 2018 Elsevier Ltd. All rights reserved.	[Caraceni, Paolo; Baldassarre, Maurizio; Tufoni, Manuel; Zaccherini, Giacomo; Bernardi, Mauro] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Caraceni, Paolo; Baldassarre, Maurizio; Tufoni, Manuel; Zaccherini, Giacomo; Bernardi, Mauro] Univ Bologna, Ctr Appl Biomed Res, Bologna, Italy; [Riggio, Oliviero; Nardelli, Silvia; Pasquale, Chiara] Sapienza Univ Rome, Dept Clin Med, Rome, Italy; [Angeli, Paolo; Piano, Salvatore; Cavallin, Marta] Univ Padua, Dept Med, Unit Internal Med & Hepatol, Padua, Italy; [Alessandria, Carlo; Elia, Chiara; Andrealli, Alida] Univ Turin, Div Gastroenterol & Hepatol, Citta Salute & Sci Hosp, Turin, Italy; [Neri, Sergio; Prestianni, Loredana; Fidone, Federica] Univ Catania, Dept Clin & Expt Med, Catania, Italy; [Foschi, Francesco G.; Cappa, Federica Mirici] Hosp Faenza, Internal Med, Azienda Unita Sanit Locale Romagna, Faenza, Italy; [Levantesi, Fabio] Hosp Bentivoglio, AUSL Bologna, Internal Med, Bologna, Italy; [Airoldi, Aldo; Cesarini, Lucia] Osped Niguarda Ca Granda, Dept Gastroenterol & Hepatol, Liver Unit, Milan, Italy; [Boccia, Sergio; Simone, Loredana] Univ Hosp, Gastroenterol Unit, Ferrara, Italy; [Svegliati-Baroni, Gianluca] Polytech Univ Marche, Dept Gastroenterol, Ancona, Italy; [Fagiuoli, Stefano] Papa Giovanni XXIII Hosp, Gastroenterol & Transplant Hepatol, Bergamo, Italy; [Romanelli, Roberto G.] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Cozzolongo, Raffaele] Natl Inst Gastroenterol S De Bellis, Div Gastroenterol, Bari, Italy; [Di Marco, Vito] Univ Palermo, Biomed Dept Internal & Specialist Med, Unit Gastroenterol & Hepatol, Palermo, Italy; [Sangiovanni, Vincenzo] Cotugno Hosp Naples, Azienda Osped Rilievo Nazl Colli, Naples, Italy; [Morisco, Filomena] Federico II Univ Naples, Dept Clin Med & Surg, Gastroenterol Unit, Naples, Italy; [Toniutto, Pierluigi] Univ Udine, Dept Med Area, Internal Med, Udine, Italy; [Tortora, Annalisa] Catholic Univ, Gemelli Fdn, Gastroenterol, Rome, Italy; [De Marco, Rosanna] Hosp Cosenza, Gastroenterol Unit, Cosenza, Italy; [Angelico, Mario] Tor Vergata Univ, Liver Unit, Rome, Italy; [Cacciola, Irene] Univ Hosp Messina, Div Clin & Mol Hepatol, Messina, Italy; [Elia, Gianfranco] Univ Hosp Parma, Infect Dis & Hepatol, Parma, Italy; [Federico, Alessandro] Univ Campania Luigi Vanvitelli, Dept Clin & Expt Internal Med, Naples, Italy; [Massironi, Sara] Fdn Ist Ricovero, Gastroenterol & Endoscopy Unit, Milan, Italy; [Massironi, Sara] Cura Carattere Sci Ca Granda Osped Maggiore Polic, Milan, Italy; [Guarisco, Riccardo] S Sebastiano Gen Hosp, Internal Med, Rome, Italy; [Galioto, Alessandra] Hosp Dolo, Internal Med, Azienda Unita Locale Sociosanit Serenissima, Venice, Italy; [Ballardini, Giorgio] Hosp Rimini, AUSL Romagna, Rimini, Italy; [Rendina, Maria] Univ Bari, Sect Gastroenterol, Dept Emergency & Organ Transplantat, Bari, Italy; [Ruggeri, Matteo] Catholic Univ, Grad Sch Hlth Econ & Management, Rome, Italy; [Roncadori, Andrea] Cineca Interuniv Consortium, Bologna, Italy	University of Bologna; University of Bologna; Sapienza University Rome; University of Padua; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; University of Catania; AUSL di Bologna; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Ferrara; Arcispedale Sant'Anna; Marche Polytechnic University; ASST Papa Giovanni XXIII; University of Florence; University of Palermo; University of Naples Federico II; University of Udine; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Rome Tor Vergata; AOU Policlinico Gaetano Martino; University of Parma; University Hospital of Parma; Universita della Campania Vanvitelli; IRCCS Ca Granda Ospedale Maggiore Policlinico; AUSL della Romagna; Hospital of Rimini; Universita degli Studi di Bari Aldo Moro; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; CINECA, Italy	Bernardi, M (corresponding author), S Orsola Malpighi Univ Hosp, I-40138 Bologna, Italy.; Bernardi, M (corresponding author), Univ Bologna, S Orsola Malpighi Univ Hosp, Dept Med & Surg Sci, I-40138 Bologna, Italy.	mauro.bernardi@unibo.it	Zaccherini, Giacomo/A-2368-2015; Tufoni, Manuel/AAC-3066-2019; Massironi, Sara/X-2547-2019; Tortora, Annalisa/AAA-9933-2019; Piano, Salvatore/K-2868-2018; ALESSANDRIA, CARLO/AAH-1448-2019; Morisco, Filomena/AHI-0851-2022; Federico, Alessandro/AAB-3893-2019; Baldassarre, Maurizio/K-6129-2016; cozzolongo, raffaele/ABH-5696-2020; Di Marco, Vito/AAC-4612-2022; Cacciola, Irene/K-1174-2019; Riggio, Oliviero/ABG-6697-2020; Massironi, Sara/X-4138-2019; guarino, maria/AAM-6001-2020; ROMANELLI, Roberto Giulio/K-4406-2018	Zaccherini, Giacomo/0000-0002-3219-6963; Tufoni, Manuel/0000-0002-8588-193X; Massironi, Sara/0000-0003-3214-8192; Piano, Salvatore/0000-0002-9356-5830; Federico, Alessandro/0000-0002-0885-0793; Cacciola, Irene/0000-0001-7721-6799; Riggio, Oliviero/0000-0003-0241-3223; guarino, maria/0000-0002-0460-4122; Marzioni, Marco/0000-0001-6014-6165; BRINGIOTTI, ROBERTO/0000-0002-3438-5776; ruggeri, matteo/0000-0002-5703-7424; Fagiuoli, Stefano/0000-0001-8308-0701; ROMANELLI, Roberto Giulio/0000-0001-9219-8189; Gasbarrini, Antonio/0000-0003-4863-6924; Roncadori, Andrea/0000-0002-0356-9273; svegliati-baroni, gianluca/0000-0003-4399-3359; cozzolongo, raffaele/0000-0002-8343-5864; Saracco, Giorgio Maria/0000-0001-5310-4143; Toniutto, Pierluigi/0000-0002-2566-3041; DALLIO, MARCELLO/0000-0003-4153-815X	Italian Medicine Agency	Italian Medicine Agency	Italian Medicine Agency.	Bernardi M, 2015, J HEPATOL, V63, P1272, DOI 10.1016/j.jhep.2015.07.004; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Campbell MK, 1999, QJM-INT J MED, V92, P177, DOI 10.1093/qjmed/92.3.177; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; FALOON WW, 1949, J CLIN INVEST, V28, P583, DOI 10.1172/JCI102108; Fernandez J, 2002, HEPATOLOGY, V35, P140, DOI 10.1053/jhep.2002.30082; Fernandez J, 2017, LIVER INT, V37, P385, DOI 10.1111/liv.13239; Ford I, 2016, NEW ENGL J MED, V375, P454, DOI 10.1056/NEJMra1510059; Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338; Gentilini P, 1999, J HEPATOL, V30, P639, DOI 10.1016/S0168-8278(99)80194-9; GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; HENRIKSEN JH, 1980, SCAND J CLIN LAB INV, V40, P493, DOI 10.3109/00365518009091956; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kim SB, 1999, AM J KIDNEY DIS, V33, P312, DOI 10.1016/S0272-6386(99)70306-9; Kochanek KD, 2016, NATL VITAL STAT REPO, V64; KUNKEL HG, 1948, J CLIN INVEST, V27, P305, DOI 10.1172/JCI101959; Levi M, 2007, SEMIN THROMB HEMOST, V33, P810, DOI 10.1055/s-2007-1000370; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; Moeller C, 2016, J CRIT CARE, V35, P75, DOI 10.1016/j.jcrc.2016.04.011; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moore KP, 2003, HEPATOLOGY, V38, P258, DOI 10.1053/jhep.2003.50315; Pintilie M, 2006, COMPETING RISKS PRAC; Romanelli RG, 2006, WORLD J GASTROENTERO, V12, P1403, DOI 10.3748/wjg.v12.i9.1403; Runyon BA, 2013, HEPATOLOGY, V57, P1651, DOI 10.1002/hep.26359; Scalone L, 2015, BMJ OPEN GASTROENTER, V2, DOI 10.1136/bmjgast-2014-000025; Scalone L, 2013, VALUE HEALTH, V16, P814, DOI 10.1016/j.jval.2013.04.008; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532; Shaw AD, 2013, CLIN J AM SOC NEPHRO, V8, P497, DOI 10.2215/CJN.10921012; Stepanova M, 2017, CLIN GASTROENTEROL H, V15, P759, DOI 10.1016/j.cgh.2016.07.020; Szende A, 2014, SELF REPORTED POPULA, DOI DOI 10.1007/978-94-007-7596-1; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; WILKINSON P, 1962, LANCET, V2, P1125; Wong F, 2010, J HEPATOL, V53, P283, DOI 10.1016/j.jhep.2010.02.036	36	210	214	4	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2018	391	10138					2417	2429		10.1016/S0140-6736(18)30840-7	http://dx.doi.org/10.1016/S0140-6736(18)30840-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK7QC	29861076	Green Published			2022-12-28	WOS:000436402000025
J	Sukhdev, P				Sukhdev, Pavan			Smarter metrics will help fix our food system	NATURE			English	Editorial Material									[Sukhdev, Pavan] GIST Advisory, Bombay, Maharashtra, India		Sukhdev, P (corresponding author), GIST Advisory, Bombay, Maharashtra, India.	pavan@gistadvisory.com						Praneetvataku S, 2013, ENVIRON SCI POLICY, V27, P103, DOI 10.1016/j.envsci.2012.10.019; Sandhu HS, 2008, ECOL ECON, V64, P835, DOI 10.1016/j.ecolecon.2007.05.007	2	10	10	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					7	7		10.1038/d41586-018-05328-1	http://dx.doi.org/10.1038/d41586-018-05328-1			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GI3LQ	29872209	Bronze			2022-12-28	WOS:000434273300013
J	Sun, BB; Maranville, JC; Peters, JE; Stacey, D; Staley, JR; Blackshaw, J; Burgess, S; Jiang, T; Paige, E; Surendran, P; Oliver-Williams, C; Kamat, MA; Prins, BP; Wilcox, SK; Zimmerman, ES; Chi, A; Bansal, N; Spain, SL; Wood, AM; Morrell, NW; Bradley, JR; Janjic, N; Roberts, DJ; Ouwehand, WH; Todd, JA; Soranzo, N; Suhre, K; Paul, DS; Fox, CS; Plenge, RM; Danesh, J; Runz, H; Butterworth, AS				Sun, Benjamin B.; Maranville, Joseph C.; Peters, James E.; Stacey, David; Staley, James R.; Blackshaw, James; Burgess, Stephen; Jiang, Tao; Paige, Ellie; Surendran, Praveen; Oliver-Williams, Clare; Kamat, Mihir A.; Prins, Bram P.; Wilcox, Sheri K.; Zimmerman, Erik S.; Chi, An; Bansal, Narinder; Spain, Sarah L.; Wood, Angela M.; Morrell, Nicholas W.; Bradley, John R.; Janjic, Nebojsa; Roberts, David J.; Ouwehand, Willem H.; Todd, John A.; Soranzo, Nicole; Suhre, Karsten; Paul, Dirk S.; Fox, Caroline S.; Plenge, Robert M.; Danesh, John; Runz, Heiko; Butterworth, Adam S.			Genomic atlas of the human plasma proteome	NATURE			English	Article							MULTIVARIABLE MENDELIAN RANDOMIZATION; PLEIOTROPIC GENETIC-VARIANTS; INFLAMMATORY-BOWEL-DISEASE; WIDE ASSOCIATION; REGULATORY VARIATION; PAGETS-DISEASE; LOCI; RISK; IDENTIFICATION; ARCHITECTURE	Although plasma proteins have important roles in biological processes and are the direct targets of many drugs, the genetic factors that control inter-individual variation in plasma protein levels are not well understood. Here we characterize the genetic architecture of the human plasma proteome in healthy blood donors from the INTERVAL study. We identify 1,927 genetic associations with 1,478 proteins, a fourfold increase on existing knowledge, including trans associations for 1,104 proteins. To understand the consequences of perturbations in plasma protein levels, we apply an integrated approach that links genetic variation with biological pathway, disease, and drug databases. We show that protein quantitative trait loci overlap with gene expression quantitative trait loci, as well as with disease-associated loci, and find evidence that protein biomarkers have causal roles in disease using Mendelian randomization analysis. By linking genetic factors to diseases via specific proteins, our analyses highlight potential therapeutic targets, opportunities for matching existing drugs with new disease indications, and potential safety concerns for drugs under development.	[Sun, Benjamin B.; Peters, James E.; Stacey, David; Staley, James R.; Blackshaw, James; Burgess, Stephen; Jiang, Tao; Paige, Ellie; Surendran, Praveen; Oliver-Williams, Clare; Kamat, Mihir A.; Prins, Bram P.; Bansal, Narinder; Wood, Angela M.; Paul, Dirk S.; Danesh, John; Butterworth, Adam S.] Univ Cambridge, Dept Publ Hlth & Primary Care, MRC BHF Cardiovasc Epidemiol Unit, Cambridge, England; [Maranville, Joseph C.; Chi, An; Fox, Caroline S.; Plenge, Robert M.; Runz, Heiko] Merck & Co Inc, MRL, Kenilworth, NJ USA; [Peters, James E.; Morrell, Nicholas W.; Ouwehand, Willem H.; Soranzo, Nicole; Danesh, John] British Heart Fdn, Cambridge Ctr Excellence, Div Cardiovasc Med, Addenbrookes Hosp, Cambridge, England; [Burgess, Stephen] Univ Cambridge, MRC Biostat Unit, Cambridge, England; [Paige, Ellie] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Oliver-Williams, Clare] Homerton Coll, Cambridge, England; [Wilcox, Sheri K.; Zimmerman, Erik S.; Janjic, Nebojsa] SomaLogic Inc, Boulder, CO USA; [Bansal, Narinder] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Spain, Sarah L.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England; [Morrell, Nicholas W.] Univ Cambridge, Dept Med, Div Resp Med, Cambridge, England; [Bradley, John R.] Cambridge Univ Hosp, NIHR Cambridge Biomed Res Ctr, BioResource, Cambridge, England; [Roberts, David J.] Univ Oxford, John Radcliffe Hosp, NIHR Oxford Biomed Res Ctr, Natl Hlth Serv NHS Blood & Transplant, Oxford, England; [Roberts, David J.] Univ Oxford, John Radcliffe Hosp, NIHR Oxford Biomed Res Ctr, Radcliffe Dept Med, Oxford, England; [Roberts, David J.] Churchill Hosp, BRC Haematol Theme, Oxford, England; [Roberts, David J.] Churchill Hosp, Dept Haematol, Oxford, England; [Ouwehand, Willem H.; Soranzo, Nicole] Univ Cambridge, Dept Haematol, Cambridge Biomed Campus, Cambridge, England; [Ouwehand, Willem H.] Natl Hlth Serv NHS Blood & Transplant, Cambridge Biomed Campus, Cambridge, England; [Ouwehand, Willem H.; Soranzo, Nicole; Danesh, John] Wellcome Trust Sanger Inst, Dept Human Genet, Wellcome Trust Genome Campus, Cambridge, England; [Ouwehand, Willem H.; Soranzo, Nicole; Danesh, John; Butterworth, Adam S.] Univ Cambridge, Dept Publ Hlth & Primary Care, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England; [Todd, John A.] Univ Oxford, JDRF Wellcome Trust Diabet & Inflammat Lab, NIHR Oxford Biomed Res Ctr, Wellcome Trust Ctr Human Genet,Nuffield Dept Med, Oxford, England; [Suhre, Karsten] Weill Cornell Med Qatar, Dept Physiol & Biophys, Doha, Qatar; [Maranville, Joseph C.; Plenge, Robert M.] Celgene Inc, Cambridge, MA USA; [Runz, Heiko] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA	University of Cambridge; Merck & Company; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; MRC Biostatistics Unit; University of Cambridge; Australian National University; University of Cambridge; University of Bristol; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Biogen	Danesh, J; Butterworth, AS (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, MRC BHF Cardiovasc Epidemiol Unit, Cambridge, England.; Danesh, J (corresponding author), British Heart Fdn, Cambridge Ctr Excellence, Div Cardiovasc Med, Addenbrookes Hosp, Cambridge, England.; Danesh, J (corresponding author), Wellcome Trust Sanger Inst, Dept Human Genet, Wellcome Trust Genome Campus, Cambridge, England.; Danesh, J; Butterworth, AS (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England.	jd292@medschl.cam.ac.uk; asb38@medschl.cam.ac.uk	Stacey, David/AFX-6013-2022; Suhre, Karsten/AAF-1778-2020; Wood, Angela/GZA-5762-2022; wei, wei/HHR-8613-2022; Paul, Dirk S./H-3469-2019; Todd, John/A-3542-2010	Stacey, David/0000-0002-9392-9235; Suhre, Karsten/0000-0001-9638-3912; Wood, Angela/0000-0002-7937-304X; Paul, Dirk S./0000-0002-8230-0116; Prins, Bram/0000-0001-5774-034X; Blackshaw, James Alan/0000-0002-0343-0319; Bradley, John/0000-0002-7774-8805; Morrell, Nicholas/0000-0001-5700-9792; Maranville, Joseph/0000-0002-1688-1573; Todd, John/0000-0003-2740-8148; Soranzo, Nicole/0000-0003-1095-3852; Paige, Ellie/0000-0003-0855-9872; Bansal, Narinder/0000-0002-6925-1719; Burgess, Stephen/0000-0001-5365-8760	British Heart Foundation [SP/12/12/29836, RG/13/13/30194, RG/16/4/32218] Funding Source: Medline; Medical Research Council [MR/S003746/1, MR/S004068/1, MR/P013880/1, MC_UU_00002/7, 1508647, MR/L003120/1] Funding Source: Medline; Wellcome Trust [204623/Z/16/Z] Funding Source: Medline; MRC [MR/S004068/1, MR/P013880/1, MR/L003120/1, MC_UU_00002/7, MR/S003746/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Albagha OME, 2010, NAT GENET, V42, P520, DOI 10.1038/ng.562; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Burgess S, 2016, STAT MED, V35, P1880, DOI 10.1002/sim.6835; Burgess S, 2015, EUR J EPIDEMIOL, V30, P543, DOI 10.1007/s10654-015-0011-z; Burgess S, 2015, AM J EPIDEMIOL, V181, P290, DOI 10.1093/aje/kwv017; Burgess S, 2015, AM J EPIDEMIOL, V181, P251, DOI 10.1093/aje/kwu283; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Dahl R, 2012, PULM PHARMACOL THER, V25, P169, DOI 10.1016/j.pupt.2011.12.011; de Vries PS, 2017, HUM MOL GENET, V26, P3442, DOI 10.1093/hmg/ddx266; Di Angelantonio E, 2017, LANCET, V390, P2360, DOI 10.1016/S0140-6736(17)31928-1; Di Narzo AF, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006565; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Ganz P, 2016, JAMA-J AM MED ASSOC, V315, P2532, DOI 10.1001/jama.2016.5951; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gooptu B, 2014, TRENDS MOL MED, V20, P116, DOI 10.1016/j.molmed.2013.10.007; Gronberg H, 2015, LANCET ONCOL, V16, P1667, DOI 10.1016/S1470-2045(15)00361-7; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Iotchkova V, 2016, GARFIELD GWAS ANAL R; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu YS, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145728; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; Malone J, 2010, BIOINFORMATICS, V26, P1112, DOI 10.1093/bioinformatics/btq099; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Menni C, 2015, J GERONTOL A-BIOL, V70, P809, DOI 10.1093/gerona/glu121; Merkel PA, 2017, ARTHRITIS RHEUMATOL, V69, P1054, DOI 10.1002/art.40034; Moore C, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-363; Nai A, 2011, BLOOD, V118, P4459, DOI 10.1182/blood-2011-06-364034; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Ngo D, 2016, CIRCULATION, V134, P270, DOI 10.1161/CIRCULATIONAHA.116.021803; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Rohloff JC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.49; Sattlecker M, 2014, ALZHEIMERS DEMENT, V10, P724, DOI 10.1016/j.jalz.2013.09.016; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schwarz P, 2012, BONE, V50, P1023, DOI 10.1016/j.bone.2012.01.020; Smith RN, 2012, BIOINFORMATICS, V28, P3163, DOI 10.1093/bioinformatics/bts577; Stacey D, 2017, PROGEM FRAMEWORK PRI, DOI [10.1101/230094, DOI 10.1101/230094]; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Suhre K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14357; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Traylor M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004469; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yao C., 2017, GENOME WIDE ASS STUD; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	68	518	521	13	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2018	558	7708					73	+		10.1038/s41586-018-0175-2	http://dx.doi.org/10.1038/s41586-018-0175-2			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI3LQ	29875488	Green Accepted, Green Submitted			2022-12-28	WOS:000434273300039
J	Bartolozzi, C				Bartolozzi, Chiara			Neuromorphic circuits impart a sense of touch	SCIENCE			English	Editorial Material									[Bartolozzi, Chiara] Ist Italiano Tecnol, iCub Facil, Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Bartolozzi, C (corresponding author), Ist Italiano Tecnol, iCub Facil, Genoa, Italy.	chiara.bartolozzi@iit.it						Bartolozzi C, 2017, IEEE INT C INT ROBOT, P166; Bartolozzi C, 2016, NAT MATER, V15, P921, DOI 10.1038/nmat4731; Chou TS, 2015, FRONT NEUROROBOTICS, V9, DOI 10.3389/fnbot.2015.00006; Friedl KE, 2016, IEEE ROBOT AUTOM LET, V1, P516, DOI 10.1109/LRA.2016.2517213; Kim Y, 2018, SCIENCE, V360, P998, DOI 10.1126/science.aao0098; MEAD C, 1990, P IEEE, V78, P1629, DOI 10.1109/5.58356; Oddo CM, 2016, ELIFE, V5, DOI 10.7554/eLife.09148; Osborn L, 2016, IEEE T HAPTICS, V9, P196, DOI 10.1109/TOH.2016.2564965; Panzeri S, 2017, NEURON, V93, P491, DOI 10.1016/j.neuron.2016.12.036; Rager D. M., 2013, 35 ANN INT C IEEE EN, P5922; Regoli M, 2017, 2017 18TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS (ICAR), P47, DOI 10.1109/ICAR.2017.8023495; Saal HP, 2016, CURR OPIN NEUROBIOL, V40, P142, DOI 10.1016/j.conb.2016.07.013; Tan DW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008669; Yi ZK, 2017, SENSOR ACTUAT A-PHYS, V255, P46, DOI 10.1016/j.sna.2016.12.021	14	6	7	7	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					966	967		10.1126/science.aat3125	http://dx.doi.org/10.1126/science.aat3125			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6SL	29853674				2022-12-28	WOS:000433574200024
J	Harland, RM				Harland, Richard M.			A new view of embryo development and regeneration	SCIENCE			English	Editorial Material									[Harland, Richard M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Harland, RM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	harland@berkeley.edu						Briggs JA, 2018, SCIENCE, V360, P980, DOI 10.1126/science.aar5780; Conklin E. G., 1905, ORG CELL LINEAGE ASC; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; Fincher CT, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1736; Nimmo RA, 2015, TRENDS CELL BIOL, V25, P459, DOI 10.1016/j.tcb.2015.04.004; Plass M, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1723; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; Vogt Walther, 1929, Wilhelm Roux Arch Entwickl Mech Org, V120, P384, DOI 10.1007/BF02109667; Wagner DE, 2018, SCIENCE, V360, P981, DOI 10.1126/science.aar4362	10	14	14	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					967	968		10.1126/science.aat8413	http://dx.doi.org/10.1126/science.aat8413			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6SL	29853675				2022-12-28	WOS:000433574200025
J	Muir, A; Vander Heiden, MG				Muir, Alexander; Vander Heiden, Matthew G.			The nutrient environment affects therapy	SCIENCE			English	Editorial Material							CANCER; METABOLISM; PRECISION; GROWTH		[Muir, Alexander; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Muir, Alexander; Vander Heiden, Matthew G.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute	Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	mvh@mit.edu		Muir, Alexander/0000-0003-3811-3054	Massachusetts Institute of Technology (MIT) Center for Precision Cancer Medicine; Lustgarten Foundation; Ludwig Center at MIT, SU2C, Howard Hughes Medical Institute; National Cancer Institute [F32CA213810, R01CA168653]; NATIONAL CANCER INSTITUTE [F32CA213810, R01CA168653, R01CA201276] Funding Source: NIH RePORTER	Massachusetts Institute of Technology (MIT) Center for Precision Cancer Medicine; Lustgarten Foundation; Ludwig Center at MIT, SU2C, Howard Hughes Medical Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank B. Bevis for assistance with the figure and acknowledge support from the Massachusetts Institute of Technology (MIT) Center for Precision Cancer Medicine, the Lustgarten Foundation, the Ludwig Center at MIT, SU2C, Howard Hughes Medical Institute, and the National Cancer Institute (F32CA213810 to A.M. and R01CA168653 to M.G.V.H.). M.G.V.H. is a consultant and scientific advisory board member for Agios Pharmaceuticals and Aeglea Biotherapeutics.	Amaravadi R, 2016, GENE DEV, V30, P1913, DOI 10.1101/gad.287524.116; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Cantor JR, 2017, CELL, V169, P258, DOI 10.1016/j.cell.2017.03.023; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; Gui DY, 2016, CELL METAB, V24, P716, DOI 10.1016/j.cmet.2016.09.006; Horvath P, 2016, NAT REV DRUG DISCOV, V15, P751, DOI 10.1038/nrd.2016.175; Letai A, 2017, NAT MED, V23, P1028, DOI 10.1038/nm.4389; Muir A, 2017, ELIFE, V6, DOI 10.7554/eLife.27713; Palm W, 2015, CELL, V162, P259, DOI 10.1016/j.cell.2015.06.017; Rancati G, 2018, NAT REV GENET, V19, P34, DOI 10.1038/nrg.2017.74; Schug ZT, 2016, NAT REV CANCER, V16, P708, DOI 10.1038/nrc.2016.87; Tardito S, 2015, NAT CELL BIOL, V17, P1556, DOI 10.1038/ncb3272; Wolpaw AJ, 2018, TRENDS CELL BIOL, V28, P201, DOI 10.1016/j.tcb.2017.11.006; Yau EH, 2017, CANCER RES, V77, P6330, DOI 10.1158/0008-5472.CAN-17-2043	15	66	66	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					962	963		10.1126/science.aar5986	http://dx.doi.org/10.1126/science.aar5986			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6SL	29853672	Green Accepted, Green Submitted			2022-12-28	WOS:000433574200022
J	Wong, K; Gehring, K				Wong, Kathy; Gehring, Kalle			Enzyme illuminates bacterial ubiquitination	NATURE			English	Editorial Material							EFFECTORS	Structural analysis reveals how a bacterial enzyme catalyses attachment of the protein tag ubiquitin to host proteins, illuminating a process that allows pathogenic bacteria to subvert host-cell function.	[Wong, Kathy; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada	McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184				Akturk A, 2018, NATURE, V557, P729, DOI 10.1038/s41586-018-0147-6; Bhogaraju S, 2016, CELL, V167, P1636, DOI 10.1016/j.cell.2016.11.019; De Leon JA, 2017, CELL REP, V21, P2031, DOI 10.1016/j.celrep.2017.10.088; Dong YA, 2018, NATURE, V557, P674, DOI 10.1038/s41586-018-0146-7; Kalayil S, 2018, NATURE, V557, P734, DOI 10.1038/s41586-018-0145-8; Kotewicz KM, 2017, CELL HOST MICROBE, V21, P169, DOI 10.1016/j.chom.2016.12.007; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Qiu JZ, 2016, NATURE, V533, P120, DOI 10.1038/nature17657; Wang Y, 2018, CELL, V173, P1231, DOI 10.1016/j.cell.2018.04.023	9	0	0	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					644	645		10.1038/d41586-018-05250-6	http://dx.doi.org/10.1038/d41586-018-05250-6			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH4WT	29805175				2022-12-28	WOS:000433412900036
J	Hawkes, N				Hawkes, Nigel			Journals retract four articles criticising vaccines by author who used a pseudonym	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Anderson L, 2019, INT J SPORT PHYSIOL, V14, P681, DOI [10.20529/IJME.2018.037, 10.1123/ijspp.2018-0520]; Andersson L, 2017, J INTERN MED, V281, P99, DOI 10.1111/joim.12583; Arbyn M, 2018, COCHRANE DB SYST REV, V5	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2018	361								k2394	10.1136/bmj.k2394	http://dx.doi.org/10.1136/bmj.k2394			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MP	29848773				2022-12-28	WOS:000434275800015
J	Shepherd, A				Shepherd, Alison			THE BIG PICTURE Fight for abortion rights moves to Northern Ireland	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2018	361								k2379	10.1136/bmj.k2379	http://dx.doi.org/10.1136/bmj.k2379			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MP	29848475				2022-12-28	WOS:000434275800011
J	Hulsmann, L; Hartig, F				Huelsmann, Lisa; Hartig, Florian			Comment on "Plant diversity increases with the strength of negative density dependence at the global scale"	SCIENCE			English	Editorial Material							TROPICAL FOREST; SEED DISPERSAL; DISTRIBUTIONS; ABUNDANCE; TREES	LaManna et al. (Reports, 30 June 2017, p. 1389) claim that subadult trees are proportionally less common at high conspecific adult density (CNDD) and that this effect increases toward the tropics and for rare species. We show that the CNDD-abundance correlation may have arisen from a methodological artifact and that a range of processes can explain the reported latitudinal pattern.	[Huelsmann, Lisa; Hartig, Florian] Univ Regensburg, Fac Biol & Preclin Med, Theoret Ecol, D-93053 Regensburg, Germany	University of Regensburg	Hulsmann, L (corresponding author), Univ Regensburg, Fac Biol & Preclin Med, Theoret Ecol, D-93053 Regensburg, Germany.	lisa.huelsmann@ur.de	Hülsmann, Lisa/B-6680-2017; Hartig, Florian/G-4510-2010	Hülsmann, Lisa/0000-0003-4252-2715; Hartig, Florian/0000-0002-6255-9059	U.S. National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF))	We thank R. Condit and S. P. Hubbell for providing the BCI data and for discussion that improved this comment. The BCI forest dynamics research project was founded by S. P. Hubbell and R. B. Foster and is now managed by R. Condit, S. Lao, and R. Perez under the Center for Tropical Forest Science and the Smithsonian Tropical Research Institute in Panama. Numerous organizations have provided funding, principally the U.S. National Science Foundation, and hundreds of field workers have contributed.	Comita LS, 2017, SCIENCE, V356, P1328, DOI 10.1126/science.aan6356; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Condit R., 2012, DATASET BARRO COLORA; CONNELL J H, 1971, P298; Freckleton RP, 2006, P R SOC B, V273, P2909, DOI 10.1098/rspb.2006.3660; Getzin S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0922; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; LaManna JA, 2017, SCIENCE, V356, P1389, DOI 10.1126/science.aam5678; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; May F, 2016, GLOBAL ECOL BIOGEOGR, V25, P575, DOI 10.1111/geb.12438; Metz MR, 2012, J ECOL, V100, P969, DOI 10.1111/j.1365-2745.2012.01972.x; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344	14	14	14	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391							eaar2435	10.1126/science.aar2435	http://dx.doi.org/10.1126/science.aar2435			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG9RW	29798852				2022-12-28	WOS:000433039800001
J	Wise, J				Wise, Jacqui			Winter pressure: England's health regulator publishes tips to help emergency departments cope better next year	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Care Quality Commission, 2018, PRESS SAF MAN INCR D	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2018	361								k2296	10.1136/bmj.k2296	http://dx.doi.org/10.1136/bmj.k2296			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH4XN	29794087				2022-12-28	WOS:000433416100007
J	Friedrich, MJ				Friedrich, M. J.			WHO's Blueprint List of Priority Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	7	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					1973	1973		10.1001/jama.2018.5712	http://dx.doi.org/10.1001/jama.2018.5712			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800221				2022-12-28	WOS:000432238300005
J	Straus, SE; Dolovich, L				Straus, Sharon E.; Dolovich, Lisa			In hospitalized adults with polypharmacy, a multifaceted pharmacist intervention reduced readmissions at 180 days	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Question In patients with an acute hospital admission and polypharmacy, does an in-hospital, multifaceted pharmacist intervention reduce readmissions compared with usual care? Methods Design: Randomized controlled trial (Odense Pharmacist Trial Investigating Medication Interventions at Sector Transfer [OPTIMIST]). ClinicalTrials.gov NCT03079375. Allocation: Concealed.* Blinding: Blinded* (patients and pharmacists for medication review). Follow-up period: 6 months. Setting: 4 hospitals in Denmark. Patients: 1499 patients >= 18 years of age (median age 72 y, 54% women) who had a new acute hospital admission and polypharmacy (>= 5 prescription drugs used daily). Exclusion criteria included aphasia, severe dementia, terminal illness, suicidality, need for isolation precautions, or incarceration. Intervention: Extended pharmacist intervention (EPI) including a structured, patient-centered medication review; medical reconciliation on discharge; motivational patient interviews (1 in hospital and 2 by telephone after discharge); and follow-up with primary care physicians, pharmacists, and nursing homes if relevant (n = 497); basic pharmacist intervention (BPI) including a single medication review (n = 498); or usual care (n = 503). All interventions were done by trained clinical pharmacists. Outcomes: Primary outcomes were readmission at 30 and 180 days, and a composite of readmission or emergency department visit at 180 days. Secondary outcomes included all-cause mortality. Patient follow-up: 98% included in intention-to-treat analysis. Main results The main results are in the Table. Conclusion In hospitalized adults with polypharmacy, a multifaceted pharmacist intervention reduced readmissions at 30 and 180 days compared with usual care.	[Straus, Sharon E.; Dolovich, Lisa] Univ Toronto, Toronto, ON, Canada	University of Toronto	Straus, SE (corresponding author), Univ Toronto, Toronto, ON, Canada.				Hospitals Pharmacies' and Amgros' Research Development Foundation; Actavis Foundation; public regional research foundation for Southern Denmark; public regional research foundation for Zealand	Hospitals Pharmacies' and Amgros' Research Development Foundation; Actavis Foundation; public regional research foundation for Southern Denmark; public regional research foundation for Zealand	Hospitals Pharmacies' and Amgros' Research Development Foundation; Actavis Foundation; public regional research foundations for Southern Denmark and Zealand.	Christensen M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008986.pub3; McNab D, 2018, BMJ QUAL SAF, V27, P308, DOI 10.1136/bmjqs-2017-007087; Patterson SM, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008165.pub3, 10.1002/14651858.CD008165.pub4]	3	0	0	4	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					JC59	JC59		10.7326/ACPJC-2018-168-10-059	http://dx.doi.org/10.7326/ACPJC-2018-168-10-059			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3DE	29800435				2022-12-28	WOS:000434250700011
J	Throckmorton, DC; Gottlieb, S; Woodcock, J				Throckmorton, Douglas C.; Gottlieb, Scott; Woodcock, Janet			The FDA and the Next Wave of Drug Abuse - Proactive Pharmacovigilance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Throckmorton, Douglas C.; Gottlieb, Scott; Woodcock, Janet] US FDA, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Throckmorton, DC (corresponding author), US FDA, Silver Spring, MD 20993 USA.							Anwar M, 2016, MMWR-MORBID MORTAL W, V65, P748, DOI 10.15585/mmwr.mm6529a4; Daniulaityte R, 2013, DRUG ALCOHOL DEPEN, V130, P241, DOI 10.1016/j.drugalcdep.2012.11.003; Goodman CW, 2017, NEW ENGL J MED, V377, P411, DOI 10.1056/NEJMp1704633; Johansen ME, 2018, JAMA INTERN MED, V178, P292, DOI 10.1001/jamainternmed.2017.7856; Urquhart L, 2018, NAT REV DRUG DISCOV, V17, P232, DOI 10.1038/nrd.2018.42	5	51	51	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2018	379	3					205	207		10.1056/NEJMp1806486	http://dx.doi.org/10.1056/NEJMp1806486			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GN5CX	29847203	Bronze			2022-12-28	WOS:000439063900001
J	Jain, S; Ba, ZQ; Zhang, Y; Dai, HQ; Alt, FW				Jain, Suvi; Ba, Zhaoqing; Zhang, Yu; Dai, Hai-Qiang; Alt, Frederick W.			CTCF-Binding Elements Mediate Accessibility of RAG Substrates During Chromatin Scanning	CELL			English	Article							DOUBLE-STRANDED BREAKS; V(D)J RECOMBINATION; LOOP DOMAINS; IGH LOCUS; B-CELLS; CHROMOSOME CONFORMATION; MAMMALIAN GENOMES; GENE SEGMENTS; ORGANIZATION; REGION	RAG endonuclease initiates antibody heavy chain variable region exon assembly from V, D, and J segments within a chromosomal V(D) J recombination center (RC) by cleaving between paired gene segments and flanking recombination signal sequences (RSSs). The IGCR1 control region promotes DJ(H) intermediate formation by isolating Ds, J(H)s, and RCs from upstream V(H)s in a chromatin loop anchored by CTCF-binding elements (CBEs). How V(H)s access the DJ(H)RC for V-H to DJ(H) rearrangement was unknown. We report that CBEs immediately downstream of frequently rearranged V-H-RSSs increase recombination potential of their associated V-H far beyond that provided by RSSs alone. This CBE activity becomes particularly striking upon IGCR1 inactivation, which allows RAG, likely via loop extrusion, to linearly scan chromatin far upstream. V-H-associated CBEs stabilize interactions of D-proximal V(H)s first encountered by the DJ(H)RC during linear RAG scanning and thereby promote dominant rearrangement of these V(H)s by an unanticipated chromatin accessibility-enhancing CBE function.	[Jain, Suvi; Ba, Zhaoqing; Zhang, Yu; Dai, Hai-Qiang; Alt, Frederick W.] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Jain, Suvi; Ba, Zhaoqing; Zhang, Yu; Dai, Hai-Qiang; Alt, Frederick W.] Harvard Med Sch, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Jain, Suvi; Ba, Zhaoqing; Zhang, Yu; Dai, Hai-Qiang; Alt, Frederick W.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Alt, FW (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.; Alt, FW (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Alt, FW (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu		Zhang, Yu/0000-0002-1126-770X; Ba, Zhaoqing/0000-0002-8431-5469; Dai, Hai-Qiang/0000-0003-4337-9770	NIH [AI020047]; Cancer Research Institute; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Hye-Suk Yoon and Arthur Su for contributions to preliminary analyses and Jeffrey Zurita for bioinformatics advice. This work was supported by NIH (AI020047). F.W.A. is a Howard Hughes Medical Institute Investigator. Z.B. is supported by a Cancer Research Institute Irvington Fellowship. Y.Z. is supported by a Leukemia and Lymphoma Society Special Fellow Award.	Aiden EL, 2015, CELL, V162, P708, DOI 10.1016/j.cell.2015.07.034; ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Benner C, 2015, P NATL ACAD SCI USA, V112, P12776, DOI 10.1073/pnas.1512995112; Bolland DJ, 2016, CELL REP, V15, P2475, DOI 10.1016/j.celrep.2016.05.020; Bossen C, 2012, ANNU REV IMMUNOL, V30, P337, DOI 10.1146/annurev-immunol-020711-075003; Chen L, 2015, NAT IMMUNOL, V16, P1085, DOI 10.1038/ni.3232; Choi NM, 2013, J IMMUNOL, V191, P2393, DOI 10.4049/jimmunol.1301279; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Wit E, 2015, MOL CELL, V60, P676, DOI 10.1016/j.molcel.2015.09.023; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Denker A, 2016, GENE DEV, V30, P1357, DOI 10.1101/gad.281964.116; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ebert A, 2015, ADV IMMUNOL, V128, P93, DOI 10.1016/bs.ai.2015.07.006; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hu JZ, 2016, NAT PROTOC, V11, P853, DOI 10.1038/nprot.2016.043; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lin SG, 2016, P NATL ACAD SCI USA, V113, P7846, DOI 10.1073/pnas.1608649113; Lin SG, 2015, P NATL ACAD SCI USA, V112, P1815, DOI 10.1073/pnas.1424936112; Lucas JS, 2014, CELL, V158, P339, DOI 10.1016/j.cell.2014.05.036; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Merkenschlager M, 2016, ANNU REV GENOM HUM G, V17, P17, DOI 10.1146/annurev-genom-083115-022339; Nichols MH, 2015, CELL, V162, P702, DOI 10.1016/j.cell.2015.07.053; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Proudhon C, 2015, ADV IMMUNOL, V128, P123, DOI 10.1016/bs.ai.2015.07.003; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ru H, 2015, CELL, V163, P1138, DOI 10.1016/j.cell.2015.10.055; Ruiz-Velasco M, 2017, CELL SYST, V5, P628, DOI 10.1016/j.cels.2017.10.018; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Teng G, 2015, ADV IMMUNOL, V128, P1, DOI 10.1016/bs.ai.2015.07.002; Volpi SA, 2012, J IMMUNOL, V188, P2556, DOI 10.4049/jimmunol.1102763; Xiang YG, 2014, J IMMUNOL, V193, P3746, DOI 10.4049/jimmunol.1401574; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao LJ, 2016, J EXP MED, V213, P1921, DOI 10.1084/jem.20160670	53	61	61	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 28	2018	174	1					102	+		10.1016/j.cell.2018.04.035	http://dx.doi.org/10.1016/j.cell.2018.04.035			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GL3CR	29804837	Green Accepted, Bronze			2022-12-28	WOS:000437005800014
J	Sarpatwari, A; Avorn, J; Kesselheim, AS				Sarpatwari, Ameet; Avorn, Jerry; Kesselheim, Aaron S.			An Incomplete Prescription President Trump's Plan to Address High Drug Prices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sarpatwari, Ameet; Avorn, Jerry; Kesselheim, Aaron S.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon,PORTAL, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sarpatwari, A (corresponding author), Brigham & Womens Hosp, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	asarpatwari@bwh.harvard.edu			Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; Engelberg Foundation	Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; Engelberg Foundation	This work was supported by the Laura and John Arnold Foundation, with additional support from the Harvard Program in Therapeutic Science and the Engelberg Foundation.	Avorn J, 2017, JAMA-J AM MED ASSOC, V317, P361, DOI 10.1001/jama.2016.16036; Cuckler GA, 2018, HEALTH AFFAIR, V37, P482, DOI 10.1377/hlthaff.2017.1655; Hwang TJ, 2017, JAMA-J AM MED ASSOC, V318, P609, DOI 10.1001/jama.2017.8255; Kaltenboeck A, 2018, JAMA; Kleutghen P, 2018, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20180205, DOI 10.1377/HBLOG20180205]; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; US Department of Health & Human Services, 2018, AM PAT 1 TRUMP ADM B; US Senate Homeland Security and Governmental Affairs Committee Minority Office, 2018, MAN CRIS DEV DRUG PR	8	7	7	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2018	319	23					2373	2374		10.1001/jama.2018.7424	http://dx.doi.org/10.1001/jama.2018.7424			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ7JX	29800027				2022-12-28	WOS:000435564100011
J	Cappell, SD; Mark, KG; Garbett, D; Pack, LR; Rape, M; Meyer, T				Cappell, Steven D.; Mark, Kevin G.; Garbett, Damien; Pack, Lindsey R.; Rape, Michael; Meyer, Tobias			EMI1 switches from being a substrate to an inhibitor of APC/C-CDH1 to start the cell cycle	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; S-PHASE ENTRY; PROLIFERATION-QUIESCENCE DECISION; MITOTIC EXIT; DEGRADATION; APC(CDH1); COMPLEX/CYCLOSOME; ACCUMULATION; PROGRESSION; MECHANISM	Mammalian cells integrate mitogen and stress signalling before the end of G1 phase to determine whether or not they enter the cell cycle(1-4). Before cells can replicate their DNA in S phase, they have to activate cyclin-dependent kinases (CDKs), induce an E2F transcription program and inactivate the anaphase-promoting complex (APC/C-CDH1, also known as the cyclosome), which is an E3 ubiquitin ligase that contains the co-activator CDH1 (also known as FZR, encoded by FZR1). It was recently shown that stress can return cells to quiescence after CDK2 activation and E2F induction but not after inactivation of APC/C-CDH1, which suggests that APC/CCDH1 inactivation is the point of no return for cell-cycle entry3. Rapid inactivation of APC/C-CDH1 requires early mitotic inhibitor 1 (EMI1)(3,5), but the molecular mechanism that controls this cell-cycle commitment step is unknown. Here we show using human cell models that cell-cycle commitment is mediated by an EMI1-APC/C-CDH1 dual-negative feedback switch, in which EMI1 is both a substrate and an inhibitor of APC/C-CDH1. The inactivation switch triggers a transition between a state with low EMI1 levels and high APC/C-CDH1 activity during G1 and a state with high EMI1 levels and low APC/C-CDH1 activity during S and G2. Cell-based analysis, in vitro reconstitution and modelling data show that the underlying dual-negative feedback is bistable and represents a robust irreversible switch. Our study suggests that mammalian cells commit to the cell cycle by increasing CDK2 activity and EMI1 mRNA expression to trigger a one-way APC/C-CDH1 inactivation switch that is mediated by EMI1 transitioning from acting as a substrate of APC/C-CDH1 to being an inhibitor of APC/C-CDH1.	[Cappell, Steven D.; Garbett, Damien; Pack, Lindsey R.; Meyer, Tobias] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Cappell, Steven D.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Mark, Kevin G.; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Mark, Kevin G.; Rape, Michael] Howard Hughes Med Inst, Berkeley, CA USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Berkeley; Howard Hughes Medical Institute	Cappell, SD; Meyer, T (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Cappell, SD (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA.	steven.cappell@nih.gov; tobias1@stanford.edu	Cappell, Steven/O-4072-2018	Cappell, Steven/0000-0002-2885-7327; Meyer, Tobias/0000-0003-4339-3804; Garbett, Damien/0000-0002-8437-3650; Mark, Kevin/0000-0001-5132-031X	Damon Runyon Cancer Research Foundation [DRG-2141]; Intramural Research Program of the National Institutes of Health, Center for Cancer Research, National Cancer Institute; NIH F32 Ruth L. Kirschstein fellowships [GM120956, GM116328, GM125246]; NIGMS R01 grants [GM083064, R35GM127026, GM118377, GM063702]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [ZIABC011830, ZIABC011832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM116328, R01GM118377, F32GM120956, R35GM127026, R01GM063702, P50GM107615, R01GM083064, F32GM125246] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Intramural Research Program of the National Institutes of Health, Center for Cancer Research, National Cancer Institute; NIH F32 Ruth L. Kirschstein fellowships; NIGMS R01 grants; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Chung, C. Liu, A. Hayer, H. W. Yang, L. Daigh, Y. Fan, A. Jaimovich, M. Koberlin, S. Spencer, S. Collins, N. Ratnayeke, J. Kamenz, and J. Ferrell for helpful discussions, and the Stanford Shared FACS Facility for cell sorting. S.D.C. was supported by the Damon Runyon Cancer Research Foundation (DRG-2141) and by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research, National Cancer Institute. K.G.M., D.G. and L.R.P. were supported by NIH F32 Ruth L. Kirschstein fellowships (GM120956, GM116328 and GM125246, respectively). M.R. is supported by NIGMS R01 grants (GM083064) and is an Investigator of the Howard Hughes Medical Institute. T.M. is supported by NIGMS R01 grants (R35GM127026, GM118377 and GM063702).	Arora M, 2017, CELL REP, V19, P1351, DOI 10.1016/j.celrep.2017.04.055; Barr AR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14728; Cappell SD, 2016, CELL, V166, P167, DOI 10.1016/j.cell.2016.05.077; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Choudhury R, 2016, CELL REP, V16, P3359, DOI 10.1016/j.celrep.2016.08.058; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Frye JJ, 2013, NAT STRUCT MOL BIOL, V20, P827, DOI 10.1038/nsmb.2593; Fukushima H, 2013, CELL REP, V4, P803, DOI 10.1016/j.celrep.2013.07.031; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Moshe Y, 2011, J BIOL CHEM, V286, P16647, DOI 10.1074/jbc.M111.223339; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wang WP, 2013, NAT CELL BIOL, V15, P797, DOI 10.1038/ncb2755; Yang HW, 2017, NATURE, V549, P404, DOI 10.1038/nature23880; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010	26	57	60	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2018	558	7709					313	+		10.1038/s41586-018-0199-7	http://dx.doi.org/10.1038/s41586-018-0199-7			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2BI	29875408	Green Accepted, Green Submitted			2022-12-28	WOS:000435071400058
J	Marhava, P; Bassukas, AEL; Zourelidou, M; Kolb, M; Moret, B; Fastner, A; Schulze, WX; Cattaneo, P; Hammes, UZ; Schwechheimer, C; Hardtke, CS				Marhava, P.; Bassukas, A. E. L.; Zourelidou, M.; Kolb, M.; Moret, B.; Fastner, A.; Schulze, W. X.; Cattaneo, P.; Hammes, U. Z.; Schwechheimer, C.; Hardtke, C. S.			A molecular rheostat adjusts auxin flux to promote root protophloem differentiation	NATURE			English	Article							PLASMA-MEMBRANE; ARABIDOPSIS-THALIANA; DEPENDENT GROWTH; TRANSPORT; EFFLUX; PROTEIN; PHOSPHORYLATION; ENDOCYTOSIS; GRADIENTS; FEEDBACK	Auxin influences plant development through several distinct concentration-dependent effects(1). In the Arabidopsis root tip, polar auxin transport by PIN-FORMED (PIN) proteins creates a local auxin accumulation that is required for the maintenance of the stem-cell niche(2-4). Proximally, stem-cell daughter cells divide repeatedly before they eventually differentiate. This developmental gradient is accompanied by a gradual decrease in auxin levels as cells divide, and subsequently by a gradual increase as the cells differentiate(5,6). However, the timing of differentiation is not uniform across cell files. For instance, developing protophloem sieve elements (PPSEs) differentiate as neighbouring cells still divide. Here we show that PPSE differentiation involves local steepening of the post-meristematic auxin gradient. BREVIS RADIX (BRX) and PROTEIN KINASE ASSOCIATED WITH BRX (PAX) are interacting plasmamembrane-associated, polarly localized proteins that co-localize with PIN proteins at the rootward end of developing PPSEs. Both brx and pax mutants display impaired PPSE differentiation. Similar to other AGC-family kinases, PAX activates PIN-mediated auxin efflux, whereas BRX strongly dampens this stimulation. Efficient BRX plasma-membrane localization depends on PAX, but auxin negatively regulates BRX plasma-membrane association and promotes PAX activity. Thus, our data support a model in which BRX and PAX are elements of a molecular rheostat that modulates auxin flux through developing PPSEs, thereby timing PPSE differentiation.	[Marhava, P.; Moret, B.; Cattaneo, P.; Hardtke, C. S.] Univ Lausanne, Dept Plant Mol Biol, Lausanne, Switzerland; [Bassukas, A. E. L.; Zourelidou, M.; Kolb, M.; Hammes, U. Z.; Schwechheimer, C.] Tech Univ Munich, Plant Syst Biol, Freising Weihenstephan, Germany; [Kolb, M.; Fastner, A.; Hammes, U. Z.] Regensburg Univ, Dept Cell Biol & Plant Biochem, Regensburg, Germany; [Schulze, W. X.] Univ Hohenheim, Dept Plant Syst Biol, Stuttgart, Germany	University of Lausanne; Technical University of Munich; University of Regensburg; University Hohenheim	Hardtke, CS (corresponding author), Univ Lausanne, Dept Plant Mol Biol, Lausanne, Switzerland.; Schwechheimer, C (corresponding author), Tech Univ Munich, Plant Syst Biol, Freising Weihenstephan, Germany.	claus.schwechheimer@wzw.tum.de; christian.hardtke@unil.ch	Schulze, Waltraud X/E-9800-2011; Marhava, Petra/HGE-5408-2022; Schwechheimer, Claus/Q-7907-2016	Schulze, Waltraud X/0000-0001-9957-7245; Marhava, Petra/0000-0001-5904-1657; Hammes, Ulrich/0000-0002-3663-4908; Bassukas, Alkistis Eleftheria Lanassa/0000-0002-3506-8537; Schwechheimer, Claus/0000-0003-0269-2330; Kolb, Martina/0000-0001-9628-4842; Hardtke, Christian S./0000-0003-3203-1058	Swiss National Science Foundation [31003A_166394]; German-Israeli Foundation [I-236-203.17-2014]; Deutsche Forschungsgemeinschaft [SCHW751/12-2, HA 3468/6-1, SFB924]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the University of Lausanne Protein Analysis Facility for mass spectrometry services, the Swiss National Science Foundation for Grant 31003A_166394 (C.S.H.), the German-Israeli Foundation for I-236-203.17-2014 (C.S.) and the Deutsche Forschungsgemeinschaft for SCHW751/12-2 (C.S.), HA 3468/6-1 and SFB924 (U.Z.H.).	Absmanner B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00241; Barbosa ICR, 2016, DEVELOPMENT, V143, P4687, DOI 10.1242/dev.137117; Barbosa ICR, 2014, DEV CELL, V29, P674, DOI 10.1016/j.devcel.2014.05.006; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bennett T, 2006, CURR BIOL, V16, P553, DOI 10.1016/j.cub.2006.01.058; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Breda AS, 2017, P NATL ACAD SCI USA, V114, pE5721, DOI 10.1073/pnas.1703258114; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Ckurshumova W, 2014, NEW PHYTOL, V204, P556, DOI 10.1111/nph.13014; Fastner A, 2017, METHODS MOL BIOL, V1497, P259, DOI 10.1007/978-1-4939-6469-7_21; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Furuta KM, 2014, SCIENCE, V345, P933, DOI 10.1126/science.1253736; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Kondo Y, 2016, PLANT CELL, V28, P1250, DOI 10.1105/tpc.16.00027; Marchant A, 2002, PLANT CELL, V14, P589, DOI 10.1105/tpc.010354; Mouchel CF, 2006, NATURE, V443, P458, DOI 10.1038/nature05130; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Rodriguez-Villalon A, 2015, DEVELOPMENT, V142, P1437, DOI 10.1242/dev.118364; Rodriguez-Villalon A, 2014, P NATL ACAD SCI USA, V111, P11551, DOI 10.1073/pnas.1407337111; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Santuari L, 2011, CURR BIOL, V21, P1918, DOI 10.1016/j.cub.2011.10.002; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Scacchi E, 2009, DEVELOPMENT, V136, P2059, DOI 10.1242/dev.035444; Truernit E, 2012, DEVELOPMENT, V139, P1306, DOI 10.1242/dev.072629; Weller B, 2017, P NATL ACAD SCI USA, V114, pE887, DOI 10.1073/pnas.1614380114; Willige BC, 2013, PLANT CELL, V25, P1674, DOI 10.1105/tpc.113.111484; Zadnikova P, 2010, DEVELOPMENT, V137, P607, DOI 10.1242/dev.041277; Zourelidou M, 2014, ELIFE, V3, DOI 10.7554/eLife.02860	31	79	81	11	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2018	558	7709					297	+		10.1038/s41586-018-0186-z	http://dx.doi.org/10.1038/s41586-018-0186-z			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ2BI	29875411				2022-12-28	WOS:000435071400055
J	Normile, D				Normile, Dennis			China takes new steps to lure science talent from abroad	SCIENCE			English	News Item																			0	5	5	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2018	360	6393					1053	1053		10.1126/science.360.6393.1053	http://dx.doi.org/10.1126/science.360.6393.1053			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI6TJ	29880664				2022-12-28	WOS:000434635500011
J	Davis, DM				Davis, Daniel M.			The art of medicine How studying the immune system leads us to new medicines	LANCET			English	Editorial Material									[Davis, Daniel M.] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9NT, Lancs, England	University of Manchester	Davis, DM (corresponding author), Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9NT, Lancs, England.	daniel.davis@manchester.ac.uk		Davis, Daniel/0000-0002-9182-291X					0	1	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2018	391	10136					2205	2206		10.1016/S0140-6736(18)31166-8	http://dx.doi.org/10.1016/S0140-6736(18)31166-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH8GC	29804630	Green Submitted			2022-12-28	WOS:000433904700014
J	Chen, M; Penfield, S				Chen, Min; Penfield, Steven			Feedback regulation of COOLAIR expression controls seed dormancy and flowering time	SCIENCE			English	Article							LOCUS-C; ARABIDOPSIS-THALIANA; ANTISENSE TRANSCRIPTS; FLORAL INDUCTION; FLC; VERNALIZATION; GERMINATION; INTEGRATION; SIGNALS; GENE	Plants integrate seasonal signals, including temperature and day length, to optimize the timing of developmental transitions. Seasonal sensing requires the activity of two proteins, FLOWERING LOCUS C (FLC) and FLOWERING LOCUS T (FT), that control certain developmental transitions in plants. During reproductive development, the mother plant uses FLC and FT to modulate progeny seed dormancy in response to temperature. We found that for regulation of seed dormancy, FLC and FT function in opposite configuration to how those same genes control time to flowering. For seed dormancy, FT regulates seed dormancy through FLC gene expression and regulates chromatin state by activating antisense FLC transcription. Thus, in Arabidopsis the same genes controlled in opposite format regulate flowering time and seed dormancy in response to the temperature changes that characterize seasons.	[Chen, Min; Penfield, Steven] John Innes Ctr, Dept Crop Genet, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Penfield, S (corresponding author), John Innes Ctr, Dept Crop Genet, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	steven.penfield@jic.ac.uk		Chen, Min/0000-0003-3294-9248	BBSRC grant [BB/P013511/1]; BBSRC [BBS/E/J/000PR9788, BBS/E/J/000C0674] Funding Source: UKRI	BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by BBSRC grant BB/P013511/1 to the John Innes Centre.	Auge GA, 2017, NEW PHYTOL, V216, P388, DOI 10.1111/nph.14520; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Chen M, 2014, P NATL ACAD SCI USA, V111, P18787, DOI 10.1073/pnas.1412274111; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Csorba T, 2014, P NATL ACAD SCI USA, V111, P16160, DOI 10.1073/pnas.1419030111; Imaizumi T, 2017, AM J BOT, V104, P516, DOI 10.3732/ajb.1600389; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Marquardt S, 2014, MOL CELL, V54, P156, DOI 10.1016/j.molcel.2014.03.026; Mateos JL, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0597-1; Michaels SD, 2005, PLANT PHYSIOL, V137, P149, DOI 10.1104/pp.104.052811; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Niwa M, 2013, PLANT CELL, V25, P1228, DOI 10.1105/tpc.112.109090; Questa JI, 2016, SCIENCE, V353, P485, DOI 10.1126/science.aaf7354; Rosa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13031; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Springthorpe V, 2015, ELIFE, V4, DOI 10.7554/eLife.05557; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358	21	61	68	8	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					1014	1016		10.1126/science.aar7361	http://dx.doi.org/10.1126/science.aar7361			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6SL	29853684				2022-12-28	WOS:000433574200041
J	Hawkes, N				Hawkes, Nigel			Hospitals' reported 1bn pound deficit masks true scale of financial woes, say analysts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							NHS											Iacobucci G, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1435; Iacobucci G, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k289	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2018	361								k2432	10.1136/bmj.k2432	http://dx.doi.org/10.1136/bmj.k2432			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MZ	29858469				2022-12-28	WOS:000434276900001
J	Leshner, AI				Leshner, Alan I.			Student-centered, modernized graduate STEM education	SCIENCE			English	Editorial Material									[Leshner, Alan I.] Amer Assoc Advancement Sci, Washington, DC 20005 USA		Leshner, AI (corresponding author), Amer Assoc Advancement Sci, Washington, DC 20005 USA.	alan.i.leshner@gmail.com						[Anonymous], 2018, GRAD STEM ED 21 CENT; Institute of Medicine, 1995, RESH GRAD ED SCI ENG	2	13	13	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					969	970		10.1126/science.aau0590	http://dx.doi.org/10.1126/science.aau0590			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH6SL	29853676				2022-12-28	WOS:000433574200026
J	Robinson, A				Robinson, Ann			Sixty seconds on . . . digitalisation of pharma	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2018	361								k2329	10.1136/bmj.k2329	http://dx.doi.org/10.1136/bmj.k2329			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MF	29844025				2022-12-28	WOS:000434274800004
J	Greet, B; Schurmann, P; Deswal, A				Greet, Brian; Schurmann, Paul; Deswal, Anita			In AF with HF, catheter ablation vs medical therapy reduced mortality and hospitalization for worsening HF	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Greet, Brian; Schurmann, Paul; Deswal, Anita] Baylor Coll Med, Houston, TX 77030 USA; [Schurmann, Paul; Deswal, Anita] Michael E DeBakey VA Med Ctr, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Greet, B (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.				Biotronik	Biotronik	Biotronik.	January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					JC55	JC55		10.7326/ACPJC-2018-168-10-055	http://dx.doi.org/10.7326/ACPJC-2018-168-10-055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3DE	29800431				2022-12-28	WOS:000434250700007
J	Marshall, J				Marshall, John			A single preoperative physiotherapy session reduced pulmonary complications after upper abdominal surgery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Marshall, John] St Michaels Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Marshall, J (corresponding author), St Michaels Hosp, Toronto, ON, Canada.				Clifford Craig Foundation; University of Tasmania; Waitemata District Health Board; Tasmanian Health Service-North	Clifford Craig Foundation; University of Tasmania; Waitemata District Health Board; Tasmanian Health Service-North	Clifford Craig Foundation; University of Tasmania; Waitemata District Health Board; Tasmanian Health Service-North.		0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					JC51	JC51		10.7326/ACPJC-2018-168-10-051	http://dx.doi.org/10.7326/ACPJC-2018-168-10-051			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3DE	29800427				2022-12-28	WOS:000434250700003
J	Nagata, JM				Nagata, Jason M.			On the Origin of Our Family	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Nagata, Jason M.] Univ Calif San Francisco, Div Adolescent & Young Adult Med, Dept Pediat, 3333 Calif St,Ste 245,POB 0503, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Nagata, JM (corresponding author), Univ Calif San Francisco, Div Adolescent & Young Adult Med, Dept Pediat, 3333 Calif St,Ste 245,POB 0503, San Francisco, CA 94143 USA.	jasonmnagata@gmail.com		Nagata, Jason/0000-0002-6541-0604				[Anonymous], 1861, ORIGIN SPECIES MEANS; Nagata JM, 2017, J PALLIAT MED, V20, P97, DOI 10.1089/jpm.2016.0306; Nagata JM, 2015, JAMA PEDIATR, V169, P1087, DOI 10.1001/jamapediatrics.2015.1924	3	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					1983	1984		10.1001/jama.2018.5078	http://dx.doi.org/10.1001/jama.2018.5078			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29800217				2022-12-28	WOS:000432238300013
J	Daniel, H; Erickson, SM; Bornstein, SS				Daniel, Hilary; Erickson, Shari M.; Bornstein, Sue S.		Amer Coll Phys	Women's Health Policy in the United States: An American College of Physicians Position Paper	ANNALS OF INTERNAL MEDICINE			English	Review							MATERNITY LEAVE; DISPARITIES; SEX; CONTRACEPTION; PREVALENCE; DISABILITY; ABORTION; VIOLENCE; TRENDS; BREAST		[Daniel, Hilary; Erickson, Shari M.] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA; [Bornstein, Sue S.] Texas Med Home Initiat, Dallas, TX USA	American College of Physicians	Daniel, H (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	hdaniel@acponline.org						AEI-Brookings Workgroup on Paid Family Leave, 2017, PAID FAM MED LEAV IS; Agency for Healthcare Research and Quality (AHRQ), 2010, AHRQ PUBL; American Lung Association, 2016, LUNG CANC FACTS; Americans United for Life, 2010, DEFINITION PERSONHOO; [Anonymous], 2016, LANCET, V387, P506, DOI 10.1016/S0140-6736(16)00267-1; [Anonymous], PREGN MORT SURV SYST; [Anonymous], 2017, DEPRESSION; Armour BS, 2009, WOMEN HEALTH ISS, V19, P406, DOI 10.1016/j.whi.2009.08.006; Bartel A, 2014, CAL PAID FAM LEAV LA; Bauman M., 2017, MULTIPLE CHRONIC CON; Belluz J., 2016, WOMENS HLTH US IS DE; Biggs MA, 2017, JAMA PSYCHIAT, V74, P169, DOI 10.1001/jamapsychiatry.2016.3478; Black M.C., 2011, NATL INTIMATE PARTNE; Bonomi AE, 2009, ARCH INTERN MED, V169, P1692, DOI 10.1001/archinternmed.2009.292; Breslow RA, 2017, ALCOHOL CLIN EXP RES, V41, P976, DOI 10.1111/acer.13365; Brief of Amici Curiae American College of Obstetricians and Gy-necologists and the American Medical Association in support of plaintiffs-appellees-cross-appellants and in support of affirmance, 2014, 1450928 BRIEF AM CUR; Butler AS, 2009, REVIEW OF THE HHS FAMILY PLANNING PROGRAM: MISSION, MANAGEMENT, AND MEASUREMENT OF RESULTS, P1; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; Catalano SM, BUR JUST STAT; Center for Young Women's Health, MED US BIRTH CONTR; Centers for Disease Control and Prevention, IN PARTN VIOL CONS; Centers for Disease Control and Prevention Foundation, 2017, BUILD US CAP REV PRE; Chen A, 2018, J WOMENS HEALTH, V27, P418, DOI 10.1089/jwh.2016.6272; Cleland K, 2016, WOMEN HEALTH ISS, V26, P622, DOI 10.1016/j.whi.2016.08.003; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; Courtney-Long EA, 2015, MMWR-MORBID MORTAL W, V64, P777, DOI 10.15585/mmwr.MM6429a2; Cox D, 2015, RACE RELIG SHAPE MIL; Dagher RK, 2014, J HEALTH POLIT POLIC, V39, P369, DOI 10.1215/03616878-2416247; Daniel H, 2015, ANN INTERN MED, V163, P135, DOI 10.7326/M14-2482; Dicken JE, 2013, COMMUNICATION   0723; Doherty RB, 2013, ANN INTERN MED, V159, P620, DOI 10.7326/0003-4819-159-9-201311050-00710; Egleston BL, 2010, NEW ENGL J MED, V362, P1054, DOI 10.1056/NEJMc0912600; Eidelman AI, 2012, PEDIATRICS, V129, pE827, DOI 10.1542/peds.2011-3552; Family Violence Prevention Fund, 2010, REPR HLTH PARTN VIOL REPR HLTH PARTN VIOL; Garcia M, 2016, CIRC RES, V118, P1273, DOI 10.1161/CIRCRESAHA.116.307547; Ginsburg J, 2012, STATEMENT PRINCIPLES; Gorgos LM, 2011, CLIN INFECT DIS, V53, pS84, DOI 10.1093/cid/cir697; Guttmacher Institute, 2017, TARG REG AB PROV; Hall KS, 2014, ANN EPIDEMIOL, V24, P135, DOI 10.1016/j.annepidem.2013.10.018; He W., 2016, INT POPULATION REPOR; Henry J., 2016, WOMENS HLTH INSURANC; Institute of Medicine, 2010, WOM HLTH RES PROGR P; Institute of Medicine Committee on Lesbian Gay Bisexual and Transgender Health Issues and Research Gaps and Opportunities. Conducting research on the health status of LGBT populations, 2011, HLTH LESB GAY BISEX, P89; Institute on Aging, 2017, WOM CAR; International Labour Organization, 2014, MAT PAT WORK LAW PRA; Jatlaoui TC, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6624a1; Johnson PA, 2014, SEX SPEC MED RES WHY; Jones RK, 2011, BIRTH CONTR OV BEN O; Kahn RS, 2000, BRIT MED J, V321, P1311, DOI 10.1136/bmj.321.7272.1311; Kimberg L., 2001, MEDGENMED, V3; Lu Y, 2016, AM ECON J-APPL ECON, V8, P100, DOI 10.1257/app.20140405; Markus AR, 2013, WOMEN HEALTH ISS, V23, pE273, DOI 10.1016/j.whi.2013.06.006; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Martinez Gladys, 2013, Natl Health Stat Report, P1; Matoff-Stepp S, 2014, J HEALTH CARE POOR U, V25, P1507, DOI 10.1353/hpu.2014.0154; Mental Health America, DEPR WOM; Mirkovic KR, 2016, BIRTH-ISS PERINAT C, V43, P233, DOI 10.1111/birt.12230; 2018, SAF QUAL AB CAR US; National Conference of State Legislatures, 2015, IMPR WOM HLTH STAT P; National Institute on Drug Abuse, 2017, SEX GEND DIFF SUBST; National Partnership for Women & Families, 2016, PAID LEAV WORKS CAL; National Women's Law Center, 2014, HLTH COV IS CRIT COM; National Women's Law Center, STEALTH ATT WOM HLTH; Nour Nawal M, 2008, Rev Obstet Gynecol, V1, P33; Office of Research on Women's Health, 2017, SEX GENDER INFLUENCE; Office on Women's Health, 2018, MAK DEC BREASTF; Owens MD, 2008, J WOMENS HEALTH, V17, P1415, DOI 10.1089/jwh.2008.1125; Parekh Ameeta, 2011, Expert Rev Clin Pharmacol, V4, P453, DOI 10.1586/ecp.11.29; Rape Abuse and Incest National Network, 2017, SEXUAL ASSAULT; Reichlin L., 2014, PAID PARENTAL LEAVE; Rubin SE, 2013, ANN FAM MED, V11, P130, DOI 10.1370/afm.1450; Salganicoff A., 2014, HENRY J KAISER FAM F; Siegel MB, 2016, VIOLENCE GEND, V3, P20, DOI 10.1089/vio.2015.0047; Smith SG, 2017, PARTNER SEXUAL VIOLE; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Stevenson AJ, 2016, NEW ENGL J MED, V374, P853, DOI 10.1056/NEJMsa1511902; Stiles-Shields C, 2015, J SEX MARITAL THER, V41, P636, DOI 10.1080/0092623X.2014.958792; The American College of Obstetricians and Gynecologists, RESTR COMPR REPR HLT; The National Alliance for Caregiving & the AARP Public Policy Institute, CAR US 2015; Tjaden P., 1998, RES BRIEF; U. S. Department of Health and Human Services, 2017, CAR STRESS; U. S. Department of Health and Human Services, 2017, DIABETES; U. S. Department of Labor, GEN FACTS WOM JOB BA; U. S. Preventive Services Task Force, 2016, INT PARTN VIOL ELD A; Waalen J, 2000, AM J PREV MED, V19, P230, DOI 10.1016/S0749-3797(00)00229-4; Zagorsky JL, 2017, AM J PUBLIC HEALTH, V107, P460, DOI 10.2105/AJPH.2016.303607	86	17	17	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2018	168	12					874	+		10.7326/M17-3344	http://dx.doi.org/10.7326/M17-3344			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GK1TE	29809243				2022-12-28	WOS:000435903500017
J	Gupte, A; Goede, D; Tuite, R; Forsmark, CE				Gupte, Anand; Goede, Dianne; Tuite, Robert; Forsmark, Chris E.			Chronic pancreatitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIABETES-MELLITUS; RISK-FACTORS; AUTOIMMUNE PANCREATITIS; EXOCRINE INSUFFICIENCY; ENDOSCOPIC ULTRASOUND; CANCER; PAIN; MANAGEMENT; PREVALENCE; GUIDELINES		[Gupte, Anand; Forsmark, Chris E.] Univ Florida, Dept Gastroenterol Hepatol & Nutr, Gainesville, FL 32611 USA; [Goede, Dianne] Univ Florida, Div Gen Internal Med, Gainesville, FL USA; [Tuite, Robert] Natl Pancreas Fdn, Florida Chapter Chair, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Forsmark, CE (corresponding author), Univ Florida, Dept Gastroenterol Hepatol & Nutr, Gainesville, FL 32611 USA.	chris.forsmark@medicine.ufl.edu	Goede, Dianne/AAZ-4872-2021; Goede, Dianne/AAY-8246-2021	Goede, Dianne/0000-0002-7791-0753; 	Consortium to study chronic pancreatitis, diabetes, and pancreatic cancer (CPDPC) [NIH: UO1DK108320]	Consortium to study chronic pancreatitis, diabetes, and pancreatic cancer (CPDPC)	NIH: UO1DK108320: Consortium to study chronic pancreatitis, diabetes, and pancreatic cancer (CPDPC)	Ali UA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007884.pub3; Andersen DK, 2013, PANCREAS, V42, P1227, DOI 10.1097/MPA.0b013e3182a9ad9d; Ashkar M, 2014, Minerva Gastroenterol Dietol, V60, P227; BOLONDI L, 1989, RADIOL CLIN N AM, V27, P815; Conwell DL, 2017, DIGEST DIS SCI, V62, P2133, DOI 10.1007/s10620-017-4621-z; Conwell DL, 2014, PANCREAS, V43, P1143, DOI 10.1097/MPA.0000000000000237; Cote GA, 2011, CLIN GASTROENTEROL H, V9, P266, DOI 10.1016/j.cgh.2010.10.015; Duggan SN, 2014, NUTR CLIN PRACT, V29, P348, DOI 10.1177/0884533614528361; Duggan SN, 2014, CLIN GASTROENTEROL H, V12, P219, DOI 10.1016/j.cgh.2013.06.016; Dominguez-Munoz JE, 2016, PANCREAS, V45, P241, DOI 10.1097/MPA.0000000000000434; Ewald N, 2012, DIABETES-METAB RES, V28, P338, DOI 10.1002/dmrr.2260; Forsmark CE, 2013, GASTROENTEROLOGY, V144, P1282, DOI 10.1053/j.gastro.2013.02.008; Giefer MJ, 2017, J PEDIATR-US, V186, P95, DOI 10.1016/j.jpeds.2017.03.063; Han S, 2018, PANCREATOLOGY, V18, P269, DOI 10.1016/j.pan.2018.02.012; Hart PA, 2015, GASTROENTEROLOGY, V149, P39, DOI 10.1053/j.gastro.2015.03.010; JADAD AR, 1995, JAMA-J AM MED ASSOC, V274, P1870, DOI 10.1001/jama.274.23.1870; Kahl S, 2002, DIGEST DIS, V20, P120, DOI 10.1159/000067481; Ketwaroo GA, 2015, PANCREAS, V44, P173, DOI 10.1097/MPA.0000000000000239; Klapdor S, 2012, ANTICANCER RES, V32, P1991; Lelic D, 2014, EUR J PAIN, V18, P968, DOI 10.1002/j.1532-2149.2013.00442.x; Lohr JM, 2017, UNITED EUR GASTROENT, V5, P153, DOI 10.1177/2050640616684695; Maisonneuve P, 2015, INT J EPIDEMIOL, V44, P186, DOI 10.1093/ije/dyu240; Mohapatra S, 2016, PANCREAS, V45, P1104, DOI 10.1097/MPA.0000000000000609; Moran RA, 2015, CURR OPIN GASTROEN, V31, P407, DOI 10.1097/MOG.0000000000000204; Mullady DK, 2011, GUT, V60, P77, DOI 10.1136/gut.2010.213835; Nikfarjam M, 2017, MED J AUSTRALIA, V207, P161, DOI 10.5694/mja16.00851; Olesen SS, 2011, GASTROENTEROLOGY, V141, P536, DOI 10.1053/j.gastro.2011.04.003; Olesen SS, 2010, CLIN GASTROENTEROL H, V8, P724, DOI 10.1016/j.cgh.2010.03.005; Raimondi S, 2010, BEST PRACT RES CL GA, V24, P349, DOI 10.1016/j.bpg.2010.02.007; Raina A, 2009, AM J GASTROENTEROL, V104, P2295, DOI 10.1038/ajg.2009.325; Rickels MR, 2013, PANCREATOLOGY, V13, P336, DOI 10.1016/j.pan.2013.05.002; Rustgi AK, 2014, GENE DEV, V28, P1, DOI 10.1101/gad.228452.113; Setiawan VW, 2016, PANCREAS, V45, P819, DOI 10.1097/MPA.0000000000000657; Singh Virmeet V, 2003, Curr Gastroenterol Rep, V5, P110, DOI 10.1007/s11894-003-0079-6; Trikudanathan G, 2016, AM J GASTROENTEROL, V111, P568, DOI 10.1038/ajg.2016.48; Whitcomb DC, 2016, PANCREATOLOGY, V16, P218, DOI 10.1016/j.pan.2016.02.001; Whitcomb DC, 2013, GASTROENTEROLOGY, V144, P1292, DOI 10.1053/j.gastro.2013.01.069; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yadav D, 2009, ARCH INTERN MED, V169, P1035, DOI 10.1001/archinternmed.2009.125	39	22	23	5	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2018	361								k2126	10.1136/bmj.k2126	http://dx.doi.org/10.1136/bmj.k2126			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BY	29880587				2022-12-28	WOS:000435073900002
J	Mulasi, I				Mulasi, Ila			The Scarlet Virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Mulasi, Ila] Univ Maryland, Med Ctr, Dept Internal Med, Baltimore, MD 21201 USA; [Mulasi, Ila] Univ Maryland, Med Ctr, Dept Palliat Med, Baltimore, MD 21201 USA; [Mulasi, Ila] Univ Maryland, Med Ctr, Dept Family & Community Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Mulasi, I (corresponding author), Univ Maryland, Med Ctr, Dept Internal Med, Baltimore, MD 21201 USA.; Mulasi, I (corresponding author), Univ Maryland, Med Ctr, Dept Palliat Med, Baltimore, MD 21201 USA.; Mulasi, I (corresponding author), Univ Maryland, Med Ctr, Dept Family & Community Med, Baltimore, MD 21201 USA.							[Anonymous], C RETR OPP INF SEATT; Centers for Disease Control and Prevention (CDC), 2017, 2016 HIV SURV REP; Coghill AE, 2015, J CLIN ONCOL, V33, P2376, DOI 10.1200/JCO.2014.59.5967; Dailey AF, 2017, MMWR-MORBID MORTAL W, V66, P1300, DOI 10.15585/mmwr.mm6647e1; Tinker B, 2017, CNN	5	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2018	378	23					2157	2159		10.1056/NEJMp1803507	http://dx.doi.org/10.1056/NEJMp1803507			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3HS	29874530				2022-12-28	WOS:000434263000003
J	Dyer, C				Dyer, Clare			Homeopathy: challenge to prescription ban is rejected by High Court	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2018	361								k2513	10.1136/bmj.k2513	http://dx.doi.org/10.1136/bmj.k2513			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ2BX	29875099				2022-12-28	WOS:000435073600011
J	Mountjoy, E; Davies, NM; Plotnikov, D; Smith, GD; Rodriguez, S; Williams, CE; Guggenheim, JA; Atan, D				Mountjoy, Edward; Davies, Neil M.; Plotnikov, Denis; Smith, George Davey; Rodriguez, Santiago; Williams, Cathy E.; Guggenheim, Jeremy A.; Atan, Denize			Education and myopia: assessing the direction of causality by mendelian randomisation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REFRACTIVE ERROR; SCHOOL-CHILDREN; TIME OUTDOORS; AUSTRALIAN SCHOOLCHILDREN; ACADEMIC-ACHIEVEMENT; GENERAL-POPULATION; PHYSICAL-ACTIVITY; WEAK INSTRUMENTS; INCIDENT MYOPIA; UNITED-STATES	OBJECTIVES To determine whether more years spent in education is a causal risk factor for myopia, or whether myopia is a causal risk factor for more years in education. DESIGN Bidirectional, two sample mendelian randomisation study. SETTING Publically available genetic data from two consortiums applied to a large, independent population cohort. Genetic variants used as proxies for myopia and years of education were derived from two large genome wide association studies: 23andMe and Social Science Genetic Association Consortium (SSGAC), respectively. PARTICIPANTS 7 798 men and women from England, Scotland, and Wales in the UK Biobank cohort with available information for years of completed education and refractive error. MAIN OUTCOME MEASURES Mendelian randomisation analyses were performed in two directions: the first exposure was the genetic predisposition to myopia, measured with 44 genetic variants strongly associated with myopia in 23andMe, and the outcome was years in education; and the second exposure was the genetic predisposition to higher levels of education, measured with 69 genetic variants from SSGAC, and the outcome was refractive error. RESULTS Conventional regression analyses of the observational data suggested that every additional year of education was associated with a more myopic refractive error of -0.18 dioptres/y (95% confidence interval -0.19 to -0.17; P<2e-16). Mendelian randomisation analyses suggested the true causal effect was even stronger: -0.27 dioptres/y (-0.37 to -0.17; P=4e-8). By contrast, there was little evidence to suggest myopia affected education (years in education per dioptre of refractive error -0.008 y/dioptre, 95% confidence interval -0.041 to 0.025, P=0.6). Thus, the cumulative effect of more years in education on refractive error means that a university graduate from the United Kingdom with 17 years of education would, on average, be at least -1 dioptre more myopic than someone who left school at age 16 (with 12 years of education). Myopia of this magnitude would be sufficient to necessitate the use of glasses for driving. Sensitivity analyses showed minimal evidence for genetic confounding that could have biased the causal effect estimates. CONCLUSIONS This study shows that exposure to more years in education contributes to the rising prevalence of myopia. Increasing the length of time spent in education may inadvertently increase the prevalence of myopia and potential future visual disability.	[Mountjoy, Edward; Davies, Neil M.; Smith, George Davey; Rodriguez, Santiago] Univ Bristol, Bristol Med Sch, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Mountjoy, Edward; Davies, Neil M.; Smith, George Davey; Rodriguez, Santiago; Williams, Cathy E.] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Plotnikov, Denis; Guggenheim, Jeremy A.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales; [Atan, Denize] Univ Bristol, Bristol Med Sch, Translat Hlth Sci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol; Cardiff University; University of Bristol	Atan, D (corresponding author), Univ Bristol, Bristol Med Sch, Translat Hlth Sci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	Denize.Atan@bristol.ac.uk	Plotnikov, Denis/AAO-3132-2021; Davey Smith, George/A-7407-2013; Atan, Denize/B-5536-2019; Williams, Cathy/K-4919-2015	Plotnikov, Denis/0000-0002-9950-8992; Davey Smith, George/0000-0002-1407-8314; Rodriguez, Santiago/0000-0001-6551-932X; Guggenheim, Jeremy/0000-0001-5164-340X; Plotnikov, Denis/0000-0002-5528-1634; Atan, Denize/0000-0003-1217-4852; Davies, Neil/0000-0002-2460-0508; Williams, Cathy/0000-0002-9133-2021; Mountjoy, Edward/0000-0002-0626-1821	Medical Research Council (MRC); Bristol Centre for Systems Biomedicine; global education programme of the Russian Federation government; National Eye Research Centre [SAC015]; National Institute for Health Research [SRF-2015-08-005]; Economics and Social Research Council [ES/N000757/1]; ESRC [ES/N000757/1] Funding Source: UKRI; MRC [MC_UU_12013/8, MC_UU_12013/9, MC_UU_12013/1, MC_UU_00011/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bristol Centre for Systems Biomedicine; global education programme of the Russian Federation government; National Eye Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR)); Economics and Social Research Council; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	EM is funded by the Medical Research Council (MRC) and Bristol Centre for Systems Biomedicine; DP by the global education programme of the Russian Federation government; JAG and CW by the National Eye Research Centre (grant SAC015) and CEW by the National Institute for Health Research (senior research fellowship SRF-2015-08-005); NMD by the Economics and Social Research Council (future research leaders grant ES/N000757/1). GDS works in the MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_12013/1, MC_UU_12013/8, MC_UU_12013/9). The funders had no role in the study design, data collection, analysis, interpretation, or writing, nor in the decision to submit the article for publication.	Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Burgess S, 2015, EUR J EPIDEMIOL, V30, P543, DOI 10.1007/s10654-015-0011-z; Casson RJ, 2012, OPHTHALMOLOGY, V119, P2021, DOI 10.1016/j.ophtha.2012.03.049; Cuellar-Partida G, 2016, GENET EPIDEMIOL, V40, P66, DOI 10.1002/gepi.21936; Cui DM, 2013, OPHTHALMOLOGY, V120, P1074, DOI 10.1016/j.ophtha.2012.10.022; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Davies NM, 2015, EPIDEMIOLOGY, V26, P505, DOI 10.1097/EDE.0000000000000302; Davies NM, 2015, STAT MED, V34, P454, DOI 10.1002/sim.6358; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Deere K, 2009, BRIT J SPORT MED, V43, P542, DOI 10.1136/bjsm.2008.049288; Eong K. G. Au, 1993, Singapore Medical Journal, V34, P489; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; French AN, 2013, OPHTHALMOLOGY, V120, P2100, DOI 10.1016/j.ophtha.2013.02.035; French AN, 2013, EXP EYE RES, V114, P58, DOI 10.1016/j.exer.2013.04.018; French AN, 2013, OPHTHALMOLOGY, V120, P1482, DOI 10.1016/j.ophtha.2012.12.018; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Gao Z, 2012, OPHTHAL EPIDEMIOL, V19, P16, DOI 10.3109/09286586.2011.632703; GARNER LF, 1985, ACTA OPHTHALMOL, V63, P323; Garner LF, 1999, OPTOMETRY VISION SCI, V76, P282, DOI 10.1097/00006324-199905000-00014; Guggenheim JA, 2015, MOL VIS, V21, P621; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Gwiazda J, 2014, INVEST OPHTH VIS SCI, V55, P752, DOI 10.1167/iovs.13-13029; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P1232; Harman N B, 1913, Proc R Soc Med, V6, P146; He MG, 2015, JAMA-J AM MED ASSOC, V314, P1142, DOI 10.1001/jama.2015.10803; Hemani G, 2016, BIORXIV; HIRSCH M J, 1959, Am J Optom Arch Am Acad Optom, V36, P12; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Holm E., 1925, ACTA OPHTHALMOL, V3, P121, DOI [10.1111/j.1755-3768.1925.tb03235.x, DOI 10.1111/J.1755-3768.1925.TB03235.X]; Hua WJ, 2015, OPHTHAL PHYSL OPT, V35, P252, DOI 10.1111/opo.12207; Jiang Y., 2014, IVPACK INSTRUMENTAL; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Jones-Jordan LA, 2012, INVEST OPHTH VIS SCI, V53, P7169, DOI 10.1167/iovs.11-8336; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; Lopes MC, 2009, INVEST OPHTH VIS SCI, V50, P126, DOI 10.1167/iovs.08-2385; Mitchell R, 2017, UK BIOBANK GENETIC D; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2018, PROG RETIN EYE RES, V62, P134, DOI 10.1016/j.preteyeres.2017.09.004; Morgan IG, 2017, RETINA-J RET VIT DIS, V37, P989, DOI 10.1097/IAE.0000000000001272; Morgan IG, 2013, OPHTHAL PHYSL OPT, V33, P329, DOI 10.1111/opo.12040; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Munafo M, 2018, JAMA CARDIOL, V3, P181, DOI 10.1001/jamacardio.2017.4279; Mutti DO, 2009, OPTOMETRY VISION SCI, V86, P76, DOI 10.1097/OPX.0b013e31819974ae; NAKAMURA A, 1985, J ECONOMETRICS, V29, P213, DOI 10.1016/0304-4076(85)90153-8; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Palmer TM, 2011, AM J EPIDEMIOL, V173, P1392, DOI 10.1093/aje/kwr026; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Rahi JS, 2011, OPHTHALMOLOGY, V118, P797, DOI 10.1016/j.ophtha.2010.09.025; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; ROSNER M, 1987, ARCH OPHTHALMOL-CHIC, V105, P1508; Sanfilippo PG, 2014, ACTA OPHTHALMOL, V92, pE458, DOI 10.1111/aos.12388; Saw SM, 2004, INVEST OPHTH VIS SCI, V45, P2943, DOI 10.1167/iovs.03-1296; Sham WK, 2010, EYE, V24, P875, DOI 10.1038/eye.2009.198; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; UK Biobank, 2015, GENOTYPE IMPUTATION; UNESCO Institute for Statistics, 2006, INT STAND CLASS ED I; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P427, DOI 10.1097/EDE.0000000000000081; Verhoeven VJM, 2015, OPHTHALMOLOGY, V122, P101, DOI 10.1016/j.ophtha.2014.07.030; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Victora CG, 2015, LANCET GLOB HEALTH, V3, pE199, DOI 10.1016/S2214-109X(15)70002-1; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; WALLMAN J, 1978, SCIENCE, V201, P1249, DOI 10.1126/science.694514; Weale RA, 2003, SURV OPHTHALMOL, V48, P515, DOI 10.1016/S0039-6257(03)00086-9; WHITE KR, 1982, PSYCHOL BULL, V91, P461, DOI 10.1037/0033-2909.91.3.461; Williams KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45977; Williams KM, 2017, JAMA OPHTHALMOL, V135, P47, DOI 10.1001/jamaophthalmol.2016.4752; Williams KM, 2015, EUR J EPIDEMIOL, V30, P305, DOI 10.1007/s10654-015-0010-0; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Zhou ZQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181772; ZYLBERMANN R, 1993, J PEDIATR OPHTHALMOL, V30, P319	80	113	117	1	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2018	361								k2022	10.1136/bmj.k2022	http://dx.doi.org/10.1136/bmj.k2022			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GJ2BX	29875094	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000435073600001
J	Salje, H; Cummings, DAT; Rodriguez-Barraquer, I; Katzelnick, LC; Lessler, J; Klungthong, C; Thaisomboonsuk, B; Nisalak, A; Weg, A; Ellison, D; Macareo, L; Yoon, IK; Jarman, R; Thomas, S; Rothman, AL; Endy, T; Cauchemez, S				Salje, Henrik; Cummings, Derek A. T.; Rodriguez-Barraquer, Isabel; Katzelnick, Leah C.; Lessler, Justin; Klungthong, Chonticha; Thaisomboonsuk, Butsaya; Nisalak, Ananda; Weg, Alden; Ellison, Damon; Macareo, Louis; Yoon, In-Kyu; Jarman, Richard; Thomas, Stephen; Rothman, Alan L.; Endy, Timothy; Cauchemez, Simon			Reconstruction of antibody dynamics and infection histories to evaluate dengue risk	NATURE			English	Article							PRIMARY-SCHOOL CHILDREN; DEPENDENT ENHANCEMENT; VIRUS SEROTYPES; KAMPHAENG PHET; LATIN-AMERICA; IMMUNITY; EPIDEMICS; VACCINE; TRANSMISSION; POPULATION	As with many pathogens, most dengue infections are subclinical and therefore unobserved(1). Coupled with limited understanding of the dynamic behaviour of potential serological markers of infection, this observational problem has wide-ranging implications, including hampering our understanding of individual-and population-level correlates of infection and disease risk and how these change over time, between assay interpretations and with cohort design. Here we develop a framework that simultaneously characterizes antibody dynamics and identifies subclinical infections via Bayesian augmentation from detailed cohort data (3,451 individuals with blood draws every 91 days, 143,548 haemagglutination inhibition assay titre measurements)(2,3). We identify 1,149 infections (95% confidence interval, 1,135-1,163) that were not detected by active surveillance and estimate that 65% of infections are subclinical. After infection, individuals develop a stable set point antibody load after one year that places them within or outside a risk window. Individuals with pre-existing titres of <= 1: 40 develop haemorrhagic fever 7.4 (95% confidence interval, 2.5-8.2) times more often than naive individuals compared to 0.0 times for individuals with titres > 1: 40 (95% confidence interval: 0.0-1.3). Plaque reduction neutralization test titres <= 1: 100 were similarly associated with severe disease. Across the population, variability in the size of epidemics results in large-scale temporal changes in infection and disease risk that correlate poorly with age.	[Salje, Henrik; Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France; [Salje, Henrik; Cauchemez, Simon] CNRS, Inst Pasteur, GEMS, UMR2000, Paris, France; [Salje, Henrik; Cauchemez, Simon] Inst Pasteur, Ctr Bioinformat Biostat & Integrat, Paris, France; [Salje, Henrik; Cummings, Derek A. T.; Lessler, Justin] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Cummings, Derek A. T.; Katzelnick, Leah C.] Univ Florida, Dept Biol, Gainesville, FL USA; [Cummings, Derek A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Rodriguez-Barraquer, Isabel] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Klungthong, Chonticha; Thaisomboonsuk, Butsaya; Nisalak, Ananda; Weg, Alden; Ellison, Damon; Macareo, Louis] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok, Thailand; [Yoon, In-Kyu] Int Vaccine Inst, Seoul, South Korea; [Jarman, Richard] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA; [Thomas, Stephen; Endy, Timothy] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Rothman, Alan L.] Univ Rhode Isl, Dept Cell & Mol Biol, Inst Immunol & Informat, 825 Chalkstone Ave, Providence, RI 02908 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California San Francisco; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); International Vaccine Institute; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Rhode Island	Salje, H (corresponding author), Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France.; Salje, H (corresponding author), CNRS, Inst Pasteur, GEMS, UMR2000, Paris, France.; Salje, H (corresponding author), Inst Pasteur, Ctr Bioinformat Biostat & Integrat, Paris, France.; Salje, H (corresponding author), Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	henrik.salje@pasteur.fr		Thomas, Stephen/0000-0002-8368-7682; Salje, Henrik/0000-0003-3626-4254; Rodriguez-Barraquer, Isabel/0000-0001-6784-1021	National Institutes of Health [R01AI114703-01, P01 AI0345333]; Investissement d'Avenir program; Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases program [ANR-10-LABX-62-IBEID]; Models of Infectious Disease Agent Study of the National Institute of General Medical Sciences; AXA Research Fund; Military Infectious Disease Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI034533, R01AI114703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investissement d'Avenir program(French National Research Agency (ANR)); Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases program; Models of Infectious Disease Agent Study of the National Institute of General Medical Sciences; AXA Research Fund(AXA Research Fund); Military Infectious Disease Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	H.S. and D.A.T.C. acknowledge funding form the National Institutes of Health (R01AI114703-01). S.C. acknowledges financial support from the Investissement d'Avenir program, the Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases program (grant ANR-10-LABX-62-IBEID), the Models of Infectious Disease Agent Study of the National Institute of General Medical Sciences, and the AXA Research Fund. The manuscript has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the author, and are not to be construed as official, or as reflecting the true views of the Department of the Army or the Department of Defence. C.K., B.T., A.N., A.W., D.E., I.-K.Y., L.M., R.J., S.T., A.M. and T.E. acknowledge funding from the National Institutes of Health (P01 AI0345333) and the Military Infectious Disease Research Program. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25.	Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Cauchemez S, 2012, J R SOC INTERFACE, V9, P456, DOI 10.1098/rsif.2011.0379; Clapham HE, 2016, J INFECT DIS, V213, P1428, DOI 10.1093/infdis/jiv759; Cobey S, 2012, SCIENCE, V335, P1376, DOI 10.1126/science.1215947; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590; Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181; Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; Halstead S. B, 2008, DENGUE; HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154; Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5; Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Lessler J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155249; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Moodie Z, 2018, J INFECT DIS, V217, P742, DOI 10.1093/infdis/jix609; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Rodriguez-Barraquer I, 2014, AM J EPIDEMIOL, V179, P353, DOI 10.1093/aje/kwt256; Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403; Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384; Salje H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002952; Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109; Smith T, 2003, STAT MED, V22, P1709, DOI 10.1002/sim.1274; Undurraga EA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002056; Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048; Venturi G, 2006, J VIROL METHODS, V134, P136, DOI 10.1016/j.jviromet.2005.12.010; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; White MT, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0117-2	37	124	125	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2018	557	7707					719	+		10.1038/s41586-018-0157-4	http://dx.doi.org/10.1038/s41586-018-0157-4			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH4WT	29795354	Green Accepted, Green Submitted			2022-12-28	WOS:000433412900053
J	Dyer, O				Dyer, Owen			Pfizer pays $24m to settle kickback claims over patient assistance charity	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2018	361								k2361	10.1136/bmj.k2361	http://dx.doi.org/10.1136/bmj.k2361			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3MF	29844104				2022-12-28	WOS:000434274800008
J	Slomski, A				Slomski, Anita			Carvedilol During Chemotherapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2069	2069		10.1001/jama.2018.6258	http://dx.doi.org/10.1001/jama.2018.6258			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800178				2022-12-28	WOS:000432679400010
J	Villani, J; Ngo-Metzger, Q; Vincent, IS; Klabunde, CN				Villani, Jennifer; Ngo-Metzger, Quyen; Vincent, Isaah S.; Klabunde, Carrie N.			Sources of Funding for Research in Evidence Reviews That Inform Recommendations of the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Villani, Jennifer; Vincent, Isaah S.; Klabunde, Carrie N.] NIH, Off Dis Prevent, 6100 Execut Blvd,Ste 2B03, Rockville, MD 20892 USA; [Ngo-Metzger, Quyen] Agcy Healthcare Res & Qual, Rockville, MD USA	National Institutes of Health (NIH) - USA; Agency for Healthcare Research & Quality	Villani, J (corresponding author), NIH, Off Dis Prevent, 6100 Execut Blvd,Ste 2B03, Rockville, MD 20892 USA.	villani@nih.gov			Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. The Agency for Healthcare Research and Quality (AHRQ) supports the US Preventive Services Task Force. No other disclosures were reported.	Kesselheim AS, 2012, NEW ENGL J MED, V367, P1119, DOI 10.1056/NEJMsa1202397; Krist AH, 2018, AM J PREV MED, V54, pS11, DOI 10.1016/j.amepre.2017.09.011	2	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2132	2133		10.1001/jama.2018.5404	http://dx.doi.org/10.1001/jama.2018.5404			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800165	Green Published, Bronze			2022-12-28	WOS:000432679400026
J	[Anonymous]				[Anonymous]			Surgeon General Urges Expanded Availability of Naloxone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2068	2068		10.1001/jama.2018.6254	http://dx.doi.org/10.1001/jama.2018.6254			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800161				2022-12-28	WOS:000432679400005
J	[Anonymous]				[Anonymous]			GAO Calls for Coordinated Efforts to Detect Arsenic in Rice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2068	2068		10.1001/jama.2018.6020	http://dx.doi.org/10.1001/jama.2018.6020			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29800159				2022-12-28	WOS:000432679400003
J	Aung, K				Aung, Koko			Guideline: TMP-SMX is recommended after uncomplicated skin abscess incision and drainage	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIBIOTICS		[Aung, Koko] Paul L Foster Sch Med, El Paso, TX 79905 USA		Aung, K (corresponding author), Paul L Foster Sch Med, El Paso, TX 79905 USA.		Aung, KoKo/I-1236-2019	Aung, KoKo/0000-0002-3152-0610				David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Esposito S, 2017, J CHEMOTHERAPY, V29, P197, DOI 10.1080/1120009X.2017.1311398; Fahimi J, 2015, CAN J EMERG MED, V17, P420, DOI 10.1017/cem.2014.52; Li SP, 2014, INDIAN J PATHOL MICR, V57, P418, DOI 10.4103/0377-4929.138737; Singer AJ, 2014, EMERG MED J, V31, P576, DOI 10.1136/emermed-2013-202571; Stevens DL, 2014, CLIN INFECT DIS, V59, P147, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296]; Vermandere M, AUTHORS RESPONSE ANT	7	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					JC50	JC50		10.7326/ACPJC-2018-168-10-050	http://dx.doi.org/10.7326/ACPJC-2018-168-10-050			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3DE	29800426				2022-12-28	WOS:000434250700002
J	Snyder, J; Turner, L; Crooks, VA				Snyder, Jeremy; Turner, Leigh; Crooks, Valorie A.			Crowdfunding for Unproven Stem Cell-Based Interventions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MEDICAL-CARE; INDUSTRY		[Snyder, Jeremy] Simon Fraser Univ, Fac Hlth Sci, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada; [Turner, Leigh] Univ Minnesota, Ctr Bioeth, Minneapolis, MN USA; [Crooks, Valorie A.] Simon Fraser Univ, Dept Geog, Burnaby, BC, Canada	Simon Fraser University; University of Minnesota System; University of Minnesota Twin Cities; Simon Fraser University	Snyder, J (corresponding author), Simon Fraser Univ, Fac Hlth Sci, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	jcs12@sfu.ca	Snyder, Jeremy/H-7227-2019	Turner, Leigh/0000-0001-7283-6809	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported through a Planning Grant from the Canadian Institutes of Health Research.	Lysaght T, 2017, J MED ETHICS, V43, P744, DOI 10.1136/medethics-2016-104046; Ogbogu U, 2013, REGEN MED, V8, P361, DOI [10.2217/rme.13.15, 10.2217/RME.13.15]; Sipp D, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0426; Snyder J, 2016, SOC SCI MED, V169, P27, DOI 10.1016/j.socscimed.2016.09.024; Turner L, 2016, CELL STEM CELL, V19, P154, DOI 10.1016/j.stem.2016.06.007; Young MJ, 2017, JAMA-J AM MED ASSOC, V317, P1623, DOI 10.1001/jama.2017.3078	6	37	38	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1935	1936		10.1001/jama.2018.3057	http://dx.doi.org/10.1001/jama.2018.3057			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29801003	Green Published, Bronze			2022-12-28	WOS:000431668600022
J	Terhune, WB				Terhune, William B.			The War Neuroses (Reprinted from JAMA, vol 70, pg 1369-1373, 1918)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1918, JAMA, V70, P1369	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1941	1941		10.1001/jama.2017.12369	http://dx.doi.org/10.1001/jama.2017.12369			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29801002				2022-12-28	WOS:000431668600031
J	Olson, CA; Vuong, HE; Yano, JM; Liang, QXY; Nusbaum, DJ; Hsiao, EY				Olson, Christine A.; Vuong, Helen E.; Yano, Jessica M.; Liang, Qingxing Y.; Nusbaum, David J.; Hsiao, Elaine Y.			The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet	CELL			English	Article							AKKERMANSIA-MUCINIPHILA; AMINO-ACIDS; METABOLISM; SPECTROSCOPY; DIVERSITY; INCREASES; GLUTAMATE; NUTRIENT; MODEL; GABA	The ketogenic diet (KD) is used to treat refractory epilepsy, but the mechanisms underlying its neuroprotective effects remain unclear. Here, we show that the gut microbiota is altered by the KD and required for protection against acute electrically induced seizures and spontaneous tonic-clonic seizures in two mousemodels. Mice treated with antibiotics or reared germ free are resistant to KD-mediated seizure protection. Enrichment of, and gnotobiotic co-colonization with, KD-associated Akkermansia and Parabacteroides restores seizure protection. Moreover, transplantation of the KD gut microbiota and treatment with Akkermansia and Parabacteroides each confer seizure protection to mice fed a control diet. Alterations in colonic lumenal, serum, and hippocampal metabolomic profiles correlate with seizure protection, including reductions in systemic gammaglutamylated amino acids and elevated hippocampal GABA/glutamate levels. Bacterial crossfeeding decreases gamma-glutamyltranspeptidase activity, and inhibiting gamma-glutamylation promotes seizure protection in vivo. Overall, this study reveals that the gut microbiota modulates host metabolism and seizure susceptibility in mice.	[Olson, Christine A.; Vuong, Helen E.; Yano, Jessica M.; Liang, Qingxing Y.; Nusbaum, David J.; Hsiao, Elaine Y.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Hsiao, EY (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	ehsiao@ucla.edu	Olson, Christine/ABB-8296-2021	Olson, Christine/0000-0002-5382-1393; Vuong, Helen/0000-0001-7837-8239; Nusbaum, David/0000-0001-6605-6187	UCLA Department of Integrative Biology & Physiology and Division of Life Sciences; Alfred P. Sloan Foundation Fellowship [FG-201606433]; Army Research Office Multidisciplinary University Research Initiative [W911NF-17-1-0402]; Mallinckrodt Foundation [20181433]; NIH Ruth L. Kirschstein Award [T32GM065823]; UPLIFT: UCLA Postdoctoral Longitudinal Investment in Faculty Award [K12GM106996]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065823, K12GM106996] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017924] Funding Source: NIH RePORTER	UCLA Department of Integrative Biology & Physiology and Division of Life Sciences; Alfred P. Sloan Foundation Fellowship(Alfred P. Sloan Foundation); Army Research Office Multidisciplinary University Research Initiative(MURI); Mallinckrodt Foundation; NIH Ruth L. Kirschstein Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UPLIFT: UCLA Postdoctoral Longitudinal Investment in Faculty Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge Julianne McGinn and Tomiko Rendon for generating and caring for the germ-free animals; Kristie Yu, Sandy Wong, and Gauri Shastri for assistance with initial experiments and data analysis; Thomas Fung, Geoffrey Pronovost, Gregory Donaldson, Xia Yang, Carlos Cepeda, and Kim McDowell for helpful advice; and Bruce Tempel and Marie Francoise-Chesselet for sharing mice and reagents. This work was supported by funds from UCLA Department of Integrative Biology & Physiology and Division of Life Sciences (to E.Y.H.), Alfred P. Sloan Foundation Fellowship (FG-201606433 to E.Y.H.), Army Research Office Multidisciplinary University Research Initiative (W911NF-17-1-0402 to E.Y.H.), Mallinckrodt Foundation (20181433 to E.Y.H.), NIH Ruth L. Kirschstein Award (T32GM065823 to C.A.O.), and UPLIFT: UCLA Postdoctoral Longitudinal Investment in Faculty Award (K12GM106996 to H.E.V.).	Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Beloosesky Y, 2000, AM J MED SCI, V319, P338, DOI 10.1097/00000441-200005000-00012; Bough KJ, 2007, EPILEPSIA, V48, P43, DOI 10.1111/j.1528-1167.2007.00915.x; Buffington SA, 2016, CELL, V165, P1762, DOI 10.1016/j.cell.2016.06.001; Calderon N, 2017, NEUROSCI LETT, V642, P158, DOI 10.1016/j.neulet.2017.02.014; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castellano I, 2012, CELL MOL LIFE SCI, V69, P3381, DOI 10.1007/s00018-012-0988-3; Cooper AJL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020016; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Dahlin M, 2005, EPILEPSY RES, V64, P115, DOI 10.1016/j.eplepsyres.2005.03.008; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Dutton SBB, 2011, EPILEPSIA, V52, P2050, DOI 10.1111/j.1528-1167.2011.03211.x; Erakovic V, 2001, EPILEPSIA, V42, P181, DOI 10.1046/j.1528-1157.2001.4220181.x; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; EWEN LM, 1973, AM J CLIN PATHOL, V59, P2; Fenoglio-Simeone KA, 2009, EPILEPSIA, V50, P2027, DOI 10.1111/j.1528-1167.2009.02163.x; Flynn JM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005846; Freeman John M, 2010, Adv Pediatr, V57, P315, DOI 10.1016/j.yapd.2010.08.003; Hartman AL, 2010, EPILEPSIA, V51, P1395, DOI 10.1111/j.1528-1167.2010.02577.x; Hornik CP, 2016, J PEDIATR-US, V178, P125, DOI 10.1016/j.jpeds.2016.07.011; Janik R, 2016, NEUROIMAGE, V125, P988, DOI 10.1016/j.neuroimage.2015.11.018; KIMBALL AW, 1957, RADIAT RES, V7, P1, DOI 10.2307/3570549; Klein MS, 2016, J PROTEOME RES, V15, P1143, DOI 10.1021/acs.jproteome.5b01025; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Newell C, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0099-3; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Remely M, 2015, WIEN KLIN WOCHENSCHR, V127, P394, DOI 10.1007/s00508-015-0755-1; Rogawski MA, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022780; Samala R, 2008, EPILEPSY RES, V81, P119, DOI 10.1016/j.eplepsyres.2008.05.001; Sariego-Jamardo A, 2015, PEDIATR NEUROL, V53, P422, DOI 10.1016/j.pediatrneurol.2015.07.013; Sato SM, 2016, ELIFE, V5, DOI [10.7554/eLife.12917, 10.7554/eLife.19109]; Simeone KA, 2016, EPILEPSIA, V57, pE178, DOI 10.1111/epi.13444; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Smith QR, 2000, J NUTR, V130, p1016S, DOI 10.1093/jn/130.4.1016S; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Stafstrom CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00059; Sutter R, 2015, NEUROLOGY, V85, P1332, DOI 10.1212/WNL.0000000000002023; van der Stel AX, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00567; Vuong HE, 2017, ANNU REV NEUROSCI, V40, P21, DOI 10.1146/annurev-neuro-072116-031347; Wang ZYJ, 2003, MAGNET RESON MED, V49, P615, DOI 10.1002/mrm.10429; Yudkoff M, 2001, J NEUROSCI RES, V66, P931, DOI 10.1002/jnr.10083; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	50	372	397	23	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 14	2018	173	7					1728	+	1741.e13	10.1016/j.cell.2018.04.027	http://dx.doi.org/10.1016/j.cell.2018.04.027			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GL3CC	30007420	Green Accepted, Bronze			2022-12-28	WOS:000437004000020
